Abacavir|N|abacavir|zidovudine|pharmacokinetic_LE1 property_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 alter_BE12 by_BE12 the_BE12 addition_BE12 of_BE12 either_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY or_RE2 the_RE2 combination_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Abacavir|N|abacavir|lamivudine|pharmacokinetic_LE1 property_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 alter_BE12 by_BE12 the_BE12 addition_BE12 of_BE12 either_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 or_RE2 the_RE2 combination_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Abacavir|N|abacavir|lamivudine|pharmacokinetic_LE1 property_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 alter_BE12 by_BE12 the_BE12 addition_BE12 of_BE12 either_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 or_BE12 the_BE12 combination_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Abacavir|N|abacavir|zidovudine|pharmacokinetic_LE1 property_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 alter_BE12 by_BE12 the_BE12 addition_BE12 of_BE12 either_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 or_BE12 the_BE12 combination_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Abacavir|N|lamivudine|zidovudine|pharmacokinetic_LE1 property_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 alter_LE1 by_LE1 the_LE1 addition_LE1 of_LE1 either_LE1 BIOENTITY or_BE12 BIOENTITY or_RE2 the_RE2 combination_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Abacavir|N|zidovudine|lamivudine|pharmacokinetic_LE1 property_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 alter_LE1 by_LE1 the_LE1 addition_LE1 of_LE1 either_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY or_BE12 the_BE12 combination_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Abacavir|N|zidovudine|zidovudine|pharmacokinetic_LE1 property_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 alter_LE1 by_LE1 the_LE1 addition_LE1 of_LE1 either_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY or_BE12 the_BE12 combination_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Abacavir|N|lamivudine|lamivudine|pharmacokinetic_LE1 property_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 alter_LE1 by_LE1 the_LE1 addition_LE1 of_LE1 either_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 or_BE12 the_BE12 combination_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Abacavir|N|lamivudine|zidovudine|pharmacokinetic_LE1 property_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 alter_LE1 by_LE1 the_LE1 addition_LE1 of_LE1 either_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 or_BE12 the_BE12 combination_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Abacavir|N|lamivudine|zidovudine|pharmacokinetic_LE1 property_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 alter_LE1 by_LE1 the_LE1 addition_LE1 of_LE1 either_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 or_LE1 the_LE1 combination_LE1 of_LE1 BIOENTITY and_BE12 BIOENTITY 
Abacavir|N|zidovudine|abacavir|no_LE1 clinical_LE1 significant_LE1 change_LE1 to_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY pharmacokinetic_BE12 be_BE12 observe_BE12 following_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOENTITY 
Abacavir|N|lamivudine|abacavir|no_LE1 clinical_LE1 significant_LE1 change_LE1 to_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 pharmacokinetic_BE12 be_BE12 observe_BE12 following_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOENTITY 
Abacavir|N|lamivudine|zidovudine|no_LE1 clinical_LE1 significant_LE1 change_LE1 to_LE1 BIOENTITY or_BE12 BIOENTITY pharmacokinetic_RE2 be_RE2 observe_RE2 following_RE2 concomitant_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 
Abacavir|N|abacavir|ethanol|BIOENTITY have_BE12 no_BE12 effect_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 property_BE12 of_BE12 BIOENTITY 
Abacavir|N|methadone|abacavir|BIOGENERAL_LE1 decrease_LE1 the_LE1 elimination_LE1 of_LE1 BIOGENERAL_LE1 cause_LE1 increase_LE1 in_LE1 overall_LE1 exposure_LE1 the_LE1 addition_LE1 of_LE1 BIOENTITY have_BE12 no_BE12 clinical_BE12 significant_BE12 effect_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 property_BE12 of_BE12 BIOENTITY 
Abacavir|N|abacavir|abacavir|BIOGENERAL_LE1 decrease_LE1 the_LE1 elimination_LE1 of_LE1 BIOENTITY cause_BE12 increase_BE12 in_BE12 overall_BE12 exposure_BE12 the_BE12 addition_BE12 of_BE12 BIOGENERAL_BE12 have_BE12 no_BE12 clinical_BE12 significant_BE12 effect_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 property_BE12 of_BE12 BIOENTITY 
Abacavir|N|ethanol|abacavir|BIOENTITY decrease_BE12 the_BE12 elimination_BE12 of_BE12 BIOGENERAL_BE12 cause_BE12 increase_BE12 in_BE12 overall_BE12 exposure_BE12 the_BE12 addition_BE12 of_BE12 BIOGENERAL_BE12 have_BE12 no_BE12 clinical_BE12 significant_BE12 effect_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 property_BE12 of_BE12 BIOENTITY 
Abacavir|N|abacavir|methadone|BIOGENERAL_LE1 decrease_LE1 the_LE1 elimination_LE1 of_LE1 BIOENTITY cause_BE12 increase_BE12 in_BE12 overall_BE12 exposure_BE12 the_BE12 addition_BE12 of_BE12 BIOENTITY have_RE2 no_RE2 clinical_RE2 significant_RE2 effect_RE2 on_RE2 the_RE2 pharmacokinetic_RE2 property_RE2 of_RE2 BIOGENERAL_RE2 
Abacavir|N|ethanol|methadone|BIOENTITY decrease_BE12 the_BE12 elimination_BE12 of_BE12 BIOGENERAL_BE12 cause_BE12 increase_BE12 in_BE12 overall_BE12 exposure_BE12 the_BE12 addition_BE12 of_BE12 BIOENTITY have_RE2 no_RE2 clinical_RE2 significant_RE2 effect_RE2 on_RE2 the_RE2 pharmacokinetic_RE2 property_RE2 of_RE2 BIOGENERAL_RE2 
Abacavir|N|ziagen|methadone|In_LE1 study_LE1 of_LE1 NUM_LE1 hivinfected_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 therapy_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 and_LE1 NUM_LE1 mg_LE1 daily_LE1 -RRB-_LE1 with_LE1 NUM_LE1 mg_LE1 of_LE1 BIOENTITY twice_BE12 daily_BE12 -LRB-_BE12 twice_BE12 the_BE12 current_BE12 recommend_BE12 dose_BE12 -RRB-_BE12 oral_BE12 BIOENTITY clearance_RE2 increase_RE2 NUM_RE2 -LRB-_RE2 NUM_RE2 ci_RE2 NUM_RE2 to_RE2 NUM_RE2 %rrb._RE2 
Abacavir|N|methadone|methadone|In_LE1 study_LE1 of_LE1 NUM_LE1 hivinfected_LE1 patient_LE1 receive_LE1 BIOENTITY therapy_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 and_BE12 NUM_BE12 mg_BE12 daily_BE12 -RRB-_BE12 with_BE12 NUM_BE12 mg_BE12 of_BE12 BIOGENERAL_BE12 twice_BE12 daily_BE12 -LRB-_BE12 twice_BE12 the_BE12 current_BE12 recommend_BE12 dose_BE12 -RRB-_BE12 oral_BE12 BIOENTITY clearance_RE2 increase_RE2 NUM_RE2 -LRB-_RE2 NUM_RE2 ci_RE2 NUM_RE2 to_RE2 NUM_RE2 %rrb._RE2 
Ezetimibe|N|cholestyramine|cholestyramine|BIOENTITY :_BE12 concomitant_BE12 BIOENTITY administration_RE2 decrease_RE2 the_RE2 mean_RE2 auc_RE2 of_RE2 total_RE2 BIOGENERAL_RE2 approximate_RE2 NUM_RE2 %._RE2 
Ezetimibe|N|cholestyramine|ezetimibe|BIOENTITY :_BE12 concomitant_BE12 BIOGENERAL_BE12 administration_BE12 decrease_BE12 the_BE12 mean_BE12 auc_BE12 of_BE12 total_BE12 BIOENTITY approximate_RE2 NUM_RE2 %._RE2 
Ezetimibe|N|fibrate|ezetimibe|BIOENTITY :_BE12 the_BE12 safety_BE12 and_BE12 effectiveness_BE12 of_BE12 BIOENTITY administer_RE2 with_RE2 BIOGENERAL_RE2 have_RE2 not_RE2 be_RE2 establish_RE2 
Ezetimibe|N|fibrate|fibrate|BIOENTITY :_BE12 the_BE12 safety_BE12 and_BE12 effectiveness_BE12 of_BE12 BIOGENERAL_BE12 administer_BE12 with_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 establish_RE2 
Ezetimibe|N|ezetimibe|fibrate|BIOGENERAL_LE1 :_LE1 the_LE1 safety_LE1 and_LE1 effectiveness_LE1 of_LE1 BIOENTITY administer_BE12 with_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 establish_RE2 
Ezetimibe|N|fenofibrate|fenofibrate|BIOENTITY :_BE12 In_BE12 pharmacokinetic_BE12 study_BE12 concomitant_BE12 BIOENTITY administration_RE2 increase_RE2 total_RE2 BIOGENERAL_RE2 concentration_RE2 approximate_RE2 .fold_RE2 
Ezetimibe|N|fenofibrate|ezetimibe|BIOENTITY :_BE12 In_BE12 pharmacokinetic_BE12 study_BE12 concomitant_BE12 BIOGENERAL_BE12 administration_BE12 increase_BE12 total_BE12 BIOENTITY concentration_RE2 approximate_RE2 .fold_RE2 
Ezetimibe|N|gemfibrozil|gemfibrozil|BIOENTITY :_BE12 In_BE12 pharmacokinetic_BE12 study_BE12 concomitant_BE12 BIOENTITY administration_RE2 increase_RE2 total_RE2 BIOGENERAL_RE2 concentration_RE2 approximate_RE2 .fold_RE2 
Ezetimibe|N|gemfibrozil|ezetimibe|BIOENTITY :_BE12 In_BE12 pharmacokinetic_BE12 study_BE12 concomitant_BE12 BIOGENERAL_BE12 administration_BE12 increase_BE12 total_BE12 BIOENTITY concentration_RE2 approximate_RE2 .fold_RE2 
Ezetimibe|N|gemfibrozil|ezetimibe|BIOGENERAL_LE1 :_LE1 In_LE1 pharmacokinetic_LE1 study_LE1 concomitant_LE1 BIOENTITY administration_BE12 increase_BE12 total_BE12 BIOENTITY concentration_RE2 approximate_RE2 .fold_RE2 
Ezetimibe|N|pravastatin|lovastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Ezetimibe|N|pravastatin|lovastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Ezetimibe|N|pravastatin|fluvastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Ezetimibe|N|pravastatin|fluvastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Ezetimibe|N|hmg-coa reductase inhibitor|pravastatin|BIOENTITY :_BE12 no_BE12 clinical_BE12 significant_BE12 pharmacokinetic_BE12 interaction_BE12 be_BE12 see_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Ezetimibe|N|ezetimibe|pravastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOENTITY be_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Ezetimibe|N|atorvastatin|pravastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Ezetimibe|N|simvastatin|pravastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Ezetimibe|N|lovastatin|fluvastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Ezetimibe|N|lovastatin|fluvastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Ezetimibe|N|hmg-coa reductase inhibitor|lovastatin|BIOENTITY :_BE12 no_BE12 clinical_BE12 significant_BE12 pharmacokinetic_BE12 interaction_BE12 be_BE12 see_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Ezetimibe|N|ezetimibe|lovastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOENTITY be_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Ezetimibe|N|atorvastatin|lovastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Ezetimibe|N|simvastatin|lovastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Ezetimibe|N|hmg-coa reductase inhibitor|fluvastatin|BIOENTITY :_BE12 no_BE12 clinical_BE12 significant_BE12 pharmacokinetic_BE12 interaction_BE12 be_BE12 see_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Ezetimibe|N|ezetimibe|fluvastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOENTITY be_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Ezetimibe|N|atorvastatin|fluvastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Ezetimibe|N|simvastatin|fluvastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Ezetimibe|N|hmg-coa reductase inhibitor|ezetimibe|BIOENTITY :_BE12 no_BE12 clinical_BE12 significant_BE12 pharmacokinetic_BE12 interaction_BE12 be_BE12 see_BE12 when_BE12 BIOENTITY be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Ezetimibe|N|hmg-coa reductase inhibitor|atorvastatin|BIOENTITY :_BE12 no_BE12 clinical_BE12 significant_BE12 pharmacokinetic_BE12 interaction_BE12 be_BE12 see_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 coadminister_BE12 with_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Ezetimibe|N|hmg-coa reductase inhibitor|simvastatin|BIOENTITY :_BE12 no_BE12 clinical_BE12 significant_BE12 pharmacokinetic_BE12 interaction_BE12 be_BE12 see_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Ezetimibe|N|ezetimibe|atorvastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOENTITY be_BE12 coadminister_BE12 with_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Ezetimibe|N|ezetimibe|simvastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOENTITY be_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Ezetimibe|N|atorvastatin|simvastatin|BIOGENERAL_LE1 :_LE1 no_LE1 clinical_LE1 significant_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 see_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Ezetimibe|N|cyclosporine|ezetimibe|BIOENTITY :_BE12 the_BE12 total_BE12 BIOENTITY level_RE2 increase_RE2 fold_RE2 in_RE2 one_RE2 renal_RE2 transplant_RE2 patient_RE2 receive_RE2 multiple_RE2 medication_RE2 including_RE2 BIOGENERAL_RE2 
Ezetimibe|N|cyclosporine|cyclosporine|BIOENTITY :_BE12 the_BE12 total_BE12 BIOGENERAL_BE12 level_BE12 increase_BE12 fold_BE12 in_BE12 one_BE12 renal_BE12 transplant_BE12 patient_BE12 receive_BE12 multiple_BE12 medication_BE12 including_BE12 BIOENTITY 
Ezetimibe|N|ezetimibe|ezetimibe|carcinogenesis_LE1 mutagenesis_LE1 impairment_LE1 of_LE1 fertility_LE1 week_LE1 dietary_LE1 carcinogenicity_LE1 study_LE1 with_LE1 BIOENTITY be_BE12 conduct_BE12 in_BE12 rat_BE12 at_BE12 dose_BE12 up_BE12 to_BE12 NUM_BE12 mg_BE12 -LRB-_BE12 male_BE12 -RRB-_BE12 and_BE12 NUM_BE12 mg_BE12 -LRB-_BE12 female_BE12 -RRB-_BE12 -LRB-_BE12 time_BE12 the_BE12 human_BE12 exposure_BE12 at_BE12 NUM_BE12 mg_BE12 daily_BE12 base_BE12 on_BE12 auchr_BE12 for_BE12 total_BE12 BIOENTITY rrb._RE2 
Ezetimibe|N|ezetimibe|ezetimibe|week_LE1 dietary_LE1 carcinogenicity_LE1 study_LE1 with_LE1 BIOENTITY be_BE12 also_BE12 conduct_BE12 in_BE12 mouse_BE12 at_BE12 dose_BE12 up_BE12 to_BE12 NUM_BE12 mg_BE12 -LRB-_BE12 time_BE12 the_BE12 human_BE12 exposure_BE12 at_BE12 NUM_BE12 mg_BE12 daily_BE12 base_BE12 on_BE12 auchr_BE12 for_BE12 total_BE12 BIOENTITY rrb._RE2 
Ezetimibe|N|ezetimibe|ezetimibe|In_LE1 oral_LE1 -LRB-_LE1 gavage_LE1 -RRB-_LE1 fertility_LE1 study_LE1 of_LE1 BIOENTITY conduct_BE12 in_BE12 rat_BE12 there_BE12 be_BE12 no_BE12 evidence_BE12 of_BE12 reproductive_BE12 toxicity_BE12 at_BE12 dose_BE12 up_BE12 to_BE12 NUM_BE12 mg_BE12 in_BE12 male_BE12 or_BE12 female_BE12 rat_BE12 -LRB-_BE12 time_BE12 the_BE12 human_BE12 exposure_BE12 at_BE12 NUM_BE12 mg_BE12 daily_BE12 base_BE12 on_BE12 auchr_BE12 for_BE12 total_BE12 BIOENTITY rrb._RE2 
Ezetimibe|N|ezetimibe|ezetimibe|In_LE1 rabbit_LE1 treat_LE1 with_LE1 BIOENTITY increase_BE12 incidence_BE12 of_BE12 extra_BE12 thoracic_BE12 rib_BE12 be_BE12 observe_BE12 at_BE12 NUM_BE12 mg_BE12 -LRB-_BE12 NUM_BE12 time_BE12 the_BE12 human_BE12 exposure_BE12 at_BE12 NUM_BE12 mg_BE12 daily_BE12 base_BE12 on_BE12 auchr_BE12 for_BE12 total_BE12 BIOENTITY rrb._RE2 
Ezetimibe|N|ezetimibe|hmg-coa reductase inhibitor|multiple_LE1 dose_LE1 study_LE1 of_LE1 BIOENTITY give_BE12 in_BE12 combination_BE12 with_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 rat_RE2 and_RE2 rabbit_RE2 during_RE2 organogenesis_RE2 result_RE2 in_RE2 high_RE2 BIOGENERAL_RE2 and_RE2 statin_RE2 exposure_RE2 
Ezetimibe|N|ezetimibe|statin|multiple_LE1 dose_LE1 study_LE1 of_LE1 BIOENTITY give_BE12 in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 in_RE2 rat_RE2 and_RE2 rabbit_RE2 during_RE2 organogenesis_RE2 result_RE2 in_RE2 high_RE2 BIOGENERAL_RE2 and_RE2 statin_RE2 exposure_RE2 
Ezetimibe|N|ezetimibe|ezetimibe|multiple_LE1 dose_LE1 study_LE1 of_LE1 BIOENTITY give_BE12 in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 in_BE12 rat_BE12 and_BE12 rabbit_BE12 during_BE12 organogenesis_BE12 result_BE12 in_BE12 high_BE12 BIOENTITY and_RE2 statin_RE2 exposure_RE2 
Ezetimibe|N|hmg-coa reductase inhibitor|statin|multiple_LE1 dose_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 give_LE1 in_LE1 combination_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 in_RE2 rat_RE2 and_RE2 rabbit_RE2 during_RE2 organogenesis_RE2 result_RE2 in_RE2 high_RE2 BIOGENERAL_RE2 and_RE2 statin_RE2 exposure_RE2 
Ezetimibe|N|hmg-coa reductase inhibitor|ezetimibe|multiple_LE1 dose_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 give_LE1 in_LE1 combination_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 in_BE12 rat_BE12 and_BE12 rabbit_BE12 during_BE12 organogenesis_BE12 result_BE12 in_BE12 high_BE12 BIOENTITY and_RE2 statin_RE2 exposure_RE2 
Ezetimibe|N|statin|ezetimibe|multiple_LE1 dose_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 give_LE1 in_LE1 combination_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 in_BE12 rat_BE12 and_BE12 rabbit_BE12 during_BE12 organogenesis_BE12 result_BE12 in_BE12 high_BE12 BIOENTITY and_RE2 statin_RE2 exposure_RE2 
Ezetimibe|N|hmg-coa reductase inhibitor|hmg-coa reductase inhibitor|when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 with_LE1 BIOENTITY in_BE12 woman_BE12 of_BE12 childbearing_BE12 potential_BE12 refer_BE12 to_BE12 the_BE12 pregnancy_BE12 category_BE12 and_BE12 package_BE12 labeling_BE12 for_BE12 the_BE12 BIOENTITY 
Ezetimibe|N|zetia|hmg-coa reductase inhibitor|when_LE1 BIOENTITY be_BE12 administer_BE12 with_BE12 BIOENTITY in_RE2 woman_RE2 of_RE2 childbearing_RE2 potential_RE2 refer_RE2 to_RE2 the_RE2 pregnancy_RE2 category_RE2 and_RE2 package_RE2 labeling_RE2 for_RE2 the_RE2 BIOGENERAL_RE2 
Ezetimibe|N|zetia|hmg-coa reductase inhibitor|when_LE1 BIOENTITY be_BE12 administer_BE12 with_BE12 BIOGENERAL_BE12 in_BE12 woman_BE12 of_BE12 childbearing_BE12 potential_BE12 refer_BE12 to_BE12 the_BE12 pregnancy_BE12 category_BE12 and_BE12 package_BE12 labeling_BE12 for_BE12 the_BE12 BIOENTITY 
Fluconazole|N|short-acting benzodiazepine|hypoglycemic|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOENTITY :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|short-acting benzodiazepine|diflucan|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOENTITY with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|short-acting benzodiazepine|hypoglycemic agent|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 oral_BE12 BIOENTITY 
Fluconazole|N|tacrolimu|short-acting benzodiazepine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|phenytoin|short-acting benzodiazepine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|cyclosporine|short-acting benzodiazepine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|hypoglycemic|short-acting benzodiazepine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|coumarin-type anticoagulant|short-acting benzodiazepine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|cisapride|short-acting benzodiazepine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|terfenadine|short-acting benzodiazepine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|theophylline|short-acting benzodiazepine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|rifampin|short-acting benzodiazepine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|rifabutin|short-acting benzodiazepine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|astemizole|short-acting benzodiazepine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|hypoglycemic|diflucan|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOENTITY with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|hypoglycemic|hypoglycemic agent|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 oral_BE12 BIOENTITY 
Fluconazole|N|tacrolimu|hypoglycemic|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOENTITY :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|phenytoin|hypoglycemic|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|cyclosporine|hypoglycemic|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|hypoglycemic|hypoglycemic|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|coumarin-type anticoagulant|hypoglycemic|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|cisapride|hypoglycemic|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|terfenadine|hypoglycemic|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|theophylline|hypoglycemic|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|rifampin|hypoglycemic|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|rifabutin|hypoglycemic|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|astemizole|hypoglycemic|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|tacrolimu|diflucan|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOENTITY with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|phenytoin|diflucan|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOENTITY with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|cyclosporine|diflucan|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOENTITY with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|hypoglycemic|diflucan|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOENTITY with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|coumarin-type anticoagulant|diflucan|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOENTITY with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|cisapride|diflucan|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOENTITY with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|terfenadine|diflucan|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOENTITY with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|theophylline|diflucan|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOENTITY with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|rifampin|diflucan|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOENTITY with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|rifabutin|diflucan|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOENTITY with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|astemizole|diflucan|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOENTITY with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|tacrolimu|hypoglycemic agent|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 oral_BE12 BIOENTITY 
Fluconazole|N|phenytoin|hypoglycemic agent|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 oral_BE12 BIOENTITY 
Fluconazole|N|cyclosporine|hypoglycemic agent|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 oral_BE12 BIOENTITY 
Fluconazole|N|hypoglycemic|hypoglycemic agent|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 oral_BE12 BIOENTITY 
Fluconazole|N|coumarin-type anticoagulant|hypoglycemic agent|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 oral_BE12 BIOENTITY 
Fluconazole|N|cisapride|hypoglycemic agent|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 oral_BE12 BIOENTITY 
Fluconazole|N|terfenadine|hypoglycemic agent|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 oral_BE12 BIOENTITY 
Fluconazole|N|theophylline|hypoglycemic agent|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 oral_BE12 BIOENTITY 
Fluconazole|N|rifampin|hypoglycemic agent|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 oral_BE12 BIOENTITY 
Fluconazole|N|rifabutin|hypoglycemic agent|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 oral_BE12 BIOENTITY 
Fluconazole|N|astemizole|hypoglycemic agent|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 :_BE12 clinical_BE12 significant_BE12 hypoglycemia_BE12 may_BE12 be_BE12 precipitated_BE12 by_BE12 the_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 oral_BE12 BIOENTITY 
Fluconazole|N|phenytoin|tacrolimu|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|cyclosporine|tacrolimu|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|hypoglycemic|tacrolimu|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|coumarin-type anticoagulant|tacrolimu|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|cisapride|tacrolimu|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|terfenadine|tacrolimu|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|theophylline|tacrolimu|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|rifampin|tacrolimu|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|rifabutin|tacrolimu|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|astemizole|tacrolimu|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|phenytoin|cyclosporine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|hypoglycemic|phenytoin|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|coumarin-type anticoagulant|phenytoin|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|phenytoin|cisapride|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|phenytoin|terfenadine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|phenytoin|theophylline|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|phenytoin|rifampin|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|phenytoin|rifabutin|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|phenytoin|astemizole|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|hypoglycemic|cyclosporine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|coumarin-type anticoagulant|cyclosporine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|cyclosporine|cisapride|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|cyclosporine|terfenadine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|cyclosporine|theophylline|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|cyclosporine|rifampin|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|cyclosporine|rifabutin|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|cyclosporine|astemizole|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|hypoglycemic|coumarin-type anticoagulant|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|hypoglycemic|cisapride|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|hypoglycemic|terfenadine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|hypoglycemic|theophylline|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|hypoglycemic|rifampin|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|hypoglycemic|rifabutin|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|hypoglycemic|astemizole|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|coumarin-type anticoagulant|cisapride|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|coumarin-type anticoagulant|terfenadine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|coumarin-type anticoagulant|theophylline|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|coumarin-type anticoagulant|rifampin|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|coumarin-type anticoagulant|rifabutin|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|coumarin-type anticoagulant|astemizole|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|terfenadine|cisapride|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|theophylline|cisapride|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|rifampin|cisapride|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|cisapride|rifabutin|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|cisapride|astemizole|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|theophylline|terfenadine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|rifampin|terfenadine|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|terfenadine|rifabutin|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|terfenadine|astemizole|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|rifampin|theophylline|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|theophylline|rifabutin|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|theophylline|astemizole|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|rifampin|rifabutin|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|rifampin|astemizole|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|astemizole|rifabutin|these_LE1 be_LE1 describe_LE1 in_LE1 great_LE1 detail_LE1 below_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 :_RE2 clinical_RE2 significant_RE2 hypoglycemia_RE2 may_RE2 be_RE2 precipitated_RE2 by_RE2 the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 oral_RE2 BIOGENERAL_RE2 
Fluconazole|N|tolbutamide|glipizide|BIOGENERAL_LE1 reduce_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY and_RE2 increase_RE2 the_RE2 plasma_RE2 concentration_RE2 of_RE2 these_RE2 agent_RE2 
Fluconazole|N|tolbutamide|glyburide|BIOGENERAL_LE1 reduce_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 and_RE2 increase_RE2 the_RE2 plasma_RE2 concentration_RE2 of_RE2 these_RE2 agent_RE2 
Fluconazole|N|glyburide|glipizide|BIOGENERAL_LE1 reduce_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY and_RE2 increase_RE2 the_RE2 plasma_RE2 concentration_RE2 of_RE2 these_RE2 agent_RE2 
Fluconazole|N|glyburide|glipizide|BIOGENERAL_LE1 reduce_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY and_RE2 increase_RE2 the_RE2 plasma_RE2 concentration_RE2 of_RE2 these_RE2 agent_RE2 
Fluconazole|N|diflucan|sulfonylurea|when_LE1 BIOENTITY be_BE12 use_BE12 concomitant_BE12 with_BE12 these_BE12 or_BE12 other_BE12 BIOGENERAL_BE12 blood_BE12 glucose_BE12 concentration_BE12 shall_BE12 be_BE12 careful_BE12 monitor_BE12 and_BE12 the_BE12 dose_BE12 of_BE12 the_BE12 BIOENTITY shall_RE2 be_RE2 adjust_RE2 as_RE2 necessary_RE2 
Fluconazole|N|sulfonylurea oral hypoglycemic agent|sulfonylurea|when_LE1 BIOGENERAL_LE1 be_LE1 use_LE1 concomitant_LE1 with_LE1 these_LE1 or_LE1 other_LE1 BIOENTITY blood_BE12 glucose_BE12 concentration_BE12 shall_BE12 be_BE12 careful_BE12 monitor_BE12 and_BE12 the_BE12 dose_BE12 of_BE12 the_BE12 BIOENTITY shall_RE2 be_RE2 adjust_RE2 as_RE2 necessary_RE2 
Fluconazole|N|coumarin-type anticoagulant|diflucan|BIOENTITY :_BE12 prothrombin_BE12 time_BE12 may_BE12 be_BE12 increase_BE12 in_BE12 patient_BE12 receive_BE12 concomitant_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Fluconazole|N|coumarin-type anticoagulant|coumarin-type anticoagulant|BIOENTITY :_BE12 prothrombin_BE12 time_BE12 may_BE12 be_BE12 increase_BE12 in_BE12 patient_BE12 receive_BE12 concomitant_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Fluconazole|N|azole antifungal|warfarin|In_LE1 postmarketing_LE1 experience_LE1 as_LE1 with_LE1 other_LE1 BIOENTITY bleeding_BE12 event_BE12 -LRB-_BE12 bruising_BE12 epistaxis_BE12 gastrointestinal_BE12 bleeding_BE12 hematuria_BE12 and_BE12 melena_BE12 -RRB-_BE12 have_BE12 be_BE12 report_BE12 in_BE12 association_BE12 with_BE12 increase_BE12 in_BE12 prothrombin_BE12 time_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 concurrent_BE12 with_BE12 BIOENTITY 
Fluconazole|N|azole antifungal|fluconazole|In_LE1 postmarketing_LE1 experience_LE1 as_LE1 with_LE1 other_LE1 BIOENTITY bleeding_BE12 event_BE12 -LRB-_BE12 bruising_BE12 epistaxis_BE12 gastrointestinal_BE12 bleeding_BE12 hematuria_BE12 and_BE12 melena_BE12 -RRB-_BE12 have_BE12 be_BE12 report_BE12 in_BE12 association_BE12 with_BE12 increase_BE12 in_BE12 prothrombin_BE12 time_BE12 in_BE12 patient_BE12 receive_BE12 BIOENTITY concurrent_RE2 with_RE2 BIOGENERAL_RE2 
Fluconazole|N|phenytoin|phenytoin|BIOENTITY :_BE12 BIOGENERAL_BE12 increase_BE12 the_BE12 plasma_BE12 concentration_BE12 of_BE12 BIOENTITY 
Fluconazole|N|phenytoin|diflucan|BIOENTITY :_BE12 BIOENTITY increase_RE2 the_RE2 plasma_RE2 concentration_RE2 of_RE2 BIOGENERAL_RE2 
Fluconazole|N|phenytoin|phenytoin|careful_LE1 monitoring_LE1 of_LE1 BIOENTITY concentration_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 recommend_RE2 
Fluconazole|N|phenytoin|diflucan|careful_LE1 monitoring_LE1 of_LE1 BIOENTITY concentration_BE12 in_BE12 patient_BE12 receive_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 recommend_RE2 
Fluconazole|N|cyclosporine|diflucan|BIOENTITY :_BE12 BIOENTITY may_RE2 significant_RE2 increase_RE2 BIOGENERAL_RE2 level_RE2 in_RE2 renal_RE2 transplant_RE2 patient_RE2 with_RE2 or_RE2 without_RE2 renal_RE2 impairment_RE2 
Fluconazole|N|cyclosporine|cyclosporine|BIOENTITY :_BE12 BIOGENERAL_BE12 may_BE12 significant_BE12 increase_BE12 BIOENTITY level_RE2 in_RE2 renal_RE2 transplant_RE2 patient_RE2 with_RE2 or_RE2 without_RE2 renal_RE2 impairment_RE2 
Fluconazole|N|cyclosporine|diflucan|careful_LE1 monitoring_LE1 of_LE1 BIOENTITY concentration_BE12 and_BE12 serum_BE12 creatinine_BE12 be_BE12 recommend_BE12 in_BE12 patient_BE12 receive_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Fluconazole|N|cyclosporine|cyclosporine|careful_LE1 monitoring_LE1 of_LE1 BIOENTITY concentration_BE12 and_BE12 serum_BE12 creatinine_BE12 be_BE12 recommend_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Fluconazole|N|rifampin|rifampin|BIOENTITY :_BE12 BIOENTITY enhance_RE2 the_RE2 metabolism_RE2 of_RE2 concurrent_RE2 administer_RE2 BIOGENERAL_RE2 
Fluconazole|N|rifampin|diflucan|BIOENTITY :_BE12 BIOGENERAL_BE12 enhance_BE12 the_BE12 metabolism_BE12 of_BE12 concurrent_BE12 administer_BE12 BIOENTITY 
Fluconazole|N|theophylline|theophylline|BIOENTITY :_BE12 BIOGENERAL_BE12 increase_BE12 the_BE12 serum_BE12 concentration_BE12 of_BE12 BIOENTITY 
Fluconazole|N|theophylline|diflucan|BIOENTITY :_BE12 BIOENTITY increase_RE2 the_RE2 serum_RE2 concentration_RE2 of_RE2 BIOGENERAL_RE2 
Fluconazole|N|theophylline|diflucan|careful_LE1 monitoring_LE1 of_LE1 serum_LE1 BIOENTITY concentration_BE12 in_BE12 patient_BE12 receive_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 recommend_RE2 
Fluconazole|N|theophylline|theophylline|careful_LE1 monitoring_LE1 of_LE1 serum_LE1 BIOENTITY concentration_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 recommend_RE2 
Fluconazole|N|terfenadine|terfenadine|BIOENTITY :_BE12 because_BE12 of_BE12 the_BE12 occurrence_BE12 of_BE12 serious_BE12 cardiac_BE12 dysrhythmia_BE12 secondary_BE12 to_BE12 prolongation_BE12 of_BE12 the_BE12 qtc_BE12 interval_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 in_BE12 conjunction_BE12 with_BE12 BIOENTITY interaction_RE2 study_RE2 have_RE2 be_RE2 perform_RE2 
Fluconazole|N|terfenadine|azole antifungal|BIOENTITY :_BE12 because_BE12 of_BE12 the_BE12 occurrence_BE12 of_BE12 serious_BE12 cardiac_BE12 dysrhythmia_BE12 secondary_BE12 to_BE12 prolongation_BE12 of_BE12 the_BE12 qtc_BE12 interval_BE12 in_BE12 patient_BE12 receive_BE12 BIOENTITY in_RE2 conjunction_RE2 with_RE2 BIOGENERAL_RE2 interaction_RE2 study_RE2 have_RE2 be_RE2 perform_RE2 
Fluconazole|N|fluconazole|terfenadine|another_LE1 study_LE1 at_LE1 mg_LE1 and_LE1 mg_LE1 daily_LE1 dose_LE1 of_LE1 BIOENTITY demonstrate_BE12 that_BE12 BIOGENERAL_BE12 take_BE12 in_BE12 dose_BE12 of_BE12 NUM_BE12 mg_BE12 per_BE12 day_BE12 or_BE12 great_BE12 significant_BE12 increase_BE12 plasma_BE12 level_BE12 of_BE12 BIOENTITY when_RE2 take_RE2 concomitant_RE2 
Fluconazole|N|fluconazole|diflucan|another_LE1 study_LE1 at_LE1 mg_LE1 and_LE1 mg_LE1 daily_LE1 dose_LE1 of_LE1 BIOENTITY demonstrate_BE12 that_BE12 BIOENTITY take_RE2 in_RE2 dose_RE2 of_RE2 NUM_RE2 mg_RE2 per_RE2 day_RE2 or_RE2 great_RE2 significant_RE2 increase_RE2 plasma_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 when_RE2 take_RE2 concomitant_RE2 
Fluconazole|N|cisapride|cisapride|BIOENTITY :_BE12 there_BE12 have_BE12 be_BE12 report_BE12 of_BE12 cardiac_BE12 event_BE12 including_BE12 torsade_BE12 de_BE12 pointe_BE12 in_BE12 patient_BE12 to_BE12 who_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 coadminister_RE2 
Fluconazole|N|cisapride|fluconazole|BIOENTITY :_BE12 there_BE12 have_BE12 be_BE12 report_BE12 of_BE12 cardiac_BE12 event_BE12 including_BE12 torsade_BE12 de_BE12 pointe_BE12 in_BE12 patient_BE12 to_BE12 who_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 coadminister_RE2 
Fluconazole|N|fluconazole|cisapride|controlled_LE1 study_LE1 find_LE1 that_LE1 concomitant_LE1 BIOENTITY NUM_BE12 mg_BE12 once_BE12 daily_BE12 and_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 four_BE12 time_BE12 day_BE12 yield_BE12 significant_BE12 increase_BE12 in_BE12 BIOENTITY plasma_RE2 level_RE2 and_RE2 prolongation_RE2 of_RE2 qtc_RE2 interval_RE2 
Fluconazole|N|cisapride|cisapride|controlled_LE1 study_LE1 find_LE1 that_LE1 concomitant_LE1 BIOGENERAL_LE1 NUM_LE1 mg_LE1 once_LE1 daily_LE1 and_LE1 BIOENTITY NUM_BE12 mg_BE12 four_BE12 time_BE12 day_BE12 yield_BE12 significant_BE12 increase_BE12 in_BE12 BIOENTITY plasma_RE2 level_RE2 and_RE2 prolongation_RE2 of_RE2 qtc_RE2 interval_RE2 
Fluconazole|N|astemizole|fluconazole|BIOENTITY :_BE12 the_BE12 use_BE12 of_BE12 BIOENTITY in_RE2 patient_RE2 concurrent_RE2 take_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 drug_RE2 metabolize_RE2 by_RE2 the_RE2 cytochrome_RE2 system_RE2 may_RE2 be_RE2 associate_RE2 with_RE2 elevation_RE2 in_RE2 serum_RE2 level_RE2 of_RE2 these_RE2 drug_RE2 
Fluconazole|N|astemizole|astemizole|BIOENTITY :_BE12 the_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 in_BE12 patient_BE12 concurrent_BE12 take_BE12 BIOENTITY or_RE2 other_RE2 drug_RE2 metabolize_RE2 by_RE2 the_RE2 cytochrome_RE2 system_RE2 may_RE2 be_RE2 associate_RE2 with_RE2 elevation_RE2 in_RE2 serum_RE2 level_RE2 of_RE2 these_RE2 drug_RE2 
Fluconazole|N|rifabutin|rifabutin|BIOENTITY :_BE12 there_BE12 have_BE12 be_BE12 report_BE12 of_BE12 uveitis_BE12 in_BE12 patient_BE12 to_BE12 who_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 coadminister_RE2 
Fluconazole|N|rifabutin|fluconazole|BIOENTITY :_BE12 there_BE12 have_BE12 be_BE12 report_BE12 of_BE12 uveitis_BE12 in_BE12 patient_BE12 to_BE12 who_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 coadminister_RE2 
Fluconazole|N|tacrolimu|fluconazole|BIOENTITY :_BE12 there_BE12 have_BE12 be_BE12 report_BE12 of_BE12 nephrotoxicity_BE12 in_BE12 patient_BE12 to_BE12 who_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 coadminister_RE2 
Fluconazole|N|tacrolimu|tacrolimu|BIOENTITY :_BE12 there_BE12 have_BE12 be_BE12 report_BE12 of_BE12 nephrotoxicity_BE12 in_BE12 patient_BE12 to_BE12 who_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 coadminister_RE2 
Fluconazole|N|short-acting benzodiazepine|midazolam|BIOENTITY :_BE12 Following_BE12 oral_BE12 administration_BE12 of_BE12 BIOENTITY BIOGENERAL_RE2 result_RE2 in_RE2 substantial_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 concentration_RE2 and_RE2 psychomotor_RE2 effect_RE2 
Fluconazole|N|midazolam|midazolam|BIOGENERAL_LE1 :_LE1 Following_LE1 oral_LE1 administration_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 result_BE12 in_BE12 substantial_BE12 increase_BE12 in_BE12 BIOENTITY concentration_RE2 and_RE2 psychomotor_RE2 effect_RE2 
Fluconazole|N|short-acting benzodiazepine|midazolam|BIOENTITY :_BE12 Following_BE12 oral_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 result_BE12 in_BE12 substantial_BE12 increase_BE12 in_BE12 BIOENTITY concentration_RE2 and_RE2 psychomotor_RE2 effect_RE2 
Fluconazole|N|short-acting benzodiazepine|fluconazole|BIOENTITY :_BE12 Following_BE12 oral_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 BIOENTITY result_RE2 in_RE2 substantial_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 concentration_RE2 and_RE2 psychomotor_RE2 effect_RE2 
Fluconazole|N|fluconazole|midazolam|BIOGENERAL_LE1 :_LE1 Following_LE1 oral_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY result_BE12 in_BE12 substantial_BE12 increase_BE12 in_BE12 BIOENTITY concentration_RE2 and_RE2 psychomotor_RE2 effect_RE2 
Fluconazole|N|midazolam|fluconazole|this_LE1 effect_LE1 on_LE1 BIOENTITY appear_BE12 to_BE12 be_BE12 much_BE12 pronounced_BE12 follow_BE12 oral_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 than_BE12 with_BE12 BIOENTITY administer_RE2 intravenous_RE2 
Fluconazole|N|fluconazole|fluconazole|this_LE1 effect_LE1 on_LE1 BIOGENERAL_LE1 appear_LE1 to_LE1 be_LE1 much_LE1 pronounced_LE1 follow_LE1 oral_LE1 administration_LE1 of_LE1 BIOENTITY than_BE12 with_BE12 BIOENTITY administer_RE2 intravenous_RE2 
Fluconazole|N|short-acting benzodiazepine|benzodiazepine|if_LE1 BIOENTITY which_BE12 be_BE12 metabolize_BE12 by_BE12 the_BE12 cytochrome_BE12 system_BE12 be_BE12 concomitant_BE12 administer_BE12 with_BE12 BIOGENERAL_BE12 consideration_BE12 shall_BE12 be_BE12 give_BE12 to_BE12 decrease_BE12 the_BE12 BIOENTITY dosage_RE2 and_RE2 the_RE2 patient_RE2 shall_RE2 be_RE2 appropriate_RE2 monitor_RE2 
Fluconazole|N|fluconazole|benzodiazepine|if_LE1 BIOGENERAL_LE1 which_LE1 be_LE1 metabolize_LE1 by_LE1 the_LE1 cytochrome_LE1 system_LE1 be_LE1 concomitant_LE1 administer_LE1 with_LE1 BIOENTITY consideration_BE12 shall_BE12 be_BE12 give_BE12 to_BE12 decrease_BE12 the_BE12 BIOENTITY dosage_RE2 and_RE2 the_RE2 patient_RE2 shall_RE2 be_RE2 appropriate_RE2 monitor_RE2 
Fluconazole|N|ethinyl estradiol|levonorgestrel|BIOGENERAL_LE1 tablet_LE1 coadminister_LE1 with_LE1 BIOENTITY and_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 produce_RE2 overall_RE2 mean_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 level_RE2 
Fluconazole|N|ethinyl estradiol|contraceptive|BIOGENERAL_LE1 tablet_LE1 coadminister_LE1 with_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY produce_RE2 overall_RE2 mean_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 level_RE2 
Fluconazole|N|ethinyl estradiol|ethinyl estradiol|BIOGENERAL_LE1 tablet_LE1 coadminister_LE1 with_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 produce_BE12 overall_BE12 mean_BE12 increase_BE12 in_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 level_RE2 
Fluconazole|N|ethinyl estradiol|levonorgestrel|BIOGENERAL_LE1 tablet_LE1 coadminister_LE1 with_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 produce_BE12 overall_BE12 mean_BE12 increase_BE12 in_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY level_RE2 
Fluconazole|N|levonorgestrel|contraceptive|BIOGENERAL_LE1 tablet_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY oral_BE12 BIOENTITY produce_RE2 overall_RE2 mean_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 level_RE2 
Fluconazole|N|levonorgestrel|ethinyl estradiol|BIOGENERAL_LE1 tablet_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 produce_BE12 overall_BE12 mean_BE12 increase_BE12 in_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 level_RE2 
Fluconazole|N|levonorgestrel|levonorgestrel|BIOGENERAL_LE1 tablet_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 produce_BE12 overall_BE12 mean_BE12 increase_BE12 in_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY level_RE2 
Fluconazole|N|contraceptive|ethinyl estradiol|BIOGENERAL_LE1 tablet_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY produce_BE12 overall_BE12 mean_BE12 increase_BE12 in_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 level_RE2 
Fluconazole|N|contraceptive|levonorgestrel|BIOGENERAL_LE1 tablet_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY produce_BE12 overall_BE12 mean_BE12 increase_BE12 in_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY level_RE2 
Fluconazole|N|fluconazole|contraceptive|BIOENTITY tablet_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY produce_RE2 overall_RE2 mean_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 level_RE2 
Fluconazole|N|ethinyl estradiol|levonorgestrel|BIOGENERAL_LE1 tablet_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 produce_LE1 overall_LE1 mean_LE1 increase_LE1 in_LE1 BIOENTITY and_BE12 BIOENTITY level_RE2 
Fluconazole|N|fluconazole|ethinyl estradiol|BIOENTITY tablet_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 produce_BE12 overall_BE12 mean_BE12 increase_BE12 in_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 level_RE2 
Fluconazole|N|fluconazole|levonorgestrel|BIOENTITY tablet_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 produce_BE12 overall_BE12 mean_BE12 increase_BE12 in_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY level_RE2 
Fluconazole|N|ethinyl estradiol|levonorgestrel|however_LE1 in_LE1 some_LE1 patient_LE1 there_LE1 be_LE1 decrease_LE1 up_LE1 to_LE1 NUM_LE1 and_LE1 NUM_LE1 of_LE1 BIOENTITY and_BE12 BIOENTITY level_RE2 
Fluconazole|N|levonorgestrel|fluconazole|the_LE1 datum_LE1 present_LE1 available_LE1 indicate_LE1 that_LE1 the_LE1 decrease_LE1 in_LE1 some_LE1 individual_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY auc_BE12 value_BE12 with_BE12 BIOENTITY treatment_RE2 be_RE2 likely_RE2 the_RE2 result_RE2 of_RE2 random_RE2 variation_RE2 
Fluconazole|N|ethinyl estradiol|fluconazole|the_LE1 datum_LE1 present_LE1 available_LE1 indicate_LE1 that_LE1 the_LE1 decrease_LE1 in_LE1 some_LE1 individual_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 auc_BE12 value_BE12 with_BE12 BIOENTITY treatment_RE2 be_RE2 likely_RE2 the_RE2 result_RE2 of_RE2 random_RE2 variation_RE2 
Fluconazole|N|ethinyl estradiol|levonorgestrel|the_LE1 datum_LE1 present_LE1 available_LE1 indicate_LE1 that_LE1 the_LE1 decrease_LE1 in_LE1 some_LE1 individual_LE1 BIOENTITY and_BE12 BIOENTITY auc_RE2 value_RE2 with_RE2 BIOGENERAL_RE2 treatment_RE2 be_RE2 likely_RE2 the_RE2 result_RE2 of_RE2 random_RE2 variation_RE2 
Fluconazole|N|ethinyl estradiol|levonorgestrel|while_LE1 there_LE1 be_LE1 evidence_LE1 that_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 there_LE1 be_LE1 no_LE1 evidence_LE1 that_LE1 BIOGENERAL_LE1 be_LE1 net_LE1 inducer_LE1 of_LE1 BIOENTITY or_BE12 BIOENTITY metabolism_RE2 
Fluconazole|N|fluconazole|levonorgestrel|while_LE1 there_LE1 be_LE1 evidence_LE1 that_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 there_LE1 be_LE1 no_LE1 evidence_LE1 that_LE1 BIOENTITY be_BE12 net_BE12 inducer_BE12 of_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY metabolism_RE2 
Fluconazole|N|levonorgestrel|levonorgestrel|while_LE1 there_LE1 be_LE1 evidence_LE1 that_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY there_BE12 be_BE12 no_BE12 evidence_BE12 that_BE12 BIOGENERAL_BE12 be_BE12 net_BE12 inducer_BE12 of_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY metabolism_RE2 
Fluconazole|N|ethinyl estradiol|levonorgestrel|while_LE1 there_LE1 be_LE1 evidence_LE1 that_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 there_BE12 be_BE12 no_BE12 evidence_BE12 that_BE12 BIOGENERAL_BE12 be_BE12 net_BE12 inducer_BE12 of_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY metabolism_RE2 
Fluconazole|N|fluconazole|levonorgestrel|while_LE1 there_LE1 be_LE1 evidence_LE1 that_LE1 BIOENTITY can_BE12 inhibit_BE12 the_BE12 metabolism_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 there_BE12 be_BE12 no_BE12 evidence_BE12 that_BE12 BIOGENERAL_BE12 be_BE12 net_BE12 inducer_BE12 of_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY metabolism_RE2 
Fluconazole|N|fluconazole|ethinyl estradiol|while_LE1 there_LE1 be_LE1 evidence_LE1 that_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 there_LE1 be_LE1 no_LE1 evidence_LE1 that_LE1 BIOENTITY be_BE12 net_BE12 inducer_BE12 of_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 metabolism_RE2 
Fluconazole|N|levonorgestrel|ethinyl estradiol|while_LE1 there_LE1 be_LE1 evidence_LE1 that_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY there_BE12 be_BE12 no_BE12 evidence_BE12 that_BE12 BIOGENERAL_BE12 be_BE12 net_BE12 inducer_BE12 of_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 metabolism_RE2 
Fluconazole|N|ethinyl estradiol|ethinyl estradiol|while_LE1 there_LE1 be_LE1 evidence_LE1 that_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 there_BE12 be_BE12 no_BE12 evidence_BE12 that_BE12 BIOGENERAL_BE12 be_BE12 net_BE12 inducer_BE12 of_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 metabolism_RE2 
Fluconazole|N|fluconazole|ethinyl estradiol|while_LE1 there_LE1 be_LE1 evidence_LE1 that_LE1 BIOENTITY can_BE12 inhibit_BE12 the_BE12 metabolism_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 there_BE12 be_BE12 no_BE12 evidence_BE12 that_BE12 BIOGENERAL_BE12 be_BE12 net_BE12 inducer_BE12 of_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 metabolism_RE2 
Fluconazole|N|levonorgestrel|fluconazole|while_LE1 there_LE1 be_LE1 evidence_LE1 that_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY there_BE12 be_BE12 no_BE12 evidence_BE12 that_BE12 BIOENTITY be_RE2 net_RE2 inducer_RE2 of_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 metabolism_RE2 
Fluconazole|N|ethinyl estradiol|fluconazole|while_LE1 there_LE1 be_LE1 evidence_LE1 that_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 there_BE12 be_BE12 no_BE12 evidence_BE12 that_BE12 BIOENTITY be_RE2 net_RE2 inducer_RE2 of_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 metabolism_RE2 
Fluconazole|N|fluconazole|fluconazole|while_LE1 there_LE1 be_LE1 evidence_LE1 that_LE1 BIOENTITY can_BE12 inhibit_BE12 the_BE12 metabolism_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 there_BE12 be_BE12 no_BE12 evidence_BE12 that_BE12 BIOENTITY be_RE2 net_RE2 inducer_RE2 of_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 metabolism_RE2 
Fluconazole|N|ethinyl estradiol|levonorgestrel|while_LE1 there_LE1 be_LE1 evidence_LE1 that_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY and_BE12 BIOENTITY there_RE2 be_RE2 no_RE2 evidence_RE2 that_RE2 BIOGENERAL_RE2 be_RE2 net_RE2 inducer_RE2 of_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 metabolism_RE2 
Mazindol|N|parnate|phenelzine|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|parnate|phenelzine|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|marplan|parnate|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|tranylcypromine|parnate|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|parnate|nardil|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|parnate|nardil|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|maoi|parnate|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|isocarboxazid|parnate|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|monoamine oxidase inhibitor|parnate|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|marplan|phenelzine|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|tranylcypromine|phenelzine|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|tranylcypromine|phenelzine|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|phenelzine|nardil|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|maoi|phenelzine|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|isocarboxazid|phenelzine|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|monoamine oxidase inhibitor|phenelzine|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|marplan|tranylcypromine|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|marplan|nardil|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|maoi|marplan|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|isocarboxazid|marplan|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|monoamine oxidase inhibitor|marplan|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|tranylcypromine|nardil|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|tranylcypromine|nardil|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|maoi|tranylcypromine|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|isocarboxazid|tranylcypromine|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|monoamine oxidase inhibitor|tranylcypromine|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|maoi|nardil|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|isocarboxazid|nardil|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|monoamine oxidase inhibitor|nardil|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|maoi|isocarboxazid|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 such_BE12 as_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|monoamine oxidase inhibitor|maoi|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|monoamine oxidase inhibitor|isocarboxazid|you_LE1 can_LE1 take_LE1 BIOGENERAL_LE1 if_LE1 you_LE1 have_LE1 take_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 such_BE12 as_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 in_RE2 the_RE2 last_RE2 NUM_RE2 day_RE2 
Mazindol|N|guanethidine|ismelin|BIOGENERAL_LE1 may_LE1 reduce_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOENTITY 
Mazindol|N|nortriptyline|pamelor|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|sinequan|pamelor|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|doxepin|pamelor|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|asendin|pamelor|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amoxapine|pamelor|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|elavil|pamelor|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amitriptyline|pamelor|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|pamelor|anafranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|pamelor|protriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|pamelor|tofranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|pamelor|clomipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|pamelor|norpramin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Mazindol|N|pamelor|vivactil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|pamelor|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|pamelor|imipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tricyclic antidepressant|pamelor|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|sinequan|nortriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|doxepin|nortriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|asendin|nortriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amoxapine|nortriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|elavil|nortriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amitriptyline|nortriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|nortriptyline|anafranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|nortriptyline|protriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|nortriptyline|tofranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|nortriptyline|clomipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|nortriptyline|norpramin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Mazindol|N|nortriptyline|vivactil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|nortriptyline|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|nortriptyline|imipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tricyclic antidepressant|nortriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|doxepin|sinequan|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|asendin|sinequan|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amoxapine|sinequan|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|elavil|sinequan|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amitriptyline|sinequan|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|sinequan|anafranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|sinequan|protriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|sinequan|tofranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|sinequan|clomipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|sinequan|norpramin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Mazindol|N|sinequan|vivactil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|sinequan|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|sinequan|imipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tricyclic antidepressant|sinequan|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|asendin|doxepin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amoxapine|doxepin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|elavil|doxepin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amitriptyline|doxepin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|doxepin|anafranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|doxepin|protriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|doxepin|tofranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|doxepin|clomipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|doxepin|norpramin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Mazindol|N|doxepin|vivactil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|doxepin|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|doxepin|imipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tricyclic antidepressant|doxepin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amoxapine|asendin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|elavil|asendin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amitriptyline|asendin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|asendin|anafranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|asendin|protriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|asendin|tofranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|asendin|clomipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|asendin|norpramin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Mazindol|N|asendin|vivactil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|asendin|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|asendin|imipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tricyclic antidepressant|asendin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|elavil|amoxapine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amitriptyline|amoxapine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amoxapine|anafranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amoxapine|protriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amoxapine|tofranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amoxapine|clomipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amoxapine|norpramin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Mazindol|N|amoxapine|vivactil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amoxapine|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amoxapine|imipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tricyclic antidepressant|amoxapine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amitriptyline|elavil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|elavil|anafranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|elavil|protriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|elavil|tofranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|elavil|clomipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|elavil|norpramin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Mazindol|N|elavil|vivactil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|elavil|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|elavil|imipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tricyclic antidepressant|elavil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amitriptyline|anafranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amitriptyline|protriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amitriptyline|tofranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amitriptyline|clomipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amitriptyline|norpramin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Mazindol|N|amitriptyline|vivactil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amitriptyline|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|amitriptyline|imipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tricyclic antidepressant|amitriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOENTITY such_BE12 as_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|anafranil|protriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|anafranil|protriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tofranil|anafranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|clomipramine|anafranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|anafranil|norpramin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Mazindol|N|anafranil|vivactil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|anafranil|vivactil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|anafranil|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|anafranil|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|imipramine|anafranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tricyclic antidepressant|anafranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tofranil|protriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|clomipramine|protriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|clomipramine|protriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|protriptyline|norpramin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Mazindol|N|protriptyline|vivactil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|protriptyline|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|protriptyline|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|imipramine|protriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tricyclic antidepressant|protriptyline|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tofranil|clomipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tofranil|norpramin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Mazindol|N|tofranil|vivactil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tofranil|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|imipramine|tofranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tricyclic antidepressant|tofranil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|clomipramine|norpramin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Mazindol|N|clomipramine|vivactil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|clomipramine|vivactil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|clomipramine|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|clomipramine|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|imipramine|clomipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tricyclic antidepressant|clomipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|vivactil|norpramin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Mazindol|N|desipramine|norpramin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOENTITY -LRB-_BE12 BIOENTITY 
Mazindol|N|imipramine|norpramin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Mazindol|N|tricyclic antidepressant|norpramin|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Mazindol|N|vivactil|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|vivactil|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|imipramine|vivactil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tricyclic antidepressant|vivactil|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|imipramine|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tricyclic antidepressant|desipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Mazindol|N|tricyclic antidepressant|imipramine|before_LE1 take_LE1 this_LE1 medication_LE1 tell_LE1 your_LE1 doctor_LE1 if_LE1 you_LE1 be_LE1 take_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Mebendazole|N|mebendazole|mebendazole|preliminary_LE1 evidence_LE1 suggest_LE1 that_LE1 BIOGENERAL_LE1 inhibit_LE1 BIOENTITY metabolism_BE12 and_BE12 may_BE12 result_BE12 in_BE12 increase_BE12 in_BE12 plasma_BE12 concentration_BE12 of_BE12 BIOENTITY 
Mebendazole|N|cimetidine|mebendazole|preliminary_LE1 evidence_LE1 suggest_LE1 that_LE1 BIOENTITY inhibit_BE12 BIOGENERAL_BE12 metabolism_BE12 and_BE12 may_BE12 result_BE12 in_BE12 increase_BE12 in_BE12 plasma_BE12 concentration_BE12 of_BE12 BIOENTITY 
Mecamylamine|N|antibiotic|sulfonamide|patient_LE1 receive_LE1 BIOENTITY and_BE12 BIOENTITY general_RE2 shall_RE2 not_RE2 be_RE2 treat_RE2 with_RE2 BIOGENERAL_RE2 
Mecamylamine|N|antihypertensive drug|alcohol|the_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 potentiate_LE1 by_LE1 anesthesia_LE1 other_LE1 BIOENTITY and_BE12 BIOENTITY 
Medroxyprogesterone|N|depo-subq provera 104|mpa|BIOGENERAL_LE1 administer_LE1 concomitant_LE1 with_LE1 BIOENTITY may_BE12 significant_BE12 decrease_BE12 the_BE12 serum_BE12 concentration_BE12 of_BE12 BIOENTITY 
Medroxyprogesterone|N|aminoglutethimide|mpa|BIOENTITY administer_BE12 concomitant_BE12 with_BE12 BIOGENERAL_BE12 may_BE12 significant_BE12 decrease_BE12 the_BE12 serum_BE12 concentration_BE12 of_BE12 BIOENTITY 
Megestrol|N|zidovudine|rifabutin|pharmacokinetic_LE1 study_LE1 show_LE1 that_LE1 there_LE1 be_LE1 no_LE1 significant_LE1 alteration_LE1 in_LE1 pharmacokinetic_LE1 parameter_LE1 of_LE1 BIOENTITY or_BE12 BIOENTITY to_RE2 warrant_RE2 dosage_RE2 adjustment_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 with_RE2 these_RE2 drug_RE2 
Megestrol|N|zidovudine|megestrol acetate|pharmacokinetic_LE1 study_LE1 show_LE1 that_LE1 there_LE1 be_LE1 no_LE1 significant_LE1 alteration_LE1 in_LE1 pharmacokinetic_LE1 parameter_LE1 of_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 to_BE12 warrant_BE12 dosage_BE12 adjustment_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 with_RE2 these_RE2 drug_RE2 
Megestrol|N|rifabutin|megestrol acetate|pharmacokinetic_LE1 study_LE1 show_LE1 that_LE1 there_LE1 be_LE1 no_LE1 significant_LE1 alteration_LE1 in_LE1 pharmacokinetic_LE1 parameter_LE1 of_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY to_BE12 warrant_BE12 dosage_BE12 adjustment_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 with_RE2 these_RE2 drug_RE2 
Megestrol|N|megestrol acetate|indinavir|pharmacokinetic_LE1 study_LE1 demonstrate_LE1 that_LE1 coadministration_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 result_BE12 in_BE12 significant_BE12 decrease_BE12 in_BE12 the_BE12 pharmacokinetic_BE12 parameter_BE12 -LRB-_BE12 for_BE12 cmax_BE12 and_BE12 for_BE12 auc_BE12 -RRB-_BE12 of_BE12 BIOENTITY 
Megestrol|N|indinavir|indinavir|pharmacokinetic_LE1 study_LE1 demonstrate_LE1 that_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY result_BE12 in_BE12 significant_BE12 decrease_BE12 in_BE12 the_BE12 pharmacokinetic_BE12 parameter_BE12 -LRB-_BE12 for_BE12 cmax_BE12 and_BE12 for_BE12 auc_BE12 -RRB-_BE12 of_BE12 BIOENTITY 
Megestrol|N|rifabutin|megestrol acetate|the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY on_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY be_RE2 not_RE2 study_RE2 
Megestrol|N|zidovudine|megestrol acetate|the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY be_RE2 not_RE2 study_RE2 
Megestrol|N|indinavir|megestrol acetate|the_LE1 effect_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY be_RE2 not_RE2 study_RE2 
Megestrol|N|zidovudine|rifabutin|the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY on_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 study_RE2 
Megestrol|N|zidovudine|rifabutin|the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY on_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 study_RE2 
Megestrol|N|indinavir|rifabutin|the_LE1 effect_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY on_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 study_RE2 
Megestrol|N|indinavir|zidovudine|the_LE1 effect_LE1 of_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 on_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 study_RE2 
Melatonin|N|aspirin|nsaid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY and_BE12 other_BE12 BIOENTITY -LRB-_RE2 may_RE2 low_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 bioavailability_RE2 of_RE2 oral_RE2 BIOGENERAL_RE2 be_RE2 increase_RE2 with_RE2 coadministration_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|aspirin|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOENTITY can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|aspirin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|aspirin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|aspirin|benzodiazepene|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOENTITY and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|aspirin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|aspirin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|aspirin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|aspirin|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|aspirin|fluoxetine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|aspirin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOENTITY level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|aspirin|beta blocker|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|aspirin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOENTITY be_RE2 increase_RE2 with_RE2 coadministration_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|aspirin|fluvoxamine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 bioavailability_RE2 of_RE2 oral_RE2 BIOGENERAL_RE2 be_RE2 increase_RE2 with_RE2 coadministration_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|aspirin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOENTITY level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 bioavailability_RE2 of_RE2 oral_RE2 BIOGENERAL_RE2 be_RE2 increase_RE2 with_RE2 coadministration_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|nsaid|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOENTITY can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|nsaid|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|nsaid|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|nsaid|benzodiazepene|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOENTITY and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|nsaid|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|nsaid|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|nsaid|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|nsaid|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|nsaid|fluoxetine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|nsaid|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOENTITY level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|nsaid|beta blocker|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|nsaid|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOENTITY be_RE2 increase_RE2 with_RE2 coadministration_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|nsaid|fluvoxamine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 bioavailability_RE2 of_RE2 oral_RE2 BIOGENERAL_RE2 be_RE2 increase_RE2 with_RE2 coadministration_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|nsaid|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY -LRB-_BE12 may_BE12 low_BE12 BIOENTITY level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 bioavailability_RE2 of_RE2 oral_RE2 BIOGENERAL_RE2 be_RE2 increase_RE2 with_RE2 coadministration_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|progestin|BIOENTITY may_BE12 interact_BE12 with_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOENTITY can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|melatonin|BIOENTITY may_BE12 interact_BE12 with_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|corticosteroid|BIOENTITY may_BE12 interact_BE12 with_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|melatonin|BIOENTITY may_BE12 interact_BE12 with_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|corticosteroid|BIOENTITY may_BE12 interact_BE12 with_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|melatonin|melatonin|BIOENTITY may_BE12 interact_BE12 with_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOENTITY level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|melatonin|BIOENTITY may_BE12 interact_BE12 with_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOENTITY be_RE2 increase_RE2 with_RE2 coadministration_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|melatonin|BIOENTITY may_BE12 interact_BE12 with_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 low_BE12 BIOENTITY level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 bioavailability_RE2 of_RE2 oral_RE2 BIOGENERAL_RE2 be_RE2 increase_RE2 with_RE2 coadministration_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|progestin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|progestin|benzodiazepene|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOENTITY and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|progestin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|progestin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|progestin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|progestin|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOENTITY can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluoxetine|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOENTITY can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOENTITY can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|beta blocker|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOENTITY can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOENTITY be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOENTITY can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluvoxamine|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOENTITY can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOENTITY can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOENTITY with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|benzodiazepene|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOENTITY with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOENTITY and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOENTITY with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOENTITY with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOENTITY with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|progestin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluoxetine|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|beta blocker|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOENTITY be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluvoxamine|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|benzodiazepene|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 ovarian_LE1 function_LE1 in_LE1 woman_LE1 -RRB-_LE1 BIOENTITY and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|corticosteroid|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 ovarian_LE1 function_LE1 in_LE1 woman_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 sedating_LE1 drug_LE1 -LRB-_LE1 may_LE1 result_LE1 in_LE1 additive_LE1 sedation_LE1 and_LE1 increase_LE1 incidence_LE1 of_LE1 adverse_LE1 effect_LE1 -RRB-_LE1 and_LE1 BIOENTITY -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|corticosteroid|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 ovarian_LE1 function_LE1 in_LE1 woman_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 sedating_LE1 drug_LE1 -LRB-_LE1 may_LE1 result_LE1 in_LE1 additive_LE1 sedation_LE1 and_LE1 increase_LE1 incidence_LE1 of_LE1 adverse_LE1 effect_LE1 -RRB-_LE1 and_LE1 BIOENTITY -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|corticosteroid|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 ovarian_LE1 function_LE1 in_LE1 woman_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 sedating_LE1 drug_LE1 -LRB-_LE1 may_LE1 result_LE1 in_LE1 additive_LE1 sedation_LE1 and_LE1 increase_LE1 incidence_LE1 of_LE1 adverse_LE1 effect_LE1 -RRB-_LE1 and_LE1 BIOENTITY -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|corticosteroid|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 ovarian_LE1 function_LE1 in_LE1 woman_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 sedating_LE1 drug_LE1 -LRB-_LE1 may_LE1 result_LE1 in_LE1 additive_LE1 sedation_LE1 and_LE1 increase_LE1 incidence_LE1 of_LE1 adverse_LE1 effect_LE1 -RRB-_LE1 and_LE1 BIOENTITY -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|corticosteroid|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 ovarian_LE1 function_LE1 in_LE1 woman_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 sedating_LE1 drug_LE1 -LRB-_LE1 may_LE1 result_LE1 in_LE1 additive_LE1 sedation_LE1 and_LE1 increase_LE1 incidence_LE1 of_LE1 adverse_LE1 effect_LE1 -RRB-_LE1 and_LE1 BIOENTITY -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|corticosteroid|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 ovarian_LE1 function_LE1 in_LE1 woman_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 sedating_LE1 drug_LE1 -LRB-_LE1 may_LE1 result_LE1 in_LE1 additive_LE1 sedation_LE1 and_LE1 increase_LE1 incidence_LE1 of_LE1 adverse_LE1 effect_LE1 -RRB-_LE1 and_LE1 BIOENTITY -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|progestin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluoxetine|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|beta blocker|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOENTITY be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluvoxamine|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|benzodiazepene|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 ovarian_LE1 function_LE1 in_LE1 woman_LE1 -RRB-_LE1 BIOENTITY and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|benzodiazepene|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 ovarian_LE1 function_LE1 in_LE1 woman_LE1 -RRB-_LE1 BIOENTITY and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|benzodiazepene|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 ovarian_LE1 function_LE1 in_LE1 woman_LE1 -RRB-_LE1 BIOENTITY and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|progestin|benzodiazepene|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOENTITY and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluoxetine|benzodiazepene|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOENTITY and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|benzodiazepene|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOENTITY and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|beta blocker|benzodiazepene|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOENTITY and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|benzodiazepene|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOENTITY be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOENTITY and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluvoxamine|benzodiazepene|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOENTITY and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|benzodiazepene|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOENTITY and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|corticosteroid|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 ovarian_LE1 function_LE1 in_LE1 woman_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 sedating_LE1 drug_LE1 -LRB-_LE1 may_LE1 result_LE1 in_LE1 additive_LE1 sedation_LE1 and_LE1 increase_LE1 incidence_LE1 of_LE1 adverse_LE1 effect_LE1 -RRB-_LE1 and_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|progestin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluoxetine|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|beta blocker|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOENTITY be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluvoxamine|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 can_LE1 inhibit_LE1 ovarian_LE1 function_LE1 in_LE1 woman_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 sedating_LE1 drug_LE1 -LRB-_LE1 may_LE1 result_LE1 in_LE1 additive_LE1 sedation_LE1 and_LE1 increase_LE1 incidence_LE1 of_LE1 adverse_LE1 effect_LE1 -RRB-_LE1 and_LE1 BIOGENERAL_LE1 -LRB-_LE1 coadministration_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|progestin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluoxetine|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|beta blocker|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOENTITY be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluvoxamine|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|progestin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 report_LE1 of_LE1 psychotic_LE1 episode_LE1 when_LE1 coadminister_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|fluoxetine|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|melatonin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|beta blocker|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|melatonin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOENTITY be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|fluvoxamine|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|melatonin|corticosteroid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 can_BE12 inhibit_BE12 ovarian_BE12 function_BE12 in_BE12 woman_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 sedating_BE12 drug_BE12 -LRB-_BE12 may_BE12 result_BE12 in_BE12 additive_BE12 sedation_BE12 and_BE12 increase_BE12 incidence_BE12 of_BE12 adverse_BE12 effect_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 efficacy_BE12 of_BE12 the_BE12 BIOENTITY rrb._RE2 
Melatonin|N|fluoxetine|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|beta blocker|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOENTITY be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluvoxamine|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|progestin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 report_BE12 of_BE12 psychotic_BE12 episode_BE12 when_BE12 coadminister_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|fluoxetine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 decrease_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|beta blocker|fluoxetine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|fluoxetine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOENTITY be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluvoxamine|fluoxetine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|fluoxetine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOGENERAL_BE12 level_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|beta blocker|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 with_LE1 coadministration_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 may_BE12 decrease_BE12 BIOENTITY level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOENTITY be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOENTITY level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluvoxamine|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOENTITY level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 may_BE12 decrease_BE12 BIOENTITY level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|beta blocker|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 bioavailability_LE1 of_LE1 oral_LE1 BIOENTITY be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluvoxamine|beta blocker|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|beta blocker|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 be_BE12 increase_BE12 with_BE12 coadministration_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|fluvoxamine|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOGENERAL_LE1 level_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOENTITY be_RE2 increase_RE2 with_RE2 coadministration_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|melatonin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 bioavailability_BE12 of_BE12 oral_BE12 BIOENTITY be_RE2 increase_RE2 with_RE2 coadministration_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Melatonin|N|melatonin|fluvoxamine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 may_LE1 low_LE1 BIOENTITY level_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 bioavailability_RE2 of_RE2 oral_RE2 BIOGENERAL_RE2 be_RE2 increase_RE2 with_RE2 coadministration_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 level_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 report_RE2 of_RE2 psychotic_RE2 episode_RE2 when_RE2 coadminister_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 inhibit_RE2 ovarian_RE2 function_RE2 in_RE2 woman_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 sedating_RE2 drug_RE2 -LRB-_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 sedation_RE2 and_RE2 increase_RE2 incidence_RE2 of_RE2 adverse_RE2 effect_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 coadministration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 interfere_RE2 with_RE2 the_RE2 efficacy_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 rrb._RE2 
Meloxicam|N|ace inhibitor|angiotensin-converting enzyme (ace) inhibitor|BIOENTITY report_BE12 suggest_BE12 that_BE12 BIOGENERAL_BE12 may_BE12 diminish_BE12 the_BE12 antihypertensive_BE12 effect_BE12 of_BE12 -LRB-_BE12 ace_BE12 -RRB-_BE12 BIOENTITY 
Meloxicam|N|ace inhibitor|nsaid|BIOENTITY report_BE12 suggest_BE12 that_BE12 BIOENTITY may_RE2 diminish_RE2 the_RE2 antihypertensive_RE2 effect_RE2 of_RE2 -LRB-_RE2 ace_RE2 -RRB-_RE2 BIOGENERAL_RE2 
Meloxicam|N|aspirin|meloxicam|BIOENTITY :_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 tid_BE12 -RRB-_BE12 to_BE12 healthy_BE12 volunteer_BE12 tend_BE12 to_BE12 increase_BE12 the_BE12 auc_BE12 -LRB-_BE12 NUM_BE12 -RRB-_BE12 and_BE12 cmax_BE12 -LRB-_BE12 NUM_BE12 -RRB-_BE12 of_BE12 BIOENTITY 
Meloxicam|N|aspirin|aspirin|BIOENTITY :_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOENTITY -LRB-_RE2 NUM_RE2 mg_RE2 tid_RE2 -RRB-_RE2 to_RE2 healthy_RE2 volunteer_RE2 tend_RE2 to_RE2 increase_RE2 the_RE2 auc_RE2 -LRB-_RE2 NUM_RE2 -RRB-_RE2 and_RE2 cmax_RE2 -LRB-_RE2 NUM_RE2 -RRB-_RE2 of_RE2 BIOGENERAL_RE2 
Meloxicam|N|nsaid|meloxicam|however_LE1 as_LE1 with_LE1 other_LE1 BIOENTITY concomitant_BE12 administration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 general_RE2 recommend_RE2 because_RE2 of_RE2 the_RE2 potential_RE2 for_RE2 increase_RE2 adverse_RE2 effect_RE2 
Meloxicam|N|mobic|mobic|concomitant_LE1 administration_LE1 of_LE1 lowdose_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY may_BE12 result_BE12 in_BE12 increase_BE12 rate_BE12 of_BE12 gi_BE12 ulceration_BE12 or_BE12 other_BE12 complication_BE12 compared_BE12 to_BE12 use_BE12 of_BE12 BIOENTITY alone_RE2 
Meloxicam|N|aspirin|mobic|concomitant_LE1 administration_LE1 of_LE1 lowdose_LE1 BIOENTITY with_BE12 BIOGENERAL_BE12 may_BE12 result_BE12 in_BE12 increase_BE12 rate_BE12 of_BE12 gi_BE12 ulceration_BE12 or_BE12 other_BE12 complication_BE12 compared_BE12 to_BE12 use_BE12 of_BE12 BIOENTITY alone_RE2 
Meloxicam|N|mobic|aspirin|BIOENTITY be_BE12 not_BE12 substitute_BE12 for_BE12 BIOENTITY for_RE2 cardiovascular_RE2 prophylaxis_RE2 
Meloxicam|N|cholestyramine|meloxicam|BIOENTITY :_BE12 pretreatment_BE12 for_BE12 four_BE12 day_BE12 with_BE12 BIOGENERAL_BE12 significant_BE12 increase_BE12 the_BE12 clearance_BE12 of_BE12 BIOENTITY by_RE2 NUM_RE2 %._RE2 
Meloxicam|N|cholestyramine|cholestyramine|BIOENTITY :_BE12 pretreatment_BE12 for_BE12 four_BE12 day_BE12 with_BE12 BIOENTITY significant_RE2 increase_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 NUM_RE2 %._RE2 
Meloxicam|N|cimetidine|cimetidine|BIOENTITY :_BE12 concomitant_BE12 administration_BE12 of_BE12 NUM_BE12 mg_BE12 BIOENTITY qid_RE2 do_RE2 not_RE2 alter_RE2 the_RE2 singledose_RE2 pharmacokinetic_RE2 of_RE2 NUM_RE2 mg_RE2 BIOGENERAL_RE2 
Meloxicam|N|cimetidine|meloxicam|BIOENTITY :_BE12 concomitant_BE12 administration_BE12 of_BE12 NUM_BE12 mg_BE12 BIOGENERAL_BE12 qid_BE12 do_BE12 not_BE12 alter_BE12 the_BE12 singledose_BE12 pharmacokinetic_BE12 of_BE12 NUM_BE12 mg_BE12 BIOENTITY 
Meloxicam|N|cimetidine|meloxicam|BIOGENERAL_LE1 :_LE1 concomitant_LE1 administration_LE1 of_LE1 NUM_LE1 mg_LE1 BIOENTITY qid_BE12 do_BE12 not_BE12 alter_BE12 the_BE12 singledose_BE12 pharmacokinetic_BE12 of_BE12 NUM_BE12 mg_BE12 BIOENTITY 
Meloxicam|N|meloxicam|digoxin|BIOGENERAL_LE1 :_LE1 BIOENTITY NUM_BE12 mg_BE12 once_BE12 daily_BE12 for_BE12 NUM_BE12 day_BE12 do_BE12 not_BE12 alter_BE12 the_BE12 plasma_BE12 concentration_BE12 profile_BE12 of_BE12 BIOENTITY after_RE2 bacetyldigoxin_RE2 administration_RE2 for_RE2 NUM_RE2 day_RE2 at_RE2 clinical_RE2 dose_RE2 
Meloxicam|N|digoxin|digoxin|BIOENTITY :_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 once_BE12 daily_BE12 for_BE12 NUM_BE12 day_BE12 do_BE12 not_BE12 alter_BE12 the_BE12 plasma_BE12 concentration_BE12 profile_BE12 of_BE12 BIOENTITY after_RE2 bacetyldigoxin_RE2 administration_RE2 for_RE2 NUM_RE2 day_RE2 at_RE2 clinical_RE2 dose_RE2 
Meloxicam|N|digoxin|meloxicam|BIOENTITY :_BE12 BIOENTITY NUM_RE2 mg_RE2 once_RE2 daily_RE2 for_RE2 NUM_RE2 day_RE2 do_RE2 not_RE2 alter_RE2 the_RE2 plasma_RE2 concentration_RE2 profile_RE2 of_RE2 BIOGENERAL_RE2 after_RE2 bacetyldigoxin_RE2 administration_RE2 for_RE2 NUM_RE2 day_RE2 at_RE2 clinical_RE2 dose_RE2 
Meloxicam|N|digoxin|meloxicam|in_LE1 vitro_LE1 testing_LE1 find_LE1 no_LE1 protein_LE1 binding_LE1 drug_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOENTITY 
Meloxicam|N|furosemide|nsaid|BIOENTITY :_BE12 clinical_BE12 study_BE12 as_BE12 well_BE12 as_BE12 postmarketing_BE12 observation_BE12 have_BE12 show_BE12 that_BE12 BIOENTITY can_RE2 reduce_RE2 the_RE2 natriuretic_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 in_RE2 some_RE2 patient_RE2 
Meloxicam|N|furosemide|thiazide diuretic|BIOENTITY :_BE12 clinical_BE12 study_BE12 as_BE12 well_BE12 as_BE12 postmarketing_BE12 observation_BE12 have_BE12 show_BE12 that_BE12 BIOGENERAL_BE12 can_BE12 reduce_BE12 the_BE12 natriuretic_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY in_RE2 some_RE2 patient_RE2 
Meloxicam|N|furosemide|furosemide|BIOENTITY :_BE12 clinical_BE12 study_BE12 as_BE12 well_BE12 as_BE12 postmarketing_BE12 observation_BE12 have_BE12 show_BE12 that_BE12 BIOGENERAL_BE12 can_BE12 reduce_BE12 the_BE12 natriuretic_BE12 effect_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 in_RE2 some_RE2 patient_RE2 
Meloxicam|N|furosemide|thiazide diuretic|BIOGENERAL_LE1 :_LE1 clinical_LE1 study_LE1 as_LE1 well_LE1 as_LE1 postmarketing_LE1 observation_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 can_LE1 reduce_LE1 the_LE1 natriuretic_LE1 effect_LE1 of_LE1 BIOENTITY and_BE12 BIOENTITY in_RE2 some_RE2 patient_RE2 
Meloxicam|N|furosemide|meloxicam|study_LE1 with_LE1 BIOENTITY agent_BE12 and_BE12 BIOENTITY have_RE2 not_RE2 demonstrate_RE2 reduction_RE2 in_RE2 natriuretic_RE2 effect_RE2 
Meloxicam|N|furosemide|meloxicam|BIOENTITY :_BE12 single_BE12 and_BE12 multiple_BE12 dose_BE12 pharmacodynamic_BE12 and_BE12 pharmacokinetic_BE12 be_BE12 not_BE12 affect_BE12 by_BE12 multiple_BE12 dose_BE12 of_BE12 BIOENTITY 
Meloxicam|N|lithium|lithium|BIOGENERAL_LE1 :_LE1 In_LE1 clinical_LE1 trial_LE1 BIOGENERAL_LE1 have_LE1 produce_LE1 elevation_LE1 of_LE1 plasma_LE1 BIOENTITY level_BE12 and_BE12 reduction_BE12 in_BE12 renal_BE12 BIOENTITY clearance_RE2 
Meloxicam|N|nsaid|lithium|BIOGENERAL_LE1 :_LE1 In_LE1 clinical_LE1 trial_LE1 BIOENTITY have_BE12 produce_BE12 elevation_BE12 of_BE12 plasma_BE12 BIOGENERAL_BE12 level_BE12 and_BE12 reduction_BE12 in_BE12 renal_BE12 BIOENTITY clearance_RE2 
Meloxicam|N|lithium|lithium|BIOENTITY :_BE12 In_BE12 clinical_BE12 trial_BE12 BIOGENERAL_BE12 have_BE12 produce_BE12 elevation_BE12 of_BE12 plasma_BE12 BIOGENERAL_BE12 level_BE12 and_BE12 reduction_BE12 in_BE12 renal_BE12 BIOENTITY clearance_RE2 
Meloxicam|N|lithium|lithium|BIOENTITY :_BE12 In_BE12 clinical_BE12 trial_BE12 BIOGENERAL_BE12 have_BE12 produce_BE12 elevation_BE12 of_BE12 plasma_BE12 BIOENTITY level_RE2 and_RE2 reduction_RE2 in_RE2 renal_RE2 BIOGENERAL_RE2 clearance_RE2 
Meloxicam|N|lithium|nsaid|BIOENTITY :_BE12 In_BE12 clinical_BE12 trial_BE12 BIOENTITY have_RE2 produce_RE2 elevation_RE2 of_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 and_RE2 reduction_RE2 in_RE2 renal_RE2 BIOGENERAL_RE2 clearance_RE2 
Meloxicam|N|lithium|lithium|In_LE1 study_LE1 conduct_LE1 in_LE1 healthy_LE1 subject_LE1 mean_LE1 predose_LE1 BIOENTITY concentration_BE12 and_BE12 auc_BE12 be_BE12 increase_BE12 by_BE12 NUM_BE12 in_BE12 subject_BE12 receive_BE12 BIOGENERAL_BE12 dose_BE12 range_BE12 from_BE12 NUM_BE12 to_BE12 NUM_BE12 mg_BE12 bid_BE12 with_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 qd_BE12 as_BE12 compare_BE12 to_BE12 subject_BE12 receive_BE12 BIOENTITY alone_RE2 
Meloxicam|N|meloxicam|lithium|In_LE1 study_LE1 conduct_LE1 in_LE1 healthy_LE1 subject_LE1 mean_LE1 predose_LE1 BIOGENERAL_LE1 concentration_LE1 and_LE1 auc_LE1 be_LE1 increase_LE1 by_LE1 NUM_LE1 in_LE1 subject_LE1 receive_LE1 BIOGENERAL_LE1 dose_LE1 range_LE1 from_LE1 NUM_LE1 to_LE1 NUM_LE1 mg_LE1 bid_LE1 with_LE1 BIOENTITY NUM_BE12 mg_BE12 qd_BE12 as_BE12 compare_BE12 to_BE12 subject_BE12 receive_BE12 BIOENTITY alone_RE2 
Meloxicam|N|lithium|lithium|In_LE1 study_LE1 conduct_LE1 in_LE1 healthy_LE1 subject_LE1 mean_LE1 predose_LE1 BIOGENERAL_LE1 concentration_LE1 and_LE1 auc_LE1 be_LE1 increase_LE1 by_LE1 NUM_LE1 in_LE1 subject_LE1 receive_LE1 BIOENTITY dose_BE12 range_BE12 from_BE12 NUM_BE12 to_BE12 NUM_BE12 mg_BE12 bid_BE12 with_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 qd_BE12 as_BE12 compare_BE12 to_BE12 subject_BE12 receive_BE12 BIOENTITY alone_RE2 
Meloxicam|N|lithium|meloxicam|In_LE1 study_LE1 conduct_LE1 in_LE1 healthy_LE1 subject_LE1 mean_LE1 predose_LE1 BIOENTITY concentration_BE12 and_BE12 auc_BE12 be_BE12 increase_BE12 by_BE12 NUM_BE12 in_BE12 subject_BE12 receive_BE12 BIOGENERAL_BE12 dose_BE12 range_BE12 from_BE12 NUM_BE12 to_BE12 NUM_BE12 mg_BE12 bid_BE12 with_BE12 BIOENTITY NUM_RE2 mg_RE2 qd_RE2 as_RE2 compare_RE2 to_RE2 subject_RE2 receive_RE2 BIOGENERAL_RE2 alone_RE2 
Meloxicam|N|lithium|lithium|In_LE1 study_LE1 conduct_LE1 in_LE1 healthy_LE1 subject_LE1 mean_LE1 predose_LE1 BIOENTITY concentration_BE12 and_BE12 auc_BE12 be_BE12 increase_BE12 by_BE12 NUM_BE12 in_BE12 subject_BE12 receive_BE12 BIOENTITY dose_RE2 range_RE2 from_RE2 NUM_RE2 to_RE2 NUM_RE2 mg_RE2 bid_RE2 with_RE2 BIOGENERAL_RE2 NUM_RE2 mg_RE2 qd_RE2 as_RE2 compare_RE2 to_RE2 subject_RE2 receive_RE2 BIOGENERAL_RE2 alone_RE2 
Meloxicam|N|methotrexate|meloxicam|BIOENTITY :_BE12 study_BE12 in_BE12 NUM_BE12 rheumatoid_BE12 arthritis_BE12 -LRB-_BE12 ra_BE12 -RRB-_BE12 patient_BE12 evaluate_BE12 the_BE12 effect_BE12 of_BE12 multiple_BE12 dose_BE12 of_BE12 BIOENTITY on_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 take_RE2 once_RE2 weekly_RE2 
Meloxicam|N|methotrexate|methotrexate|BIOENTITY :_BE12 study_BE12 in_BE12 NUM_BE12 rheumatoid_BE12 arthritis_BE12 -LRB-_BE12 ra_BE12 -RRB-_BE12 patient_BE12 evaluate_BE12 the_BE12 effect_BE12 of_BE12 multiple_BE12 dose_BE12 of_BE12 BIOGENERAL_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY take_RE2 once_RE2 weekly_RE2 
Meloxicam|N|meloxicam|methotrexate|BIOGENERAL_LE1 :_LE1 study_LE1 in_LE1 NUM_LE1 rheumatoid_LE1 arthritis_LE1 -LRB-_LE1 ra_LE1 -RRB-_LE1 patient_LE1 evaluate_LE1 the_LE1 effect_LE1 of_LE1 multiple_LE1 dose_LE1 of_LE1 BIOENTITY on_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY take_RE2 once_RE2 weekly_RE2 
Meloxicam|N|meloxicam|methotrexate|BIOENTITY do_BE12 not_BE12 have_BE12 significant_BE12 effect_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 single_BE12 dose_BE12 of_BE12 BIOENTITY 
Meloxicam|N|methotrexate|meloxicam|in_LE1 vitro_LE1 BIOENTITY do_BE12 not_BE12 displace_BE12 BIOENTITY from_RE2 its_RE2 human_RE2 serum_RE2 binding_RE2 site_RE2 
Meloxicam|N|warfarin|mobic|BIOENTITY :_BE12 anticoagulant_BE12 activity_BE12 shall_BE12 be_BE12 monitor_BE12 particular_BE12 in_BE12 the_BE12 first_BE12 few_BE12 day_BE12 after_BE12 initiate_BE12 or_BE12 change_BE12 BIOENTITY therapy_RE2 in_RE2 patient_RE2 receive_RE2 BIOGENERAL_RE2 or_RE2 similar_RE2 agent_RE2 since_RE2 these_RE2 patient_RE2 be_RE2 at_RE2 increase_RE2 risk_RE2 of_RE2 bleeding_RE2 
Meloxicam|N|warfarin|warfarin|BIOENTITY :_BE12 anticoagulant_BE12 activity_BE12 shall_BE12 be_BE12 monitor_BE12 particular_BE12 in_BE12 the_BE12 first_BE12 few_BE12 day_BE12 after_BE12 initiate_BE12 or_BE12 change_BE12 BIOGENERAL_BE12 therapy_BE12 in_BE12 patient_BE12 receive_BE12 BIOENTITY or_RE2 similar_RE2 agent_RE2 since_RE2 these_RE2 patient_RE2 be_RE2 at_RE2 increase_RE2 risk_RE2 of_RE2 bleeding_RE2 
Meloxicam|N|meloxicam|warfarin|the_LE1 effect_LE1 of_LE1 BIOENTITY on_BE12 the_BE12 anticoagulant_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 study_BE12 in_BE12 group_BE12 of_BE12 healthy_BE12 subject_BE12 receive_BE12 daily_BE12 dose_BE12 of_BE12 BIOENTITY that_RE2 produce_RE2 inr_RE2 -LRB-_RE2 international_RE2 normalize_RE2 ratio_RE2 -RRB-_RE2 between_RE2 and_RE2 
Meloxicam|N|warfarin|warfarin|the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 the_LE1 anticoagulant_LE1 effect_LE1 of_LE1 BIOENTITY be_BE12 study_BE12 in_BE12 group_BE12 of_BE12 healthy_BE12 subject_BE12 receive_BE12 daily_BE12 dose_BE12 of_BE12 BIOENTITY that_RE2 produce_RE2 inr_RE2 -LRB-_RE2 international_RE2 normalize_RE2 ratio_RE2 -RRB-_RE2 between_RE2 and_RE2 
Meloxicam|N|meloxicam|warfarin|the_LE1 effect_LE1 of_LE1 BIOENTITY on_BE12 the_BE12 anticoagulant_BE12 effect_BE12 of_BE12 BIOENTITY be_RE2 study_RE2 in_RE2 group_RE2 of_RE2 healthy_RE2 subject_RE2 receive_RE2 daily_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 that_RE2 produce_RE2 inr_RE2 -LRB-_RE2 international_RE2 normalize_RE2 ratio_RE2 -RRB-_RE2 between_RE2 and_RE2 
Meloxicam|N|meloxicam|warfarin|In_LE1 these_LE1 subject_LE1 BIOENTITY do_BE12 not_BE12 alter_BE12 BIOGENERAL_BE12 pharmacokinetic_BE12 and_BE12 the_BE12 average_BE12 anticoagulant_BE12 effect_BE12 of_BE12 BIOENTITY as_RE2 determine_RE2 by_RE2 prothrombin_RE2 time_RE2 
Meloxicam|N|meloxicam|warfarin|In_LE1 these_LE1 subject_LE1 BIOENTITY do_BE12 not_BE12 alter_BE12 BIOENTITY pharmacokinetic_RE2 and_RE2 the_RE2 average_RE2 anticoagulant_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 as_RE2 determine_RE2 by_RE2 prothrombin_RE2 time_RE2 
Meloxicam|N|warfarin|warfarin|In_LE1 these_LE1 subject_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 alter_LE1 BIOENTITY pharmacokinetic_BE12 and_BE12 the_BE12 average_BE12 anticoagulant_BE12 effect_BE12 of_BE12 BIOENTITY as_RE2 determine_RE2 by_RE2 prothrombin_RE2 time_RE2 
Meloxicam|N|mobic|warfarin|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 administer_LE1 BIOENTITY with_BE12 BIOGENERAL_BE12 since_BE12 patient_BE12 on_BE12 BIOENTITY may_RE2 experience_RE2 change_RE2 in_RE2 inr_RE2 and_RE2 increase_RE2 risk_RE2 of_RE2 bleeding_RE2 complication_RE2 when_RE2 new_RE2 medication_RE2 be_RE2 introduce_RE2 
Meloxicam|N|warfarin|warfarin|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 administer_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY since_BE12 patient_BE12 on_BE12 BIOENTITY may_RE2 experience_RE2 change_RE2 in_RE2 inr_RE2 and_RE2 increase_RE2 risk_RE2 of_RE2 bleeding_RE2 complication_RE2 when_RE2 new_RE2 medication_RE2 be_RE2 introduce_RE2 
Melphalan|N|alkeran|melphalan|drug_LE1 interaction_LE1 there_LE1 be_LE1 no_LE1 known_LE1 drug_LE1 interaction_LE1 with_LE1 oral_LE1 BIOENTITY vaccinations_BE12 with_BE12 BIOGENERAL_BE12 be_BE12 not_BE12 recommend_BE12 in_BE12 immunocompromised_BE12 individual_BE12 BIOGENERAL_BE12 together_BE12 with_BE12 highdose_BE12 intravenous_BE12 BIOENTITY have_RE2 cause_RE2 death_RE2 in_RE2 child_RE2 due_RE2 to_RE2 haemorrhagic_RE2 enterocolitis_RE2 
Melphalan|N|live organism vaccine|melphalan|drug_LE1 interaction_LE1 there_LE1 be_LE1 no_LE1 known_LE1 drug_LE1 interaction_LE1 with_LE1 oral_LE1 BIOGENERAL_LE1 vaccinations_LE1 with_LE1 BIOENTITY be_BE12 not_BE12 recommend_BE12 in_BE12 immunocompromised_BE12 individual_BE12 BIOGENERAL_BE12 together_BE12 with_BE12 highdose_BE12 intravenous_BE12 BIOENTITY have_RE2 cause_RE2 death_RE2 in_RE2 child_RE2 due_RE2 to_RE2 haemorrhagic_RE2 enterocolitis_RE2 
Melphalan|N|alkeran|live organism vaccine|drug_LE1 interaction_LE1 there_LE1 be_LE1 no_LE1 known_LE1 drug_LE1 interaction_LE1 with_LE1 oral_LE1 BIOENTITY vaccinations_BE12 with_BE12 BIOENTITY be_RE2 not_RE2 recommend_RE2 in_RE2 immunocompromised_RE2 individual_RE2 BIOGENERAL_RE2 together_RE2 with_RE2 highdose_RE2 intravenous_RE2 BIOGENERAL_RE2 have_RE2 cause_RE2 death_RE2 in_RE2 child_RE2 due_RE2 to_RE2 haemorrhagic_RE2 enterocolitis_RE2 
Melphalan|N|alkeran|nalidixic acid|drug_LE1 interaction_LE1 there_LE1 be_LE1 no_LE1 known_LE1 drug_LE1 interaction_LE1 with_LE1 oral_LE1 BIOENTITY vaccinations_BE12 with_BE12 BIOGENERAL_BE12 be_BE12 not_BE12 recommend_BE12 in_BE12 immunocompromised_BE12 individual_BE12 BIOENTITY together_RE2 with_RE2 highdose_RE2 intravenous_RE2 BIOGENERAL_RE2 have_RE2 cause_RE2 death_RE2 in_RE2 child_RE2 due_RE2 to_RE2 haemorrhagic_RE2 enterocolitis_RE2 
Melphalan|N|live organism vaccine|nalidixic acid|drug_LE1 interaction_LE1 there_LE1 be_LE1 no_LE1 known_LE1 drug_LE1 interaction_LE1 with_LE1 oral_LE1 BIOGENERAL_LE1 vaccinations_LE1 with_LE1 BIOENTITY be_BE12 not_BE12 recommend_BE12 in_BE12 immunocompromised_BE12 individual_BE12 BIOENTITY together_RE2 with_RE2 highdose_RE2 intravenous_RE2 BIOGENERAL_RE2 have_RE2 cause_RE2 death_RE2 in_RE2 child_RE2 due_RE2 to_RE2 haemorrhagic_RE2 enterocolitis_RE2 
Mepenzolate|N|sympathomimetic agent|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|sympathomimetic agent|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|nitrite|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|nitrate|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|nitrate|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antipsychotic agent|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antipsychotic agent|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|meperidine|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|meperidine|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|phenothiazine|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|phenothiazine|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|benzodiazepine|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|benzodiazepine|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|mao inhibitor|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|mao inhibitor|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|narcotic analgesic|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|narcotic analgesic|tricyclic antidepressant|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|nitrite|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|nitrate|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|nitrate|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antipsychotic agent|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antipsychotic agent|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|meperidine|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|meperidine|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|phenothiazine|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|phenothiazine|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|benzodiazepine|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|benzodiazepine|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|mao inhibitor|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|mao inhibitor|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|narcotic analgesic|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|narcotic analgesic|sympathomimetic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|nitrite|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|quinidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|antipsychotic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|antipsychotic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|antihistamine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|antihistamine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|quinidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|quinidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|phenothiazine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|phenothiazine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|benzodiazepine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|benzodiazepine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|mao inhibitor|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|mao inhibitor|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|narcotic analgesic|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|quinidine|narcotic analgesic|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|nitrite|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|nitrate|nitrite|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY and_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antipsychotic agent|nitrite|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|meperidine|nitrite|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|nitrite|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|nitrite|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|phenothiazine|nitrite|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|benzodiazepine|nitrite|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|mao inhibitor|nitrite|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|narcotic analgesic|nitrite|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|antipsychotic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|antipsychotic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|antihistamine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|antihistamine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|antiarrhythmic agents of class i|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|antiarrhythmic agents of class i|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|phenothiazine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|phenothiazine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|benzodiazepine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|benzodiazepine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|mao inhibitor|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|mao inhibitor|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|narcotic analgesic|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antiarrhythmic agents of class i|narcotic analgesic|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antipsychotic agent|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antipsychotic agent|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|meperidine|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|meperidine|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|phenothiazine|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|phenothiazine|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|benzodiazepine|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|benzodiazepine|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|mao inhibitor|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|mao inhibitor|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|narcotic analgesic|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|narcotic analgesic|nitrate|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antipsychotic agent|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antipsychotic agent|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|antipsychotic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|antipsychotic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|antipsychotic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|antipsychotic agent|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antipsychotic agent|phenothiazine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antipsychotic agent|benzodiazepine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antipsychotic agent|benzodiazepine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antipsychotic agent|mao inhibitor|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antipsychotic agent|mao inhibitor|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antipsychotic agent|narcotic analgesic|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antipsychotic agent|narcotic analgesic|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|phenothiazine|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|phenothiazine|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|benzodiazepine|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|benzodiazepine|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|mao inhibitor|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|mao inhibitor|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|narcotic analgesic|meperidine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|antihistamine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|antihistamine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|phenothiazine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|phenothiazine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|benzodiazepine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|benzodiazepine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|mao inhibitor|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|mao inhibitor|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|narcotic analgesic|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|antihistamine|narcotic analgesic|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|phenothiazine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|phenothiazine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|benzodiazepine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|benzodiazepine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|mao inhibitor|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|mao inhibitor|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|narcotic analgesic|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|amantadine|narcotic analgesic|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|phenothiazine|benzodiazepine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|phenothiazine|benzodiazepine|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|phenothiazine|mao inhibitor|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|phenothiazine|mao inhibitor|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|phenothiazine|narcotic analgesic|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|phenothiazine|narcotic analgesic|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|benzodiazepine|mao inhibitor|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|benzodiazepine|mao inhibitor|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|benzodiazepine|narcotic analgesic|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|benzodiazepine|narcotic analgesic|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|mao inhibitor|narcotic analgesic|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Mepenzolate|N|mao inhibitor|narcotic analgesic|the_LE1 follow_LE1 may_LE1 increase_LE1 certain_LE1 action_LE1 or_LE1 side_LE1 effect_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 drug_RE2 have_RE2 anticholinergic_RE2 activity_RE2 
Meperidine|N|phenothiazine|tranquilizer|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|phenothiazine|tranquilizer|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|narcotic analgesic|phenothiazine|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOENTITY other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|narcotic analgesic|phenothiazine|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOENTITY other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|anesthetic|phenothiazine|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOENTITY other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|central nervous system depressant|phenothiazine|interaction_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 use_BE12 WITH_BE12 great_BE12 caution_BE12 AND_BE12 in_BE12 reduce_BE12 dosage_BE12 IN_BE12 patient_BE12 WHO_BE12 be_BE12 concurrent_BE12 receive_BE12 other_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOENTITY other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|phenothiazine|tricyclic antidepressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|phenothiazine|tricyclic antidepressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|phenothiazine|cns depressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|phenothiazine|cns depressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|phenothiazine|alcohol|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY rrb._RE2 
Meperidine|N|phenothiazine|sedative-hypnotic|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|phenothiazine|sedative-hypnotic|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|phenothiazine|barbiturate|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|phenothiazine|barbiturate|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|narcotic analgesic|tranquilizer|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|narcotic analgesic|tranquilizer|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|anesthetic|tranquilizer|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOGENERAL_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|central nervous system depressant|tranquilizer|interaction_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 use_BE12 WITH_BE12 great_BE12 caution_BE12 AND_BE12 in_BE12 reduce_BE12 dosage_BE12 IN_BE12 patient_BE12 WHO_BE12 be_BE12 concurrent_BE12 receive_BE12 other_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|tranquilizer|tricyclic antidepressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|tranquilizer|tricyclic antidepressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|tranquilizer|cns depressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|tranquilizer|cns depressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|tranquilizer|alcohol|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY rrb._RE2 
Meperidine|N|tranquilizer|sedative-hypnotic|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|tranquilizer|sedative-hypnotic|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|tranquilizer|barbiturate|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|tranquilizer|barbiturate|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|narcotic analgesic|anesthetic|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOENTITY general_BE12 BIOENTITY BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|narcotic analgesic|anesthetic|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOENTITY general_BE12 BIOENTITY BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|central nervous system depressant|narcotic analgesic|interaction_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 use_BE12 WITH_BE12 great_BE12 caution_BE12 AND_BE12 in_BE12 reduce_BE12 dosage_BE12 IN_BE12 patient_BE12 WHO_BE12 be_BE12 concurrent_BE12 receive_BE12 other_BE12 BIOENTITY general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|central nervous system depressant|narcotic analgesic|interaction_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 use_BE12 WITH_BE12 great_BE12 caution_BE12 AND_BE12 in_BE12 reduce_BE12 dosage_BE12 IN_BE12 patient_BE12 WHO_BE12 be_BE12 concurrent_BE12 receive_BE12 other_BE12 BIOENTITY general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|narcotic analgesic|tricyclic antidepressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|narcotic analgesic|tricyclic antidepressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|narcotic analgesic|cns depressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|narcotic analgesic|cns depressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|narcotic analgesic|alcohol|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY rrb._RE2 
Meperidine|N|narcotic analgesic|alcohol|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY rrb._RE2 
Meperidine|N|narcotic analgesic|sedative-hypnotic|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|narcotic analgesic|sedative-hypnotic|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|narcotic analgesic|barbiturate|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|narcotic analgesic|barbiturate|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|central nervous system depressant|anesthetic|interaction_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 use_BE12 WITH_BE12 great_BE12 caution_BE12 AND_BE12 in_BE12 reduce_BE12 dosage_BE12 IN_BE12 patient_BE12 WHO_BE12 be_BE12 concurrent_BE12 receive_BE12 other_BE12 BIOGENERAL_BE12 general_BE12 BIOENTITY BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|anesthetic|tricyclic antidepressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|anesthetic|cns depressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|anesthetic|alcohol|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY rrb._RE2 
Meperidine|N|anesthetic|sedative-hypnotic|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|anesthetic|barbiturate|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|central nervous system depressant|meperidine|interaction_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 BIOENTITY shall_RE2 be_RE2 use_RE2 WITH_RE2 great_RE2 caution_RE2 AND_RE2 in_RE2 reduce_RE2 dosage_RE2 IN_RE2 patient_RE2 WHO_RE2 be_RE2 concurrent_RE2 receive_RE2 other_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|central nervous system depressant|tricyclic antidepressant|interaction_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 use_BE12 WITH_BE12 great_BE12 caution_BE12 AND_BE12 in_BE12 reduce_BE12 dosage_BE12 IN_BE12 patient_BE12 WHO_BE12 be_BE12 concurrent_BE12 receive_BE12 other_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|central nervous system depressant|cns depressant|interaction_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 use_BE12 WITH_BE12 great_BE12 caution_BE12 AND_BE12 in_BE12 reduce_BE12 dosage_BE12 IN_BE12 patient_BE12 WHO_BE12 be_BE12 concurrent_BE12 receive_BE12 other_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|central nervous system depressant|alcohol|interaction_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 use_BE12 WITH_BE12 great_BE12 caution_BE12 AND_BE12 in_BE12 reduce_BE12 dosage_BE12 IN_BE12 patient_BE12 WHO_BE12 be_BE12 concurrent_BE12 receive_BE12 other_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY rrb._RE2 
Meperidine|N|central nervous system depressant|sedative-hypnotic|interaction_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 use_BE12 WITH_BE12 great_BE12 caution_BE12 AND_BE12 in_BE12 reduce_BE12 dosage_BE12 IN_BE12 patient_BE12 WHO_BE12 be_BE12 concurrent_BE12 receive_BE12 other_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|central nervous system depressant|barbiturate|interaction_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 use_BE12 WITH_BE12 great_BE12 caution_BE12 AND_BE12 in_BE12 reduce_BE12 dosage_BE12 IN_BE12 patient_BE12 WHO_BE12 be_BE12 concurrent_BE12 receive_BE12 other_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|tricyclic antidepressant|cns depressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY AND_BE12 other_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|tricyclic antidepressant|cns depressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY AND_BE12 other_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|tricyclic antidepressant|alcohol|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY AND_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY rrb._RE2 
Meperidine|N|sedative-hypnotic|tricyclic antidepressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|sedative-hypnotic|tricyclic antidepressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|barbiturate|tricyclic antidepressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOENTITY -RRB-_BE12 BIOENTITY AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|barbiturate|tricyclic antidepressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOENTITY -RRB-_BE12 BIOENTITY AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|cns depressant|alcohol|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 AND_LE1 other_LE1 BIOENTITY -LRB-_BE12 include_BE12 BIOENTITY rrb._RE2 
Meperidine|N|sedative-hypnotic|cns depressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|sedative-hypnotic|cns depressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|barbiturate|cns depressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|barbiturate|cns depressant|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Meperidine|N|sedative-hypnotic|alcohol|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY rrb._RE2 
Meperidine|N|barbiturate|alcohol|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 AND_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY rrb._RE2 
Meperidine|N|sedative-hypnotic|barbiturate|interaction_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 WITH_LE1 great_LE1 caution_LE1 AND_LE1 in_LE1 reduce_LE1 dosage_LE1 IN_LE1 patient_LE1 WHO_LE1 be_LE1 concurrent_LE1 receive_LE1 other_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 include_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 AND_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 include_RE2 BIOGENERAL_RE2 rrb._RE2 
Mephenytoin|N|anticonvulsant|valproic acid|those_LE1 BIOENTITY include_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mephenytoin|N|anticonvulsant|divalproex sodium|those_LE1 BIOENTITY include_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mephenytoin|N|anticonvulsant|phenobarbital|those_LE1 BIOENTITY include_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mephenytoin|N|divalproex sodium|valproic acid|those_LE1 BIOGENERAL_LE1 include_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Mephenytoin|N|valproic acid|phenobarbital|those_LE1 BIOGENERAL_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Mephenytoin|N|valproic acid|phenobarbital|those_LE1 BIOGENERAL_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Mephenytoin|N|divalproex sodium|phenobarbital|those_LE1 BIOGENERAL_LE1 include_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mephenytoin|N|furosemide|theophylline|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 certain_LE1 heart_LE1 medicine_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY please_RE2 note_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|anti-infective medicine|theophylline|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 certain_LE1 heart_LE1 medicine_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY please_RE2 note_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|anti-infective medicine|theophylline|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 certain_LE1 heart_LE1 medicine_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY please_RE2 note_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|warfarin|theophylline|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOGENERAL_LE1 BIOENTITY certain_BE12 heart_BE12 medicine_BE12 birth_BE12 control_BE12 pill_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY please_RE2 note_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|warfarin|theophylline|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOGENERAL_LE1 BIOENTITY certain_BE12 heart_BE12 medicine_BE12 birth_BE12 control_BE12 pill_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY please_RE2 note_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|theophylline|mephenytoin|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 certain_LE1 heart_LE1 medicine_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY please_BE12 note_BE12 that_BE12 BIOENTITY may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|steroid medication|theophylline|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOENTITY BIOGENERAL_BE12 certain_BE12 heart_BE12 medicine_BE12 birth_BE12 control_BE12 pill_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY please_RE2 note_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|steroid medication|theophylline|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOENTITY BIOGENERAL_BE12 certain_BE12 heart_BE12 medicine_BE12 birth_BE12 control_BE12 pill_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY please_RE2 note_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|anti-infective medicine|furosemide|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 certain_LE1 heart_LE1 medicine_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 please_RE2 note_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|anti-infective medicine|furosemide|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 certain_LE1 heart_LE1 medicine_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 please_RE2 note_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|warfarin|furosemide|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOGENERAL_LE1 BIOENTITY certain_BE12 heart_BE12 medicine_BE12 birth_BE12 control_BE12 pill_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 please_RE2 note_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|warfarin|furosemide|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOGENERAL_LE1 BIOENTITY certain_BE12 heart_BE12 medicine_BE12 birth_BE12 control_BE12 pill_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 please_RE2 note_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|furosemide|mephenytoin|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 certain_LE1 heart_LE1 medicine_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 please_BE12 note_BE12 that_BE12 BIOENTITY may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|steroid medication|furosemide|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOENTITY BIOGENERAL_BE12 certain_BE12 heart_BE12 medicine_BE12 birth_BE12 control_BE12 pill_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 please_RE2 note_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|steroid medication|furosemide|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOENTITY BIOGENERAL_BE12 certain_BE12 heart_BE12 medicine_BE12 birth_BE12 control_BE12 pill_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 please_RE2 note_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|warfarin|anti-infective medicine|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOGENERAL_LE1 BIOENTITY certain_BE12 heart_BE12 medicine_BE12 birth_BE12 control_BE12 pill_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 please_RE2 note_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|anti-infective medicine|mephenytoin|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 certain_LE1 heart_LE1 medicine_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 please_BE12 note_BE12 that_BE12 BIOENTITY may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|anti-infective medicine|mephenytoin|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 certain_LE1 heart_LE1 medicine_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 please_BE12 note_BE12 that_BE12 BIOENTITY may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|steroid medication|anti-infective medicine|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOENTITY BIOGENERAL_BE12 certain_BE12 heart_BE12 medicine_BE12 birth_BE12 control_BE12 pill_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 please_RE2 note_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|warfarin|mephenytoin|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOGENERAL_LE1 BIOENTITY certain_BE12 heart_BE12 medicine_BE12 birth_BE12 control_BE12 pill_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 please_BE12 note_BE12 that_BE12 BIOENTITY may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|warfarin|mephenytoin|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOGENERAL_LE1 BIOENTITY certain_BE12 heart_BE12 medicine_BE12 birth_BE12 control_BE12 pill_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 please_BE12 note_BE12 that_BE12 BIOENTITY may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|steroid medication|warfarin|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOENTITY BIOENTITY certain_RE2 heart_RE2 medicine_RE2 birth_RE2 control_RE2 pill_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 please_RE2 note_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|mephenytoin|mephenytoin|BIOENTITY may_BE12 also_BE12 affect_BE12 the_BE12 effect_BE12 of_BE12 other_BE12 drug_BE12 which_BE12 include_BE12 some_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 certain_BE12 heart_BE12 medicine_BE12 birth_BE12 control_BE12 pill_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 please_BE12 note_BE12 that_BE12 BIOENTITY may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|steroid medication|mephenytoin|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOENTITY BIOGENERAL_BE12 certain_BE12 heart_BE12 medicine_BE12 birth_BE12 control_BE12 pill_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 please_BE12 note_BE12 that_BE12 BIOENTITY may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mephenytoin|N|steroid medication|mephenytoin|BIOGENERAL_LE1 may_LE1 also_LE1 affect_LE1 the_LE1 effect_LE1 of_LE1 other_LE1 drug_LE1 which_LE1 include_LE1 some_LE1 BIOENTITY BIOGENERAL_BE12 certain_BE12 heart_BE12 medicine_BE12 birth_BE12 control_BE12 pill_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 please_BE12 note_BE12 that_BE12 BIOENTITY may_RE2 interact_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 not_RE2 list_RE2 here_RE2 
Mequitazine|N|cns depressant|antichlolinergic|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mequitazine|N|cns depressant|tca|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mequitazine|N|cns depressant|maoi|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mequitazine|N|cns depressant|alcohol|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mequitazine|N|antichlolinergic|tca|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mequitazine|N|antichlolinergic|tca|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mequitazine|N|antichlolinergic|maoi|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mequitazine|N|antichlolinergic|maoi|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mequitazine|N|antichlolinergic|alcohol|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mequitazine|N|antichlolinergic|alcohol|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mequitazine|N|tca|maoi|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Mequitazine|N|tca|maoi|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Mequitazine|N|tca|alcohol|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mequitazine|N|tca|alcohol|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mequitazine|N|maoi|alcohol|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Mequitazine|N|maoi|alcohol|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Meropenem|N|probenecid|meropenem|BIOENTITY compete_BE12 with_BE12 BIOGENERAL_BE12 for_BE12 active_BE12 tubular_BE12 secretion_BE12 and_BE12 thus_BE12 inhibit_BE12 the_BE12 renal_BE12 excretion_BE12 of_BE12 BIOENTITY 
Meropenem|N|meropenem|meropenem|BIOGENERAL_LE1 compete_LE1 with_LE1 BIOENTITY for_BE12 active_BE12 tubular_BE12 secretion_BE12 and_BE12 thus_BE12 inhibit_BE12 the_BE12 renal_BE12 excretion_BE12 of_BE12 BIOENTITY 
Meropenem|N|valproic acid|valproate|there_LE1 be_LE1 evidence_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 reduce_LE1 serum_LE1 level_LE1 of_LE1 BIOENTITY to_BE12 subtherapeutic_BE12 level_BE12 -LRB-_BE12 therapeutic_BE12 range_BE12 consider_BE12 to_BE12 be_BE12 NUM_BE12 to_BE12 NUM_BE12 total_BE12 BIOENTITY rrb._RE2 
Meropenem|N|meropenem|valproate|there_LE1 be_LE1 evidence_LE1 that_LE1 BIOENTITY may_BE12 reduce_BE12 serum_BE12 level_BE12 of_BE12 BIOGENERAL_BE12 to_BE12 subtherapeutic_BE12 level_BE12 -LRB-_BE12 therapeutic_BE12 range_BE12 consider_BE12 to_BE12 be_BE12 NUM_BE12 to_BE12 NUM_BE12 total_BE12 BIOENTITY rrb._RE2 
Metaraminol|N|aramine|digitali|BIOENTITY shall_BE12 be_BE12 use_BE12 with_BE12 caution_BE12 in_BE12 digitalized_BE12 patient_BE12 since_BE12 the_BE12 combination_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 cause_RE2 ectopic_RE2 arrhythmia_RE2 
Metaraminol|N|aramine|sympathomimetic amine|BIOENTITY shall_BE12 be_BE12 use_BE12 with_BE12 caution_BE12 in_BE12 digitalized_BE12 patient_BE12 since_BE12 the_BE12 combination_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 cause_RE2 ectopic_RE2 arrhythmia_RE2 
Metaraminol|N|monoamine oxidase inhibitor|tricyclic antidepressant|BIOENTITY or_BE12 BIOENTITY may_RE2 potentiate_RE2 the_RE2 action_RE2 of_RE2 BIOGENERAL_RE2 
Metaxalone|N|alcohol|barbiturate|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY BIOENTITY and_RE2 other_RE2 BIOGENERAL_RE2 
Metaxalone|N|barbiturate|cns depressant|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 other_BE12 BIOENTITY 
Metaxalone|N|alcohol|cns depressant|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 other_BE12 BIOENTITY 
Methazolamide|N|methazolamide|carbonic anhydrase inhibitor|caution_LE1 be_LE1 advise_LE1 for_LE1 patient_LE1 receive_LE1 highdose_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY concomitant_BE12 as_BE12 anorexia_BE12 tachypnea_BE12 lethargy_BE12 coma_BE12 and_BE12 death_BE12 have_BE12 be_BE12 report_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 highdose_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Methazolamide|N|methazolamide|aspirin|caution_LE1 be_LE1 advise_LE1 for_LE1 patient_LE1 receive_LE1 highdose_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY concomitant_BE12 as_BE12 anorexia_BE12 tachypnea_BE12 lethargy_BE12 coma_BE12 and_BE12 death_BE12 have_BE12 be_BE12 report_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 highdose_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Methazolamide|N|aspirin|carbonic anhydrase inhibitor|caution_LE1 be_LE1 advise_LE1 for_LE1 patient_LE1 receive_LE1 highdose_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 concomitant_BE12 as_BE12 anorexia_BE12 tachypnea_BE12 lethargy_BE12 coma_BE12 and_BE12 death_BE12 have_BE12 be_BE12 report_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 highdose_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Methazolamide|N|aspirin|aspirin|caution_LE1 be_LE1 advise_LE1 for_LE1 patient_LE1 receive_LE1 highdose_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 concomitant_BE12 as_BE12 anorexia_BE12 tachypnea_BE12 lethargy_BE12 coma_BE12 and_BE12 death_BE12 have_BE12 be_BE12 report_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 highdose_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Methimazole|N|anticoagulant|methimazole|BIOENTITY -LRB-_BE12 oral_BE12 -RRB-_BE12 :_BE12 the_BE12 activity_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 may_BE12 be_BE12 potentiate_BE12 by_BE12 antivitamink_BE12 activity_BE12 attribute_BE12 to_BE12 BIOENTITY 
Methimazole|N|anticoagulant|anticoagulant|BIOENTITY -LRB-_BE12 oral_BE12 -RRB-_BE12 :_BE12 the_BE12 activity_BE12 of_BE12 oral_BE12 BIOENTITY may_RE2 be_RE2 potentiate_RE2 by_RE2 antivitamink_RE2 activity_RE2 attribute_RE2 to_RE2 BIOGENERAL_RE2 
Methimazole|N|digitalis glycoside|digitalis glycoside|BIOENTITY :_BE12 serum_BE12 digitalis_BE12 level_BE12 may_BE12 be_BE12 increase_BE12 when_BE12 hyperthyroid_BE12 patient_BE12 on_BE12 stable_BE12 BIOENTITY regimen_RE2 become_RE2 euthyroid_RE2 
Methimazole|N|theophylline|theophylline|BIOENTITY :_BE12 BIOGENERAL_BE12 clearance_BE12 may_BE12 decrease_BE12 when_BE12 hyperthyroid_BE12 patient_BE12 on_BE12 stable_BE12 BIOENTITY regimen_RE2 become_RE2 euthyroid_RE2 
Methimazole|N|theophylline|theophylline|BIOGENERAL_LE1 :_LE1 BIOENTITY clearance_BE12 may_BE12 decrease_BE12 when_BE12 hyperthyroid_BE12 patient_BE12 on_BE12 stable_BE12 BIOENTITY regimen_RE2 become_RE2 euthyroid_RE2 
Methimazole|N|theophylline|theophylline|BIOENTITY :_BE12 BIOENTITY clearance_RE2 may_RE2 decrease_RE2 when_RE2 hyperthyroid_RE2 patient_RE2 on_RE2 stable_RE2 BIOGENERAL_RE2 regimen_RE2 become_RE2 euthyroid_RE2 
Methotrimeprazine|N|opioid|opioid|dosage_LE1 of_LE1 concomitant_LE1 administer_LE1 BIOENTITY shall_BE12 be_BE12 reduce_BE12 by_BE12 approximate_BE12 half_BE12 because_BE12 BIOGENERAL_BE12 amplify_BE12 the_BE12 therapeutic_BE12 action_BE12 and_BE12 sideeffect_BE12 of_BE12 BIOENTITY 
Methotrimeprazine|N|tramadol|ultram|combination_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 be_RE2 associate_RE2 with_RE2 increase_RE2 risk_RE2 of_RE2 seizure_RE2 
Methotrimeprazine|N|benzodiazepine|barbiturate|additive_LE1 sedative_LE1 effect_LE1 and_LE1 confusional_LE1 state_LE1 may_LE1 emerge_LE1 if_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOENTITY or_BE12 BIOENTITY 
Methotrimeprazine|N|tricyclic antidepressant|antiparkinsonian-agent|exert_LE1 particular_LE1 caution_LE1 in_LE1 combine_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 :_RE2 particular_RE2 the_RE2 elderly_RE2 may_RE2 develop_RE2 delirium_RE2 high_RE2 fever_RE2 severe_RE2 obstipation_RE2 even_RE2 ileus_RE2 and_RE2 glaucoma_RE2 
Methotrimeprazine|N|anticholinergic drug|tricyclic antidepressant|exert_LE1 particular_LE1 caution_LE1 in_LE1 combine_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 BIOENTITY -LRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 :_RE2 particular_RE2 the_RE2 elderly_RE2 may_RE2 develop_RE2 delirium_RE2 high_RE2 fever_RE2 severe_RE2 obstipation_RE2 even_RE2 ileus_RE2 and_RE2 glaucoma_RE2 
Methotrimeprazine|N|anticholinergic drug|antiparkinsonian-agent|exert_LE1 particular_LE1 caution_LE1 in_LE1 combine_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 :_RE2 particular_RE2 the_RE2 elderly_RE2 may_RE2 develop_RE2 delirium_RE2 high_RE2 fever_RE2 severe_RE2 obstipation_RE2 even_RE2 ileus_RE2 and_RE2 glaucoma_RE2 
Methotrimeprazine|N|ephedrine|amphetamine|BIOGENERAL_LE1 and_LE1 stimulantes_LE1 of_LE1 the_LE1 BIOENTITY type_RE2 may_RE2 counteract_RE2 the_RE2 specific_RE2 action_RE2 of_RE2 BIOGENERAL_RE2 
Methotrimeprazine|N|caffeine|amphetamine|BIOENTITY and_BE12 stimulantes_BE12 of_BE12 the_BE12 BIOENTITY type_RE2 may_RE2 counteract_RE2 the_RE2 specific_RE2 action_RE2 of_RE2 BIOGENERAL_RE2 
Methotrimeprazine|N|caffeine|amphetamine|BIOENTITY and_BE12 stimulantes_BE12 of_BE12 the_BE12 BIOENTITY type_RE2 may_RE2 counteract_RE2 the_RE2 specific_RE2 action_RE2 of_RE2 BIOGENERAL_RE2 
Methsuximide|N|phenytoin|phenobarbital|since_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 may_LE1 interact_LE1 with_LE1 concurrent_LE1 administer_LE1 BIOGENERAL_LE1 periodic_LE1 serum_LE1 level_LE1 determination_LE1 of_LE1 these_LE1 drug_LE1 may_LE1 be_LE1 necessary_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 may_LE1 increase_LE1 the_LE1 plasma_LE1 concentration_LE1 of_LE1 BIOENTITY and_BE12 BIOENTITY rrb._RE2 
Methsuximide|N|celontin|phenobarbital|since_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 interact_BE12 with_BE12 concurrent_BE12 administer_BE12 BIOGENERAL_BE12 periodic_BE12 serum_BE12 level_BE12 determination_BE12 of_BE12 these_BE12 drug_BE12 may_BE12 be_BE12 necessary_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 may_BE12 increase_BE12 the_BE12 plasma_BE12 concentration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Methsuximide|N|methsuximide|phenobarbital|since_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 may_BE12 interact_BE12 with_BE12 concurrent_BE12 administer_BE12 BIOGENERAL_BE12 periodic_BE12 serum_BE12 level_BE12 determination_BE12 of_BE12 these_BE12 drug_BE12 may_BE12 be_BE12 necessary_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 may_BE12 increase_BE12 the_BE12 plasma_BE12 concentration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Methsuximide|N|antiepileptic drug|phenobarbital|since_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 may_LE1 interact_LE1 with_LE1 concurrent_LE1 administer_LE1 BIOENTITY periodic_BE12 serum_BE12 level_BE12 determination_BE12 of_BE12 these_BE12 drug_BE12 may_BE12 be_BE12 necessary_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 may_BE12 increase_BE12 the_BE12 plasma_BE12 concentration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Methsuximide|N|celontin|phenytoin|since_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 interact_BE12 with_BE12 concurrent_BE12 administer_BE12 BIOGENERAL_BE12 periodic_BE12 serum_BE12 level_BE12 determination_BE12 of_BE12 these_BE12 drug_BE12 may_BE12 be_BE12 necessary_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 may_BE12 increase_BE12 the_BE12 plasma_BE12 concentration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Methsuximide|N|methsuximide|phenytoin|since_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 may_BE12 interact_BE12 with_BE12 concurrent_BE12 administer_BE12 BIOGENERAL_BE12 periodic_BE12 serum_BE12 level_BE12 determination_BE12 of_BE12 these_BE12 drug_BE12 may_BE12 be_BE12 necessary_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 may_BE12 increase_BE12 the_BE12 plasma_BE12 concentration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Methsuximide|N|antiepileptic drug|phenytoin|since_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 may_LE1 interact_LE1 with_LE1 concurrent_LE1 administer_LE1 BIOENTITY periodic_BE12 serum_BE12 level_BE12 determination_BE12 of_BE12 these_BE12 drug_BE12 may_BE12 be_BE12 necessary_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 may_BE12 increase_BE12 the_BE12 plasma_BE12 concentration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Methsuximide|N|celontin|methsuximide|since_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 may_RE2 interact_RE2 with_RE2 concurrent_RE2 administer_RE2 BIOGENERAL_RE2 periodic_RE2 serum_RE2 level_RE2 determination_RE2 of_RE2 these_RE2 drug_RE2 may_RE2 be_RE2 necessary_RE2 -LRB-_RE2 eg_RE2 BIOGENERAL_RE2 may_RE2 increase_RE2 the_RE2 plasma_RE2 concentration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Methsuximide|N|celontin|methsuximide|since_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 interact_BE12 with_BE12 concurrent_BE12 administer_BE12 BIOGENERAL_BE12 periodic_BE12 serum_BE12 level_BE12 determination_BE12 of_BE12 these_BE12 drug_BE12 may_BE12 be_BE12 necessary_BE12 -LRB-_BE12 eg_BE12 BIOENTITY may_RE2 increase_RE2 the_RE2 plasma_RE2 concentration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Methsuximide|N|methsuximide|methsuximide|since_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 may_BE12 interact_BE12 with_BE12 concurrent_BE12 administer_BE12 BIOGENERAL_BE12 periodic_BE12 serum_BE12 level_BE12 determination_BE12 of_BE12 these_BE12 drug_BE12 may_BE12 be_BE12 necessary_BE12 -LRB-_BE12 eg_BE12 BIOENTITY may_RE2 increase_RE2 the_RE2 plasma_RE2 concentration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Methsuximide|N|antiepileptic drug|methsuximide|since_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 may_LE1 interact_LE1 with_LE1 concurrent_LE1 administer_LE1 BIOENTITY periodic_BE12 serum_BE12 level_BE12 determination_BE12 of_BE12 these_BE12 drug_BE12 may_BE12 be_BE12 necessary_BE12 -LRB-_BE12 eg_BE12 BIOENTITY may_RE2 increase_RE2 the_RE2 plasma_RE2 concentration_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Methyclothiazide|N|steroid|acth|hypokalemia_LE1 may_LE1 develop_LE1 during_LE1 concomitant_LE1 use_LE1 of_LE1 BIOENTITY or_BE12 BIOENTITY 
Methyclothiazide|N|lithium|lithium|BIOENTITY renal_BE12 clearance_BE12 be_BE12 reduce_BE12 by_BE12 BIOGENERAL_BE12 increase_BE12 the_BE12 risk_BE12 of_BE12 BIOENTITY toxicity_RE2 
Methyclothiazide|N|thiazide|lithium|BIOGENERAL_LE1 renal_LE1 clearance_LE1 be_LE1 reduce_LE1 by_LE1 BIOENTITY increase_BE12 the_BE12 risk_BE12 of_BE12 BIOENTITY toxicity_RE2 
Methyclothiazide|N|ganglionic adrenergic blocking drug|peripheral adrenergic blocking drug|potentiation_LE1 occur_LE1 with_LE1 BIOENTITY or_BE12 BIOENTITY 
Methyldopa|N|lithium|lithium|when_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY be_BE12 give_BE12 concomitant_BE12 the_BE12 patient_BE12 shall_BE12 be_BE12 careful_BE12 monitor_BE12 for_BE12 symptom_BE12 of_BE12 BIOENTITY toxicity_RE2 
Methyldopa|N|methyldopa|lithium|when_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 be_BE12 give_BE12 concomitant_BE12 the_BE12 patient_BE12 shall_BE12 be_BE12 careful_BE12 monitor_BE12 for_BE12 symptom_BE12 of_BE12 BIOENTITY toxicity_RE2 
Methyldopa|N|ferrous sulfate|ferrous gluconate|several_LE1 study_LE1 demonstrate_LE1 decrease_LE1 in_LE1 the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 when_LE1 it_LE1 be_LE1 ingest_LE1 with_LE1 BIOENTITY or_BE12 BIOENTITY 
Methyldopa|N|ferrous sulfate|ferrous gluconate|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY or_BE12 BIOENTITY be_RE2 not_RE2 recommend_RE2 
Methyldopa|N|methyldopa|vma|BIOENTITY do_BE12 not_BE12 interfere_BE12 with_BE12 measurement_BE12 of_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 test_RE2 for_RE2 pheochromocytoma_RE2 by_RE2 those_RE2 method_RE2 which_RE2 convert_RE2 BIOGENERAL_RE2 to_RE2 BIOGENERAL_RE2 
Methyldopa|N|vma|vma|BIOGENERAL_LE1 do_LE1 not_LE1 interfere_LE1 with_LE1 measurement_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 test_BE12 for_BE12 pheochromocytoma_BE12 by_BE12 those_BE12 method_BE12 which_BE12 convert_BE12 BIOENTITY to_RE2 BIOGENERAL_RE2 
Methyldopa|N|vma|vma|BIOGENERAL_LE1 do_LE1 not_LE1 interfere_LE1 with_LE1 measurement_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 test_BE12 for_BE12 pheochromocytoma_BE12 by_BE12 those_BE12 method_BE12 which_BE12 convert_BE12 BIOENTITY to_RE2 BIOGENERAL_RE2 
Methyldopa|N|vma|vanillylmandelic acid|BIOGENERAL_LE1 do_LE1 not_LE1 interfere_LE1 with_LE1 measurement_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 test_RE2 for_RE2 pheochromocytoma_RE2 by_RE2 those_RE2 method_RE2 which_RE2 convert_RE2 BIOGENERAL_RE2 to_RE2 BIOGENERAL_RE2 
Methyldopa|N|vma|vanillin|BIOGENERAL_LE1 do_LE1 not_LE1 interfere_LE1 with_LE1 measurement_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 test_BE12 for_BE12 pheochromocytoma_BE12 by_BE12 those_BE12 method_BE12 which_BE12 convert_BE12 BIOGENERAL_BE12 to_BE12 BIOENTITY 
Methyldopa|N|vma|vanillin|BIOGENERAL_LE1 do_LE1 not_LE1 interfere_LE1 with_LE1 measurement_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 test_BE12 for_BE12 pheochromocytoma_BE12 by_BE12 those_BE12 method_BE12 which_BE12 convert_BE12 BIOGENERAL_BE12 to_BE12 BIOENTITY 
Methyldopa|N|methyldopa|vma|BIOENTITY do_BE12 not_BE12 interfere_BE12 with_BE12 measurement_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 test_BE12 for_BE12 pheochromocytoma_BE12 by_BE12 those_BE12 method_BE12 which_BE12 convert_BE12 BIOENTITY to_RE2 BIOGENERAL_RE2 
Methyldopa|N|methyldopa|vma|BIOENTITY do_BE12 not_BE12 interfere_BE12 with_BE12 measurement_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 test_BE12 for_BE12 pheochromocytoma_BE12 by_BE12 those_BE12 method_BE12 which_BE12 convert_BE12 BIOENTITY to_RE2 BIOGENERAL_RE2 
Methyldopa|N|methyldopa|vanillylmandelic acid|BIOENTITY do_BE12 not_BE12 interfere_BE12 with_BE12 measurement_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 test_RE2 for_RE2 pheochromocytoma_RE2 by_RE2 those_RE2 method_RE2 which_RE2 convert_RE2 BIOGENERAL_RE2 to_RE2 BIOGENERAL_RE2 
Methyldopa|N|methyldopa|vanillin|BIOENTITY do_BE12 not_BE12 interfere_BE12 with_BE12 measurement_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 test_BE12 for_BE12 pheochromocytoma_BE12 by_BE12 those_BE12 method_BE12 which_BE12 convert_BE12 BIOGENERAL_BE12 to_BE12 BIOENTITY 
Methyldopa|N|methyldopa|vanillin|BIOENTITY do_BE12 not_BE12 interfere_BE12 with_BE12 measurement_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 test_BE12 for_BE12 pheochromocytoma_BE12 by_BE12 those_BE12 method_BE12 which_BE12 convert_BE12 BIOGENERAL_BE12 to_BE12 BIOENTITY 
Methyldopa|N|vanillylmandelic acid|vma|BIOGENERAL_LE1 do_LE1 not_LE1 interfere_LE1 with_LE1 measurement_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 test_BE12 for_BE12 pheochromocytoma_BE12 by_BE12 those_BE12 method_BE12 which_BE12 convert_BE12 BIOENTITY to_RE2 BIOGENERAL_RE2 
Methyldopa|N|vanillylmandelic acid|vma|BIOGENERAL_LE1 do_LE1 not_LE1 interfere_LE1 with_LE1 measurement_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 test_BE12 for_BE12 pheochromocytoma_BE12 by_BE12 those_BE12 method_BE12 which_BE12 convert_BE12 BIOENTITY to_RE2 BIOGENERAL_RE2 
Methyldopa|N|vma|vanillin|BIOGENERAL_LE1 do_LE1 not_LE1 interfere_LE1 with_LE1 measurement_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 test_LE1 for_LE1 pheochromocytoma_LE1 by_LE1 those_LE1 method_LE1 which_LE1 convert_LE1 BIOENTITY to_BE12 BIOENTITY 
Methyldopa|N|vanillylmandelic acid|vanillin|BIOGENERAL_LE1 do_LE1 not_LE1 interfere_LE1 with_LE1 measurement_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 test_BE12 for_BE12 pheochromocytoma_BE12 by_BE12 those_BE12 method_BE12 which_BE12 convert_BE12 BIOGENERAL_BE12 to_BE12 BIOENTITY 
Methyldopa|N|vanillylmandelic acid|vanillin|BIOGENERAL_LE1 do_LE1 not_LE1 interfere_LE1 with_LE1 measurement_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 test_BE12 for_BE12 pheochromocytoma_BE12 by_BE12 those_BE12 method_BE12 which_BE12 convert_BE12 BIOGENERAL_BE12 to_BE12 BIOENTITY 
Methylergonovine|N|ergot alkaloid drug|dihydroergotamine|cyp_LE1 inhibitor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 there_LE1 have_LE1 be_LE1 rare_LE1 report_LE1 of_LE1 serious_LE1 adverse_LE1 event_LE1 in_LE1 connection_LE1 with_LE1 the_LE1 coadministration_LE1 of_LE1 certain_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 and_RE2 potent_RE2 cyp_RE2 inhibitor_RE2 result_RE2 in_RE2 vasospasm_RE2 lead_RE2 to_RE2 cerebral_RE2 ischemia_RE2 and_RE2 ischemia_RE2 of_RE2 the_RE2 extremity_RE2 
Methylergonovine|N|macrolide antibiotic|ergot alkaloid drug|cyp_LE1 inhibitor_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 there_BE12 have_BE12 be_BE12 rare_BE12 report_BE12 of_BE12 serious_BE12 adverse_BE12 event_BE12 in_BE12 connection_BE12 with_BE12 the_BE12 coadministration_BE12 of_BE12 certain_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 and_RE2 potent_RE2 cyp_RE2 inhibitor_RE2 result_RE2 in_RE2 vasospasm_RE2 lead_RE2 to_RE2 cerebral_RE2 ischemia_RE2 and_RE2 ischemia_RE2 of_RE2 the_RE2 extremity_RE2 
Methylergonovine|N|protease inhibitor|ergot alkaloid drug|cyp_LE1 inhibitor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 there_BE12 have_BE12 be_BE12 rare_BE12 report_BE12 of_BE12 serious_BE12 adverse_BE12 event_BE12 in_BE12 connection_BE12 with_BE12 the_BE12 coadministration_BE12 of_BE12 certain_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 and_RE2 potent_RE2 cyp_RE2 inhibitor_RE2 result_RE2 in_RE2 vasospasm_RE2 lead_RE2 to_RE2 cerebral_RE2 ischemia_RE2 and_RE2 ischemia_RE2 of_RE2 the_RE2 extremity_RE2 
Methylergonovine|N|ergot alkaloid drug|ergotamine|cyp_LE1 inhibitor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 there_LE1 have_LE1 be_LE1 rare_LE1 report_LE1 of_LE1 serious_LE1 adverse_LE1 event_LE1 in_LE1 connection_LE1 with_LE1 the_LE1 coadministration_LE1 of_LE1 certain_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 and_RE2 potent_RE2 cyp_RE2 inhibitor_RE2 result_RE2 in_RE2 vasospasm_RE2 lead_RE2 to_RE2 cerebral_RE2 ischemia_RE2 and_RE2 ischemia_RE2 of_RE2 the_RE2 extremity_RE2 
Methylergonovine|N|macrolide antibiotic|dihydroergotamine|cyp_LE1 inhibitor_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 there_BE12 have_BE12 be_BE12 rare_BE12 report_BE12 of_BE12 serious_BE12 adverse_BE12 event_BE12 in_BE12 connection_BE12 with_BE12 the_BE12 coadministration_BE12 of_BE12 certain_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 and_RE2 potent_RE2 cyp_RE2 inhibitor_RE2 result_RE2 in_RE2 vasospasm_RE2 lead_RE2 to_RE2 cerebral_RE2 ischemia_RE2 and_RE2 ischemia_RE2 of_RE2 the_RE2 extremity_RE2 
Methylergonovine|N|protease inhibitor|dihydroergotamine|cyp_LE1 inhibitor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 there_BE12 have_BE12 be_BE12 rare_BE12 report_BE12 of_BE12 serious_BE12 adverse_BE12 event_BE12 in_BE12 connection_BE12 with_BE12 the_BE12 coadministration_BE12 of_BE12 certain_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 and_RE2 potent_RE2 cyp_RE2 inhibitor_RE2 result_RE2 in_RE2 vasospasm_RE2 lead_RE2 to_RE2 cerebral_RE2 ischemia_RE2 and_RE2 ischemia_RE2 of_RE2 the_RE2 extremity_RE2 
Methylergonovine|N|dihydroergotamine|ergotamine|cyp_LE1 inhibitor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 there_LE1 have_LE1 be_LE1 rare_LE1 report_LE1 of_LE1 serious_LE1 adverse_LE1 event_LE1 in_LE1 connection_LE1 with_LE1 the_LE1 coadministration_LE1 of_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 and_RE2 potent_RE2 cyp_RE2 inhibitor_RE2 result_RE2 in_RE2 vasospasm_RE2 lead_RE2 to_RE2 cerebral_RE2 ischemia_RE2 and_RE2 ischemia_RE2 of_RE2 the_RE2 extremity_RE2 
Methylergonovine|N|macrolide antibiotic|protease inhibitor|cyp_LE1 inhibitor_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 there_RE2 have_RE2 be_RE2 rare_RE2 report_RE2 of_RE2 serious_RE2 adverse_RE2 event_RE2 in_RE2 connection_RE2 with_RE2 the_RE2 coadministration_RE2 of_RE2 certain_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 and_RE2 potent_RE2 cyp_RE2 inhibitor_RE2 result_RE2 in_RE2 vasospasm_RE2 lead_RE2 to_RE2 cerebral_RE2 ischemia_RE2 and_RE2 ischemia_RE2 of_RE2 the_RE2 extremity_RE2 
Methylergonovine|N|macrolide antibiotic|ergotamine|cyp_LE1 inhibitor_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 there_BE12 have_BE12 be_BE12 rare_BE12 report_BE12 of_BE12 serious_BE12 adverse_BE12 event_BE12 in_BE12 connection_BE12 with_BE12 the_BE12 coadministration_BE12 of_BE12 certain_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 and_RE2 potent_RE2 cyp_RE2 inhibitor_RE2 result_RE2 in_RE2 vasospasm_RE2 lead_RE2 to_RE2 cerebral_RE2 ischemia_RE2 and_RE2 ischemia_RE2 of_RE2 the_RE2 extremity_RE2 
Methylergonovine|N|protease inhibitor|ergotamine|cyp_LE1 inhibitor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 there_BE12 have_BE12 be_BE12 rare_BE12 report_BE12 of_BE12 serious_BE12 adverse_BE12 event_BE12 in_BE12 connection_BE12 with_BE12 the_BE12 coadministration_BE12 of_BE12 certain_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 and_RE2 potent_RE2 cyp_RE2 inhibitor_RE2 result_RE2 in_RE2 vasospasm_RE2 lead_RE2 to_RE2 cerebral_RE2 ischemia_RE2 and_RE2 ischemia_RE2 of_RE2 the_RE2 extremity_RE2 
Methylergonovine|N|ketoconazole|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|azole antifungal|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|erythromycin|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|macrolide antibiotic|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|itraconazole|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY rrb._RE2 
Methylergonovine|N|reverse transcriptase inhibitor|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|hiv protease inhibitor|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|hiv protease inhibitor|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|clarithromycin|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|troleandomycin|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|nelfinavir|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|nelfinavir|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|delavirdine|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|delavirdine|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|ritonavir|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|ritonavir|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|indinavir|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|indinavir|itraconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|azole antifungal|ketoconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|erythromycin|ketoconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|macrolide antibiotic|ketoconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|ketoconazole|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|reverse transcriptase inhibitor|ketoconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|hiv protease inhibitor|ketoconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|hiv protease inhibitor|ketoconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|clarithromycin|ketoconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|troleandomycin|ketoconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|nelfinavir|ketoconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|nelfinavir|ketoconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|delavirdine|ketoconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|delavirdine|ketoconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|ritonavir|ketoconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|ritonavir|ketoconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|indinavir|ketoconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|indinavir|ketoconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|erythromycin|azole antifungal|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|macrolide antibiotic|azole antifungal|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|azole antifungal|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|reverse transcriptase inhibitor|azole antifungal|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|hiv protease inhibitor|azole antifungal|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|hiv protease inhibitor|azole antifungal|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|clarithromycin|azole antifungal|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|troleandomycin|azole antifungal|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|nelfinavir|azole antifungal|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|nelfinavir|azole antifungal|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|delavirdine|azole antifungal|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|delavirdine|azole antifungal|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|ritonavir|azole antifungal|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|ritonavir|azole antifungal|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|indinavir|azole antifungal|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|indinavir|azole antifungal|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|macrolide antibiotic|erythromycin|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|erythromycin|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|erythromycin|reverse transcriptase inhibitor|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|erythromycin|hiv protease inhibitor|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|erythromycin|clarithromycin|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|erythromycin|troleandomycin|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|erythromycin|nelfinavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|erythromycin|delavirdine|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|erythromycin|ritonavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|erythromycin|indinavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|macrolide antibiotic|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|macrolide antibiotic|reverse transcriptase inhibitor|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|macrolide antibiotic|hiv protease inhibitor|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|macrolide antibiotic|clarithromycin|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|macrolide antibiotic|troleandomycin|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|macrolide antibiotic|nelfinavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|macrolide antibiotic|delavirdine|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|macrolide antibiotic|ritonavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|macrolide antibiotic|indinavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|reverse transcriptase inhibitor|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|hiv protease inhibitor|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|hiv protease inhibitor|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|clarithromycin|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|troleandomycin|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|nelfinavir|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|nelfinavir|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|delavirdine|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|delavirdine|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|ritonavir|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|ritonavir|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|indinavir|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|indinavir|voriconazole|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylergonovine|N|hiv protease inhibitor|reverse transcriptase inhibitor|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|clarithromycin|reverse transcriptase inhibitor|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|troleandomycin|reverse transcriptase inhibitor|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|reverse transcriptase inhibitor|nelfinavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|reverse transcriptase inhibitor|delavirdine|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|reverse transcriptase inhibitor|ritonavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|reverse transcriptase inhibitor|indinavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|clarithromycin|hiv protease inhibitor|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|troleandomycin|hiv protease inhibitor|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|hiv protease inhibitor|nelfinavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|hiv protease inhibitor|delavirdine|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|hiv protease inhibitor|ritonavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|hiv protease inhibitor|indinavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|troleandomycin|clarithromycin|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|clarithromycin|nelfinavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|clarithromycin|delavirdine|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|clarithromycin|ritonavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|clarithromycin|indinavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|troleandomycin|nelfinavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|troleandomycin|delavirdine|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|troleandomycin|ritonavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|troleandomycin|indinavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|nelfinavir|delavirdine|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|ritonavir|nelfinavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|indinavir|nelfinavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|ritonavir|delavirdine|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|indinavir|delavirdine|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|ritonavir|indinavir|example_LE1 of_LE1 some_LE1 of_LE1 the_LE1 much_LE1 potent_LE1 cyp_LE1 include_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylergonovine|N|saquinavir|nefazodone|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 grapefruit_RE2 juice_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|saquinavir|fluconazole|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY grapefruit_RE2 juice_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|saquinavir|fluoxetine|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 grapefruit_BE12 juice_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|saquinavir|fluvoxamine|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 grapefruit_BE12 juice_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|saquinavir|zileuton|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 grapefruit_BE12 juice_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|saquinavir|clotrimazole|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 grapefruit_BE12 juice_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Methylergonovine|N|nefazodone|fluconazole|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY grapefruit_RE2 juice_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|nefazodone|fluconazole|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY grapefruit_RE2 juice_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|nefazodone|fluoxetine|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 grapefruit_BE12 juice_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|nefazodone|fluoxetine|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 grapefruit_BE12 juice_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|nefazodone|fluvoxamine|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 grapefruit_BE12 juice_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|nefazodone|fluvoxamine|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 grapefruit_BE12 juice_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|nefazodone|zileuton|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 grapefruit_BE12 juice_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|nefazodone|zileuton|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 grapefruit_BE12 juice_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|nefazodone|clotrimazole|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 grapefruit_BE12 juice_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Methylergonovine|N|nefazodone|clotrimazole|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 grapefruit_BE12 juice_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Methylergonovine|N|fluconazole|fluoxetine|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY grapefruit_BE12 juice_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|fluconazole|fluoxetine|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY grapefruit_BE12 juice_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|fluconazole|fluvoxamine|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY grapefruit_BE12 juice_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|fluconazole|fluvoxamine|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY grapefruit_BE12 juice_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|fluconazole|zileuton|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY grapefruit_BE12 juice_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|fluconazole|zileuton|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY grapefruit_BE12 juice_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|fluconazole|clotrimazole|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY grapefruit_BE12 juice_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Methylergonovine|N|fluconazole|clotrimazole|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY grapefruit_BE12 juice_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Methylergonovine|N|fluoxetine|fluvoxamine|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 grapefruit_LE1 juice_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|fluoxetine|fluvoxamine|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 grapefruit_LE1 juice_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|fluoxetine|zileuton|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 grapefruit_LE1 juice_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|fluoxetine|zileuton|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 grapefruit_LE1 juice_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|fluoxetine|clotrimazole|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 grapefruit_LE1 juice_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Methylergonovine|N|fluoxetine|clotrimazole|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 grapefruit_LE1 juice_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Methylergonovine|N|fluvoxamine|zileuton|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 grapefruit_LE1 juice_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|fluvoxamine|zileuton|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 grapefruit_LE1 juice_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Methylergonovine|N|fluvoxamine|clotrimazole|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 grapefruit_LE1 juice_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Methylergonovine|N|fluvoxamine|clotrimazole|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 grapefruit_LE1 juice_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Methylergonovine|N|zileuton|clotrimazole|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 grapefruit_LE1 juice_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Methylergonovine|N|zileuton|clotrimazole|little_LE1 potent_LE1 inhibitor_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 grapefruit_LE1 juice_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Methylergonovine|N|vasoconstrictor|ergot alkaloid|caution_LE1 shall_LE1 be_LE1 exercise_LE1 when_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 other_LE1 BIOENTITY or_BE12 BIOENTITY 
Methylergonovine|N|methylergonovine maleate|ergot alkaloid|caution_LE1 shall_LE1 be_LE1 exercise_LE1 when_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 be_BE12 use_BE12 concurrent_BE12 with_BE12 other_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Methylergonovine|N|methergine|methylergonovine maleate|caution_LE1 shall_LE1 be_LE1 exercise_LE1 when_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 be_RE2 use_RE2 concurrent_RE2 with_RE2 other_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Methylphenidate|N|tricyclic drug|clomipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|imipramine|clomipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|coumarin anticoagulant|clomipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|clomipramine|desipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY rrb._RE2 
Methylphenidate|N|anticonvulsant|clomipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|primidone|clomipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|phenylbutazone|clomipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|phenobarbital|clomipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|diphenylhydantoin|clomipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|tricyclic drug|imipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|coumarin anticoagulant|tricyclic drug|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|tricyclic drug|desipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylphenidate|N|anticonvulsant|tricyclic drug|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|anticonvulsant|tricyclic drug|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|primidone|tricyclic drug|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|primidone|tricyclic drug|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|phenylbutazone|tricyclic drug|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY and_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|phenylbutazone|tricyclic drug|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY and_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|phenobarbital|tricyclic drug|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|phenobarbital|tricyclic drug|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|diphenylhydantoin|tricyclic drug|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|diphenylhydantoin|tricyclic drug|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|coumarin anticoagulant|imipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|imipramine|desipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylphenidate|N|anticonvulsant|imipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|primidone|imipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|phenylbutazone|imipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|phenobarbital|imipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|diphenylhydantoin|imipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|coumarin anticoagulant|desipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylphenidate|N|coumarin anticoagulant|anticonvulsant|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|coumarin anticoagulant|primidone|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|coumarin anticoagulant|phenylbutazone|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|coumarin anticoagulant|phenobarbital|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|coumarin anticoagulant|diphenylhydantoin|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|anticonvulsant|desipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylphenidate|N|primidone|desipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylphenidate|N|phenylbutazone|desipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylphenidate|N|phenobarbital|desipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylphenidate|N|diphenylhydantoin|desipramine|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylphenidate|N|anticonvulsant|primidone|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|anticonvulsant|phenylbutazone|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|anticonvulsant|phenylbutazone|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|anticonvulsant|phenobarbital|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|anticonvulsant|diphenylhydantoin|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|primidone|phenylbutazone|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|primidone|phenylbutazone|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|phenobarbital|primidone|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|diphenylhydantoin|primidone|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|phenobarbital|phenylbutazone|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|phenobarbital|phenylbutazone|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|diphenylhydantoin|phenylbutazone|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|diphenylhydantoin|phenylbutazone|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|phenobarbital|diphenylhydantoin|human_LE1 pharmacologic_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylphenidate|N|methylphenidate|clonidine|the_LE1 safety_LE1 of_LE1 use_LE1 BIOENTITY in_BE12 combination_BE12 with_BE12 BIOENTITY or_RE2 other_RE2 central_RE2 act_RE2 BIOGENERAL_RE2 have_RE2 not_RE2 be_RE2 systemic_RE2 evaluate_RE2 
Methylphenidate|N|methylphenidate|alpha-2 agonist|the_LE1 safety_LE1 of_LE1 use_LE1 BIOENTITY in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 or_BE12 other_BE12 central_BE12 act_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 systemic_RE2 evaluate_RE2 
Methylphenidate|N|clonidine|alpha-2 agonist|the_LE1 safety_LE1 of_LE1 use_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOENTITY or_BE12 other_BE12 central_BE12 act_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 systemic_RE2 evaluate_RE2 
Methylprednisolone|N|phenobarbital|rifampin|drug_LE1 that_LE1 induce_LE1 hepatic_LE1 enzyme_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 increase_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 may_RE2 require_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 dose_RE2 to_RE2 achieve_RE2 the_RE2 desired_RE2 response_RE2 
Methylprednisolone|N|phenytoin|rifampin|drug_LE1 that_LE1 induce_LE1 hepatic_LE1 enzyme_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY may_RE2 increase_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 may_RE2 require_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 dose_RE2 to_RE2 achieve_RE2 the_RE2 desired_RE2 response_RE2 
Methylprednisolone|N|phenytoin|rifampin|drug_LE1 that_LE1 induce_LE1 hepatic_LE1 enzyme_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY may_RE2 increase_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 may_RE2 require_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 dose_RE2 to_RE2 achieve_RE2 the_RE2 desired_RE2 response_RE2 
Methylprednisolone|N|methylprednisolone|methylprednisolone|drug_LE1 that_LE1 induce_LE1 hepatic_LE1 enzyme_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 may_LE1 increase_LE1 the_LE1 clearance_LE1 of_LE1 BIOENTITY and_BE12 may_BE12 require_BE12 increase_BE12 in_BE12 BIOENTITY dose_RE2 to_RE2 achieve_RE2 the_RE2 desired_RE2 response_RE2 
Methylprednisolone|N|phenobarbital|phenytoin|drug_LE1 that_LE1 induce_LE1 hepatic_LE1 enzyme_LE1 such_LE1 as_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 increase_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 may_RE2 require_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 dose_RE2 to_RE2 achieve_RE2 the_RE2 desired_RE2 response_RE2 
Methylprednisolone|N|troleandomycin|ketoconazole|drug_LE1 such_LE1 as_LE1 BIOENTITY and_BE12 BIOENTITY may_RE2 inhibit_RE2 the_RE2 metabolism_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 thus_RE2 decrease_RE2 its_RE2 clearance_RE2 
Methylprednisolone|N|salicylate|methylprednisolone|this_LE1 can_LE1 lead_LE1 to_LE1 decrease_LE1 BIOENTITY serum_BE12 level_BE12 or_BE12 increase_BE12 the_BE12 risk_BE12 of_BE12 BIOGENERAL_BE12 toxicity_BE12 when_BE12 BIOENTITY be_RE2 withdraw_RE2 
Methylprednisolone|N|salicylate|salicylate|this_LE1 can_LE1 lead_LE1 to_LE1 decrease_LE1 BIOENTITY serum_BE12 level_BE12 or_BE12 increase_BE12 the_BE12 risk_BE12 of_BE12 BIOENTITY toxicity_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 withdraw_RE2 
Methylprednisolone|N|methylprednisolone|anticoagulant|the_LE1 effect_LE1 of_LE1 BIOENTITY on_BE12 oral_BE12 BIOENTITY be_RE2 variable_RE2 
Methylscopolamine|N|mao inhibitor|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|absorbent-type anti-diarrhea medicine|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|linezolid|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|kaolin|pectin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|isocarboxazid|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tranylcypromine|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|furazolidone|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|selegiline|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|amantadine|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antihistamine|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|quinidine|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|kaolin|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|potassium chloride|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|kaolin|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antacid|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|kaolin|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|diphenhydramine|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|anticholinergic|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|mao inhibitor|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|absorbent-type anti-diarrhea medicine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|linezolid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|phenelzine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|isocarboxazid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|tranylcypromine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|furazolidone|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|selegiline|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|amantadine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|antihistamine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|quinidine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|potassium chloride|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|antacid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|mao inhibitor|diphenhydramine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|mao inhibitor|anticholinergic|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|mao inhibitor|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|absorbent-type anti-diarrhea medicine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|linezolid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|phenelzine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|isocarboxazid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|tranylcypromine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|furazolidone|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|selegiline|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|amantadine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|antihistamine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|quinidine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|potassium chloride|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|antacid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|tricyclic|diphenhydramine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tricyclic|anticholinergic|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|tricyclic|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOENTITY type_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|linezolid|absorbent-type anti-diarrhea medicine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|absorbent-type anti-diarrhea medicine|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|absorbent-type anti-diarrhea medicine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|isocarboxazid|absorbent-type anti-diarrhea medicine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tranylcypromine|absorbent-type anti-diarrhea medicine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|furazolidone|absorbent-type anti-diarrhea medicine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|selegiline|absorbent-type anti-diarrhea medicine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|amantadine|absorbent-type anti-diarrhea medicine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antihistamine|absorbent-type anti-diarrhea medicine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|quinidine|absorbent-type anti-diarrhea medicine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|absorbent-type anti-diarrhea medicine|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|potassium chloride|absorbent-type anti-diarrhea medicine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY supplement_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|absorbent-type anti-diarrhea medicine|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antacid|absorbent-type anti-diarrhea medicine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOENTITY BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|absorbent-type anti-diarrhea medicine|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|diphenhydramine|absorbent-type anti-diarrhea medicine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|anticholinergic|absorbent-type anti-diarrhea medicine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|absorbent-type anti-diarrhea medicine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|linezolid|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|linezolid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|linezolid|isocarboxazid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|linezolid|tranylcypromine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|linezolid|furazolidone|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|linezolid|selegiline|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|linezolid|amantadine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|linezolid|antihistamine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|linezolid|quinidine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|linezolid|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|linezolid|potassium chloride|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|linezolid|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|linezolid|antacid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|linezolid|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|linezolid|diphenhydramine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|linezolid|anticholinergic|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|linezolid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|isocarboxazid|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tranylcypromine|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|furazolidone|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|selegiline|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|amantadine|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antihistamine|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|quinidine|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|kaolin|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|potassium chloride|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|kaolin|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antacid|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|kaolin|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|diphenhydramine|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|anticholinergic|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|kaolin|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|isocarboxazid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|tranylcypromine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|furazolidone|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|selegiline|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|amantadine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|antihistamine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|quinidine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|potassium chloride|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|antacid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|phenelzine|diphenhydramine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenelzine|anticholinergic|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|phenelzine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tranylcypromine|isocarboxazid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|isocarboxazid|furazolidone|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|isocarboxazid|selegiline|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|isocarboxazid|amantadine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|isocarboxazid|antihistamine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|isocarboxazid|quinidine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|isocarboxazid|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|isocarboxazid|potassium chloride|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|isocarboxazid|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|isocarboxazid|antacid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|isocarboxazid|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|isocarboxazid|diphenhydramine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|isocarboxazid|anticholinergic|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|isocarboxazid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tranylcypromine|furazolidone|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tranylcypromine|selegiline|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tranylcypromine|amantadine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tranylcypromine|antihistamine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tranylcypromine|quinidine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tranylcypromine|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tranylcypromine|potassium chloride|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tranylcypromine|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tranylcypromine|antacid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tranylcypromine|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|tranylcypromine|diphenhydramine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|tranylcypromine|anticholinergic|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|tranylcypromine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|selegiline|furazolidone|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|furazolidone|amantadine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|furazolidone|antihistamine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|furazolidone|quinidine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|furazolidone|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|furazolidone|potassium chloride|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|furazolidone|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|furazolidone|antacid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|furazolidone|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|furazolidone|diphenhydramine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|furazolidone|anticholinergic|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|furazolidone|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|selegiline|amantadine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|selegiline|antihistamine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|selegiline|quinidine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|selegiline|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|selegiline|potassium chloride|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|selegiline|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|selegiline|antacid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|selegiline|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|selegiline|diphenhydramine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|selegiline|anticholinergic|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|selegiline|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|amantadine|antihistamine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|quinidine|amantadine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|amantadine|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|amantadine|potassium chloride|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|amantadine|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|amantadine|antacid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|amantadine|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|amantadine|diphenhydramine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|amantadine|anticholinergic|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|amantadine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|quinidine|antihistamine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antihistamine|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antihistamine|potassium chloride|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antihistamine|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antihistamine|antacid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antihistamine|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|antihistamine|diphenhydramine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antihistamine|anticholinergic|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|antihistamine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|quinidine|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|quinidine|potassium chloride|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|quinidine|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|quinidine|antacid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|quinidine|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|quinidine|diphenhydramine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|quinidine|anticholinergic|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|quinidine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|potassium chloride|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenothiazine|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antacid|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|phenothiazine|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|diphenhydramine|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|anticholinergic|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|phenothiazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|potassium chloride|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|potassium chloride|antacid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY supplement_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|potassium chloride|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|diphenhydramine|potassium chloride|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|anticholinergic|potassium chloride|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOENTITY BIOENTITY supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|potassium chloride|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antacid|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|chlorpromazine|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY rrb._RE2 
Methylscopolamine|N|diphenhydramine|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|anticholinergic|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|chlorpromazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antacid|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 supplement_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|diphenhydramine|antacid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|anticholinergic|antacid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 supplement_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|antacid|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|diphenhydramine|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|anticholinergic|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|antidepressant|promethazine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 supplement_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Methylscopolamine|N|diphenhydramine|anticholinergic|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 type_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|diphenhydramine|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|antidepressant|anticholinergic|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 type_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 -RRB-_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methylscopolamine|N|methscopolamine|antidepressant|BIOENTITY may_BE12 interact_BE12 with_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 type_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 supplement_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Methyprylon|N|alcohol|cns depression-producing drug|concurrent_LE1 use_LE1 of_LE1 BIOENTITY and_BE12 other_BE12 BIOENTITY may_RE2 increase_RE2 the_RE2 cns_RE2 depressant_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 or_RE2 these_RE2 other_RE2 medication_RE2 
Methysergide|N|sumatriptan|nicotine|concurrent_LE1 use_LE1 with_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 smoking_RE2 -RRB-_RE2 may_RE2 result_RE2 in_RE2 enhance_RE2 vasoconstriction_RE2 
Methysergide|N|sumatriptan|nicotine|concurrent_LE1 use_LE1 with_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 smoking_RE2 -RRB-_RE2 may_RE2 result_RE2 in_RE2 enhance_RE2 vasoconstriction_RE2 
Methysergide|N|ergot alkaloid|nicotine|concurrent_LE1 use_LE1 with_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 smoking_RE2 -RRB-_RE2 may_RE2 result_RE2 in_RE2 enhance_RE2 vasoconstriction_RE2 
Methysergide|N|vasoconstrictor agent|nicotine|concurrent_LE1 use_LE1 with_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 smoking_RE2 -RRB-_RE2 may_RE2 result_RE2 in_RE2 enhance_RE2 vasoconstriction_RE2 
Methysergide|N|ergot alkaloid|sumatriptan|concurrent_LE1 use_LE1 with_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 smoking_RE2 -RRB-_RE2 may_RE2 result_RE2 in_RE2 enhance_RE2 vasoconstriction_RE2 
Methysergide|N|vasoconstrictor agent|sumatriptan|concurrent_LE1 use_LE1 with_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 smoking_RE2 -RRB-_RE2 may_RE2 result_RE2 in_RE2 enhance_RE2 vasoconstriction_RE2 
Methysergide|N|vasoconstrictor agent|ergot alkaloid|concurrent_LE1 use_LE1 with_LE1 BIOENTITY including_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 smoking_RE2 -RRB-_RE2 may_RE2 result_RE2 in_RE2 enhance_RE2 vasoconstriction_RE2 
Metoclopramide|N|anticholinergic drug|narcotic analgesic|the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 gastrointestinal_LE1 motility_LE1 be_LE1 antagonize_LE1 by_LE1 BIOENTITY and_BE12 BIOENTITY 
Metoclopramide|N|narcotic|tranquilizer|additive_LE1 sedative_LE1 effect_LE1 can_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Metoclopramide|N|narcotic|tranquilizer|additive_LE1 sedative_LE1 effect_LE1 can_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Metoclopramide|N|sedative|narcotic|additive_LE1 sedative_LE1 effect_LE1 can_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Metoclopramide|N|sedative|narcotic|additive_LE1 sedative_LE1 effect_LE1 can_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Metoclopramide|N|hypnotic|narcotic|additive_LE1 sedative_LE1 effect_LE1 can_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Metoclopramide|N|hypnotic|narcotic|additive_LE1 sedative_LE1 effect_LE1 can_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Metoclopramide|N|alcohol|narcotic|additive_LE1 sedative_LE1 effect_LE1 can_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Metoclopramide|N|sedative|tranquilizer|additive_LE1 sedative_LE1 effect_LE1 can_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Metoclopramide|N|sedative|tranquilizer|additive_LE1 sedative_LE1 effect_LE1 can_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Metoclopramide|N|hypnotic|tranquilizer|additive_LE1 sedative_LE1 effect_LE1 can_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Metoclopramide|N|hypnotic|tranquilizer|additive_LE1 sedative_LE1 effect_LE1 can_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Metoclopramide|N|alcohol|tranquilizer|additive_LE1 sedative_LE1 effect_LE1 can_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Metoclopramide|N|sedative|hypnotic|additive_LE1 sedative_LE1 effect_LE1 can_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Metoclopramide|N|sedative|hypnotic|additive_LE1 sedative_LE1 effect_LE1 can_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Metoclopramide|N|alcohol|sedative|additive_LE1 sedative_LE1 effect_LE1 can_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Metoclopramide|N|alcohol|hypnotic|additive_LE1 sedative_LE1 effect_LE1 can_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Metoclopramide|N|digoxin|acetaminophen|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 by_BE12 BIOGENERAL_BE12 whereas_BE12 the_BE12 rate_BE12 and_BE12 extent_BE12 of_BE12 absorption_BE12 of_BE12 drug_BE12 from_BE12 the_BE12 small_BE12 bowel_BE12 may_BE12 be_BE12 increase_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Metoclopramide|N|digoxin|tetracycline|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 by_BE12 BIOGENERAL_BE12 whereas_BE12 the_BE12 rate_BE12 and_BE12 extent_BE12 of_BE12 absorption_BE12 of_BE12 drug_BE12 from_BE12 the_BE12 small_BE12 bowel_BE12 may_BE12 be_BE12 increase_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Metoclopramide|N|digoxin|levodopa|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 by_BE12 BIOGENERAL_BE12 whereas_BE12 the_BE12 rate_BE12 and_BE12 extent_BE12 of_BE12 absorption_BE12 of_BE12 drug_BE12 from_BE12 the_BE12 small_BE12 bowel_BE12 may_BE12 be_BE12 increase_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Metoclopramide|N|digoxin|ethanol|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 by_BE12 BIOGENERAL_BE12 whereas_BE12 the_BE12 rate_BE12 and_BE12 extent_BE12 of_BE12 absorption_BE12 of_BE12 drug_BE12 from_BE12 the_BE12 small_BE12 bowel_BE12 may_BE12 be_BE12 increase_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Metoclopramide|N|digoxin|cyclosporine|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY -RRB-_BE12 by_BE12 BIOGENERAL_BE12 whereas_BE12 the_BE12 rate_BE12 and_BE12 extent_BE12 of_BE12 absorption_BE12 of_BE12 drug_BE12 from_BE12 the_BE12 small_BE12 bowel_BE12 may_BE12 be_BE12 increase_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Metoclopramide|N|metoclopramide|tetracycline|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 by_LE1 BIOENTITY whereas_BE12 the_BE12 rate_BE12 and_BE12 extent_BE12 of_BE12 absorption_BE12 of_BE12 drug_BE12 from_BE12 the_BE12 small_BE12 bowel_BE12 may_BE12 be_BE12 increase_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Metoclopramide|N|metoclopramide|levodopa|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 by_LE1 BIOENTITY whereas_BE12 the_BE12 rate_BE12 and_BE12 extent_BE12 of_BE12 absorption_BE12 of_BE12 drug_BE12 from_BE12 the_BE12 small_BE12 bowel_BE12 may_BE12 be_BE12 increase_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Metoclopramide|N|metoclopramide|ethanol|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 by_LE1 BIOENTITY whereas_BE12 the_BE12 rate_BE12 and_BE12 extent_BE12 of_BE12 absorption_BE12 of_BE12 drug_BE12 from_BE12 the_BE12 small_BE12 bowel_BE12 may_BE12 be_BE12 increase_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Metoclopramide|N|metoclopramide|cyclosporine|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 by_LE1 BIOENTITY whereas_BE12 the_BE12 rate_BE12 and_BE12 extent_BE12 of_BE12 absorption_BE12 of_BE12 drug_BE12 from_BE12 the_BE12 small_BE12 bowel_BE12 may_BE12 be_BE12 increase_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Metoclopramide|N|acetaminophen|tetracycline|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 by_LE1 BIOGENERAL_LE1 whereas_LE1 the_LE1 rate_LE1 and_LE1 extent_LE1 of_LE1 absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 small_LE1 bowel_LE1 may_LE1 be_LE1 increase_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Metoclopramide|N|acetaminophen|levodopa|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 by_LE1 BIOGENERAL_LE1 whereas_LE1 the_LE1 rate_LE1 and_LE1 extent_LE1 of_LE1 absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 small_LE1 bowel_LE1 may_LE1 be_LE1 increase_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Metoclopramide|N|acetaminophen|ethanol|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 by_LE1 BIOGENERAL_LE1 whereas_LE1 the_LE1 rate_LE1 and_LE1 extent_LE1 of_LE1 absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 small_LE1 bowel_LE1 may_LE1 be_LE1 increase_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Metoclopramide|N|acetaminophen|cyclosporine|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 by_LE1 BIOGENERAL_LE1 whereas_LE1 the_LE1 rate_LE1 and_LE1 extent_LE1 of_LE1 absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 small_LE1 bowel_LE1 may_LE1 be_LE1 increase_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Metoclopramide|N|tetracycline|levodopa|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 by_LE1 BIOGENERAL_LE1 whereas_LE1 the_LE1 rate_LE1 and_LE1 extent_LE1 of_LE1 absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 small_LE1 bowel_LE1 may_LE1 be_LE1 increase_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Metoclopramide|N|tetracycline|ethanol|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 by_LE1 BIOGENERAL_LE1 whereas_LE1 the_LE1 rate_LE1 and_LE1 extent_LE1 of_LE1 absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 small_LE1 bowel_LE1 may_LE1 be_LE1 increase_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Metoclopramide|N|tetracycline|cyclosporine|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 by_LE1 BIOGENERAL_LE1 whereas_LE1 the_LE1 rate_LE1 and_LE1 extent_LE1 of_LE1 absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 small_LE1 bowel_LE1 may_LE1 be_LE1 increase_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Metoclopramide|N|levodopa|ethanol|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 by_LE1 BIOGENERAL_LE1 whereas_LE1 the_LE1 rate_LE1 and_LE1 extent_LE1 of_LE1 absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 small_LE1 bowel_LE1 may_LE1 be_LE1 increase_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Metoclopramide|N|levodopa|cyclosporine|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 by_LE1 BIOGENERAL_LE1 whereas_LE1 the_LE1 rate_LE1 and_LE1 extent_LE1 of_LE1 absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 small_LE1 bowel_LE1 may_LE1 be_LE1 increase_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Metoclopramide|N|ethanol|cyclosporine|absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 stomach_LE1 may_LE1 be_LE1 diminish_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 -RRB-_LE1 by_LE1 BIOGENERAL_LE1 whereas_LE1 the_LE1 rate_LE1 and_LE1 extent_LE1 of_LE1 absorption_LE1 of_LE1 drug_LE1 from_LE1 the_LE1 small_LE1 bowel_LE1 may_LE1 be_LE1 increase_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY rrb._RE2 
Metolazone|N|diuretic|metolazone|BIOENTITY :_BE12 BIOGENERAL_BE12 and_BE12 probable_BE12 other_BE12 BIOGENERAL_BE12 give_BE12 concomitant_BE12 with_BE12 BIOENTITY can_RE2 cause_RE2 unusual_RE2 large_RE2 or_RE2 prolonged_RE2 loss_RE2 of_RE2 fluid_RE2 and_RE2 electrolyte_RE2 
Metolazone|N|diuretic|loop diuretic|BIOENTITY :_BE12 BIOGENERAL_BE12 and_BE12 probable_BE12 other_BE12 BIOENTITY give_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 cause_RE2 unusual_RE2 large_RE2 or_RE2 prolonged_RE2 loss_RE2 of_RE2 fluid_RE2 and_RE2 electrolyte_RE2 
Metolazone|N|diuretic|furosemide|BIOENTITY :_BE12 BIOENTITY and_RE2 probable_RE2 other_RE2 BIOGENERAL_RE2 give_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 cause_RE2 unusual_RE2 large_RE2 or_RE2 prolonged_RE2 loss_RE2 of_RE2 fluid_RE2 and_RE2 electrolyte_RE2 
Metolazone|N|furosemide|loop diuretic|BIOGENERAL_LE1 :_LE1 BIOENTITY and_BE12 probable_BE12 other_BE12 BIOENTITY give_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 cause_RE2 unusual_RE2 large_RE2 or_RE2 prolonged_RE2 loss_RE2 of_RE2 fluid_RE2 and_RE2 electrolyte_RE2 
Metolazone|N|antihypertensive|antihypertensive drug|other_LE1 BIOENTITY :_BE12 when_BE12 BIOGENERAL_BE12 tablet_BE12 be_BE12 use_BE12 with_BE12 other_BE12 BIOENTITY care_RE2 must_RE2 be_RE2 take_RE2 especial_RE2 during_RE2 initial_RE2 therapy_RE2 
Metolazone|N|antihypertensive|mykrox|other_LE1 BIOENTITY :_BE12 when_BE12 BIOENTITY tablet_RE2 be_RE2 use_RE2 with_RE2 other_RE2 BIOGENERAL_RE2 care_RE2 must_RE2 be_RE2 take_RE2 especial_RE2 during_RE2 initial_RE2 therapy_RE2 
Metolazone|N|narcotic|metolazone|BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY :_BE12 the_BE12 hypotensive_BE12 effect_BE12 of_BE12 these_BE12 drug_BE12 may_BE12 be_BE12 potentiate_BE12 by_BE12 the_BE12 volume_BE12 contraction_BE12 that_BE12 may_BE12 be_BE12 associate_BE12 with_BE12 BIOENTITY therapy_RE2 
Metolazone|N|narcotic|metolazone|BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY :_BE12 the_BE12 hypotensive_BE12 effect_BE12 of_BE12 these_BE12 drug_BE12 may_BE12 be_BE12 potentiate_BE12 by_BE12 the_BE12 volume_BE12 contraction_BE12 that_BE12 may_BE12 be_BE12 associate_BE12 with_BE12 BIOENTITY therapy_RE2 
Metolazone|N|alcohol|narcotic|BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY :_RE2 the_RE2 hypotensive_RE2 effect_RE2 of_RE2 these_RE2 drug_RE2 may_RE2 be_RE2 potentiate_RE2 by_RE2 the_RE2 volume_RE2 contraction_RE2 that_RE2 may_RE2 be_RE2 associate_RE2 with_RE2 BIOGENERAL_RE2 therapy_RE2 
Metolazone|N|barbiturate|narcotic|BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY :_RE2 the_RE2 hypotensive_RE2 effect_RE2 of_RE2 these_RE2 drug_RE2 may_RE2 be_RE2 potentiate_RE2 by_RE2 the_RE2 volume_RE2 contraction_RE2 that_RE2 may_RE2 be_RE2 associate_RE2 with_RE2 BIOGENERAL_RE2 therapy_RE2 
Metolazone|N|alcohol|metolazone|BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 :_BE12 the_BE12 hypotensive_BE12 effect_BE12 of_BE12 these_BE12 drug_BE12 may_BE12 be_BE12 potentiate_BE12 by_BE12 the_BE12 volume_BE12 contraction_BE12 that_BE12 may_BE12 be_BE12 associate_BE12 with_BE12 BIOENTITY therapy_RE2 
Metolazone|N|alcohol|metolazone|BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 :_BE12 the_BE12 hypotensive_BE12 effect_BE12 of_BE12 these_BE12 drug_BE12 may_BE12 be_BE12 potentiate_BE12 by_BE12 the_BE12 volume_BE12 contraction_BE12 that_BE12 may_BE12 be_BE12 associate_BE12 with_BE12 BIOENTITY therapy_RE2 
Metolazone|N|barbiturate|metolazone|BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 :_BE12 the_BE12 hypotensive_BE12 effect_BE12 of_BE12 these_BE12 drug_BE12 may_BE12 be_BE12 potentiate_BE12 by_BE12 the_BE12 volume_BE12 contraction_BE12 that_BE12 may_BE12 be_BE12 associate_BE12 with_BE12 BIOENTITY therapy_RE2 
Metolazone|N|barbiturate|metolazone|BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 :_BE12 the_BE12 hypotensive_BE12 effect_BE12 of_BE12 these_BE12 drug_BE12 may_BE12 be_BE12 potentiate_BE12 by_BE12 the_BE12 volume_BE12 contraction_BE12 that_BE12 may_BE12 be_BE12 associate_BE12 with_BE12 BIOENTITY therapy_RE2 
Metolazone|N|alcohol|barbiturate|BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 :_RE2 the_RE2 hypotensive_RE2 effect_RE2 of_RE2 these_RE2 drug_RE2 may_RE2 be_RE2 potentiate_RE2 by_RE2 the_RE2 volume_RE2 contraction_RE2 that_RE2 may_RE2 be_RE2 associate_RE2 with_RE2 BIOGENERAL_RE2 therapy_RE2 
Metolazone|N|digitalis glycoside|diuretic|BIOENTITY :_BE12 BIOENTITY hypokalemia_RE2 can_RE2 increase_RE2 the_RE2 sensitivity_RE2 of_RE2 the_RE2 myocardium_RE2 to_RE2 BIOGENERAL_RE2 
Metolazone|N|digitalis glycoside|digitali|BIOENTITY :_BE12 BIOGENERAL_BE12 hypokalemia_BE12 can_BE12 increase_BE12 the_BE12 sensitivity_BE12 of_BE12 the_BE12 myocardium_BE12 to_BE12 BIOENTITY 
Metolazone|N|corticosteroid|acth|BIOENTITY or_BE12 BIOENTITY :_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hypokalemia_RE2 and_RE2 increase_RE2 salt_RE2 and_RE2 water_RE2 retention_RE2 
Metolazone|N|lithium|lithium|BIOENTITY :_BE12 serum_BE12 BIOENTITY level_RE2 may_RE2 increase_RE2 
Metolazone|N|curariform drug|diuretic|BIOENTITY :_BE12 BIOENTITY hypokalemia_RE2 may_RE2 enhance_RE2 neuromuscular_RE2 blocking_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 -RRB-_RE2 the_RE2 much_RE2 serious_RE2 effect_RE2 will_RE2 be_RE2 respiratory_RE2 depression_RE2 which_RE2 can_RE2 proceed_RE2 to_RE2 apnea_RE2 
Metolazone|N|curariform drug|curariform drug|BIOENTITY :_BE12 BIOGENERAL_BE12 hypokalemia_BE12 may_BE12 enhance_BE12 neuromuscular_BE12 blocking_BE12 effect_BE12 of_BE12 BIOENTITY -LRB-_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 -RRB-_RE2 the_RE2 much_RE2 serious_RE2 effect_RE2 will_RE2 be_RE2 respiratory_RE2 depression_RE2 which_RE2 can_RE2 proceed_RE2 to_RE2 apnea_RE2 
Metolazone|N|curariform drug|tubocurarine|BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 hypokalemia_LE1 may_LE1 enhance_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOENTITY -LRB-_BE12 such_BE12 as_BE12 BIOENTITY -RRB-_RE2 the_RE2 much_RE2 serious_RE2 effect_RE2 will_RE2 be_RE2 respiratory_RE2 depression_RE2 which_RE2 can_RE2 proceed_RE2 to_RE2 apnea_RE2 
Metolazone|N|curariform drug|tubocurarine|BIOENTITY :_BE12 BIOGENERAL_BE12 hypokalemia_BE12 may_BE12 enhance_BE12 neuromuscular_BE12 blocking_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOENTITY -RRB-_RE2 the_RE2 much_RE2 serious_RE2 effect_RE2 will_RE2 be_RE2 respiratory_RE2 depression_RE2 which_RE2 can_RE2 proceed_RE2 to_RE2 apnea_RE2 
Metolazone|N|salicylate|non-steroidal anti-inflammatory drug|BIOENTITY and_BE12 other_BE12 BIOENTITY :_RE2 may_RE2 decrease_RE2 the_RE2 antihypertensive_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 tablet_RE2 
Metolazone|N|sympathomimetic|norepinephrine|BIOENTITY :_BE12 BIOGENERAL_BE12 may_BE12 decrease_BE12 arterial_BE12 responsiveness_BE12 to_BE12 BIOENTITY but_RE2 this_RE2 diminution_RE2 be_RE2 not_RE2 sufficient_RE2 to_RE2 preclude_RE2 effectiveness_RE2 of_RE2 the_RE2 pressor_RE2 agent_RE2 for_RE2 therapeutic_RE2 use_RE2 
Metolazone|N|sympathomimetic|metolazone|BIOENTITY :_BE12 BIOENTITY may_RE2 decrease_RE2 arterial_RE2 responsiveness_RE2 to_RE2 BIOGENERAL_RE2 but_RE2 this_RE2 diminution_RE2 be_RE2 not_RE2 sufficient_RE2 to_RE2 preclude_RE2 effectiveness_RE2 of_RE2 the_RE2 pressor_RE2 agent_RE2 for_RE2 therapeutic_RE2 use_RE2 
Metolazone|N|anticoagulant|metolazone|BIOENTITY :_BE12 BIOENTITY as_RE2 well_RE2 as_RE2 other_RE2 BIOGENERAL_RE2 may_RE2 affect_RE2 the_RE2 hypoprothrombinemic_RE2 response_RE2 to_RE2 BIOGENERAL_RE2 
Metolazone|N|anticoagulant|thiazide-like diuretic|BIOENTITY :_BE12 BIOGENERAL_BE12 as_BE12 well_BE12 as_BE12 other_BE12 BIOENTITY may_RE2 affect_RE2 the_RE2 hypoprothrombinemic_RE2 response_RE2 to_RE2 BIOGENERAL_RE2 
Metolazone|N|anticoagulant|anticoagulant|BIOENTITY :_BE12 BIOGENERAL_BE12 as_BE12 well_BE12 as_BE12 other_BE12 BIOGENERAL_BE12 may_BE12 affect_BE12 the_BE12 hypoprothrombinemic_BE12 response_BE12 to_BE12 BIOENTITY 
Metolazone|N|metolazone|thiazide-like diuretic|BIOGENERAL_LE1 :_LE1 BIOENTITY as_BE12 well_BE12 as_BE12 other_BE12 BIOENTITY may_RE2 affect_RE2 the_RE2 hypoprothrombinemic_RE2 response_RE2 to_RE2 BIOGENERAL_RE2 
Metolazone|N|thiazide-like diuretic|anticoagulant|BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 as_LE1 well_LE1 as_LE1 other_LE1 BIOENTITY may_BE12 affect_BE12 the_BE12 hypoprothrombinemic_BE12 response_BE12 to_BE12 BIOENTITY 
Metronidazole|N|coumarin|warfarin|oral_LE1 BIOGENERAL_LE1 have_LE1 be_LE1 report_LE1 to_LE1 potentiate_LE1 the_LE1 anticoagulant_LE1 effect_LE1 of_LE1 BIOENTITY and_BE12 BIOENTITY result_RE2 in_RE2 prolongation_RE2 of_RE2 prothrombin_RE2 time_RE2 
Metronidazole|N|metronidazole|metronidazole|drug_LE1 interaction_LE1 shall_LE1 be_LE1 keep_LE1 in_LE1 mind_LE1 when_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY gel_BE12 -RRB-_BE12 NUM_BE12 be_BE12 prescribe_BE12 for_BE12 patient_BE12 who_BE12 be_BE12 receive_BE12 anticoagulant_BE12 treatment_BE12 although_BE12 they_BE12 be_BE12 little_BE12 likely_BE12 to_BE12 occur_BE12 with_BE12 topical_BE12 BIOENTITY administration_RE2 because_RE2 of_RE2 low_RE2 absorption_RE2 
Metronidazole|N|metronidazole|metronidazole|drug_LE1 interaction_LE1 shall_LE1 be_LE1 keep_LE1 in_LE1 mind_LE1 when_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY gel_BE12 -RRB-_BE12 NUM_BE12 be_BE12 prescribe_BE12 for_BE12 patient_BE12 who_BE12 be_BE12 receive_BE12 anticoagulant_BE12 treatment_BE12 although_BE12 they_BE12 be_BE12 little_BE12 likely_BE12 to_BE12 occur_BE12 with_BE12 topical_BE12 BIOENTITY administration_RE2 because_RE2 of_RE2 low_RE2 absorption_RE2 
Metronidazole|N|metrogel|metronidazole|drug_LE1 interaction_LE1 shall_LE1 be_LE1 keep_LE1 in_LE1 mind_LE1 when_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 gel_BE12 -RRB-_BE12 NUM_BE12 be_BE12 prescribe_BE12 for_BE12 patient_BE12 who_BE12 be_BE12 receive_BE12 anticoagulant_BE12 treatment_BE12 although_BE12 they_BE12 be_BE12 little_BE12 likely_BE12 to_BE12 occur_BE12 with_BE12 topical_BE12 BIOENTITY administration_RE2 because_RE2 of_RE2 low_RE2 absorption_RE2 
Metronidazole|N|metrogel|metronidazole|drug_LE1 interaction_LE1 shall_LE1 be_LE1 keep_LE1 in_LE1 mind_LE1 when_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 gel_BE12 -RRB-_BE12 NUM_BE12 be_BE12 prescribe_BE12 for_BE12 patient_BE12 who_BE12 be_BE12 receive_BE12 anticoagulant_BE12 treatment_BE12 although_BE12 they_BE12 be_BE12 little_BE12 likely_BE12 to_BE12 occur_BE12 with_BE12 topical_BE12 BIOENTITY administration_RE2 because_RE2 of_RE2 low_RE2 absorption_RE2 
Metronidazole|N|metrogel|metronidazole|drug_LE1 interaction_LE1 shall_LE1 be_LE1 keep_LE1 in_LE1 mind_LE1 when_LE1 BIOENTITY -LRB-_BE12 BIOENTITY gel_RE2 -RRB-_RE2 NUM_RE2 be_RE2 prescribe_RE2 for_RE2 patient_RE2 who_RE2 be_RE2 receive_RE2 anticoagulant_RE2 treatment_RE2 although_RE2 they_RE2 be_RE2 little_RE2 likely_RE2 to_RE2 occur_RE2 with_RE2 topical_RE2 BIOGENERAL_RE2 administration_RE2 because_RE2 of_RE2 low_RE2 absorption_RE2 
Metyrapone|N|acetaminophen|acetaminophen|BIOGENERAL_LE1 inhibit_LE1 the_LE1 glucuronidation_LE1 of_LE1 BIOENTITY and_BE12 can_BE12 possible_BE12 potentiate_BE12 BIOENTITY toxicity_RE2 
Metyrosine|N|phenothiazine|haloperidol|caution_LE1 shall_LE1 be_LE1 observe_LE1 in_LE1 administer_LE1 BIOGENERAL_LE1 to_LE1 patient_LE1 receive_LE1 BIOENTITY or_BE12 BIOENTITY because_RE2 the_RE2 extrapyramidal_RE2 effect_RE2 of_RE2 these_RE2 drug_RE2 can_RE2 be_RE2 expect_RE2 to_RE2 be_RE2 potentiate_RE2 by_RE2 inhibition_RE2 of_RE2 catecholamine_RE2 synthesis_RE2 
Metyrosine|N|alcohol|cns depressant|concurrent_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY or_BE12 other_BE12 BIOENTITY can_RE2 increase_RE2 their_RE2 sedative_RE2 effect_RE2 
Mexiletine|N|mexitil|mexiletine|since_LE1 BIOENTITY be_BE12 substrate_BE12 for_BE12 the_BE12 metabolic_BE12 pathway_BE12 involve_BE12 cypd_BE12 and_BE12 cypa_BE12 enzyme_BE12 inhibition_BE12 or_BE12 induction_BE12 of_BE12 either_BE12 of_BE12 these_BE12 enzyme_BE12 will_BE12 be_BE12 expect_BE12 to_BE12 alter_BE12 BIOENTITY plasma_RE2 concentration_RE2 
Mexiletine|N|propafenone|mexiletine|In_LE1 another_LE1 formal_LE1 study_LE1 -LRB-_LE1 NUM_LE1 extensive_LE1 and_LE1 NUM_LE1 poor_LE1 metabolizer_LE1 of_LE1 cypd_LE1 -RRB-_LE1 coadministration_LE1 of_LE1 BIOENTITY do_BE12 not_BE12 alter_BE12 the_BE12 kinetic_BE12 of_BE12 BIOENTITY in_RE2 the_RE2 poor_RE2 cypd_RE2 metabolizer_RE2 group_RE2 
Mexiletine|N|propafenone|mexiletine|In_LE1 this_LE1 crossover_LE1 steady_LE1 state_LE1 study_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOENTITY be_BE12 unaffect_BE12 in_BE12 either_BE12 phenotype_BE12 by_BE12 the_BE12 coadministration_BE12 of_BE12 BIOENTITY 
Mexiletine|N|mexiletine|propafenone|addition_LE1 of_LE1 BIOENTITY to_BE12 BIOENTITY do_RE2 not_RE2 lead_RE2 to_RE2 further_RE2 electrocardiographic_RE2 parameter_RE2 change_RE2 of_RE2 qrs_RE2 qtc_RE2 rr_RE2 and_RE2 pr_RE2 interval_RE2 than_RE2 BIOGENERAL_RE2 alone_RE2 
Mexiletine|N|mexiletine|propafenone|addition_LE1 of_LE1 BIOENTITY to_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 lead_BE12 to_BE12 further_BE12 electrocardiographic_BE12 parameter_BE12 change_BE12 of_BE12 qrs_BE12 qtc_BE12 rr_BE12 and_BE12 pr_BE12 interval_BE12 than_BE12 BIOENTITY alone_RE2 
Mexiletine|N|propafenone|propafenone|addition_LE1 of_LE1 BIOGENERAL_LE1 to_LE1 BIOENTITY do_BE12 not_BE12 lead_BE12 to_BE12 further_BE12 electrocardiographic_BE12 parameter_BE12 change_BE12 of_BE12 qrs_BE12 qtc_BE12 rr_BE12 and_BE12 pr_BE12 interval_BE12 than_BE12 BIOENTITY alone_RE2 
Mexiletine|N|mexiletine|mexiletine|when_LE1 concomitant_LE1 administration_LE1 of_LE1 either_LE1 of_LE1 these_LE1 two_LE1 drug_LE1 with_LE1 BIOENTITY be_BE12 initiate_BE12 the_BE12 dose_BE12 of_BE12 BIOENTITY shall_RE2 be_RE2 slow_RE2 titrate_RE2 to_RE2 desired_RE2 effect_RE2 
Mexiletine|N|mexitil|antihypertensive|In_LE1 large_LE1 compassionate_LE1 use_LE1 program_LE1 BIOENTITY have_BE12 be_BE12 use_BE12 concurrent_BE12 with_BE12 common_BE12 employ_BE12 antianginal_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 interaction_RE2 
Mexiletine|N|mexitil|anticoagulant drug|In_LE1 large_LE1 compassionate_LE1 use_LE1 program_LE1 BIOENTITY have_BE12 be_BE12 use_BE12 concurrent_BE12 with_BE12 common_BE12 employ_BE12 antianginal_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY without_RE2 observe_RE2 interaction_RE2 
Mexiletine|N|antihypertensive|anticoagulant drug|In_LE1 large_LE1 compassionate_LE1 use_LE1 program_LE1 BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 common_LE1 employ_LE1 antianginal_LE1 BIOENTITY and_BE12 BIOENTITY without_RE2 observe_RE2 interaction_RE2 
Mexiletine|N|antiarrhythmic|propranolol|variety_LE1 of_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY be_RE2 also_RE2 add_RE2 sometimes_RE2 with_RE2 improved_RE2 control_RE2 of_RE2 ventricular_RE2 ectopy_RE2 
Mexiletine|N|quinidine|propranolol|variety_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY or_BE12 BIOENTITY be_RE2 also_RE2 add_RE2 sometimes_RE2 with_RE2 improved_RE2 control_RE2 of_RE2 ventricular_RE2 ectopy_RE2 
Mexiletine|N|antiarrhythmic|quinidine|variety_LE1 of_LE1 BIOENTITY such_BE12 as_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 be_RE2 also_RE2 add_RE2 sometimes_RE2 with_RE2 improved_RE2 control_RE2 of_RE2 ventricular_RE2 ectopy_RE2 
Mexiletine|N|rifampin|phenobarbital|when_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 hepatic_LE1 enzyme_LE1 inducer_LE1 such_LE1 as_LE1 BIOENTITY and_BE12 BIOENTITY have_RE2 be_RE2 take_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 lowered_RE2 BIOGENERAL_RE2 plasma_RE2 level_RE2 have_RE2 be_RE2 report_RE2 
Mexiletine|N|phenytoin|rifampin|when_LE1 BIOENTITY or_BE12 other_BE12 hepatic_BE12 enzyme_BE12 inducer_BE12 such_BE12 as_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 take_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 lowered_RE2 BIOGENERAL_RE2 plasma_RE2 level_RE2 have_RE2 be_RE2 report_RE2 
Mexiletine|N|rifampin|mexitil|when_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 hepatic_LE1 enzyme_LE1 inducer_LE1 such_LE1 as_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 take_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 lowered_BE12 BIOENTITY plasma_RE2 level_RE2 have_RE2 be_RE2 report_RE2 
Mexiletine|N|phenytoin|phenobarbital|when_LE1 BIOENTITY or_BE12 other_BE12 hepatic_BE12 enzyme_BE12 inducer_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY have_RE2 be_RE2 take_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 lowered_RE2 BIOGENERAL_RE2 plasma_RE2 level_RE2 have_RE2 be_RE2 report_RE2 
Mexiletine|N|phenobarbital|mexitil|when_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 hepatic_LE1 enzyme_LE1 inducer_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY have_BE12 be_BE12 take_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 lowered_BE12 BIOENTITY plasma_RE2 level_RE2 have_RE2 be_RE2 report_RE2 
Mexiletine|N|phenytoin|mexitil|when_LE1 BIOENTITY or_BE12 other_BE12 hepatic_BE12 enzyme_BE12 inducer_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 take_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 lowered_BE12 BIOENTITY plasma_RE2 level_RE2 have_RE2 be_RE2 report_RE2 
Mexiletine|N|mexitil|mexitil|when_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 hepatic_LE1 enzyme_LE1 inducer_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 have_LE1 be_LE1 take_LE1 concurrent_LE1 with_LE1 BIOENTITY lowered_BE12 BIOENTITY plasma_RE2 level_RE2 have_RE2 be_RE2 report_RE2 
Mexiletine|N|benzodiazepine|mexitil|In_LE1 formal_LE1 study_LE1 BIOENTITY be_BE12 show_BE12 not_BE12 to_BE12 affect_BE12 BIOENTITY plasma_RE2 concentration_RE2 
Mexiletine|N|digoxin|propranolol|ecg_LE1 interval_LE1 -LRB-_LE1 pr_LE1 qrs_LE1 and_LE1 qt_LE1 -RRB-_LE1 be_LE1 not_LE1 affect_LE1 by_LE1 concurrent_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Mexiletine|N|digoxin|propranolol|ecg_LE1 interval_LE1 -LRB-_LE1 pr_LE1 qrs_LE1 and_LE1 qt_LE1 -RRB-_LE1 be_LE1 not_LE1 affect_LE1 by_LE1 concurrent_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Mexiletine|N|diuretic|propranolol|ecg_LE1 interval_LE1 -LRB-_LE1 pr_LE1 qrs_LE1 and_LE1 qt_LE1 -RRB-_LE1 be_LE1 not_LE1 affect_LE1 by_LE1 concurrent_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Mexiletine|N|diuretic|propranolol|ecg_LE1 interval_LE1 -LRB-_LE1 pr_LE1 qrs_LE1 and_LE1 qt_LE1 -RRB-_LE1 be_LE1 not_LE1 affect_LE1 by_LE1 concurrent_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Mexiletine|N|mexitil|propranolol|ecg_LE1 interval_LE1 -LRB-_LE1 pr_LE1 qrs_LE1 and_LE1 qt_LE1 -RRB-_LE1 be_LE1 not_LE1 affect_LE1 by_LE1 concurrent_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Mexiletine|N|digoxin|diuretic|ecg_LE1 interval_LE1 -LRB-_LE1 pr_LE1 qrs_LE1 and_LE1 qt_LE1 -RRB-_LE1 be_LE1 not_LE1 affect_LE1 by_LE1 concurrent_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Mexiletine|N|digoxin|diuretic|ecg_LE1 interval_LE1 -LRB-_LE1 pr_LE1 qrs_LE1 and_LE1 qt_LE1 -RRB-_LE1 be_LE1 not_LE1 affect_LE1 by_LE1 concurrent_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Mexiletine|N|mexitil|digoxin|ecg_LE1 interval_LE1 -LRB-_LE1 pr_LE1 qrs_LE1 and_LE1 qt_LE1 -RRB-_LE1 be_LE1 not_LE1 affect_LE1 by_LE1 concurrent_LE1 BIOENTITY and_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mexiletine|N|mexitil|diuretic|ecg_LE1 interval_LE1 -LRB-_LE1 pr_LE1 qrs_LE1 and_LE1 qt_LE1 -RRB-_LE1 be_LE1 not_LE1 affect_LE1 by_LE1 concurrent_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Mexiletine|N|cimetidine|mexitil|concurrent_LE1 administration_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 report_BE12 to_BE12 increase_BE12 decrease_BE12 or_BE12 leave_BE12 unchanged_BE12 BIOENTITY plasma_RE2 level_RE2 
Mexiletine|N|cimetidine|mexitil|concurrent_LE1 administration_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 report_BE12 to_BE12 increase_BE12 decrease_BE12 or_BE12 leave_BE12 unchanged_BE12 BIOENTITY plasma_RE2 level_RE2 
Mexiletine|N|mexitil|mexitil|concurrent_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY have_BE12 be_BE12 report_BE12 to_BE12 increase_BE12 decrease_BE12 or_BE12 leave_BE12 unchanged_BE12 BIOENTITY plasma_RE2 level_RE2 
Mexiletine|N|mexitil|mexitil|concurrent_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY have_BE12 be_BE12 report_BE12 to_BE12 increase_BE12 decrease_BE12 or_BE12 leave_BE12 unchanged_BE12 BIOENTITY plasma_RE2 level_RE2 
Mexiletine|N|mexitil|digoxin|BIOENTITY do_BE12 not_BE12 alter_BE12 serum_BE12 BIOENTITY level_RE2 but_RE2 BIOGENERAL_RE2 when_RE2 use_RE2 to_RE2 treat_RE2 gastrointestinal_RE2 symptom_RE2 due_RE2 to_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 low_RE2 serum_RE2 BIOGENERAL_RE2 level_RE2 
Mexiletine|N|digoxin|mexitil|BIOGENERAL_LE1 do_LE1 not_LE1 alter_LE1 serum_LE1 BIOENTITY level_BE12 but_BE12 BIOGENERAL_BE12 when_BE12 use_BE12 to_BE12 treat_BE12 gastrointestinal_BE12 symptom_BE12 due_BE12 to_BE12 BIOENTITY have_RE2 be_RE2 report_RE2 to_RE2 low_RE2 serum_RE2 BIOGENERAL_RE2 level_RE2 
Mexiletine|N|digoxin|magnesium-aluminum hydroxide|BIOGENERAL_LE1 do_LE1 not_LE1 alter_LE1 serum_LE1 BIOENTITY level_BE12 but_BE12 BIOENTITY when_RE2 use_RE2 to_RE2 treat_RE2 gastrointestinal_RE2 symptom_RE2 due_RE2 to_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 low_RE2 serum_RE2 BIOGENERAL_RE2 level_RE2 
Mexiletine|N|digoxin|digoxin|BIOGENERAL_LE1 do_LE1 not_LE1 alter_LE1 serum_LE1 BIOENTITY level_BE12 but_BE12 BIOGENERAL_BE12 when_BE12 use_BE12 to_BE12 treat_BE12 gastrointestinal_BE12 symptom_BE12 due_BE12 to_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 report_BE12 to_BE12 low_BE12 serum_BE12 BIOENTITY level_RE2 
Mexiletine|N|mexitil|mexitil|BIOENTITY do_BE12 not_BE12 alter_BE12 serum_BE12 BIOGENERAL_BE12 level_BE12 but_BE12 BIOGENERAL_BE12 when_BE12 use_BE12 to_BE12 treat_BE12 gastrointestinal_BE12 symptom_BE12 due_BE12 to_BE12 BIOENTITY have_RE2 be_RE2 report_RE2 to_RE2 low_RE2 serum_RE2 BIOGENERAL_RE2 level_RE2 
Mexiletine|N|mexitil|magnesium-aluminum hydroxide|BIOENTITY do_BE12 not_BE12 alter_BE12 serum_BE12 BIOGENERAL_BE12 level_BE12 but_BE12 BIOENTITY when_RE2 use_RE2 to_RE2 treat_RE2 gastrointestinal_RE2 symptom_RE2 due_RE2 to_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 low_RE2 serum_RE2 BIOGENERAL_RE2 level_RE2 
Mexiletine|N|mexitil|digoxin|BIOENTITY do_BE12 not_BE12 alter_BE12 serum_BE12 BIOGENERAL_BE12 level_BE12 but_BE12 BIOGENERAL_BE12 when_BE12 use_BE12 to_BE12 treat_BE12 gastrointestinal_BE12 symptom_BE12 due_BE12 to_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 report_BE12 to_BE12 low_BE12 serum_BE12 BIOENTITY level_RE2 
Mexiletine|N|magnesium-aluminum hydroxide|mexitil|BIOGENERAL_LE1 do_LE1 not_LE1 alter_LE1 serum_LE1 BIOGENERAL_LE1 level_LE1 but_LE1 BIOENTITY when_BE12 use_BE12 to_BE12 treat_BE12 gastrointestinal_BE12 symptom_BE12 due_BE12 to_BE12 BIOENTITY have_RE2 be_RE2 report_RE2 to_RE2 low_RE2 serum_RE2 BIOGENERAL_RE2 level_RE2 
Mexiletine|N|mexitil|digoxin|BIOGENERAL_LE1 do_LE1 not_LE1 alter_LE1 serum_LE1 BIOGENERAL_LE1 level_LE1 but_LE1 BIOGENERAL_LE1 when_LE1 use_LE1 to_LE1 treat_LE1 gastrointestinal_LE1 symptom_LE1 due_LE1 to_LE1 BIOENTITY have_BE12 be_BE12 report_BE12 to_BE12 low_BE12 serum_BE12 BIOENTITY level_RE2 
Mexiletine|N|mexitil|theophylline|concurrent_LE1 use_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 may_BE12 lead_BE12 to_BE12 increase_BE12 plasma_BE12 BIOENTITY level_RE2 
Mexiletine|N|theophylline|theophylline|concurrent_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY may_BE12 lead_BE12 to_BE12 increase_BE12 plasma_BE12 BIOENTITY level_RE2 
Mexiletine|N|mexitil|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 plasma_LE1 level_LE1 return_LE1 to_LE1 BIOGENERAL_LE1 value_LE1 within_LE1 NUM_LE1 hour_LE1 after_LE1 discontinuing_LE1 BIOGENERAL_LE1 if_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 be_BE12 to_BE12 be_BE12 use_BE12 concurrent_BE12 BIOGENERAL_BE12 blood_BE12 level_BE12 shall_BE12 be_BE12 monitor_BE12 particular_BE12 when_BE12 the_BE12 BIOENTITY dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 plasma_LE1 level_LE1 return_LE1 to_LE1 BIOGENERAL_LE1 value_LE1 within_LE1 NUM_LE1 hour_LE1 after_LE1 discontinuing_LE1 BIOENTITY if_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 to_BE12 be_BE12 use_BE12 concurrent_BE12 BIOGENERAL_BE12 blood_BE12 level_BE12 shall_BE12 be_BE12 monitor_BE12 particular_BE12 when_BE12 the_BE12 BIOENTITY dose_RE2 be_RE2 change_RE2 
Mexiletine|N|theophylline|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 plasma_LE1 level_LE1 return_LE1 to_LE1 BIOGENERAL_LE1 value_LE1 within_LE1 NUM_LE1 hour_LE1 after_LE1 discontinuing_LE1 BIOGENERAL_LE1 if_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 be_LE1 to_LE1 be_LE1 use_LE1 concurrent_LE1 BIOENTITY blood_BE12 level_BE12 shall_BE12 be_BE12 monitor_BE12 particular_BE12 when_BE12 the_BE12 BIOENTITY dose_RE2 be_RE2 change_RE2 
Mexiletine|N|theophylline|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 plasma_LE1 level_LE1 return_LE1 to_LE1 BIOGENERAL_LE1 value_LE1 within_LE1 NUM_LE1 hour_LE1 after_LE1 discontinuing_LE1 BIOGENERAL_LE1 if_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY be_BE12 to_BE12 be_BE12 use_BE12 concurrent_BE12 BIOGENERAL_BE12 blood_BE12 level_BE12 shall_BE12 be_BE12 monitor_BE12 particular_BE12 when_BE12 the_BE12 BIOENTITY dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOENTITY BIOGENERAL_BE12 plasma_BE12 level_BE12 return_BE12 to_BE12 BIOGENERAL_BE12 value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOGENERAL_BE12 if_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 to_BE12 be_BE12 use_BE12 concurrent_BE12 BIOGENERAL_BE12 blood_BE12 level_BE12 shall_BE12 be_BE12 monitor_BE12 particular_BE12 when_BE12 the_BE12 BIOENTITY dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOENTITY BIOGENERAL_BE12 plasma_BE12 level_BE12 return_BE12 to_BE12 BIOGENERAL_BE12 value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOGENERAL_BE12 if_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 to_BE12 be_BE12 use_BE12 concurrent_BE12 BIOGENERAL_BE12 blood_BE12 level_BE12 shall_BE12 be_BE12 monitor_BE12 particular_BE12 when_BE12 the_BE12 BIOENTITY dose_RE2 be_RE2 change_RE2 
Mexiletine|N|theophylline|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOENTITY plasma_BE12 level_BE12 return_BE12 to_BE12 BIOGENERAL_BE12 value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOGENERAL_BE12 if_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 to_BE12 be_BE12 use_BE12 concurrent_BE12 BIOGENERAL_BE12 blood_BE12 level_BE12 shall_BE12 be_BE12 monitor_BE12 particular_BE12 when_BE12 the_BE12 BIOENTITY dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 plasma_LE1 level_LE1 return_LE1 to_LE1 BIOENTITY value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOGENERAL_BE12 if_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 to_BE12 be_BE12 use_BE12 concurrent_BE12 BIOGENERAL_BE12 blood_BE12 level_BE12 shall_BE12 be_BE12 monitor_BE12 particular_BE12 when_BE12 the_BE12 BIOENTITY dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 plasma_LE1 level_LE1 return_LE1 to_LE1 BIOGENERAL_LE1 value_LE1 within_LE1 NUM_LE1 hour_LE1 after_LE1 discontinuing_LE1 BIOENTITY if_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|theophylline|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 plasma_LE1 level_LE1 return_LE1 to_LE1 BIOGENERAL_LE1 value_LE1 within_LE1 NUM_LE1 hour_LE1 after_LE1 discontinuing_LE1 BIOGENERAL_LE1 if_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 be_BE12 to_BE12 be_BE12 use_BE12 concurrent_BE12 BIOENTITY blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOENTITY BIOGENERAL_BE12 plasma_BE12 level_BE12 return_BE12 to_BE12 BIOGENERAL_BE12 value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOGENERAL_BE12 if_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOENTITY BIOGENERAL_BE12 plasma_BE12 level_BE12 return_BE12 to_BE12 BIOGENERAL_BE12 value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOGENERAL_BE12 if_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|theophylline|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOENTITY plasma_BE12 level_BE12 return_BE12 to_BE12 BIOGENERAL_BE12 value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOGENERAL_BE12 if_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 plasma_LE1 level_LE1 return_LE1 to_LE1 BIOENTITY value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOGENERAL_BE12 if_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|theophylline|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 plasma_LE1 level_LE1 return_LE1 to_LE1 BIOGENERAL_LE1 value_LE1 within_LE1 NUM_LE1 hour_LE1 after_LE1 discontinuing_LE1 BIOENTITY if_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 to_BE12 be_BE12 use_BE12 concurrent_BE12 BIOENTITY blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|theophylline|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 plasma_LE1 level_LE1 return_LE1 to_LE1 BIOGENERAL_LE1 value_LE1 within_LE1 NUM_LE1 hour_LE1 after_LE1 discontinuing_LE1 BIOENTITY if_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOENTITY BIOGENERAL_BE12 plasma_BE12 level_BE12 return_BE12 to_BE12 BIOGENERAL_BE12 value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOENTITY if_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOENTITY BIOGENERAL_BE12 plasma_BE12 level_BE12 return_BE12 to_BE12 BIOGENERAL_BE12 value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOENTITY if_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 plasma_LE1 level_LE1 return_LE1 to_LE1 BIOENTITY value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOENTITY if_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|theophylline|theophylline|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 plasma_LE1 level_LE1 return_LE1 to_LE1 BIOGENERAL_LE1 value_LE1 within_LE1 NUM_LE1 hour_LE1 after_LE1 discontinuing_LE1 BIOGENERAL_LE1 if_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY be_BE12 to_BE12 be_BE12 use_BE12 concurrent_BE12 BIOENTITY blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|theophylline|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOENTITY BIOGENERAL_BE12 plasma_BE12 level_BE12 return_BE12 to_BE12 BIOGENERAL_BE12 value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOGENERAL_BE12 if_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 to_BE12 be_BE12 use_BE12 concurrent_BE12 BIOENTITY blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|theophylline|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOENTITY BIOGENERAL_BE12 plasma_BE12 level_BE12 return_BE12 to_BE12 BIOGENERAL_BE12 value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOGENERAL_BE12 if_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 to_BE12 be_BE12 use_BE12 concurrent_BE12 BIOENTITY blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|theophylline|theophylline|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOENTITY plasma_BE12 level_BE12 return_BE12 to_BE12 BIOGENERAL_BE12 value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOGENERAL_BE12 if_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 to_BE12 be_BE12 use_BE12 concurrent_BE12 BIOENTITY blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|theophylline|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 plasma_LE1 level_LE1 return_LE1 to_LE1 BIOENTITY value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOGENERAL_BE12 if_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 to_BE12 be_BE12 use_BE12 concurrent_BE12 BIOENTITY blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|theophylline|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOENTITY BIOGENERAL_BE12 plasma_BE12 level_BE12 return_BE12 to_BE12 BIOGENERAL_BE12 value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOGENERAL_BE12 if_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|theophylline|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOENTITY BIOGENERAL_BE12 plasma_BE12 level_BE12 return_BE12 to_BE12 BIOGENERAL_BE12 value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOGENERAL_BE12 if_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|theophylline|theophylline|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOENTITY plasma_BE12 level_BE12 return_BE12 to_BE12 BIOGENERAL_BE12 value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOGENERAL_BE12 if_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|theophylline|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 plasma_LE1 level_LE1 return_LE1 to_LE1 BIOENTITY value_BE12 within_BE12 NUM_BE12 hour_BE12 after_BE12 discontinuing_BE12 BIOGENERAL_BE12 if_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|theophylline|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOENTITY BIOENTITY plasma_RE2 level_RE2 return_RE2 to_RE2 BIOGENERAL_RE2 value_RE2 within_RE2 NUM_RE2 hour_RE2 after_RE2 discontinuing_RE2 BIOGENERAL_RE2 if_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|theophylline|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOENTITY BIOENTITY plasma_RE2 level_RE2 return_RE2 to_RE2 BIOGENERAL_RE2 value_RE2 within_RE2 NUM_RE2 hour_RE2 after_RE2 discontinuing_RE2 BIOGENERAL_RE2 if_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOENTITY BIOGENERAL_BE12 plasma_BE12 level_BE12 return_BE12 to_BE12 BIOENTITY value_RE2 within_RE2 NUM_RE2 hour_RE2 after_RE2 discontinuing_RE2 BIOGENERAL_RE2 if_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|mexitil|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOENTITY BIOGENERAL_BE12 plasma_BE12 level_BE12 return_BE12 to_BE12 BIOENTITY value_RE2 within_RE2 NUM_RE2 hour_RE2 after_RE2 discontinuing_RE2 BIOGENERAL_RE2 if_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mexiletine|N|theophylline|mexitil|this_LE1 increase_LE1 be_LE1 observe_LE1 at_LE1 the_LE1 first_LE1 test_LE1 point_LE1 which_LE1 be_LE1 the_LE1 second_LE1 day_LE1 after_LE1 start_LE1 BIOGENERAL_LE1 BIOENTITY plasma_BE12 level_BE12 return_BE12 to_BE12 BIOENTITY value_RE2 within_RE2 NUM_RE2 hour_RE2 after_RE2 discontinuing_RE2 BIOGENERAL_RE2 if_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 to_RE2 be_RE2 use_RE2 concurrent_RE2 BIOGENERAL_RE2 blood_RE2 level_RE2 shall_RE2 be_RE2 monitor_RE2 particular_RE2 when_RE2 the_RE2 BIOGENERAL_RE2 dose_RE2 be_RE2 change_RE2 
Mibefradil|N|terfenadine|cyclosporine|BIOGENERAL_LE1 inhibit_LE1 some_LE1 of_LE1 the_LE1 liver_LE1 's_LE1 ability_LE1 to_LE1 metabolize_LE1 some_LE1 other_LE1 drug_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mibefradil|N|terfenadine|tricyclic antidepressant|BIOGENERAL_LE1 inhibit_LE1 some_LE1 of_LE1 the_LE1 liver_LE1 's_LE1 ability_LE1 to_LE1 metabolize_LE1 some_LE1 other_LE1 drug_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mibefradil|N|terfenadine|astemizole|BIOGENERAL_LE1 inhibit_LE1 some_LE1 of_LE1 the_LE1 liver_LE1 's_LE1 ability_LE1 to_LE1 metabolize_LE1 some_LE1 other_LE1 drug_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mibefradil|N|terfenadine|cisapride|BIOGENERAL_LE1 inhibit_LE1 some_LE1 of_LE1 the_LE1 liver_LE1 's_LE1 ability_LE1 to_LE1 metabolize_LE1 some_LE1 other_LE1 drug_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mibefradil|N|cyclosporine|tricyclic antidepressant|BIOGENERAL_LE1 inhibit_LE1 some_LE1 of_LE1 the_LE1 liver_LE1 's_LE1 ability_LE1 to_LE1 metabolize_LE1 some_LE1 other_LE1 drug_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Mibefradil|N|cyclosporine|tricyclic antidepressant|BIOGENERAL_LE1 inhibit_LE1 some_LE1 of_LE1 the_LE1 liver_LE1 's_LE1 ability_LE1 to_LE1 metabolize_LE1 some_LE1 other_LE1 drug_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Mibefradil|N|astemizole|cyclosporine|BIOGENERAL_LE1 inhibit_LE1 some_LE1 of_LE1 the_LE1 liver_LE1 's_LE1 ability_LE1 to_LE1 metabolize_LE1 some_LE1 other_LE1 drug_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mibefradil|N|astemizole|cyclosporine|BIOGENERAL_LE1 inhibit_LE1 some_LE1 of_LE1 the_LE1 liver_LE1 's_LE1 ability_LE1 to_LE1 metabolize_LE1 some_LE1 other_LE1 drug_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mibefradil|N|cisapride|cyclosporine|BIOGENERAL_LE1 inhibit_LE1 some_LE1 of_LE1 the_LE1 liver_LE1 's_LE1 ability_LE1 to_LE1 metabolize_LE1 some_LE1 other_LE1 drug_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Mibefradil|N|cisapride|cyclosporine|BIOGENERAL_LE1 inhibit_LE1 some_LE1 of_LE1 the_LE1 liver_LE1 's_LE1 ability_LE1 to_LE1 metabolize_LE1 some_LE1 other_LE1 drug_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Mibefradil|N|astemizole|tricyclic antidepressant|BIOGENERAL_LE1 inhibit_LE1 some_LE1 of_LE1 the_LE1 liver_LE1 's_LE1 ability_LE1 to_LE1 metabolize_LE1 some_LE1 other_LE1 drug_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mibefradil|N|astemizole|tricyclic antidepressant|BIOGENERAL_LE1 inhibit_LE1 some_LE1 of_LE1 the_LE1 liver_LE1 's_LE1 ability_LE1 to_LE1 metabolize_LE1 some_LE1 other_LE1 drug_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mibefradil|N|cisapride|tricyclic antidepressant|BIOGENERAL_LE1 inhibit_LE1 some_LE1 of_LE1 the_LE1 liver_LE1 's_LE1 ability_LE1 to_LE1 metabolize_LE1 some_LE1 other_LE1 drug_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mibefradil|N|cisapride|tricyclic antidepressant|BIOGENERAL_LE1 inhibit_LE1 some_LE1 of_LE1 the_LE1 liver_LE1 's_LE1 ability_LE1 to_LE1 metabolize_LE1 some_LE1 other_LE1 drug_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mibefradil|N|astemizole|cisapride|BIOGENERAL_LE1 inhibit_LE1 some_LE1 of_LE1 the_LE1 liver_LE1 's_LE1 ability_LE1 to_LE1 metabolize_LE1 some_LE1 other_LE1 drug_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mibefradil|N|astemizole|cisapride|BIOGENERAL_LE1 inhibit_LE1 some_LE1 of_LE1 the_LE1 liver_LE1 's_LE1 ability_LE1 to_LE1 metabolize_LE1 some_LE1 other_LE1 drug_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|mycophenolate mofetil|cyclosporine|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|mycamine|cyclosporine|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|cyclosporine|nifedipine|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|cyclosporine|sirolimu|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|cyclosporine|prednisolone|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|cyclosporine|tacrolimu|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|cyclosporine|rifampin|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Micafungin|N|cyclosporine|ritonavir|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Micafungin|N|cyclosporine|fluconazole|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|mycamine|mycophenolate mofetil|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|mycophenolate mofetil|nifedipine|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|mycophenolate mofetil|sirolimu|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|mycophenolate mofetil|prednisolone|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|mycophenolate mofetil|tacrolimu|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|mycophenolate mofetil|rifampin|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Micafungin|N|mycophenolate mofetil|ritonavir|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Micafungin|N|mycophenolate mofetil|fluconazole|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|mycamine|nifedipine|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|mycamine|sirolimu|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|mycamine|prednisolone|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|mycamine|tacrolimu|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|mycamine|rifampin|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Micafungin|N|mycamine|ritonavir|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Micafungin|N|mycamine|fluconazole|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|sirolimu|nifedipine|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|sirolimu|nifedipine|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|prednisolone|nifedipine|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|prednisolone|nifedipine|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|tacrolimu|nifedipine|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|tacrolimu|nifedipine|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|nifedipine|rifampin|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Micafungin|N|nifedipine|rifampin|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Micafungin|N|nifedipine|ritonavir|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Micafungin|N|nifedipine|ritonavir|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Micafungin|N|nifedipine|fluconazole|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|nifedipine|fluconazole|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|prednisolone|sirolimu|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|prednisolone|sirolimu|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|tacrolimu|sirolimu|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|tacrolimu|sirolimu|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|sirolimu|rifampin|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Micafungin|N|sirolimu|rifampin|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Micafungin|N|sirolimu|ritonavir|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Micafungin|N|sirolimu|ritonavir|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Micafungin|N|sirolimu|fluconazole|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|sirolimu|fluconazole|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|tacrolimu|prednisolone|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|tacrolimu|prednisolone|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|prednisolone|rifampin|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Micafungin|N|prednisolone|rifampin|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Micafungin|N|prednisolone|ritonavir|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Micafungin|N|prednisolone|ritonavir|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Micafungin|N|prednisolone|fluconazole|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|prednisolone|fluconazole|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|tacrolimu|rifampin|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Micafungin|N|tacrolimu|rifampin|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Micafungin|N|tacrolimu|ritonavir|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Micafungin|N|tacrolimu|ritonavir|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Micafungin|N|tacrolimu|fluconazole|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|tacrolimu|fluconazole|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Micafungin|N|ritonavir|rifampin|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Micafungin|N|ritonavir|rifampin|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Micafungin|N|fluconazole|rifampin|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Micafungin|N|fluconazole|rifampin|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Micafungin|N|fluconazole|ritonavir|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Micafungin|N|fluconazole|ritonavir|total_LE1 of_LE1 NUM_LE1 clinical_LE1 drugdrug_LE1 interaction_LE1 study_LE1 be_LE1 conduct_LE1 in_LE1 healthy_LE1 volunteer_LE1 to_LE1 evaluate_LE1 the_LE1 potential_LE1 for_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Micafungin|N|tacrolimu|prednisolone|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 pharmacokinetic_RE2 
Micafungin|N|tacrolimu|prednisolone|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 pharmacokinetic_RE2 
Micafungin|N|cyclosporine|prednisolone|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 pharmacokinetic_RE2 
Micafungin|N|mycophenolate mofetil|prednisolone|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 pharmacokinetic_RE2 
Micafungin|N|prednisolone|fluconazole|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY pharmacokinetic_RE2 
Micafungin|N|prednisolone|fluconazole|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY pharmacokinetic_RE2 
Micafungin|N|mycamine|prednisolone|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOENTITY on_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 pharmacokinetic_RE2 
Micafungin|N|cyclosporine|tacrolimu|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 pharmacokinetic_RE2 
Micafungin|N|mycophenolate mofetil|tacrolimu|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 pharmacokinetic_RE2 
Micafungin|N|tacrolimu|fluconazole|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY pharmacokinetic_RE2 
Micafungin|N|tacrolimu|fluconazole|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY pharmacokinetic_RE2 
Micafungin|N|mycamine|tacrolimu|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOENTITY on_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 pharmacokinetic_RE2 
Micafungin|N|mycophenolate mofetil|cyclosporine|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 pharmacokinetic_RE2 
Micafungin|N|cyclosporine|fluconazole|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY pharmacokinetic_RE2 
Micafungin|N|mycamine|cyclosporine|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOENTITY on_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 pharmacokinetic_RE2 
Micafungin|N|mycophenolate mofetil|fluconazole|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY pharmacokinetic_RE2 
Micafungin|N|mycamine|mycophenolate mofetil|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOENTITY on_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 pharmacokinetic_RE2 
Micafungin|N|mycamine|fluconazole|there_LE1 be_LE1 no_LE1 effect_LE1 of_LE1 single_LE1 dose_LE1 or_LE1 multiple_LE1 dose_LE1 of_LE1 BIOENTITY on_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY pharmacokinetic_RE2 
Micafungin|N|mycamine|sirolimu|BIOGENERAL_LE1 auc_LE1 be_LE1 increase_LE1 by_LE1 NUM_LE1 with_LE1 no_LE1 effect_LE1 on_LE1 cmax_LE1 in_LE1 the_LE1 presence_LE1 of_LE1 steadystate_LE1 BIOENTITY compared_BE12 with_BE12 BIOENTITY alone_RE2 
Micafungin|N|sirolimu|sirolimu|BIOENTITY auc_BE12 be_BE12 increase_BE12 by_BE12 NUM_BE12 with_BE12 no_BE12 effect_BE12 on_BE12 cmax_BE12 in_BE12 the_BE12 presence_BE12 of_BE12 steadystate_BE12 BIOGENERAL_BE12 compared_BE12 with_BE12 BIOENTITY alone_RE2 
Micafungin|N|mycamine|nifedipine|BIOGENERAL_LE1 auc_LE1 and_LE1 cmax_LE1 be_LE1 increase_LE1 by_LE1 NUM_LE1 and_LE1 NUM_LE1 respective_LE1 in_LE1 the_LE1 presence_LE1 of_LE1 steadystate_LE1 BIOENTITY compared_BE12 with_BE12 BIOENTITY alone_RE2 
Micafungin|N|nifedipine|nifedipine|BIOENTITY auc_BE12 and_BE12 cmax_BE12 be_BE12 increase_BE12 by_BE12 NUM_BE12 and_BE12 NUM_BE12 respective_BE12 in_BE12 the_BE12 presence_BE12 of_BE12 steadystate_BE12 BIOGENERAL_BE12 compared_BE12 with_BE12 BIOENTITY alone_RE2 
Micafungin|N|mycamine|sirolimu|patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOENTITY shall_BE12 be_BE12 monitor_BE12 for_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 toxicity_RE2 and_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|mycamine|nifedipine|patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOENTITY shall_BE12 be_BE12 monitor_BE12 for_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 toxicity_BE12 and_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|mycamine|sirolimu|patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOENTITY shall_BE12 be_BE12 monitor_BE12 for_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 toxicity_BE12 and_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|mycamine|nifedipine|patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOENTITY shall_BE12 be_BE12 monitor_BE12 for_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY toxicity_RE2 and_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|sirolimu|sirolimu|patient_LE1 receive_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 monitor_BE12 for_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 toxicity_RE2 and_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|nifedipine|sirolimu|patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 monitor_BE12 for_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 toxicity_RE2 and_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|sirolimu|nifedipine|patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 monitor_LE1 for_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 toxicity_BE12 and_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|sirolimu|sirolimu|patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 monitor_LE1 for_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 toxicity_BE12 and_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|sirolimu|nifedipine|patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 monitor_LE1 for_LE1 BIOENTITY or_BE12 BIOENTITY toxicity_RE2 and_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|sirolimu|nifedipine|patient_LE1 receive_LE1 BIOENTITY or_BE12 BIOENTITY in_RE2 combination_RE2 with_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 monitor_RE2 for_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 toxicity_RE2 and_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|sirolimu|nifedipine|patient_LE1 receive_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 monitor_BE12 for_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 toxicity_BE12 and_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|sirolimu|sirolimu|patient_LE1 receive_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 monitor_BE12 for_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 toxicity_BE12 and_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|sirolimu|nifedipine|patient_LE1 receive_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 monitor_BE12 for_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY toxicity_RE2 and_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|nifedipine|nifedipine|patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 monitor_BE12 for_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 toxicity_BE12 and_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|nifedipine|sirolimu|patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 monitor_BE12 for_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 toxicity_BE12 and_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|nifedipine|nifedipine|patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 monitor_BE12 for_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY toxicity_RE2 and_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|sirolimu|nifedipine|patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 monitor_LE1 for_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 toxicity_LE1 and_LE1 BIOENTITY or_BE12 BIOENTITY dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|nifedipine|nifedipine|patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 monitor_LE1 for_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY toxicity_BE12 and_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|nifedipine|sirolimu|patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 monitor_LE1 for_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY toxicity_BE12 and_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Micafungin|N|nifedipine|sirolimu|patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 monitor_LE1 for_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY toxicity_BE12 and_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 dosage_RE2 shall_RE2 be_RE2 reduce_RE2 if_RE2 necessary_RE2 
Midazolam|N|azole antimycotic|macrolide antibiotic|drug_LE1 interaction_LE1 :_LE1 inhibitor_LE1 of_LE1 cypa_LE1 isozyme_LE1 :_LE1 caution_LE1 be_LE1 advised_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 drug_LE1 that_LE1 be_LE1 know_LE1 to_LE1 inhibit_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 -LRB-_LE1 ie_LE1 some_LE1 drug_LE1 in_LE1 the_LE1 drug_LE1 class_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Midazolam|N|calcium channel antagonist|macrolide antibiotic|drug_LE1 interaction_LE1 :_LE1 inhibitor_LE1 of_LE1 cypa_LE1 isozyme_LE1 :_LE1 caution_LE1 be_LE1 advised_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 drug_LE1 that_LE1 be_LE1 know_LE1 to_LE1 inhibit_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 -LRB-_LE1 ie_LE1 some_LE1 drug_LE1 in_LE1 the_LE1 drug_LE1 class_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY rrb._RE2 
Midazolam|N|calcium channel antagonist|macrolide antibiotic|drug_LE1 interaction_LE1 :_LE1 inhibitor_LE1 of_LE1 cypa_LE1 isozyme_LE1 :_LE1 caution_LE1 be_LE1 advised_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 drug_LE1 that_LE1 be_LE1 know_LE1 to_LE1 inhibit_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 -LRB-_LE1 ie_LE1 some_LE1 drug_LE1 in_LE1 the_LE1 drug_LE1 class_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY rrb._RE2 
Midazolam|N|protease inhibitor|macrolide antibiotic|drug_LE1 interaction_LE1 :_LE1 inhibitor_LE1 of_LE1 cypa_LE1 isozyme_LE1 :_LE1 caution_LE1 be_LE1 advised_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 drug_LE1 that_LE1 be_LE1 know_LE1 to_LE1 inhibit_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 -LRB-_LE1 ie_LE1 some_LE1 drug_LE1 in_LE1 the_LE1 drug_LE1 class_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Midazolam|N|protease inhibitor|macrolide antibiotic|drug_LE1 interaction_LE1 :_LE1 inhibitor_LE1 of_LE1 cypa_LE1 isozyme_LE1 :_LE1 caution_LE1 be_LE1 advised_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 drug_LE1 that_LE1 be_LE1 know_LE1 to_LE1 inhibit_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 -LRB-_LE1 ie_LE1 some_LE1 drug_LE1 in_LE1 the_LE1 drug_LE1 class_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Midazolam|N|azole antimycotic|calcium channel antagonist|drug_LE1 interaction_LE1 :_LE1 inhibitor_LE1 of_LE1 cypa_LE1 isozyme_LE1 :_LE1 caution_LE1 be_LE1 advised_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 drug_LE1 that_LE1 be_LE1 know_LE1 to_LE1 inhibit_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 -LRB-_LE1 ie_LE1 some_LE1 drug_LE1 in_LE1 the_LE1 drug_LE1 class_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Midazolam|N|azole antimycotic|protease inhibitor|drug_LE1 interaction_LE1 :_LE1 inhibitor_LE1 of_LE1 cypa_LE1 isozyme_LE1 :_LE1 caution_LE1 be_LE1 advised_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 drug_LE1 that_LE1 be_LE1 know_LE1 to_LE1 inhibit_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 -LRB-_LE1 ie_LE1 some_LE1 drug_LE1 in_LE1 the_LE1 drug_LE1 class_LE1 of_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Midazolam|N|protease inhibitor|calcium channel antagonist|drug_LE1 interaction_LE1 :_LE1 inhibitor_LE1 of_LE1 cypa_LE1 isozyme_LE1 :_LE1 caution_LE1 be_LE1 advised_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 drug_LE1 that_LE1 be_LE1 know_LE1 to_LE1 inhibit_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 -LRB-_LE1 ie_LE1 some_LE1 drug_LE1 in_LE1 the_LE1 drug_LE1 class_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Midazolam|N|protease inhibitor|calcium channel antagonist|drug_LE1 interaction_LE1 :_LE1 inhibitor_LE1 of_LE1 cypa_LE1 isozyme_LE1 :_LE1 caution_LE1 be_LE1 advised_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 drug_LE1 that_LE1 be_LE1 know_LE1 to_LE1 inhibit_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 -LRB-_LE1 ie_LE1 some_LE1 drug_LE1 in_LE1 the_LE1 drug_LE1 class_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Midazolam|N|diltiazem|itraconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|diltiazem|itraconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|verapamil|itraconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|verapamil|itraconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|ketoconazole|itraconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|ketoconazole|itraconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|fluconazole|itraconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|fluconazole|itraconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|erythromycin|itraconazole|drug_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|diltiazem|verapamil|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|diltiazem|verapamil|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|diltiazem|ketoconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|diltiazem|ketoconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|diltiazem|fluconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|diltiazem|fluconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|erythromycin|diltiazem|drug_LE1 such_LE1 as_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|verapamil|ketoconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|verapamil|ketoconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|verapamil|fluconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|verapamil|fluconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|erythromycin|verapamil|drug_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|ketoconazole|fluconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|ketoconazole|fluconazole|drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|erythromycin|ketoconazole|drug_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|erythromycin|fluconazole|drug_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 show_RE2 to_RE2 significant_RE2 increase_RE2 the_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 administer_RE2 BIOGENERAL_RE2 
Midazolam|N|ritonavir|nelfinavir|although_LE1 not_LE1 study_LE1 the_LE1 potent_LE1 cytochrome_LE1 inhibitor_LE1 BIOENTITY and_BE12 BIOENTITY may_RE2 cause_RE2 intense_RE2 and_RE2 prolonged_RE2 sedation_RE2 and_RE2 respiratory_RE2 depression_RE2 due_RE2 to_RE2 decrease_RE2 in_RE2 plasma_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Midazolam|N|rifampin|carbamazepine|inducer_LE1 of_LE1 cypa_LE1 isozyme_LE1 :_LE1 cytochrome_LE1 inducer_LE1 such_LE1 as_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 induce_RE2 metabolism_RE2 and_RE2 cause_RE2 marked_RE2 decrease_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 BIOGENERAL_RE2 in_RE2 adult_RE2 study_RE2 
Midazolam|N|carbamazepine|phenytoin|inducer_LE1 of_LE1 cypa_LE1 isozyme_LE1 :_LE1 cytochrome_LE1 inducer_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY induce_RE2 metabolism_RE2 and_RE2 cause_RE2 marked_RE2 decrease_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 BIOGENERAL_RE2 in_RE2 adult_RE2 study_RE2 
Midazolam|N|carbamazepine|phenytoin|inducer_LE1 of_LE1 cypa_LE1 isozyme_LE1 :_LE1 cytochrome_LE1 inducer_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY induce_RE2 metabolism_RE2 and_RE2 cause_RE2 marked_RE2 decrease_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 BIOGENERAL_RE2 in_RE2 adult_RE2 study_RE2 
Midazolam|N|rifampin|phenytoin|inducer_LE1 of_LE1 cypa_LE1 isozyme_LE1 :_LE1 cytochrome_LE1 inducer_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY induce_RE2 metabolism_RE2 and_RE2 cause_RE2 marked_RE2 decrease_RE2 max_RE2 and_RE2 auc_RE2 of_RE2 oral_RE2 BIOGENERAL_RE2 in_RE2 adult_RE2 study_RE2 
Midazolam|N|sedative|methylphenidate|the_LE1 difficulty_LE1 in_LE1 achieve_LE1 adequate_LE1 sedation_LE1 may_LE1 have_LE1 be_LE1 the_LE1 result_LE1 of_LE1 decrease_LE1 absorption_LE1 of_LE1 the_LE1 BIOENTITY due_BE12 to_BE12 both_BE12 the_BE12 gastrointestinal_BE12 effect_BE12 and_BE12 stimulant_BE12 effect_BE12 of_BE12 BIOENTITY 
Midazolam|N|morphine|droperidol|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midazolam|N|narcotic|droperidol|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midazolam|N|fentanyl|droperidol|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midazolam|N|meperidine|droperidol|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midazolam|N|ketamine|droperidol|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midazolam|N|ketamine|droperidol|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midazolam|N|propofol|droperidol|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midazolam|N|secobarbital|droperidol|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Midazolam|N|secobarbital|droperidol|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Midazolam|N|nitrous oxide|droperidol|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midazolam|N|nitrous oxide|droperidol|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midazolam|N|narcotic|morphine|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|morphine|fentanyl|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|morphine|fentanyl|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|morphine|meperidine|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|morphine|meperidine|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|morphine|ketamine|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|morphine|propofol|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|morphine|secobarbital|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midazolam|N|morphine|nitrous oxide|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|narcotic|fentanyl|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|narcotic|meperidine|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|narcotic|ketamine|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|narcotic|propofol|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|narcotic|secobarbital|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midazolam|N|narcotic|nitrous oxide|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|meperidine|fentanyl|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|meperidine|fentanyl|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|fentanyl|ketamine|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|fentanyl|propofol|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|fentanyl|secobarbital|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midazolam|N|fentanyl|nitrous oxide|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|meperidine|ketamine|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|meperidine|propofol|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|meperidine|secobarbital|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midazolam|N|meperidine|nitrous oxide|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|propofol|ketamine|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|ketamine|secobarbital|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midazolam|N|ketamine|secobarbital|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midazolam|N|ketamine|nitrous oxide|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|ketamine|nitrous oxide|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|propofol|secobarbital|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midazolam|N|propofol|nitrous oxide|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midazolam|N|nitrous oxide|secobarbital|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Midazolam|N|nitrous oxide|secobarbital|the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 accentuate_LE1 by_LE1 any_LE1 concomitant_LE1 administer_LE1 medication_LE1 which_LE1 depress_LE1 the_LE1 central_LE1 nervous_LE1 system_LE1 particular_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Midazolam|N|diazepam|hydroxyzine|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 other_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|diazepam|hydroxyzine|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 other_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|hydroxyzine|anesthetic|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 local_BE12 BIOENTITY have_RE2 be_RE2 observe_RE2 
Midazolam|N|hydroxyzine|muscle relaxant|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 other_BE12 BIOENTITY -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|hydroxyzine|muscle relaxant|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 other_BE12 BIOENTITY -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|atropine|hydroxyzine|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|glycopyrrolate|hydroxyzine|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|glycopyrrolate|hydroxyzine|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|scopolamine|hydroxyzine|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|scopolamine|hydroxyzine|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|diazepam|anesthetic|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 other_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 local_BE12 BIOENTITY have_RE2 be_RE2 observe_RE2 
Midazolam|N|diazepam|muscle relaxant|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 other_BE12 BIOENTITY -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|diazepam|muscle relaxant|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 other_BE12 BIOENTITY -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|atropine|diazepam|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|glycopyrrolate|diazepam|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|glycopyrrolate|diazepam|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|scopolamine|diazepam|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|scopolamine|diazepam|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|muscle relaxant|anesthetic|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY -RRB-_BE12 or_BE12 local_BE12 BIOENTITY have_RE2 be_RE2 observe_RE2 
Midazolam|N|atropine|anesthetic|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 local_BE12 BIOENTITY have_RE2 be_RE2 observe_RE2 
Midazolam|N|glycopyrrolate|anesthetic|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 local_BE12 BIOENTITY have_RE2 be_RE2 observe_RE2 
Midazolam|N|scopolamine|anesthetic|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 local_BE12 BIOENTITY have_RE2 be_RE2 observe_RE2 
Midazolam|N|atropine|muscle relaxant|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOENTITY -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|glycopyrrolate|muscle relaxant|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOENTITY -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|glycopyrrolate|muscle relaxant|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOENTITY -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|scopolamine|muscle relaxant|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOENTITY -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|scopolamine|muscle relaxant|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOENTITY -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|atropine|glycopyrrolate|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|atropine|scopolamine|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|scopolamine|glycopyrrolate|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midazolam|N|scopolamine|glycopyrrolate|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 premedication_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 local_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 
Midodrine|N|phenylephrine|dihydroergotamine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY -RRB-_RE2 may_RE2 enhance_RE2 or_RE2 potentiate_RE2 the_RE2 pressor_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 therefore_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|phenylephrine|phenylpropanolamine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 enhance_RE2 or_RE2 potentiate_RE2 the_RE2 pressor_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 therefore_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|phenylephrine|ephedrine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 enhance_RE2 or_RE2 potentiate_RE2 the_RE2 pressor_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 therefore_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|phenylephrine|pseudoephedrine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 enhance_RE2 or_RE2 potentiate_RE2 the_RE2 pressor_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 therefore_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|phenylephrine|proamatine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 enhance_BE12 or_BE12 potentiate_BE12 the_BE12 pressor_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 therefore_BE12 caution_BE12 shall_BE12 be_BE12 use_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|phenylephrine|proamatine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 enhance_BE12 or_BE12 potentiate_BE12 the_BE12 pressor_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 therefore_BE12 caution_BE12 shall_BE12 be_BE12 use_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|phenylpropanolamine|dihydroergotamine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY -RRB-_RE2 may_RE2 enhance_RE2 or_RE2 potentiate_RE2 the_RE2 pressor_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 therefore_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|phenylpropanolamine|dihydroergotamine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY -RRB-_RE2 may_RE2 enhance_RE2 or_RE2 potentiate_RE2 the_RE2 pressor_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 therefore_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|ephedrine|dihydroergotamine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY -RRB-_RE2 may_RE2 enhance_RE2 or_RE2 potentiate_RE2 the_RE2 pressor_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 therefore_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|ephedrine|dihydroergotamine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY -RRB-_RE2 may_RE2 enhance_RE2 or_RE2 potentiate_RE2 the_RE2 pressor_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 therefore_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|pseudoephedrine|dihydroergotamine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY -RRB-_RE2 may_RE2 enhance_RE2 or_RE2 potentiate_RE2 the_RE2 pressor_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 therefore_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|pseudoephedrine|dihydroergotamine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY -RRB-_RE2 may_RE2 enhance_RE2 or_RE2 potentiate_RE2 the_RE2 pressor_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 therefore_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|dihydroergotamine|proamatine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY -RRB-_BE12 may_BE12 enhance_BE12 or_BE12 potentiate_BE12 the_BE12 pressor_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 therefore_BE12 caution_BE12 shall_BE12 be_BE12 use_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|dihydroergotamine|proamatine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY -RRB-_BE12 may_BE12 enhance_BE12 or_BE12 potentiate_BE12 the_BE12 pressor_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 therefore_BE12 caution_BE12 shall_BE12 be_BE12 use_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|ephedrine|phenylpropanolamine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 enhance_RE2 or_RE2 potentiate_RE2 the_RE2 pressor_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 therefore_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|ephedrine|phenylpropanolamine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 enhance_RE2 or_RE2 potentiate_RE2 the_RE2 pressor_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 therefore_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|pseudoephedrine|phenylpropanolamine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 enhance_RE2 or_RE2 potentiate_RE2 the_RE2 pressor_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 therefore_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|pseudoephedrine|phenylpropanolamine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 enhance_RE2 or_RE2 potentiate_RE2 the_RE2 pressor_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 therefore_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|phenylpropanolamine|proamatine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 enhance_BE12 or_BE12 potentiate_BE12 the_BE12 pressor_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 therefore_BE12 caution_BE12 shall_BE12 be_BE12 use_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|phenylpropanolamine|proamatine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 enhance_BE12 or_BE12 potentiate_BE12 the_BE12 pressor_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 therefore_BE12 caution_BE12 shall_BE12 be_BE12 use_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|pseudoephedrine|ephedrine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 enhance_RE2 or_RE2 potentiate_RE2 the_RE2 pressor_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 therefore_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|pseudoephedrine|ephedrine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 enhance_RE2 or_RE2 potentiate_RE2 the_RE2 pressor_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 therefore_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|ephedrine|proamatine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 enhance_BE12 or_BE12 potentiate_BE12 the_BE12 pressor_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 therefore_BE12 caution_BE12 shall_BE12 be_BE12 use_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|ephedrine|proamatine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 enhance_BE12 or_BE12 potentiate_BE12 the_BE12 pressor_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 therefore_BE12 caution_BE12 shall_BE12 be_BE12 use_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|pseudoephedrine|proamatine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 enhance_BE12 or_BE12 potentiate_BE12 the_BE12 pressor_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 therefore_BE12 caution_BE12 shall_BE12 be_BE12 use_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|pseudoephedrine|proamatine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 enhance_BE12 or_BE12 potentiate_BE12 the_BE12 pressor_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 therefore_BE12 caution_BE12 shall_BE12 be_BE12 use_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|proamatine|proamatine|the_LE1 use_LE1 of_LE1 drug_LE1 that_LE1 stimulate_LE1 alphaadrenergic_LE1 receptor_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -RRB-_LE1 may_LE1 enhance_LE1 or_LE1 potentiate_LE1 the_LE1 pressor_LE1 effect_LE1 of_LE1 BIOENTITY therefore_BE12 caution_BE12 shall_BE12 be_BE12 use_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 concomitant_RE2 with_RE2 agent_RE2 that_RE2 cause_RE2 vasoconstriction_RE2 
Midodrine|N|proamatine|fludrocortisone acetate|BIOENTITY have_BE12 be_BE12 use_BE12 in_BE12 patient_BE12 concomitant_BE12 treat_BE12 with_BE12 saltretaining_BE12 steroid_BE12 therapy_BE12 -LRB-_BE12 i.e._BE12 BIOENTITY -RRB-_RE2 with_RE2 or_RE2 without_RE2 salt_RE2 supplementation_RE2 
Midodrine|N|triamterene|quinidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midodrine|N|triamterene|quinidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midodrine|N|flecainide|quinidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Midodrine|N|flecainide|quinidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Midodrine|N|procainamide|quinidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midodrine|N|procainamide|quinidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midodrine|N|alpha-adrenergic blocking agent|quinidine|BIOGENERAL_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midodrine|N|proamatine|quinidine|BIOENTITY BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midodrine|N|terazosin|quinidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midodrine|N|prazosin|quinidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midodrine|N|cimetidine|quinidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midodrine|N|cimetidine|quinidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midodrine|N|ranitidine|quinidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midodrine|N|ranitidine|quinidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midodrine|N|doxazosin|quinidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midodrine|N|proamatine|quinidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midodrine|N|metformin|quinidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Midodrine|N|triamterene|flecainide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Midodrine|N|triamterene|flecainide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Midodrine|N|procainamide|triamterene|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|procainamide|triamterene|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|alpha-adrenergic blocking agent|triamterene|BIOGENERAL_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|triamterene|BIOENTITY BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|terazosin|triamterene|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|prazosin|triamterene|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|cimetidine|triamterene|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|cimetidine|triamterene|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|ranitidine|triamterene|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|ranitidine|triamterene|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|doxazosin|triamterene|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|triamterene|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|metformin|triamterene|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|procainamide|flecainide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midodrine|N|procainamide|flecainide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midodrine|N|alpha-adrenergic blocking agent|flecainide|BIOGENERAL_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|flecainide|BIOENTITY BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midodrine|N|terazosin|flecainide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midodrine|N|prazosin|flecainide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midodrine|N|cimetidine|flecainide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midodrine|N|cimetidine|flecainide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midodrine|N|ranitidine|flecainide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midodrine|N|ranitidine|flecainide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midodrine|N|doxazosin|flecainide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|flecainide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midodrine|N|metformin|flecainide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Midodrine|N|alpha-adrenergic blocking agent|procainamide|BIOGENERAL_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|procainamide|BIOENTITY BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|terazosin|procainamide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|prazosin|procainamide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|cimetidine|procainamide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|cimetidine|procainamide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|ranitidine|procainamide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|ranitidine|procainamide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|doxazosin|procainamide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|procainamide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|metformin|procainamide|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|alpha-adrenergic blocking agent|BIOENTITY BIOENTITY such_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 can_RE2 antagonize_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 potential_RE2 for_RE2 drug_RE2 interaction_RE2 :_RE2 it_RE2 appear_RE2 possible_RE2 although_RE2 there_RE2 be_RE2 no_RE2 support_RE2 experimental_RE2 evidence_RE2 that_RE2 the_RE2 high_RE2 renal_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|alpha-adrenergic blocking agent|terazosin|BIOGENERAL_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 can_RE2 antagonize_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 potential_RE2 for_RE2 drug_RE2 interaction_RE2 :_RE2 it_RE2 appear_RE2 possible_RE2 although_RE2 there_RE2 be_RE2 no_RE2 support_RE2 experimental_RE2 evidence_RE2 that_RE2 the_RE2 high_RE2 renal_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|alpha-adrenergic blocking agent|prazosin|BIOGENERAL_LE1 BIOENTITY such_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 can_RE2 antagonize_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 potential_RE2 for_RE2 drug_RE2 interaction_RE2 :_RE2 it_RE2 appear_RE2 possible_RE2 although_RE2 there_RE2 be_RE2 no_RE2 support_RE2 experimental_RE2 evidence_RE2 that_RE2 the_RE2 high_RE2 renal_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|alpha-adrenergic blocking agent|cimetidine|BIOGENERAL_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|alpha-adrenergic blocking agent|ranitidine|BIOGENERAL_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|alpha-adrenergic blocking agent|doxazosin|BIOGENERAL_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY can_RE2 antagonize_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 potential_RE2 for_RE2 drug_RE2 interaction_RE2 :_RE2 it_RE2 appear_RE2 possible_RE2 although_RE2 there_RE2 be_RE2 no_RE2 support_RE2 experimental_RE2 evidence_RE2 that_RE2 the_RE2 high_RE2 renal_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|alpha-adrenergic blocking agent|desglymidodrine|BIOGENERAL_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOENTITY -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|alpha-adrenergic blocking agent|metformin|BIOGENERAL_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|terazosin|BIOENTITY BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 can_RE2 antagonize_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 potential_RE2 for_RE2 drug_RE2 interaction_RE2 :_RE2 it_RE2 appear_RE2 possible_RE2 although_RE2 there_RE2 be_RE2 no_RE2 support_RE2 experimental_RE2 evidence_RE2 that_RE2 the_RE2 high_RE2 renal_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|prazosin|BIOENTITY BIOGENERAL_BE12 such_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 can_RE2 antagonize_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 potential_RE2 for_RE2 drug_RE2 interaction_RE2 :_RE2 it_RE2 appear_RE2 possible_RE2 although_RE2 there_RE2 be_RE2 no_RE2 support_RE2 experimental_RE2 evidence_RE2 that_RE2 the_RE2 high_RE2 renal_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|cimetidine|BIOENTITY BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|ranitidine|BIOENTITY BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|doxazosin|BIOENTITY BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY can_RE2 antagonize_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 potential_RE2 for_RE2 drug_RE2 interaction_RE2 :_RE2 it_RE2 appear_RE2 possible_RE2 although_RE2 there_RE2 be_RE2 no_RE2 support_RE2 experimental_RE2 evidence_RE2 that_RE2 the_RE2 high_RE2 renal_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|proamatine|BIOENTITY BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOENTITY potential_RE2 for_RE2 drug_RE2 interaction_RE2 :_RE2 it_RE2 appear_RE2 possible_RE2 although_RE2 there_RE2 be_RE2 no_RE2 support_RE2 experimental_RE2 evidence_RE2 that_RE2 the_RE2 high_RE2 renal_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|desglymidodrine|BIOENTITY BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOENTITY -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|metformin|BIOENTITY BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|prazosin|terazosin|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 can_RE2 antagonize_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 potential_RE2 for_RE2 drug_RE2 interaction_RE2 :_RE2 it_RE2 appear_RE2 possible_RE2 although_RE2 there_RE2 be_RE2 no_RE2 support_RE2 experimental_RE2 evidence_RE2 that_RE2 the_RE2 high_RE2 renal_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|terazosin|cimetidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|terazosin|ranitidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|terazosin|doxazosin|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY can_RE2 antagonize_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 potential_RE2 for_RE2 drug_RE2 interaction_RE2 :_RE2 it_RE2 appear_RE2 possible_RE2 although_RE2 there_RE2 be_RE2 no_RE2 support_RE2 experimental_RE2 evidence_RE2 that_RE2 the_RE2 high_RE2 renal_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|terazosin|doxazosin|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY can_RE2 antagonize_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 potential_RE2 for_RE2 drug_RE2 interaction_RE2 :_RE2 it_RE2 appear_RE2 possible_RE2 although_RE2 there_RE2 be_RE2 no_RE2 support_RE2 experimental_RE2 evidence_RE2 that_RE2 the_RE2 high_RE2 renal_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|terazosin|desglymidodrine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOENTITY -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|terazosin|metformin|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|prazosin|cimetidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|prazosin|ranitidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|prazosin|doxazosin|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY can_RE2 antagonize_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 potential_RE2 for_RE2 drug_RE2 interaction_RE2 :_RE2 it_RE2 appear_RE2 possible_RE2 although_RE2 there_RE2 be_RE2 no_RE2 support_RE2 experimental_RE2 evidence_RE2 that_RE2 the_RE2 high_RE2 renal_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|prazosin|desglymidodrine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOENTITY -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|prazosin|metformin|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|cimetidine|ranitidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|cimetidine|ranitidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|doxazosin|cimetidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|cimetidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|metformin|cimetidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|doxazosin|ranitidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|ranitidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|metformin|ranitidine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 potential_LE1 for_LE1 drug_LE1 interaction_LE1 :_LE1 it_LE1 appear_LE1 possible_LE1 although_LE1 there_LE1 be_LE1 no_LE1 support_LE1 experimental_LE1 evidence_LE1 that_LE1 the_LE1 high_LE1 renal_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 base_LE1 -RRB-_LE1 be_LE1 due_LE1 to_LE1 active_LE1 tubular_LE1 secretion_LE1 by_LE1 the_LE1 basesecreting_LE1 system_LE1 also_LE1 responsible_LE1 for_LE1 the_LE1 secretion_LE1 of_LE1 such_LE1 drug_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|doxazosin|desglymidodrine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOENTITY -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|doxazosin|metformin|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY can_BE12 antagonize_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|desglymidodrine|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOENTITY -LRB-_RE2 base_RE2 -RRB-_RE2 be_RE2 due_RE2 to_RE2 active_RE2 tubular_RE2 secretion_RE2 by_RE2 the_RE2 basesecreting_RE2 system_RE2 also_RE2 responsible_RE2 for_RE2 the_RE2 secretion_RE2 of_RE2 such_RE2 drug_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Midodrine|N|proamatine|metformin|BIOGENERAL_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY potential_BE12 for_BE12 drug_BE12 interaction_BE12 :_BE12 it_BE12 appear_BE12 possible_BE12 although_BE12 there_BE12 be_BE12 no_BE12 support_BE12 experimental_BE12 evidence_BE12 that_BE12 the_BE12 high_BE12 renal_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 base_BE12 -RRB-_BE12 be_BE12 due_BE12 to_BE12 active_BE12 tubular_BE12 secretion_BE12 by_BE12 the_BE12 basesecreting_BE12 system_BE12 also_BE12 responsible_BE12 for_BE12 the_BE12 secretion_BE12 of_BE12 such_BE12 drug_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mifepristone|N|mifepristone|mifepristone|although_LE1 specific_LE1 drug_LE1 or_LE1 food_LE1 interaction_LE1 with_LE1 BIOENTITY have_BE12 not_BE12 be_BE12 study_BE12 on_BE12 the_BE12 basis_BE12 of_BE12 this_BE12 drug_BE12 metabolism_BE12 by_BE12 cyp_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 grapefruit_BE12 juice_BE12 may_BE12 inhibit_BE12 its_BE12 metabolism_BE12 -LRB-_BE12 increase_BE12 serum_BE12 level_BE12 of_BE12 BIOENTITY rrb._RE2 
Mifepristone|N|mifepristone|ketoconazole|although_LE1 specific_LE1 drug_LE1 or_LE1 food_LE1 interaction_LE1 with_LE1 BIOENTITY have_BE12 not_BE12 be_BE12 study_BE12 on_BE12 the_BE12 basis_BE12 of_BE12 this_BE12 drug_BE12 metabolism_BE12 by_BE12 cyp_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 grapefruit_RE2 juice_RE2 may_RE2 inhibit_RE2 its_RE2 metabolism_RE2 -LRB-_RE2 increase_RE2 serum_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Mifepristone|N|mifepristone|itraconazole|although_LE1 specific_LE1 drug_LE1 or_LE1 food_LE1 interaction_LE1 with_LE1 BIOENTITY have_BE12 not_BE12 be_BE12 study_BE12 on_BE12 the_BE12 basis_BE12 of_BE12 this_BE12 drug_BE12 metabolism_BE12 by_BE12 cyp_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 grapefruit_RE2 juice_RE2 may_RE2 inhibit_RE2 its_RE2 metabolism_RE2 -LRB-_RE2 increase_RE2 serum_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Mifepristone|N|mifepristone|erythromycin|although_LE1 specific_LE1 drug_LE1 or_LE1 food_LE1 interaction_LE1 with_LE1 BIOENTITY have_BE12 not_BE12 be_BE12 study_BE12 on_BE12 the_BE12 basis_BE12 of_BE12 this_BE12 drug_BE12 metabolism_BE12 by_BE12 cyp_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 grapefruit_RE2 juice_RE2 may_RE2 inhibit_RE2 its_RE2 metabolism_RE2 -LRB-_RE2 increase_RE2 serum_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Mifepristone|N|ketoconazole|itraconazole|although_LE1 specific_LE1 drug_LE1 or_LE1 food_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 study_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 this_LE1 drug_LE1 metabolism_LE1 by_LE1 cyp_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 grapefruit_RE2 juice_RE2 may_RE2 inhibit_RE2 its_RE2 metabolism_RE2 -LRB-_RE2 increase_RE2 serum_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Mifepristone|N|ketoconazole|erythromycin|although_LE1 specific_LE1 drug_LE1 or_LE1 food_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 study_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 this_LE1 drug_LE1 metabolism_LE1 by_LE1 cyp_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 grapefruit_RE2 juice_RE2 may_RE2 inhibit_RE2 its_RE2 metabolism_RE2 -LRB-_RE2 increase_RE2 serum_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Mifepristone|N|itraconazole|erythromycin|although_LE1 specific_LE1 drug_LE1 or_LE1 food_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 study_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 this_LE1 drug_LE1 metabolism_LE1 by_LE1 cyp_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 grapefruit_RE2 juice_RE2 may_RE2 inhibit_RE2 its_RE2 metabolism_RE2 -LRB-_RE2 increase_RE2 serum_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Mifepristone|N|itraconazole|erythromycin|although_LE1 specific_LE1 drug_LE1 or_LE1 food_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 study_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 this_LE1 drug_LE1 metabolism_LE1 by_LE1 cyp_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 grapefruit_RE2 juice_RE2 may_RE2 inhibit_RE2 its_RE2 metabolism_RE2 -LRB-_RE2 increase_RE2 serum_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Mifepristone|N|rifampin|dexamethasone|furthermore_LE1 BIOENTITY BIOENTITY st._RE2 
Mifepristone|N|phenobarbital|carbamazepine|john_LE1 wort_LE1 and_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY -RRB-_RE2 may_RE2 induce_RE2 BIOGENERAL_RE2 metabolism_RE2 -LRB-_RE2 lower_RE2 serum_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Mifepristone|N|carbamazepine|mifepristone|john_LE1 wort_LE1 and_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 may_BE12 induce_BE12 BIOGENERAL_BE12 metabolism_BE12 -LRB-_BE12 lower_BE12 serum_BE12 level_BE12 of_BE12 BIOENTITY rrb._RE2 
Mifepristone|N|anticonvulsant|carbamazepine|john_LE1 wort_LE1 and_LE1 certain_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 may_RE2 induce_RE2 BIOGENERAL_RE2 metabolism_RE2 -LRB-_RE2 lower_RE2 serum_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Mifepristone|N|phenytoin|carbamazepine|john_LE1 wort_LE1 and_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 may_RE2 induce_RE2 BIOGENERAL_RE2 metabolism_RE2 -LRB-_RE2 lower_RE2 serum_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Mifepristone|N|phenobarbital|mifepristone|john_LE1 wort_LE1 and_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 may_BE12 induce_BE12 BIOGENERAL_BE12 metabolism_BE12 -LRB-_BE12 lower_BE12 serum_BE12 level_BE12 of_BE12 BIOENTITY rrb._RE2 
Mifepristone|N|anticonvulsant|phenobarbital|john_LE1 wort_LE1 and_LE1 certain_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 may_RE2 induce_RE2 BIOGENERAL_RE2 metabolism_RE2 -LRB-_RE2 lower_RE2 serum_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Mifepristone|N|phenytoin|phenobarbital|john_LE1 wort_LE1 and_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 may_RE2 induce_RE2 BIOGENERAL_RE2 metabolism_RE2 -LRB-_RE2 lower_RE2 serum_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Mifepristone|N|mifepristone|mifepristone|john_LE1 wort_LE1 and_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 may_LE1 induce_LE1 BIOENTITY metabolism_BE12 -LRB-_BE12 lower_BE12 serum_BE12 level_BE12 of_BE12 BIOENTITY rrb._RE2 
Mifepristone|N|anticonvulsant|mifepristone|john_LE1 wort_LE1 and_LE1 certain_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 induce_BE12 BIOGENERAL_BE12 metabolism_BE12 -LRB-_BE12 lower_BE12 serum_BE12 level_BE12 of_BE12 BIOENTITY rrb._RE2 
Mifepristone|N|phenytoin|mifepristone|john_LE1 wort_LE1 and_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 induce_BE12 BIOGENERAL_BE12 metabolism_BE12 -LRB-_BE12 lower_BE12 serum_BE12 level_BE12 of_BE12 BIOENTITY rrb._RE2 
Mifepristone|N|anticonvulsant|phenytoin|john_LE1 wort_LE1 and_LE1 certain_LE1 BIOENTITY -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 induce_RE2 BIOGENERAL_RE2 metabolism_RE2 -LRB-_RE2 lower_RE2 serum_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Miglustat|N|zavesca|cerezyme|while_LE1 coadministration_LE1 of_LE1 BIOENTITY appear_BE12 to_BE12 increase_BE12 the_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 NUM_BE12 these_BE12 result_BE12 be_BE12 not_BE12 conclusive_BE12 because_BE12 of_BE12 the_BE12 small_BE12 number_BE12 of_BE12 subject_BE12 study_BE12 and_BE12 because_BE12 patient_BE12 take_BE12 variable_BE12 dose_BE12 of_BE12 BIOENTITY 
Miglustat|N|cerezyme|cerezyme|while_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 appear_LE1 to_LE1 increase_LE1 the_LE1 clearance_LE1 of_LE1 BIOENTITY by_BE12 NUM_BE12 these_BE12 result_BE12 be_BE12 not_BE12 conclusive_BE12 because_BE12 of_BE12 the_BE12 small_BE12 number_BE12 of_BE12 subject_BE12 study_BE12 and_BE12 because_BE12 patient_BE12 take_BE12 variable_BE12 dose_BE12 of_BE12 BIOENTITY 
Miglustat|N|cerezyme|imiglucerase|combination_LE1 therapy_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 and_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 indicate_RE2 
Minocycline|N|anticoagulant|anticoagulant|because_LE1 BIOGENERAL_LE1 have_LE1 be_LE1 show_LE1 to_LE1 depress_LE1 plasma_LE1 prothrombin_LE1 activity_LE1 patient_LE1 who_LE1 be_LE1 on_LE1 BIOENTITY therapy_BE12 may_BE12 require_BE12 downward_BE12 adjustment_BE12 of_BE12 their_BE12 BIOENTITY dosage_RE2 
Minocycline|N|anticoagulant|anticoagulant|because_LE1 BIOGENERAL_LE1 have_LE1 be_LE1 show_LE1 to_LE1 depress_LE1 plasma_LE1 prothrombin_LE1 activity_LE1 patient_LE1 who_LE1 be_LE1 on_LE1 BIOENTITY therapy_BE12 may_BE12 require_BE12 downward_BE12 adjustment_BE12 of_BE12 their_BE12 BIOENTITY dosage_RE2 
Minocycline|N|tetracycline|anticoagulant|because_LE1 BIOENTITY have_BE12 be_BE12 show_BE12 to_BE12 depress_BE12 plasma_BE12 prothrombin_BE12 activity_BE12 patient_BE12 who_BE12 be_BE12 on_BE12 BIOGENERAL_BE12 therapy_BE12 may_BE12 require_BE12 downward_BE12 adjustment_BE12 of_BE12 their_BE12 BIOENTITY dosage_RE2 
Minocycline|N|penicillin|tetracycline class drug|since_LE1 bacteriostatic_LE1 drug_LE1 may_LE1 interfere_LE1 with_LE1 the_LE1 bactericidal_LE1 action_LE1 of_LE1 BIOENTITY it_BE12 be_BE12 advisable_BE12 to_BE12 avoid_BE12 giving_BE12 BIOENTITY in_RE2 conjunction_RE2 with_RE2 BIOGENERAL_RE2 
Minocycline|N|penicillin|penicillin|since_LE1 bacteriostatic_LE1 drug_LE1 may_LE1 interfere_LE1 with_LE1 the_LE1 bactericidal_LE1 action_LE1 of_LE1 BIOENTITY it_BE12 be_BE12 advisable_BE12 to_BE12 avoid_BE12 giving_BE12 BIOGENERAL_BE12 in_BE12 conjunction_BE12 with_BE12 BIOENTITY 
Minocycline|N|antacid|aluminum|absorption_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 impair_LE1 by_LE1 BIOENTITY contain_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 preparation_RE2 
Minocycline|N|tetracycline|antacid|absorption_LE1 of_LE1 BIOENTITY be_BE12 impair_BE12 by_BE12 BIOENTITY contain_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 preparation_RE2 
Minocycline|N|antacid|iron|absorption_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 impair_LE1 by_LE1 BIOENTITY contain_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY preparation_RE2 
Minocycline|N|antacid|magnesium|absorption_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 impair_LE1 by_LE1 BIOENTITY contain_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 preparation_RE2 
Minocycline|N|antacid|calcium|absorption_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 impair_LE1 by_LE1 BIOENTITY contain_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 preparation_RE2 
Minocycline|N|aluminum|iron|absorption_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 impair_LE1 by_LE1 BIOGENERAL_LE1 contain_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY preparation_RE2 
Minocycline|N|aluminum|magnesium|absorption_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 impair_LE1 by_LE1 BIOGENERAL_LE1 contain_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 preparation_RE2 
Minocycline|N|aluminum|calcium|absorption_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 impair_LE1 by_LE1 BIOGENERAL_LE1 contain_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 preparation_RE2 
Minocycline|N|magnesium|iron|absorption_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 impair_LE1 by_LE1 BIOGENERAL_LE1 contain_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY and_BE12 BIOENTITY preparation_RE2 
Minocycline|N|calcium|iron|absorption_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 impair_LE1 by_LE1 BIOGENERAL_LE1 contain_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY preparation_RE2 
Minocycline|N|calcium|iron|absorption_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 impair_LE1 by_LE1 BIOGENERAL_LE1 contain_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY preparation_RE2 
Minocycline|N|calcium|magnesium|absorption_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 impair_LE1 by_LE1 BIOGENERAL_LE1 contain_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 preparation_RE2 
Minocycline|N|tetracycline|contraceptive|concurrent_LE1 use_LE1 of_LE1 BIOENTITY with_BE12 oral_BE12 BIOGENERAL_BE12 may_BE12 render_BE12 oral_BE12 BIOENTITY little_RE2 effective_RE2 
Minocycline|N|contraceptive|contraceptive|concurrent_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 oral_LE1 BIOENTITY may_BE12 render_BE12 oral_BE12 BIOENTITY little_RE2 effective_RE2 
Minoxidil|N|guanethidine|guanethidine|interaction_LE1 with_LE1 BIOENTITY :_BE12 although_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 itself_BE12 cause_BE12 orthostatic_BE12 hypotension_BE12 its_BE12 administration_BE12 to_BE12 patient_BE12 already_BE12 receive_BE12 BIOENTITY can_RE2 result_RE2 in_RE2 profound_RE2 orthostatic_RE2 effect_RE2 
Minoxidil|N|guanethidine|minoxidil|interaction_LE1 with_LE1 BIOENTITY :_BE12 although_BE12 BIOENTITY do_RE2 not_RE2 itself_RE2 cause_RE2 orthostatic_RE2 hypotension_RE2 its_RE2 administration_RE2 to_RE2 patient_RE2 already_RE2 receive_RE2 BIOGENERAL_RE2 can_RE2 result_RE2 in_RE2 profound_RE2 orthostatic_RE2 effect_RE2 
Mirtazapine|N|remeron soltab|mirtazapine|drug_LE1 affect_LE1 hepatic_LE1 metabolism_LE1 the_LE1 metabolism_LE1 and_LE1 pharmacokinetic_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 oral_RE2 disintegrating_RE2 tablet_RE2 may_RE2 be_RE2 affect_RE2 by_RE2 the_RE2 induction_RE2 or_RE2 inhibition_RE2 of_RE2 drugmetabolizing_RE2 enzyme_RE2 
Mirtazapine|N|mirtazapine|mirtazapine|while_LE1 in_LE1 vitro_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOENTITY be_BE12 not_BE12 potent_BE12 inhibitor_BE12 of_BE12 any_BE12 of_BE12 these_BE12 enzyme_BE12 indication_BE12 that_BE12 BIOENTITY be_RE2 not_RE2 likely_RE2 to_RE2 have_RE2 clinical_RE2 significant_RE2 inhibitory_RE2 effect_RE2 on_RE2 the_RE2 metabolism_RE2 of_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 substrate_RE2 for_RE2 these_RE2 cytochrome_RE2 enzyme_RE2 the_RE2 concomitant_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 many_RE2 other_RE2 drug_RE2 metabolize_RE2 by_RE2 these_RE2 enzyme_RE2 have_RE2 not_RE2 be_RE2 formal_RE2 study_RE2 
Mirtazapine|N|mirtazapine|remeron soltab|while_LE1 in_LE1 vitro_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 potent_LE1 inhibitor_LE1 of_LE1 any_LE1 of_LE1 these_LE1 enzyme_LE1 indication_LE1 that_LE1 BIOENTITY be_BE12 not_BE12 likely_BE12 to_BE12 have_BE12 clinical_BE12 significant_BE12 inhibitory_BE12 effect_BE12 on_BE12 the_BE12 metabolism_BE12 of_BE12 other_BE12 drug_BE12 that_BE12 be_BE12 substrate_BE12 for_BE12 these_BE12 cytochrome_BE12 enzyme_BE12 the_BE12 concomitant_BE12 use_BE12 of_BE12 BIOENTITY with_RE2 many_RE2 other_RE2 drug_RE2 metabolize_RE2 by_RE2 these_RE2 enzyme_RE2 have_RE2 not_RE2 be_RE2 formal_RE2 study_RE2 
Mirtazapine|N|mirtazapine|remeron soltab|while_LE1 in_LE1 vitro_LE1 study_LE1 have_LE1 show_LE1 that_LE1 BIOENTITY be_BE12 not_BE12 potent_BE12 inhibitor_BE12 of_BE12 any_BE12 of_BE12 these_BE12 enzyme_BE12 indication_BE12 that_BE12 BIOGENERAL_BE12 be_BE12 not_BE12 likely_BE12 to_BE12 have_BE12 clinical_BE12 significant_BE12 inhibitory_BE12 effect_BE12 on_BE12 the_BE12 metabolism_BE12 of_BE12 other_BE12 drug_BE12 that_BE12 be_BE12 substrate_BE12 for_BE12 these_BE12 cytochrome_BE12 enzyme_BE12 the_BE12 concomitant_BE12 use_BE12 of_BE12 BIOENTITY with_RE2 many_RE2 other_RE2 drug_RE2 metabolize_RE2 by_RE2 these_RE2 enzyme_RE2 have_RE2 not_RE2 be_RE2 formal_RE2 study_RE2 
Mirtazapine|N|alcohol|alcohol|BIOENTITY :_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOENTITY -LRB-_RE2 equivalent_RE2 to_RE2 NUM_RE2 -RRB-_RE2 have_RE2 minimal_RE2 effect_RE2 on_RE2 plasma_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 in_RE2 NUM_RE2 healthy_RE2 male_RE2 subject_RE2 
Mirtazapine|N|alcohol|mirtazapine|BIOENTITY :_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 equivalent_BE12 to_BE12 NUM_BE12 -RRB-_BE12 have_BE12 minimal_BE12 effect_BE12 on_BE12 plasma_BE12 level_BE12 of_BE12 BIOENTITY -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 in_RE2 NUM_RE2 healthy_RE2 male_RE2 subject_RE2 
Mirtazapine|N|remeron soltab|diazepam|according_LE1 patient_LE1 shall_LE1 be_LE1 advise_LE1 to_LE1 avoid_LE1 BIOGENERAL_LE1 while_LE1 take_LE1 BIOENTITY BIOGENERAL_BE12 :_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOENTITY -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 have_RE2 minimal_RE2 effect_RE2 on_RE2 plasma_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 in_RE2 NUM_RE2 healthy_RE2 subject_RE2 
Mirtazapine|N|remeron soltab|diazepam|according_LE1 patient_LE1 shall_LE1 be_LE1 advise_LE1 to_LE1 avoid_LE1 BIOGENERAL_LE1 while_LE1 take_LE1 BIOENTITY BIOENTITY :_RE2 concomitant_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 have_RE2 minimal_RE2 effect_RE2 on_RE2 plasma_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 in_RE2 NUM_RE2 healthy_RE2 subject_RE2 
Mirtazapine|N|remeron soltab|mirtazapine|according_LE1 patient_LE1 shall_LE1 be_LE1 advise_LE1 to_LE1 avoid_LE1 BIOGENERAL_LE1 while_LE1 take_LE1 BIOENTITY BIOGENERAL_BE12 :_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 have_BE12 minimal_BE12 effect_BE12 on_BE12 plasma_BE12 level_BE12 of_BE12 BIOENTITY -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 in_RE2 NUM_RE2 healthy_RE2 subject_RE2 
Mirtazapine|N|alcohol|diazepam|according_LE1 patient_LE1 shall_LE1 be_LE1 advise_LE1 to_LE1 avoid_LE1 BIOENTITY while_BE12 take_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 :_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOENTITY -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 have_RE2 minimal_RE2 effect_RE2 on_RE2 plasma_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 in_RE2 NUM_RE2 healthy_RE2 subject_RE2 
Mirtazapine|N|alcohol|diazepam|according_LE1 patient_LE1 shall_LE1 be_LE1 advise_LE1 to_LE1 avoid_LE1 BIOENTITY while_BE12 take_BE12 BIOGENERAL_BE12 BIOENTITY :_RE2 concomitant_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 have_RE2 minimal_RE2 effect_RE2 on_RE2 plasma_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 in_RE2 NUM_RE2 healthy_RE2 subject_RE2 
Mirtazapine|N|alcohol|mirtazapine|according_LE1 patient_LE1 shall_LE1 be_LE1 advise_LE1 to_LE1 avoid_LE1 BIOENTITY while_BE12 take_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 :_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 have_BE12 minimal_BE12 effect_BE12 on_BE12 plasma_BE12 level_BE12 of_BE12 BIOENTITY -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 in_RE2 NUM_RE2 healthy_RE2 subject_RE2 
Mirtazapine|N|diazepam|diazepam|according_LE1 patient_LE1 shall_LE1 be_LE1 advise_LE1 to_LE1 avoid_LE1 BIOGENERAL_LE1 while_LE1 take_LE1 BIOGENERAL_LE1 BIOENTITY :_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOENTITY -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 have_RE2 minimal_RE2 effect_RE2 on_RE2 plasma_RE2 level_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 in_RE2 NUM_RE2 healthy_RE2 subject_RE2 
Mirtazapine|N|diazepam|mirtazapine|according_LE1 patient_LE1 shall_LE1 be_LE1 advise_LE1 to_LE1 avoid_LE1 BIOGENERAL_LE1 while_LE1 take_LE1 BIOGENERAL_LE1 BIOENTITY :_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 have_BE12 minimal_BE12 effect_BE12 on_BE12 plasma_BE12 level_BE12 of_BE12 BIOENTITY -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 in_RE2 NUM_RE2 healthy_RE2 subject_RE2 
Mitotane|N|warfarin|warfarin|BIOGENERAL_LE1 have_LE1 be_LE1 report_LE1 to_LE1 accelerate_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY by_BE12 the_BE12 mechanism_BE12 of_BE12 hepatic_BE12 microsomal_BE12 enzyme_BE12 induction_BE12 lead_BE12 to_BE12 increase_BE12 in_BE12 dosage_BE12 requirement_BE12 for_BE12 BIOENTITY 
Mitotane|N|mitotane|warfarin|BIOENTITY have_BE12 be_BE12 report_BE12 to_BE12 accelerate_BE12 the_BE12 metabolism_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 the_BE12 mechanism_BE12 of_BE12 hepatic_BE12 microsomal_BE12 enzyme_BE12 induction_BE12 lead_BE12 to_BE12 increase_BE12 in_BE12 dosage_BE12 requirement_BE12 for_BE12 BIOENTITY 
Mitotane|N|anticoagulant|mitotane|therefore_LE1 physician_LE1 shall_LE1 close_LE1 monitor_LE1 patient_LE1 for_LE1 change_LE1 in_LE1 BIOENTITY dosage_BE12 requirement_BE12 when_BE12 administer_BE12 BIOENTITY to_RE2 patient_RE2 on_RE2 BIOGENERAL_RE2 
Mitotane|N|anticoagulant|coumarin-type anticoagulant|therefore_LE1 physician_LE1 shall_LE1 close_LE1 monitor_LE1 patient_LE1 for_LE1 change_LE1 in_LE1 BIOENTITY dosage_BE12 requirement_BE12 when_BE12 administer_BE12 BIOGENERAL_BE12 to_BE12 patient_BE12 on_BE12 BIOENTITY 
Mivacurium|N|mivacron|succinylcholine|although_LE1 BIOGENERAL_LE1 -LRB-_LE1 mixture_LE1 of_LE1 three_LE1 stereoisomer_LE1 -RRB-_LE1 have_LE1 be_LE1 administer_LE1 safe_LE1 follow_LE1 succinylcholinefacilitated_LE1 tracheal_LE1 intubation_LE1 the_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 systematic_RE2 study_RE2 
Mivacurium|N|mivacron|mivacron|although_LE1 BIOENTITY -LRB-_BE12 mixture_BE12 of_BE12 three_BE12 stereoisomer_BE12 -RRB-_BE12 have_BE12 be_BE12 administer_BE12 safe_BE12 follow_BE12 succinylcholinefacilitated_BE12 tracheal_BE12 intubation_BE12 the_BE12 interaction_BE12 between_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 have_RE2 not_RE2 be_RE2 systematic_RE2 study_RE2 
Mivacurium|N|mivacron|succinylcholine|although_LE1 BIOENTITY -LRB-_BE12 mixture_BE12 of_BE12 three_BE12 stereoisomer_BE12 -RRB-_BE12 have_BE12 be_BE12 administer_BE12 safe_BE12 follow_BE12 succinylcholinefacilitated_BE12 tracheal_BE12 intubation_BE12 the_BE12 interaction_BE12 between_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 systematic_RE2 study_RE2 
Mivacurium|N|mivacron|succinylcholine|the_LE1 use_LE1 of_LE1 BIOENTITY before_BE12 BIOENTITY to_RE2 attenuate_RE2 some_RE2 of_RE2 the_RE2 side_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 have_RE2 not_RE2 be_RE2 study_RE2 
Mivacurium|N|mivacron|succinylcholine|the_LE1 use_LE1 of_LE1 BIOENTITY before_BE12 BIOGENERAL_BE12 to_BE12 attenuate_BE12 some_BE12 of_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 study_RE2 
Mivacurium|N|succinylcholine|succinylcholine|the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 before_LE1 BIOENTITY to_BE12 attenuate_BE12 some_BE12 of_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 study_RE2 
Mivacurium|N|mivacron|nondepolarizing neuromuscular blocking agent|there_LE1 be_LE1 no_LE1 clinical_LE1 datum_LE1 on_LE1 the_LE1 use_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 BIOENTITY 
Mivacurium|N|oxide|oxygen|BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -LRB-_LE1 administer_LE1 with_LE1 BIOENTITY to_RE2 achieve_RE2 m.c._RE2 
Mivacurium|N|enflurane|nitrous oxide|BIOGENERAL_LE1 and_LE1 BIOENTITY -LRB-_BE12 administer_BE12 with_BE12 BIOENTITY to_RE2 achieve_RE2 m.c._RE2 
Mivacurium|N|enflurane|nitrous oxide|BIOGENERAL_LE1 and_LE1 BIOENTITY -LRB-_BE12 administer_BE12 with_BE12 BIOENTITY to_RE2 achieve_RE2 m.c._RE2 
Mivacurium|N|isoflurane|nitrous oxide|BIOENTITY and_BE12 BIOGENERAL_BE12 -LRB-_BE12 administer_BE12 with_BE12 BIOENTITY to_RE2 achieve_RE2 m.c._RE2 
Mivacurium|N|enflurane|nitrous oxide|BIOGENERAL_LE1 and_LE1 BIOENTITY -LRB-_BE12 administer_BE12 with_BE12 BIOENTITY to_RE2 achieve_RE2 m.c._RE2 
Mivacurium|N|enflurane|nitrous oxide|BIOGENERAL_LE1 and_LE1 BIOENTITY -LRB-_BE12 administer_BE12 with_BE12 BIOENTITY to_RE2 achieve_RE2 m.c._RE2 
Mivacurium|N|isoflurane|nitrous oxide|BIOENTITY and_BE12 BIOGENERAL_BE12 -LRB-_BE12 administer_BE12 with_BE12 BIOENTITY to_RE2 achieve_RE2 m.c._RE2 
Mivacurium|N|isoflurane|enflurane|BIOENTITY and_BE12 BIOENTITY -LRB-_RE2 administer_RE2 with_RE2 BIOGENERAL_RE2 to_RE2 achieve_RE2 m.c._RE2 
Mivacurium|N|enflurane|isoflurane|great_LE1 potentiation_LE1 of_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 expect_LE1 with_LE1 high_LE1 concentration_LE1 of_LE1 BIOENTITY or_BE12 BIOENTITY 
Mivacurium|N|mivacron|enflurane|great_LE1 potentiation_LE1 of_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOENTITY may_BE12 be_BE12 expect_BE12 with_BE12 high_BE12 concentration_BE12 of_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Mivacurium|N|mivacron|isoflurane|great_LE1 potentiation_LE1 of_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOENTITY may_BE12 be_BE12 expect_BE12 with_BE12 high_BE12 concentration_BE12 of_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Mivacurium|N|anesthetic|procainamide|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 salt_LE1 BIOGENERAL_LE1 local_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Mivacurium|N|anesthetic|procainamide|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 salt_LE1 BIOGENERAL_LE1 local_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Mivacurium|N|procainamide|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 salt_LE1 BIOGENERAL_LE1 local_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Mivacurium|N|procainamide|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 salt_LE1 BIOGENERAL_LE1 local_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Mivacurium|N|sodium colistimethate|procainamide|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mivacurium|N|lithium|procainamide|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 salt_LE1 BIOENTITY local_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mivacurium|N|lithium|procainamide|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 salt_LE1 BIOENTITY local_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mivacurium|N|magnesium|procainamide|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mivacurium|N|magnesium|procainamide|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin|procainamide|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mivacurium|N|lincomycin|procainamide|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mivacurium|N|clindamycin|procainamide|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mivacurium|N|colistin|procainamide|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|procainamide|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mivacurium|N|aminoglycoside|procainamide|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mivacurium|N|tetracycline|procainamide|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|procainamide|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Mivacurium|N|anesthetic|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 salt_LE1 BIOGENERAL_LE1 local_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mivacurium|N|anesthetic|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 salt_LE1 BIOGENERAL_LE1 local_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mivacurium|N|sodium colistimethate|anesthetic|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|lithium|anesthetic|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 salt_LE1 BIOENTITY local_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|lithium|anesthetic|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 salt_LE1 BIOENTITY local_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|magnesium|anesthetic|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY salt_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|magnesium|anesthetic|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY salt_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin|anesthetic|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|lincomycin|anesthetic|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|clindamycin|anesthetic|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|colistin|anesthetic|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|anesthetic|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|aminoglycoside|anesthetic|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|tetracycline|anesthetic|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|anesthetic|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|sodium colistimethate|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mivacurium|N|lithium|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 salt_LE1 BIOENTITY local_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mivacurium|N|lithium|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 salt_LE1 BIOENTITY local_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mivacurium|N|magnesium|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mivacurium|N|magnesium|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mivacurium|N|polymyxin|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mivacurium|N|lincomycin|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mivacurium|N|clindamycin|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mivacurium|N|colistin|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mivacurium|N|antibiotic|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mivacurium|N|aminoglycoside|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mivacurium|N|tetracycline|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mivacurium|N|bacitracin|quinidine|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Mivacurium|N|sodium colistimethate|lithium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|sodium colistimethate|magnesium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 BIOENTITY salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin|sodium colistimethate|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin|sodium colistimethate|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|lincomycin|sodium colistimethate|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|lincomycin|sodium colistimethate|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|clindamycin|sodium colistimethate|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|clindamycin|sodium colistimethate|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|colistin|sodium colistimethate|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|colistin|sodium colistimethate|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|sodium colistimethate|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|aminoglycoside|sodium colistimethate|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|tetracycline|sodium colistimethate|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|tetracycline|sodium colistimethate|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|sodium colistimethate|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|sodium colistimethate|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|magnesium|lithium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY salt_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|magnesium|lithium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY salt_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin|lithium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|lincomycin|lithium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|clindamycin|lithium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|colistin|lithium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|lithium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|aminoglycoside|lithium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|tetracycline|lithium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|lithium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 salt_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin|magnesium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|lincomycin|magnesium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|clindamycin|magnesium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|colistin|magnesium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|magnesium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|aminoglycoside|magnesium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|tetracycline|magnesium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|magnesium|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin|lincomycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin|lincomycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin|clindamycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin|clindamycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin|colistin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin|colistin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|polymyxin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|aminoglycoside|polymyxin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|tetracycline|polymyxin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|tetracycline|polymyxin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|polymyxin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|polymyxin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|lincomycin|clindamycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|lincomycin|clindamycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|lincomycin|colistin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|lincomycin|colistin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|lincomycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|aminoglycoside|lincomycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|tetracycline|lincomycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|tetracycline|lincomycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|lincomycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|lincomycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|clindamycin|colistin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|clindamycin|colistin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|clindamycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|aminoglycoside|clindamycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|tetracycline|clindamycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|tetracycline|clindamycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|clindamycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|clindamycin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|colistin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|aminoglycoside|colistin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|tetracycline|colistin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|tetracycline|colistin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|colistin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|colistin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|aminoglycoside|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|tetracycline|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|bacitracin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|aminoglycoside|tetracycline|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|aminoglycoside|bacitracin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|tetracycline|bacitracin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|tetracycline|bacitracin|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 include_LE1 certain_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|nondepolarizing agent|mivacron|other_LE1 drug_LE1 which_LE1 may_LE1 enhance_LE1 the_LE1 neuromuscular_LE1 blocking_LE1 action_LE1 of_LE1 BIOENTITY such_BE12 as_BE12 BIOENTITY include_RE2 certain_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 salt_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Mivacurium|N|contraceptive|glucocorticoid|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOENTITY BIOENTITY or_RE2 certain_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 by_RE2 drug_RE2 that_RE2 irreversible_RE2 inhibit_RE2 plasma_RE2 cholinesterase_RE2 resistance_RE2 to_RE2 the_RE2 neuromuscular_RE2 block_RE2 action_RE2 of_RE2 nondepolarizing_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 demonstrate_RE2 in_RE2 patient_RE2 chronic_RE2 administer_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mivacurium|N|glucocorticoid|carbamazepine|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 certain_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 demonstrate_BE12 in_BE12 patient_BE12 chronic_BE12 administer_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Mivacurium|N|glucocorticoid|carbamazepine|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 certain_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 demonstrate_BE12 in_BE12 patient_BE12 chronic_BE12 administer_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Mivacurium|N|glucocorticoid|phenytoin|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 certain_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 demonstrate_BE12 in_BE12 patient_BE12 chronic_BE12 administer_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Mivacurium|N|glucocorticoid|phenytoin|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 certain_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 demonstrate_BE12 in_BE12 patient_BE12 chronic_BE12 administer_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Mivacurium|N|glucocorticoid|neuromuscular blocking agent|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 certain_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOENTITY have_RE2 be_RE2 demonstrate_RE2 in_RE2 patient_RE2 chronic_RE2 administer_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mivacurium|N|glucocorticoid|neuromuscular blocking agent|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 certain_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOENTITY have_RE2 be_RE2 demonstrate_RE2 in_RE2 patient_RE2 chronic_RE2 administer_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mivacurium|N|glucocorticoid|monoamine oxidase inhibitor|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 certain_BE12 BIOENTITY -RRB-_RE2 or_RE2 by_RE2 drug_RE2 that_RE2 irreversible_RE2 inhibit_RE2 plasma_RE2 cholinesterase_RE2 resistance_RE2 to_RE2 the_RE2 neuromuscular_RE2 block_RE2 action_RE2 of_RE2 nondepolarizing_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 demonstrate_RE2 in_RE2 patient_RE2 chronic_RE2 administer_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mivacurium|N|glucocorticoid|monoamine oxidase inhibitor|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 certain_BE12 BIOENTITY -RRB-_RE2 or_RE2 by_RE2 drug_RE2 that_RE2 irreversible_RE2 inhibit_RE2 plasma_RE2 cholinesterase_RE2 resistance_RE2 to_RE2 the_RE2 neuromuscular_RE2 block_RE2 action_RE2 of_RE2 nondepolarizing_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 demonstrate_RE2 in_RE2 patient_RE2 chronic_RE2 administer_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mivacurium|N|contraceptive|carbamazepine|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 certain_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 demonstrate_BE12 in_BE12 patient_BE12 chronic_BE12 administer_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Mivacurium|N|contraceptive|carbamazepine|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 certain_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 demonstrate_BE12 in_BE12 patient_BE12 chronic_BE12 administer_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Mivacurium|N|contraceptive|phenytoin|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 certain_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 demonstrate_BE12 in_BE12 patient_BE12 chronic_BE12 administer_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Mivacurium|N|contraceptive|phenytoin|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 certain_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 demonstrate_BE12 in_BE12 patient_BE12 chronic_BE12 administer_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Mivacurium|N|contraceptive|neuromuscular blocking agent|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 certain_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOENTITY have_RE2 be_RE2 demonstrate_RE2 in_RE2 patient_RE2 chronic_RE2 administer_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mivacurium|N|contraceptive|neuromuscular blocking agent|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 certain_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOENTITY have_RE2 be_RE2 demonstrate_RE2 in_RE2 patient_RE2 chronic_RE2 administer_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mivacurium|N|contraceptive|monoamine oxidase inhibitor|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 certain_BE12 BIOENTITY -RRB-_RE2 or_RE2 by_RE2 drug_RE2 that_RE2 irreversible_RE2 inhibit_RE2 plasma_RE2 cholinesterase_RE2 resistance_RE2 to_RE2 the_RE2 neuromuscular_RE2 block_RE2 action_RE2 of_RE2 nondepolarizing_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 demonstrate_RE2 in_RE2 patient_RE2 chronic_RE2 administer_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mivacurium|N|mivacron|carbamazepine|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOENTITY may_BE12 be_BE12 enhance_BE12 by_BE12 drug_BE12 that_BE12 reduce_BE12 plasma_BE12 cholinesterase_BE12 activity_BE12 -LRB-_BE12 e.g._BE12 chronic_BE12 administer_BE12 oral_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 certain_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 demonstrate_BE12 in_BE12 patient_BE12 chronic_BE12 administer_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Mivacurium|N|mivacron|phenytoin|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOENTITY may_BE12 be_BE12 enhance_BE12 by_BE12 drug_BE12 that_BE12 reduce_BE12 plasma_BE12 cholinesterase_BE12 activity_BE12 -LRB-_BE12 e.g._BE12 chronic_BE12 administer_BE12 oral_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 certain_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 demonstrate_BE12 in_BE12 patient_BE12 chronic_BE12 administer_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Mivacurium|N|mivacron|neuromuscular blocking agent|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOENTITY may_BE12 be_BE12 enhance_BE12 by_BE12 drug_BE12 that_BE12 reduce_BE12 plasma_BE12 cholinesterase_BE12 activity_BE12 -LRB-_BE12 e.g._BE12 chronic_BE12 administer_BE12 oral_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 certain_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOENTITY have_RE2 be_RE2 demonstrate_RE2 in_RE2 patient_RE2 chronic_RE2 administer_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mivacurium|N|phenytoin|carbamazepine|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 certain_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 by_LE1 drug_LE1 that_LE1 irreversible_LE1 inhibit_LE1 plasma_LE1 cholinesterase_LE1 resistance_LE1 to_LE1 the_LE1 neuromuscular_LE1 block_LE1 action_LE1 of_LE1 nondepolarizing_LE1 BIOGENERAL_LE1 have_LE1 be_LE1 demonstrate_LE1 in_LE1 patient_LE1 chronic_LE1 administer_LE1 BIOENTITY or_BE12 BIOENTITY 
Mivacurium|N|monoamine oxidase inhibitor|carbamazepine|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 certain_LE1 BIOENTITY -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 demonstrate_BE12 in_BE12 patient_BE12 chronic_BE12 administer_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Mivacurium|N|monoamine oxidase inhibitor|carbamazepine|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 certain_LE1 BIOENTITY -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 demonstrate_BE12 in_BE12 patient_BE12 chronic_BE12 administer_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Mivacurium|N|monoamine oxidase inhibitor|phenytoin|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 certain_LE1 BIOENTITY -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 demonstrate_BE12 in_BE12 patient_BE12 chronic_BE12 administer_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Mivacurium|N|monoamine oxidase inhibitor|phenytoin|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 certain_LE1 BIOENTITY -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 demonstrate_BE12 in_BE12 patient_BE12 chronic_BE12 administer_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Mivacurium|N|monoamine oxidase inhibitor|neuromuscular blocking agent|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 certain_LE1 BIOENTITY -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOENTITY have_RE2 be_RE2 demonstrate_RE2 in_RE2 patient_RE2 chronic_RE2 administer_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mivacurium|N|monoamine oxidase inhibitor|neuromuscular blocking agent|the_LE1 neuromuscular_LE1 blocking_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 enhance_LE1 by_LE1 drug_LE1 that_LE1 reduce_LE1 plasma_LE1 cholinesterase_LE1 activity_LE1 -LRB-_LE1 e.g._LE1 chronic_LE1 administer_LE1 oral_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 certain_LE1 BIOENTITY -RRB-_BE12 or_BE12 by_BE12 drug_BE12 that_BE12 irreversible_BE12 inhibit_BE12 plasma_BE12 cholinesterase_BE12 resistance_BE12 to_BE12 the_BE12 neuromuscular_BE12 block_BE12 action_BE12 of_BE12 nondepolarizing_BE12 BIOENTITY have_RE2 be_RE2 demonstrate_RE2 in_RE2 patient_RE2 chronic_RE2 administer_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mivacurium|N|phenytoin|carbamazepine|while_LE1 the_LE1 effect_LE1 of_LE1 chronic_LE1 BIOENTITY or_BE12 BIOENTITY therapy_RE2 on_RE2 the_RE2 action_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 unknown_RE2 slight_RE2 short_RE2 duration_RE2 of_RE2 neuromuscular_RE2 block_RE2 may_RE2 be_RE2 anticipate_RE2 and_RE2 infusion_RE2 rate_RE2 requirement_RE2 may_RE2 be_RE2 high_RE2 
Mivacurium|N|edrophonium|neostigmine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|edrophonium|neostigmine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|edrophonium|polymyxin b|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|edrophonium|bacitracin|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|edrophonium|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|corticosteroid|edrophonium|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY medicine_BE12 for_BE12 angina_BE12 or_BE12 high_BE12 blood_BE12 pressure_BE12 medicine_BE12 for_BE12 pain_BE12 medicine_BE12 to_BE12 control_BE12 seizure_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|phenytoin|edrophonium|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|carbamazepine|edrophonium|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|carbamazepine|edrophonium|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|edrophonium|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|edrophonium|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|cisplatin|edrophonium|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|edrophonium|procaine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOENTITY general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|edrophonium|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|edrophonium|succinylcholine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|edrophonium|muscle relaxant|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 other_BE12 BIOENTITY 
Mivacurium|N|neostigmine|polymyxin b|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|neostigmine|bacitracin|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|neostigmine|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|corticosteroid|neostigmine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY medicine_BE12 for_BE12 angina_BE12 or_BE12 high_BE12 blood_BE12 pressure_BE12 medicine_BE12 for_BE12 pain_BE12 medicine_BE12 to_BE12 control_BE12 seizure_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|phenytoin|neostigmine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|carbamazepine|neostigmine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|carbamazepine|neostigmine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|neostigmine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|neostigmine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|cisplatin|neostigmine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|neostigmine|procaine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOENTITY general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|neostigmine|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|neostigmine|succinylcholine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|neostigmine|muscle relaxant|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 other_BE12 BIOENTITY 
Mivacurium|N|polymyxin b|bacitracin|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin b|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|corticosteroid|polymyxin b|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY medicine_BE12 for_BE12 angina_BE12 or_BE12 high_BE12 blood_BE12 pressure_BE12 medicine_BE12 for_BE12 pain_BE12 medicine_BE12 to_BE12 control_BE12 seizure_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|phenytoin|polymyxin b|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|carbamazepine|polymyxin b|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|polymyxin b|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|cisplatin|polymyxin b|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin b|procaine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOENTITY general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin b|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin b|succinylcholine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|polymyxin b|muscle relaxant|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 other_BE12 BIOENTITY 
Mivacurium|N|bacitracin|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY local_BE12 BIOENTITY such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|corticosteroid|bacitracin|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY medicine_BE12 for_BE12 angina_BE12 or_BE12 high_BE12 blood_BE12 pressure_BE12 medicine_BE12 for_BE12 pain_BE12 medicine_BE12 to_BE12 control_BE12 seizure_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|phenytoin|bacitracin|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|carbamazepine|bacitracin|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|bacitracin|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|cisplatin|bacitracin|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|procaine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOENTITY general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|succinylcholine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|bacitracin|muscle relaxant|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 other_BE12 BIOENTITY 
Mivacurium|N|corticosteroid|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY medicine_BE12 for_BE12 angina_BE12 or_BE12 high_BE12 blood_BE12 pressure_BE12 medicine_BE12 for_BE12 pain_BE12 medicine_BE12 to_BE12 control_BE12 seizure_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|phenytoin|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|carbamazepine|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|cisplatin|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOENTITY such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|anesthetic|procaine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 local_LE1 BIOENTITY such_BE12 as_BE12 BIOENTITY general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|anesthetic|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 local_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|anesthetic|succinylcholine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 local_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|anesthetic|muscle relaxant|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 local_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 other_BE12 BIOENTITY 
Mivacurium|N|corticosteroid|phenytoin|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY medicine_BE12 for_BE12 angina_BE12 or_BE12 high_BE12 blood_BE12 pressure_BE12 medicine_BE12 for_BE12 pain_BE12 medicine_BE12 to_BE12 control_BE12 seizure_BE12 such_BE12 as_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 certain_RE2 BIOGENERAL_RE2 give_RE2 by_RE2 injection_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|corticosteroid|carbamazepine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY medicine_BE12 for_BE12 angina_BE12 or_BE12 high_BE12 blood_BE12 pressure_BE12 medicine_BE12 for_BE12 pain_BE12 medicine_BE12 to_BE12 control_BE12 seizure_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY certain_RE2 BIOGENERAL_RE2 give_RE2 by_RE2 injection_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|corticosteroid|antibiotic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY medicine_BE12 for_BE12 angina_BE12 or_BE12 high_BE12 blood_BE12 pressure_BE12 medicine_BE12 for_BE12 pain_BE12 medicine_BE12 to_BE12 control_BE12 seizure_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 certain_BE12 BIOENTITY give_RE2 by_RE2 injection_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|corticosteroid|cisplatin|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY medicine_BE12 for_BE12 angina_BE12 or_BE12 high_BE12 blood_BE12 pressure_BE12 medicine_BE12 for_BE12 pain_BE12 medicine_BE12 to_BE12 control_BE12 seizure_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|corticosteroid|procaine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY medicine_BE12 for_BE12 angina_BE12 or_BE12 high_BE12 blood_BE12 pressure_BE12 medicine_BE12 for_BE12 pain_BE12 medicine_BE12 to_BE12 control_BE12 seizure_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOENTITY general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|corticosteroid|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY medicine_BE12 for_BE12 angina_BE12 or_BE12 high_BE12 blood_BE12 pressure_BE12 medicine_BE12 for_BE12 pain_BE12 medicine_BE12 to_BE12 control_BE12 seizure_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|corticosteroid|succinylcholine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY medicine_BE12 for_BE12 angina_BE12 or_BE12 high_BE12 blood_BE12 pressure_BE12 medicine_BE12 for_BE12 pain_BE12 medicine_BE12 to_BE12 control_BE12 seizure_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|corticosteroid|muscle relaxant|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOENTITY medicine_BE12 for_BE12 angina_BE12 or_BE12 high_BE12 blood_BE12 pressure_BE12 medicine_BE12 for_BE12 pain_BE12 medicine_BE12 to_BE12 control_BE12 seizure_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 other_BE12 BIOENTITY 
Mivacurium|N|phenytoin|carbamazepine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOENTITY or_BE12 BIOENTITY certain_RE2 BIOGENERAL_RE2 give_RE2 by_RE2 injection_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|phenytoin|antibiotic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 certain_BE12 BIOENTITY give_RE2 by_RE2 injection_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|phenytoin|cisplatin|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|phenytoin|procaine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOENTITY general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|phenytoin|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|phenytoin|succinylcholine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|phenytoin|muscle relaxant|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 other_BE12 BIOENTITY 
Mivacurium|N|carbamazepine|antibiotic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY certain_BE12 BIOENTITY give_RE2 by_RE2 injection_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|carbamazepine|antibiotic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY certain_BE12 BIOENTITY give_RE2 by_RE2 injection_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|carbamazepine|cisplatin|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|carbamazepine|procaine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOENTITY general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|carbamazepine|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|carbamazepine|succinylcholine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|carbamazepine|muscle relaxant|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 other_BE12 BIOENTITY 
Mivacurium|N|antibiotic|cisplatin|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY give_BE12 by_BE12 injection_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 local_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|procaine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOENTITY general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|succinylcholine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|antibiotic|muscle relaxant|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY give_BE12 by_BE12 injection_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 other_BE12 BIOENTITY 
Mivacurium|N|cisplatin|procaine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOENTITY general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|cisplatin|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|cisplatin|succinylcholine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|cisplatin|muscle relaxant|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 local_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 other_BE12 BIOENTITY 
Mivacurium|N|procaine|anesthetic|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 local_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY general_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|procaine|succinylcholine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 local_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|procaine|muscle relaxant|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 local_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 other_BE12 BIOENTITY 
Mivacurium|N|anesthetic|succinylcholine|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 local_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOENTITY or_RE2 other_RE2 BIOGENERAL_RE2 
Mivacurium|N|anesthetic|muscle relaxant|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 local_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 other_BE12 BIOENTITY 
Mivacurium|N|succinylcholine|muscle relaxant|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 local_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 other_BE12 BIOENTITY 
Mivacurium|N|succinylcholine|muscle relaxant|some_LE1 drug_LE1 interaction_LE1 be_LE1 :_LE1 birth_LE1 control_LE1 pill_LE1 BIOGENERAL_LE1 medicine_LE1 for_LE1 angina_LE1 or_LE1 high_LE1 blood_LE1 pressure_LE1 medicine_LE1 for_LE1 pain_LE1 medicine_LE1 to_LE1 control_LE1 seizure_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 give_LE1 by_LE1 injection_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 local_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 other_BE12 BIOENTITY 
Moexipril|N|diuretic|ace inhibitor|BIOENTITY :_BE12 excessive_BE12 reduction_BE12 in_BE12 blood_BE12 pressure_BE12 may_BE12 occur_BE12 in_BE12 patient_BE12 on_BE12 diuretic_BE12 therapy_BE12 when_BE12 BIOENTITY be_RE2 start_RE2 
Moexipril|N|univasc|moexpril|the_LE1 possibility_LE1 of_LE1 hypotensive_LE1 effect_LE1 with_LE1 BIOENTITY can_BE12 be_BE12 minimize_BE12 by_BE12 discontinue_BE12 diuretic_BE12 therapy_BE12 for_BE12 several_BE12 day_BE12 or_BE12 cautious_BE12 increase_BE12 salt_BE12 intake_BE12 before_BE12 initiation_BE12 of_BE12 treatment_BE12 with_BE12 BIOGENERAL_BE12 if_BE12 this_BE12 be_BE12 not_BE12 possible_BE12 the_BE12 start_BE12 dose_BE12 of_BE12 BIOENTITY shall_RE2 be_RE2 reduce_RE2 .._RE2 
Moexipril|N|univasc|univasc|the_LE1 possibility_LE1 of_LE1 hypotensive_LE1 effect_LE1 with_LE1 BIOENTITY can_BE12 be_BE12 minimize_BE12 by_BE12 discontinue_BE12 diuretic_BE12 therapy_BE12 for_BE12 several_BE12 day_BE12 or_BE12 cautious_BE12 increase_BE12 salt_BE12 intake_BE12 before_BE12 initiation_BE12 of_BE12 treatment_BE12 with_BE12 BIOENTITY if_RE2 this_RE2 be_RE2 not_RE2 possible_RE2 the_RE2 start_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 reduce_RE2 .._RE2 
Moexipril|N|univasc|moexpril|the_LE1 possibility_LE1 of_LE1 hypotensive_LE1 effect_LE1 with_LE1 BIOGENERAL_LE1 can_LE1 be_LE1 minimize_LE1 by_LE1 discontinue_LE1 diuretic_LE1 therapy_LE1 for_LE1 several_LE1 day_LE1 or_LE1 cautious_LE1 increase_LE1 salt_LE1 intake_LE1 before_LE1 initiation_LE1 of_LE1 treatment_LE1 with_LE1 BIOENTITY if_BE12 this_BE12 be_BE12 not_BE12 possible_BE12 the_BE12 start_BE12 dose_BE12 of_BE12 BIOENTITY shall_RE2 be_RE2 reduce_RE2 .._RE2 
Moexipril|N|potassium|potassium-sparing diuretic|BIOENTITY supplement_BE12 and_BE12 BIOENTITY :_RE2 BIOGENERAL_RE2 can_RE2 increase_RE2 serum_RE2 potassium_RE2 because_RE2 it_RE2 decrease_RE2 aldosterone_RE2 secretion_RE2 
Moexipril|N|potassium|univasc|BIOENTITY supplement_BE12 and_BE12 BIOGENERAL_BE12 :_BE12 BIOENTITY can_RE2 increase_RE2 serum_RE2 potassium_RE2 because_RE2 it_RE2 decrease_RE2 aldosterone_RE2 secretion_RE2 
Moexipril|N|potassium-sparing diuretic|univasc|BIOGENERAL_LE1 supplement_LE1 and_LE1 BIOENTITY :_BE12 BIOENTITY can_RE2 increase_RE2 serum_RE2 potassium_RE2 because_RE2 it_RE2 decrease_RE2 aldosterone_RE2 secretion_RE2 
Moexipril|N|potassium-sparing diuretic|amiloride|use_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 supplement_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Moexipril|N|potassium-sparing diuretic|potassium|use_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY supplement_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Moexipril|N|potassium-sparing diuretic|spironolactone|use_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 supplement_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Moexipril|N|potassium-sparing diuretic|triamterene|use_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 supplement_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Moexipril|N|amiloride|potassium|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOENTITY supplement_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Moexipril|N|spironolactone|amiloride|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 supplement_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Moexipril|N|triamterene|amiloride|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 supplement_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Moexipril|N|spironolactone|potassium|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY supplement_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Moexipril|N|triamterene|potassium|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY supplement_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Moexipril|N|spironolactone|triamterene|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 supplement_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Moexipril|N|anticoagulant|anticoagulant|oral_LE1 BIOENTITY :_BE12 interaction_BE12 study_BE12 with_BE12 BIOGENERAL_BE12 fail_BE12 to_BE12 identify_BE12 any_BE12 clinical_BE12 important_BE12 effect_BE12 on_BE12 the_BE12 serum_BE12 concentration_BE12 of_BE12 the_BE12 BIOENTITY or_RE2 on_RE2 its_RE2 anticoagulant_RE2 effect_RE2 
Moexipril|N|anticoagulant|warfarin|oral_LE1 BIOENTITY :_BE12 interaction_BE12 study_BE12 with_BE12 BIOENTITY fail_RE2 to_RE2 identify_RE2 any_RE2 clinical_RE2 important_RE2 effect_RE2 on_RE2 the_RE2 serum_RE2 concentration_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 or_RE2 on_RE2 its_RE2 anticoagulant_RE2 effect_RE2 
Moexipril|N|warfarin|anticoagulant|oral_LE1 BIOGENERAL_LE1 :_LE1 interaction_LE1 study_LE1 with_LE1 BIOENTITY fail_BE12 to_BE12 identify_BE12 any_BE12 clinical_BE12 important_BE12 effect_BE12 on_BE12 the_BE12 serum_BE12 concentration_BE12 of_BE12 the_BE12 BIOENTITY or_RE2 on_RE2 its_RE2 anticoagulant_RE2 effect_RE2 
Moexipril|N|lithium|lithium|BIOGENERAL_LE1 :_LE1 increase_LE1 serum_LE1 BIOGENERAL_LE1 level_LE1 and_LE1 symptom_LE1 of_LE1 BIOENTITY toxicity_BE12 have_BE12 be_BE12 report_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 during_BE12 therapy_BE12 with_BE12 BIOENTITY 
Moexipril|N|lithium|lithium|BIOENTITY :_BE12 increase_BE12 serum_BE12 BIOGENERAL_BE12 level_BE12 and_BE12 symptom_BE12 of_BE12 BIOGENERAL_BE12 toxicity_BE12 have_BE12 be_BE12 report_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 during_BE12 therapy_BE12 with_BE12 BIOENTITY 
Moexipril|N|lithium|lithium|BIOGENERAL_LE1 :_LE1 increase_LE1 serum_LE1 BIOENTITY level_BE12 and_BE12 symptom_BE12 of_BE12 BIOGENERAL_BE12 toxicity_BE12 have_BE12 be_BE12 report_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 during_BE12 therapy_BE12 with_BE12 BIOENTITY 
Moexipril|N|lithium|ace inhibitor|BIOGENERAL_LE1 :_LE1 increase_LE1 serum_LE1 BIOGENERAL_LE1 level_LE1 and_LE1 symptom_LE1 of_LE1 BIOENTITY toxicity_BE12 have_BE12 be_BE12 report_BE12 in_BE12 patient_BE12 receive_BE12 BIOENTITY during_RE2 therapy_RE2 with_RE2 BIOGENERAL_RE2 
Moexipril|N|lithium|lithium|BIOENTITY :_BE12 increase_BE12 serum_BE12 BIOGENERAL_BE12 level_BE12 and_BE12 symptom_BE12 of_BE12 BIOENTITY toxicity_RE2 have_RE2 be_RE2 report_RE2 in_RE2 patient_RE2 receive_RE2 BIOGENERAL_RE2 during_RE2 therapy_RE2 with_RE2 BIOGENERAL_RE2 
Moexipril|N|lithium|lithium|BIOGENERAL_LE1 :_LE1 increase_LE1 serum_LE1 BIOENTITY level_BE12 and_BE12 symptom_BE12 of_BE12 BIOENTITY toxicity_RE2 have_RE2 be_RE2 report_RE2 in_RE2 patient_RE2 receive_RE2 BIOGENERAL_RE2 during_RE2 therapy_RE2 with_RE2 BIOGENERAL_RE2 
Moexipril|N|lithium|ace inhibitor|BIOENTITY :_BE12 increase_BE12 serum_BE12 BIOGENERAL_BE12 level_BE12 and_BE12 symptom_BE12 of_BE12 BIOGENERAL_BE12 toxicity_BE12 have_BE12 be_BE12 report_BE12 in_BE12 patient_BE12 receive_BE12 BIOENTITY during_RE2 therapy_RE2 with_RE2 BIOGENERAL_RE2 
Moexipril|N|lithium|ace inhibitor|BIOGENERAL_LE1 :_LE1 increase_LE1 serum_LE1 BIOENTITY level_BE12 and_BE12 symptom_BE12 of_BE12 BIOGENERAL_BE12 toxicity_BE12 have_BE12 be_BE12 report_BE12 in_BE12 patient_BE12 receive_BE12 BIOENTITY during_RE2 therapy_RE2 with_RE2 BIOGENERAL_RE2 
Moexipril|N|lithium|lithium|BIOENTITY :_BE12 increase_BE12 serum_BE12 BIOENTITY level_RE2 and_RE2 symptom_RE2 of_RE2 BIOGENERAL_RE2 toxicity_RE2 have_RE2 be_RE2 report_RE2 in_RE2 patient_RE2 receive_RE2 BIOGENERAL_RE2 during_RE2 therapy_RE2 with_RE2 BIOGENERAL_RE2 
Moexipril|N|hydrochlorothiazide|cimetidine|other_LE1 agent_LE1 :_LE1 no_LE1 clinical_LE1 important_LE1 pharmacokinetic_LE1 interaction_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Moexipril|N|digoxin|cimetidine|other_LE1 agent_LE1 :_LE1 no_LE1 clinical_LE1 important_LE1 pharmacokinetic_LE1 interaction_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Moexipril|N|digoxin|cimetidine|other_LE1 agent_LE1 :_LE1 no_LE1 clinical_LE1 important_LE1 pharmacokinetic_LE1 interaction_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Moexipril|N|univasc|cimetidine|other_LE1 agent_LE1 :_LE1 no_LE1 clinical_LE1 important_LE1 pharmacokinetic_LE1 interaction_LE1 occur_LE1 when_LE1 BIOENTITY be_BE12 administer_BE12 concomitant_BE12 with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Moexipril|N|hydrochlorothiazide|digoxin|other_LE1 agent_LE1 :_LE1 no_LE1 clinical_LE1 important_LE1 pharmacokinetic_LE1 interaction_LE1 occur_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Moexipril|N|univasc|hydrochlorothiazide|other_LE1 agent_LE1 :_LE1 no_LE1 clinical_LE1 important_LE1 pharmacokinetic_LE1 interaction_LE1 occur_LE1 when_LE1 BIOENTITY be_BE12 administer_BE12 concomitant_BE12 with_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Moexipril|N|univasc|digoxin|other_LE1 agent_LE1 :_LE1 no_LE1 clinical_LE1 important_LE1 pharmacokinetic_LE1 interaction_LE1 occur_LE1 when_LE1 BIOENTITY be_BE12 administer_BE12 concomitant_BE12 with_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Moexipril|N|calcium-channel-blocking agent|diuretic|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 in_LE1 clinical_LE1 trial_LE1 concomitant_LE1 with_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|univasc|diuretic|BIOENTITY have_BE12 be_BE12 use_BE12 in_BE12 clinical_BE12 trial_BE12 concomitant_BE12 with_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|diuretic|hypoglycemic agent|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 in_LE1 clinical_LE1 trial_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|diuretic|hypoglycemic agent|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 in_LE1 clinical_LE1 trial_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|diuretic|digoxin|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 in_LE1 clinical_LE1 trial_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|diuretic|digoxin|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 in_LE1 clinical_LE1 trial_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|diuretic|h2 blocker|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 in_LE1 clinical_LE1 trial_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|diuretic|h2 blocker|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 in_LE1 clinical_LE1 trial_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|univasc|calcium-channel-blocking agent|BIOENTITY have_BE12 be_BE12 use_BE12 in_BE12 clinical_BE12 trial_BE12 concomitant_BE12 with_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|calcium-channel-blocking agent|hypoglycemic agent|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 in_LE1 clinical_LE1 trial_LE1 concomitant_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|calcium-channel-blocking agent|digoxin|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 in_LE1 clinical_LE1 trial_LE1 concomitant_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|calcium-channel-blocking agent|h2 blocker|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 in_LE1 clinical_LE1 trial_LE1 concomitant_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|univasc|hypoglycemic agent|BIOENTITY have_BE12 be_BE12 use_BE12 in_BE12 clinical_BE12 trial_BE12 concomitant_BE12 with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|univasc|digoxin|BIOENTITY have_BE12 be_BE12 use_BE12 in_BE12 clinical_BE12 trial_BE12 concomitant_BE12 with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|univasc|h2 blocker|BIOENTITY have_BE12 be_BE12 use_BE12 in_BE12 clinical_BE12 trial_BE12 concomitant_BE12 with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|digoxin|hypoglycemic agent|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 in_LE1 clinical_LE1 trial_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOENTITY and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|digoxin|hypoglycemic agent|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 in_LE1 clinical_LE1 trial_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOENTITY and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|h2 blocker|hypoglycemic agent|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 in_LE1 clinical_LE1 trial_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOENTITY and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|h2 blocker|hypoglycemic agent|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 in_LE1 clinical_LE1 trial_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOENTITY and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|h2 blocker|digoxin|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 in_LE1 clinical_LE1 trial_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY oral_RE2 BIOGENERAL_RE2 and_RE2 cholesterollowering_RE2 agent_RE2 
Moexipril|N|h2 blocker|digoxin|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 in_LE1 clinical_LE1 trial_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY oral_RE2 BIOGENERAL_RE2 and_RE2 cholesterollowering_RE2 agent_RE2 
Montelukast|N|montelukast|theophylline|BIOENTITY at_BE12 dose_BE12 of_BE12 NUM_BE12 mg_BE12 once_BE12 daily_BE12 dosed_BE12 to_BE12 pharmacokinetic_BE12 steady_BE12 state_BE12 do_BE12 not_BE12 cause_BE12 clinical_BE12 significant_BE12 change_BE12 in_BE12 the_BE12 kinetic_BE12 of_BE12 single_BE12 intravenous_BE12 dose_BE12 of_BE12 BIOENTITY -LRB-_RE2 predominant_RE2 cytochrome_RE2 substrate_RE2 rrb._RE2 
Montelukast|N|warfarin|warfarin|do_LE1 not_LE1 change_LE1 the_LE1 pharmacokinetic_LE1 profile_LE1 of_LE1 BIOENTITY -LRB-_BE12 substrate_BE12 of_BE12 cytochrome_BE12 and_BE12 -RRB-_BE12 or_BE12 influence_BE12 the_BE12 effect_BE12 of_BE12 single_BE12 mg_BE12 oral_BE12 dose_BE12 of_BE12 BIOENTITY on_RE2 prothrombin_RE2 time_RE2 or_RE2 the_RE2 inr_RE2 -LRB-_RE2 international_RE2 normalize_RE2 ratio_RE2 rrb._RE2 
Montelukast|N|terfenadine|fexofenadine|do_LE1 not_LE1 change_LE1 the_LE1 plasma_LE1 concentration_LE1 profile_LE1 of_LE1 BIOENTITY -LRB-_BE12 substrate_BE12 of_BE12 cytochrome_BE12 -RRB-_BE12 or_BE12 BIOENTITY its_RE2 carboxylated_RE2 metabolite_RE2 and_RE2 do_RE2 not_RE2 prolong_RE2 the_RE2 qtc_RE2 interval_RE2 following_RE2 coadministration_RE2 with_RE2 BIOGENERAL_RE2 NUM_RE2 mg_RE2 twice_RE2 daily_RE2 
Montelukast|N|fexofenadine|terfenadine|do_LE1 not_LE1 change_LE1 the_LE1 plasma_LE1 concentration_LE1 profile_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 substrate_LE1 of_LE1 cytochrome_LE1 -RRB-_LE1 or_LE1 BIOENTITY its_BE12 carboxylated_BE12 metabolite_BE12 and_BE12 do_BE12 not_BE12 prolong_BE12 the_BE12 qtc_BE12 interval_BE12 following_BE12 coadministration_BE12 with_BE12 BIOENTITY NUM_RE2 mg_RE2 twice_RE2 daily_RE2 
Montelukast|N|terfenadine|terfenadine|do_LE1 not_LE1 change_LE1 the_LE1 plasma_LE1 concentration_LE1 profile_LE1 of_LE1 BIOENTITY -LRB-_BE12 substrate_BE12 of_BE12 cytochrome_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 its_BE12 carboxylated_BE12 metabolite_BE12 and_BE12 do_BE12 not_BE12 prolong_BE12 the_BE12 qtc_BE12 interval_BE12 following_BE12 coadministration_BE12 with_BE12 BIOENTITY NUM_RE2 mg_RE2 twice_RE2 daily_RE2 
Montelukast|N|montelukast|norethindrone|BIOENTITY at_BE12 dose_BE12 of_BE12 NUM_BE12 mg_BE12 daily_BE12 dose_BE12 to_BE12 pharmacokinetic_BE12 steady_BE12 state_BE12 :_BE12 do_BE12 not_BE12 significant_BE12 alter_BE12 the_BE12 plasma_BE12 concentration_BE12 of_BE12 either_BE12 component_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 contain_BE12 BIOENTITY NUM_RE2 mg_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 
Montelukast|N|montelukast|contraceptive|BIOENTITY at_BE12 dose_BE12 of_BE12 NUM_BE12 mg_BE12 daily_BE12 dose_BE12 to_BE12 pharmacokinetic_BE12 steady_BE12 state_BE12 :_BE12 do_BE12 not_BE12 significant_BE12 alter_BE12 the_BE12 plasma_BE12 concentration_BE12 of_BE12 either_BE12 component_BE12 of_BE12 oral_BE12 BIOENTITY contain_RE2 BIOGENERAL_RE2 NUM_RE2 mg_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 
Montelukast|N|montelukast|estradiol|BIOENTITY at_BE12 dose_BE12 of_BE12 NUM_BE12 mg_BE12 daily_BE12 dose_BE12 to_BE12 pharmacokinetic_BE12 steady_BE12 state_BE12 :_BE12 do_BE12 not_BE12 significant_BE12 alter_BE12 the_BE12 plasma_BE12 concentration_BE12 of_BE12 either_BE12 component_BE12 of_BE12 oral_BE12 BIOGENERAL_BE12 contain_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 BIOENTITY NUM_RE2 mcg_RE2 
Montelukast|N|contraceptive|norethindrone|BIOGENERAL_LE1 at_LE1 dose_LE1 of_LE1 NUM_LE1 mg_LE1 daily_LE1 dose_LE1 to_LE1 pharmacokinetic_LE1 steady_LE1 state_LE1 :_LE1 do_LE1 not_LE1 significant_LE1 alter_LE1 the_LE1 plasma_LE1 concentration_LE1 of_LE1 either_LE1 component_LE1 of_LE1 oral_LE1 BIOENTITY contain_BE12 BIOENTITY NUM_RE2 mg_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 
Montelukast|N|norethindrone|estradiol|BIOGENERAL_LE1 at_LE1 dose_LE1 of_LE1 NUM_LE1 mg_LE1 daily_LE1 dose_LE1 to_LE1 pharmacokinetic_LE1 steady_LE1 state_LE1 :_LE1 do_LE1 not_LE1 significant_LE1 alter_LE1 the_LE1 plasma_LE1 concentration_LE1 of_LE1 either_LE1 component_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 contain_LE1 BIOENTITY NUM_BE12 mg_BE12 BIOENTITY NUM_RE2 mcg_RE2 
Montelukast|N|contraceptive|estradiol|BIOGENERAL_LE1 at_LE1 dose_LE1 of_LE1 NUM_LE1 mg_LE1 daily_LE1 dose_LE1 to_LE1 pharmacokinetic_LE1 steady_LE1 state_LE1 :_LE1 do_LE1 not_LE1 significant_LE1 alter_LE1 the_LE1 plasma_LE1 concentration_LE1 of_LE1 either_LE1 component_LE1 of_LE1 oral_LE1 BIOENTITY contain_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 BIOENTITY NUM_RE2 mcg_RE2 
Montelukast|N|prednisone|prednisolone|do_LE1 not_LE1 cause_LE1 any_LE1 clinical_LE1 significant_LE1 change_LE1 in_LE1 plasma_LE1 profile_LE1 of_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 follow_LE1 administration_LE1 of_LE1 either_LE1 oral_LE1 BIOENTITY or_BE12 intravenous_BE12 BIOENTITY 
Montelukast|N|prednisolone|prednisolone|do_LE1 not_LE1 cause_LE1 any_LE1 clinical_LE1 significant_LE1 change_LE1 in_LE1 plasma_LE1 profile_LE1 of_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY follow_BE12 administration_BE12 of_BE12 either_BE12 oral_BE12 BIOGENERAL_BE12 or_BE12 intravenous_BE12 BIOENTITY 
Montelukast|N|prednisone|prednisolone|do_LE1 not_LE1 cause_LE1 any_LE1 clinical_LE1 significant_LE1 change_LE1 in_LE1 plasma_LE1 profile_LE1 of_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 follow_BE12 administration_BE12 of_BE12 either_BE12 oral_BE12 BIOGENERAL_BE12 or_BE12 intravenous_BE12 BIOENTITY 
Montelukast|N|prednisolone|prednisone|do_LE1 not_LE1 cause_LE1 any_LE1 clinical_LE1 significant_LE1 change_LE1 in_LE1 plasma_LE1 profile_LE1 of_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY follow_BE12 administration_BE12 of_BE12 either_BE12 oral_BE12 BIOENTITY or_RE2 intravenous_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisone|prednisone|do_LE1 not_LE1 cause_LE1 any_LE1 clinical_LE1 significant_LE1 change_LE1 in_LE1 plasma_LE1 profile_LE1 of_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 follow_BE12 administration_BE12 of_BE12 either_BE12 oral_BE12 BIOENTITY or_RE2 intravenous_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisone|prednisolone|do_LE1 not_LE1 cause_LE1 any_LE1 clinical_LE1 significant_LE1 change_LE1 in_LE1 plasma_LE1 profile_LE1 of_LE1 BIOENTITY or_BE12 BIOENTITY follow_RE2 administration_RE2 of_RE2 either_RE2 oral_RE2 BIOGENERAL_RE2 or_RE2 intravenous_RE2 BIOGENERAL_RE2 
Montelukast|N|phenobarbital|montelukast|BIOENTITY which_BE12 induce_BE12 hepatic_BE12 metabolism_BE12 decrease_BE12 the_BE12 auc_BE12 of_BE12 BIOGENERAL_BE12 approximate_BE12 NUM_BE12 following_BE12 single_BE12 mg_BE12 dose_BE12 of_BE12 BIOENTITY 
Montelukast|N|phenobarbital|montelukast|BIOENTITY which_BE12 induce_BE12 hepatic_BE12 metabolism_BE12 decrease_BE12 the_BE12 auc_BE12 of_BE12 BIOENTITY approximate_RE2 NUM_RE2 following_RE2 single_RE2 mg_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 
Montelukast|N|montelukast|montelukast|BIOGENERAL_LE1 which_LE1 induce_LE1 hepatic_LE1 metabolism_LE1 decrease_LE1 the_LE1 auc_LE1 of_LE1 BIOENTITY approximate_BE12 NUM_BE12 following_BE12 single_BE12 mg_BE12 dose_BE12 of_BE12 BIOENTITY 
Montelukast|N|phenobarbital|rifampin|it_LE1 be_LE1 reasonable_LE1 to_LE1 employ_LE1 appropriate_LE1 clinical_LE1 monitoring_LE1 when_LE1 potent_LE1 cytochrome_LE1 enzyme_LE1 inducer_LE1 such_LE1 as_LE1 BIOENTITY or_BE12 BIOENTITY be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Montelukast|N|montelukast|theophylline|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOENTITY do_BE12 not_BE12 have_BE12 clinical_BE12 important_BE12 effect_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|theophylline|ethinyl estradiol|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOENTITY NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|theophylline|terfenadine|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|theophylline|digoxin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|theophylline|warfarin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|theophylline|prednisone|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|theophylline|prednisolone|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|theophylline|contraceptive|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|theophylline|norethindrone|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|montelukast|ethinyl estradiol|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOENTITY do_BE12 not_BE12 have_BE12 clinical_BE12 important_BE12 effect_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOENTITY NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|montelukast|terfenadine|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOENTITY do_BE12 not_BE12 have_BE12 clinical_BE12 important_BE12 effect_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|montelukast|digoxin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOENTITY do_BE12 not_BE12 have_BE12 clinical_BE12 important_BE12 effect_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|montelukast|warfarin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOENTITY do_BE12 not_BE12 have_BE12 clinical_BE12 important_BE12 effect_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|montelukast|prednisone|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOENTITY do_BE12 not_BE12 have_BE12 clinical_BE12 important_BE12 effect_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|montelukast|prednisolone|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOENTITY do_BE12 not_BE12 have_BE12 clinical_BE12 important_BE12 effect_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|montelukast|contraceptive|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOENTITY do_BE12 not_BE12 have_BE12 clinical_BE12 important_BE12 effect_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|montelukast|norethindrone|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOENTITY do_BE12 not_BE12 have_BE12 clinical_BE12 important_BE12 effect_BE12 on_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 the_BE12 following_BE12 drug_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|ethinyl estradiol|terfenadine|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 NUM_LE1 BIOENTITY NUM_BE12 mcg_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|ethinyl estradiol|terfenadine|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 NUM_LE1 BIOENTITY NUM_BE12 mcg_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|ethinyl estradiol|digoxin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 NUM_LE1 BIOENTITY NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|ethinyl estradiol|digoxin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 NUM_LE1 BIOENTITY NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|ethinyl estradiol|warfarin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 NUM_LE1 BIOENTITY NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|ethinyl estradiol|warfarin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 NUM_LE1 BIOENTITY NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|prednisone|ethinyl estradiol|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOENTITY NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisone|ethinyl estradiol|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOENTITY NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisolone|ethinyl estradiol|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOENTITY NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisolone|ethinyl estradiol|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOENTITY NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|contraceptive|ethinyl estradiol|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOENTITY NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|norethindrone|ethinyl estradiol|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY NUM_BE12 BIOENTITY NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|terfenadine|digoxin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 NUM_LE1 BIOGENERAL_LE1 NUM_LE1 mcg_LE1 -RRB-_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|terfenadine|digoxin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 NUM_LE1 BIOGENERAL_LE1 NUM_LE1 mcg_LE1 -RRB-_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|terfenadine|warfarin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 NUM_LE1 BIOGENERAL_LE1 NUM_LE1 mcg_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|terfenadine|warfarin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 NUM_LE1 BIOGENERAL_LE1 NUM_LE1 mcg_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|prednisone|terfenadine|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisone|terfenadine|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisolone|terfenadine|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisolone|terfenadine|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|contraceptive|terfenadine|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|contraceptive|terfenadine|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|norethindrone|terfenadine|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|norethindrone|terfenadine|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|digoxin|warfarin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 NUM_LE1 BIOGENERAL_LE1 NUM_LE1 mcg_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Montelukast|N|digoxin|warfarin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 NUM_LE1 BIOGENERAL_LE1 NUM_LE1 mcg_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Montelukast|N|prednisone|digoxin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisone|digoxin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisolone|digoxin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisolone|digoxin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|contraceptive|digoxin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|contraceptive|digoxin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|norethindrone|digoxin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|norethindrone|digoxin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisone|warfarin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|prednisone|warfarin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|prednisolone|warfarin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|prednisolone|warfarin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|contraceptive|warfarin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|contraceptive|warfarin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|norethindrone|warfarin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|norethindrone|warfarin|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY NUM_BE12 BIOGENERAL_BE12 NUM_BE12 mcg_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|prednisone|prednisolone|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisone|prednisolone|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisone|contraceptive|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisone|contraceptive|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisone|norethindrone|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisone|norethindrone|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisolone|contraceptive|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisolone|contraceptive|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisolone|norethindrone|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|prednisolone|norethindrone|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|contraceptive|norethindrone|In_LE1 druginteraction_LE1 study_LE1 the_LE1 recommend_LE1 clinical_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 have_LE1 clinical_LE1 important_LE1 effect_LE1 on_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 the_LE1 following_LE1 drug_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOENTITY NUM_RE2 BIOGENERAL_RE2 NUM_RE2 mcg_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|thyroid hormone|sedative hypnotic|these_LE1 medication_LE1 include_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|sedative hypnotic|benzodiazepine|these_LE1 medication_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|sedative hypnotic|benzodiazepine|these_LE1 medication_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|sedative hypnotic|non-steroidal anti-inflammatory agent|these_LE1 medication_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|sedative hypnotic|non-steroidal anti-inflammatory agent|these_LE1 medication_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|sedative hypnotic|decongestant|these_LE1 medication_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|sedative hypnotic|decongestant|these_LE1 medication_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|thyroid hormone|benzodiazepine|these_LE1 medication_LE1 include_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|thyroid hormone|non-steroidal anti-inflammatory agent|these_LE1 medication_LE1 include_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Montelukast|N|thyroid hormone|decongestant|these_LE1 medication_LE1 include_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|non-steroidal anti-inflammatory agent|benzodiazepine|these_LE1 medication_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|non-steroidal anti-inflammatory agent|benzodiazepine|these_LE1 medication_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Montelukast|N|benzodiazepine|decongestant|these_LE1 medication_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Montelukast|N|benzodiazepine|decongestant|these_LE1 medication_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Montelukast|N|non-steroidal anti-inflammatory agent|decongestant|these_LE1 medication_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|non-steroidal anti-inflammatory agent|decongestant|these_LE1 medication_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Montelukast|N|phenobarbital|montelukast|BIOENTITY which_BE12 induce_BE12 hepatic_BE12 metabolism_BE12 decrease_BE12 the_BE12 auc_BE12 of_BE12 BIOGENERAL_BE12 approximate_BE12 NUM_BE12 following_BE12 single_BE12 mg_BE12 dose_BE12 of_BE12 BIOENTITY 
Montelukast|N|phenobarbital|montelukast|BIOENTITY which_BE12 induce_BE12 hepatic_BE12 metabolism_BE12 decrease_BE12 the_BE12 auc_BE12 of_BE12 BIOENTITY approximate_RE2 NUM_RE2 following_RE2 single_RE2 mg_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 
Montelukast|N|montelukast|montelukast|BIOGENERAL_LE1 which_LE1 induce_LE1 hepatic_LE1 metabolism_LE1 decrease_LE1 the_LE1 auc_LE1 of_LE1 BIOENTITY approximate_BE12 NUM_BE12 following_BE12 single_BE12 mg_BE12 dose_BE12 of_BE12 BIOENTITY 
Montelukast|N|phenobarbital|rifampin|it_LE1 be_LE1 reasonable_LE1 to_LE1 employ_LE1 appropriate_LE1 clinical_LE1 monitoring_LE1 when_LE1 potent_LE1 cytochrome_LE1 enzyme_LE1 inducer_LE1 such_LE1 as_LE1 BIOENTITY or_BE12 BIOENTITY be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Morphine|N|cns depressant|alcohol|use_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 the_LE1 depressant_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 potentiate_LE1 by_LE1 the_LE1 presence_LE1 of_LE1 other_LE1 BIOENTITY such_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Morphine|N|alcohol|antihistaminic|use_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 the_LE1 depressant_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 potentiate_LE1 by_LE1 the_LE1 presence_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Morphine|N|alcohol|sedative|use_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 the_LE1 depressant_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 potentiate_LE1 by_LE1 the_LE1 presence_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Morphine|N|central nervous system depressant|alcohol|use_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 the_BE12 depressant_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 potentiate_BE12 by_BE12 the_BE12 presence_BE12 of_BE12 other_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Morphine|N|alcohol|psychotropic drug|use_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 the_LE1 depressant_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 potentiate_LE1 by_LE1 the_LE1 presence_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Morphine|N|cns depressant|antihistaminic|use_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 the_LE1 depressant_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 potentiate_LE1 by_LE1 the_LE1 presence_LE1 of_LE1 other_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Morphine|N|cns depressant|sedative|use_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 the_LE1 depressant_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 potentiate_LE1 by_LE1 the_LE1 presence_LE1 of_LE1 other_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Morphine|N|central nervous system depressant|cns depressant|use_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 the_BE12 depressant_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 potentiate_BE12 by_BE12 the_BE12 presence_BE12 of_BE12 other_BE12 BIOENTITY such_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Morphine|N|cns depressant|psychotropic drug|use_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 the_LE1 depressant_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 potentiate_LE1 by_LE1 the_LE1 presence_LE1 of_LE1 other_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Morphine|N|sedative|antihistaminic|use_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 the_LE1 depressant_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 potentiate_LE1 by_LE1 the_LE1 presence_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Morphine|N|sedative|antihistaminic|use_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 the_LE1 depressant_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 potentiate_LE1 by_LE1 the_LE1 presence_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Morphine|N|central nervous system depressant|antihistaminic|use_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 the_BE12 depressant_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 potentiate_BE12 by_BE12 the_BE12 presence_BE12 of_BE12 other_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Morphine|N|antihistaminic|psychotropic drug|use_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 the_LE1 depressant_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 potentiate_LE1 by_LE1 the_LE1 presence_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Morphine|N|antihistaminic|psychotropic drug|use_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 the_LE1 depressant_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 potentiate_LE1 by_LE1 the_LE1 presence_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Morphine|N|central nervous system depressant|sedative|use_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 the_BE12 depressant_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 potentiate_BE12 by_BE12 the_BE12 presence_BE12 of_BE12 other_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Morphine|N|sedative|psychotropic drug|use_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 the_LE1 depressant_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 potentiate_LE1 by_LE1 the_LE1 presence_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Morphine|N|sedative|psychotropic drug|use_LE1 with_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 the_LE1 depressant_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 potentiate_LE1 by_LE1 the_LE1 presence_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Morphine|N|central nervous system depressant|morphine|use_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 the_BE12 depressant_BE12 effect_BE12 of_BE12 BIOENTITY be_RE2 potentiate_RE2 by_RE2 the_RE2 presence_RE2 of_RE2 other_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Morphine|N|central nervous system depressant|psychotropic drug|use_LE1 with_LE1 other_LE1 BIOENTITY :_BE12 the_BE12 depressant_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 potentiate_BE12 by_BE12 the_BE12 presence_BE12 of_BE12 other_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Morphine|N|mixed agonist/antagonist opioid analgesic|agonist/antagonist analgesic|interaction_LE1 with_LE1 BIOENTITY :_BE12 BIOENTITY -LRB-_RE2 i.e._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|mixed agonist/antagonist opioid analgesic|pentazocine|interaction_LE1 with_LE1 BIOENTITY :_BE12 BIOGENERAL_BE12 -LRB-_BE12 i.e._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|mixed agonist/antagonist opioid analgesic|nalbuphine|interaction_LE1 with_LE1 BIOENTITY :_BE12 BIOGENERAL_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|mixed agonist/antagonist opioid analgesic|butorphanol|interaction_LE1 with_LE1 BIOENTITY :_BE12 BIOGENERAL_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|mixed agonist/antagonist opioid analgesic|buprenorphine|interaction_LE1 with_LE1 BIOENTITY :_BE12 BIOGENERAL_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|mixed agonist/antagonist opioid analgesic|opioid agonist analgesic|interaction_LE1 with_LE1 BIOENTITY :_BE12 BIOGENERAL_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -RRB-_BE12 shall_BE12 not_BE12 be_BE12 administer_BE12 to_BE12 patient_BE12 who_BE12 have_BE12 receive_BE12 or_BE12 be_BE12 receive_BE12 course_BE12 of_BE12 therapy_BE12 with_BE12 proof_BE12 BIOENTITY 
Morphine|N|mixed agonist/antagonist opioid analgesic|opioid agonist analgesic|interaction_LE1 with_LE1 BIOENTITY :_BE12 BIOGENERAL_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 -RRB-_BE12 shall_BE12 not_BE12 be_BE12 administer_BE12 to_BE12 patient_BE12 who_BE12 have_BE12 receive_BE12 or_BE12 be_BE12 receive_BE12 course_BE12 of_BE12 therapy_BE12 with_BE12 proof_BE12 BIOENTITY 
Morphine|N|agonist/antagonist analgesic|pentazocine|interaction_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY -LRB-_BE12 i.e._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|agonist/antagonist analgesic|nalbuphine|interaction_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|agonist/antagonist analgesic|butorphanol|interaction_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|agonist/antagonist analgesic|buprenorphine|interaction_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 BIOENTITY -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|pentazocine|nalbuphine|interaction_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 -LRB-_LE1 i.e._LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|pentazocine|butorphanol|interaction_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 -LRB-_LE1 i.e._LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|pentazocine|buprenorphine|interaction_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 -LRB-_LE1 i.e._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|nalbuphine|butorphanol|interaction_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 -LRB-_LE1 i.e._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|nalbuphine|butorphanol|interaction_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 -LRB-_LE1 i.e._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|nalbuphine|buprenorphine|interaction_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 -LRB-_LE1 i.e._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|nalbuphine|buprenorphine|interaction_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 -LRB-_LE1 i.e._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|butorphanol|buprenorphine|interaction_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 -LRB-_LE1 i.e._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Morphine|N|butorphanol|buprenorphine|interaction_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 -LRB-_LE1 i.e._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY -RRB-_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 to_RE2 patient_RE2 who_RE2 have_RE2 receive_RE2 or_RE2 be_RE2 receive_RE2 course_RE2 of_RE2 therapy_RE2 with_RE2 proof_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|antacid|antacid|BIOENTITY :_BE12 absorption_BE12 of_BE12 single_BE12 dose_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 decrease_BE12 when_BE12 administer_BE12 to_BE12 NUM_BE12 stable_BE12 renal_BE12 transplant_BE12 patient_BE12 also_BE12 take_BE12 BIOGENERAL_BE12 contain_BE12 BIOENTITY -LRB-_RE2 NUM_RE2 ml_RE2 -RRB-_RE2 :_RE2 the_RE2 mean_RE2 cmax_RE2 and_RE2 auc_RE2 -LRB-_RE2 -RRB-_RE2 value_RE2 for_RE2 mpa_RE2 be_RE2 NUM_RE2 and_RE2 NUM_RE2 low_RE2 respective_RE2 than_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 alone_RE2 under_RE2 fast_RE2 condition_RE2 
Mycophenolic acid|N|antacid|antacid|BIOENTITY :_BE12 absorption_BE12 of_BE12 single_BE12 dose_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 decrease_BE12 when_BE12 administer_BE12 to_BE12 NUM_BE12 stable_BE12 renal_BE12 transplant_BE12 patient_BE12 also_BE12 take_BE12 BIOGENERAL_BE12 contain_BE12 BIOENTITY -LRB-_RE2 NUM_RE2 ml_RE2 -RRB-_RE2 :_RE2 the_RE2 mean_RE2 cmax_RE2 and_RE2 auc_RE2 -LRB-_RE2 -RRB-_RE2 value_RE2 for_RE2 mpa_RE2 be_RE2 NUM_RE2 and_RE2 NUM_RE2 low_RE2 respective_RE2 than_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 alone_RE2 under_RE2 fast_RE2 condition_RE2 
Mycophenolic acid|N|antacid|magnesium|BIOENTITY :_BE12 absorption_BE12 of_BE12 single_BE12 dose_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 decrease_BE12 when_BE12 administer_BE12 to_BE12 NUM_BE12 stable_BE12 renal_BE12 transplant_BE12 patient_BE12 also_BE12 take_BE12 BIOENTITY contain_RE2 BIOGENERAL_RE2 -LRB-_RE2 NUM_RE2 ml_RE2 -RRB-_RE2 :_RE2 the_RE2 mean_RE2 cmax_RE2 and_RE2 auc_RE2 -LRB-_RE2 -RRB-_RE2 value_RE2 for_RE2 mpa_RE2 be_RE2 NUM_RE2 and_RE2 NUM_RE2 low_RE2 respective_RE2 than_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 alone_RE2 under_RE2 fast_RE2 condition_RE2 
Mycophenolic acid|N|antacid|magnesium|BIOENTITY :_BE12 absorption_BE12 of_BE12 single_BE12 dose_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 decrease_BE12 when_BE12 administer_BE12 to_BE12 NUM_BE12 stable_BE12 renal_BE12 transplant_BE12 patient_BE12 also_BE12 take_BE12 BIOENTITY contain_RE2 BIOGENERAL_RE2 -LRB-_RE2 NUM_RE2 ml_RE2 -RRB-_RE2 :_RE2 the_RE2 mean_RE2 cmax_RE2 and_RE2 auc_RE2 -LRB-_RE2 -RRB-_RE2 value_RE2 for_RE2 mpa_RE2 be_RE2 NUM_RE2 and_RE2 NUM_RE2 low_RE2 respective_RE2 than_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 alone_RE2 under_RE2 fast_RE2 condition_RE2 
Mycophenolic acid|N|antacid|myfortic|BIOENTITY :_BE12 absorption_BE12 of_BE12 single_BE12 dose_BE12 of_BE12 BIOENTITY be_RE2 decrease_RE2 when_RE2 administer_RE2 to_RE2 NUM_RE2 stable_RE2 renal_RE2 transplant_RE2 patient_RE2 also_RE2 take_RE2 BIOGENERAL_RE2 contain_RE2 BIOGENERAL_RE2 -LRB-_RE2 NUM_RE2 ml_RE2 -RRB-_RE2 :_RE2 the_RE2 mean_RE2 cmax_RE2 and_RE2 auc_RE2 -LRB-_RE2 -RRB-_RE2 value_RE2 for_RE2 mpa_RE2 be_RE2 NUM_RE2 and_RE2 NUM_RE2 low_RE2 respective_RE2 than_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 alone_RE2 under_RE2 fast_RE2 condition_RE2 
Mycophenolic acid|N|antacid|myfortic|BIOENTITY :_BE12 absorption_BE12 of_BE12 single_BE12 dose_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 decrease_BE12 when_BE12 administer_BE12 to_BE12 NUM_BE12 stable_BE12 renal_BE12 transplant_BE12 patient_BE12 also_BE12 take_BE12 BIOGENERAL_BE12 contain_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 ml_BE12 -RRB-_BE12 :_BE12 the_BE12 mean_BE12 cmax_BE12 and_BE12 auc_BE12 -LRB-_BE12 -RRB-_BE12 value_BE12 for_BE12 mpa_BE12 be_BE12 NUM_BE12 and_BE12 NUM_BE12 low_BE12 respective_BE12 than_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 alone_RE2 under_RE2 fast_RE2 condition_RE2 
Mycophenolic acid|N|magnesium|antacid|BIOGENERAL_LE1 :_LE1 absorption_LE1 of_LE1 single_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 when_LE1 administer_LE1 to_LE1 NUM_LE1 stable_LE1 renal_LE1 transplant_LE1 patient_LE1 also_LE1 take_LE1 BIOENTITY contain_BE12 BIOENTITY -LRB-_RE2 NUM_RE2 ml_RE2 -RRB-_RE2 :_RE2 the_RE2 mean_RE2 cmax_RE2 and_RE2 auc_RE2 -LRB-_RE2 -RRB-_RE2 value_RE2 for_RE2 mpa_RE2 be_RE2 NUM_RE2 and_RE2 NUM_RE2 low_RE2 respective_RE2 than_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 alone_RE2 under_RE2 fast_RE2 condition_RE2 
Mycophenolic acid|N|magnesium|antacid|BIOGENERAL_LE1 :_LE1 absorption_LE1 of_LE1 single_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 when_LE1 administer_LE1 to_LE1 NUM_LE1 stable_LE1 renal_LE1 transplant_LE1 patient_LE1 also_LE1 take_LE1 BIOENTITY contain_BE12 BIOENTITY -LRB-_RE2 NUM_RE2 ml_RE2 -RRB-_RE2 :_RE2 the_RE2 mean_RE2 cmax_RE2 and_RE2 auc_RE2 -LRB-_RE2 -RRB-_RE2 value_RE2 for_RE2 mpa_RE2 be_RE2 NUM_RE2 and_RE2 NUM_RE2 low_RE2 respective_RE2 than_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 alone_RE2 under_RE2 fast_RE2 condition_RE2 
Mycophenolic acid|N|myfortic|antacid|BIOGENERAL_LE1 :_LE1 absorption_LE1 of_LE1 single_LE1 dose_LE1 of_LE1 BIOENTITY be_BE12 decrease_BE12 when_BE12 administer_BE12 to_BE12 NUM_BE12 stable_BE12 renal_BE12 transplant_BE12 patient_BE12 also_BE12 take_BE12 BIOGENERAL_BE12 contain_BE12 BIOENTITY -LRB-_RE2 NUM_RE2 ml_RE2 -RRB-_RE2 :_RE2 the_RE2 mean_RE2 cmax_RE2 and_RE2 auc_RE2 -LRB-_RE2 -RRB-_RE2 value_RE2 for_RE2 mpa_RE2 be_RE2 NUM_RE2 and_RE2 NUM_RE2 low_RE2 respective_RE2 than_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 alone_RE2 under_RE2 fast_RE2 condition_RE2 
Mycophenolic acid|N|myfortic|antacid|BIOGENERAL_LE1 :_LE1 absorption_LE1 of_LE1 single_LE1 dose_LE1 of_LE1 BIOENTITY be_BE12 decrease_BE12 when_BE12 administer_BE12 to_BE12 NUM_BE12 stable_BE12 renal_BE12 transplant_BE12 patient_BE12 also_BE12 take_BE12 BIOGENERAL_BE12 contain_BE12 BIOENTITY -LRB-_RE2 NUM_RE2 ml_RE2 -RRB-_RE2 :_RE2 the_RE2 mean_RE2 cmax_RE2 and_RE2 auc_RE2 -LRB-_RE2 -RRB-_RE2 value_RE2 for_RE2 mpa_RE2 be_RE2 NUM_RE2 and_RE2 NUM_RE2 low_RE2 respective_RE2 than_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 alone_RE2 under_RE2 fast_RE2 condition_RE2 
Mycophenolic acid|N|antacid|myfortic|BIOGENERAL_LE1 :_LE1 absorption_LE1 of_LE1 single_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 when_LE1 administer_LE1 to_LE1 NUM_LE1 stable_LE1 renal_LE1 transplant_LE1 patient_LE1 also_LE1 take_LE1 BIOGENERAL_LE1 contain_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 ml_BE12 -RRB-_BE12 :_BE12 the_BE12 mean_BE12 cmax_BE12 and_BE12 auc_BE12 -LRB-_BE12 -RRB-_BE12 value_BE12 for_BE12 mpa_BE12 be_BE12 NUM_BE12 and_BE12 NUM_BE12 low_BE12 respective_BE12 than_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 alone_RE2 under_RE2 fast_RE2 condition_RE2 
Mycophenolic acid|N|antacid|myfortic|BIOGENERAL_LE1 :_LE1 absorption_LE1 of_LE1 single_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 when_LE1 administer_LE1 to_LE1 NUM_LE1 stable_LE1 renal_LE1 transplant_LE1 patient_LE1 also_LE1 take_LE1 BIOGENERAL_LE1 contain_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 ml_BE12 -RRB-_BE12 :_BE12 the_BE12 mean_BE12 cmax_BE12 and_BE12 auc_BE12 -LRB-_BE12 -RRB-_BE12 value_BE12 for_BE12 mpa_BE12 be_BE12 NUM_BE12 and_BE12 NUM_BE12 low_BE12 respective_BE12 than_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 alone_RE2 under_RE2 fast_RE2 condition_RE2 
Mycophenolic acid|N|magnesium|aluminum|BIOGENERAL_LE1 :_LE1 absorption_LE1 of_LE1 single_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 when_LE1 administer_LE1 to_LE1 NUM_LE1 stable_LE1 renal_LE1 transplant_LE1 patient_LE1 also_LE1 take_LE1 BIOENTITY contain_RE2 BIOGENERAL_RE2 -LRB-_RE2 NUM_RE2 ml_RE2 -RRB-_RE2 :_RE2 the_RE2 mean_RE2 cmax_RE2 and_RE2 auc_RE2 -LRB-_RE2 -RRB-_RE2 value_RE2 for_RE2 mpa_RE2 be_RE2 NUM_RE2 and_RE2 NUM_RE2 low_RE2 respective_RE2 than_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 alone_RE2 under_RE2 fast_RE2 condition_RE2 
Mycophenolic acid|N|magnesium|myfortic|BIOGENERAL_LE1 :_LE1 absorption_LE1 of_LE1 single_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 when_LE1 administer_LE1 to_LE1 NUM_LE1 stable_LE1 renal_LE1 transplant_LE1 patient_LE1 also_LE1 take_LE1 BIOENTITY contain_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 ml_BE12 -RRB-_BE12 :_BE12 the_BE12 mean_BE12 cmax_BE12 and_BE12 auc_BE12 -LRB-_BE12 -RRB-_BE12 value_BE12 for_BE12 mpa_BE12 be_BE12 NUM_BE12 and_BE12 NUM_BE12 low_BE12 respective_BE12 than_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 alone_RE2 under_RE2 fast_RE2 condition_RE2 
Mycophenolic acid|N|magnesium|myfortic|BIOGENERAL_LE1 :_LE1 absorption_LE1 of_LE1 single_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 when_LE1 administer_LE1 to_LE1 NUM_LE1 stable_LE1 renal_LE1 transplant_LE1 patient_LE1 also_LE1 take_LE1 BIOENTITY contain_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 ml_BE12 -RRB-_BE12 :_BE12 the_BE12 mean_BE12 cmax_BE12 and_BE12 auc_BE12 -LRB-_BE12 -RRB-_BE12 value_BE12 for_BE12 mpa_BE12 be_BE12 NUM_BE12 and_BE12 NUM_BE12 low_BE12 respective_BE12 than_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 alone_RE2 under_RE2 fast_RE2 condition_RE2 
Mycophenolic acid|N|myfortic|myfortic|BIOGENERAL_LE1 :_LE1 absorption_LE1 of_LE1 single_LE1 dose_LE1 of_LE1 BIOENTITY be_BE12 decrease_BE12 when_BE12 administer_BE12 to_BE12 NUM_BE12 stable_BE12 renal_BE12 transplant_BE12 patient_BE12 also_BE12 take_BE12 BIOGENERAL_BE12 contain_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 ml_BE12 -RRB-_BE12 :_BE12 the_BE12 mean_BE12 cmax_BE12 and_BE12 auc_BE12 -LRB-_BE12 -RRB-_BE12 value_BE12 for_BE12 mpa_BE12 be_BE12 NUM_BE12 and_BE12 NUM_BE12 low_BE12 respective_BE12 than_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 alone_RE2 under_RE2 fast_RE2 condition_RE2 
Mycophenolic acid|N|cyclosporine|myfortic|BIOENTITY :_BE12 when_BE12 study_BE12 in_BE12 stable_BE12 renal_BE12 transplant_BE12 patient_BE12 BIOGENERAL_BE12 usp_BE12 -LRB-_BE12 modified_BE12 -RRB-_BE12 pharmacokinetic_BE12 be_BE12 unaffect_BE12 by_BE12 steady_BE12 state_BE12 dosing_BE12 of_BE12 BIOENTITY 
Mycophenolic acid|N|cyclosporine|cyclosporine|BIOENTITY :_BE12 when_BE12 study_BE12 in_BE12 stable_BE12 renal_BE12 transplant_BE12 patient_BE12 BIOENTITY usp_RE2 -LRB-_RE2 modified_RE2 -RRB-_RE2 pharmacokinetic_RE2 be_RE2 unaffect_RE2 by_RE2 steady_RE2 state_RE2 dosing_RE2 of_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|cyclosporine|myfortic|BIOGENERAL_LE1 :_LE1 when_LE1 study_LE1 in_LE1 stable_LE1 renal_LE1 transplant_LE1 patient_LE1 BIOENTITY usp_BE12 -LRB-_BE12 modified_BE12 -RRB-_BE12 pharmacokinetic_BE12 be_BE12 unaffect_BE12 by_BE12 steady_BE12 state_BE12 dosing_BE12 of_BE12 BIOENTITY 
Mycophenolic acid|N|ganciclovir|myfortic|BIOENTITY :_BE12 may_BE12 be_BE12 take_BE12 with_BE12 BIOENTITY 
Mycophenolic acid|N|ganciclovir|myfortic|BIOENTITY :_BE12 may_BE12 be_BE12 take_BE12 with_BE12 BIOENTITY 
Mycophenolic acid|N|acyclovir|ganciclovir|BIOENTITY :_RE2 may_RE2 be_RE2 take_RE2 with_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|acyclovir|ganciclovir|both_LE1 BIOENTITY and_RE2 BIOGENERAL_RE2 concentration_RE2 be_RE2 increase_RE2 in_RE2 the_RE2 presence_RE2 of_RE2 renal_RE2 impairment_RE2 their_RE2 coexistence_RE2 may_RE2 compete_RE2 for_RE2 tubular_RE2 secretion_RE2 and_RE2 further_RE2 increase_RE2 in_RE2 the_RE2 concentration_RE2 of_RE2 the_RE2 two_RE2 
Mycophenolic acid|N|acyclovir|mpag|both_LE1 BIOENTITY and_BE12 BIOENTITY concentration_RE2 be_RE2 increase_RE2 in_RE2 the_RE2 presence_RE2 of_RE2 renal_RE2 impairment_RE2 their_RE2 coexistence_RE2 may_RE2 compete_RE2 for_RE2 tubular_RE2 secretion_RE2 and_RE2 further_RE2 increase_RE2 in_RE2 the_RE2 concentration_RE2 of_RE2 the_RE2 two_RE2 
Mycophenolic acid|N|acyclovir|mpag|both_LE1 BIOENTITY and_BE12 BIOENTITY concentration_RE2 be_RE2 increase_RE2 in_RE2 the_RE2 presence_RE2 of_RE2 renal_RE2 impairment_RE2 their_RE2 coexistence_RE2 may_RE2 compete_RE2 for_RE2 tubular_RE2 secretion_RE2 and_RE2 further_RE2 increase_RE2 in_RE2 the_RE2 concentration_RE2 of_RE2 the_RE2 two_RE2 
Mycophenolic acid|N|azathioprine|mycophenolate mofetil|BIOGENERAL_LE1 BIOGENERAL_LE1 :_LE1 given_LE1 that_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 inhibit_LE1 purine_LE1 metabolism_LE1 it_LE1 be_LE1 recommend_LE1 that_LE1 BIOGENERAL_LE1 not_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 BIOENTITY or_BE12 BIOENTITY 
Mycophenolic acid|N|mycophenolate mofetil|mycophenolate mofetil|BIOGENERAL_LE1 BIOGENERAL_LE1 :_LE1 given_LE1 that_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY inhibit_BE12 purine_BE12 metabolism_BE12 it_BE12 be_BE12 recommend_BE12 that_BE12 BIOGENERAL_BE12 not_BE12 be_BE12 administer_BE12 concomitant_BE12 with_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Mycophenolic acid|N|azathioprine|mycophenolate mofetil|BIOGENERAL_LE1 BIOGENERAL_LE1 :_LE1 given_LE1 that_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 inhibit_BE12 purine_BE12 metabolism_BE12 it_BE12 be_BE12 recommend_BE12 that_BE12 BIOGENERAL_BE12 not_BE12 be_BE12 administer_BE12 concomitant_BE12 with_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Mycophenolic acid|N|mycophenolate mofetil|mycophenolate mofetil|BIOGENERAL_LE1 BIOENTITY :_BE12 given_BE12 that_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 inhibit_BE12 purine_BE12 metabolism_BE12 it_BE12 be_BE12 recommend_BE12 that_BE12 BIOGENERAL_BE12 not_BE12 be_BE12 administer_BE12 concomitant_BE12 with_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Mycophenolic acid|N|azathioprine|mycophenolate mofetil|BIOENTITY BIOGENERAL_BE12 :_BE12 given_BE12 that_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 inhibit_BE12 purine_BE12 metabolism_BE12 it_BE12 be_BE12 recommend_BE12 that_BE12 BIOGENERAL_BE12 not_BE12 be_BE12 administer_BE12 concomitant_BE12 with_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Mycophenolic acid|N|mycophenolate mofetil|azathioprine|BIOGENERAL_LE1 BIOGENERAL_LE1 :_LE1 given_LE1 that_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY inhibit_BE12 purine_BE12 metabolism_BE12 it_BE12 be_BE12 recommend_BE12 that_BE12 BIOGENERAL_BE12 not_BE12 be_BE12 administer_BE12 concomitant_BE12 with_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|azathioprine|azathioprine|BIOGENERAL_LE1 BIOGENERAL_LE1 :_LE1 given_LE1 that_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 inhibit_BE12 purine_BE12 metabolism_BE12 it_BE12 be_BE12 recommend_BE12 that_BE12 BIOGENERAL_BE12 not_BE12 be_BE12 administer_BE12 concomitant_BE12 with_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|mycophenolate mofetil|azathioprine|BIOGENERAL_LE1 BIOENTITY :_BE12 given_BE12 that_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 inhibit_BE12 purine_BE12 metabolism_BE12 it_BE12 be_BE12 recommend_BE12 that_BE12 BIOGENERAL_BE12 not_BE12 be_BE12 administer_BE12 concomitant_BE12 with_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|azathioprine|azathioprine|BIOENTITY BIOGENERAL_BE12 :_BE12 given_BE12 that_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 inhibit_BE12 purine_BE12 metabolism_BE12 it_BE12 be_BE12 recommend_BE12 that_BE12 BIOGENERAL_BE12 not_BE12 be_BE12 administer_BE12 concomitant_BE12 with_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|mycophenolate mofetil|myfortic|BIOGENERAL_LE1 BIOGENERAL_LE1 :_LE1 given_LE1 that_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY inhibit_BE12 purine_BE12 metabolism_BE12 it_BE12 be_BE12 recommend_BE12 that_BE12 BIOENTITY not_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|azathioprine|myfortic|BIOGENERAL_LE1 BIOGENERAL_LE1 :_LE1 given_LE1 that_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 inhibit_BE12 purine_BE12 metabolism_BE12 it_BE12 be_BE12 recommend_BE12 that_BE12 BIOENTITY not_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|mycophenolate mofetil|myfortic|BIOGENERAL_LE1 BIOENTITY :_BE12 given_BE12 that_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 inhibit_BE12 purine_BE12 metabolism_BE12 it_BE12 be_BE12 recommend_BE12 that_BE12 BIOENTITY not_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|azathioprine|myfortic|BIOENTITY BIOGENERAL_BE12 :_BE12 given_BE12 that_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 inhibit_BE12 purine_BE12 metabolism_BE12 it_BE12 be_BE12 recommend_BE12 that_BE12 BIOENTITY not_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|azathioprine|mycophenolate mofetil|BIOGENERAL_LE1 BIOGENERAL_LE1 :_LE1 given_LE1 that_LE1 BIOENTITY and_BE12 BIOENTITY inhibit_RE2 purine_RE2 metabolism_RE2 it_RE2 be_RE2 recommend_RE2 that_RE2 BIOGENERAL_RE2 not_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|mycophenolate mofetil|mycophenolate mofetil|BIOGENERAL_LE1 BIOENTITY :_BE12 given_BE12 that_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY inhibit_RE2 purine_RE2 metabolism_RE2 it_RE2 be_RE2 recommend_RE2 that_RE2 BIOGENERAL_RE2 not_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|azathioprine|mycophenolate mofetil|BIOENTITY BIOGENERAL_BE12 :_BE12 given_BE12 that_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY inhibit_RE2 purine_RE2 metabolism_RE2 it_RE2 be_RE2 recommend_RE2 that_RE2 BIOGENERAL_RE2 not_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|mycophenolate mofetil|azathioprine|BIOGENERAL_LE1 BIOENTITY :_BE12 given_BE12 that_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 inhibit_RE2 purine_RE2 metabolism_RE2 it_RE2 be_RE2 recommend_RE2 that_RE2 BIOGENERAL_RE2 not_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|azathioprine|azathioprine|BIOENTITY BIOGENERAL_BE12 :_BE12 given_BE12 that_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 inhibit_RE2 purine_RE2 metabolism_RE2 it_RE2 be_RE2 recommend_RE2 that_RE2 BIOGENERAL_RE2 not_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|azathioprine|mycophenolate mofetil|BIOENTITY BIOENTITY :_RE2 given_RE2 that_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 inhibit_RE2 purine_RE2 metabolism_RE2 it_RE2 be_RE2 recommend_RE2 that_RE2 BIOGENERAL_RE2 not_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|cholestyramine|mpa|BIOENTITY and_BE12 drug_BE12 that_BE12 bind_BE12 bile_BE12 acid_BE12 :_BE12 these_BE12 drug_BE12 interrupt_BE12 enterohepatic_BE12 recirculation_BE12 and_BE12 reduce_BE12 BIOENTITY exposure_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|mpa|mycophenolate mofetil|BIOGENERAL_LE1 and_LE1 drug_LE1 that_LE1 bind_LE1 bile_LE1 acid_LE1 :_LE1 these_LE1 drug_LE1 interrupt_LE1 enterohepatic_LE1 recirculation_LE1 and_LE1 reduce_LE1 BIOENTITY exposure_BE12 when_BE12 coadminister_BE12 with_BE12 BIOENTITY 
Mycophenolic acid|N|cholestyramine|mycophenolate mofetil|BIOENTITY and_BE12 drug_BE12 that_BE12 bind_BE12 bile_BE12 acid_BE12 :_BE12 these_BE12 drug_BE12 interrupt_BE12 enterohepatic_BE12 recirculation_BE12 and_BE12 reduce_BE12 BIOGENERAL_BE12 exposure_BE12 when_BE12 coadminister_BE12 with_BE12 BIOENTITY 
Mycophenolic acid|N|myfortic|myfortic|therefore_LE1 do_LE1 not_LE1 administer_LE1 BIOENTITY with_BE12 BIOGENERAL_BE12 or_BE12 other_BE12 agent_BE12 that_BE12 may_BE12 interfere_BE12 with_BE12 enterohepatic_BE12 recirculation_BE12 or_BE12 drug_BE12 that_BE12 may_BE12 bind_BE12 bile_BE12 acid_BE12 for_BE12 example_BE12 bile_BE12 acid_BE12 sequestrate_BE12 or_BE12 oral_BE12 BIOGENERAL_BE12 because_BE12 of_BE12 the_BE12 potential_BE12 to_BE12 reduce_BE12 the_BE12 efficacy_BE12 of_BE12 BIOENTITY 
Mycophenolic acid|N|myfortic|myfortic|therefore_LE1 do_LE1 not_LE1 administer_LE1 BIOENTITY with_BE12 BIOGENERAL_BE12 or_BE12 other_BE12 agent_BE12 that_BE12 may_BE12 interfere_BE12 with_BE12 enterohepatic_BE12 recirculation_BE12 or_BE12 drug_BE12 that_BE12 may_BE12 bind_BE12 bile_BE12 acid_BE12 for_BE12 example_BE12 bile_BE12 acid_BE12 sequestrate_BE12 or_BE12 oral_BE12 BIOGENERAL_BE12 because_BE12 of_BE12 the_BE12 potential_BE12 to_BE12 reduce_BE12 the_BE12 efficacy_BE12 of_BE12 BIOENTITY 
Mycophenolic acid|N|cholestyramine|myfortic|therefore_LE1 do_LE1 not_LE1 administer_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY or_BE12 other_BE12 agent_BE12 that_BE12 may_BE12 interfere_BE12 with_BE12 enterohepatic_BE12 recirculation_BE12 or_BE12 drug_BE12 that_BE12 may_BE12 bind_BE12 bile_BE12 acid_BE12 for_BE12 example_BE12 bile_BE12 acid_BE12 sequestrate_BE12 or_BE12 oral_BE12 BIOGENERAL_BE12 because_BE12 of_BE12 the_BE12 potential_BE12 to_BE12 reduce_BE12 the_BE12 efficacy_BE12 of_BE12 BIOENTITY 
Mycophenolic acid|N|cholestyramine|myfortic|therefore_LE1 do_LE1 not_LE1 administer_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY or_BE12 other_BE12 agent_BE12 that_BE12 may_BE12 interfere_BE12 with_BE12 enterohepatic_BE12 recirculation_BE12 or_BE12 drug_BE12 that_BE12 may_BE12 bind_BE12 bile_BE12 acid_BE12 for_BE12 example_BE12 bile_BE12 acid_BE12 sequestrate_BE12 or_BE12 oral_BE12 BIOGENERAL_BE12 because_BE12 of_BE12 the_BE12 potential_BE12 to_BE12 reduce_BE12 the_BE12 efficacy_BE12 of_BE12 BIOENTITY 
Mycophenolic acid|N|activated charcoal|myfortic|therefore_LE1 do_LE1 not_LE1 administer_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 agent_LE1 that_LE1 may_LE1 interfere_LE1 with_LE1 enterohepatic_LE1 recirculation_LE1 or_LE1 drug_LE1 that_LE1 may_LE1 bind_LE1 bile_LE1 acid_LE1 for_LE1 example_LE1 bile_LE1 acid_LE1 sequestrate_LE1 or_LE1 oral_LE1 BIOENTITY because_BE12 of_BE12 the_BE12 potential_BE12 to_BE12 reduce_BE12 the_BE12 efficacy_BE12 of_BE12 BIOENTITY 
Mycophenolic acid|N|cholestyramine|activated charcoal|therefore_LE1 do_LE1 not_LE1 administer_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY or_BE12 other_BE12 agent_BE12 that_BE12 may_BE12 interfere_BE12 with_BE12 enterohepatic_BE12 recirculation_BE12 or_BE12 drug_BE12 that_BE12 may_BE12 bind_BE12 bile_BE12 acid_BE12 for_BE12 example_BE12 bile_BE12 acid_BE12 sequestrate_BE12 or_BE12 oral_BE12 BIOENTITY because_RE2 of_RE2 the_RE2 potential_RE2 to_RE2 reduce_RE2 the_RE2 efficacy_RE2 of_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|cholestyramine|activated charcoal|therefore_LE1 do_LE1 not_LE1 administer_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY or_BE12 other_BE12 agent_BE12 that_BE12 may_BE12 interfere_BE12 with_BE12 enterohepatic_BE12 recirculation_BE12 or_BE12 drug_BE12 that_BE12 may_BE12 bind_BE12 bile_BE12 acid_BE12 for_BE12 example_BE12 bile_BE12 acid_BE12 sequestrate_BE12 or_BE12 oral_BE12 BIOENTITY because_RE2 of_RE2 the_RE2 potential_RE2 to_RE2 reduce_RE2 the_RE2 efficacy_RE2 of_RE2 BIOGENERAL_RE2 
Mycophenolic acid|N|contraceptive|myfortic|oral_LE1 BIOENTITY :_BE12 given_BE12 the_BE12 different_BE12 metabolism_BE12 of_BE12 BIOENTITY and_RE2 oral_RE2 BIOGENERAL_RE2 no_RE2 drug_RE2 interaction_RE2 between_RE2 these_RE2 two_RE2 class_RE2 of_RE2 drug_RE2 be_RE2 expect_RE2 
Mycophenolic acid|N|contraceptive|contraceptive|oral_LE1 BIOENTITY :_BE12 given_BE12 the_BE12 different_BE12 metabolism_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 oral_BE12 BIOENTITY no_RE2 drug_RE2 interaction_RE2 between_RE2 these_RE2 two_RE2 class_RE2 of_RE2 drug_RE2 be_RE2 expect_RE2 
Mycophenolic acid|N|myfortic|contraceptive|oral_LE1 BIOGENERAL_LE1 :_LE1 given_LE1 the_LE1 different_LE1 metabolism_LE1 of_LE1 BIOENTITY and_BE12 oral_BE12 BIOENTITY no_RE2 drug_RE2 interaction_RE2 between_RE2 these_RE2 two_RE2 class_RE2 of_RE2 drug_RE2 be_RE2 expect_RE2 
Mycophenolic acid|N|live vaccine|live attenuated vaccine|BIOENTITY :_BE12 During_BE12 treatment_BE12 with_BE12 BIOGENERAL_BE12 the_BE12 use_BE12 of_BE12 BIOENTITY shall_RE2 be_RE2 avoid_RE2 and_RE2 patient_RE2 shall_RE2 be_RE2 advise_RE2 that_RE2 vaccinations_RE2 may_RE2 be_RE2 little_RE2 effective_RE2 
Mycophenolic acid|N|live vaccine|myfortic|BIOENTITY :_BE12 During_BE12 treatment_BE12 with_BE12 BIOENTITY the_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 and_RE2 patient_RE2 shall_RE2 be_RE2 advise_RE2 that_RE2 vaccinations_RE2 may_RE2 be_RE2 little_RE2 effective_RE2 
Mycophenolic acid|N|mpag|mpa|interference_LE1 of_LE1 BIOENTITY hydrolysis_BE12 may_BE12 lead_BE12 to_BE12 little_BE12 BIOENTITY available_RE2 for_RE2 absorption_RE2 
Ondansetron|N|ondansetron|ondansetron|because_LE1 BIOENTITY be_BE12 metabolize_BE12 by_BE12 hepatic_BE12 cytochrome_BE12 drugmetabolizing_BE12 enzyme_BE12 -LRB-_BE12 cypa_BE12 cypd_BE12 cypa_BE12 -RRB-_BE12 inducer_BE12 or_BE12 inhibitor_BE12 of_BE12 these_BE12 enzyme_BE12 may_BE12 change_BE12 the_BE12 clearance_BE12 and_BE12 hence_BE12 the_BE12 halflife_BE12 of_BE12 BIOENTITY 
Ondansetron|N|carbamazepine|rifampicin|BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY :_RE2 In_RE2 patient_RE2 treat_RE2 with_RE2 potent_RE2 inducer_RE2 of_RE2 cypa_RE2 -LRB-_RE2 i.e._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|phenytoin|rifampicin|BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY :_RE2 In_RE2 patient_RE2 treat_RE2 with_RE2 potent_RE2 inducer_RE2 of_RE2 cypa_RE2 -LRB-_RE2 i.e._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|rifampicin|ondansetron|BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY :_BE12 In_BE12 patient_BE12 treat_BE12 with_BE12 potent_BE12 inducer_BE12 of_BE12 cypa_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 the_BE12 clearance_BE12 of_BE12 BIOENTITY be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|rifampicin|rifampicin|BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY :_BE12 In_BE12 patient_BE12 treat_BE12 with_BE12 potent_BE12 inducer_BE12 of_BE12 cypa_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|rifampicin|carbamazepine|BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY :_BE12 In_BE12 patient_BE12 treat_BE12 with_BE12 potent_BE12 inducer_BE12 of_BE12 cypa_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|rifampicin|phenytoin|BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY :_BE12 In_BE12 patient_BE12 treat_BE12 with_BE12 potent_BE12 inducer_BE12 of_BE12 cypa_BE12 -LRB-_BE12 i.e._BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|rifampicin|ondansetron|BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY :_BE12 In_BE12 patient_BE12 treat_BE12 with_BE12 potent_BE12 inducer_BE12 of_BE12 cypa_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 the_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 significant_BE12 increase_BE12 and_BE12 BIOENTITY blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|phenytoin|carbamazepine|BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 :_RE2 In_RE2 patient_RE2 treat_RE2 with_RE2 potent_RE2 inducer_RE2 of_RE2 cypa_RE2 -LRB-_RE2 i.e._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|carbamazepine|ondansetron|BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 :_BE12 In_BE12 patient_BE12 treat_BE12 with_BE12 potent_BE12 inducer_BE12 of_BE12 cypa_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 the_BE12 clearance_BE12 of_BE12 BIOENTITY be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|carbamazepine|rifampicin|BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 :_BE12 In_BE12 patient_BE12 treat_BE12 with_BE12 potent_BE12 inducer_BE12 of_BE12 cypa_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|carbamazepine|carbamazepine|BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 :_BE12 In_BE12 patient_BE12 treat_BE12 with_BE12 potent_BE12 inducer_BE12 of_BE12 cypa_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|carbamazepine|phenytoin|BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 :_BE12 In_BE12 patient_BE12 treat_BE12 with_BE12 potent_BE12 inducer_BE12 of_BE12 cypa_BE12 -LRB-_BE12 i.e._BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|carbamazepine|ondansetron|BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 :_BE12 In_BE12 patient_BE12 treat_BE12 with_BE12 potent_BE12 inducer_BE12 of_BE12 cypa_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 the_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 significant_BE12 increase_BE12 and_BE12 BIOENTITY blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|phenytoin|ondansetron|BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 :_BE12 In_BE12 patient_BE12 treat_BE12 with_BE12 potent_BE12 inducer_BE12 of_BE12 cypa_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 the_BE12 clearance_BE12 of_BE12 BIOENTITY be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|phenytoin|rifampicin|BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 :_BE12 In_BE12 patient_BE12 treat_BE12 with_BE12 potent_BE12 inducer_BE12 of_BE12 cypa_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|phenytoin|carbamazepine|BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 :_BE12 In_BE12 patient_BE12 treat_BE12 with_BE12 potent_BE12 inducer_BE12 of_BE12 cypa_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|phenytoin|phenytoin|BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 :_BE12 In_BE12 patient_BE12 treat_BE12 with_BE12 potent_BE12 inducer_BE12 of_BE12 cypa_BE12 -LRB-_BE12 i.e._BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|phenytoin|ondansetron|BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 :_BE12 In_BE12 patient_BE12 treat_BE12 with_BE12 potent_BE12 inducer_BE12 of_BE12 cypa_BE12 -LRB-_BE12 i.e._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 the_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 significant_BE12 increase_BE12 and_BE12 BIOENTITY blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|ondansetron|ondansetron|BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 :_LE1 In_LE1 patient_LE1 treat_LE1 with_LE1 potent_LE1 inducer_LE1 of_LE1 cypa_LE1 -LRB-_LE1 i.e._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 the_LE1 clearance_LE1 of_LE1 BIOENTITY be_BE12 significant_BE12 increase_BE12 and_BE12 BIOENTITY blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|carbamazepine|rifampicin|BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 :_LE1 In_LE1 patient_LE1 treat_LE1 with_LE1 potent_LE1 inducer_LE1 of_LE1 cypa_LE1 -LRB-_LE1 i.e._LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|carbamazepine|rifampicin|BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 :_LE1 In_LE1 patient_LE1 treat_LE1 with_LE1 potent_LE1 inducer_LE1 of_LE1 cypa_LE1 -LRB-_LE1 i.e._LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|phenytoin|rifampicin|BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 :_LE1 In_LE1 patient_LE1 treat_LE1 with_LE1 potent_LE1 inducer_LE1 of_LE1 cypa_LE1 -LRB-_LE1 i.e._LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|phenytoin|carbamazepine|BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 :_LE1 In_LE1 patient_LE1 treat_LE1 with_LE1 potent_LE1 inducer_LE1 of_LE1 cypa_LE1 -LRB-_LE1 i.e._LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 significant_RE2 increase_RE2 and_RE2 BIOGENERAL_RE2 blood_RE2 concentration_RE2 be_RE2 decrease_RE2 
Ondansetron|N|ondansetron|tramadol|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOENTITY be_BE12 recommend_BE12 for_BE12 patient_BE12 on_BE12 these_BE12 drugs.,_BE12 BIOENTITY :_RE2 although_RE2 no_RE2 pharmacokinetic_RE2 drug_RE2 interaction_RE2 between_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 datum_RE2 from_RE2 NUM_RE2 small_RE2 study_RE2 indicate_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 be_RE2 associate_RE2 with_RE2 increase_RE2 in_RE2 patient_RE2 controlled_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 chemotherapy_RE2 :_RE2 tumor_RE2 response_RE2 to_RE2 chemotherapy_RE2 in_RE2 the_RE2 NUM_RE2 mouse_RE2 leukemia_RE2 model_RE2 be_RE2 not_RE2 affect_RE2 by_RE2 BIOGENERAL_RE2 
Ondansetron|N|ondansetron|ondansetron|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOENTITY be_BE12 recommend_BE12 for_BE12 patient_BE12 on_BE12 these_BE12 drugs.,_BE12 BIOGENERAL_BE12 :_BE12 although_BE12 no_BE12 pharmacokinetic_BE12 drug_BE12 interaction_BE12 between_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 datum_RE2 from_RE2 NUM_RE2 small_RE2 study_RE2 indicate_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 be_RE2 associate_RE2 with_RE2 increase_RE2 in_RE2 patient_RE2 controlled_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 chemotherapy_RE2 :_RE2 tumor_RE2 response_RE2 to_RE2 chemotherapy_RE2 in_RE2 the_RE2 NUM_RE2 mouse_RE2 leukemia_RE2 model_RE2 be_RE2 not_RE2 affect_RE2 by_RE2 BIOGENERAL_RE2 
Ondansetron|N|ondansetron|tramadol|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOENTITY be_BE12 recommend_BE12 for_BE12 patient_BE12 on_BE12 these_BE12 drugs.,_BE12 BIOGENERAL_BE12 :_BE12 although_BE12 no_BE12 pharmacokinetic_BE12 drug_BE12 interaction_BE12 between_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY have_RE2 be_RE2 observe_RE2 datum_RE2 from_RE2 NUM_RE2 small_RE2 study_RE2 indicate_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 be_RE2 associate_RE2 with_RE2 increase_RE2 in_RE2 patient_RE2 controlled_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 chemotherapy_RE2 :_RE2 tumor_RE2 response_RE2 to_RE2 chemotherapy_RE2 in_RE2 the_RE2 NUM_RE2 mouse_RE2 leukemia_RE2 model_RE2 be_RE2 not_RE2 affect_RE2 by_RE2 BIOGENERAL_RE2 
Ondansetron|N|ondansetron|ondansetron|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOENTITY be_BE12 recommend_BE12 for_BE12 patient_BE12 on_BE12 these_BE12 drugs.,_BE12 BIOGENERAL_BE12 :_BE12 although_BE12 no_BE12 pharmacokinetic_BE12 drug_BE12 interaction_BE12 between_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 observe_BE12 datum_BE12 from_BE12 NUM_BE12 small_BE12 study_BE12 indicate_BE12 that_BE12 BIOENTITY may_RE2 be_RE2 associate_RE2 with_RE2 increase_RE2 in_RE2 patient_RE2 controlled_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 chemotherapy_RE2 :_RE2 tumor_RE2 response_RE2 to_RE2 chemotherapy_RE2 in_RE2 the_RE2 NUM_RE2 mouse_RE2 leukemia_RE2 model_RE2 be_RE2 not_RE2 affect_RE2 by_RE2 BIOGENERAL_RE2 
Ondansetron|N|ondansetron|tramadol|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOENTITY be_BE12 recommend_BE12 for_BE12 patient_BE12 on_BE12 these_BE12 drugs.,_BE12 BIOGENERAL_BE12 :_BE12 although_BE12 no_BE12 pharmacokinetic_BE12 drug_BE12 interaction_BE12 between_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 observe_BE12 datum_BE12 from_BE12 NUM_BE12 small_BE12 study_BE12 indicate_BE12 that_BE12 BIOGENERAL_BE12 may_BE12 be_BE12 associate_BE12 with_BE12 increase_BE12 in_BE12 patient_BE12 controlled_BE12 administration_BE12 of_BE12 BIOENTITY chemotherapy_RE2 :_RE2 tumor_RE2 response_RE2 to_RE2 chemotherapy_RE2 in_RE2 the_RE2 NUM_RE2 mouse_RE2 leukemia_RE2 model_RE2 be_RE2 not_RE2 affect_RE2 by_RE2 BIOGENERAL_RE2 
Ondansetron|N|ondansetron|ondansetron|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOENTITY be_BE12 recommend_BE12 for_BE12 patient_BE12 on_BE12 these_BE12 drugs.,_BE12 BIOGENERAL_BE12 :_BE12 although_BE12 no_BE12 pharmacokinetic_BE12 drug_BE12 interaction_BE12 between_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 observe_BE12 datum_BE12 from_BE12 NUM_BE12 small_BE12 study_BE12 indicate_BE12 that_BE12 BIOGENERAL_BE12 may_BE12 be_BE12 associate_BE12 with_BE12 increase_BE12 in_BE12 patient_BE12 controlled_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 chemotherapy_BE12 :_BE12 tumor_BE12 response_BE12 to_BE12 chemotherapy_BE12 in_BE12 the_BE12 NUM_BE12 mouse_BE12 leukemia_BE12 model_BE12 be_BE12 not_BE12 affect_BE12 by_BE12 BIOENTITY 
Ondansetron|N|tramadol|ondansetron|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOGENERAL_LE1 be_LE1 recommend_LE1 for_LE1 patient_LE1 on_LE1 these_LE1 drugs.,_LE1 BIOENTITY :_BE12 although_BE12 no_BE12 pharmacokinetic_BE12 drug_BE12 interaction_BE12 between_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 observe_RE2 datum_RE2 from_RE2 NUM_RE2 small_RE2 study_RE2 indicate_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 be_RE2 associate_RE2 with_RE2 increase_RE2 in_RE2 patient_RE2 controlled_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 chemotherapy_RE2 :_RE2 tumor_RE2 response_RE2 to_RE2 chemotherapy_RE2 in_RE2 the_RE2 NUM_RE2 mouse_RE2 leukemia_RE2 model_RE2 be_RE2 not_RE2 affect_RE2 by_RE2 BIOGENERAL_RE2 
Ondansetron|N|tramadol|tramadol|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOGENERAL_LE1 be_LE1 recommend_LE1 for_LE1 patient_LE1 on_LE1 these_LE1 drugs.,_LE1 BIOENTITY :_BE12 although_BE12 no_BE12 pharmacokinetic_BE12 drug_BE12 interaction_BE12 between_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY have_RE2 be_RE2 observe_RE2 datum_RE2 from_RE2 NUM_RE2 small_RE2 study_RE2 indicate_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 be_RE2 associate_RE2 with_RE2 increase_RE2 in_RE2 patient_RE2 controlled_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 chemotherapy_RE2 :_RE2 tumor_RE2 response_RE2 to_RE2 chemotherapy_RE2 in_RE2 the_RE2 NUM_RE2 mouse_RE2 leukemia_RE2 model_RE2 be_RE2 not_RE2 affect_RE2 by_RE2 BIOGENERAL_RE2 
Ondansetron|N|tramadol|ondansetron|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOGENERAL_LE1 be_LE1 recommend_LE1 for_LE1 patient_LE1 on_LE1 these_LE1 drugs.,_LE1 BIOENTITY :_BE12 although_BE12 no_BE12 pharmacokinetic_BE12 drug_BE12 interaction_BE12 between_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 observe_BE12 datum_BE12 from_BE12 NUM_BE12 small_BE12 study_BE12 indicate_BE12 that_BE12 BIOENTITY may_RE2 be_RE2 associate_RE2 with_RE2 increase_RE2 in_RE2 patient_RE2 controlled_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 chemotherapy_RE2 :_RE2 tumor_RE2 response_RE2 to_RE2 chemotherapy_RE2 in_RE2 the_RE2 NUM_RE2 mouse_RE2 leukemia_RE2 model_RE2 be_RE2 not_RE2 affect_RE2 by_RE2 BIOGENERAL_RE2 
Ondansetron|N|tramadol|tramadol|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOGENERAL_LE1 be_LE1 recommend_LE1 for_LE1 patient_LE1 on_LE1 these_LE1 drugs.,_LE1 BIOENTITY :_BE12 although_BE12 no_BE12 pharmacokinetic_BE12 drug_BE12 interaction_BE12 between_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 observe_BE12 datum_BE12 from_BE12 NUM_BE12 small_BE12 study_BE12 indicate_BE12 that_BE12 BIOGENERAL_BE12 may_BE12 be_BE12 associate_BE12 with_BE12 increase_BE12 in_BE12 patient_BE12 controlled_BE12 administration_BE12 of_BE12 BIOENTITY chemotherapy_RE2 :_RE2 tumor_RE2 response_RE2 to_RE2 chemotherapy_RE2 in_RE2 the_RE2 NUM_RE2 mouse_RE2 leukemia_RE2 model_RE2 be_RE2 not_RE2 affect_RE2 by_RE2 BIOGENERAL_RE2 
Ondansetron|N|tramadol|ondansetron|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOGENERAL_LE1 be_LE1 recommend_LE1 for_LE1 patient_LE1 on_LE1 these_LE1 drugs.,_LE1 BIOENTITY :_BE12 although_BE12 no_BE12 pharmacokinetic_BE12 drug_BE12 interaction_BE12 between_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 observe_BE12 datum_BE12 from_BE12 NUM_BE12 small_BE12 study_BE12 indicate_BE12 that_BE12 BIOGENERAL_BE12 may_BE12 be_BE12 associate_BE12 with_BE12 increase_BE12 in_BE12 patient_BE12 controlled_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 chemotherapy_BE12 :_BE12 tumor_BE12 response_BE12 to_BE12 chemotherapy_BE12 in_BE12 the_BE12 NUM_BE12 mouse_BE12 leukemia_BE12 model_BE12 be_BE12 not_BE12 affect_BE12 by_BE12 BIOENTITY 
Ondansetron|N|ondansetron|tramadol|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOGENERAL_LE1 be_LE1 recommend_LE1 for_LE1 patient_LE1 on_LE1 these_LE1 drugs.,_LE1 BIOGENERAL_LE1 :_LE1 although_LE1 no_LE1 pharmacokinetic_LE1 drug_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOENTITY have_RE2 be_RE2 observe_RE2 datum_RE2 from_RE2 NUM_RE2 small_RE2 study_RE2 indicate_RE2 that_RE2 BIOGENERAL_RE2 may_RE2 be_RE2 associate_RE2 with_RE2 increase_RE2 in_RE2 patient_RE2 controlled_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 chemotherapy_RE2 :_RE2 tumor_RE2 response_RE2 to_RE2 chemotherapy_RE2 in_RE2 the_RE2 NUM_RE2 mouse_RE2 leukemia_RE2 model_RE2 be_RE2 not_RE2 affect_RE2 by_RE2 BIOGENERAL_RE2 
Ondansetron|N|ondansetron|ondansetron|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOGENERAL_LE1 be_LE1 recommend_LE1 for_LE1 patient_LE1 on_LE1 these_LE1 drugs.,_LE1 BIOGENERAL_LE1 :_LE1 although_LE1 no_LE1 pharmacokinetic_LE1 drug_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 observe_BE12 datum_BE12 from_BE12 NUM_BE12 small_BE12 study_BE12 indicate_BE12 that_BE12 BIOENTITY may_RE2 be_RE2 associate_RE2 with_RE2 increase_RE2 in_RE2 patient_RE2 controlled_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 chemotherapy_RE2 :_RE2 tumor_RE2 response_RE2 to_RE2 chemotherapy_RE2 in_RE2 the_RE2 NUM_RE2 mouse_RE2 leukemia_RE2 model_RE2 be_RE2 not_RE2 affect_RE2 by_RE2 BIOGENERAL_RE2 
Ondansetron|N|ondansetron|tramadol|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOGENERAL_LE1 be_LE1 recommend_LE1 for_LE1 patient_LE1 on_LE1 these_LE1 drugs.,_LE1 BIOGENERAL_LE1 :_LE1 although_LE1 no_LE1 pharmacokinetic_LE1 drug_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 observe_BE12 datum_BE12 from_BE12 NUM_BE12 small_BE12 study_BE12 indicate_BE12 that_BE12 BIOGENERAL_BE12 may_BE12 be_BE12 associate_BE12 with_BE12 increase_BE12 in_BE12 patient_BE12 controlled_BE12 administration_BE12 of_BE12 BIOENTITY chemotherapy_RE2 :_RE2 tumor_RE2 response_RE2 to_RE2 chemotherapy_RE2 in_RE2 the_RE2 NUM_RE2 mouse_RE2 leukemia_RE2 model_RE2 be_RE2 not_RE2 affect_RE2 by_RE2 BIOGENERAL_RE2 
Ondansetron|N|ondansetron|ondansetron|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOGENERAL_LE1 be_LE1 recommend_LE1 for_LE1 patient_LE1 on_LE1 these_LE1 drugs.,_LE1 BIOGENERAL_LE1 :_LE1 although_LE1 no_LE1 pharmacokinetic_LE1 drug_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 observe_BE12 datum_BE12 from_BE12 NUM_BE12 small_BE12 study_BE12 indicate_BE12 that_BE12 BIOGENERAL_BE12 may_BE12 be_BE12 associate_BE12 with_BE12 increase_BE12 in_BE12 patient_BE12 controlled_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 chemotherapy_BE12 :_BE12 tumor_BE12 response_BE12 to_BE12 chemotherapy_BE12 in_BE12 the_BE12 NUM_BE12 mouse_BE12 leukemia_BE12 model_BE12 be_BE12 not_BE12 affect_BE12 by_BE12 BIOENTITY 
Ondansetron|N|tramadol|ondansetron|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOGENERAL_LE1 be_LE1 recommend_LE1 for_LE1 patient_LE1 on_LE1 these_LE1 drugs.,_LE1 BIOGENERAL_LE1 :_LE1 although_LE1 no_LE1 pharmacokinetic_LE1 drug_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY have_BE12 be_BE12 observe_BE12 datum_BE12 from_BE12 NUM_BE12 small_BE12 study_BE12 indicate_BE12 that_BE12 BIOENTITY may_RE2 be_RE2 associate_RE2 with_RE2 increase_RE2 in_RE2 patient_RE2 controlled_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 chemotherapy_RE2 :_RE2 tumor_RE2 response_RE2 to_RE2 chemotherapy_RE2 in_RE2 the_RE2 NUM_RE2 mouse_RE2 leukemia_RE2 model_RE2 be_RE2 not_RE2 affect_RE2 by_RE2 BIOGENERAL_RE2 
Ondansetron|N|tramadol|tramadol|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOGENERAL_LE1 be_LE1 recommend_LE1 for_LE1 patient_LE1 on_LE1 these_LE1 drugs.,_LE1 BIOGENERAL_LE1 :_LE1 although_LE1 no_LE1 pharmacokinetic_LE1 drug_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY have_BE12 be_BE12 observe_BE12 datum_BE12 from_BE12 NUM_BE12 small_BE12 study_BE12 indicate_BE12 that_BE12 BIOGENERAL_BE12 may_BE12 be_BE12 associate_BE12 with_BE12 increase_BE12 in_BE12 patient_BE12 controlled_BE12 administration_BE12 of_BE12 BIOENTITY chemotherapy_RE2 :_RE2 tumor_RE2 response_RE2 to_RE2 chemotherapy_RE2 in_RE2 the_RE2 NUM_RE2 mouse_RE2 leukemia_RE2 model_RE2 be_RE2 not_RE2 affect_RE2 by_RE2 BIOGENERAL_RE2 
Ondansetron|N|tramadol|ondansetron|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOGENERAL_LE1 be_LE1 recommend_LE1 for_LE1 patient_LE1 on_LE1 these_LE1 drugs.,_LE1 BIOGENERAL_LE1 :_LE1 although_LE1 no_LE1 pharmacokinetic_LE1 drug_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY have_BE12 be_BE12 observe_BE12 datum_BE12 from_BE12 NUM_BE12 small_BE12 study_BE12 indicate_BE12 that_BE12 BIOGENERAL_BE12 may_BE12 be_BE12 associate_BE12 with_BE12 increase_BE12 in_BE12 patient_BE12 controlled_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 chemotherapy_BE12 :_BE12 tumor_BE12 response_BE12 to_BE12 chemotherapy_BE12 in_BE12 the_BE12 NUM_BE12 mouse_BE12 leukemia_BE12 model_BE12 be_BE12 not_BE12 affect_BE12 by_BE12 BIOENTITY 
Ondansetron|N|ondansetron|ondansetron|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOGENERAL_LE1 be_LE1 recommend_LE1 for_LE1 patient_LE1 on_LE1 these_LE1 drugs.,_LE1 BIOGENERAL_LE1 :_LE1 although_LE1 no_LE1 pharmacokinetic_LE1 drug_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 have_LE1 be_LE1 observe_LE1 datum_LE1 from_LE1 NUM_LE1 small_LE1 study_LE1 indicate_LE1 that_LE1 BIOENTITY may_BE12 be_BE12 associate_BE12 with_BE12 increase_BE12 in_BE12 patient_BE12 controlled_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 chemotherapy_BE12 :_BE12 tumor_BE12 response_BE12 to_BE12 chemotherapy_BE12 in_BE12 the_BE12 NUM_BE12 mouse_BE12 leukemia_BE12 model_BE12 be_BE12 not_BE12 affect_BE12 by_BE12 BIOENTITY 
Ondansetron|N|tramadol|ondansetron|however_LE1 on_LE1 the_LE1 basis_LE1 of_LE1 available_LE1 datum_LE1 no_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOGENERAL_LE1 be_LE1 recommend_LE1 for_LE1 patient_LE1 on_LE1 these_LE1 drugs.,_LE1 BIOGENERAL_LE1 :_LE1 although_LE1 no_LE1 pharmacokinetic_LE1 drug_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 have_LE1 be_LE1 observe_LE1 datum_LE1 from_LE1 NUM_LE1 small_LE1 study_LE1 indicate_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 be_LE1 associate_LE1 with_LE1 increase_LE1 in_LE1 patient_LE1 controlled_LE1 administration_LE1 of_LE1 BIOENTITY chemotherapy_BE12 :_BE12 tumor_BE12 response_BE12 to_BE12 chemotherapy_BE12 in_BE12 the_BE12 NUM_BE12 mouse_BE12 leukemia_BE12 model_BE12 be_BE12 not_BE12 affect_BE12 by_BE12 BIOENTITY 
Ondansetron|N|etoposide|ondansetron|In_LE1 human_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 affect_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY 
Ondansetron|N|cisplatin|ondansetron|In_LE1 human_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY do_BE12 not_BE12 affect_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY 
Ondansetron|N|carmustine|ondansetron|In_LE1 human_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 affect_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY 
Ondansetron|N|etoposide|cisplatin|In_LE1 human_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY do_RE2 not_RE2 affect_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 
Ondansetron|N|etoposide|cisplatin|In_LE1 human_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY do_RE2 not_RE2 affect_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 
Ondansetron|N|carmustine|etoposide|In_LE1 human_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 do_RE2 not_RE2 affect_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 
Ondansetron|N|carmustine|cisplatin|In_LE1 human_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY do_RE2 not_RE2 affect_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 
Ondansetron|N|ondansetron|methotrexate|BIOENTITY do_BE12 not_BE12 increase_BE12 blood_BE12 level_BE12 of_BE12 highdose_BE12 BIOENTITY 
Orciprenaline|N|alupent|metaproterenol sulfate|other_LE1 BIOGENERAL_LE1 shall_LE1 not_LE1 be_LE1 use_LE1 concomitant_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOENTITY usp_RE2 -RRB-_RE2 because_RE2 they_RE2 may_RE2 have_RE2 additive_RE2 effect_RE2 
Orciprenaline|N|monoamine oxidase inhibitor|tricyclic antidepressant|BIOGENERAL_LE1 shall_LE1 be_LE1 administer_LE1 with_LE1 caution_LE1 to_LE1 patient_LE1 be_LE1 treat_LE1 with_LE1 BIOENTITY or_BE12 BIOENTITY since_RE2 the_RE2 action_RE2 of_RE2 BIOGENERAL_RE2 on_RE2 the_RE2 vascular_RE2 system_RE2 may_RE2 be_RE2 potentiate_RE2 
Orciprenaline|N|tricyclic antidepressant|beta adrenergic agonist|BIOGENERAL_LE1 shall_LE1 be_LE1 administer_LE1 with_LE1 caution_LE1 to_LE1 patient_LE1 be_LE1 treat_LE1 with_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY since_BE12 the_BE12 action_BE12 of_BE12 BIOENTITY on_RE2 the_RE2 vascular_RE2 system_RE2 may_RE2 be_RE2 potentiate_RE2 
Orciprenaline|N|monoamine oxidase inhibitor|beta adrenergic agonist|BIOGENERAL_LE1 shall_LE1 be_LE1 administer_LE1 with_LE1 caution_LE1 to_LE1 patient_LE1 be_LE1 treat_LE1 with_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 since_BE12 the_BE12 action_BE12 of_BE12 BIOENTITY on_RE2 the_RE2 vascular_RE2 system_RE2 may_RE2 be_RE2 potentiate_RE2 
Orciprenaline|N|beta adrenergic agonist|beta adrenergic agonist|BIOENTITY shall_BE12 be_BE12 administer_BE12 with_BE12 caution_BE12 to_BE12 patient_BE12 be_BE12 treat_BE12 with_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 since_BE12 the_BE12 action_BE12 of_BE12 BIOENTITY on_RE2 the_RE2 vascular_RE2 system_RE2 may_RE2 be_RE2 potentiate_RE2 
Orlistat|N|orlistat|orlistat|BIOGENERAL_LE1 :_LE1 In_LE1 multipledose_LE1 study_LE1 in_LE1 NUM_LE1 normal_LE1 weight_LE1 subject_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 NUM_LE1 gram_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 approximate_LE1 NUM_LE1 glass_LE1 of_LE1 wine_LE1 -RRB-_LE1 do_LE1 not_LE1 result_LE1 in_LE1 alteration_LE1 of_LE1 BIOGENERAL_LE1 pharmacokinetic_LE1 BIOENTITY pharmacodynamic_BE12 -LRB-_BE12 fecal_BE12 fat_BE12 excretion_BE12 -RRB-_BE12 or_BE12 systemic_BE12 exposure_BE12 to_BE12 BIOENTITY 
Orlistat|N|orlistat|orlistat|BIOGENERAL_LE1 :_LE1 In_LE1 multipledose_LE1 study_LE1 in_LE1 NUM_LE1 normal_LE1 weight_LE1 subject_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 NUM_LE1 gram_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 approximate_LE1 NUM_LE1 glass_LE1 of_LE1 wine_LE1 -RRB-_LE1 do_LE1 not_LE1 result_LE1 in_LE1 alteration_LE1 of_LE1 BIOGENERAL_LE1 pharmacokinetic_LE1 BIOENTITY pharmacodynamic_BE12 -LRB-_BE12 fecal_BE12 fat_BE12 excretion_BE12 -RRB-_BE12 or_BE12 systemic_BE12 exposure_BE12 to_BE12 BIOENTITY 
Orlistat|N|alcohol|orlistat|BIOGENERAL_LE1 :_LE1 In_LE1 multipledose_LE1 study_LE1 in_LE1 NUM_LE1 normal_LE1 weight_LE1 subject_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 NUM_LE1 gram_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 approximate_LE1 NUM_LE1 glass_LE1 of_LE1 wine_LE1 -RRB-_LE1 do_LE1 not_LE1 result_LE1 in_LE1 alteration_LE1 of_LE1 BIOENTITY pharmacokinetic_BE12 BIOGENERAL_BE12 pharmacodynamic_BE12 -LRB-_BE12 fecal_BE12 fat_BE12 excretion_BE12 -RRB-_BE12 or_BE12 systemic_BE12 exposure_BE12 to_BE12 BIOENTITY 
Orlistat|N|alcohol|orlistat|BIOGENERAL_LE1 :_LE1 In_LE1 multipledose_LE1 study_LE1 in_LE1 NUM_LE1 normal_LE1 weight_LE1 subject_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 NUM_LE1 gram_LE1 of_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 approximate_BE12 NUM_BE12 glass_BE12 of_BE12 wine_BE12 -RRB-_BE12 do_BE12 not_BE12 result_BE12 in_BE12 alteration_BE12 of_BE12 BIOGENERAL_BE12 pharmacokinetic_BE12 BIOGENERAL_BE12 pharmacodynamic_BE12 -LRB-_BE12 fecal_BE12 fat_BE12 excretion_BE12 -RRB-_BE12 or_BE12 systemic_BE12 exposure_BE12 to_BE12 BIOENTITY 
Orlistat|N|xenical|orlistat|BIOGENERAL_LE1 :_LE1 In_LE1 multipledose_LE1 study_LE1 in_LE1 NUM_LE1 normal_LE1 weight_LE1 subject_LE1 coadministration_LE1 of_LE1 BIOENTITY and_BE12 NUM_BE12 gram_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 approximate_BE12 NUM_BE12 glass_BE12 of_BE12 wine_BE12 -RRB-_BE12 do_BE12 not_BE12 result_BE12 in_BE12 alteration_BE12 of_BE12 BIOGENERAL_BE12 pharmacokinetic_BE12 BIOGENERAL_BE12 pharmacodynamic_BE12 -LRB-_BE12 fecal_BE12 fat_BE12 excretion_BE12 -RRB-_BE12 or_BE12 systemic_BE12 exposure_BE12 to_BE12 BIOENTITY 
Orlistat|N|alcohol|orlistat|BIOENTITY :_BE12 In_BE12 multipledose_BE12 study_BE12 in_BE12 NUM_BE12 normal_BE12 weight_BE12 subject_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 NUM_BE12 gram_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 approximate_BE12 NUM_BE12 glass_BE12 of_BE12 wine_BE12 -RRB-_BE12 do_BE12 not_BE12 result_BE12 in_BE12 alteration_BE12 of_BE12 BIOGENERAL_BE12 pharmacokinetic_BE12 BIOGENERAL_BE12 pharmacodynamic_BE12 -LRB-_BE12 fecal_BE12 fat_BE12 excretion_BE12 -RRB-_BE12 or_BE12 systemic_BE12 exposure_BE12 to_BE12 BIOENTITY 
Orlistat|N|alcohol|orlistat|BIOGENERAL_LE1 :_LE1 In_LE1 multipledose_LE1 study_LE1 in_LE1 NUM_LE1 normal_LE1 weight_LE1 subject_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 NUM_LE1 gram_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 approximate_LE1 NUM_LE1 glass_LE1 of_LE1 wine_LE1 -RRB-_LE1 do_LE1 not_LE1 result_LE1 in_LE1 alteration_LE1 of_LE1 BIOENTITY pharmacokinetic_BE12 BIOENTITY pharmacodynamic_RE2 -LRB-_RE2 fecal_RE2 fat_RE2 excretion_RE2 -RRB-_RE2 or_RE2 systemic_RE2 exposure_RE2 to_RE2 BIOGENERAL_RE2 
Orlistat|N|alcohol|orlistat|BIOGENERAL_LE1 :_LE1 In_LE1 multipledose_LE1 study_LE1 in_LE1 NUM_LE1 normal_LE1 weight_LE1 subject_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 NUM_LE1 gram_LE1 of_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 approximate_BE12 NUM_BE12 glass_BE12 of_BE12 wine_BE12 -RRB-_BE12 do_BE12 not_BE12 result_BE12 in_BE12 alteration_BE12 of_BE12 BIOGENERAL_BE12 pharmacokinetic_BE12 BIOENTITY pharmacodynamic_RE2 -LRB-_RE2 fecal_RE2 fat_RE2 excretion_RE2 -RRB-_RE2 or_RE2 systemic_RE2 exposure_RE2 to_RE2 BIOGENERAL_RE2 
Orlistat|N|xenical|orlistat|BIOGENERAL_LE1 :_LE1 In_LE1 multipledose_LE1 study_LE1 in_LE1 NUM_LE1 normal_LE1 weight_LE1 subject_LE1 coadministration_LE1 of_LE1 BIOENTITY and_BE12 NUM_BE12 gram_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 approximate_BE12 NUM_BE12 glass_BE12 of_BE12 wine_BE12 -RRB-_BE12 do_BE12 not_BE12 result_BE12 in_BE12 alteration_BE12 of_BE12 BIOGENERAL_BE12 pharmacokinetic_BE12 BIOENTITY pharmacodynamic_RE2 -LRB-_RE2 fecal_RE2 fat_RE2 excretion_RE2 -RRB-_RE2 or_RE2 systemic_RE2 exposure_RE2 to_RE2 BIOGENERAL_RE2 
Orlistat|N|alcohol|orlistat|BIOENTITY :_BE12 In_BE12 multipledose_BE12 study_BE12 in_BE12 NUM_BE12 normal_BE12 weight_BE12 subject_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 NUM_BE12 gram_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 approximate_BE12 NUM_BE12 glass_BE12 of_BE12 wine_BE12 -RRB-_BE12 do_BE12 not_BE12 result_BE12 in_BE12 alteration_BE12 of_BE12 BIOGENERAL_BE12 pharmacokinetic_BE12 BIOENTITY pharmacodynamic_RE2 -LRB-_RE2 fecal_RE2 fat_RE2 excretion_RE2 -RRB-_RE2 or_RE2 systemic_RE2 exposure_RE2 to_RE2 BIOGENERAL_RE2 
Orlistat|N|alcohol|alcohol|BIOGENERAL_LE1 :_LE1 In_LE1 multipledose_LE1 study_LE1 in_LE1 NUM_LE1 normal_LE1 weight_LE1 subject_LE1 coadministration_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 NUM_LE1 gram_LE1 of_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 approximate_BE12 NUM_BE12 glass_BE12 of_BE12 wine_BE12 -RRB-_BE12 do_BE12 not_BE12 result_BE12 in_BE12 alteration_BE12 of_BE12 BIOENTITY pharmacokinetic_RE2 BIOGENERAL_RE2 pharmacodynamic_RE2 -LRB-_RE2 fecal_RE2 fat_RE2 excretion_RE2 -RRB-_RE2 or_RE2 systemic_RE2 exposure_RE2 to_RE2 BIOGENERAL_RE2 
Orlistat|N|xenical|alcohol|BIOGENERAL_LE1 :_LE1 In_LE1 multipledose_LE1 study_LE1 in_LE1 NUM_LE1 normal_LE1 weight_LE1 subject_LE1 coadministration_LE1 of_LE1 BIOENTITY and_BE12 NUM_BE12 gram_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 approximate_BE12 NUM_BE12 glass_BE12 of_BE12 wine_BE12 -RRB-_BE12 do_BE12 not_BE12 result_BE12 in_BE12 alteration_BE12 of_BE12 BIOENTITY pharmacokinetic_RE2 BIOGENERAL_RE2 pharmacodynamic_RE2 -LRB-_RE2 fecal_RE2 fat_RE2 excretion_RE2 -RRB-_RE2 or_RE2 systemic_RE2 exposure_RE2 to_RE2 BIOGENERAL_RE2 
Orlistat|N|alcohol|alcohol|BIOENTITY :_BE12 In_BE12 multipledose_BE12 study_BE12 in_BE12 NUM_BE12 normal_BE12 weight_BE12 subject_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 NUM_BE12 gram_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 approximate_BE12 NUM_BE12 glass_BE12 of_BE12 wine_BE12 -RRB-_BE12 do_BE12 not_BE12 result_BE12 in_BE12 alteration_BE12 of_BE12 BIOENTITY pharmacokinetic_RE2 BIOGENERAL_RE2 pharmacodynamic_RE2 -LRB-_RE2 fecal_RE2 fat_RE2 excretion_RE2 -RRB-_RE2 or_RE2 systemic_RE2 exposure_RE2 to_RE2 BIOGENERAL_RE2 
Orlistat|N|xenical|alcohol|BIOGENERAL_LE1 :_LE1 In_LE1 multipledose_LE1 study_LE1 in_LE1 NUM_LE1 normal_LE1 weight_LE1 subject_LE1 coadministration_LE1 of_LE1 BIOENTITY and_BE12 NUM_BE12 gram_BE12 of_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 approximate_RE2 NUM_RE2 glass_RE2 of_RE2 wine_RE2 -RRB-_RE2 do_RE2 not_RE2 result_RE2 in_RE2 alteration_RE2 of_RE2 BIOGENERAL_RE2 pharmacokinetic_RE2 BIOGENERAL_RE2 pharmacodynamic_RE2 -LRB-_RE2 fecal_RE2 fat_RE2 excretion_RE2 -RRB-_RE2 or_RE2 systemic_RE2 exposure_RE2 to_RE2 BIOGENERAL_RE2 
Orlistat|N|alcohol|alcohol|BIOENTITY :_BE12 In_BE12 multipledose_BE12 study_BE12 in_BE12 NUM_BE12 normal_BE12 weight_BE12 subject_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 NUM_BE12 gram_BE12 of_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 approximate_RE2 NUM_RE2 glass_RE2 of_RE2 wine_RE2 -RRB-_RE2 do_RE2 not_RE2 result_RE2 in_RE2 alteration_RE2 of_RE2 BIOGENERAL_RE2 pharmacokinetic_RE2 BIOGENERAL_RE2 pharmacodynamic_RE2 -LRB-_RE2 fecal_RE2 fat_RE2 excretion_RE2 -RRB-_RE2 or_RE2 systemic_RE2 exposure_RE2 to_RE2 BIOGENERAL_RE2 
Orlistat|N|alcohol|xenical|BIOENTITY :_BE12 In_BE12 multipledose_BE12 study_BE12 in_BE12 NUM_BE12 normal_BE12 weight_BE12 subject_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 NUM_RE2 gram_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 approximate_RE2 NUM_RE2 glass_RE2 of_RE2 wine_RE2 -RRB-_RE2 do_RE2 not_RE2 result_RE2 in_RE2 alteration_RE2 of_RE2 BIOGENERAL_RE2 pharmacokinetic_RE2 BIOGENERAL_RE2 pharmacodynamic_RE2 -LRB-_RE2 fecal_RE2 fat_RE2 excretion_RE2 -RRB-_RE2 or_RE2 systemic_RE2 exposure_RE2 to_RE2 BIOGENERAL_RE2 
Orlistat|N|cyclosporine|xenical|BIOENTITY :_BE12 preliminary_BE12 datum_BE12 from_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 drug_RE2 interaction_RE2 study_RE2 indicate_RE2 reduction_RE2 in_RE2 BIOGENERAL_RE2 plasma_RE2 level_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Orlistat|N|cyclosporine|cyclosporine|BIOENTITY :_BE12 preliminary_BE12 datum_BE12 from_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY drug_RE2 interaction_RE2 study_RE2 indicate_RE2 reduction_RE2 in_RE2 BIOGENERAL_RE2 plasma_RE2 level_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Orlistat|N|cyclosporine|cyclosporine|BIOENTITY :_BE12 preliminary_BE12 datum_BE12 from_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 drug_BE12 interaction_BE12 study_BE12 indicate_BE12 reduction_BE12 in_BE12 BIOENTITY plasma_RE2 level_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Orlistat|N|cyclosporine|xenical|BIOENTITY :_BE12 preliminary_BE12 datum_BE12 from_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 drug_BE12 interaction_BE12 study_BE12 indicate_BE12 reduction_BE12 in_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 when_BE12 BIOENTITY be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Orlistat|N|cyclosporine|xenical|BIOENTITY :_BE12 preliminary_BE12 datum_BE12 from_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 drug_BE12 interaction_BE12 study_BE12 indicate_BE12 reduction_BE12 in_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 when_BE12 BIOENTITY be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Orlistat|N|cyclosporine|cyclosporine|BIOENTITY :_BE12 preliminary_BE12 datum_BE12 from_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 drug_BE12 interaction_BE12 study_BE12 indicate_BE12 reduction_BE12 in_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 coadminister_BE12 with_BE12 BIOENTITY 
Orlistat|N|cyclosporine|cyclosporine|BIOENTITY :_BE12 preliminary_BE12 datum_BE12 from_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 drug_BE12 interaction_BE12 study_BE12 indicate_BE12 reduction_BE12 in_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 coadminister_BE12 with_BE12 BIOENTITY 
Orlistat|N|xenical|cyclosporine|BIOGENERAL_LE1 :_LE1 preliminary_LE1 datum_LE1 from_LE1 BIOENTITY and_BE12 BIOENTITY drug_RE2 interaction_RE2 study_RE2 indicate_RE2 reduction_RE2 in_RE2 BIOGENERAL_RE2 plasma_RE2 level_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Orlistat|N|xenical|cyclosporine|BIOGENERAL_LE1 :_LE1 preliminary_LE1 datum_LE1 from_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 drug_BE12 interaction_BE12 study_BE12 indicate_BE12 reduction_BE12 in_BE12 BIOENTITY plasma_RE2 level_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Orlistat|N|xenical|xenical|BIOGENERAL_LE1 :_LE1 preliminary_LE1 datum_LE1 from_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 drug_BE12 interaction_BE12 study_BE12 indicate_BE12 reduction_BE12 in_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 when_BE12 BIOENTITY be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Orlistat|N|xenical|xenical|BIOGENERAL_LE1 :_LE1 preliminary_LE1 datum_LE1 from_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 drug_BE12 interaction_BE12 study_BE12 indicate_BE12 reduction_BE12 in_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 when_BE12 BIOENTITY be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Orlistat|N|xenical|cyclosporine|BIOGENERAL_LE1 :_LE1 preliminary_LE1 datum_LE1 from_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 drug_BE12 interaction_BE12 study_BE12 indicate_BE12 reduction_BE12 in_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 coadminister_BE12 with_BE12 BIOENTITY 
Orlistat|N|xenical|cyclosporine|BIOGENERAL_LE1 :_LE1 preliminary_LE1 datum_LE1 from_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 drug_BE12 interaction_BE12 study_BE12 indicate_BE12 reduction_BE12 in_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 coadminister_BE12 with_BE12 BIOENTITY 
Orlistat|N|cyclosporine|cyclosporine|BIOGENERAL_LE1 :_LE1 preliminary_LE1 datum_LE1 from_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY drug_BE12 interaction_BE12 study_BE12 indicate_BE12 reduction_BE12 in_BE12 BIOENTITY plasma_RE2 level_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Orlistat|N|cyclosporine|xenical|BIOGENERAL_LE1 :_LE1 preliminary_LE1 datum_LE1 from_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY drug_BE12 interaction_BE12 study_BE12 indicate_BE12 reduction_BE12 in_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 when_BE12 BIOENTITY be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Orlistat|N|cyclosporine|xenical|BIOGENERAL_LE1 :_LE1 preliminary_LE1 datum_LE1 from_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY drug_BE12 interaction_BE12 study_BE12 indicate_BE12 reduction_BE12 in_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 when_BE12 BIOENTITY be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Orlistat|N|cyclosporine|cyclosporine|BIOGENERAL_LE1 :_LE1 preliminary_LE1 datum_LE1 from_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY drug_BE12 interaction_BE12 study_BE12 indicate_BE12 reduction_BE12 in_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 coadminister_BE12 with_BE12 BIOENTITY 
Orlistat|N|cyclosporine|cyclosporine|BIOGENERAL_LE1 :_LE1 preliminary_LE1 datum_LE1 from_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY drug_BE12 interaction_BE12 study_BE12 indicate_BE12 reduction_BE12 in_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 coadminister_BE12 with_BE12 BIOENTITY 
Orlistat|N|cyclosporine|xenical|BIOGENERAL_LE1 :_LE1 preliminary_LE1 datum_LE1 from_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 study_LE1 indicate_LE1 reduction_LE1 in_LE1 BIOENTITY plasma_BE12 level_BE12 when_BE12 BIOENTITY be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Orlistat|N|cyclosporine|xenical|BIOGENERAL_LE1 :_LE1 preliminary_LE1 datum_LE1 from_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 study_LE1 indicate_LE1 reduction_LE1 in_LE1 BIOENTITY plasma_BE12 level_BE12 when_BE12 BIOENTITY be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Orlistat|N|cyclosporine|cyclosporine|BIOGENERAL_LE1 :_LE1 preliminary_LE1 datum_LE1 from_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 study_LE1 indicate_LE1 reduction_LE1 in_LE1 BIOENTITY plasma_BE12 level_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 coadminister_BE12 with_BE12 BIOENTITY 
Orlistat|N|cyclosporine|cyclosporine|BIOGENERAL_LE1 :_LE1 preliminary_LE1 datum_LE1 from_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 study_LE1 indicate_LE1 reduction_LE1 in_LE1 BIOENTITY plasma_BE12 level_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 coadminister_BE12 with_BE12 BIOENTITY 
Orlistat|N|xenical|digoxin|BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 normalweight_LE1 subject_LE1 receive_LE1 BIOGENERAL_LE1 NUM_LE1 mg_LE1 three_LE1 time_LE1 day_LE1 for_LE1 NUM_LE1 day_LE1 BIOENTITY do_BE12 not_BE12 alter_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 single_BE12 dose_BE12 of_BE12 BIOENTITY 
Orlistat|N|digoxin|xenical|BIOENTITY :_BE12 In_BE12 NUM_BE12 normalweight_BE12 subject_BE12 receive_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOENTITY do_RE2 not_RE2 alter_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 single_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 
Orlistat|N|xenical|xenical|BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 normalweight_LE1 subject_LE1 receive_LE1 BIOENTITY NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOENTITY do_RE2 not_RE2 alter_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 single_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 
Orlistat|N|digoxin|digoxin|BIOENTITY :_BE12 In_BE12 NUM_BE12 normalweight_BE12 subject_BE12 receive_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 alter_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 single_BE12 dose_BE12 of_BE12 BIOENTITY 
Orlistat|N|xenical|digoxin|BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 normalweight_LE1 subject_LE1 receive_LE1 BIOENTITY NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 alter_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 single_BE12 dose_BE12 of_BE12 BIOENTITY 
Orlistat|N|digoxin|xenical|BIOENTITY :_BE12 In_BE12 NUM_BE12 normalweight_BE12 subject_BE12 receive_BE12 BIOENTITY NUM_RE2 mg_RE2 three_RE2 time_RE2 day_RE2 for_RE2 NUM_RE2 day_RE2 BIOGENERAL_RE2 do_RE2 not_RE2 alter_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 single_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 
Orlistat|N|fat-soluble vitamin supplement|beta-carotene|BIOENTITY and_BE12 analogue_BE12 :_BE12 pharmacokinetic_BE12 interaction_BE12 study_BE12 show_BE12 NUM_BE12 reduction_BE12 in_BE12 BIOENTITY supplement_RE2 absorption_RE2 when_RE2 concomitant_RE2 administer_RE2 with_RE2 BIOGENERAL_RE2 
Orlistat|N|fat-soluble vitamin supplement|xenical|BIOENTITY and_BE12 analogue_BE12 :_BE12 pharmacokinetic_BE12 interaction_BE12 study_BE12 show_BE12 NUM_BE12 reduction_BE12 in_BE12 BIOGENERAL_BE12 supplement_BE12 absorption_BE12 when_BE12 concomitant_BE12 administer_BE12 with_BE12 BIOENTITY 
Orlistat|N|vitamin d|vitamin k|the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 the_LE1 absorption_LE1 of_LE1 supplemental_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 nutritionallyderived_BE12 BIOENTITY be_RE2 not_RE2 know_RE2 at_RE2 this_RE2 time_RE2 
Orlistat|N|vitamin a|vitamin k|the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 the_LE1 absorption_LE1 of_LE1 supplemental_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 nutritionallyderived_BE12 BIOENTITY be_RE2 not_RE2 know_RE2 at_RE2 this_RE2 time_RE2 
Orlistat|N|vitamin a|vitamin k|the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 the_LE1 absorption_LE1 of_LE1 supplemental_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 nutritionallyderived_BE12 BIOENTITY be_RE2 not_RE2 know_RE2 at_RE2 this_RE2 time_RE2 
Orlistat|N|orlistat|vitamin k|the_LE1 effect_LE1 of_LE1 BIOENTITY on_BE12 the_BE12 absorption_BE12 of_BE12 supplemental_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 nutritionallyderived_BE12 BIOENTITY be_RE2 not_RE2 know_RE2 at_RE2 this_RE2 time_RE2 
Orlistat|N|vitamin d|vitamin a|the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 the_LE1 absorption_LE1 of_LE1 supplemental_LE1 BIOENTITY BIOENTITY and_RE2 nutritionallyderived_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 know_RE2 at_RE2 this_RE2 time_RE2 
Orlistat|N|orlistat|vitamin d|the_LE1 effect_LE1 of_LE1 BIOENTITY on_BE12 the_BE12 absorption_BE12 of_BE12 supplemental_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 nutritionallyderived_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 know_RE2 at_RE2 this_RE2 time_RE2 
Orlistat|N|orlistat|vitamin a|the_LE1 effect_LE1 of_LE1 BIOENTITY on_BE12 the_BE12 absorption_BE12 of_BE12 supplemental_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 nutritionallyderived_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 know_RE2 at_RE2 this_RE2 time_RE2 
Orlistat|N|glyburide|orlistat|BIOENTITY :_BE12 In_BE12 NUM_BE12 normalweight_BE12 subject_BE12 receive_BE12 BIOENTITY NUM_RE2 mg_RE2 three_RE2 time_RE2 day_RE2 for_RE2 NUM_RE2 day_RE2 BIOGENERAL_RE2 do_RE2 not_RE2 alter_RE2 the_RE2 pharmacokinetic_RE2 or_RE2 pharmacodynamic_RE2 -LRB-_RE2 blood_RE2 glucoselowering_RE2 -RRB-_RE2 of_RE2 BIOGENERAL_RE2 
Orlistat|N|glyburide|orlistat|BIOENTITY :_BE12 In_BE12 NUM_BE12 normalweight_BE12 subject_BE12 receive_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOENTITY do_RE2 not_RE2 alter_RE2 the_RE2 pharmacokinetic_RE2 or_RE2 pharmacodynamic_RE2 -LRB-_RE2 blood_RE2 glucoselowering_RE2 -RRB-_RE2 of_RE2 BIOGENERAL_RE2 
Orlistat|N|glyburide|glyburide|BIOENTITY :_BE12 In_BE12 NUM_BE12 normalweight_BE12 subject_BE12 receive_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 alter_BE12 the_BE12 pharmacokinetic_BE12 or_BE12 pharmacodynamic_BE12 -LRB-_BE12 blood_BE12 glucoselowering_BE12 -RRB-_BE12 of_BE12 BIOENTITY 
Orlistat|N|orlistat|orlistat|BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 normalweight_LE1 subject_LE1 receive_LE1 BIOENTITY NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOENTITY do_RE2 not_RE2 alter_RE2 the_RE2 pharmacokinetic_RE2 or_RE2 pharmacodynamic_RE2 -LRB-_RE2 blood_RE2 glucoselowering_RE2 -RRB-_RE2 of_RE2 BIOGENERAL_RE2 
Orlistat|N|orlistat|glyburide|BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 normalweight_LE1 subject_LE1 receive_LE1 BIOENTITY NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 alter_BE12 the_BE12 pharmacokinetic_BE12 or_BE12 pharmacodynamic_BE12 -LRB-_BE12 blood_BE12 glucoselowering_BE12 -RRB-_BE12 of_BE12 BIOENTITY 
Orlistat|N|orlistat|glyburide|BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 normalweight_LE1 subject_LE1 receive_LE1 BIOGENERAL_LE1 NUM_LE1 mg_LE1 three_LE1 time_LE1 day_LE1 for_LE1 NUM_LE1 day_LE1 BIOENTITY do_BE12 not_BE12 alter_BE12 the_BE12 pharmacokinetic_BE12 or_BE12 pharmacodynamic_BE12 -LRB-_BE12 blood_BE12 glucoselowering_BE12 -RRB-_BE12 of_BE12 BIOENTITY 
Orlistat|N|xenical|xenical|BIOGENERAL_LE1 -LRB-_LE1 extendedrelease_LE1 tablet_LE1 -RRB-_LE1 :_LE1 In_LE1 NUM_LE1 normalweight_LE1 subject_LE1 receive_LE1 BIOENTITY NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOENTITY do_RE2 not_RE2 alter_RE2 the_RE2 bioavailability_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 extendedrelease_RE2 tablet_RE2 rrb._RE2 
Orlistat|N|xenical|nifedipine|BIOGENERAL_LE1 -LRB-_LE1 extendedrelease_LE1 tablet_LE1 -RRB-_LE1 :_LE1 In_LE1 NUM_LE1 normalweight_LE1 subject_LE1 receive_LE1 BIOENTITY NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 alter_BE12 the_BE12 bioavailability_BE12 of_BE12 BIOENTITY -LRB-_RE2 extendedrelease_RE2 tablet_RE2 rrb._RE2 
Orlistat|N|nifedipine|xenical|BIOENTITY -LRB-_BE12 extendedrelease_BE12 tablet_BE12 -RRB-_BE12 :_BE12 In_BE12 NUM_BE12 normalweight_BE12 subject_BE12 receive_BE12 BIOENTITY NUM_RE2 mg_RE2 three_RE2 time_RE2 day_RE2 for_RE2 NUM_RE2 day_RE2 BIOGENERAL_RE2 do_RE2 not_RE2 alter_RE2 the_RE2 bioavailability_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 extendedrelease_RE2 tablet_RE2 rrb._RE2 
Orlistat|N|xenical|nifedipine|BIOGENERAL_LE1 -LRB-_LE1 extendedrelease_LE1 tablet_LE1 -RRB-_LE1 :_LE1 In_LE1 NUM_LE1 normalweight_LE1 subject_LE1 receive_LE1 BIOGENERAL_LE1 NUM_LE1 mg_LE1 three_LE1 time_LE1 day_LE1 for_LE1 NUM_LE1 day_LE1 BIOENTITY do_BE12 not_BE12 alter_BE12 the_BE12 bioavailability_BE12 of_BE12 BIOENTITY -LRB-_RE2 extendedrelease_RE2 tablet_RE2 rrb._RE2 
Orlistat|N|nifedipine|xenical|BIOENTITY -LRB-_BE12 extendedrelease_BE12 tablet_BE12 -RRB-_BE12 :_BE12 In_BE12 NUM_BE12 normalweight_BE12 subject_BE12 receive_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOENTITY do_RE2 not_RE2 alter_RE2 the_RE2 bioavailability_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 extendedrelease_RE2 tablet_RE2 rrb._RE2 
Orlistat|N|nifedipine|nifedipine|BIOENTITY -LRB-_BE12 extendedrelease_BE12 tablet_BE12 -RRB-_BE12 :_BE12 In_BE12 NUM_BE12 normalweight_BE12 subject_BE12 receive_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 alter_BE12 the_BE12 bioavailability_BE12 of_BE12 BIOENTITY -LRB-_RE2 extendedrelease_RE2 tablet_RE2 rrb._RE2 
Orlistat|N|contraceptive|xenical|oral_LE1 BIOENTITY :_BE12 In_BE12 NUM_BE12 normalweight_BE12 female_BE12 subject_BE12 the_BE12 treatment_BE12 of_BE12 BIOENTITY NUM_RE2 mg_RE2 three_RE2 time_RE2 day_RE2 for_RE2 NUM_RE2 day_RE2 result_RE2 in_RE2 no_RE2 change_RE2 in_RE2 the_RE2 ovulationsuppressing_RE2 action_RE2 of_RE2 oral_RE2 BIOGENERAL_RE2 
Orlistat|N|xenical|contraceptive|oral_LE1 BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 normalweight_LE1 female_LE1 subject_LE1 the_LE1 treatment_LE1 of_LE1 BIOENTITY NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 result_BE12 in_BE12 no_BE12 change_BE12 in_BE12 the_BE12 ovulationsuppressing_BE12 action_BE12 of_BE12 oral_BE12 BIOENTITY 
Orlistat|N|contraceptive|contraceptive|oral_LE1 BIOENTITY :_BE12 In_BE12 NUM_BE12 normalweight_BE12 female_BE12 subject_BE12 the_BE12 treatment_BE12 of_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 result_BE12 in_BE12 no_BE12 change_BE12 in_BE12 the_BE12 ovulationsuppressing_BE12 action_BE12 of_BE12 oral_BE12 BIOENTITY 
Orlistat|N|xenical|phenytoin|BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 normalweight_LE1 subject_LE1 receive_LE1 BIOENTITY NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 alter_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 single_BE12 mg_BE12 dose_BE12 of_BE12 BIOENTITY 
Orlistat|N|xenical|phenytoin|BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 normalweight_LE1 subject_LE1 receive_LE1 BIOGENERAL_LE1 NUM_LE1 mg_LE1 three_LE1 time_LE1 day_LE1 for_LE1 NUM_LE1 day_LE1 BIOENTITY do_BE12 not_BE12 alter_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 single_BE12 mg_BE12 dose_BE12 of_BE12 BIOENTITY 
Orlistat|N|phenytoin|phenytoin|BIOENTITY :_BE12 In_BE12 NUM_BE12 normalweight_BE12 subject_BE12 receive_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 alter_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 single_BE12 mg_BE12 dose_BE12 of_BE12 BIOENTITY 
Orlistat|N|xenical|xenical|BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 normalweight_LE1 subject_LE1 receive_LE1 BIOENTITY NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOENTITY do_RE2 not_RE2 alter_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 single_RE2 mg_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 
Orlistat|N|phenytoin|xenical|BIOENTITY :_BE12 In_BE12 NUM_BE12 normalweight_BE12 subject_BE12 receive_BE12 BIOENTITY NUM_RE2 mg_RE2 three_RE2 time_RE2 day_RE2 for_RE2 NUM_RE2 day_RE2 BIOGENERAL_RE2 do_RE2 not_RE2 alter_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 single_RE2 mg_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 
Orlistat|N|phenytoin|xenical|BIOENTITY :_BE12 In_BE12 NUM_BE12 normalweight_BE12 subject_BE12 receive_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOENTITY do_RE2 not_RE2 alter_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 single_RE2 mg_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 
Orlistat|N|pravastatin|pravastatin|BIOENTITY :_BE12 In_BE12 way_BE12 crossover_BE12 study_BE12 of_BE12 NUM_BE12 normalweight_BE12 mild_BE12 hypercholesterolemic_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 affect_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY 
Orlistat|N|xenical|pravastatin|BIOGENERAL_LE1 :_LE1 In_LE1 way_LE1 crossover_LE1 study_LE1 of_LE1 NUM_LE1 normalweight_LE1 mild_LE1 hypercholesterolemic_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 NUM_LE1 mg_LE1 three_LE1 time_LE1 day_LE1 for_LE1 NUM_LE1 day_LE1 BIOENTITY do_BE12 not_BE12 affect_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY 
Orlistat|N|xenical|pravastatin|BIOGENERAL_LE1 :_LE1 In_LE1 way_LE1 crossover_LE1 study_LE1 of_LE1 NUM_LE1 normalweight_LE1 mild_LE1 hypercholesterolemic_LE1 patient_LE1 receive_LE1 BIOENTITY NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 affect_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY 
Orlistat|N|pravastatin|xenical|BIOENTITY :_BE12 In_BE12 way_BE12 crossover_BE12 study_BE12 of_BE12 NUM_BE12 normalweight_BE12 mild_BE12 hypercholesterolemic_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOENTITY do_RE2 not_RE2 affect_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 
Orlistat|N|pravastatin|xenical|BIOENTITY :_BE12 In_BE12 way_BE12 crossover_BE12 study_BE12 of_BE12 NUM_BE12 normalweight_BE12 mild_BE12 hypercholesterolemic_BE12 patient_BE12 receive_BE12 BIOENTITY NUM_RE2 mg_RE2 three_RE2 time_RE2 day_RE2 for_RE2 NUM_RE2 day_RE2 BIOGENERAL_RE2 do_RE2 not_RE2 affect_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 
Orlistat|N|xenical|xenical|BIOGENERAL_LE1 :_LE1 In_LE1 way_LE1 crossover_LE1 study_LE1 of_LE1 NUM_LE1 normalweight_LE1 mild_LE1 hypercholesterolemic_LE1 patient_LE1 receive_LE1 BIOENTITY NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 BIOENTITY do_RE2 not_RE2 affect_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 
Orlistat|N|warfarin|warfarin|BIOENTITY :_BE12 In_BE12 NUM_BE12 normalweight_BE12 subject_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 do_BE12 not_BE12 result_BE12 in_BE12 any_BE12 change_BE12 in_BE12 either_BE12 BIOENTITY pharmacokinetic_RE2 -LRB-_RE2 both_RE2 and_RE2 senantiomers_RE2 -RRB-_RE2 or_RE2 pharmacodynamic_RE2 -LRB-_RE2 prothrombin_RE2 time_RE2 and_RE2 serum_RE2 factor_RE2 vii_RE2 rrb._RE2 
Orlistat|N|xenical|warfarin|BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 normalweight_LE1 subject_LE1 administration_LE1 of_LE1 BIOENTITY NUM_BE12 mg_BE12 three_BE12 time_BE12 day_BE12 for_BE12 NUM_BE12 day_BE12 do_BE12 not_BE12 result_BE12 in_BE12 any_BE12 change_BE12 in_BE12 either_BE12 BIOENTITY pharmacokinetic_RE2 -LRB-_RE2 both_RE2 and_RE2 senantiomers_RE2 -RRB-_RE2 or_RE2 pharmacodynamic_RE2 -LRB-_RE2 prothrombin_RE2 time_RE2 and_RE2 serum_RE2 factor_RE2 vii_RE2 rrb._RE2 
Orlistat|N|warfarin|xenical|BIOENTITY :_BE12 In_BE12 NUM_BE12 normalweight_BE12 subject_BE12 administration_BE12 of_BE12 BIOENTITY NUM_RE2 mg_RE2 three_RE2 time_RE2 day_RE2 for_RE2 NUM_RE2 day_RE2 do_RE2 not_RE2 result_RE2 in_RE2 any_RE2 change_RE2 in_RE2 either_RE2 BIOGENERAL_RE2 pharmacokinetic_RE2 -LRB-_RE2 both_RE2 and_RE2 senantiomers_RE2 -RRB-_RE2 or_RE2 pharmacodynamic_RE2 -LRB-_RE2 prothrombin_RE2 time_RE2 and_RE2 serum_RE2 factor_RE2 vii_RE2 rrb._RE2 
Orlistat|N|xenical|xenical|although_LE1 undercarboxylated_LE1 osteocalcin_LE1 marker_LE1 of_LE1 vitamin_LE1 nutritional_LE1 status_LE1 be_LE1 unaltered_LE1 with_LE1 BIOENTITY administration_BE12 vitamin_BE12 level_BE12 tend_BE12 to_BE12 decline_BE12 in_BE12 subject_BE12 take_BE12 BIOENTITY 
Orlistat|N|xenical|xenical|therefore_LE1 as_LE1 BIOGENERAL_LE1 absorption_LE1 may_LE1 be_LE1 decrease_LE1 with_LE1 BIOENTITY patient_BE12 on_BE12 chronic_BE12 stable_BE12 dose_BE12 of_BE12 BIOGENERAL_BE12 who_BE12 be_BE12 prescribe_BE12 BIOENTITY shall_RE2 be_RE2 monitor_RE2 close_RE2 for_RE2 change_RE2 in_RE2 coagulation_RE2 parameter_RE2 
Orlistat|N|xenical|xenical|therefore_LE1 as_LE1 BIOGENERAL_LE1 absorption_LE1 may_LE1 be_LE1 decrease_LE1 with_LE1 BIOENTITY patient_BE12 on_BE12 chronic_BE12 stable_BE12 dose_BE12 of_BE12 BIOGENERAL_BE12 who_BE12 be_BE12 prescribe_BE12 BIOENTITY shall_RE2 be_RE2 monitor_RE2 close_RE2 for_RE2 change_RE2 in_RE2 coagulation_RE2 parameter_RE2 
Orlistat|N|xenical|warfarin|therefore_LE1 as_LE1 BIOGENERAL_LE1 absorption_LE1 may_LE1 be_LE1 decrease_LE1 with_LE1 BIOENTITY patient_BE12 on_BE12 chronic_BE12 stable_BE12 dose_BE12 of_BE12 BIOENTITY who_RE2 be_RE2 prescribe_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 monitor_RE2 close_RE2 for_RE2 change_RE2 in_RE2 coagulation_RE2 parameter_RE2 
Orlistat|N|vitamin k|xenical|therefore_LE1 as_LE1 BIOENTITY absorption_BE12 may_BE12 be_BE12 decrease_BE12 with_BE12 BIOGENERAL_BE12 patient_BE12 on_BE12 chronic_BE12 stable_BE12 dose_BE12 of_BE12 BIOGENERAL_BE12 who_BE12 be_BE12 prescribe_BE12 BIOENTITY shall_RE2 be_RE2 monitor_RE2 close_RE2 for_RE2 change_RE2 in_RE2 coagulation_RE2 parameter_RE2 
Orlistat|N|vitamin k|xenical|therefore_LE1 as_LE1 BIOENTITY absorption_BE12 may_BE12 be_BE12 decrease_BE12 with_BE12 BIOGENERAL_BE12 patient_BE12 on_BE12 chronic_BE12 stable_BE12 dose_BE12 of_BE12 BIOGENERAL_BE12 who_BE12 be_BE12 prescribe_BE12 BIOENTITY shall_RE2 be_RE2 monitor_RE2 close_RE2 for_RE2 change_RE2 in_RE2 coagulation_RE2 parameter_RE2 
Orlistat|N|vitamin k|warfarin|therefore_LE1 as_LE1 BIOENTITY absorption_BE12 may_BE12 be_BE12 decrease_BE12 with_BE12 BIOGENERAL_BE12 patient_BE12 on_BE12 chronic_BE12 stable_BE12 dose_BE12 of_BE12 BIOENTITY who_RE2 be_RE2 prescribe_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 monitor_RE2 close_RE2 for_RE2 change_RE2 in_RE2 coagulation_RE2 parameter_RE2 
Oxacillin|N|antibiotic|penicillin|BIOGENERAL_LE1 bacteriostatic_LE1 BIOENTITY may_BE12 antagonize_BE12 the_BE12 bactericidal_BE12 effect_BE12 of_BE12 BIOENTITY and_RE2 concurrent_RE2 use_RE2 of_RE2 these_RE2 drug_RE2 shall_RE2 be_RE2 avoid_RE2 
Oxacillin|N|tetracycline|antibiotic|BIOENTITY bacteriostatic_BE12 BIOENTITY may_RE2 antagonize_RE2 the_RE2 bactericidal_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 concurrent_RE2 use_RE2 of_RE2 these_RE2 drug_RE2 shall_RE2 be_RE2 avoid_RE2 
Oxaliplatin|N|eloxatin|5-fu|no_LE1 pharmacokinetic_LE1 interaction_LE1 between_LE1 NUM_LE1 mg_LE1 BIOENTITY and_BE12 infusional_BE12 BIOENTITY have_RE2 be_RE2 observe_RE2 in_RE2 patient_RE2 treat_RE2 every_RE2 NUM_RE2 week_RE2 
Oxandrolone|N|anticoagulant|anticoagulant|BIOENTITY BIOGENERAL_BE12 may_BE12 increase_BE12 sensitivity_BE12 to_BE12 oral_BE12 BIOENTITY 
Oxandrolone|N|anticoagulant|anabolic steroid|BIOENTITY BIOENTITY may_RE2 increase_RE2 sensitivity_RE2 to_RE2 oral_RE2 BIOGENERAL_RE2 
Oxandrolone|N|warfarin|oxandrolone|BIOENTITY :_BE12 multidose_BE12 study_BE12 of_BE12 BIOENTITY give_RE2 as_RE2 NUM_RE2 or_RE2 NUM_RE2 mg_RE2 bid_RE2 in_RE2 NUM_RE2 healthy_RE2 subject_RE2 concurrent_RE2 treat_RE2 with_RE2 BIOGENERAL_RE2 result_RE2 in_RE2 mean_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 halflife_RE2 from_RE2 NUM_RE2 to_RE2 NUM_RE2 hour_RE2 and_RE2 auc_RE2 from_RE2 to_RE2 ng_RE2 hr_RE2 :_RE2 similar_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 halflife_RE2 and_RE2 auc_RE2 be_RE2 also_RE2 detect_RE2 
Oxandrolone|N|warfarin|warfarin|BIOENTITY :_BE12 multidose_BE12 study_BE12 of_BE12 BIOGENERAL_BE12 give_BE12 as_BE12 NUM_BE12 or_BE12 NUM_BE12 mg_BE12 bid_BE12 in_BE12 NUM_BE12 healthy_BE12 subject_BE12 concurrent_BE12 treat_BE12 with_BE12 BIOENTITY result_RE2 in_RE2 mean_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 halflife_RE2 from_RE2 NUM_RE2 to_RE2 NUM_RE2 hour_RE2 and_RE2 auc_RE2 from_RE2 to_RE2 ng_RE2 hr_RE2 :_RE2 similar_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 halflife_RE2 and_RE2 auc_RE2 be_RE2 also_RE2 detect_RE2 
Oxandrolone|N|warfarin|s-warfarin|BIOENTITY :_BE12 multidose_BE12 study_BE12 of_BE12 BIOGENERAL_BE12 give_BE12 as_BE12 NUM_BE12 or_BE12 NUM_BE12 mg_BE12 bid_BE12 in_BE12 NUM_BE12 healthy_BE12 subject_BE12 concurrent_BE12 treat_BE12 with_BE12 BIOGENERAL_BE12 result_BE12 in_BE12 mean_BE12 increase_BE12 in_BE12 BIOENTITY halflife_RE2 from_RE2 NUM_RE2 to_RE2 NUM_RE2 hour_RE2 and_RE2 auc_RE2 from_RE2 to_RE2 ng_RE2 hr_RE2 :_RE2 similar_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 halflife_RE2 and_RE2 auc_RE2 be_RE2 also_RE2 detect_RE2 
Oxandrolone|N|warfarin|r-warfarin|BIOENTITY :_BE12 multidose_BE12 study_BE12 of_BE12 BIOGENERAL_BE12 give_BE12 as_BE12 NUM_BE12 or_BE12 NUM_BE12 mg_BE12 bid_BE12 in_BE12 NUM_BE12 healthy_BE12 subject_BE12 concurrent_BE12 treat_BE12 with_BE12 BIOGENERAL_BE12 result_BE12 in_BE12 mean_BE12 increase_BE12 in_BE12 BIOGENERAL_BE12 halflife_BE12 from_BE12 NUM_BE12 to_BE12 NUM_BE12 hour_BE12 and_BE12 auc_BE12 from_BE12 to_BE12 ng_BE12 hr_BE12 :_BE12 similar_BE12 increase_BE12 in_BE12 BIOENTITY halflife_RE2 and_RE2 auc_RE2 be_RE2 also_RE2 detect_RE2 
Oxandrolone|N|oxandrolone|s-warfarin|BIOGENERAL_LE1 :_LE1 multidose_LE1 study_LE1 of_LE1 BIOENTITY give_BE12 as_BE12 NUM_BE12 or_BE12 NUM_BE12 mg_BE12 bid_BE12 in_BE12 NUM_BE12 healthy_BE12 subject_BE12 concurrent_BE12 treat_BE12 with_BE12 BIOGENERAL_BE12 result_BE12 in_BE12 mean_BE12 increase_BE12 in_BE12 BIOENTITY halflife_RE2 from_RE2 NUM_RE2 to_RE2 NUM_RE2 hour_RE2 and_RE2 auc_RE2 from_RE2 to_RE2 ng_RE2 hr_RE2 :_RE2 similar_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 halflife_RE2 and_RE2 auc_RE2 be_RE2 also_RE2 detect_RE2 
Oxandrolone|N|oxandrolone|r-warfarin|BIOGENERAL_LE1 :_LE1 multidose_LE1 study_LE1 of_LE1 BIOENTITY give_BE12 as_BE12 NUM_BE12 or_BE12 NUM_BE12 mg_BE12 bid_BE12 in_BE12 NUM_BE12 healthy_BE12 subject_BE12 concurrent_BE12 treat_BE12 with_BE12 BIOGENERAL_BE12 result_BE12 in_BE12 mean_BE12 increase_BE12 in_BE12 BIOGENERAL_BE12 halflife_BE12 from_BE12 NUM_BE12 to_BE12 NUM_BE12 hour_BE12 and_BE12 auc_BE12 from_BE12 to_BE12 ng_BE12 hr_BE12 :_BE12 similar_BE12 increase_BE12 in_BE12 BIOENTITY halflife_RE2 and_RE2 auc_RE2 be_RE2 also_RE2 detect_RE2 
Oxandrolone|N|warfarin|s-warfarin|BIOGENERAL_LE1 :_LE1 multidose_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 give_LE1 as_LE1 NUM_LE1 or_LE1 NUM_LE1 mg_LE1 bid_LE1 in_LE1 NUM_LE1 healthy_LE1 subject_LE1 concurrent_LE1 treat_LE1 with_LE1 BIOENTITY result_BE12 in_BE12 mean_BE12 increase_BE12 in_BE12 BIOENTITY halflife_RE2 from_RE2 NUM_RE2 to_RE2 NUM_RE2 hour_RE2 and_RE2 auc_RE2 from_RE2 to_RE2 ng_RE2 hr_RE2 :_RE2 similar_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 halflife_RE2 and_RE2 auc_RE2 be_RE2 also_RE2 detect_RE2 
Oxandrolone|N|warfarin|r-warfarin|BIOGENERAL_LE1 :_LE1 multidose_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 give_LE1 as_LE1 NUM_LE1 or_LE1 NUM_LE1 mg_LE1 bid_LE1 in_LE1 NUM_LE1 healthy_LE1 subject_LE1 concurrent_LE1 treat_LE1 with_LE1 BIOENTITY result_BE12 in_BE12 mean_BE12 increase_BE12 in_BE12 BIOGENERAL_BE12 halflife_BE12 from_BE12 NUM_BE12 to_BE12 NUM_BE12 hour_BE12 and_BE12 auc_BE12 from_BE12 to_BE12 ng_BE12 hr_BE12 :_BE12 similar_BE12 increase_BE12 in_BE12 BIOENTITY halflife_RE2 and_RE2 auc_RE2 be_RE2 also_RE2 detect_RE2 
Oxandrolone|N|s-warfarin|r-warfarin|BIOGENERAL_LE1 :_LE1 multidose_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 give_LE1 as_LE1 NUM_LE1 or_LE1 NUM_LE1 mg_LE1 bid_LE1 in_LE1 NUM_LE1 healthy_LE1 subject_LE1 concurrent_LE1 treat_LE1 with_LE1 BIOGENERAL_LE1 result_LE1 in_LE1 mean_LE1 increase_LE1 in_LE1 BIOENTITY halflife_BE12 from_BE12 NUM_BE12 to_BE12 NUM_BE12 hour_BE12 and_BE12 auc_BE12 from_BE12 to_BE12 ng_BE12 hr_BE12 :_BE12 similar_BE12 increase_BE12 in_BE12 BIOENTITY halflife_RE2 and_RE2 auc_RE2 be_RE2 also_RE2 detect_RE2 
Oxandrolone|N|warfarin|warfarin|.fold_LE1 decrease_LE1 in_LE1 the_LE1 mean_LE1 BIOENTITY dose_BE12 from_BE12 mg_BE12 to_BE12 mg_BE12 -LRB-_BE12 approximate_BE12 NUM_BE12 reduction_BE12 of_BE12 BIOENTITY dose_RE2 -RRB-_RE2 be_RE2 necessary_RE2 to_RE2 maintain_RE2 target_RE2 inr_RE2 of_RE2 
Oxandrolone|N|warfarin|warfarin|when_LE1 BIOGENERAL_LE1 therapy_LE1 be_LE1 initiate_LE1 in_LE1 patient_LE1 already_LE1 receive_LE1 treatment_LE1 with_LE1 BIOENTITY the_BE12 inr_BE12 or_BE12 prothrombin_BE12 time_BE12 -LRB-_BE12 pt_BE12 -RRB-_BE12 shall_BE12 be_BE12 monitor_BE12 close_BE12 and_BE12 the_BE12 dose_BE12 of_BE12 BIOENTITY adjust_RE2 as_RE2 necessary_RE2 until_RE2 stable_RE2 target_RE2 inr_RE2 or_RE2 pt_RE2 have_RE2 be_RE2 achieve_RE2 
Oxandrolone|N|oxandrolone|warfarin|when_LE1 BIOENTITY therapy_BE12 be_BE12 initiate_BE12 in_BE12 patient_BE12 already_BE12 receive_BE12 treatment_BE12 with_BE12 BIOGENERAL_BE12 the_BE12 inr_BE12 or_BE12 prothrombin_BE12 time_BE12 -LRB-_BE12 pt_BE12 -RRB-_BE12 shall_BE12 be_BE12 monitor_BE12 close_BE12 and_BE12 the_BE12 dose_BE12 of_BE12 BIOENTITY adjust_RE2 as_RE2 necessary_RE2 until_RE2 stable_RE2 target_RE2 inr_RE2 or_RE2 pt_RE2 have_RE2 be_RE2 achieve_RE2 
Oxandrolone|N|hypoglycemic agent|oxandrolone|oral_LE1 BIOENTITY BIOENTITY may_RE2 inhibit_RE2 the_RE2 metabolism_RE2 of_RE2 oral_RE2 BIOGENERAL_RE2 
Oxandrolone|N|hypoglycemic agent|hypoglycemic agent|oral_LE1 BIOENTITY BIOGENERAL_BE12 may_BE12 inhibit_BE12 the_BE12 metabolism_BE12 of_BE12 oral_BE12 BIOENTITY 
Oxandrolone|N|adrenal steroid|acth|BIOENTITY or_BE12 BIOENTITY In_RE2 patient_RE2 with_RE2 edema_RE2 concomitant_RE2 administration_RE2 with_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 increase_RE2 the_RE2 edema_RE2 
Oxandrolone|N|adrenal steroid|adrenal cortical steroid|BIOENTITY or_BE12 BIOGENERAL_BE12 In_BE12 patient_BE12 with_BE12 edema_BE12 concomitant_BE12 administration_BE12 with_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 may_RE2 increase_RE2 the_RE2 edema_RE2 
Oxandrolone|N|adrenal steroid|acth|BIOENTITY or_BE12 BIOGENERAL_BE12 In_BE12 patient_BE12 with_BE12 edema_BE12 concomitant_BE12 administration_BE12 with_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY may_RE2 increase_RE2 the_RE2 edema_RE2 
Oxandrolone|N|acth|adrenal cortical steroid|BIOGENERAL_LE1 or_LE1 BIOENTITY In_BE12 patient_BE12 with_BE12 edema_BE12 concomitant_BE12 administration_BE12 with_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 may_RE2 increase_RE2 the_RE2 edema_RE2 
Oxandrolone|N|acth|acth|BIOGENERAL_LE1 or_LE1 BIOENTITY In_BE12 patient_BE12 with_BE12 edema_BE12 concomitant_BE12 administration_BE12 with_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY may_RE2 increase_RE2 the_RE2 edema_RE2 
Oxandrolone|N|adrenal cortical steroid|acth|BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 In_LE1 patient_LE1 with_LE1 edema_LE1 concomitant_LE1 administration_LE1 with_LE1 BIOENTITY or_BE12 BIOENTITY may_RE2 increase_RE2 the_RE2 edema_RE2 
Oxandrolone|N|adrenal cortical steroid|acth|BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 In_LE1 patient_LE1 with_LE1 edema_LE1 concomitant_LE1 administration_LE1 with_LE1 BIOENTITY or_BE12 BIOENTITY may_RE2 increase_RE2 the_RE2 edema_RE2 
Oxybutynin|N|oxybutynin chloride|ditropan xl|mean_LE1 BIOENTITY plasma_BE12 concentration_BE12 be_BE12 approximate_BE12 NUM_BE12 fold_BE12 high_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 with_RE2 BIOGENERAL_RE2 potent_RE2 cypa_RE2 inhibitor_RE2 
Oxybutynin|N|oxybutynin chloride|ketoconazole|mean_LE1 BIOENTITY plasma_BE12 concentration_BE12 be_BE12 approximate_BE12 NUM_BE12 fold_BE12 high_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 with_BE12 BIOENTITY potent_RE2 cypa_RE2 inhibitor_RE2 
Oxybutynin|N|antimycotic agent|clarithromycin|other_LE1 inhibitor_LE1 of_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 may_RE2 alter_RE2 BIOGENERAL_RE2 mean_RE2 pharmacokinetic_RE2 parameter_RE2 -LRB-_RE2 i.e._RE2 cmax_RE2 and_RE2 auc_RE2 rrb._RE2 
Oxybutynin|N|antimycotic agent|itraconazole|other_LE1 inhibitor_LE1 of_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 alter_RE2 BIOGENERAL_RE2 mean_RE2 pharmacokinetic_RE2 parameter_RE2 -LRB-_RE2 i.e._RE2 cmax_RE2 and_RE2 auc_RE2 rrb._RE2 
Oxybutynin|N|antimycotic agent|miconazole|other_LE1 inhibitor_LE1 of_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 alter_RE2 BIOGENERAL_RE2 mean_RE2 pharmacokinetic_RE2 parameter_RE2 -LRB-_RE2 i.e._RE2 cmax_RE2 and_RE2 auc_RE2 rrb._RE2 
Oxybutynin|N|antimycotic agent|macrolide antibiotic|other_LE1 inhibitor_LE1 of_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 alter_RE2 BIOGENERAL_RE2 mean_RE2 pharmacokinetic_RE2 parameter_RE2 -LRB-_RE2 i.e._RE2 cmax_RE2 and_RE2 auc_RE2 rrb._RE2 
Oxybutynin|N|antimycotic agent|erythromycin|other_LE1 inhibitor_LE1 of_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 alter_RE2 BIOGENERAL_RE2 mean_RE2 pharmacokinetic_RE2 parameter_RE2 -LRB-_RE2 i.e._RE2 cmax_RE2 and_RE2 auc_RE2 rrb._RE2 
Oxybutynin|N|itraconazole|clarithromycin|other_LE1 inhibitor_LE1 of_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 may_RE2 alter_RE2 BIOGENERAL_RE2 mean_RE2 pharmacokinetic_RE2 parameter_RE2 -LRB-_RE2 i.e._RE2 cmax_RE2 and_RE2 auc_RE2 rrb._RE2 
Oxybutynin|N|miconazole|clarithromycin|other_LE1 inhibitor_LE1 of_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 may_RE2 alter_RE2 BIOGENERAL_RE2 mean_RE2 pharmacokinetic_RE2 parameter_RE2 -LRB-_RE2 i.e._RE2 cmax_RE2 and_RE2 auc_RE2 rrb._RE2 
Oxybutynin|N|macrolide antibiotic|clarithromycin|other_LE1 inhibitor_LE1 of_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 may_RE2 alter_RE2 BIOGENERAL_RE2 mean_RE2 pharmacokinetic_RE2 parameter_RE2 -LRB-_RE2 i.e._RE2 cmax_RE2 and_RE2 auc_RE2 rrb._RE2 
Oxybutynin|N|erythromycin|clarithromycin|other_LE1 inhibitor_LE1 of_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 may_RE2 alter_RE2 BIOGENERAL_RE2 mean_RE2 pharmacokinetic_RE2 parameter_RE2 -LRB-_RE2 i.e._RE2 cmax_RE2 and_RE2 auc_RE2 rrb._RE2 
Oxybutynin|N|itraconazole|miconazole|other_LE1 inhibitor_LE1 of_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 alter_RE2 BIOGENERAL_RE2 mean_RE2 pharmacokinetic_RE2 parameter_RE2 -LRB-_RE2 i.e._RE2 cmax_RE2 and_RE2 auc_RE2 rrb._RE2 
Oxybutynin|N|itraconazole|macrolide antibiotic|other_LE1 inhibitor_LE1 of_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 alter_RE2 BIOGENERAL_RE2 mean_RE2 pharmacokinetic_RE2 parameter_RE2 -LRB-_RE2 i.e._RE2 cmax_RE2 and_RE2 auc_RE2 rrb._RE2 
Oxybutynin|N|itraconazole|erythromycin|other_LE1 inhibitor_LE1 of_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 alter_RE2 BIOGENERAL_RE2 mean_RE2 pharmacokinetic_RE2 parameter_RE2 -LRB-_RE2 i.e._RE2 cmax_RE2 and_RE2 auc_RE2 rrb._RE2 
Oxybutynin|N|miconazole|macrolide antibiotic|other_LE1 inhibitor_LE1 of_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 alter_RE2 BIOGENERAL_RE2 mean_RE2 pharmacokinetic_RE2 parameter_RE2 -LRB-_RE2 i.e._RE2 cmax_RE2 and_RE2 auc_RE2 rrb._RE2 
Oxybutynin|N|miconazole|erythromycin|other_LE1 inhibitor_LE1 of_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 alter_RE2 BIOGENERAL_RE2 mean_RE2 pharmacokinetic_RE2 parameter_RE2 -LRB-_RE2 i.e._RE2 cmax_RE2 and_RE2 auc_RE2 rrb._RE2 
Oxybutynin|N|macrolide antibiotic|erythromycin|other_LE1 inhibitor_LE1 of_LE1 the_LE1 cytochrome_LE1 enzyme_LE1 system_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 alter_RE2 BIOGENERAL_RE2 mean_RE2 pharmacokinetic_RE2 parameter_RE2 -LRB-_RE2 i.e._RE2 cmax_RE2 and_RE2 auc_RE2 rrb._RE2 
Oxybutynin|N|antacid|antacid|concurrent_LE1 ingestion_LE1 of_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 ml_BE12 of_BE12 BIOENTITY containing_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 do_RE2 not_RE2 significant_RE2 affect_RE2 the_RE2 exposure_RE2 of_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Oxybutynin|N|antacid|aluminum hydroxide|concurrent_LE1 ingestion_LE1 of_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 ml_BE12 of_BE12 BIOGENERAL_BE12 containing_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 do_RE2 not_RE2 significant_RE2 affect_RE2 the_RE2 exposure_RE2 of_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Oxybutynin|N|antacid|magnesium hydroxide|concurrent_LE1 ingestion_LE1 of_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 ml_BE12 of_BE12 BIOGENERAL_BE12 containing_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 do_RE2 not_RE2 significant_RE2 affect_RE2 the_RE2 exposure_RE2 of_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Oxybutynin|N|antacid|simethicone|concurrent_LE1 ingestion_LE1 of_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 ml_BE12 of_BE12 BIOGENERAL_BE12 containing_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 do_RE2 not_RE2 significant_RE2 affect_RE2 the_RE2 exposure_RE2 of_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Oxybutynin|N|antacid|oxybutynin|concurrent_LE1 ingestion_LE1 of_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 ml_BE12 of_BE12 BIOGENERAL_BE12 containing_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 do_BE12 not_BE12 significant_BE12 affect_BE12 the_BE12 exposure_BE12 of_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Oxybutynin|N|antacid|desethyloxybutynin|concurrent_LE1 ingestion_LE1 of_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 ml_BE12 of_BE12 BIOGENERAL_BE12 containing_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 do_BE12 not_BE12 significant_BE12 affect_BE12 the_BE12 exposure_BE12 of_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Oxybutynin|N|antacid|aluminum hydroxide|concurrent_LE1 ingestion_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 ml_LE1 of_LE1 BIOENTITY containing_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 do_RE2 not_RE2 significant_RE2 affect_RE2 the_RE2 exposure_RE2 of_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Oxybutynin|N|antacid|magnesium hydroxide|concurrent_LE1 ingestion_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 ml_LE1 of_LE1 BIOENTITY containing_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 do_RE2 not_RE2 significant_RE2 affect_RE2 the_RE2 exposure_RE2 of_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Oxybutynin|N|antacid|simethicone|concurrent_LE1 ingestion_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 ml_LE1 of_LE1 BIOENTITY containing_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 do_RE2 not_RE2 significant_RE2 affect_RE2 the_RE2 exposure_RE2 of_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Oxybutynin|N|antacid|oxybutynin|concurrent_LE1 ingestion_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 ml_LE1 of_LE1 BIOENTITY containing_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 do_BE12 not_BE12 significant_BE12 affect_BE12 the_BE12 exposure_BE12 of_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Oxybutynin|N|antacid|desethyloxybutynin|concurrent_LE1 ingestion_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 ml_LE1 of_LE1 BIOENTITY containing_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 do_BE12 not_BE12 significant_BE12 affect_BE12 the_BE12 exposure_BE12 of_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Oxybutynin|N|aluminum hydroxide|magnesium hydroxide|concurrent_LE1 ingestion_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 ml_LE1 of_LE1 BIOGENERAL_LE1 containing_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 do_RE2 not_RE2 significant_RE2 affect_RE2 the_RE2 exposure_RE2 of_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Oxybutynin|N|aluminum hydroxide|simethicone|concurrent_LE1 ingestion_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 ml_LE1 of_LE1 BIOGENERAL_LE1 containing_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 do_RE2 not_RE2 significant_RE2 affect_RE2 the_RE2 exposure_RE2 of_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Oxybutynin|N|aluminum hydroxide|oxybutynin|concurrent_LE1 ingestion_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 ml_LE1 of_LE1 BIOGENERAL_LE1 containing_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 do_BE12 not_BE12 significant_BE12 affect_BE12 the_BE12 exposure_BE12 of_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Oxybutynin|N|aluminum hydroxide|desethyloxybutynin|concurrent_LE1 ingestion_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 ml_LE1 of_LE1 BIOGENERAL_LE1 containing_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 do_BE12 not_BE12 significant_BE12 affect_BE12 the_BE12 exposure_BE12 of_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Oxybutynin|N|magnesium hydroxide|simethicone|concurrent_LE1 ingestion_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 ml_LE1 of_LE1 BIOGENERAL_LE1 containing_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 do_RE2 not_RE2 significant_RE2 affect_RE2 the_RE2 exposure_RE2 of_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Oxybutynin|N|magnesium hydroxide|simethicone|concurrent_LE1 ingestion_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 ml_LE1 of_LE1 BIOGENERAL_LE1 containing_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 do_RE2 not_RE2 significant_RE2 affect_RE2 the_RE2 exposure_RE2 of_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Oxybutynin|N|magnesium hydroxide|oxybutynin|concurrent_LE1 ingestion_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 ml_LE1 of_LE1 BIOGENERAL_LE1 containing_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 do_BE12 not_BE12 significant_BE12 affect_BE12 the_BE12 exposure_BE12 of_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Oxybutynin|N|magnesium hydroxide|desethyloxybutynin|concurrent_LE1 ingestion_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 ml_LE1 of_LE1 BIOGENERAL_LE1 containing_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 do_BE12 not_BE12 significant_BE12 affect_BE12 the_BE12 exposure_BE12 of_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Oxybutynin|N|simethicone|oxybutynin|concurrent_LE1 ingestion_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 ml_LE1 of_LE1 BIOGENERAL_LE1 containing_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 do_BE12 not_BE12 significant_BE12 affect_BE12 the_BE12 exposure_BE12 of_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Oxybutynin|N|simethicone|desethyloxybutynin|concurrent_LE1 ingestion_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 ml_LE1 of_LE1 BIOGENERAL_LE1 containing_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 do_BE12 not_BE12 significant_BE12 affect_BE12 the_BE12 exposure_BE12 of_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Oxybutynin|N|oxybutynin|desethyloxybutynin|concurrent_LE1 ingestion_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 ml_LE1 of_LE1 BIOGENERAL_LE1 containing_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 do_LE1 not_LE1 significant_LE1 affect_LE1 the_LE1 exposure_LE1 of_LE1 BIOENTITY or_BE12 BIOENTITY 
Oxymorphone|N|cns depressant|hypnotic|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|cns depressant|sedative|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOENTITY including_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|cns depressant|tranquilizer|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|cns depressant|anesthetic|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 general_BE12 BIOENTITY BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|cns depressant|phenothiazine|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOENTITY other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|cns depressant|opioid|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|cns depressant|tricyclic antidepressant|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|cns depressant|monoamine oxidase (mao) inhibitor|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|cns depressant|alcohol|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|sedative|hypnotic|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|hypnotic|tranquilizer|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|hypnotic|tranquilizer|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|hypnotic|anesthetic|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 general_BE12 BIOENTITY BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|hypnotic|anesthetic|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 general_BE12 BIOENTITY BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|hypnotic|phenothiazine|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOENTITY other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|hypnotic|phenothiazine|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOENTITY other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|hypnotic|opioid|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|hypnotic|opioid|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|hypnotic|tricyclic antidepressant|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|hypnotic|tricyclic antidepressant|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|hypnotic|monoamine oxidase (mao) inhibitor|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|hypnotic|monoamine oxidase (mao) inhibitor|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|hypnotic|alcohol|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|hypnotic|alcohol|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|sedative|tranquilizer|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY general_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|sedative|anesthetic|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 general_BE12 BIOENTITY BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|sedative|phenothiazine|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOENTITY other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|sedative|opioid|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|sedative|tricyclic antidepressant|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|sedative|monoamine oxidase (mao) inhibitor|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|sedative|alcohol|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|tranquilizer|anesthetic|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY general_BE12 BIOENTITY BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|tranquilizer|anesthetic|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY general_BE12 BIOENTITY BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|tranquilizer|phenothiazine|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOENTITY other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|tranquilizer|phenothiazine|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOENTITY other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|tranquilizer|opioid|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|tranquilizer|opioid|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|tranquilizer|tricyclic antidepressant|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|tranquilizer|tricyclic antidepressant|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|tranquilizer|monoamine oxidase (mao) inhibitor|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|tranquilizer|monoamine oxidase (mao) inhibitor|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|tranquilizer|alcohol|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|tranquilizer|alcohol|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY general_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|anesthetic|phenothiazine|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOENTITY other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|anesthetic|phenothiazine|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOENTITY other_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|anesthetic|opioid|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOGENERAL_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|anesthetic|opioid|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOGENERAL_BE12 other_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|anesthetic|tricyclic antidepressant|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|anesthetic|tricyclic antidepressant|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|anesthetic|monoamine oxidase (mao) inhibitor|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|anesthetic|monoamine oxidase (mao) inhibitor|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|anesthetic|alcohol|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|anesthetic|alcohol|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOENTITY BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|phenothiazine|opioid|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|phenothiazine|opioid|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|phenothiazine|tricyclic antidepressant|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|phenothiazine|tricyclic antidepressant|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|phenothiazine|monoamine oxidase (mao) inhibitor|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|phenothiazine|monoamine oxidase (mao) inhibitor|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|phenothiazine|alcohol|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|phenothiazine|alcohol|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|opioid|tricyclic antidepressant|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY BIOENTITY -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|opioid|tricyclic antidepressant|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY BIOENTITY -LRB-_RE2 mao_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|opioid|monoamine oxidase (mao) inhibitor|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|opioid|monoamine oxidase (mao) inhibitor|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|opioid|alcohol|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|opioid|alcohol|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|tricyclic antidepressant|monoamine oxidase (mao) inhibitor|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|tricyclic antidepressant|monoamine oxidase (mao) inhibitor|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|tricyclic antidepressant|alcohol|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|tricyclic antidepressant|alcohol|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 mao_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|monoamine oxidase (mao) inhibitor|alcohol|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 mao_LE1 -RRB-_LE1 BIOENTITY and_BE12 BIOENTITY may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Oxymorphone|N|monoamine oxidase (mao) inhibitor|alcohol|the_LE1 concomitant_LE1 use_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 general_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 mao_LE1 -RRB-_LE1 BIOENTITY and_BE12 BIOENTITY may_RE2 produce_RE2 additive_RE2 cns_RE2 depressant_RE2 effect_RE2 
Paliperidone|N|invega|paliperidone|potential_LE1 for_LE1 BIOENTITY to_BE12 affect_BE12 other_BE12 drug_BE12 BIOENTITY be_RE2 not_RE2 expect_RE2 to_RE2 cause_RE2 clinical_RE2 important_RE2 pharmacokinetic_RE2 interaction_RE2 with_RE2 drug_RE2 that_RE2 be_RE2 metabolize_RE2 by_RE2 cytochrome_RE2 isozyme_RE2 
Paliperidone|N|paliperidone|invega|given_LE1 the_LE1 primary_LE1 cns_LE1 effect_LE1 of_LE1 BIOENTITY BIOENTITY shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 in_RE2 combination_RE2 with_RE2 other_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Paliperidone|N|centrally acting drug|alcohol|given_LE1 the_LE1 primary_LE1 cns_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 with_LE1 caution_LE1 in_LE1 combination_LE1 with_LE1 other_LE1 BIOENTITY and_BE12 BIOENTITY 
Paliperidone|N|levodopa|dopamine agonist|BIOGENERAL_LE1 may_LE1 antagonize_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY and_BE12 other_BE12 BIOENTITY 
Paliperidone|N|invega|paliperidone|potential_LE1 for_LE1 other_LE1 drug_LE1 to_LE1 affect_LE1 BIOENTITY BIOENTITY be_RE2 not_RE2 substrate_RE2 of_RE2 cypa_RE2 cypa_RE2 cypc_RE2 and_RE2 cypc_RE2 so_RE2 that_RE2 interaction_RE2 with_RE2 inhibitor_RE2 or_RE2 inducer_RE2 of_RE2 these_RE2 isozyme_RE2 be_RE2 unlikely_RE2 
Pantoprazole|N|pantoprazole|cisapride|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|theophylline|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|caffeine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|contraceptive|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|antipyrine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|levonorgestrel|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|ethanol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|diazepam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|carbamazepine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|glyburide|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|piroxicam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|diclofenac|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|digoxin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|desmethyldiazepam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|naproxen|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|ethinyl estradiol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|pantoprazole|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 other_BE12 drug_BE12 no_BE12 dosage_BE12 adjustment_BE12 be_BE12 need_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 the_BE12 follow_BE12 :_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|cisapride|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|caffeine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|contraceptive|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|antipyrine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|levonorgestrel|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|ethanol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|diazepam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|carbamazepine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|glyburide|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|piroxicam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|diclofenac|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|digoxin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|desmethyldiazepam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|naproxen|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|ethinyl estradiol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|cisapride|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|cisapride|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|caffeine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|contraceptive|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|antipyrine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|levonorgestrel|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|ethanol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|diazepam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|carbamazepine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|glyburide|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|piroxicam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|diclofenac|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|digoxin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|desmethyldiazepam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|naproxen|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|ethinyl estradiol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|theophylline|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|theophylline|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|contraceptive|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|caffeine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|levonorgestrel|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|ethanol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|diazepam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|carbamazepine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|glyburide|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|piroxicam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|diclofenac|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|digoxin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|desmethyldiazepam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|naproxen|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|ethinyl estradiol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|caffeine|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|caffeine|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|contraceptive|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|contraceptive|levonorgestrel|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethanol|contraceptive|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|contraceptive|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|contraceptive|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|glyburide|contraceptive|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|piroxicam|contraceptive|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diclofenac|contraceptive|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|digoxin|contraceptive|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|desmethyldiazepam|contraceptive|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|naproxen|contraceptive|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|contraceptive|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|contraceptive|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|contraceptive|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|contraceptive|ethinyl estradiol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|contraceptive|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|contraceptive|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|contraceptive|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|contraceptive|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|contraceptive|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|levonorgestrel|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|ethanol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|diazepam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|carbamazepine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|glyburide|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|piroxicam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|diclofenac|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|digoxin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|desmethyldiazepam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|naproxen|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|ethinyl estradiol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|antipyrine|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|antipyrine|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethanol|levonorgestrel|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|levonorgestrel|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|levonorgestrel|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|glyburide|levonorgestrel|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|piroxicam|levonorgestrel|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diclofenac|levonorgestrel|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|digoxin|levonorgestrel|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|desmethyldiazepam|levonorgestrel|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|naproxen|levonorgestrel|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|levonorgestrel|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|levonorgestrel|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|levonorgestrel|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|levonorgestrel|ethinyl estradiol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|levonorgestrel|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|levonorgestrel|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|levonorgestrel|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|levonorgestrel|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|levonorgestrel|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|ethanol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|ethanol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethanol|glyburide|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|piroxicam|ethanol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diclofenac|ethanol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|digoxin|ethanol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|desmethyldiazepam|ethanol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|naproxen|ethanol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethanol|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethanol|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethanol|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethanol|ethinyl estradiol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethanol|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethanol|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|ethanol|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethanol|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethanol|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|diazepam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY -LRB-_RE2 and_RE2 its_RE2 active_RE2 metabolite_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|glyburide|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|piroxicam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|diclofenac|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|digoxin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|desmethyldiazepam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|naproxen|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|ethinyl estradiol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|diazepam|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diazepam|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|glyburide|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|piroxicam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|diclofenac|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|digoxin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|desmethyldiazepam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|naproxen|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|ethinyl estradiol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|carbamazepine|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|carbamazepine|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 and_BE12 its_BE12 active_BE12 metabolite_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|piroxicam|glyburide|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diclofenac|glyburide|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|digoxin|glyburide|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|desmethyldiazepam|glyburide|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|naproxen|glyburide|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|glyburide|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|glyburide|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|glyburide|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|glyburide|ethinyl estradiol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|glyburide|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|glyburide|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|glyburide|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|glyburide|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|glyburide|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diclofenac|piroxicam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|piroxicam|digoxin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|desmethyldiazepam|piroxicam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|naproxen|piroxicam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|piroxicam|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|piroxicam|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|piroxicam|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|piroxicam|ethinyl estradiol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|piroxicam|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|piroxicam|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|piroxicam|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|piroxicam|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|piroxicam|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diclofenac|digoxin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|desmethyldiazepam|diclofenac|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diclofenac|naproxen|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diclofenac|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diclofenac|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diclofenac|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diclofenac|ethinyl estradiol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diclofenac|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diclofenac|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|diclofenac|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diclofenac|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|diclofenac|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|desmethyldiazepam|digoxin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|naproxen|digoxin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|digoxin|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|digoxin|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|digoxin|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|digoxin|ethinyl estradiol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|digoxin|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|digoxin|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|digoxin|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|digoxin|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|digoxin|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|desmethyldiazepam|naproxen|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|desmethyldiazepam|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|desmethyldiazepam|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|desmethyldiazepam|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|desmethyldiazepam|ethinyl estradiol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|desmethyldiazepam|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|desmethyldiazepam|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|desmethyldiazepam|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|desmethyldiazepam|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|desmethyldiazepam|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|naproxen|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|naproxen|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|naproxen|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|naproxen|ethinyl estradiol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|naproxen|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|naproxen|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|naproxen|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|naproxen|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|naproxen|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 oral_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|nifedipine|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|metoprolol|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethinyl estradiol|phenytoin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|phenytoin|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|phenytoin|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|phenytoin|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|phenytoin|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|phenytoin|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|metoprolol|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethinyl estradiol|nifedipine|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|nifedipine|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|nifedipine|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|nifedipine|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|nifedipine|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|nifedipine|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethinyl estradiol|metoprolol|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|metoprolol|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|metoprolol|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|metoprolol|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|metoprolol|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|metoprolol|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethinyl estradiol|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethinyl estradiol|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|ethinyl estradiol|warfarin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethinyl estradiol|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|ethinyl estradiol|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|metronidazole|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Pantoprazole|N|metronidazole|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Pantoprazole|N|warfarin|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|midazolam|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|clarithromycin|metronidazole|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|warfarin|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|midazolam|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|clarithromycin|amoxicillin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Pantoprazole|N|warfarin|midazolam|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|warfarin|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|midazolam|clarithromycin|Based_LE1 on_LE1 study_LE1 evaluate_LE1 possible_LE1 interaction_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 drug_LE1 no_LE1 dosage_LE1 adjustment_LE1 be_LE1 need_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 the_LE1 follow_LE1 :_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 and_LE1 its_LE1 active_LE1 metabolite_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Pantoprazole|N|pantoprazole|pantoprazole|therefore_LE1 when_LE1 coadminister_LE1 with_LE1 BIOENTITY adjustment_BE12 of_BE12 the_BE12 dosage_BE12 of_BE12 BIOENTITY or_RE2 of_RE2 such_RE2 drug_RE2 may_RE2 not_RE2 be_RE2 necessary_RE2 
Pantoprazole|N|proton pump inhibitor|pantoprazole|there_LE1 have_LE1 be_LE1 postmarketing_LE1 report_LE1 of_LE1 increase_LE1 inr_LE1 and_LE1 prothrombin_LE1 time_LE1 in_LE1 patient_LE1 receive_LE1 BIOENTITY including_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 concomitant_RE2 
Pantoprazole|N|ketoconazole|ampicillin|Because_LE1 of_LE1 profound_LE1 and_LE1 long_LE1 lasting_LE1 inhibition_LE1 of_LE1 gastric_LE1 acid_LE1 secretion_LE1 BIOGENERAL_LE1 may_LE1 interfere_LE1 with_LE1 absorption_LE1 of_LE1 drug_LE1 where_LE1 gastric_LE1 ph_LE1 be_LE1 important_LE1 determinant_LE1 of_LE1 their_LE1 bioavailability_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOENTITY ester_RE2 and_RE2 BIOGENERAL_RE2 salt_RE2 rrb._RE2 
Pantoprazole|N|ketoconazole|ampicillin|Because_LE1 of_LE1 profound_LE1 and_LE1 long_LE1 lasting_LE1 inhibition_LE1 of_LE1 gastric_LE1 acid_LE1 secretion_LE1 BIOGENERAL_LE1 may_LE1 interfere_LE1 with_LE1 absorption_LE1 of_LE1 drug_LE1 where_LE1 gastric_LE1 ph_LE1 be_LE1 important_LE1 determinant_LE1 of_LE1 their_LE1 bioavailability_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOENTITY ester_RE2 and_RE2 BIOGENERAL_RE2 salt_RE2 rrb._RE2 
Pantoprazole|N|ketoconazole|iron|Because_LE1 of_LE1 profound_LE1 and_LE1 long_LE1 lasting_LE1 inhibition_LE1 of_LE1 gastric_LE1 acid_LE1 secretion_LE1 BIOGENERAL_LE1 may_LE1 interfere_LE1 with_LE1 absorption_LE1 of_LE1 drug_LE1 where_LE1 gastric_LE1 ph_LE1 be_LE1 important_LE1 determinant_LE1 of_LE1 their_LE1 bioavailability_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 ester_BE12 and_BE12 BIOENTITY salt_RE2 rrb._RE2 
Pantoprazole|N|ketoconazole|iron|Because_LE1 of_LE1 profound_LE1 and_LE1 long_LE1 lasting_LE1 inhibition_LE1 of_LE1 gastric_LE1 acid_LE1 secretion_LE1 BIOGENERAL_LE1 may_LE1 interfere_LE1 with_LE1 absorption_LE1 of_LE1 drug_LE1 where_LE1 gastric_LE1 ph_LE1 be_LE1 important_LE1 determinant_LE1 of_LE1 their_LE1 bioavailability_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 ester_BE12 and_BE12 BIOENTITY salt_RE2 rrb._RE2 
Pantoprazole|N|ampicillin|iron|Because_LE1 of_LE1 profound_LE1 and_LE1 long_LE1 lasting_LE1 inhibition_LE1 of_LE1 gastric_LE1 acid_LE1 secretion_LE1 BIOGENERAL_LE1 may_LE1 interfere_LE1 with_LE1 absorption_LE1 of_LE1 drug_LE1 where_LE1 gastric_LE1 ph_LE1 be_LE1 important_LE1 determinant_LE1 of_LE1 their_LE1 bioavailability_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY ester_BE12 and_BE12 BIOENTITY salt_RE2 rrb._RE2 
Pantoprazole|N|ampicillin|iron|Because_LE1 of_LE1 profound_LE1 and_LE1 long_LE1 lasting_LE1 inhibition_LE1 of_LE1 gastric_LE1 acid_LE1 secretion_LE1 BIOGENERAL_LE1 may_LE1 interfere_LE1 with_LE1 absorption_LE1 of_LE1 drug_LE1 where_LE1 gastric_LE1 ph_LE1 be_LE1 important_LE1 determinant_LE1 of_LE1 their_LE1 bioavailability_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY ester_BE12 and_BE12 BIOENTITY salt_RE2 rrb._RE2 
Pantoprazole|N|thc|proton pump inhibitor|laboratory_LE1 test_LE1 there_LE1 have_LE1 be_LE1 report_LE1 of_LE1 falsepositive_LE1 urine_LE1 screening_LE1 test_LE1 for_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 in_BE12 patient_BE12 receive_BE12 many_BE12 BIOENTITY including_RE2 BIOGENERAL_RE2 
Pantoprazole|N|tetrahydrocannabinol|thc|laboratory_LE1 test_LE1 there_LE1 have_LE1 be_LE1 report_LE1 of_LE1 falsepositive_LE1 urine_LE1 screening_LE1 test_LE1 for_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 in_RE2 patient_RE2 receive_RE2 many_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 
Pantoprazole|N|thc|pantoprazole|laboratory_LE1 test_LE1 there_LE1 have_LE1 be_LE1 report_LE1 of_LE1 falsepositive_LE1 urine_LE1 screening_LE1 test_LE1 for_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 in_BE12 patient_BE12 receive_BE12 many_BE12 BIOGENERAL_BE12 including_BE12 BIOENTITY 
Pantoprazole|N|tetrahydrocannabinol|proton pump inhibitor|laboratory_LE1 test_LE1 there_LE1 have_LE1 be_LE1 report_LE1 of_LE1 falsepositive_LE1 urine_LE1 screening_LE1 test_LE1 for_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 in_BE12 patient_BE12 receive_BE12 many_BE12 BIOENTITY including_RE2 BIOGENERAL_RE2 
Pantoprazole|N|proton pump inhibitor|pantoprazole|laboratory_LE1 test_LE1 there_LE1 have_LE1 be_LE1 report_LE1 of_LE1 falsepositive_LE1 urine_LE1 screening_LE1 test_LE1 for_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 in_LE1 patient_LE1 receive_LE1 many_LE1 BIOENTITY including_BE12 BIOENTITY 
Pantoprazole|N|tetrahydrocannabinol|pantoprazole|laboratory_LE1 test_LE1 there_LE1 have_LE1 be_LE1 report_LE1 of_LE1 falsepositive_LE1 urine_LE1 screening_LE1 test_LE1 for_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 in_BE12 patient_BE12 receive_BE12 many_BE12 BIOGENERAL_BE12 including_BE12 BIOENTITY 
Paricalcitol|N|saquinavir|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|saquinavir|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|telithromycin|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Paricalcitol|N|telithromycin|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Paricalcitol|N|atazanavir|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|nefazodone|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|nefazodone|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|clarithromycin|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|clarithromycin|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|indinavir|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|indinavir|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|ritonavir|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|ritonavir|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|itraconazole|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|itraconazole|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|nelfinavir|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|nelfinavir|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|paricalcitol|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOENTITY be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|ketoconazole|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOENTITY le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|ketoconazole|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|ketoconazole|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOENTITY approximate_BE12 double_BE12 BIOGENERAL_BE12 auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|paricalcitol|voriconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOENTITY auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Paricalcitol|N|saquinavir|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|saquinavir|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|atazanavir|saquinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|nefazodone|saquinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|clarithromycin|saquinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|clarithromycin|saquinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|indinavir|saquinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ritonavir|saquinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|itraconazole|saquinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|nelfinavir|saquinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|saquinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOENTITY be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|saquinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOENTITY le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|saquinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|saquinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOENTITY approximate_BE12 double_BE12 BIOGENERAL_BE12 auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|saquinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOENTITY auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|atazanavir|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|nefazodone|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|nefazodone|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|clarithromycin|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|clarithromycin|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|indinavir|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|indinavir|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ritonavir|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ritonavir|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|itraconazole|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|itraconazole|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|nelfinavir|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|nelfinavir|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOENTITY be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOENTITY le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOENTITY approximate_BE12 double_BE12 BIOGENERAL_BE12 auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|telithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOENTITY auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|atazanavir|nefazodone|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|atazanavir|clarithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|atazanavir|indinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|atazanavir|ritonavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|atazanavir|itraconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|atazanavir|nelfinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|atazanavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOENTITY be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|atazanavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOENTITY le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|atazanavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|atazanavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOENTITY approximate_BE12 double_BE12 BIOGENERAL_BE12 auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|atazanavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOENTITY auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|clarithromycin|nefazodone|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|clarithromycin|nefazodone|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|indinavir|nefazodone|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|nefazodone|ritonavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|itraconazole|nefazodone|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|nefazodone|nelfinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|nefazodone|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOENTITY be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|nefazodone|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOENTITY le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|nefazodone|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|nefazodone|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOENTITY approximate_BE12 double_BE12 BIOGENERAL_BE12 auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|nefazodone|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOENTITY auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|clarithromycin|indinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|clarithromycin|indinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|clarithromycin|ritonavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|clarithromycin|ritonavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|clarithromycin|itraconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|clarithromycin|itraconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|clarithromycin|nelfinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|clarithromycin|nelfinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|clarithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOENTITY be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|clarithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOENTITY le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|clarithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|clarithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOENTITY approximate_BE12 double_BE12 BIOGENERAL_BE12 auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|clarithromycin|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOENTITY auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|indinavir|ritonavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|indinavir|itraconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|indinavir|nelfinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|indinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOENTITY be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|indinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOENTITY le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|indinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|indinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOENTITY approximate_BE12 double_BE12 BIOGENERAL_BE12 auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|indinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOENTITY auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|itraconazole|ritonavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|nelfinavir|ritonavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|ritonavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOENTITY be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|ritonavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOENTITY le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|ritonavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|ritonavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOENTITY approximate_BE12 double_BE12 BIOGENERAL_BE12 auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|ritonavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOENTITY auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|itraconazole|nelfinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 strong_LE1 inhibitor_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|itraconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOENTITY be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|itraconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOENTITY le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|itraconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|itraconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOENTITY approximate_BE12 double_BE12 BIOGENERAL_BE12 auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|itraconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOENTITY auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|nelfinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOENTITY be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|nelfinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOENTITY le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|nelfinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOGENERAL_LE1 le_LE1 be_LE1 know_LE1 to_LE1 be_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 care_LE1 shall_LE1 be_LE1 take_LE1 while_LE1 dosing_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|nelfinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOENTITY approximate_BE12 double_BE12 BIOGENERAL_BE12 auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|nelfinavir|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOENTITY auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 strong_BE12 inhibitor_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|ketoconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOENTITY be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOENTITY le_RE2 be_RE2 know_RE2 to_RE2 be_RE2 strong_RE2 inhibitor_RE2 of_RE2 cytochrome_RE2 enzyme_RE2 care_RE2 shall_RE2 be_RE2 take_RE2 while_RE2 dosing_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 strong_RE2 inhibitor_RE2 including_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|paricalcitol|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOENTITY be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOENTITY with_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 strong_RE2 inhibitor_RE2 including_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|ketoconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOENTITY be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOENTITY and_RE2 other_RE2 strong_RE2 inhibitor_RE2 including_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|paricalcitol|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOENTITY approximate_BE12 double_BE12 BIOGENERAL_BE12 auc_BE12 since_BE12 BIOENTITY be_RE2 partial_RE2 metabolize_RE2 by_RE2 cypa_RE2 and_RE2 BIOGENERAL_RE2 le_RE2 be_RE2 know_RE2 to_RE2 be_RE2 strong_RE2 inhibitor_RE2 of_RE2 cytochrome_RE2 enzyme_RE2 care_RE2 shall_RE2 be_RE2 take_RE2 while_RE2 dosing_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 strong_RE2 inhibitor_RE2 including_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|paricalcitol|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOENTITY auc_BE12 since_BE12 BIOENTITY be_RE2 partial_RE2 metabolize_RE2 by_RE2 cypa_RE2 and_RE2 BIOGENERAL_RE2 le_RE2 be_RE2 know_RE2 to_RE2 be_RE2 strong_RE2 inhibitor_RE2 of_RE2 cytochrome_RE2 enzyme_RE2 care_RE2 shall_RE2 be_RE2 take_RE2 while_RE2 dosing_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 strong_RE2 inhibitor_RE2 including_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|paricalcitol|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOENTITY le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOENTITY with_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 strong_RE2 inhibitor_RE2 including_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|ketoconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOGENERAL_LE1 auc_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 partial_LE1 metabolize_LE1 by_LE1 cypa_LE1 and_LE1 BIOENTITY le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOENTITY and_RE2 other_RE2 strong_RE2 inhibitor_RE2 including_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|ketoconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOENTITY approximate_BE12 double_BE12 BIOGENERAL_BE12 auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOENTITY le_RE2 be_RE2 know_RE2 to_RE2 be_RE2 strong_RE2 inhibitor_RE2 of_RE2 cytochrome_RE2 enzyme_RE2 care_RE2 shall_RE2 be_RE2 take_RE2 while_RE2 dosing_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 strong_RE2 inhibitor_RE2 including_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|ketoconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOENTITY auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOENTITY le_RE2 be_RE2 know_RE2 to_RE2 be_RE2 strong_RE2 inhibitor_RE2 of_RE2 cytochrome_RE2 enzyme_RE2 care_RE2 shall_RE2 be_RE2 take_RE2 while_RE2 dosing_RE2 BIOGENERAL_RE2 with_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 strong_RE2 inhibitor_RE2 including_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|paricalcitol|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOENTITY approximate_BE12 double_BE12 BIOGENERAL_BE12 auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOENTITY with_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 strong_RE2 inhibitor_RE2 including_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|paricalcitol|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOENTITY auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOENTITY with_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 strong_RE2 inhibitor_RE2 including_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|ketoconazole|ketoconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOENTITY approximate_BE12 double_BE12 BIOGENERAL_BE12 auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOENTITY and_RE2 other_RE2 strong_RE2 inhibitor_RE2 including_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|paricalcitol|ketoconazole|multiple_LE1 dose_LE1 drugdrug_LE1 interaction_LE1 study_LE1 demonstrate_LE1 that_LE1 BIOGENERAL_LE1 approximate_LE1 double_LE1 BIOENTITY auc_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 partial_BE12 metabolize_BE12 by_BE12 cypa_BE12 and_BE12 BIOGENERAL_BE12 le_BE12 be_BE12 know_BE12 to_BE12 be_BE12 strong_BE12 inhibitor_BE12 of_BE12 cytochrome_BE12 enzyme_BE12 care_BE12 shall_BE12 be_BE12 take_BE12 while_BE12 dosing_BE12 BIOGENERAL_BE12 with_BE12 BIOENTITY and_RE2 other_RE2 strong_RE2 inhibitor_RE2 including_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Paricalcitol|N|fat-soluble vitamin|zemplar|drug_LE1 that_LE1 impair_LE1 intestinal_LE1 absorption_LE1 of_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 absorption_BE12 of_BE12 BIOENTITY capsule_RE2 
Paricalcitol|N|fat-soluble vitamin|zemplar|drug_LE1 that_LE1 impair_LE1 intestinal_LE1 absorption_LE1 of_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 may_BE12 interfere_BE12 with_BE12 the_BE12 absorption_BE12 of_BE12 BIOENTITY capsule_RE2 
Peginterferon alfa-2b|N|methadone|methadone|In_LE1 pharmacokinetic_LE1 study_LE1 of_LE1 NUM_LE1 chronic_LE1 hepatitis_LE1 patient_LE1 concomitant_LE1 receive_LE1 BIOENTITY treatment_BE12 with_BE12 BIOGENERAL_BE12 once_BE12 weekly_BE12 for_BE12 NUM_BE12 week_BE12 be_BE12 associate_BE12 with_BE12 mean_BE12 increase_BE12 of_BE12 NUM_BE12 in_BE12 BIOENTITY auc_RE2 
Peginterferon alfa-2b|N|peg-intron|methadone|In_LE1 pharmacokinetic_LE1 study_LE1 of_LE1 NUM_LE1 chronic_LE1 hepatitis_LE1 patient_LE1 concomitant_LE1 receive_LE1 BIOGENERAL_LE1 treatment_LE1 with_LE1 BIOENTITY once_BE12 weekly_BE12 for_BE12 NUM_BE12 week_BE12 be_BE12 associate_BE12 with_BE12 mean_BE12 increase_BE12 of_BE12 NUM_BE12 in_BE12 BIOENTITY auc_RE2 
Pegvisomant|N|insulin|hypoglycemic|acromegalic_LE1 patient_LE1 with_LE1 diabetes_LE1 mellitus_LE1 be_LE1 treat_LE1 with_LE1 BIOENTITY and_BE12 oral_BE12 BIOENTITY agent_RE2 may_RE2 require_RE2 dose_RE2 reduction_RE2 of_RE2 these_RE2 therapeutic_RE2 agent_RE2 after_RE2 the_RE2 initiation_RE2 of_RE2 therapy_RE2 with_RE2 BIOGENERAL_RE2 
Pegvisomant|N|pegvisomant|opioid|In_LE1 clinical_LE1 study_LE1 patient_LE1 on_LE1 BIOGENERAL_LE1 often_LE1 need_LE1 high_LE1 serum_LE1 BIOENTITY concentration_BE12 to_BE12 achieve_BE12 appropriate_BE12 igfi_BE12 suppression_BE12 compared_BE12 with_BE12 patient_BE12 not_BE12 receive_BE12 BIOENTITY 
Pegvisomant|N|opioid|opioid|In_LE1 clinical_LE1 study_LE1 patient_LE1 on_LE1 BIOENTITY often_BE12 need_BE12 high_BE12 serum_BE12 BIOGENERAL_BE12 concentration_BE12 to_BE12 achieve_BE12 appropriate_BE12 igfi_BE12 suppression_BE12 compared_BE12 with_BE12 patient_BE12 not_BE12 receive_BE12 BIOENTITY 
Pemetrexed|N|ibuprofen|ibuprofen|although_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 mg_BE12 qid_BE12 -RRB-_BE12 can_BE12 be_BE12 administer_BE12 with_BE12 BIOGENERAL_BE12 in_BE12 patient_BE12 with_BE12 normal_BE12 renal_BE12 function_BE12 -LRB-_BE12 creatinine_BE12 clearance_BE12 NUM_BE12 ml_BE12 -RRB-_BE12 caution_BE12 shall_BE12 be_BE12 use_BE12 when_BE12 administer_BE12 BIOENTITY concurrent_RE2 with_RE2 BIOGENERAL_RE2 to_RE2 patient_RE2 with_RE2 mild_RE2 to_RE2 moderate_RE2 renal_RE2 insufficiency_RE2 -LRB-_RE2 creatinine_RE2 clearance_RE2 from_RE2 NUM_RE2 to_RE2 NUM_RE2 ml_RE2 rrb._RE2 
Pemetrexed|N|alimta|ibuprofen|although_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 qid_LE1 -RRB-_LE1 can_LE1 be_LE1 administer_LE1 with_LE1 BIOENTITY in_BE12 patient_BE12 with_BE12 normal_BE12 renal_BE12 function_BE12 -LRB-_BE12 creatinine_BE12 clearance_BE12 NUM_BE12 ml_BE12 -RRB-_BE12 caution_BE12 shall_BE12 be_BE12 use_BE12 when_BE12 administer_BE12 BIOENTITY concurrent_RE2 with_RE2 BIOGENERAL_RE2 to_RE2 patient_RE2 with_RE2 mild_RE2 to_RE2 moderate_RE2 renal_RE2 insufficiency_RE2 -LRB-_RE2 creatinine_RE2 clearance_RE2 from_RE2 NUM_RE2 to_RE2 NUM_RE2 ml_RE2 rrb._RE2 
Pemetrexed|N|ibuprofen|alimta|although_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 mg_BE12 qid_BE12 -RRB-_BE12 can_BE12 be_BE12 administer_BE12 with_BE12 BIOGENERAL_BE12 in_BE12 patient_BE12 with_BE12 normal_BE12 renal_BE12 function_BE12 -LRB-_BE12 creatinine_BE12 clearance_BE12 NUM_BE12 ml_BE12 -RRB-_BE12 caution_BE12 shall_BE12 be_BE12 use_BE12 when_BE12 administer_BE12 BIOGENERAL_BE12 concurrent_BE12 with_BE12 BIOENTITY to_RE2 patient_RE2 with_RE2 mild_RE2 to_RE2 moderate_RE2 renal_RE2 insufficiency_RE2 -LRB-_RE2 creatinine_RE2 clearance_RE2 from_RE2 NUM_RE2 to_RE2 NUM_RE2 ml_RE2 rrb._RE2 
Pemetrexed|N|alimta|alimta|although_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 qid_LE1 -RRB-_LE1 can_LE1 be_LE1 administer_LE1 with_LE1 BIOENTITY in_BE12 patient_BE12 with_BE12 normal_BE12 renal_BE12 function_BE12 -LRB-_BE12 creatinine_BE12 clearance_BE12 NUM_BE12 ml_BE12 -RRB-_BE12 caution_BE12 shall_BE12 be_BE12 use_BE12 when_BE12 administer_BE12 BIOGENERAL_BE12 concurrent_BE12 with_BE12 BIOENTITY to_RE2 patient_RE2 with_RE2 mild_RE2 to_RE2 moderate_RE2 renal_RE2 insufficiency_RE2 -LRB-_RE2 creatinine_RE2 clearance_RE2 from_RE2 NUM_RE2 to_RE2 NUM_RE2 ml_RE2 rrb._RE2 
Pemetrexed|N|ibuprofen|alimta|although_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 mg_BE12 qid_BE12 -RRB-_BE12 can_BE12 be_BE12 administer_BE12 with_BE12 BIOENTITY in_RE2 patient_RE2 with_RE2 normal_RE2 renal_RE2 function_RE2 -LRB-_RE2 creatinine_RE2 clearance_RE2 NUM_RE2 ml_RE2 -RRB-_RE2 caution_RE2 shall_RE2 be_RE2 use_RE2 when_RE2 administer_RE2 BIOGENERAL_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 to_RE2 patient_RE2 with_RE2 mild_RE2 to_RE2 moderate_RE2 renal_RE2 insufficiency_RE2 -LRB-_RE2 creatinine_RE2 clearance_RE2 from_RE2 NUM_RE2 to_RE2 NUM_RE2 ml_RE2 rrb._RE2 
Pemetrexed|N|nsaid|alimta|In_LE1 the_LE1 absence_LE1 of_LE1 datum_LE1 regarding_LE1 potential_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY with_BE12 long_BE12 halflive_BE12 all_BE12 patient_BE12 take_BE12 these_BE12 BIOGENERAL_BE12 shall_BE12 interrupt_BE12 dosing_BE12 for_BE12 at_BE12 little_BE12 NUM_BE12 day_BE12 before_BE12 the_BE12 day_BE12 of_BE12 and_BE12 NUM_BE12 day_BE12 follow_BE12 BIOENTITY administration_RE2 
Pemetrexed|N|alimta|alimta|In_LE1 the_LE1 absence_LE1 of_LE1 datum_LE1 regarding_LE1 potential_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 with_BE12 long_BE12 halflive_BE12 all_BE12 patient_BE12 take_BE12 these_BE12 BIOGENERAL_BE12 shall_BE12 interrupt_BE12 dosing_BE12 for_BE12 at_BE12 little_BE12 NUM_BE12 day_BE12 before_BE12 the_BE12 day_BE12 of_BE12 and_BE12 NUM_BE12 day_BE12 follow_BE12 BIOENTITY administration_RE2 
Pemetrexed|N|nsaid|nsaid|In_LE1 the_LE1 absence_LE1 of_LE1 datum_LE1 regarding_LE1 potential_LE1 interaction_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY with_BE12 long_BE12 halflive_BE12 all_BE12 patient_BE12 take_BE12 these_BE12 BIOENTITY shall_RE2 interrupt_RE2 dosing_RE2 for_RE2 at_RE2 little_RE2 NUM_RE2 day_RE2 before_RE2 the_RE2 day_RE2 of_RE2 and_RE2 NUM_RE2 day_RE2 follow_RE2 BIOGENERAL_RE2 administration_RE2 
Pemetrexed|N|alimta|nsaid|In_LE1 the_LE1 absence_LE1 of_LE1 datum_LE1 regarding_LE1 potential_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 with_BE12 long_BE12 halflive_BE12 all_BE12 patient_BE12 take_BE12 these_BE12 BIOENTITY shall_RE2 interrupt_RE2 dosing_RE2 for_RE2 at_RE2 little_RE2 NUM_RE2 day_RE2 before_RE2 the_RE2 day_RE2 of_RE2 and_RE2 NUM_RE2 day_RE2 follow_RE2 BIOGENERAL_RE2 administration_RE2 
Pemetrexed|N|alimta|nsaid|In_LE1 the_LE1 absence_LE1 of_LE1 datum_LE1 regarding_LE1 potential_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOENTITY with_RE2 long_RE2 halflive_RE2 all_RE2 patient_RE2 take_RE2 these_RE2 BIOGENERAL_RE2 shall_RE2 interrupt_RE2 dosing_RE2 for_RE2 at_RE2 little_RE2 NUM_RE2 day_RE2 before_RE2 the_RE2 day_RE2 of_RE2 and_RE2 NUM_RE2 day_RE2 follow_RE2 BIOGENERAL_RE2 administration_RE2 
Pemoline|N|cylert|pemoline|the_LE1 interaction_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 with_RE2 other_RE2 drug_RE2 have_RE2 not_RE2 be_RE2 study_RE2 in_RE2 human_RE2 
Penicillin G|N|bacteriostatic antibiotic|tetracycline|concurrent_LE1 administration_LE1 of_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 may_RE2 diminish_RE2 the_RE2 bactericidal_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 slow_RE2 the_RE2 rate_RE2 of_RE2 bacterial_RE2 growth_RE2 
Penicillin G|N|bacteriostatic antibiotic|erythromycin|concurrent_LE1 administration_LE1 of_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 may_RE2 diminish_RE2 the_RE2 bactericidal_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 slow_RE2 the_RE2 rate_RE2 of_RE2 bacterial_RE2 growth_RE2 
Penicillin G|N|erythromycin|tetracycline|concurrent_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY -RRB-_RE2 may_RE2 diminish_RE2 the_RE2 bactericidal_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 slow_RE2 the_RE2 rate_RE2 of_RE2 bacterial_RE2 growth_RE2 
Penicillin G|N|penicillin|penicillin|BIOENTITY blood_BE12 level_BE12 may_BE12 be_BE12 prolong_BE12 by_BE12 concurrent_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 which_BE12 block_BE12 the_BE12 renal_BE12 tubular_BE12 secretion_BE12 of_BE12 BIOENTITY 
Penicillin G|N|penicillin|penicillin|BIOENTITY blood_BE12 level_BE12 may_BE12 be_BE12 prolong_BE12 by_BE12 concurrent_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 which_BE12 block_BE12 the_BE12 renal_BE12 tubular_BE12 secretion_BE12 of_BE12 BIOENTITY 
Penicillin G|N|probenecid|penicillin|BIOGENERAL_LE1 blood_LE1 level_LE1 may_LE1 be_LE1 prolong_LE1 by_LE1 concurrent_LE1 administration_LE1 of_LE1 BIOENTITY which_BE12 block_BE12 the_BE12 renal_BE12 tubular_BE12 secretion_BE12 of_BE12 BIOENTITY 
Penicillin G|N|probenecid|penicillin|BIOGENERAL_LE1 blood_LE1 level_LE1 may_LE1 be_LE1 prolong_LE1 by_LE1 concurrent_LE1 administration_LE1 of_LE1 BIOENTITY which_BE12 block_BE12 the_BE12 renal_BE12 tubular_BE12 secretion_BE12 of_BE12 BIOENTITY 
Penicillin G|N|penicillin|penicillin|displacement_LE1 of_LE1 BIOENTITY from_BE12 plasma_BE12 protein_BE12 binding_BE12 site_BE12 will_BE12 elevate_BE12 the_BE12 level_BE12 of_BE12 free_BE12 BIOENTITY in_RE2 the_RE2 serum_RE2 
Pentazocine|N|alcohol|pentazocine|usage_LE1 with_LE1 BIOENTITY :_BE12 Due_BE12 to_BE12 the_BE12 potential_BE12 for_BE12 increase_BE12 cns_BE12 depressants_BE12 effect_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 use_BE12 with_BE12 caution_BE12 in_BE12 patient_BE12 who_BE12 be_BE12 current_BE12 receive_BE12 BIOENTITY 
Pentazocine|N|alcohol|pentazocine|usage_LE1 with_LE1 BIOENTITY :_BE12 Due_BE12 to_BE12 the_BE12 potential_BE12 for_BE12 increase_BE12 cns_BE12 depressants_BE12 effect_BE12 BIOGENERAL_BE12 shall_BE12 be_BE12 use_BE12 with_BE12 caution_BE12 in_BE12 patient_BE12 who_BE12 be_BE12 current_BE12 receive_BE12 BIOENTITY 
Pentazocine|N|alcohol|alcohol|usage_LE1 with_LE1 BIOENTITY :_BE12 Due_BE12 to_BE12 the_BE12 potential_BE12 for_BE12 increase_BE12 cns_BE12 depressants_BE12 effect_BE12 BIOENTITY shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 in_RE2 patient_RE2 who_RE2 be_RE2 current_RE2 receive_RE2 BIOGENERAL_RE2 
Pentoxifylline|N|anticoagulant|platelet aggregation inhibitor|although_LE1 causal_LE1 relationship_LE1 have_LE1 not_LE1 be_LE1 establish_LE1 there_LE1 have_LE1 be_LE1 report_LE1 of_LE1 bleeding_LE1 and_LE1 prolonged_LE1 prothrombin_LE1 time_LE1 in_LE1 patient_LE1 treat_LE1 with_LE1 BIOGENERAL_LE1 with_LE1 and_LE1 without_LE1 BIOENTITY or_BE12 BIOENTITY 
Pentoxifylline|N|theophylline|theophylline|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY drug_BE12 lead_BE12 to_BE12 increase_BE12 BIOGENERAL_BE12 level_BE12 and_BE12 BIOENTITY toxicity_RE2 in_RE2 some_RE2 individual_RE2 
Pentoxifylline|N|theophylline|theophylline|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY drug_BE12 lead_BE12 to_BE12 increase_BE12 BIOENTITY level_RE2 and_RE2 BIOGENERAL_RE2 toxicity_RE2 in_RE2 some_RE2 individual_RE2 
Pentoxifylline|N|trental|theophylline|concomitant_LE1 administration_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 drug_BE12 lead_BE12 to_BE12 increase_BE12 BIOGENERAL_BE12 level_BE12 and_BE12 BIOENTITY toxicity_RE2 in_RE2 some_RE2 individual_RE2 
Pentoxifylline|N|trental|theophylline|concomitant_LE1 administration_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 drug_BE12 lead_BE12 to_BE12 increase_BE12 BIOENTITY level_RE2 and_RE2 BIOGENERAL_RE2 toxicity_RE2 in_RE2 some_RE2 individual_RE2 
Pentoxifylline|N|theophylline|theophylline|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 drug_LE1 lead_LE1 to_LE1 increase_LE1 BIOENTITY level_BE12 and_BE12 BIOENTITY toxicity_RE2 in_RE2 some_RE2 individual_RE2 
Pentoxifylline|N|trental|antihypertensive drug|BIOENTITY have_BE12 be_BE12 use_BE12 concurrent_BE12 with_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|trental|antidiabetic agent|BIOENTITY have_BE12 be_BE12 use_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|trental|diuretic|BIOENTITY have_BE12 be_BE12 use_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|trental|digitali|BIOENTITY have_BE12 be_BE12 use_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|trental|beta blocker|BIOENTITY have_BE12 be_BE12 use_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|trental|antiarrhythmic|BIOENTITY have_BE12 be_BE12 use_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|antihypertensive drug|antidiabetic agent|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|antihypertensive drug|diuretic|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|antihypertensive drug|digitali|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|antihypertensive drug|beta blocker|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|antihypertensive drug|antiarrhythmic|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|diuretic|antidiabetic agent|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|diuretic|antidiabetic agent|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|digitali|antidiabetic agent|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|digitali|antidiabetic agent|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|beta blocker|antidiabetic agent|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|beta blocker|antidiabetic agent|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|antidiabetic agent|antiarrhythmic|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|antidiabetic agent|antiarrhythmic|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|digitali|diuretic|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|digitali|diuretic|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|beta blocker|diuretic|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|beta blocker|diuretic|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|diuretic|antiarrhythmic|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|diuretic|antiarrhythmic|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|beta blocker|digitali|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|beta blocker|digitali|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|digitali|antiarrhythmic|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|digitali|antiarrhythmic|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|beta blocker|antiarrhythmic|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY without_RE2 observe_RE2 problem_RE2 
Pentoxifylline|N|beta blocker|antiarrhythmic|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY without_RE2 observe_RE2 problem_RE2 
Pergolide|N|neuroleptic|dopamine agonist|BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 ordinary_BE12 shall_BE12 not_BE12 be_BE12 administer_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY rrb;_RE2 
Pergolide|N|phenothiazine|dopamine agonist|BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 ordinary_BE12 shall_BE12 not_BE12 be_BE12 administer_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY rrb;_RE2 
Pergolide|N|dopamine antagonist|dopamine agonist|BIOENTITY such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 ordinary_BE12 shall_BE12 not_BE12 be_BE12 administer_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY rrb;_RE2 
Pergolide|N|metoclopramide|dopamine agonist|BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOENTITY ordinary_BE12 shall_BE12 not_BE12 be_BE12 administer_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY rrb;_RE2 
Pergolide|N|permax|dopamine agonist|BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOGENERAL_LE1 ordinary_LE1 shall_LE1 not_LE1 be_LE1 administer_LE1 concurrent_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOENTITY rrb;_RE2 
Pergolide|N|butyrophenone|dopamine agonist|BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 ordinary_BE12 shall_BE12 not_BE12 be_BE12 administer_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY rrb;_RE2 
Pergolide|N|thioxanthine|dopamine agonist|BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 ordinary_BE12 shall_BE12 not_BE12 be_BE12 administer_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY rrb;_RE2 
Pergolide|N|neuroleptic|phenothiazine|BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOENTITY -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 ordinary_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 rrb;_RE2 
Pergolide|N|dopamine antagonist|neuroleptic|BIOENTITY such_BE12 as_BE12 the_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 ordinary_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 rrb;_RE2 
Pergolide|N|neuroleptic|metoclopramide|BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY ordinary_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 rrb;_RE2 
Pergolide|N|neuroleptic|butyrophenone|BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 ordinary_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 rrb;_RE2 
Pergolide|N|neuroleptic|thioxanthine|BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 ordinary_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 rrb;_RE2 
Pergolide|N|dopamine antagonist|phenothiazine|BIOENTITY such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 ordinary_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 rrb;_RE2 
Pergolide|N|phenothiazine|metoclopramide|BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY ordinary_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 rrb;_RE2 
Pergolide|N|phenothiazine|butyrophenone|BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 ordinary_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 rrb;_RE2 
Pergolide|N|phenothiazine|thioxanthine|BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 ordinary_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 rrb;_RE2 
Pergolide|N|dopamine antagonist|metoclopramide|BIOENTITY such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY ordinary_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 rrb;_RE2 
Pergolide|N|dopamine antagonist|butyrophenone|BIOENTITY such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 ordinary_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 rrb;_RE2 
Pergolide|N|dopamine antagonist|thioxanthine|BIOENTITY such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 ordinary_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 rrb;_RE2 
Pergolide|N|butyrophenone|metoclopramide|BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY ordinary_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 rrb;_RE2 
Pergolide|N|thioxanthine|metoclopramide|BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOENTITY ordinary_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 rrb;_RE2 
Pergolide|N|butyrophenone|thioxanthine|BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 ordinary_RE2 shall_RE2 not_RE2 be_RE2 administer_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 rrb;_RE2 
Pergolide|N|pergolide mesylate|pergolide mesylate|because_LE1 BIOENTITY be_BE12 approximate_BE12 NUM_BE12 bind_BE12 to_BE12 plasma_BE12 protein_BE12 caution_BE12 shall_BE12 be_BE12 exercise_BE12 if_BE12 BIOENTITY be_RE2 coadminister_RE2 with_RE2 other_RE2 drug_RE2 know_RE2 to_RE2 affect_RE2 protein_RE2 binding_RE2 
Perindopril|N|diuretic|diuretic|BIOENTITY :_BE12 patient_BE12 on_BE12 BIOENTITY and_RE2 especial_RE2 those_RE2 start_RE2 recent_RE2 may_RE2 occasional_RE2 experience_RE2 excessive_RE2 reduction_RE2 of_RE2 blood_RE2 pressure_RE2 after_RE2 initiation_RE2 of_RE2 BIOGENERAL_RE2 tablet_RE2 therapy_RE2 
Perindopril|N|diuretic|aceon|BIOENTITY :_BE12 patient_BE12 on_BE12 BIOGENERAL_BE12 and_BE12 especial_BE12 those_BE12 start_BE12 recent_BE12 may_BE12 occasional_BE12 experience_BE12 excessive_BE12 reduction_BE12 of_BE12 blood_BE12 pressure_BE12 after_BE12 initiation_BE12 of_BE12 BIOENTITY tablet_RE2 therapy_RE2 
Perindopril|N|perindopril|diuretic|the_LE1 rate_LE1 and_LE1 extent_LE1 of_LE1 BIOENTITY absorption_BE12 and_BE12 elimination_BE12 be_BE12 not_BE12 affect_BE12 by_BE12 concomitant_BE12 BIOENTITY 
Perindopril|N|perindoprilat|diuretic|the_LE1 bioavailability_LE1 of_LE1 BIOENTITY be_BE12 reduce_BE12 by_BE12 BIOENTITY however_RE2 and_RE2 this_RE2 be_RE2 associate_RE2 with_RE2 decrease_RE2 in_RE2 plasma_RE2 ace_RE2 inhibition_RE2 
Perindopril|N|potassium-sparing diuretic|aceon|BIOGENERAL_LE1 supplement_LE1 and_LE1 BIOENTITY :_BE12 BIOENTITY tablet_RE2 may_RE2 increase_RE2 serum_RE2 potassium_RE2 because_RE2 of_RE2 its_RE2 potential_RE2 to_RE2 decrease_RE2 aldosterone_RE2 production_RE2 
Perindopril|N|potassium|potassium-sparing diuretic|BIOENTITY supplement_BE12 and_BE12 BIOENTITY :_RE2 BIOGENERAL_RE2 tablet_RE2 may_RE2 increase_RE2 serum_RE2 potassium_RE2 because_RE2 of_RE2 its_RE2 potential_RE2 to_RE2 decrease_RE2 aldosterone_RE2 production_RE2 
Perindopril|N|potassium|aceon|BIOENTITY supplement_BE12 and_BE12 BIOGENERAL_BE12 :_BE12 BIOENTITY tablet_RE2 may_RE2 increase_RE2 serum_RE2 potassium_RE2 because_RE2 of_RE2 its_RE2 potential_RE2 to_RE2 decrease_RE2 aldosterone_RE2 production_RE2 
Perindopril|N|potassium|indomethacin|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 -RRB-_LE1 BIOENTITY supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|potassium|indomethacin|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 -RRB-_LE1 BIOENTITY supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|amiloride|potassium|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 other_BE12 -RRB-_BE12 BIOENTITY supplement_RE2 or_RE2 other_RE2 drug_RE2 capable_RE2 of_RE2 increase_RE2 serum_RE2 potassium_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|triamterene|potassium|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 other_BE12 -RRB-_BE12 BIOENTITY supplement_RE2 or_RE2 other_RE2 drug_RE2 capable_RE2 of_RE2 increase_RE2 serum_RE2 potassium_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|potassium-sparing diuretic|potassium|use_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 -RRB-_BE12 BIOENTITY supplement_RE2 or_RE2 other_RE2 drug_RE2 capable_RE2 of_RE2 increase_RE2 serum_RE2 potassium_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|spironolactone|potassium|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 -RRB-_BE12 BIOENTITY supplement_RE2 or_RE2 other_RE2 drug_RE2 capable_RE2 of_RE2 increase_RE2 serum_RE2 potassium_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|potassium|heparin|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 -RRB-_LE1 BIOENTITY supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|potassium|heparin|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 -RRB-_LE1 BIOENTITY supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|potassium|cyclosporine|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 -RRB-_LE1 BIOENTITY supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|potassium|cyclosporine|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 -RRB-_LE1 BIOENTITY supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|amiloride|indomethacin|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 other_BE12 -RRB-_BE12 BIOGENERAL_BE12 supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|triamterene|indomethacin|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 other_BE12 -RRB-_BE12 BIOGENERAL_BE12 supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|potassium-sparing diuretic|indomethacin|use_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 -RRB-_BE12 BIOGENERAL_BE12 supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|spironolactone|indomethacin|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 -RRB-_BE12 BIOGENERAL_BE12 supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|indomethacin|heparin|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 -RRB-_LE1 BIOGENERAL_LE1 supplement_LE1 or_LE1 other_LE1 drug_LE1 capable_LE1 of_LE1 increase_LE1 serum_LE1 potassium_LE1 -LRB-_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|indomethacin|cyclosporine|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 -RRB-_LE1 BIOGENERAL_LE1 supplement_LE1 or_LE1 other_LE1 drug_LE1 capable_LE1 of_LE1 increase_LE1 serum_LE1 potassium_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|amiloride|triamterene|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 other_RE2 -RRB-_RE2 BIOGENERAL_RE2 supplement_RE2 or_RE2 other_RE2 drug_RE2 capable_RE2 of_RE2 increase_RE2 serum_RE2 potassium_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|amiloride|triamterene|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 other_RE2 -RRB-_RE2 BIOGENERAL_RE2 supplement_RE2 or_RE2 other_RE2 drug_RE2 capable_RE2 of_RE2 increase_RE2 serum_RE2 potassium_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|potassium-sparing diuretic|amiloride|use_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 BIOGENERAL_RE2 supplement_RE2 or_RE2 other_RE2 drug_RE2 capable_RE2 of_RE2 increase_RE2 serum_RE2 potassium_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|spironolactone|amiloride|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 BIOGENERAL_RE2 supplement_RE2 or_RE2 other_RE2 drug_RE2 capable_RE2 of_RE2 increase_RE2 serum_RE2 potassium_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|amiloride|heparin|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 other_BE12 -RRB-_BE12 BIOGENERAL_BE12 supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|amiloride|cyclosporine|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 other_BE12 -RRB-_BE12 BIOGENERAL_BE12 supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|potassium-sparing diuretic|triamterene|use_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 -RRB-_RE2 BIOGENERAL_RE2 supplement_RE2 or_RE2 other_RE2 drug_RE2 capable_RE2 of_RE2 increase_RE2 serum_RE2 potassium_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|spironolactone|triamterene|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 -RRB-_RE2 BIOGENERAL_RE2 supplement_RE2 or_RE2 other_RE2 drug_RE2 capable_RE2 of_RE2 increase_RE2 serum_RE2 potassium_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|triamterene|heparin|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 other_BE12 -RRB-_BE12 BIOGENERAL_BE12 supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|triamterene|cyclosporine|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 other_BE12 -RRB-_BE12 BIOGENERAL_BE12 supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|potassium-sparing diuretic|spironolactone|use_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 BIOGENERAL_RE2 supplement_RE2 or_RE2 other_RE2 drug_RE2 capable_RE2 of_RE2 increase_RE2 serum_RE2 potassium_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|potassium-sparing diuretic|heparin|use_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 -RRB-_BE12 BIOGENERAL_BE12 supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|potassium-sparing diuretic|cyclosporine|use_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 -RRB-_BE12 BIOGENERAL_BE12 supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|spironolactone|heparin|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 -RRB-_BE12 BIOGENERAL_BE12 supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|spironolactone|cyclosporine|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 -RRB-_BE12 BIOGENERAL_BE12 supplement_BE12 or_BE12 other_BE12 drug_BE12 capable_BE12 of_BE12 increase_BE12 serum_BE12 potassium_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|heparin|cyclosporine|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 -RRB-_LE1 BIOGENERAL_LE1 supplement_LE1 or_LE1 other_LE1 drug_LE1 capable_LE1 of_LE1 increase_LE1 serum_LE1 potassium_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|heparin|cyclosporine|use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 -RRB-_LE1 BIOGENERAL_LE1 supplement_LE1 or_LE1 other_LE1 drug_LE1 capable_LE1 of_LE1 increase_LE1 serum_LE1 potassium_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 other_RE2 -RRB-_RE2 can_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 hyperkalemia_RE2 
Perindopril|N|lithium|lithium|BIOGENERAL_LE1 :_LE1 increase_LE1 serum_LE1 BIOGENERAL_LE1 and_LE1 symptom_LE1 of_LE1 BIOENTITY toxicity_BE12 have_BE12 be_BE12 report_BE12 in_BE12 patient_BE12 receive_BE12 concomitant_BE12 BIOENTITY and_RE2 ace_RE2 inhibitor_RE2 therapy_RE2 
Perindopril|N|lithium|lithium|BIOGENERAL_LE1 :_LE1 increase_LE1 serum_LE1 BIOENTITY and_BE12 symptom_BE12 of_BE12 BIOGENERAL_BE12 toxicity_BE12 have_BE12 be_BE12 report_BE12 in_BE12 patient_BE12 receive_BE12 concomitant_BE12 BIOENTITY and_RE2 ace_RE2 inhibitor_RE2 therapy_RE2 
Perindopril|N|lithium|lithium|BIOENTITY :_BE12 increase_BE12 serum_BE12 BIOGENERAL_BE12 and_BE12 symptom_BE12 of_BE12 BIOGENERAL_BE12 toxicity_BE12 have_BE12 be_BE12 report_BE12 in_BE12 patient_BE12 receive_BE12 concomitant_BE12 BIOENTITY and_RE2 ace_RE2 inhibitor_RE2 therapy_RE2 
Perindopril|N|lithium|lithium|BIOGENERAL_LE1 :_LE1 increase_LE1 serum_LE1 BIOENTITY and_BE12 symptom_BE12 of_BE12 BIOENTITY toxicity_RE2 have_RE2 be_RE2 report_RE2 in_RE2 patient_RE2 receive_RE2 concomitant_RE2 BIOGENERAL_RE2 and_RE2 ace_RE2 inhibitor_RE2 therapy_RE2 
Perindopril|N|lithium|lithium|BIOENTITY :_BE12 increase_BE12 serum_BE12 BIOGENERAL_BE12 and_BE12 symptom_BE12 of_BE12 BIOENTITY toxicity_RE2 have_RE2 be_RE2 report_RE2 in_RE2 patient_RE2 receive_RE2 concomitant_RE2 BIOGENERAL_RE2 and_RE2 ace_RE2 inhibitor_RE2 therapy_RE2 
Perindopril|N|lithium|lithium|BIOENTITY :_BE12 increase_BE12 serum_BE12 BIOENTITY and_RE2 symptom_RE2 of_RE2 BIOGENERAL_RE2 toxicity_RE2 have_RE2 be_RE2 report_RE2 in_RE2 patient_RE2 receive_RE2 concomitant_RE2 BIOGENERAL_RE2 and_RE2 ace_RE2 inhibitor_RE2 therapy_RE2 
Perindopril|N|diuretic|lithium|use_LE1 of_LE1 BIOENTITY may_BE12 further_BE12 increase_BE12 the_BE12 risk_BE12 of_BE12 BIOENTITY toxicity_RE2 
Perindopril|N|digoxin|digoxin|BIOENTITY :_BE12 controlled_BE12 pharmacokinetic_BE12 study_BE12 have_BE12 show_BE12 no_BE12 effect_BE12 on_BE12 plasma_BE12 BIOENTITY concentration_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 tablet_RE2 but_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 on_RE2 the_RE2 plasma_RE2 concentration_RE2 of_RE2 BIOGENERAL_RE2 have_RE2 not_RE2 be_RE2 exclude_RE2 
Perindopril|N|digoxin|digoxin|BIOGENERAL_LE1 :_LE1 controlled_LE1 pharmacokinetic_LE1 study_LE1 have_LE1 show_LE1 no_LE1 effect_LE1 on_LE1 plasma_LE1 BIOENTITY concentration_BE12 when_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 tablet_BE12 but_BE12 effect_BE12 of_BE12 BIOENTITY on_RE2 the_RE2 plasma_RE2 concentration_RE2 of_RE2 BIOGENERAL_RE2 have_RE2 not_RE2 be_RE2 exclude_RE2 
Perindopril|N|digoxin|aceon|BIOGENERAL_LE1 :_LE1 controlled_LE1 pharmacokinetic_LE1 study_LE1 have_LE1 show_LE1 no_LE1 effect_LE1 on_LE1 plasma_LE1 BIOENTITY concentration_BE12 when_BE12 coadminister_BE12 with_BE12 BIOENTITY tablet_RE2 but_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 on_RE2 the_RE2 plasma_RE2 concentration_RE2 of_RE2 BIOGENERAL_RE2 have_RE2 not_RE2 be_RE2 exclude_RE2 
Perindopril|N|digoxin|perindopril|BIOGENERAL_LE1 :_LE1 controlled_LE1 pharmacokinetic_LE1 study_LE1 have_LE1 show_LE1 no_LE1 effect_LE1 on_LE1 plasma_LE1 BIOENTITY concentration_BE12 when_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 tablet_BE12 but_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 on_BE12 the_BE12 plasma_BE12 concentration_BE12 of_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 exclude_RE2 
Perindopril|N|digoxin|perindopril|BIOGENERAL_LE1 :_LE1 controlled_LE1 pharmacokinetic_LE1 study_LE1 have_LE1 show_LE1 no_LE1 effect_LE1 on_LE1 plasma_LE1 BIOENTITY concentration_BE12 when_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 tablet_BE12 but_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 on_BE12 the_BE12 plasma_BE12 concentration_BE12 of_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 exclude_RE2 
Perindopril|N|digoxin|digoxin|BIOENTITY :_BE12 controlled_BE12 pharmacokinetic_BE12 study_BE12 have_BE12 show_BE12 no_BE12 effect_BE12 on_BE12 plasma_BE12 BIOGENERAL_BE12 concentration_BE12 when_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 tablet_BE12 but_BE12 effect_BE12 of_BE12 BIOENTITY on_RE2 the_RE2 plasma_RE2 concentration_RE2 of_RE2 BIOGENERAL_RE2 have_RE2 not_RE2 be_RE2 exclude_RE2 
Perindopril|N|digoxin|aceon|BIOENTITY :_BE12 controlled_BE12 pharmacokinetic_BE12 study_BE12 have_BE12 show_BE12 no_BE12 effect_BE12 on_BE12 plasma_BE12 BIOGENERAL_BE12 concentration_BE12 when_BE12 coadminister_BE12 with_BE12 BIOENTITY tablet_RE2 but_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 on_RE2 the_RE2 plasma_RE2 concentration_RE2 of_RE2 BIOGENERAL_RE2 have_RE2 not_RE2 be_RE2 exclude_RE2 
Perindopril|N|digoxin|perindopril|BIOENTITY :_BE12 controlled_BE12 pharmacokinetic_BE12 study_BE12 have_BE12 show_BE12 no_BE12 effect_BE12 on_BE12 plasma_BE12 BIOGENERAL_BE12 concentration_BE12 when_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 tablet_BE12 but_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 on_BE12 the_BE12 plasma_BE12 concentration_BE12 of_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 exclude_RE2 
Perindopril|N|digoxin|perindopril|BIOENTITY :_BE12 controlled_BE12 pharmacokinetic_BE12 study_BE12 have_BE12 show_BE12 no_BE12 effect_BE12 on_BE12 plasma_BE12 BIOGENERAL_BE12 concentration_BE12 when_BE12 coadminister_BE12 with_BE12 BIOGENERAL_BE12 tablet_BE12 but_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 on_BE12 the_BE12 plasma_BE12 concentration_BE12 of_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 exclude_RE2 
Perindopril|N|aceon|digoxin|BIOGENERAL_LE1 :_LE1 controlled_LE1 pharmacokinetic_LE1 study_LE1 have_LE1 show_LE1 no_LE1 effect_LE1 on_LE1 plasma_LE1 BIOGENERAL_LE1 concentration_LE1 when_LE1 coadminister_LE1 with_LE1 BIOENTITY tablet_BE12 but_BE12 effect_BE12 of_BE12 BIOENTITY on_RE2 the_RE2 plasma_RE2 concentration_RE2 of_RE2 BIOGENERAL_RE2 have_RE2 not_RE2 be_RE2 exclude_RE2 
Perindopril|N|aceon|perindopril|BIOGENERAL_LE1 :_LE1 controlled_LE1 pharmacokinetic_LE1 study_LE1 have_LE1 show_LE1 no_LE1 effect_LE1 on_LE1 plasma_LE1 BIOGENERAL_LE1 concentration_LE1 when_LE1 coadminister_LE1 with_LE1 BIOENTITY tablet_BE12 but_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 on_BE12 the_BE12 plasma_BE12 concentration_BE12 of_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 exclude_RE2 
Perindopril|N|aceon|perindopril|BIOGENERAL_LE1 :_LE1 controlled_LE1 pharmacokinetic_LE1 study_LE1 have_LE1 show_LE1 no_LE1 effect_LE1 on_LE1 plasma_LE1 BIOGENERAL_LE1 concentration_LE1 when_LE1 coadminister_LE1 with_LE1 BIOENTITY tablet_BE12 but_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 on_BE12 the_BE12 plasma_BE12 concentration_BE12 of_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 exclude_RE2 
Perindopril|N|perindopril|perindoprilat|BIOGENERAL_LE1 :_LE1 controlled_LE1 pharmacokinetic_LE1 study_LE1 have_LE1 show_LE1 no_LE1 effect_LE1 on_LE1 plasma_LE1 BIOGENERAL_LE1 concentration_LE1 when_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 tablet_LE1 but_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 the_LE1 plasma_LE1 concentration_LE1 of_LE1 BIOENTITY have_RE2 not_RE2 be_RE2 exclude_RE2 
Perindopril|N|gentamicin|gentamicin|BIOENTITY :_BE12 animal_BE12 datum_BE12 have_BE12 suggest_BE12 the_BE12 possibility_BE12 of_BE12 interaction_BE12 between_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Perindopril|N|gentamicin|perindopril|BIOENTITY :_BE12 animal_BE12 datum_BE12 have_BE12 suggest_BE12 the_BE12 possibility_BE12 of_BE12 interaction_BE12 between_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Perindopril|N|aceon|perindopril|food_LE1 interaction_LE1 :_LE1 oral_LE1 administration_LE1 of_LE1 BIOENTITY tablet_BE12 with_BE12 food_BE12 do_BE12 not_BE12 significant_BE12 low_BE12 the_BE12 rate_BE12 or_BE12 extent_BE12 of_BE12 BIOENTITY absorption_RE2 relative_RE2 to_RE2 the_RE2 fasted_RE2 state_RE2 
Perindopril|N|perindopril|perindoprilat|however_LE1 the_LE1 extent_LE1 of_LE1 biotransformation_LE1 of_LE1 BIOENTITY to_BE12 the_BE12 active_BE12 metabolite_BE12 BIOENTITY be_RE2 reduce_RE2 approximate_RE2 NUM_RE2 result_RE2 in_RE2 reduction_RE2 in_RE2 the_RE2 plasma_RE2 ace_RE2 inhibition_RE2 curve_RE2 of_RE2 approximate_RE2 NUM_RE2 probable_RE2 clinical_RE2 insignificant_RE2 
Phenylephrine|N|vasopressor|metaraminol|BIOENTITY particular_BE12 BIOENTITY may_RE2 cause_RE2 serious_RE2 cardiac_RE2 arrhythmia_RE2 during_RE2 BIOGENERAL_RE2 anesthesia_RE2 and_RE2 therefore_RE2 shall_RE2 be_RE2 use_RE2 only_RE2 with_RE2 great_RE2 caution_RE2 or_RE2 not_RE2 at_RE2 all_RE2 
Phenylephrine|N|mao inhibitor|sympathomimetic pressor amine|BIOENTITY :_BE12 the_BE12 pressor_BE12 effect_BE12 of_BE12 BIOENTITY be_RE2 marked_RE2 potentiate_RE2 in_RE2 patient_RE2 receive_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Phenylephrine|N|mao inhibitor|monoamine oxidase inhibitor|BIOENTITY :_BE12 the_BE12 pressor_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 marked_BE12 potentiate_BE12 in_BE12 patient_BE12 receive_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Phenylephrine|N|monoamine oxidase inhibitor|maoi|BIOGENERAL_LE1 :_LE1 the_LE1 pressor_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 marked_LE1 potentiate_LE1 in_LE1 patient_LE1 receive_LE1 BIOENTITY -LRB-_BE12 BIOENTITY 
Phenylephrine|N|mao inhibitor|maoi|BIOENTITY :_BE12 the_BE12 pressor_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 marked_BE12 potentiate_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Phenylpropanolamine|N|vasopressor|metaraminol|BIOENTITY particular_BE12 BIOENTITY may_RE2 cause_RE2 serious_RE2 cardiac_RE2 arrhythmia_RE2 during_RE2 BIOGENERAL_RE2 anesthesia_RE2 and_RE2 therefore_RE2 shall_RE2 be_RE2 use_RE2 only_RE2 with_RE2 great_RE2 caution_RE2 or_RE2 not_RE2 at_RE2 all_RE2 
Phenylpropanolamine|N|mao inhibitor|sympathomimetic pressor amine|BIOENTITY the_BE12 pressor_BE12 effect_BE12 of_BE12 BIOENTITY be_RE2 marked_RE2 potentiate_RE2 in_RE2 patient_RE2 receive_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 
Phenylpropanolamine|N|mao inhibitor|monoamine oxidase inhibitor|BIOENTITY the_BE12 pressor_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 marked_BE12 potentiate_BE12 in_BE12 patient_BE12 receive_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 
Phenylpropanolamine|N|mao inhibitor|maoi|BIOENTITY the_BE12 pressor_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 marked_BE12 potentiate_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY 
Phenylpropanolamine|N|monoamine oxidase inhibitor|maoi|BIOGENERAL_LE1 the_LE1 pressor_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 marked_LE1 potentiate_LE1 in_LE1 patient_LE1 receive_LE1 BIOENTITY -LRB-_BE12 BIOENTITY 
Pilocarpine|N|atropine|ipratropium|these_LE1 effect_LE1 shall_LE1 be_LE1 consider_LE1 when_LE1 anticholinergic_LE1 property_LE1 may_LE1 be_LE1 contribute_LE1 to_LE1 the_LE1 therapeutic_LE1 effect_LE1 of_LE1 concomitant_LE1 medication_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY inhaled_BE12 BIOENTITY rrb._RE2 
Pilocarpine|N|acetylsalicylic acid|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOENTITY artificial_BE12 tear_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|acetylsalicylic acid|conjugated estrogen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOENTITY artificial_BE12 tear_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|acetylsalicylic acid|calcium|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOENTITY artificial_BE12 tear_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|acetylsalicylic acid|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOENTITY artificial_BE12 tear_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|acetylsalicylic acid|ibuprofen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOENTITY artificial_BE12 tear_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|acetylsalicylic acid|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOENTITY artificial_BE12 tear_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|acetylsalicylic acid|hydroxychloroquine sulfate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOENTITY artificial_BE12 tear_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|acetylsalicylic acid|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOENTITY artificial_BE12 tear_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|acetylsalicylic acid|medroxyprogesterone acetate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOENTITY artificial_BE12 tear_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|acetylsalicylic acid|levothyroxine sodium|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOENTITY artificial_BE12 tear_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|acetylsalicylic acid|multivitamin|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOENTITY artificial_BE12 tear_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|acetylsalicylic acid|methotrexate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOENTITY artificial_BE12 tear_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|naproxen|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|naproxen|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|ibuprofen|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|ibuprofen|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|naproxen|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|naproxen|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|hydroxychloroquine sulfate|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|hydroxychloroquine sulfate|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|naproxen|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|naproxen|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|medroxyprogesterone acetate|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|medroxyprogesterone acetate|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|levothyroxine sodium|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|levothyroxine sodium|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|multivitamin|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|multivitamin|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|methotrexate|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|methotrexate|naproxen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|conjugated estrogen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|conjugated estrogen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|conjugated estrogen|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|conjugated estrogen|ibuprofen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|ibuprofen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|hydroxychloroquine sulfate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|hydroxychloroquine sulfate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|medroxyprogesterone acetate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|medroxyprogesterone acetate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|levothyroxine sodium|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|levothyroxine sodium|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|multivitamin|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|multivitamin|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|methotrexate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|conjugated estrogen|methotrexate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|calcium|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|calcium|ibuprofen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|ibuprofen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|hydroxychloroquine sulfate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|hydroxychloroquine sulfate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|medroxyprogesterone acetate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|medroxyprogesterone acetate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|levothyroxine sodium|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|levothyroxine sodium|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|multivitamin|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|multivitamin|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|methotrexate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|calcium|methotrexate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|ibuprofen|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|ibuprofen|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|paracetamol|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Pilocarpine|N|paracetamol|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Pilocarpine|N|hydroxychloroquine sulfate|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|hydroxychloroquine sulfate|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|omeprazole|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|omeprazole|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|medroxyprogesterone acetate|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|medroxyprogesterone acetate|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|levothyroxine sodium|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|levothyroxine sodium|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|multivitamin|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|multivitamin|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|methotrexate|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|methotrexate|prednisone|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pilocarpine|N|ibuprofen|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|ibuprofen|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|hydroxychloroquine sulfate|ibuprofen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|hydroxychloroquine sulfate|ibuprofen|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|ibuprofen|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|ibuprofen|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|ibuprofen|medroxyprogesterone acetate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|ibuprofen|medroxyprogesterone acetate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|ibuprofen|levothyroxine sodium|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|ibuprofen|levothyroxine sodium|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|ibuprofen|multivitamin|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|ibuprofen|multivitamin|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|ibuprofen|methotrexate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|ibuprofen|methotrexate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|hydroxychloroquine sulfate|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|hydroxychloroquine sulfate|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|omeprazole|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|omeprazole|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|medroxyprogesterone acetate|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|medroxyprogesterone acetate|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|levothyroxine sodium|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|levothyroxine sodium|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|multivitamin|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|multivitamin|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|methotrexate|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|methotrexate|paracetamol|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|hydroxychloroquine sulfate|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|hydroxychloroquine sulfate|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|hydroxychloroquine sulfate|medroxyprogesterone acetate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|hydroxychloroquine sulfate|medroxyprogesterone acetate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|hydroxychloroquine sulfate|levothyroxine sodium|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|hydroxychloroquine sulfate|levothyroxine sodium|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|hydroxychloroquine sulfate|multivitamin|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|hydroxychloroquine sulfate|multivitamin|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|hydroxychloroquine sulfate|methotrexate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|hydroxychloroquine sulfate|methotrexate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|medroxyprogesterone acetate|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|medroxyprogesterone acetate|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|levothyroxine sodium|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|levothyroxine sodium|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|multivitamin|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|multivitamin|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|methotrexate|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|methotrexate|omeprazole|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|levothyroxine sodium|medroxyprogesterone acetate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|levothyroxine sodium|medroxyprogesterone acetate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|medroxyprogesterone acetate|multivitamin|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|medroxyprogesterone acetate|multivitamin|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|medroxyprogesterone acetate|methotrexate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|medroxyprogesterone acetate|methotrexate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|levothyroxine sodium|multivitamin|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|levothyroxine sodium|multivitamin|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|levothyroxine sodium|methotrexate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|levothyroxine sodium|methotrexate|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|methotrexate|multivitamin|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pilocarpine|N|methotrexate|multivitamin|while_LE1 no_LE1 formal_LE1 drug_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 the_LE1 following_LE1 concomitant_LE1 drug_LE1 be_LE1 use_LE1 in_LE1 at_LE1 little_LE1 NUM_LE1 of_LE1 patient_LE1 in_LE1 either_LE1 or_LE1 both_LE1 sj_LE1 gren_LE1 efficacy_LE1 study_LE1 :_LE1 BIOGENERAL_LE1 artificial_LE1 tear_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pindolol|N|hydrochlorothiazide|hydralazine|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 with_LE1 variety_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 without_RE2 unexpected_RE2 adverse_RE2 interaction_RE2 
Pindolol|N|pindolol|hydrochlorothiazide|BIOENTITY have_BE12 be_BE12 use_BE12 with_BE12 variety_BE12 of_BE12 BIOGENERAL_BE12 including_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 without_RE2 unexpected_RE2 adverse_RE2 interaction_RE2 
Pindolol|N|antihypertensive agent|hydrochlorothiazide|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 with_LE1 variety_LE1 of_LE1 BIOENTITY including_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 without_RE2 unexpected_RE2 adverse_RE2 interaction_RE2 
Pindolol|N|hydrochlorothiazide|guanethidine|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 with_LE1 variety_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY without_RE2 unexpected_RE2 adverse_RE2 interaction_RE2 
Pindolol|N|pindolol|hydralazine|BIOENTITY have_BE12 be_BE12 use_BE12 with_BE12 variety_BE12 of_BE12 BIOGENERAL_BE12 including_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 without_RE2 unexpected_RE2 adverse_RE2 interaction_RE2 
Pindolol|N|antihypertensive agent|hydralazine|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 with_LE1 variety_LE1 of_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 without_RE2 unexpected_RE2 adverse_RE2 interaction_RE2 
Pindolol|N|hydralazine|guanethidine|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 with_LE1 variety_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY without_RE2 unexpected_RE2 adverse_RE2 interaction_RE2 
Pindolol|N|hydralazine|guanethidine|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 with_LE1 variety_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY without_RE2 unexpected_RE2 adverse_RE2 interaction_RE2 
Pindolol|N|pindolol|antihypertensive agent|BIOENTITY have_BE12 be_BE12 use_BE12 with_BE12 variety_BE12 of_BE12 BIOENTITY including_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 without_RE2 unexpected_RE2 adverse_RE2 interaction_RE2 
Pindolol|N|pindolol|guanethidine|BIOENTITY have_BE12 be_BE12 use_BE12 with_BE12 variety_BE12 of_BE12 BIOGENERAL_BE12 including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY without_RE2 unexpected_RE2 adverse_RE2 interaction_RE2 
Pindolol|N|antihypertensive agent|guanethidine|BIOGENERAL_LE1 have_LE1 be_LE1 use_LE1 with_LE1 variety_LE1 of_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY without_RE2 unexpected_RE2 adverse_RE2 interaction_RE2 
Piroxicam|N|coumarin-type anticoagulant|coumarin-type anticoagulant|although_LE1 this_LE1 have_LE1 not_LE1 occur_LE1 in_LE1 in_LE1 vitro_LE1 study_LE1 with_LE1 BIOENTITY interaction_BE12 with_BE12 BIOENTITY have_RE2 be_RE2 report_RE2 with_RE2 BIOGENERAL_RE2 since_RE2 marketing_RE2 therefore_RE2 physician_RE2 shall_RE2 close_RE2 monitor_RE2 patient_RE2 for_RE2 change_RE2 in_RE2 dosage_RE2 requirement_RE2 when_RE2 administer_RE2 BIOGENERAL_RE2 to_RE2 patient_RE2 on_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 high_RE2 proteinbound_RE2 drug_RE2 
Piroxicam|N|coumarin-type anticoagulant|feldene|although_LE1 this_LE1 have_LE1 not_LE1 occur_LE1 in_LE1 in_LE1 vitro_LE1 study_LE1 with_LE1 BIOGENERAL_LE1 interaction_LE1 with_LE1 BIOENTITY have_BE12 be_BE12 report_BE12 with_BE12 BIOGENERAL_BE12 since_BE12 marketing_BE12 therefore_BE12 physician_BE12 shall_BE12 close_BE12 monitor_BE12 patient_BE12 for_BE12 change_BE12 in_BE12 dosage_BE12 requirement_BE12 when_BE12 administer_BE12 BIOENTITY to_RE2 patient_RE2 on_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 high_RE2 proteinbound_RE2 drug_RE2 
Piroxicam|N|coumarin-type anticoagulant|coumarin-type anticoagulant|although_LE1 this_LE1 have_LE1 not_LE1 occur_LE1 in_LE1 in_LE1 vitro_LE1 study_LE1 with_LE1 BIOGENERAL_LE1 interaction_LE1 with_LE1 BIOENTITY have_BE12 be_BE12 report_BE12 with_BE12 BIOGENERAL_BE12 since_BE12 marketing_BE12 therefore_BE12 physician_BE12 shall_BE12 close_BE12 monitor_BE12 patient_BE12 for_BE12 change_BE12 in_BE12 dosage_BE12 requirement_BE12 when_BE12 administer_BE12 BIOGENERAL_BE12 to_BE12 patient_BE12 on_BE12 BIOENTITY and_RE2 other_RE2 high_RE2 proteinbound_RE2 drug_RE2 
Piroxicam|N|coumarin-type anticoagulant|feldene|although_LE1 this_LE1 have_LE1 not_LE1 occur_LE1 in_LE1 in_LE1 vitro_LE1 study_LE1 with_LE1 BIOENTITY interaction_BE12 with_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 report_BE12 with_BE12 BIOENTITY since_RE2 marketing_RE2 therefore_RE2 physician_RE2 shall_RE2 close_RE2 monitor_RE2 patient_RE2 for_RE2 change_RE2 in_RE2 dosage_RE2 requirement_RE2 when_RE2 administer_RE2 BIOGENERAL_RE2 to_RE2 patient_RE2 on_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 high_RE2 proteinbound_RE2 drug_RE2 
Piroxicam|N|coumarin-type anticoagulant|feldene|although_LE1 this_LE1 have_LE1 not_LE1 occur_LE1 in_LE1 in_LE1 vitro_LE1 study_LE1 with_LE1 BIOENTITY interaction_BE12 with_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 report_BE12 with_BE12 BIOGENERAL_BE12 since_BE12 marketing_BE12 therefore_BE12 physician_BE12 shall_BE12 close_BE12 monitor_BE12 patient_BE12 for_BE12 change_BE12 in_BE12 dosage_BE12 requirement_BE12 when_BE12 administer_BE12 BIOENTITY to_RE2 patient_RE2 on_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 high_RE2 proteinbound_RE2 drug_RE2 
Piroxicam|N|coumarin-type anticoagulant|coumarin-type anticoagulant|although_LE1 this_LE1 have_LE1 not_LE1 occur_LE1 in_LE1 in_LE1 vitro_LE1 study_LE1 with_LE1 BIOENTITY interaction_BE12 with_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 report_BE12 with_BE12 BIOGENERAL_BE12 since_BE12 marketing_BE12 therefore_BE12 physician_BE12 shall_BE12 close_BE12 monitor_BE12 patient_BE12 for_BE12 change_BE12 in_BE12 dosage_BE12 requirement_BE12 when_BE12 administer_BE12 BIOGENERAL_BE12 to_BE12 patient_BE12 on_BE12 BIOENTITY and_RE2 other_RE2 high_RE2 proteinbound_RE2 drug_RE2 
Piroxicam|N|feldene|feldene|although_LE1 this_LE1 have_LE1 not_LE1 occur_LE1 in_LE1 in_LE1 vitro_LE1 study_LE1 with_LE1 BIOGENERAL_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 be_LE1 report_LE1 with_LE1 BIOENTITY since_BE12 marketing_BE12 therefore_BE12 physician_BE12 shall_BE12 close_BE12 monitor_BE12 patient_BE12 for_BE12 change_BE12 in_BE12 dosage_BE12 requirement_BE12 when_BE12 administer_BE12 BIOENTITY to_RE2 patient_RE2 on_RE2 BIOGENERAL_RE2 and_RE2 other_RE2 high_RE2 proteinbound_RE2 drug_RE2 
Piroxicam|N|feldene|coumarin-type anticoagulant|although_LE1 this_LE1 have_LE1 not_LE1 occur_LE1 in_LE1 in_LE1 vitro_LE1 study_LE1 with_LE1 BIOGENERAL_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 be_LE1 report_LE1 with_LE1 BIOENTITY since_BE12 marketing_BE12 therefore_BE12 physician_BE12 shall_BE12 close_BE12 monitor_BE12 patient_BE12 for_BE12 change_BE12 in_BE12 dosage_BE12 requirement_BE12 when_BE12 administer_BE12 BIOGENERAL_BE12 to_BE12 patient_BE12 on_BE12 BIOENTITY and_RE2 other_RE2 high_RE2 proteinbound_RE2 drug_RE2 
Piroxicam|N|piroxicam|aspirin|plasma_LE1 level_LE1 of_LE1 BIOENTITY be_BE12 depress_BE12 to_BE12 approximate_BE12 NUM_BE12 of_BE12 their_BE12 normal_BE12 value_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 in_BE12 conjunction_BE12 with_BE12 BIOENTITY -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 but_RE2 concomitant_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 have_RE2 no_RE2 effect_RE2 on_RE2 BIOGENERAL_RE2 plasma_RE2 level_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|aspirin|nonsteroidal anti-inflammatory agent|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 in_LE1 conjunction_LE1 with_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 but_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 have_BE12 no_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 BIOENTITY including_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|aspirin|feldene|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 in_LE1 conjunction_LE1 with_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 but_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 have_BE12 no_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 BIOGENERAL_BE12 including_BE12 BIOENTITY have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|aspirin|antacid|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 in_LE1 conjunction_LE1 with_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 but_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOENTITY have_RE2 no_RE2 effect_RE2 on_RE2 BIOGENERAL_RE2 plasma_RE2 level_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|aspirin|piroxicam|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 in_LE1 conjunction_LE1 with_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 but_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 have_BE12 no_BE12 effect_BE12 on_BE12 BIOENTITY plasma_RE2 level_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|aspirin|lithium|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 in_LE1 conjunction_LE1 with_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 but_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 have_BE12 no_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 BIOGENERAL_BE12 including_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 report_BE12 to_BE12 increase_BE12 steady_BE12 state_BE12 plasma_BE12 BIOENTITY level_RE2 
Piroxicam|N|piroxicam|feldene|plasma_LE1 level_LE1 of_LE1 BIOENTITY be_BE12 depress_BE12 to_BE12 approximate_BE12 NUM_BE12 of_BE12 their_BE12 normal_BE12 value_BE12 when_BE12 BIOENTITY be_RE2 administer_RE2 in_RE2 conjunction_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 but_RE2 concomitant_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 have_RE2 no_RE2 effect_RE2 on_RE2 BIOGENERAL_RE2 plasma_RE2 level_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|feldene|nonsteroidal anti-inflammatory agent|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOENTITY be_BE12 administer_BE12 in_BE12 conjunction_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 but_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 have_BE12 no_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 BIOENTITY including_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|feldene|feldene|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOENTITY be_BE12 administer_BE12 in_BE12 conjunction_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 but_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 have_BE12 no_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 BIOGENERAL_BE12 including_BE12 BIOENTITY have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|feldene|antacid|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOENTITY be_BE12 administer_BE12 in_BE12 conjunction_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 but_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOENTITY have_RE2 no_RE2 effect_RE2 on_RE2 BIOGENERAL_RE2 plasma_RE2 level_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|feldene|piroxicam|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOENTITY be_BE12 administer_BE12 in_BE12 conjunction_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 but_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 have_BE12 no_BE12 effect_BE12 on_BE12 BIOENTITY plasma_RE2 level_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|feldene|lithium|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOENTITY be_BE12 administer_BE12 in_BE12 conjunction_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 but_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 have_BE12 no_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 BIOGENERAL_BE12 including_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 report_BE12 to_BE12 increase_BE12 steady_BE12 state_BE12 plasma_BE12 BIOENTITY level_RE2 
Piroxicam|N|piroxicam|nonsteroidal anti-inflammatory agent|plasma_LE1 level_LE1 of_LE1 BIOENTITY be_BE12 depress_BE12 to_BE12 approximate_BE12 NUM_BE12 of_BE12 their_BE12 normal_BE12 value_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 in_BE12 conjunction_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 but_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 have_BE12 no_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 BIOENTITY including_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|piroxicam|feldene|plasma_LE1 level_LE1 of_LE1 BIOENTITY be_BE12 depress_BE12 to_BE12 approximate_BE12 NUM_BE12 of_BE12 their_BE12 normal_BE12 value_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 in_BE12 conjunction_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 but_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 have_BE12 no_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 BIOGENERAL_BE12 including_BE12 BIOENTITY have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|piroxicam|antacid|plasma_LE1 level_LE1 of_LE1 BIOENTITY be_BE12 depress_BE12 to_BE12 approximate_BE12 NUM_BE12 of_BE12 their_BE12 normal_BE12 value_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 in_BE12 conjunction_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 but_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOENTITY have_RE2 no_RE2 effect_RE2 on_RE2 BIOGENERAL_RE2 plasma_RE2 level_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|piroxicam|piroxicam|plasma_LE1 level_LE1 of_LE1 BIOENTITY be_BE12 depress_BE12 to_BE12 approximate_BE12 NUM_BE12 of_BE12 their_BE12 normal_BE12 value_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 in_BE12 conjunction_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 but_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 have_BE12 no_BE12 effect_BE12 on_BE12 BIOENTITY plasma_RE2 level_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|piroxicam|lithium|plasma_LE1 level_LE1 of_LE1 BIOENTITY be_BE12 depress_BE12 to_BE12 approximate_BE12 NUM_BE12 of_BE12 their_BE12 normal_BE12 value_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 in_BE12 conjunction_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 -RRB-_BE12 but_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 have_BE12 no_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 BIOGENERAL_BE12 including_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 report_BE12 to_BE12 increase_BE12 steady_BE12 state_BE12 plasma_BE12 BIOENTITY level_RE2 
Piroxicam|N|nonsteroidal anti-inflammatory agent|feldene|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 in_LE1 conjunction_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 -RRB-_LE1 but_LE1 concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 have_LE1 no_LE1 effect_LE1 on_LE1 BIOGENERAL_LE1 plasma_LE1 level_LE1 BIOENTITY including_BE12 BIOENTITY have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|antacid|nonsteroidal anti-inflammatory agent|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 in_LE1 conjunction_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 -RRB-_LE1 but_LE1 concomitant_LE1 administration_LE1 of_LE1 BIOENTITY have_BE12 no_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 BIOENTITY including_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|piroxicam|nonsteroidal anti-inflammatory agent|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 in_LE1 conjunction_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 -RRB-_LE1 but_LE1 concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 have_LE1 no_LE1 effect_LE1 on_LE1 BIOENTITY plasma_BE12 level_BE12 BIOENTITY including_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|antacid|feldene|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 in_LE1 conjunction_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 -RRB-_LE1 but_LE1 concomitant_LE1 administration_LE1 of_LE1 BIOENTITY have_BE12 no_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 BIOGENERAL_BE12 including_BE12 BIOENTITY have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|piroxicam|feldene|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 in_LE1 conjunction_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 -RRB-_LE1 but_LE1 concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 have_LE1 no_LE1 effect_LE1 on_LE1 BIOENTITY plasma_BE12 level_BE12 BIOGENERAL_BE12 including_BE12 BIOENTITY have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|antacid|piroxicam|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 in_LE1 conjunction_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 -RRB-_LE1 but_LE1 concomitant_LE1 administration_LE1 of_LE1 BIOENTITY have_BE12 no_BE12 effect_BE12 on_BE12 BIOENTITY plasma_RE2 level_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 have_RE2 be_RE2 report_RE2 to_RE2 increase_RE2 steady_RE2 state_RE2 plasma_RE2 BIOGENERAL_RE2 level_RE2 
Piroxicam|N|antacid|lithium|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 in_LE1 conjunction_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 -RRB-_LE1 but_LE1 concomitant_LE1 administration_LE1 of_LE1 BIOENTITY have_BE12 no_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 plasma_BE12 level_BE12 BIOGENERAL_BE12 including_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 report_BE12 to_BE12 increase_BE12 steady_BE12 state_BE12 plasma_BE12 BIOENTITY level_RE2 
Piroxicam|N|piroxicam|lithium|plasma_LE1 level_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 depress_LE1 to_LE1 approximate_LE1 NUM_LE1 of_LE1 their_LE1 normal_LE1 value_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 in_LE1 conjunction_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 -RRB-_LE1 but_LE1 concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 have_LE1 no_LE1 effect_LE1 on_LE1 BIOENTITY plasma_BE12 level_BE12 BIOGENERAL_BE12 including_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 report_BE12 to_BE12 increase_BE12 steady_BE12 state_BE12 plasma_BE12 BIOENTITY level_RE2 
Pralidoxime|N|pralidoxime|atropine|when_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY be_BE12 use_BE12 together_BE12 the_BE12 sign_BE12 of_BE12 atropinization_BE12 -LRB-_BE12 flush_BE12 mydriasis_BE12 tachycardia_BE12 dryness_BE12 of_BE12 the_BE12 mouth_BE12 and_BE12 nose_BE12 -RRB-_BE12 may_BE12 occur_BE12 early_BE12 than_BE12 may_BE12 be_BE12 expect_BE12 when_BE12 BIOENTITY be_RE2 use_RE2 alone_RE2 
Pralidoxime|N|atropine|atropine|when_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 be_BE12 use_BE12 together_BE12 the_BE12 sign_BE12 of_BE12 atropinization_BE12 -LRB-_BE12 flush_BE12 mydriasis_BE12 tachycardia_BE12 dryness_BE12 of_BE12 the_BE12 mouth_BE12 and_BE12 nose_BE12 -RRB-_BE12 may_BE12 occur_BE12 early_BE12 than_BE12 may_BE12 be_BE12 expect_BE12 when_BE12 BIOENTITY be_RE2 use_RE2 alone_RE2 
Pralidoxime|N|atropine|pralidoxime|this_LE1 be_LE1 especial_LE1 true_LE1 if_LE1 the_LE1 total_LE1 dose_LE1 of_LE1 BIOENTITY have_BE12 be_BE12 large_BE12 and_BE12 the_BE12 administration_BE12 of_BE12 BIOENTITY have_RE2 be_RE2 delay_RE2 
Pralidoxime|N|pralidoxime|anticholinesterase|NUM_LE1 NUM_LE1 the_LE1 follow_LE1 precaution_LE1 shall_LE1 be_LE1 keep_LE1 in_LE1 mind_LE1 in_LE1 the_LE1 treatment_LE1 of_LE1 anticholinesterase_LE1 poisoning_LE1 although_LE1 they_LE1 do_LE1 not_LE1 bear_LE1 direct_LE1 on_LE1 the_LE1 use_LE1 of_LE1 BIOENTITY :_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 potentiate_BE12 by_BE12 the_BE12 BIOENTITY they_RE2 shall_RE2 be_RE2 use_RE2 cautious_RE2 in_RE2 the_RE2 treatment_RE2 of_RE2 convulsion_RE2 
Pralidoxime|N|pralidoxime|barbiturate|NUM_LE1 NUM_LE1 the_LE1 follow_LE1 precaution_LE1 shall_LE1 be_LE1 keep_LE1 in_LE1 mind_LE1 in_LE1 the_LE1 treatment_LE1 of_LE1 anticholinesterase_LE1 poisoning_LE1 although_LE1 they_LE1 do_LE1 not_LE1 bear_LE1 direct_LE1 on_LE1 the_LE1 use_LE1 of_LE1 BIOENTITY :_BE12 since_BE12 BIOENTITY be_RE2 potentiate_RE2 by_RE2 the_RE2 BIOGENERAL_RE2 they_RE2 shall_RE2 be_RE2 use_RE2 cautious_RE2 in_RE2 the_RE2 treatment_RE2 of_RE2 convulsion_RE2 
Pralidoxime|N|succinylcholine|phenothiazine-type tranquilizer|BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|reserpine|phenothiazine-type tranquilizer|BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|theophylline|phenothiazine-type tranquilizer|BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|aminophylline|phenothiazine-type tranquilizer|BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|morphine|phenothiazine-type tranquilizer|BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|succinylcholine|reserpine|BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|succinylcholine|reserpine|BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|theophylline|succinylcholine|BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|theophylline|succinylcholine|BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|aminophylline|succinylcholine|BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|aminophylline|succinylcholine|BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|morphine|succinylcholine|BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|theophylline|reserpine|BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|theophylline|reserpine|BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|aminophylline|reserpine|BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|aminophylline|reserpine|BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|morphine|reserpine|BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|theophylline|aminophylline|BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|theophylline|aminophylline|BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|morphine|theophylline|BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pralidoxime|N|morphine|aminophylline|BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 avoid_RE2 in_RE2 patient_RE2 with_RE2 organophosphate_RE2 poisoning_RE2 
Pramipexole|N|carbidopa|levodopa|BIOENTITY :_BE12 BIOENTITY do_RE2 not_RE2 influence_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 in_RE2 healthy_RE2 volunteer_RE2 -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|carbidopa|levodopa|BIOENTITY :_BE12 BIOENTITY do_RE2 not_RE2 influence_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 in_RE2 healthy_RE2 volunteer_RE2 -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|carbidopa|pramipexole|BIOENTITY :_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 influence_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY in_RE2 healthy_RE2 volunteer_RE2 -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|carbidopa|levodopa|BIOENTITY :_RE2 BIOGENERAL_RE2 do_RE2 not_RE2 influence_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 in_RE2 healthy_RE2 volunteer_RE2 -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|carbidopa|levodopa|BIOGENERAL_LE1 :_LE1 BIOENTITY do_RE2 not_RE2 influence_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 in_RE2 healthy_RE2 volunteer_RE2 -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|levodopa|pramipexole|BIOGENERAL_LE1 :_LE1 BIOENTITY do_BE12 not_BE12 influence_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY in_RE2 healthy_RE2 volunteer_RE2 -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|carbidopa|levodopa|BIOENTITY :_BE12 BIOENTITY do_RE2 not_RE2 influence_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 in_RE2 healthy_RE2 volunteer_RE2 -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|levodopa|pramipexole|BIOGENERAL_LE1 :_LE1 BIOENTITY do_BE12 not_BE12 influence_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY in_RE2 healthy_RE2 volunteer_RE2 -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|carbidopa|levodopa|BIOENTITY :_BE12 BIOENTITY do_RE2 not_RE2 influence_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 in_RE2 healthy_RE2 volunteer_RE2 -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|carbidopa|pramipexole|BIOENTITY :_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 influence_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY in_RE2 healthy_RE2 volunteer_RE2 -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|selegiline|pramipexole|BIOGENERAL_LE1 :_LE1 In_LE1 healthy_LE1 volunteer_LE1 -LRB-_LE1 n=_LE1 NUM_LE1 -RRB-_LE1 BIOENTITY do_BE12 not_BE12 influence_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY 
Pramipexole|N|selegiline|pramipexole|BIOENTITY :_BE12 In_BE12 healthy_BE12 volunteer_BE12 -LRB-_BE12 n=_BE12 NUM_BE12 -RRB-_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 influence_BE12 the_BE12 pharmacokinetic_BE12 of_BE12 BIOENTITY 
Pramipexole|N|selegiline|selegiline|BIOENTITY :_BE12 In_BE12 healthy_BE12 volunteer_BE12 -LRB-_BE12 n=_BE12 NUM_BE12 -RRB-_BE12 BIOENTITY do_RE2 not_RE2 influence_RE2 the_RE2 pharmacokinetic_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|amantadine|pramipexole|BIOENTITY :_BE12 population_BE12 pharmacokinetic_BE12 analysis_BE12 suggest_BE12 that_BE12 BIOGENERAL_BE12 be_BE12 unlikely_BE12 to_BE12 alter_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|amantadine|pramipexole|BIOGENERAL_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 BIOENTITY be_BE12 unlikely_BE12 to_BE12 alter_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|amantadine|amantadine|BIOENTITY :_BE12 population_BE12 pharmacokinetic_BE12 analysis_BE12 suggest_BE12 that_BE12 BIOENTITY be_RE2 unlikely_RE2 to_RE2 alter_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|cimetidine|cimetidine|BIOENTITY :_BE12 BIOENTITY known_RE2 inhibitor_RE2 of_RE2 renal_RE2 tubular_RE2 secretion_RE2 of_RE2 organic_RE2 base_RE2 via_RE2 the_RE2 cationic_RE2 transport_RE2 system_RE2 cause_RE2 NUM_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 auc_RE2 and_RE2 NUM_RE2 increase_RE2 in_RE2 halflife_RE2 -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|cimetidine|pramipexole|BIOENTITY :_BE12 BIOGENERAL_BE12 known_BE12 inhibitor_BE12 of_BE12 renal_BE12 tubular_BE12 secretion_BE12 of_BE12 organic_BE12 base_BE12 via_BE12 the_BE12 cationic_BE12 transport_BE12 system_BE12 cause_BE12 NUM_BE12 increase_BE12 in_BE12 BIOENTITY auc_RE2 and_RE2 NUM_RE2 increase_RE2 in_RE2 halflife_RE2 -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|probenecid|pramipexole|BIOGENERAL_LE1 :_LE1 BIOENTITY known_BE12 inhibitor_BE12 of_BE12 renal_BE12 tubular_BE12 secretion_BE12 of_BE12 organic_BE12 acid_BE12 via_BE12 the_BE12 aruonic_BE12 transporter_BE12 do_BE12 not_BE12 noticeable_BE12 influence_BE12 BIOENTITY pharmacokinetic_RE2 -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|probenecid|pramipexole|BIOENTITY :_BE12 BIOGENERAL_BE12 known_BE12 inhibitor_BE12 of_BE12 renal_BE12 tubular_BE12 secretion_BE12 of_BE12 organic_BE12 acid_BE12 via_BE12 the_BE12 aruonic_BE12 transporter_BE12 do_BE12 not_BE12 noticeable_BE12 influence_BE12 BIOENTITY pharmacokinetic_RE2 -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|probenecid|probenecid|BIOENTITY :_BE12 BIOENTITY known_RE2 inhibitor_RE2 of_RE2 renal_RE2 tubular_RE2 secretion_RE2 of_RE2 organic_RE2 acid_RE2 via_RE2 the_RE2 aruonic_RE2 transporter_RE2 do_RE2 not_RE2 noticeable_RE2 influence_RE2 BIOGENERAL_RE2 pharmacokinetic_RE2 -LRB-_RE2 n=_RE2 NUM_RE2 rrb._RE2 
Pramipexole|N|pramipexole|cephalosporin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOENTITY by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|cephalosporin|penicillin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 by_LE1 about_LE1 NUM_LE1 while_LE1 those_LE1 secrete_LE1 by_LE1 the_LE1 anionic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|verapamil|cephalosporin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|verapamil|cephalosporin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|cephalosporin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|cephalosporin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinine|cephalosporin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinine|cephalosporin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinidine|cephalosporin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinidine|cephalosporin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|cimetidine|cephalosporin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|cimetidine|cephalosporin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|cephalosporin|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 by_LE1 about_LE1 NUM_LE1 while_LE1 those_LE1 secrete_LE1 by_LE1 the_LE1 anionic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|cephalosporin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|cephalosporin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|cephalosporin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|cephalosporin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|cephalosporin|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 by_LE1 about_LE1 NUM_LE1 while_LE1 those_LE1 secrete_LE1 by_LE1 the_LE1 anionic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|cephalosporin|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 by_LE1 about_LE1 NUM_LE1 while_LE1 those_LE1 secrete_LE1 by_LE1 the_LE1 anionic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|pramipexole|penicillin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOENTITY by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|pramipexole|pramipexole|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOENTITY by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 be_BE12 likely_BE12 to_BE12 have_BE12 little_BE12 effect_BE12 on_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY 
Pramipexole|N|pramipexole|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOENTITY by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|pramipexole|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOENTITY by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|pramipexole|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOENTITY by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|verapamil|penicillin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|verapamil|penicillin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|penicillin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|penicillin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinine|penicillin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinine|penicillin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinidine|penicillin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinidine|penicillin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|cimetidine|penicillin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|cimetidine|penicillin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|penicillin|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 by_LE1 about_LE1 NUM_LE1 while_LE1 those_LE1 secrete_LE1 by_LE1 the_LE1 anionic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|penicillin|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 by_LE1 about_LE1 NUM_LE1 while_LE1 those_LE1 secrete_LE1 by_LE1 the_LE1 anionic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|penicillin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|penicillin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|penicillin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|penicillin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|penicillin|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 by_LE1 about_LE1 NUM_LE1 while_LE1 those_LE1 secrete_LE1 by_LE1 the_LE1 anionic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|penicillin|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 by_LE1 about_LE1 NUM_LE1 while_LE1 those_LE1 secrete_LE1 by_LE1 the_LE1 anionic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|penicillin|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 by_LE1 about_LE1 NUM_LE1 while_LE1 those_LE1 secrete_LE1 by_LE1 the_LE1 anionic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|penicillin|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 by_LE1 about_LE1 NUM_LE1 while_LE1 those_LE1 secrete_LE1 by_LE1 the_LE1 anionic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|verapamil|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|verapamil|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|verapamil|quinine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|verapamil|quinine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|verapamil|quinidine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|verapamil|quinidine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|verapamil|pramipexole|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 be_BE12 likely_BE12 to_BE12 have_BE12 little_BE12 effect_BE12 on_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY 
Pramipexole|N|verapamil|pramipexole|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 be_BE12 likely_BE12 to_BE12 have_BE12 little_BE12 effect_BE12 on_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY 
Pramipexole|N|cimetidine|verapamil|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|verapamil|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|verapamil|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|verapamil|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|verapamil|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|verapamil|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|verapamil|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|verapamil|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|verapamil|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|verapamil|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|verapamil|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|quinine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|quinine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|quinidine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|quinidine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|pramipexole|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 be_BE12 likely_BE12 to_BE12 have_BE12 little_BE12 effect_BE12 on_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY 
Pramipexole|N|triamterene|pramipexole|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 be_BE12 likely_BE12 to_BE12 have_BE12 little_BE12 effect_BE12 on_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY 
Pramipexole|N|cimetidine|triamterene|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|triamterene|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|triamterene|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|triamterene|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|triamterene|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|triamterene|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinidine|quinine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinidine|quinine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinine|pramipexole|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 be_BE12 likely_BE12 to_BE12 have_BE12 little_BE12 effect_BE12 on_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY 
Pramipexole|N|quinine|pramipexole|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 be_BE12 likely_BE12 to_BE12 have_BE12 little_BE12 effect_BE12 on_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY 
Pramipexole|N|cimetidine|quinine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinine|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinine|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|quinine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|quinine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|quinine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|quinine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinine|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinine|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinine|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinine|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinidine|pramipexole|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 be_BE12 likely_BE12 to_BE12 have_BE12 little_BE12 effect_BE12 on_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY 
Pramipexole|N|quinidine|pramipexole|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 be_BE12 likely_BE12 to_BE12 have_BE12 little_BE12 effect_BE12 on_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY 
Pramipexole|N|cimetidine|quinidine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinidine|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinidine|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|quinidine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|quinidine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|quinidine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|quinidine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinidine|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinidine|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinidine|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|quinidine|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|cimetidine|pramipexole|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 be_BE12 likely_BE12 to_BE12 have_BE12 little_BE12 effect_BE12 on_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY 
Pramipexole|N|cimetidine|pramipexole|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 be_BE12 likely_BE12 to_BE12 have_BE12 little_BE12 effect_BE12 on_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY 
Pramipexole|N|ranitidine|pramipexole|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 be_BE12 likely_BE12 to_BE12 have_BE12 little_BE12 effect_BE12 on_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY 
Pramipexole|N|ranitidine|pramipexole|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 be_BE12 likely_BE12 to_BE12 have_BE12 little_BE12 effect_BE12 on_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY 
Pramipexole|N|diltiazem|pramipexole|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 be_BE12 likely_BE12 to_BE12 have_BE12 little_BE12 effect_BE12 on_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY 
Pramipexole|N|diltiazem|pramipexole|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 be_BE12 likely_BE12 to_BE12 have_BE12 little_BE12 effect_BE12 on_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOENTITY 
Pramipexole|N|cimetidine|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|cimetidine|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|cimetidine|ranitidine|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|cimetidine|diltiazem|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|cimetidine|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|cimetidine|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|cimetidine|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|cimetidine|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|hydrochlorothiazide|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 by_LE1 about_LE1 NUM_LE1 while_LE1 those_LE1 secrete_LE1 by_LE1 the_LE1 anionic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|hydrochlorothiazide|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 by_LE1 about_LE1 NUM_LE1 while_LE1 those_LE1 secrete_LE1 by_LE1 the_LE1 anionic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|indomethacin|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 by_LE1 about_LE1 NUM_LE1 while_LE1 those_LE1 secrete_LE1 by_LE1 the_LE1 anionic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|indomethacin|chlorpropamide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 by_LE1 about_LE1 NUM_LE1 while_LE1 those_LE1 secrete_LE1 by_LE1 the_LE1 anionic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|diltiazem|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|diltiazem|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 decrease_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 by_RE2 about_RE2 NUM_RE2 while_RE2 those_RE2 secrete_RE2 by_RE2 the_RE2 anionic_RE2 transport_RE2 system_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|ranitidine|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|diltiazem|indomethacin|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 decrease_BE12 the_BE12 oral_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 about_BE12 NUM_BE12 while_BE12 those_BE12 secrete_BE12 by_BE12 the_BE12 anionic_BE12 transport_BE12 system_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|indomethacin|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 by_LE1 about_LE1 NUM_LE1 while_LE1 those_LE1 secrete_LE1 by_LE1 the_LE1 anionic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|indomethacin|hydrochlorothiazide|other_LE1 drug_LE1 eliminate_LE1 via_LE1 renal_LE1 secretion_LE1 :_LE1 population_LE1 pharmacokinetic_LE1 analysis_LE1 suggest_LE1 that_LE1 coadministration_LE1 of_LE1 drug_LE1 that_LE1 be_LE1 secrete_LE1 by_LE1 the_LE1 cationic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 decrease_LE1 the_LE1 oral_LE1 clearance_LE1 of_LE1 BIOGENERAL_LE1 by_LE1 about_LE1 NUM_LE1 while_LE1 those_LE1 secrete_LE1 by_LE1 the_LE1 anionic_LE1 transport_LE1 system_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 likely_RE2 to_RE2 have_RE2 little_RE2 effect_RE2 on_RE2 the_RE2 oral_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|pramipexole|pramipexole|cyp_LE1 interaction_LE1 :_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 enzyme_LE1 will_LE1 not_LE1 be_LE1 expect_LE1 to_LE1 affect_LE1 BIOENTITY elimination_BE12 because_BE12 BIOENTITY be_RE2 not_RE2 appreciable_RE2 metabolize_RE2 by_RE2 these_RE2 enzyme_RE2 in_RE2 vivo_RE2 or_RE2 in_RE2 vitro_RE2 
Pramipexole|N|dopamine agonist|dopamine antagonist|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOENTITY it_BE12 be_BE12 possible_BE12 that_BE12 BIOENTITY such_RE2 as_RE2 the_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine antagonist|dopamine agonist|BIOENTITY :_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 BIOENTITY it_RE2 be_RE2 possible_RE2 that_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 the_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|pramipexole|dopamine agonist|BIOGENERAL_LE1 :_LE1 since_LE1 BIOENTITY be_BE12 BIOENTITY it_RE2 be_RE2 possible_RE2 that_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 the_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine agonist|butyrophenone|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOENTITY it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine agonist|thioxanthene|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOENTITY it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine agonist|neuroleptic|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOENTITY it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine agonist|phenothiazine|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOENTITY it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine agonist|metoclopramide|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOENTITY it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine agonist|mirapex|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOENTITY it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 may_BE12 diminish_BE12 the_BE12 effectiveness_BE12 of_BE12 BIOENTITY 
Pramipexole|N|dopamine antagonist|dopamine antagonist|BIOENTITY :_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 BIOGENERAL_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOENTITY such_RE2 as_RE2 the_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|pramipexole|dopamine antagonist|BIOGENERAL_LE1 :_LE1 since_LE1 BIOENTITY be_BE12 BIOGENERAL_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOENTITY such_RE2 as_RE2 the_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine antagonist|butyrophenone|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOGENERAL_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOENTITY such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine antagonist|thioxanthene|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOGENERAL_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOENTITY such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine antagonist|neuroleptic|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOGENERAL_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOENTITY such_BE12 as_BE12 the_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine antagonist|phenothiazine|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOGENERAL_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOENTITY such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine antagonist|metoclopramide|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOGENERAL_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOENTITY such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine antagonist|pramipexole|BIOENTITY :_BE12 since_BE12 BIOENTITY be_RE2 BIOGENERAL_RE2 it_RE2 be_RE2 possible_RE2 that_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 the_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine antagonist|butyrophenone|BIOENTITY :_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 BIOGENERAL_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine antagonist|thioxanthene|BIOENTITY :_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 BIOGENERAL_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine antagonist|neuroleptic|BIOENTITY :_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 BIOGENERAL_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine antagonist|phenothiazine|BIOENTITY :_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 BIOGENERAL_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine antagonist|metoclopramide|BIOENTITY :_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 BIOGENERAL_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|dopamine antagonist|mirapex|BIOENTITY :_BE12 since_BE12 BIOGENERAL_BE12 be_BE12 BIOGENERAL_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 may_BE12 diminish_BE12 the_BE12 effectiveness_BE12 of_BE12 BIOENTITY 
Pramipexole|N|pramipexole|butyrophenone|BIOGENERAL_LE1 :_LE1 since_LE1 BIOENTITY be_BE12 BIOGENERAL_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|pramipexole|thioxanthene|BIOGENERAL_LE1 :_LE1 since_LE1 BIOENTITY be_BE12 BIOGENERAL_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|pramipexole|neuroleptic|BIOGENERAL_LE1 :_LE1 since_LE1 BIOENTITY be_BE12 BIOGENERAL_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|pramipexole|phenothiazine|BIOGENERAL_LE1 :_LE1 since_LE1 BIOENTITY be_BE12 BIOGENERAL_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|pramipexole|metoclopramide|BIOGENERAL_LE1 :_LE1 since_LE1 BIOENTITY be_BE12 BIOGENERAL_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|pramipexole|mirapex|BIOGENERAL_LE1 :_LE1 since_LE1 BIOENTITY be_BE12 BIOGENERAL_BE12 it_BE12 be_BE12 possible_BE12 that_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 the_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 may_BE12 diminish_BE12 the_BE12 effectiveness_BE12 of_BE12 BIOENTITY 
Pramipexole|N|butyrophenone|thioxanthene|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOGENERAL_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|neuroleptic|butyrophenone|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOGENERAL_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|phenothiazine|butyrophenone|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOGENERAL_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|butyrophenone|metoclopramide|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOGENERAL_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|neuroleptic|thioxanthene|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOGENERAL_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|phenothiazine|thioxanthene|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOGENERAL_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|thioxanthene|metoclopramide|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOGENERAL_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOENTITY may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|neuroleptic|phenothiazine|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOGENERAL_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOENTITY -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|neuroleptic|metoclopramide|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOGENERAL_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramipexole|N|phenothiazine|metoclopramide|BIOGENERAL_LE1 :_LE1 since_LE1 BIOGENERAL_LE1 be_LE1 BIOGENERAL_LE1 it_LE1 be_LE1 possible_LE1 that_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 the_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY may_RE2 diminish_RE2 the_RE2 effectiveness_RE2 of_RE2 BIOGENERAL_RE2 
Pramlintide|N|anticholinergic agent|atropine|Due_LE1 to_LE1 its_LE1 effect_LE1 on_LE1 gastric_LE1 emptying_LE1 BIOGENERAL_LE1 therapy_LE1 shall_LE1 not_LE1 be_LE1 consider_LE1 for_LE1 patient_LE1 take_LE1 drug_LE1 that_LE1 alter_LE1 gastrointestinal_LE1 motility_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY such_BE12 as_BE12 BIOENTITY -RRB-_RE2 and_RE2 agent_RE2 that_RE2 slow_RE2 the_RE2 intestinal_RE2 absorption_RE2 of_RE2 nutrient_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 rrb._RE2 
Pramlintide|N|atropine|alpha glucosidase inhibitor|Due_LE1 to_LE1 its_LE1 effect_LE1 on_LE1 gastric_LE1 emptying_LE1 BIOGENERAL_LE1 therapy_LE1 shall_LE1 not_LE1 be_LE1 consider_LE1 for_LE1 patient_LE1 take_LE1 drug_LE1 that_LE1 alter_LE1 gastrointestinal_LE1 motility_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -RRB-_BE12 and_BE12 agent_BE12 that_BE12 slow_BE12 the_BE12 intestinal_BE12 absorption_BE12 of_BE12 nutrient_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY rrb._RE2 
Pramlintide|N|atropine|alpha glucosidase inhibitor|Due_LE1 to_LE1 its_LE1 effect_LE1 on_LE1 gastric_LE1 emptying_LE1 BIOGENERAL_LE1 therapy_LE1 shall_LE1 not_LE1 be_LE1 consider_LE1 for_LE1 patient_LE1 take_LE1 drug_LE1 that_LE1 alter_LE1 gastrointestinal_LE1 motility_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY -RRB-_BE12 and_BE12 agent_BE12 that_BE12 slow_BE12 the_BE12 intestinal_BE12 absorption_BE12 of_BE12 nutrient_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY rrb._RE2 
Pramlintide|N|anticholinergic agent|alpha glucosidase inhibitor|Due_LE1 to_LE1 its_LE1 effect_LE1 on_LE1 gastric_LE1 emptying_LE1 BIOGENERAL_LE1 therapy_LE1 shall_LE1 not_LE1 be_LE1 consider_LE1 for_LE1 patient_LE1 take_LE1 drug_LE1 that_LE1 alter_LE1 gastrointestinal_LE1 motility_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -RRB-_BE12 and_BE12 agent_BE12 that_BE12 slow_BE12 the_BE12 intestinal_BE12 absorption_BE12 of_BE12 nutrient_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY rrb._RE2 
Pramlintide|N|anticholinergic agent|alpha glucosidase inhibitor|Due_LE1 to_LE1 its_LE1 effect_LE1 on_LE1 gastric_LE1 emptying_LE1 BIOGENERAL_LE1 therapy_LE1 shall_LE1 not_LE1 be_LE1 consider_LE1 for_LE1 patient_LE1 take_LE1 drug_LE1 that_LE1 alter_LE1 gastrointestinal_LE1 motility_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 -RRB-_BE12 and_BE12 agent_BE12 that_BE12 slow_BE12 the_BE12 intestinal_BE12 absorption_BE12 of_BE12 nutrient_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY rrb._RE2 
Pramlintide|N|biguanide|symlin|In_LE1 clinical_LE1 trial_LE1 the_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY do_BE12 not_BE12 alter_BE12 the_BE12 adverse_BE12 event_BE12 profile_BE12 of_BE12 BIOENTITY 
Pramlintide|N|sulfonylurea|symlin|In_LE1 clinical_LE1 trial_LE1 the_LE1 concomitant_LE1 use_LE1 of_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 do_BE12 not_BE12 alter_BE12 the_BE12 adverse_BE12 event_BE12 profile_BE12 of_BE12 BIOENTITY 
Pramlintide|N|sulfonylurea|biguanide|In_LE1 clinical_LE1 trial_LE1 the_LE1 concomitant_LE1 use_LE1 of_LE1 BIOENTITY or_BE12 BIOENTITY do_RE2 not_RE2 alter_RE2 the_RE2 adverse_RE2 event_RE2 profile_RE2 of_RE2 BIOGENERAL_RE2 
Pramlintide|N|symlin|antidiabetic agent|no_LE1 formal_LE1 interaction_LE1 study_LE1 have_LE1 be_LE1 perform_LE1 to_LE1 assess_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY on_BE12 the_BE12 kinetic_BE12 of_BE12 oral_BE12 BIOENTITY 
Pramlintide|N|insulin|symlin|mix_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY the_BE12 pharmacokinetic_BE12 parameter_BE12 of_BE12 BIOENTITY be_RE2 alter_RE2 when_RE2 mix_RE2 with_RE2 regular_RE2 nph_RE2 and_RE2 premix_RE2 formulation_RE2 of_RE2 recombinant_RE2 BIOGENERAL_RE2 immediate_RE2 prior_RE2 to_RE2 injection_RE2 
Pramlintide|N|insulin|human insulin|mix_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY the_BE12 pharmacokinetic_BE12 parameter_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 alter_BE12 when_BE12 mix_BE12 with_BE12 regular_BE12 nph_BE12 and_BE12 premix_BE12 formulation_BE12 of_BE12 recombinant_BE12 BIOENTITY immediate_RE2 prior_RE2 to_RE2 injection_RE2 
Pramlintide|N|symlin|insulin|mix_LE1 BIOENTITY and_BE12 BIOENTITY the_RE2 pharmacokinetic_RE2 parameter_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 alter_RE2 when_RE2 mix_RE2 with_RE2 regular_RE2 nph_RE2 and_RE2 premix_RE2 formulation_RE2 of_RE2 recombinant_RE2 BIOGENERAL_RE2 immediate_RE2 prior_RE2 to_RE2 injection_RE2 
Pramlintide|N|symlin|symlin|mix_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 the_BE12 pharmacokinetic_BE12 parameter_BE12 of_BE12 BIOENTITY be_RE2 alter_RE2 when_RE2 mix_RE2 with_RE2 regular_RE2 nph_RE2 and_RE2 premix_RE2 formulation_RE2 of_RE2 recombinant_RE2 BIOGENERAL_RE2 immediate_RE2 prior_RE2 to_RE2 injection_RE2 
Pramlintide|N|symlin|human insulin|mix_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 the_BE12 pharmacokinetic_BE12 parameter_BE12 of_BE12 BIOGENERAL_BE12 be_BE12 alter_BE12 when_BE12 mix_BE12 with_BE12 regular_BE12 nph_BE12 and_BE12 premix_BE12 formulation_BE12 of_BE12 recombinant_BE12 BIOENTITY immediate_RE2 prior_RE2 to_RE2 injection_RE2 
Pramlintide|N|symlin|insulin|thus_LE1 BIOENTITY and_BE12 BIOENTITY shall_RE2 not_RE2 be_RE2 mix_RE2 and_RE2 must_RE2 be_RE2 administer_RE2 separate_RE2 
Prednisone|N|phenytoin|rifampin|drug_LE1 that_LE1 induce_LE1 hepatic_LE1 enzyme_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY may_RE2 increase_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 may_RE2 require_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 dose_RE2 to_RE2 achieve_RE2 the_RE2 desired_RE2 response_RE2 
Prednisone|N|phenytoin|rifampin|drug_LE1 that_LE1 induce_LE1 hepatic_LE1 enzyme_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY may_RE2 increase_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 may_RE2 require_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 dose_RE2 to_RE2 achieve_RE2 the_RE2 desired_RE2 response_RE2 
Prednisone|N|phenobarbital|rifampin|drug_LE1 that_LE1 induce_LE1 hepatic_LE1 enzyme_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 increase_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 may_RE2 require_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 dose_RE2 to_RE2 achieve_RE2 the_RE2 desired_RE2 response_RE2 
Prednisone|N|phenobarbital|phenytoin|drug_LE1 that_LE1 induce_LE1 hepatic_LE1 enzyme_LE1 such_LE1 as_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 increase_RE2 the_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 may_RE2 require_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 dose_RE2 to_RE2 achieve_RE2 the_RE2 desired_RE2 response_RE2 
Prednisone|N|corticosteroid|corticosteroid|drug_LE1 that_LE1 induce_LE1 hepatic_LE1 enzyme_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 may_LE1 increase_LE1 the_LE1 clearance_LE1 of_LE1 BIOENTITY and_BE12 may_BE12 require_BE12 increase_BE12 in_BE12 BIOENTITY dose_RE2 to_RE2 achieve_RE2 the_RE2 desired_RE2 response_RE2 
Prednisone|N|troleandomycin|ketoconazole|drug_LE1 such_LE1 as_LE1 BIOENTITY and_BE12 BIOENTITY may_RE2 inhibit_RE2 the_RE2 metabolism_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 thus_RE2 decrease_RE2 their_RE2 clearance_RE2 
Prednisone|N|salicylate|corticosteroid|this_LE1 can_LE1 lead_LE1 to_LE1 decrease_LE1 BIOENTITY serum_BE12 level_BE12 or_BE12 increase_BE12 the_BE12 risk_BE12 of_BE12 BIOGENERAL_BE12 toxicity_BE12 when_BE12 BIOENTITY be_RE2 withdraw_RE2 
Prednisone|N|salicylate|salicylate|this_LE1 can_LE1 lead_LE1 to_LE1 decrease_LE1 BIOENTITY serum_BE12 level_BE12 or_BE12 increase_BE12 the_BE12 risk_BE12 of_BE12 BIOENTITY toxicity_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 withdraw_RE2 
Procaine|N|procaine hydrochloride|anticholinesterase|BIOGENERAL_LE1 :_LE1 concurrent_LE1 use_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 may_BE12 result_BE12 in_BE12 increase_BE12 systemic_BE12 toxicity_BE12 since_BE12 BIOENTITY inhibit_RE2 the_RE2 breakdown_RE2 of_RE2 BIOGENERAL_RE2 
Procaine|N|procaine hydrochloride|procaine hydrochloride|BIOGENERAL_LE1 :_LE1 concurrent_LE1 use_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 may_BE12 result_BE12 in_BE12 increase_BE12 systemic_BE12 toxicity_BE12 since_BE12 BIOGENERAL_BE12 inhibit_BE12 the_BE12 breakdown_BE12 of_BE12 BIOENTITY 
Procaine|N|anticholinesterase|procaine hydrochloride|BIOENTITY :_BE12 concurrent_BE12 use_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 result_RE2 in_RE2 increase_RE2 systemic_RE2 toxicity_RE2 since_RE2 BIOGENERAL_RE2 inhibit_RE2 the_RE2 breakdown_RE2 of_RE2 BIOGENERAL_RE2 
Procaine|N|anticholinesterase agent|anticholinesterase|BIOGENERAL_LE1 :_LE1 concurrent_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY may_BE12 result_BE12 in_BE12 increase_BE12 systemic_BE12 toxicity_BE12 since_BE12 BIOENTITY inhibit_RE2 the_RE2 breakdown_RE2 of_RE2 BIOGENERAL_RE2 
Procaine|N|anticholinesterase agent|procaine hydrochloride|BIOGENERAL_LE1 :_LE1 concurrent_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY may_BE12 result_BE12 in_BE12 increase_BE12 systemic_BE12 toxicity_BE12 since_BE12 BIOGENERAL_BE12 inhibit_BE12 the_BE12 breakdown_BE12 of_BE12 BIOENTITY 
Procaine|N|anticholinesterase|anticholinesterase agent|BIOENTITY :_BE12 concurrent_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 result_RE2 in_RE2 increase_RE2 systemic_RE2 toxicity_RE2 since_RE2 BIOGENERAL_RE2 inhibit_RE2 the_RE2 breakdown_RE2 of_RE2 BIOGENERAL_RE2 
Procaine|N|anticholinesterase|anticholinesterase|BIOENTITY :_BE12 concurrent_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 result_BE12 in_BE12 increase_BE12 systemic_BE12 toxicity_BE12 since_BE12 BIOENTITY inhibit_RE2 the_RE2 breakdown_RE2 of_RE2 BIOGENERAL_RE2 
Procaine|N|anticholinesterase|procaine hydrochloride|BIOENTITY :_BE12 concurrent_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 result_BE12 in_BE12 increase_BE12 systemic_BE12 toxicity_BE12 since_BE12 BIOGENERAL_BE12 inhibit_BE12 the_BE12 breakdown_BE12 of_BE12 BIOENTITY 
Procaine|N|cns depressant|cns depressant medication|BIOENTITY medication_BE12 :_BE12 concurrent_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 result_RE2 in_RE2 additive_RE2 depressant_RE2 effect_RE2 
Procaine|N|cns depressant|procaine hydrochloride|BIOENTITY medication_BE12 :_BE12 concurrent_BE12 use_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 result_RE2 in_RE2 additive_RE2 depressant_RE2 effect_RE2 
Procaine|N|hyaluronidase|hyaluronidase|BIOENTITY :_BE12 BIOENTITY may_RE2 increase_RE2 the_RE2 diffusion_RE2 rate_RE2 of_RE2 BIOGENERAL_RE2 result_RE2 in_RE2 decrease_RE2 time_RE2 of_RE2 onset_RE2 but_RE2 increase_RE2 in_RE2 systemic_RE2 toxicity_RE2 
Procaine|N|hyaluronidase|procaine hydrochloride|BIOENTITY :_BE12 BIOGENERAL_BE12 may_BE12 increase_BE12 the_BE12 diffusion_BE12 rate_BE12 of_BE12 BIOENTITY result_RE2 in_RE2 decrease_RE2 time_RE2 of_RE2 onset_RE2 but_RE2 increase_RE2 in_RE2 systemic_RE2 toxicity_RE2 
Procaine|N|neuromuscular blocking agent|neuromuscular blocking agent|BIOENTITY -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -RRB-_BE12 :_BE12 concurrent_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 result_RE2 in_RE2 prolongation_RE2 or_RE2 enhancement_RE2 of_RE2 the_RE2 neuromuscular_RE2 blockade_RE2 
Procaine|N|suxamethonium chloride|neuromuscular blocking agent|BIOGENERAL_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOENTITY -RRB-_BE12 :_BE12 concurrent_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 result_RE2 in_RE2 prolongation_RE2 or_RE2 enhancement_RE2 of_RE2 the_RE2 neuromuscular_RE2 blockade_RE2 
Procaine|N|neuromuscular blocking agent|procaine hydrochloride|BIOENTITY -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -RRB-_BE12 :_BE12 concurrent_BE12 use_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 result_RE2 in_RE2 prolongation_RE2 or_RE2 enhancement_RE2 of_RE2 the_RE2 neuromuscular_RE2 blockade_RE2 
Procaine|N|neuromuscular blocking agent|suxamethonium chloride|BIOENTITY -LRB-_BE12 such_BE12 as_BE12 BIOENTITY -RRB-_RE2 :_RE2 concurrent_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 result_RE2 in_RE2 prolongation_RE2 or_RE2 enhancement_RE2 of_RE2 the_RE2 neuromuscular_RE2 blockade_RE2 
Procaine|N|suxamethonium chloride|procaine hydrochloride|BIOGENERAL_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOENTITY -RRB-_BE12 :_BE12 concurrent_BE12 use_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 result_RE2 in_RE2 prolongation_RE2 or_RE2 enhancement_RE2 of_RE2 the_RE2 neuromuscular_RE2 blockade_RE2 
Procaine|N|sulfonamide|sulfonamide|BIOGENERAL_LE1 :_LE1 concurrent_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY may_BE12 result_BE12 in_BE12 reduction_BE12 of_BE12 the_BE12 antibacterial_BE12 action_BE12 of_BE12 the_BE12 BIOENTITY 
Procaine|N|procaine hydrochloride|sulfonamide|BIOGENERAL_LE1 :_LE1 concurrent_LE1 use_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 may_BE12 result_BE12 in_BE12 reduction_BE12 of_BE12 the_BE12 antibacterial_BE12 action_BE12 of_BE12 the_BE12 BIOENTITY 
Procaine|N|sulfonamide|sulfonamide|BIOENTITY :_BE12 concurrent_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 result_BE12 in_BE12 reduction_BE12 of_BE12 the_BE12 antibacterial_BE12 action_BE12 of_BE12 the_BE12 BIOENTITY 
Procaine|N|sulfonamide|sulfonamide|BIOENTITY :_BE12 concurrent_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 result_RE2 in_RE2 reduction_RE2 of_RE2 the_RE2 antibacterial_RE2 action_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 
Procaine|N|sulfonamide|procaine hydrochloride|BIOENTITY :_BE12 concurrent_BE12 use_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 result_RE2 in_RE2 reduction_RE2 of_RE2 the_RE2 antibacterial_RE2 action_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 
Procaine|N|acetazolamide|procaine hydrochloride|BIOENTITY :_BE12 concurrent_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 extend_RE2 the_RE2 plasma_RE2 halflife_RE2 of_RE2 BIOGENERAL_RE2 
Procaine|N|acetazolamide|acetazolamide|BIOENTITY :_BE12 concurrent_BE12 use_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 extend_RE2 the_RE2 plasma_RE2 halflife_RE2 of_RE2 BIOGENERAL_RE2 
Procaine|N|acetazolamide|procaine|BIOENTITY :_BE12 concurrent_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 may_BE12 extend_BE12 the_BE12 plasma_BE12 halflife_BE12 of_BE12 BIOENTITY 
Procaine|N|procaine hydrochloride|procaine|BIOGENERAL_LE1 :_LE1 concurrent_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY may_BE12 extend_BE12 the_BE12 plasma_BE12 halflife_BE12 of_BE12 BIOENTITY 
Procaine|N|acetazolamide|procaine|BIOGENERAL_LE1 :_LE1 concurrent_LE1 use_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 may_BE12 extend_BE12 the_BE12 plasma_BE12 halflife_BE12 of_BE12 BIOENTITY 
Procarbazine|N|hypotensive agent|phenothiazine|to_LE1 minimize_LE1 cns_LE1 depression_LE1 and_LE1 possible_LE1 potentiation_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Procarbazine|N|hypotensive agent|phenothiazine|to_LE1 minimize_LE1 cns_LE1 depression_LE1 and_LE1 possible_LE1 potentiation_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Procarbazine|N|antihistamine|phenothiazine|to_LE1 minimize_LE1 cns_LE1 depression_LE1 and_LE1 possible_LE1 potentiation_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Procarbazine|N|antihistamine|phenothiazine|to_LE1 minimize_LE1 cns_LE1 depression_LE1 and_LE1 possible_LE1 potentiation_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Procarbazine|N|narcotic|phenothiazine|to_LE1 minimize_LE1 cns_LE1 depression_LE1 and_LE1 possible_LE1 potentiation_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Procarbazine|N|narcotic|phenothiazine|to_LE1 minimize_LE1 cns_LE1 depression_LE1 and_LE1 possible_LE1 potentiation_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Procarbazine|N|barbiturate|phenothiazine|to_LE1 minimize_LE1 cns_LE1 depression_LE1 and_LE1 possible_LE1 potentiation_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Procarbazine|N|antihistamine|hypotensive agent|to_LE1 minimize_LE1 cns_LE1 depression_LE1 and_LE1 possible_LE1 potentiation_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Procarbazine|N|antihistamine|hypotensive agent|to_LE1 minimize_LE1 cns_LE1 depression_LE1 and_LE1 possible_LE1 potentiation_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Procarbazine|N|narcotic|hypotensive agent|to_LE1 minimize_LE1 cns_LE1 depression_LE1 and_LE1 possible_LE1 potentiation_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Procarbazine|N|narcotic|hypotensive agent|to_LE1 minimize_LE1 cns_LE1 depression_LE1 and_LE1 possible_LE1 potentiation_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Procarbazine|N|barbiturate|hypotensive agent|to_LE1 minimize_LE1 cns_LE1 depression_LE1 and_LE1 possible_LE1 potentiation_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Procarbazine|N|antihistamine|narcotic|to_LE1 minimize_LE1 cns_LE1 depression_LE1 and_LE1 possible_LE1 potentiation_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Procarbazine|N|antihistamine|narcotic|to_LE1 minimize_LE1 cns_LE1 depression_LE1 and_LE1 possible_LE1 potentiation_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Procarbazine|N|barbiturate|antihistamine|to_LE1 minimize_LE1 cns_LE1 depression_LE1 and_LE1 possible_LE1 potentiation_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Procarbazine|N|barbiturate|narcotic|to_LE1 minimize_LE1 cns_LE1 depression_LE1 and_LE1 possible_LE1 potentiation_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Procarbazine|N|amitriptyline hcl|imipramine hcl|because_LE1 BIOGENERAL_LE1 exhibit_LE1 some_LE1 monoamine_LE1 oxidase_LE1 inhibitory_LE1 activity_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 drug_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY -RRB-_RE2 and_RE2 other_RE2 drug_RE2 and_RE2 food_RE2 with_RE2 known_RE2 high_RE2 BIOGENERAL_RE2 content_RE2 such_RE2 as_RE2 wine_RE2 yogurt_RE2 ripe_RE2 cheese_RE2 and_RE2 banana_RE2 shall_RE2 be_RE2 avoid_RE2 
Procarbazine|N|tricyclic antidepressant|imipramine hcl|because_LE1 BIOGENERAL_LE1 exhibit_LE1 some_LE1 monoamine_LE1 oxidase_LE1 inhibitory_LE1 activity_LE1 BIOGENERAL_LE1 BIOENTITY drug_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 and_RE2 other_RE2 drug_RE2 and_RE2 food_RE2 with_RE2 known_RE2 high_RE2 BIOGENERAL_RE2 content_RE2 such_RE2 as_RE2 wine_RE2 yogurt_RE2 ripe_RE2 cheese_RE2 and_RE2 banana_RE2 shall_RE2 be_RE2 avoid_RE2 
Procarbazine|N|sympathomimetic drug|imipramine hcl|because_LE1 BIOGENERAL_LE1 exhibit_LE1 some_LE1 monoamine_LE1 oxidase_LE1 inhibitory_LE1 activity_LE1 BIOENTITY BIOGENERAL_BE12 drug_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 and_RE2 other_RE2 drug_RE2 and_RE2 food_RE2 with_RE2 known_RE2 high_RE2 BIOGENERAL_RE2 content_RE2 such_RE2 as_RE2 wine_RE2 yogurt_RE2 ripe_RE2 cheese_RE2 and_RE2 banana_RE2 shall_RE2 be_RE2 avoid_RE2 
Procarbazine|N|imipramine hcl|tyramine|because_LE1 BIOGENERAL_LE1 exhibit_LE1 some_LE1 monoamine_LE1 oxidase_LE1 inhibitory_LE1 activity_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 drug_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 and_BE12 other_BE12 drug_BE12 and_BE12 food_BE12 with_BE12 known_BE12 high_BE12 BIOENTITY content_RE2 such_RE2 as_RE2 wine_RE2 yogurt_RE2 ripe_RE2 cheese_RE2 and_RE2 banana_RE2 shall_RE2 be_RE2 avoid_RE2 
Procarbazine|N|imipramine hcl|tyramine|because_LE1 BIOGENERAL_LE1 exhibit_LE1 some_LE1 monoamine_LE1 oxidase_LE1 inhibitory_LE1 activity_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 drug_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 and_BE12 other_BE12 drug_BE12 and_BE12 food_BE12 with_BE12 known_BE12 high_BE12 BIOENTITY content_RE2 such_RE2 as_RE2 wine_RE2 yogurt_RE2 ripe_RE2 cheese_RE2 and_RE2 banana_RE2 shall_RE2 be_RE2 avoid_RE2 
Procarbazine|N|tricyclic antidepressant|amitriptyline hcl|because_LE1 BIOGENERAL_LE1 exhibit_LE1 some_LE1 monoamine_LE1 oxidase_LE1 inhibitory_LE1 activity_LE1 BIOGENERAL_LE1 BIOENTITY drug_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 and_RE2 other_RE2 drug_RE2 and_RE2 food_RE2 with_RE2 known_RE2 high_RE2 BIOGENERAL_RE2 content_RE2 such_RE2 as_RE2 wine_RE2 yogurt_RE2 ripe_RE2 cheese_RE2 and_RE2 banana_RE2 shall_RE2 be_RE2 avoid_RE2 
Procarbazine|N|sympathomimetic drug|amitriptyline hcl|because_LE1 BIOGENERAL_LE1 exhibit_LE1 some_LE1 monoamine_LE1 oxidase_LE1 inhibitory_LE1 activity_LE1 BIOENTITY BIOGENERAL_BE12 drug_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 and_RE2 other_RE2 drug_RE2 and_RE2 food_RE2 with_RE2 known_RE2 high_RE2 BIOGENERAL_RE2 content_RE2 such_RE2 as_RE2 wine_RE2 yogurt_RE2 ripe_RE2 cheese_RE2 and_RE2 banana_RE2 shall_RE2 be_RE2 avoid_RE2 
Procarbazine|N|amitriptyline hcl|tyramine|because_LE1 BIOGENERAL_LE1 exhibit_LE1 some_LE1 monoamine_LE1 oxidase_LE1 inhibitory_LE1 activity_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 drug_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 and_BE12 other_BE12 drug_BE12 and_BE12 food_BE12 with_BE12 known_BE12 high_BE12 BIOENTITY content_RE2 such_RE2 as_RE2 wine_RE2 yogurt_RE2 ripe_RE2 cheese_RE2 and_RE2 banana_RE2 shall_RE2 be_RE2 avoid_RE2 
Procarbazine|N|amitriptyline hcl|tyramine|because_LE1 BIOGENERAL_LE1 exhibit_LE1 some_LE1 monoamine_LE1 oxidase_LE1 inhibitory_LE1 activity_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 drug_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 and_BE12 other_BE12 drug_BE12 and_BE12 food_BE12 with_BE12 known_BE12 high_BE12 BIOENTITY content_RE2 such_RE2 as_RE2 wine_RE2 yogurt_RE2 ripe_RE2 cheese_RE2 and_RE2 banana_RE2 shall_RE2 be_RE2 avoid_RE2 
Procarbazine|N|sympathomimetic drug|tricyclic antidepressant|because_LE1 BIOGENERAL_LE1 exhibit_LE1 some_LE1 monoamine_LE1 oxidase_LE1 inhibitory_LE1 activity_LE1 BIOENTITY BIOENTITY drug_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 and_RE2 other_RE2 drug_RE2 and_RE2 food_RE2 with_RE2 known_RE2 high_RE2 BIOGENERAL_RE2 content_RE2 such_RE2 as_RE2 wine_RE2 yogurt_RE2 ripe_RE2 cheese_RE2 and_RE2 banana_RE2 shall_RE2 be_RE2 avoid_RE2 
Procarbazine|N|tricyclic antidepressant|tyramine|because_LE1 BIOGENERAL_LE1 exhibit_LE1 some_LE1 monoamine_LE1 oxidase_LE1 inhibitory_LE1 activity_LE1 BIOGENERAL_LE1 BIOENTITY drug_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 and_BE12 other_BE12 drug_BE12 and_BE12 food_BE12 with_BE12 known_BE12 high_BE12 BIOENTITY content_RE2 such_RE2 as_RE2 wine_RE2 yogurt_RE2 ripe_RE2 cheese_RE2 and_RE2 banana_RE2 shall_RE2 be_RE2 avoid_RE2 
Procarbazine|N|tricyclic antidepressant|tyramine|because_LE1 BIOGENERAL_LE1 exhibit_LE1 some_LE1 monoamine_LE1 oxidase_LE1 inhibitory_LE1 activity_LE1 BIOGENERAL_LE1 BIOENTITY drug_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 and_BE12 other_BE12 drug_BE12 and_BE12 food_BE12 with_BE12 known_BE12 high_BE12 BIOENTITY content_RE2 such_RE2 as_RE2 wine_RE2 yogurt_RE2 ripe_RE2 cheese_RE2 and_RE2 banana_RE2 shall_RE2 be_RE2 avoid_RE2 
Procarbazine|N|sympathomimetic drug|tyramine|because_LE1 BIOGENERAL_LE1 exhibit_LE1 some_LE1 monoamine_LE1 oxidase_LE1 inhibitory_LE1 activity_LE1 BIOENTITY BIOGENERAL_BE12 drug_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 and_BE12 other_BE12 drug_BE12 and_BE12 food_BE12 with_BE12 known_BE12 high_BE12 BIOENTITY content_RE2 such_RE2 as_RE2 wine_RE2 yogurt_RE2 ripe_RE2 cheese_RE2 and_RE2 banana_RE2 shall_RE2 be_RE2 avoid_RE2 
Procarbazine|N|chemotherapeutic agent|steroid|no_LE1 crossresistance_LE1 with_LE1 other_LE1 BIOENTITY radiotherapy_BE12 or_BE12 BIOENTITY have_RE2 be_RE2 demonstrate_RE2 
Propofol|N|meperidine|fentanyl|the_LE1 induction_LE1 dose_LE1 requirement_LE1 of_LE1 BIOGENERAL_LE1 injectable_LE1 emulsion_LE1 may_LE1 be_LE1 reduce_LE1 in_LE1 patient_LE1 with_LE1 intramuscular_LE1 or_LE1 intravenous_LE1 premedication_LE1 particular_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY etc_RE2 .rrb_RE2 
Propofol|N|meperidine|fentanyl|the_LE1 induction_LE1 dose_LE1 requirement_LE1 of_LE1 BIOGENERAL_LE1 injectable_LE1 emulsion_LE1 may_LE1 be_LE1 reduce_LE1 in_LE1 patient_LE1 with_LE1 intramuscular_LE1 or_LE1 intravenous_LE1 premedication_LE1 particular_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY etc_RE2 .rrb_RE2 
Propofol|N|morphine|fentanyl|the_LE1 induction_LE1 dose_LE1 requirement_LE1 of_LE1 BIOGENERAL_LE1 injectable_LE1 emulsion_LE1 may_LE1 be_LE1 reduce_LE1 in_LE1 patient_LE1 with_LE1 intramuscular_LE1 or_LE1 intravenous_LE1 premedication_LE1 particular_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY etc_RE2 .rrb_RE2 
Propofol|N|morphine|fentanyl|the_LE1 induction_LE1 dose_LE1 requirement_LE1 of_LE1 BIOGENERAL_LE1 injectable_LE1 emulsion_LE1 may_LE1 be_LE1 reduce_LE1 in_LE1 patient_LE1 with_LE1 intramuscular_LE1 or_LE1 intravenous_LE1 premedication_LE1 particular_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY etc_RE2 .rrb_RE2 
Propofol|N|narcotic|fentanyl|the_LE1 induction_LE1 dose_LE1 requirement_LE1 of_LE1 BIOGENERAL_LE1 injectable_LE1 emulsion_LE1 may_LE1 be_LE1 reduce_LE1 in_LE1 patient_LE1 with_LE1 intramuscular_LE1 or_LE1 intravenous_LE1 premedication_LE1 particular_LE1 with_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY etc_RE2 .rrb_RE2 
Propofol|N|morphine|meperidine|the_LE1 induction_LE1 dose_LE1 requirement_LE1 of_LE1 BIOGENERAL_LE1 injectable_LE1 emulsion_LE1 may_LE1 be_LE1 reduce_LE1 in_LE1 patient_LE1 with_LE1 intramuscular_LE1 or_LE1 intravenous_LE1 premedication_LE1 particular_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 etc_RE2 .rrb_RE2 
Propofol|N|morphine|meperidine|the_LE1 induction_LE1 dose_LE1 requirement_LE1 of_LE1 BIOGENERAL_LE1 injectable_LE1 emulsion_LE1 may_LE1 be_LE1 reduce_LE1 in_LE1 patient_LE1 with_LE1 intramuscular_LE1 or_LE1 intravenous_LE1 premedication_LE1 particular_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 etc_RE2 .rrb_RE2 
Propofol|N|narcotic|meperidine|the_LE1 induction_LE1 dose_LE1 requirement_LE1 of_LE1 BIOGENERAL_LE1 injectable_LE1 emulsion_LE1 may_LE1 be_LE1 reduce_LE1 in_LE1 patient_LE1 with_LE1 intramuscular_LE1 or_LE1 intravenous_LE1 premedication_LE1 particular_LE1 with_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 etc_RE2 .rrb_RE2 
Propofol|N|narcotic|morphine|the_LE1 induction_LE1 dose_LE1 requirement_LE1 of_LE1 BIOGENERAL_LE1 injectable_LE1 emulsion_LE1 may_LE1 be_LE1 reduce_LE1 in_LE1 patient_LE1 with_LE1 intramuscular_LE1 or_LE1 intravenous_LE1 premedication_LE1 particular_LE1 with_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 etc_RE2 .rrb_RE2 
Propofol|N|opioid|barbiturate|and_LE1 combination_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 etc_RE2 .rrb._RE2 
Propofol|N|opioid|chloral hydrate|and_LE1 combination_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 etc_RE2 .rrb._RE2 
Propofol|N|opioid|sedative|and_LE1 combination_LE1 of_LE1 BIOENTITY and_BE12 BIOENTITY -LRB-_RE2 eg_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 etc_RE2 .rrb._RE2 
Propofol|N|opioid|benzodiazepine|and_LE1 combination_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 etc_RE2 .rrb._RE2 
Propofol|N|opioid|droperidol|and_LE1 combination_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY etc_RE2 .rrb._RE2 
Propofol|N|barbiturate|chloral hydrate|and_LE1 combination_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 etc_RE2 .rrb._RE2 
Propofol|N|sedative|barbiturate|and_LE1 combination_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 etc_RE2 .rrb._RE2 
Propofol|N|benzodiazepine|barbiturate|and_LE1 combination_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 etc_RE2 .rrb._RE2 
Propofol|N|barbiturate|droperidol|and_LE1 combination_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY etc_RE2 .rrb._RE2 
Propofol|N|sedative|chloral hydrate|and_LE1 combination_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 etc_RE2 .rrb._RE2 
Propofol|N|benzodiazepine|chloral hydrate|and_LE1 combination_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 etc_RE2 .rrb._RE2 
Propofol|N|chloral hydrate|droperidol|and_LE1 combination_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY etc_RE2 .rrb._RE2 
Propofol|N|sedative|benzodiazepine|and_LE1 combination_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 etc_RE2 .rrb._RE2 
Propofol|N|sedative|droperidol|and_LE1 combination_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY etc_RE2 .rrb._RE2 
Propofol|N|benzodiazepine|droperidol|and_LE1 combination_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY etc_RE2 .rrb._RE2 
Propofol|N|analgesic agent|opioid|During_LE1 maintenance_LE1 of_LE1 anesthesia_LE1 or_LE1 sedation_LE1 the_LE1 rate_LE1 of_LE1 BIOGENERAL_LE1 injectable_LE1 emulsion_LE1 administration_LE1 shall_LE1 be_LE1 adjust_LE1 according_LE1 to_LE1 the_LE1 desired_LE1 level_LE1 of_LE1 anesthesia_LE1 or_LE1 sedation_LE1 and_LE1 may_LE1 be_LE1 reduce_LE1 in_LE1 the_LE1 presence_LE1 of_LE1 supplemental_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY rrb._RE2 
Propofol|N|nitrous oxide|opioid|During_LE1 maintenance_LE1 of_LE1 anesthesia_LE1 or_LE1 sedation_LE1 the_LE1 rate_LE1 of_LE1 BIOGENERAL_LE1 injectable_LE1 emulsion_LE1 administration_LE1 shall_LE1 be_LE1 adjust_LE1 according_LE1 to_LE1 the_LE1 desired_LE1 level_LE1 of_LE1 anesthesia_LE1 or_LE1 sedation_LE1 and_LE1 may_LE1 be_LE1 reduce_LE1 in_LE1 the_LE1 presence_LE1 of_LE1 supplemental_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY or_BE12 BIOENTITY rrb._RE2 
Propofol|N|analgesic agent|nitrous oxide|During_LE1 maintenance_LE1 of_LE1 anesthesia_LE1 or_LE1 sedation_LE1 the_LE1 rate_LE1 of_LE1 BIOGENERAL_LE1 injectable_LE1 emulsion_LE1 administration_LE1 shall_LE1 be_LE1 adjust_LE1 according_LE1 to_LE1 the_LE1 desired_LE1 level_LE1 of_LE1 anesthesia_LE1 or_LE1 sedation_LE1 and_LE1 may_LE1 be_LE1 reduce_LE1 in_LE1 the_LE1 presence_LE1 of_LE1 supplemental_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 rrb._RE2 
Propofol|N|halothane|diprivan|the_LE1 concurrent_LE1 administration_LE1 of_LE1 potent_LE1 inhalational_LE1 agent_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 during_BE12 maintenance_BE12 with_BE12 BIOENTITY injectable_RE2 emulsion_RE2 have_RE2 not_RE2 be_RE2 extensive_RE2 evaluate_RE2 
Propofol|N|enflurane|diprivan|the_LE1 concurrent_LE1 administration_LE1 of_LE1 potent_LE1 inhalational_LE1 agent_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 during_BE12 maintenance_BE12 with_BE12 BIOENTITY injectable_RE2 emulsion_RE2 have_RE2 not_RE2 be_RE2 extensive_RE2 evaluate_RE2 
Propofol|N|isoflurane|diprivan|the_LE1 concurrent_LE1 administration_LE1 of_LE1 potent_LE1 inhalational_LE1 agent_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 during_BE12 maintenance_BE12 with_BE12 BIOENTITY injectable_RE2 emulsion_RE2 have_RE2 not_RE2 be_RE2 extensive_RE2 evaluate_RE2 
Propofol|N|enflurane|halothane|the_LE1 concurrent_LE1 administration_LE1 of_LE1 potent_LE1 inhalational_LE1 agent_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 during_RE2 maintenance_RE2 with_RE2 BIOGENERAL_RE2 injectable_RE2 emulsion_RE2 have_RE2 not_RE2 be_RE2 extensive_RE2 evaluate_RE2 
Propofol|N|enflurane|halothane|the_LE1 concurrent_LE1 administration_LE1 of_LE1 potent_LE1 inhalational_LE1 agent_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 during_RE2 maintenance_RE2 with_RE2 BIOGENERAL_RE2 injectable_RE2 emulsion_RE2 have_RE2 not_RE2 be_RE2 extensive_RE2 evaluate_RE2 
Propofol|N|isoflurane|halothane|the_LE1 concurrent_LE1 administration_LE1 of_LE1 potent_LE1 inhalational_LE1 agent_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 during_RE2 maintenance_RE2 with_RE2 BIOGENERAL_RE2 injectable_RE2 emulsion_RE2 have_RE2 not_RE2 be_RE2 extensive_RE2 evaluate_RE2 
Propofol|N|isoflurane|halothane|the_LE1 concurrent_LE1 administration_LE1 of_LE1 potent_LE1 inhalational_LE1 agent_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 during_RE2 maintenance_RE2 with_RE2 BIOGENERAL_RE2 injectable_RE2 emulsion_RE2 have_RE2 not_RE2 be_RE2 extensive_RE2 evaluate_RE2 
Propofol|N|isoflurane|enflurane|the_LE1 concurrent_LE1 administration_LE1 of_LE1 potent_LE1 inhalational_LE1 agent_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 during_RE2 maintenance_RE2 with_RE2 BIOGENERAL_RE2 injectable_RE2 emulsion_RE2 have_RE2 not_RE2 be_RE2 extensive_RE2 evaluate_RE2 
Propofol|N|isoflurane|enflurane|the_LE1 concurrent_LE1 administration_LE1 of_LE1 potent_LE1 inhalational_LE1 agent_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 during_RE2 maintenance_RE2 with_RE2 BIOGENERAL_RE2 injectable_RE2 emulsion_RE2 have_RE2 not_RE2 be_RE2 extensive_RE2 evaluate_RE2 
Propofol|N|diprivan|neuromuscular blocking agent|BIOENTITY injectable_BE12 emulsion_BE12 do_BE12 not_BE12 cause_BE12 clinical_BE12 significant_BE12 change_BE12 in_BE12 onset_BE12 intensity_BE12 or_BE12 duration_BE12 of_BE12 action_BE12 of_BE12 the_BE12 common_BE12 use_BE12 BIOENTITY -LRB-_RE2 eg_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Propofol|N|neuromuscular blocking agent|succinylcholine|BIOGENERAL_LE1 injectable_LE1 emulsion_LE1 do_LE1 not_LE1 cause_LE1 clinical_LE1 significant_LE1 change_LE1 in_LE1 onset_LE1 intensity_LE1 or_LE1 duration_LE1 of_LE1 action_LE1 of_LE1 the_LE1 common_LE1 use_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Propofol|N|neuromuscular blocking agent|nondepolarizing muscle relaxant|BIOGENERAL_LE1 injectable_LE1 emulsion_LE1 do_LE1 not_LE1 cause_LE1 clinical_LE1 significant_LE1 change_LE1 in_LE1 onset_LE1 intensity_LE1 or_LE1 duration_LE1 of_LE1 action_LE1 of_LE1 the_LE1 common_LE1 use_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Propofol|N|diprivan|succinylcholine|BIOENTITY injectable_BE12 emulsion_BE12 do_BE12 not_BE12 cause_BE12 clinical_BE12 significant_BE12 change_BE12 in_BE12 onset_BE12 intensity_BE12 or_BE12 duration_BE12 of_BE12 action_BE12 of_BE12 the_BE12 common_BE12 use_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Propofol|N|diprivan|nondepolarizing muscle relaxant|BIOENTITY injectable_BE12 emulsion_BE12 do_BE12 not_BE12 cause_BE12 clinical_BE12 significant_BE12 change_BE12 in_BE12 onset_BE12 intensity_BE12 or_BE12 duration_BE12 of_BE12 action_BE12 of_BE12 the_BE12 common_BE12 use_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Propofol|N|succinylcholine|nondepolarizing muscle relaxant|BIOGENERAL_LE1 injectable_LE1 emulsion_LE1 do_LE1 not_LE1 cause_LE1 clinical_LE1 significant_LE1 change_LE1 in_LE1 onset_LE1 intensity_LE1 or_LE1 duration_LE1 of_LE1 action_LE1 of_LE1 the_LE1 common_LE1 use_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY and_BE12 BIOENTITY rrb._RE2 
Propofol|N|succinylcholine|nondepolarizing muscle relaxant|BIOGENERAL_LE1 injectable_LE1 emulsion_LE1 do_LE1 not_LE1 cause_LE1 clinical_LE1 significant_LE1 change_LE1 in_LE1 onset_LE1 intensity_LE1 or_LE1 duration_LE1 of_LE1 action_LE1 of_LE1 the_LE1 common_LE1 use_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY and_BE12 BIOENTITY rrb._RE2 
Propofol|N|analgesic agent|anesthetic agent|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 use_LE1 premedication_LE1 or_LE1 drug_LE1 use_LE1 during_LE1 anesthesia_LE1 or_LE1 sedation_LE1 -LRB-_LE1 include_LE1 range_LE1 of_LE1 BIOGENERAL_LE1 inhalational_LE1 agent_LE1 BIOENTITY and_BE12 local_BE12 BIOENTITY -RRB-_RE2 have_RE2 be_RE2 observe_RE2 
Propofol|N|analgesic agent|anesthetic agent|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 use_LE1 premedication_LE1 or_LE1 drug_LE1 use_LE1 during_LE1 anesthesia_LE1 or_LE1 sedation_LE1 -LRB-_LE1 include_LE1 range_LE1 of_LE1 BIOGENERAL_LE1 inhalational_LE1 agent_LE1 BIOENTITY and_BE12 local_BE12 BIOENTITY -RRB-_RE2 have_RE2 be_RE2 observe_RE2 
Propofol|N|muscle relaxant|anesthetic agent|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 use_LE1 premedication_LE1 or_LE1 drug_LE1 use_LE1 during_LE1 anesthesia_LE1 or_LE1 sedation_LE1 -LRB-_LE1 include_LE1 range_LE1 of_LE1 BIOENTITY inhalational_BE12 agent_BE12 BIOGENERAL_BE12 and_BE12 local_BE12 BIOENTITY -RRB-_RE2 have_RE2 be_RE2 observe_RE2 
Propofol|N|muscle relaxant|analgesic agent|no_LE1 significant_LE1 adverse_LE1 interaction_LE1 with_LE1 common_LE1 use_LE1 premedication_LE1 or_LE1 drug_LE1 use_LE1 during_LE1 anesthesia_LE1 or_LE1 sedation_LE1 -LRB-_LE1 include_LE1 range_LE1 of_LE1 BIOENTITY inhalational_BE12 agent_BE12 BIOENTITY and_RE2 local_RE2 BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 observe_RE2 
Propoxyphene|N|cns depressant|alcohol|the_LE1 cnsdepressant_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 additive_LE1 with_LE1 that_LE1 of_LE1 other_LE1 BIOENTITY including_BE12 BIOENTITY 
Propoxyphene|N|propoxyphene|antidepressant|such_LE1 occurrence_LE1 have_LE1 be_LE1 report_LE1 when_LE1 BIOENTITY be_BE12 administer_BE12 to_BE12 patient_BE12 on_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 drug_RE2 
Propoxyphene|N|antidepressant|warfarin|such_LE1 occurrence_LE1 have_LE1 be_LE1 report_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 to_LE1 patient_LE1 on_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY drug_RE2 
Propoxyphene|N|antidepressant|anticonvulsant|such_LE1 occurrence_LE1 have_LE1 be_LE1 report_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 to_LE1 patient_LE1 on_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 drug_RE2 
Propoxyphene|N|propoxyphene|warfarin|such_LE1 occurrence_LE1 have_LE1 be_LE1 report_LE1 when_LE1 BIOENTITY be_BE12 administer_BE12 to_BE12 patient_BE12 on_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY drug_RE2 
Propoxyphene|N|propoxyphene|anticonvulsant|such_LE1 occurrence_LE1 have_LE1 be_LE1 report_LE1 when_LE1 BIOENTITY be_BE12 administer_BE12 to_BE12 patient_BE12 on_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 drug_RE2 
Propoxyphene|N|anticonvulsant|warfarin|such_LE1 occurrence_LE1 have_LE1 be_LE1 report_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 to_LE1 patient_LE1 on_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY drug_RE2 
Propoxyphene|N|anticonvulsant|warfarin|such_LE1 occurrence_LE1 have_LE1 be_LE1 report_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 to_LE1 patient_LE1 on_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY drug_RE2 
Pseudoephedrine|N|mao inhibitor|beta adrenergic blocker|BIOENTITY and_BE12 BIOENTITY increase_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 
Pseudoephedrine|N|methyldopa|mecamylamine|BIOGENERAL_LE1 may_LE1 reduce_LE1 the_LE1 antihypertensive_LE1 effect_LE1 of_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Pseudoephedrine|N|methyldopa|reserpine|BIOGENERAL_LE1 may_LE1 reduce_LE1 the_LE1 antihypertensive_LE1 effect_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Pseudoephedrine|N|methyldopa|veratrum alkaloid|BIOGENERAL_LE1 may_LE1 reduce_LE1 the_LE1 antihypertensive_LE1 effect_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pseudoephedrine|N|mecamylamine|reserpine|BIOGENERAL_LE1 may_LE1 reduce_LE1 the_LE1 antihypertensive_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Pseudoephedrine|N|mecamylamine|reserpine|BIOGENERAL_LE1 may_LE1 reduce_LE1 the_LE1 antihypertensive_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Pseudoephedrine|N|mecamylamine|veratrum alkaloid|BIOGENERAL_LE1 may_LE1 reduce_LE1 the_LE1 antihypertensive_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Pseudoephedrine|N|reserpine|veratrum alkaloid|BIOGENERAL_LE1 may_LE1 reduce_LE1 the_LE1 antihypertensive_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Pyrimethamine|N|pyrimethamine|sulfonamide|BIOENTITY may_BE12 be_BE12 use_BE12 with_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 other_RE2 BIOGENERAL_RE2 and_RE2 with_RE2 other_RE2 BIOGENERAL_RE2 
Pyrimethamine|N|pyrimethamine|quinine|BIOENTITY may_BE12 be_BE12 use_BE12 with_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 other_RE2 BIOGENERAL_RE2 and_RE2 with_RE2 other_RE2 BIOGENERAL_RE2 
Pyrimethamine|N|pyrimethamine|antimalarial|BIOENTITY may_BE12 be_BE12 use_BE12 with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOENTITY and_RE2 with_RE2 other_RE2 BIOGENERAL_RE2 
Pyrimethamine|N|pyrimethamine|antibiotic|BIOENTITY may_BE12 be_BE12 use_BE12 with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOGENERAL_BE12 and_BE12 with_BE12 other_BE12 BIOENTITY 
Pyrimethamine|N|sulfonamide|quinine|BIOGENERAL_LE1 may_LE1 be_LE1 use_LE1 with_LE1 BIOENTITY BIOENTITY and_RE2 other_RE2 BIOGENERAL_RE2 and_RE2 with_RE2 other_RE2 BIOGENERAL_RE2 
Pyrimethamine|N|sulfonamide|antimalarial|BIOGENERAL_LE1 may_LE1 be_LE1 use_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 other_BE12 BIOENTITY and_RE2 with_RE2 other_RE2 BIOGENERAL_RE2 
Pyrimethamine|N|sulfonamide|antibiotic|BIOGENERAL_LE1 may_LE1 be_LE1 use_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 other_BE12 BIOGENERAL_BE12 and_BE12 with_BE12 other_BE12 BIOENTITY 
Pyrimethamine|N|quinine|antimalarial|BIOGENERAL_LE1 may_LE1 be_LE1 use_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 other_BE12 BIOENTITY and_RE2 with_RE2 other_RE2 BIOGENERAL_RE2 
Pyrimethamine|N|quinine|antibiotic|BIOGENERAL_LE1 may_LE1 be_LE1 use_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 and_BE12 with_BE12 other_BE12 BIOENTITY 
Pyrimethamine|N|antimalarial|antibiotic|BIOGENERAL_LE1 may_LE1 be_LE1 use_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY and_BE12 with_BE12 other_BE12 BIOENTITY 
Pyrimethamine|N|folinic acid|leucovorin|BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 shall_RE2 be_RE2 administer_RE2 until_RE2 normal_RE2 hematopoiesis_RE2 be_RE2 restore_RE2 
Raloxifene|N|raloxifene|evista|BIOGENERAL_LE1 :_LE1 BIOGENERAL_LE1 cause_LE1 NUM_LE1 reduction_LE1 in_LE1 the_LE1 absorption_LE1 and_LE1 enterohepatic_LE1 cycling_LE1 of_LE1 BIOENTITY and_BE12 shall_BE12 not_BE12 be_BE12 coadminister_BE12 with_BE12 BIOENTITY 
Raloxifene|N|cholestyramine|raloxifene|BIOENTITY :_BE12 BIOGENERAL_BE12 cause_BE12 NUM_BE12 reduction_BE12 in_BE12 the_BE12 absorption_BE12 and_BE12 enterohepatic_BE12 cycling_BE12 of_BE12 BIOENTITY and_RE2 shall_RE2 not_RE2 be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Raloxifene|N|cholestyramine|evista|BIOENTITY :_BE12 BIOGENERAL_BE12 cause_BE12 NUM_BE12 reduction_BE12 in_BE12 the_BE12 absorption_BE12 and_BE12 enterohepatic_BE12 cycling_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 shall_BE12 not_BE12 be_BE12 coadminister_BE12 with_BE12 BIOENTITY 
Raloxifene|N|cholestyramine|cholestyramine|BIOENTITY :_BE12 BIOENTITY cause_RE2 NUM_RE2 reduction_RE2 in_RE2 the_RE2 absorption_RE2 and_RE2 enterohepatic_RE2 cycling_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 shall_RE2 not_RE2 be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Raloxifene|N|cholestyramine|cholestyramine|BIOENTITY :_BE12 BIOENTITY cause_RE2 NUM_RE2 reduction_RE2 in_RE2 the_RE2 absorption_RE2 and_RE2 enterohepatic_RE2 cycling_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 shall_RE2 not_RE2 be_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Raloxifene|N|warfarin|warfarin|BIOENTITY :_BE12 the_BE12 coadministration_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 assess_RE2 under_RE2 chronic_RE2 condition_RE2 
Raloxifene|N|warfarin|evista|BIOENTITY :_BE12 the_BE12 coadministration_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 have_RE2 not_RE2 be_RE2 assess_RE2 under_RE2 chronic_RE2 condition_RE2 
Raloxifene|N|evista|warfarin|BIOGENERAL_LE1 :_LE1 the_LE1 coadministration_LE1 of_LE1 BIOENTITY and_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 assess_RE2 under_RE2 chronic_RE2 condition_RE2 
Raloxifene|N|raloxifene|tamoxifen|in_LE1 vitro_LE1 BIOENTITY do_BE12 not_BE12 affect_BE12 the_BE12 binding_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Raloxifene|N|warfarin|tamoxifen|in_LE1 vitro_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 affect_LE1 the_LE1 binding_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Raloxifene|N|phenytoin|tamoxifen|in_LE1 vitro_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 affect_LE1 the_LE1 binding_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Raloxifene|N|phenytoin|tamoxifen|in_LE1 vitro_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 affect_LE1 the_LE1 binding_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Raloxifene|N|raloxifene|warfarin|in_LE1 vitro_LE1 BIOENTITY do_BE12 not_BE12 affect_BE12 the_BE12 binding_BE12 of_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Raloxifene|N|raloxifene|phenytoin|in_LE1 vitro_LE1 BIOENTITY do_BE12 not_BE12 affect_BE12 the_BE12 binding_BE12 of_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Raloxifene|N|warfarin|phenytoin|in_LE1 vitro_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 affect_LE1 the_LE1 binding_LE1 of_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Raloxifene|N|clofibrate|indomethacin|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Raloxifene|N|clofibrate|naproxen|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Raloxifene|N|clofibrate|diazepam|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Raloxifene|N|clofibrate|ibuprofen|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Raloxifene|N|clofibrate|diazoxide|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Raloxifene|N|indomethacin|naproxen|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Raloxifene|N|indomethacin|diazepam|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Raloxifene|N|indomethacin|ibuprofen|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Raloxifene|N|indomethacin|diazoxide|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Raloxifene|N|naproxen|diazepam|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Raloxifene|N|naproxen|diazepam|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Raloxifene|N|naproxen|ibuprofen|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Raloxifene|N|naproxen|ibuprofen|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Raloxifene|N|naproxen|diazoxide|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Raloxifene|N|naproxen|diazoxide|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Raloxifene|N|ibuprofen|diazepam|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Raloxifene|N|ibuprofen|diazepam|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Raloxifene|N|diazepam|diazoxide|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Raloxifene|N|diazepam|diazoxide|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Raloxifene|N|ibuprofen|diazoxide|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Raloxifene|N|ibuprofen|diazoxide|caution_LE1 shall_LE1 be_LE1 use_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 coadminister_LE1 with_LE1 other_LE1 high_LE1 proteinbound_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Ranitidine|N|clarithromycin|14- hydroxy- clarithromycin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY result_BE12 in_BE12 increase_BE12 plasma_BE12 BIOGENERAL_BE12 concentration_BE12 -LRB-_BE12 NUM_BE12 -RRB-_BE12 increase_BE12 plasma_BE12 bismuth_BE12 trough_BE12 concentration_BE12 -LRB-_BE12 NUM_BE12 -RRB-_BE12 and_BE12 increase_BE12 BIOENTITY plasma_RE2 concentration_RE2 -LRB-_RE2 %rrb._RE2 
Ranitidine|N|clarithromycin|ranitidine|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY result_BE12 in_BE12 increase_BE12 plasma_BE12 BIOENTITY concentration_RE2 -LRB-_RE2 NUM_RE2 -RRB-_RE2 increase_RE2 plasma_RE2 bismuth_RE2 trough_RE2 concentration_RE2 -LRB-_RE2 NUM_RE2 -RRB-_RE2 and_RE2 increase_RE2 BIOGENERAL_RE2 plasma_RE2 concentration_RE2 -LRB-_RE2 %rrb._RE2 
Ranitidine|N|tritec|14- hydroxy- clarithromycin|coadministration_LE1 of_LE1 BIOENTITY with_BE12 BIOGENERAL_BE12 result_BE12 in_BE12 increase_BE12 plasma_BE12 BIOGENERAL_BE12 concentration_BE12 -LRB-_BE12 NUM_BE12 -RRB-_BE12 increase_BE12 plasma_BE12 bismuth_BE12 trough_BE12 concentration_BE12 -LRB-_BE12 NUM_BE12 -RRB-_BE12 and_BE12 increase_BE12 BIOENTITY plasma_RE2 concentration_RE2 -LRB-_RE2 %rrb._RE2 
Ranitidine|N|tritec|ranitidine|coadministration_LE1 of_LE1 BIOENTITY with_BE12 BIOGENERAL_BE12 result_BE12 in_BE12 increase_BE12 plasma_BE12 BIOENTITY concentration_RE2 -LRB-_RE2 NUM_RE2 -RRB-_RE2 increase_RE2 plasma_RE2 bismuth_RE2 trough_RE2 concentration_RE2 -LRB-_RE2 NUM_RE2 -RRB-_RE2 and_RE2 increase_RE2 BIOGENERAL_RE2 plasma_RE2 concentration_RE2 -LRB-_RE2 %rrb._RE2 
Ranitidine|N|ranitidine|14- hydroxy- clarithromycin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 result_LE1 in_LE1 increase_LE1 plasma_LE1 BIOENTITY concentration_BE12 -LRB-_BE12 NUM_BE12 -RRB-_BE12 increase_BE12 plasma_BE12 bismuth_BE12 trough_BE12 concentration_BE12 -LRB-_BE12 NUM_BE12 -RRB-_BE12 and_BE12 increase_BE12 BIOENTITY plasma_RE2 concentration_RE2 -LRB-_RE2 %rrb._RE2 
Ranitidine|N|aspirin|salicylate|coadministration_LE1 with_LE1 BIOENTITY result_BE12 in_BE12 slight_BE12 decrease_BE12 in_BE12 the_BE12 rate_BE12 of_BE12 BIOENTITY absorption_RE2 that_RE2 be_RE2 clinical_RE2 unimportant_RE2 
Ranitidine|N|ranitidine|tritec|coadministration_LE1 with_LE1 high_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 meq_LE1 -RRB-_LE1 result_LE1 in_LE1 NUM_LE1 decrease_LE1 in_LE1 plasma_LE1 concentration_LE1 of_LE1 BIOENTITY and_BE12 may_BE12 decrease_BE12 plasma_BE12 concentration_BE12 of_BE12 bismuth_BE12 from_BE12 BIOENTITY 
Ranitidine|N|ranitidine|zantac|For_LE1 information_LE1 on_LE1 drug_LE1 interaction_LE1 associate_LE1 with_LE1 BIOENTITY refer_BE12 to_BE12 the_BE12 BIOENTITY package_RE2 insert_RE2 
Retapamulin|N|ketoconazole|retapamulin|coadministration_LE1 of_LE1 oral_LE1 BIOENTITY NUM_BE12 mg_BE12 twice_BE12 daily_BE12 increase_BE12 BIOENTITY geometric_RE2 mean_RE2 auc_RE2 -LRB-_RE2 NUM_RE2 -RRB-_RE2 and_RE2 cmax_RE2 by_RE2 NUM_RE2 after_RE2 topical_RE2 application_RE2 of_RE2 BIOGENERAL_RE2 ointment_RE2 NUM_RE2 on_RE2 the_RE2 abraded_RE2 skin_RE2 of_RE2 healthy_RE2 adult_RE2 male_RE2 
Retapamulin|N|retapamulin|retapamulin|coadministration_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 NUM_LE1 mg_LE1 twice_LE1 daily_LE1 increase_LE1 BIOENTITY geometric_BE12 mean_BE12 auc_BE12 -LRB-_BE12 NUM_BE12 -RRB-_BE12 and_BE12 cmax_BE12 by_BE12 NUM_BE12 after_BE12 topical_BE12 application_BE12 of_BE12 BIOENTITY ointment_RE2 NUM_RE2 on_RE2 the_RE2 abraded_RE2 skin_RE2 of_RE2 healthy_RE2 adult_RE2 male_RE2 
Retapamulin|N|retapamulin|retapamulin|Due_LE1 to_LE1 low_LE1 systemic_LE1 exposure_LE1 to_LE1 BIOENTITY following_BE12 topical_BE12 application_BE12 in_BE12 patient_BE12 dosage_BE12 adjustment_BE12 for_BE12 BIOENTITY be_RE2 unnecessary_RE2 when_RE2 coadminister_RE2 with_RE2 cypa_RE2 inhibitor_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 
Retapamulin|N|retapamulin|ketoconazole|Due_LE1 to_LE1 low_LE1 systemic_LE1 exposure_LE1 to_LE1 BIOGENERAL_LE1 following_LE1 topical_LE1 application_LE1 in_LE1 patient_LE1 dosage_LE1 adjustment_LE1 for_LE1 BIOENTITY be_BE12 unnecessary_BE12 when_BE12 coadminister_BE12 with_BE12 cypa_BE12 inhibitor_BE12 such_BE12 as_BE12 BIOENTITY 
Retapamulin|N|retapamulin|ketoconazole|Due_LE1 to_LE1 low_LE1 systemic_LE1 exposure_LE1 to_LE1 BIOENTITY following_BE12 topical_BE12 application_BE12 in_BE12 patient_BE12 dosage_BE12 adjustment_BE12 for_BE12 BIOGENERAL_BE12 be_BE12 unnecessary_BE12 when_BE12 coadminister_BE12 with_BE12 cypa_BE12 inhibitor_BE12 such_BE12 as_BE12 BIOENTITY 
Retapamulin|N|altabax|retapamulin|Based_LE1 on_LE1 in_LE1 vitro_LE1 inhibition_LE1 study_LE1 and_LE1 the_LE1 low_LE1 systemic_LE1 exposure_LE1 observe_LE1 following_LE1 topical_LE1 application_LE1 of_LE1 BIOENTITY BIOENTITY be_RE2 unlikely_RE2 to_RE2 affect_RE2 the_RE2 metabolism_RE2 of_RE2 other_RE2 substrate_RE2 
Reteplase|N|heparin|abciximab|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Reteplase|N|heparin|abciximab|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Reteplase|N|vitamin k antagonist|abciximab|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Reteplase|N|vitamin k antagonist|abciximab|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Reteplase|N|aspirin|abciximab|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 drug_LE1 that_LE1 alter_LE1 platelet_LE1 function_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Reteplase|N|dipyridamole|abciximab|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 drug_LE1 that_LE1 alter_LE1 platelet_LE1 function_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Reteplase|N|dipyridamole|abciximab|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 drug_LE1 that_LE1 alter_LE1 platelet_LE1 function_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Reteplase|N|heparin|vitamin k antagonist|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOENTITY and_BE12 BIOENTITY drug_RE2 that_RE2 alter_RE2 platelet_RE2 function_RE2 -LRB-_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Reteplase|N|heparin|aspirin|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Reteplase|N|heparin|aspirin|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Reteplase|N|heparin|dipyridamole|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Reteplase|N|heparin|dipyridamole|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Reteplase|N|vitamin k antagonist|aspirin|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Reteplase|N|vitamin k antagonist|aspirin|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Reteplase|N|vitamin k antagonist|dipyridamole|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Reteplase|N|vitamin k antagonist|dipyridamole|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Reteplase|N|aspirin|dipyridamole|In_LE1 addition_LE1 to_LE1 bleeding_LE1 associate_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 drug_LE1 that_LE1 alter_LE1 platelet_LE1 function_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Riboflavin|N|riboflavin|riboflavin|interaction_LE1 for_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 :_BE12 BIOGENERAL_BE12 impair_BE12 the_BE12 intestinal_BE12 absorption_BE12 of_BE12 BIOENTITY 
Riboflavin|N|vitamin b2|riboflavin|interaction_LE1 for_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 :_BE12 BIOGENERAL_BE12 impair_BE12 the_BE12 intestinal_BE12 absorption_BE12 of_BE12 BIOENTITY 
Riboflavin|N|riboflavin|alcohol|interaction_LE1 for_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 :_BE12 BIOENTITY impair_RE2 the_RE2 intestinal_RE2 absorption_RE2 of_RE2 BIOGENERAL_RE2 
Riboflavin|N|vitamin b2|alcohol|interaction_LE1 for_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 :_BE12 BIOENTITY impair_RE2 the_RE2 intestinal_RE2 absorption_RE2 of_RE2 BIOGENERAL_RE2 
Riboflavin|N|vitamin b2|riboflavin|interaction_LE1 for_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 :_RE2 BIOGENERAL_RE2 impair_RE2 the_RE2 intestinal_RE2 absorption_RE2 of_RE2 BIOGENERAL_RE2 
Rimantadine|N|cimetidine|rimantadine|BIOGENERAL_LE1 :_LE1 the_LE1 effect_LE1 of_LE1 chronic_LE1 BIOENTITY use_BE12 on_BE12 the_BE12 metabolism_BE12 of_BE12 BIOENTITY be_RE2 not_RE2 know_RE2 
Rimantadine|N|cimetidine|rimantadine|BIOENTITY :_BE12 the_BE12 effect_BE12 of_BE12 chronic_BE12 BIOGENERAL_BE12 use_BE12 on_BE12 the_BE12 metabolism_BE12 of_BE12 BIOENTITY be_RE2 not_RE2 know_RE2 
Rimantadine|N|cimetidine|cimetidine|BIOENTITY :_BE12 the_BE12 effect_BE12 of_BE12 chronic_BE12 BIOENTITY use_RE2 on_RE2 the_RE2 metabolism_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 know_RE2 
Rimantadine|N|cimetidine|rimantadine|when_LE1 single_LE1 NUM_LE1 mg_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 one_LE1 hour_LE1 after_LE1 the_LE1 initiation_LE1 of_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 mg_BE12 four_BE12 time_BE12 day_BE12 -RRB-_BE12 the_BE12 apparent_BE12 total_BE12 BIOENTITY clearance_RE2 of_RE2 this_RE2 single_RE2 dose_RE2 in_RE2 normal_RE2 healthy_RE2 adult_RE2 be_RE2 reduce_RE2 by_RE2 NUM_RE2 -LRB-_RE2 compare_RE2 to_RE2 the_RE2 apparent_RE2 total_RE2 BIOGENERAL_RE2 clearance_RE2 in_RE2 the_RE2 same_RE2 subject_RE2 in_RE2 the_RE2 absence_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Rimantadine|N|cimetidine|cimetidine|when_LE1 single_LE1 NUM_LE1 mg_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 one_LE1 hour_LE1 after_LE1 the_LE1 initiation_LE1 of_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 mg_BE12 four_BE12 time_BE12 day_BE12 -RRB-_BE12 the_BE12 apparent_BE12 total_BE12 BIOGENERAL_BE12 clearance_BE12 of_BE12 this_BE12 single_BE12 dose_BE12 in_BE12 normal_BE12 healthy_BE12 adult_BE12 be_BE12 reduce_BE12 by_BE12 NUM_BE12 -LRB-_BE12 compare_BE12 to_BE12 the_BE12 apparent_BE12 total_BE12 BIOGENERAL_BE12 clearance_BE12 in_BE12 the_BE12 same_BE12 subject_BE12 in_BE12 the_BE12 absence_BE12 of_BE12 BIOENTITY rrb._RE2 
Rimantadine|N|cimetidine|rimantadine|when_LE1 single_LE1 NUM_LE1 mg_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 one_LE1 hour_LE1 after_LE1 the_LE1 initiation_LE1 of_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 mg_BE12 four_BE12 time_BE12 day_BE12 -RRB-_BE12 the_BE12 apparent_BE12 total_BE12 BIOGENERAL_BE12 clearance_BE12 of_BE12 this_BE12 single_BE12 dose_BE12 in_BE12 normal_BE12 healthy_BE12 adult_BE12 be_BE12 reduce_BE12 by_BE12 NUM_BE12 -LRB-_BE12 compare_BE12 to_BE12 the_BE12 apparent_BE12 total_BE12 BIOENTITY clearance_RE2 in_RE2 the_RE2 same_RE2 subject_RE2 in_RE2 the_RE2 absence_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Rimantadine|N|rimantadine hcl|rimantadine|when_LE1 single_LE1 NUM_LE1 mg_LE1 dose_LE1 of_LE1 BIOENTITY be_BE12 administer_BE12 one_BE12 hour_BE12 after_BE12 the_BE12 initiation_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 four_BE12 time_BE12 day_BE12 -RRB-_BE12 the_BE12 apparent_BE12 total_BE12 BIOENTITY clearance_RE2 of_RE2 this_RE2 single_RE2 dose_RE2 in_RE2 normal_RE2 healthy_RE2 adult_RE2 be_RE2 reduce_RE2 by_RE2 NUM_RE2 -LRB-_RE2 compare_RE2 to_RE2 the_RE2 apparent_RE2 total_RE2 BIOGENERAL_RE2 clearance_RE2 in_RE2 the_RE2 same_RE2 subject_RE2 in_RE2 the_RE2 absence_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Rimantadine|N|rimantadine|cimetidine|when_LE1 single_LE1 NUM_LE1 mg_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 one_LE1 hour_LE1 after_LE1 the_LE1 initiation_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 four_LE1 time_LE1 day_LE1 -RRB-_LE1 the_LE1 apparent_LE1 total_LE1 BIOENTITY clearance_BE12 of_BE12 this_BE12 single_BE12 dose_BE12 in_BE12 normal_BE12 healthy_BE12 adult_BE12 be_BE12 reduce_BE12 by_BE12 NUM_BE12 -LRB-_BE12 compare_BE12 to_BE12 the_BE12 apparent_BE12 total_BE12 BIOGENERAL_BE12 clearance_BE12 in_BE12 the_BE12 same_BE12 subject_BE12 in_BE12 the_BE12 absence_BE12 of_BE12 BIOENTITY rrb._RE2 
Rimantadine|N|rimantadine|rimantadine|when_LE1 single_LE1 NUM_LE1 mg_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 one_LE1 hour_LE1 after_LE1 the_LE1 initiation_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 four_LE1 time_LE1 day_LE1 -RRB-_LE1 the_LE1 apparent_LE1 total_LE1 BIOENTITY clearance_BE12 of_BE12 this_BE12 single_BE12 dose_BE12 in_BE12 normal_BE12 healthy_BE12 adult_BE12 be_BE12 reduce_BE12 by_BE12 NUM_BE12 -LRB-_BE12 compare_BE12 to_BE12 the_BE12 apparent_BE12 total_BE12 BIOENTITY clearance_RE2 in_RE2 the_RE2 same_RE2 subject_RE2 in_RE2 the_RE2 absence_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Rimantadine|N|rimantadine hcl|cimetidine|when_LE1 single_LE1 NUM_LE1 mg_LE1 dose_LE1 of_LE1 BIOENTITY be_BE12 administer_BE12 one_BE12 hour_BE12 after_BE12 the_BE12 initiation_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 four_BE12 time_BE12 day_BE12 -RRB-_BE12 the_BE12 apparent_BE12 total_BE12 BIOGENERAL_BE12 clearance_BE12 of_BE12 this_BE12 single_BE12 dose_BE12 in_BE12 normal_BE12 healthy_BE12 adult_BE12 be_BE12 reduce_BE12 by_BE12 NUM_BE12 -LRB-_BE12 compare_BE12 to_BE12 the_BE12 apparent_BE12 total_BE12 BIOGENERAL_BE12 clearance_BE12 in_BE12 the_BE12 same_BE12 subject_BE12 in_BE12 the_BE12 absence_BE12 of_BE12 BIOENTITY rrb._RE2 
Rimantadine|N|rimantadine hcl|rimantadine|when_LE1 single_LE1 NUM_LE1 mg_LE1 dose_LE1 of_LE1 BIOENTITY be_BE12 administer_BE12 one_BE12 hour_BE12 after_BE12 the_BE12 initiation_BE12 of_BE12 BIOGENERAL_BE12 -LRB-_BE12 NUM_BE12 mg_BE12 four_BE12 time_BE12 day_BE12 -RRB-_BE12 the_BE12 apparent_BE12 total_BE12 BIOGENERAL_BE12 clearance_BE12 of_BE12 this_BE12 single_BE12 dose_BE12 in_BE12 normal_BE12 healthy_BE12 adult_BE12 be_BE12 reduce_BE12 by_BE12 NUM_BE12 -LRB-_BE12 compare_BE12 to_BE12 the_BE12 apparent_BE12 total_BE12 BIOENTITY clearance_RE2 in_RE2 the_RE2 same_RE2 subject_RE2 in_RE2 the_RE2 absence_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Rimantadine|N|rimantadine|cimetidine|when_LE1 single_LE1 NUM_LE1 mg_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 one_LE1 hour_LE1 after_LE1 the_LE1 initiation_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 four_LE1 time_LE1 day_LE1 -RRB-_LE1 the_LE1 apparent_LE1 total_LE1 BIOGENERAL_LE1 clearance_LE1 of_LE1 this_LE1 single_LE1 dose_LE1 in_LE1 normal_LE1 healthy_LE1 adult_LE1 be_LE1 reduce_LE1 by_LE1 NUM_LE1 -LRB-_LE1 compare_LE1 to_LE1 the_LE1 apparent_LE1 total_LE1 BIOENTITY clearance_BE12 in_BE12 the_BE12 same_BE12 subject_BE12 in_BE12 the_BE12 absence_BE12 of_BE12 BIOENTITY rrb._RE2 
Rimantadine|N|acetaminophen|rimantadine hcl|BIOENTITY :_BE12 BIOENTITY NUM_RE2 mg_RE2 be_RE2 give_RE2 twice_RE2 daily_RE2 for_RE2 NUM_RE2 day_RE2 to_RE2 NUM_RE2 healthy_RE2 volunteer_RE2 
Rimantadine|N|aspirin|rimantadine hcl|BIOENTITY :_BE12 BIOENTITY NUM_RE2 mg_RE2 be_RE2 give_RE2 twice_RE2 daily_RE2 fro_RE2 NUM_RE2 day_RE2 to_RE2 NUM_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|exelon|rivastigmine tartrate|drugdrug_LE1 interaction_LE1 effect_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 on_RE2 the_RE2 metabolism_RE2 of_RE2 other_RE2 drug_RE2 :_RE2 BIOGENERAL_RE2 be_RE2 primary_RE2 metabolize_RE2 through_RE2 hydrolysis_RE2 by_RE2 esterase_RE2 
Rivastigmine|N|rivastigmine tartrate|rivastigmine|drugdrug_LE1 interaction_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 on_BE12 the_BE12 metabolism_BE12 of_BE12 other_BE12 drug_BE12 :_BE12 BIOENTITY be_RE2 primary_RE2 metabolize_RE2 through_RE2 hydrolysis_RE2 by_RE2 esterase_RE2 
Rivastigmine|N|exelon|rivastigmine|drugdrug_LE1 interaction_LE1 effect_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 on_BE12 the_BE12 metabolism_BE12 of_BE12 other_BE12 drug_BE12 :_BE12 BIOENTITY be_RE2 primary_RE2 metabolize_RE2 through_RE2 hydrolysis_RE2 by_RE2 esterase_RE2 
Rivastigmine|N|digoxin|warfarin|no_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 observe_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 in_RE2 study_RE2 in_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|digoxin|warfarin|no_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 observe_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 in_RE2 study_RE2 in_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|digoxin|diazepam|no_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 observe_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 in_RE2 study_RE2 in_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|digoxin|diazepam|no_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 observe_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 in_RE2 study_RE2 in_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|digoxin|fluoxetine|no_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 observe_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY in_RE2 study_RE2 in_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|digoxin|fluoxetine|no_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 observe_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY in_RE2 study_RE2 in_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|rivastigmine|digoxin|no_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 observe_LE1 between_LE1 BIOENTITY and_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 in_RE2 study_RE2 in_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|warfarin|diazepam|no_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 observe_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 in_RE2 study_RE2 in_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|warfarin|diazepam|no_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 observe_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 in_RE2 study_RE2 in_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|warfarin|fluoxetine|no_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 observe_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY in_RE2 study_RE2 in_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|warfarin|fluoxetine|no_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 observe_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY in_RE2 study_RE2 in_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|rivastigmine|warfarin|no_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 observe_LE1 between_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 in_RE2 study_RE2 in_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|diazepam|fluoxetine|no_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 observe_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY in_RE2 study_RE2 in_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|diazepam|fluoxetine|no_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 observe_LE1 between_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY in_RE2 study_RE2 in_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|rivastigmine|diazepam|no_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 observe_LE1 between_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 in_RE2 study_RE2 in_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|rivastigmine|fluoxetine|no_LE1 pharmacokinetic_LE1 interaction_LE1 be_LE1 observe_LE1 between_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY in_RE2 study_RE2 in_RE2 healthy_RE2 volunteer_RE2 
Rivastigmine|N|warfarin|exelon|the_LE1 elevation_LE1 of_LE1 prothrombin_LE1 time_LE1 induce_LE1 by_LE1 BIOENTITY be_BE12 not_BE12 affect_BE12 by_BE12 administration_BE12 of_BE12 BIOENTITY 
Rivastigmine|N|exelon|rivastigmine|effect_LE1 of_LE1 other_LE1 drug_LE1 on_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY :_BE12 drug_BE12 that_BE12 induce_BE12 or_BE12 inhibit_BE12 cyp_BE12 metabolism_BE12 be_BE12 not_BE12 expect_BE12 to_BE12 alter_BE12 the_BE12 metabolism_BE12 of_BE12 BIOENTITY 
Rivastigmine|N|warfarin|diazepam|single_LE1 dose_LE1 pharmacokinetic_LE1 study_LE1 demonstrate_LE1 that_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 significant_LE1 affect_LE1 by_LE1 concurrent_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Rivastigmine|N|warfarin|diazepam|single_LE1 dose_LE1 pharmacokinetic_LE1 study_LE1 demonstrate_LE1 that_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 significant_LE1 affect_LE1 by_LE1 concurrent_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Rivastigmine|N|digoxin|diazepam|single_LE1 dose_LE1 pharmacokinetic_LE1 study_LE1 demonstrate_LE1 that_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 significant_LE1 affect_LE1 by_LE1 concurrent_LE1 administration_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Rivastigmine|N|rivastigmine|diazepam|single_LE1 dose_LE1 pharmacokinetic_LE1 study_LE1 demonstrate_LE1 that_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 significant_BE12 affect_BE12 by_BE12 concurrent_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Rivastigmine|N|diazepam|fluoxetine|single_LE1 dose_LE1 pharmacokinetic_LE1 study_LE1 demonstrate_LE1 that_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 significant_LE1 affect_LE1 by_LE1 concurrent_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Rivastigmine|N|diazepam|fluoxetine|single_LE1 dose_LE1 pharmacokinetic_LE1 study_LE1 demonstrate_LE1 that_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 significant_LE1 affect_LE1 by_LE1 concurrent_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Rivastigmine|N|digoxin|warfarin|single_LE1 dose_LE1 pharmacokinetic_LE1 study_LE1 demonstrate_LE1 that_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 significant_LE1 affect_LE1 by_LE1 concurrent_LE1 administration_LE1 of_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Rivastigmine|N|rivastigmine|warfarin|single_LE1 dose_LE1 pharmacokinetic_LE1 study_LE1 demonstrate_LE1 that_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 significant_BE12 affect_BE12 by_BE12 concurrent_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Rivastigmine|N|warfarin|fluoxetine|single_LE1 dose_LE1 pharmacokinetic_LE1 study_LE1 demonstrate_LE1 that_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 significant_LE1 affect_LE1 by_LE1 concurrent_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Rivastigmine|N|warfarin|fluoxetine|single_LE1 dose_LE1 pharmacokinetic_LE1 study_LE1 demonstrate_LE1 that_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 significant_LE1 affect_LE1 by_LE1 concurrent_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Rivastigmine|N|rivastigmine|digoxin|single_LE1 dose_LE1 pharmacokinetic_LE1 study_LE1 demonstrate_LE1 that_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 significant_BE12 affect_BE12 by_BE12 concurrent_BE12 administration_BE12 of_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Rivastigmine|N|digoxin|fluoxetine|single_LE1 dose_LE1 pharmacokinetic_LE1 study_LE1 demonstrate_LE1 that_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 significant_LE1 affect_LE1 by_LE1 concurrent_LE1 administration_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Rivastigmine|N|rivastigmine|fluoxetine|single_LE1 dose_LE1 pharmacokinetic_LE1 study_LE1 demonstrate_LE1 that_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 significant_BE12 affect_BE12 by_BE12 concurrent_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Rivastigmine|N|salicylate analgesic|antianginal|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|salicylate analgesic|antianginal|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|nonsteroidal anti-inflammatory drug|salicylate analgesic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|nonsteroidal anti-inflammatory drug|salicylate analgesic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|estrogen|salicylate analgesic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|estrogen|salicylate analgesic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|salicylate analgesic|antihistamine|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|salicylate analgesic|antihistamine|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|rivastigmine|salicylate analgesic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 influence_BE12 by_BE12 common_BE12 prescribe_BE12 medication_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|calcium channel blocker|salicylate analgesic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|calcium channel blocker|salicylate analgesic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antidiabetic|salicylate analgesic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antidiabetic|salicylate analgesic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antacid|salicylate analgesic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antihypertensive|salicylate analgesic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antihypertensive|salicylate analgesic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|nonsteroidal anti-inflammatory drug|antianginal|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|nonsteroidal anti-inflammatory drug|antianginal|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|estrogen|antianginal|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|estrogen|antianginal|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antianginal|antihistamine|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antianginal|antihistamine|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|rivastigmine|antianginal|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 influence_BE12 by_BE12 common_BE12 prescribe_BE12 medication_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|calcium channel blocker|antianginal|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|calcium channel blocker|antianginal|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antidiabetic|antianginal|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antidiabetic|antianginal|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antacid|antianginal|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antihypertensive|antianginal|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antihypertensive|antianginal|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|nonsteroidal anti-inflammatory drug|estrogen|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|nonsteroidal anti-inflammatory drug|estrogen|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|nonsteroidal anti-inflammatory drug|antihistamine|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|nonsteroidal anti-inflammatory drug|antihistamine|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|rivastigmine|nonsteroidal anti-inflammatory drug|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 influence_BE12 by_BE12 common_BE12 prescribe_BE12 medication_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|calcium channel blocker|nonsteroidal anti-inflammatory drug|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|calcium channel blocker|nonsteroidal anti-inflammatory drug|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antidiabetic|nonsteroidal anti-inflammatory drug|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antidiabetic|nonsteroidal anti-inflammatory drug|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antacid|nonsteroidal anti-inflammatory drug|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antihypertensive|nonsteroidal anti-inflammatory drug|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antihypertensive|nonsteroidal anti-inflammatory drug|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|estrogen|antihistamine|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|estrogen|antihistamine|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|rivastigmine|estrogen|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 influence_BE12 by_BE12 common_BE12 prescribe_BE12 medication_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|calcium channel blocker|estrogen|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|calcium channel blocker|estrogen|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antidiabetic|estrogen|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antidiabetic|estrogen|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antacid|estrogen|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antihypertensive|estrogen|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antihypertensive|estrogen|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|rivastigmine|antihistamine|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 influence_BE12 by_BE12 common_BE12 prescribe_BE12 medication_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|calcium channel blocker|antihistamine|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|calcium channel blocker|antihistamine|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antidiabetic|antihistamine|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antidiabetic|antihistamine|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antacid|antihistamine|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antihypertensive|antihistamine|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antihypertensive|antihistamine|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|rivastigmine|calcium channel blocker|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 influence_BE12 by_BE12 common_BE12 prescribe_BE12 medication_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|rivastigmine|antidiabetic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 influence_BE12 by_BE12 common_BE12 prescribe_BE12 medication_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|rivastigmine|antacid|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 influence_BE12 by_BE12 common_BE12 prescribe_BE12 medication_BE12 such_BE12 as_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|rivastigmine|antihypertensive|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 influence_BE12 by_BE12 common_BE12 prescribe_BE12 medication_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|calcium channel blocker|antidiabetic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|calcium channel blocker|antidiabetic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antacid|calcium channel blocker|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antihypertensive|calcium channel blocker|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antihypertensive|calcium channel blocker|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antacid|antidiabetic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antihypertensive|antidiabetic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antihypertensive|antidiabetic|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 n=_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|antacid|antihypertensive|population_LE1 pk_LE1 analysis_LE1 with_LE1 database_LE1 of_LE1 NUM_LE1 patient_LE1 show_LE1 that_LE1 the_LE1 pharmacokinetic_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 not_LE1 influence_LE1 by_LE1 common_LE1 prescribe_LE1 medication_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 n=_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 n=rrb._RE2 
Rivastigmine|N|anticholinergic|anticholinergic medication|use_LE1 with_LE1 BIOENTITY :_BE12 Because_BE12 of_BE12 their_BE12 mechanism_BE12 of_BE12 action_BE12 BIOGENERAL_BE12 have_BE12 the_BE12 potential_BE12 to_BE12 interfere_BE12 with_BE12 the_BE12 activity_BE12 of_BE12 BIOENTITY 
Rivastigmine|N|anticholinergic|cholinesterase inhibitor|use_LE1 with_LE1 BIOENTITY :_BE12 Because_BE12 of_BE12 their_BE12 mechanism_BE12 of_BE12 action_BE12 BIOENTITY have_RE2 the_RE2 potential_RE2 to_RE2 interfere_RE2 with_RE2 the_RE2 activity_RE2 of_RE2 BIOGENERAL_RE2 
Rivastigmine|N|cholinesterase inhibitor|cholinesterase inhibitor|use_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY :_BE12 synergistic_BE12 effect_BE12 may_BE12 be_BE12 expect_BE12 when_BE12 BIOENTITY be_RE2 give_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 similar_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 
Rivastigmine|N|cholinomimetic|cholinesterase inhibitor|use_LE1 with_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 :_BE12 synergistic_BE12 effect_BE12 may_BE12 be_BE12 expect_BE12 when_BE12 BIOENTITY be_RE2 give_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 similar_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 
Rivastigmine|N|cholinomimetic|cholinesterase inhibitor|use_LE1 with_LE1 BIOENTITY and_BE12 other_BE12 BIOENTITY :_RE2 synergistic_RE2 effect_RE2 may_RE2 be_RE2 expect_RE2 when_RE2 BIOGENERAL_RE2 be_RE2 give_RE2 concurrent_RE2 with_RE2 BIOGENERAL_RE2 similar_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 
Rivastigmine|N|cholinesterase inhibitor|bethanechol|use_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY :_BE12 synergistic_BE12 effect_BE12 may_BE12 be_BE12 expect_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 give_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 similar_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOENTITY 
Rivastigmine|N|cholinesterase inhibitor|cholinergic agonist|use_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY :_BE12 synergistic_BE12 effect_BE12 may_BE12 be_BE12 expect_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 give_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 similar_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY such_RE2 as_RE2 BIOGENERAL_RE2 
Rivastigmine|N|cholinesterase inhibitor|neuromuscular blocking agent|use_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY :_BE12 synergistic_BE12 effect_BE12 may_BE12 be_BE12 expect_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 give_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 similar_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 
Rivastigmine|N|cholinesterase inhibitor|succinylcholine|use_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY :_BE12 synergistic_BE12 effect_BE12 may_BE12 be_BE12 expect_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 give_BE12 concurrent_BE12 with_BE12 BIOENTITY similar_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 
Rivastigmine|N|cholinomimetic|bethanechol|use_LE1 with_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 :_BE12 synergistic_BE12 effect_BE12 may_BE12 be_BE12 expect_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 give_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 similar_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOENTITY 
Rivastigmine|N|cholinomimetic|cholinergic agonist|use_LE1 with_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 :_BE12 synergistic_BE12 effect_BE12 may_BE12 be_BE12 expect_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 give_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 similar_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY such_RE2 as_RE2 BIOGENERAL_RE2 
Rivastigmine|N|cholinomimetic|neuromuscular blocking agent|use_LE1 with_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 :_BE12 synergistic_BE12 effect_BE12 may_BE12 be_BE12 expect_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 give_BE12 concurrent_BE12 with_BE12 BIOGENERAL_BE12 similar_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 
Rivastigmine|N|cholinomimetic|succinylcholine|use_LE1 with_LE1 BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 :_BE12 synergistic_BE12 effect_BE12 may_BE12 be_BE12 expect_BE12 when_BE12 BIOGENERAL_BE12 be_BE12 give_BE12 concurrent_BE12 with_BE12 BIOENTITY similar_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 
Rivastigmine|N|cholinergic agonist|bethanechol|use_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 synergistic_LE1 effect_LE1 may_LE1 be_LE1 expect_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 similar_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY such_BE12 as_BE12 BIOENTITY 
Rivastigmine|N|neuromuscular blocking agent|bethanechol|use_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 synergistic_LE1 effect_LE1 may_LE1 be_LE1 expect_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 similar_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOENTITY 
Rivastigmine|N|succinylcholine|bethanechol|use_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 synergistic_LE1 effect_LE1 may_LE1 be_LE1 expect_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 concurrent_LE1 with_LE1 BIOENTITY similar_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 such_BE12 as_BE12 BIOENTITY 
Rivastigmine|N|neuromuscular blocking agent|cholinergic agonist|use_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 synergistic_LE1 effect_LE1 may_LE1 be_LE1 expect_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 concurrent_LE1 with_LE1 BIOGENERAL_LE1 similar_LE1 BIOENTITY or_BE12 BIOENTITY such_RE2 as_RE2 BIOGENERAL_RE2 
Rivastigmine|N|succinylcholine|cholinergic agonist|use_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 synergistic_LE1 effect_LE1 may_LE1 be_LE1 expect_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 concurrent_LE1 with_LE1 BIOENTITY similar_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY such_RE2 as_RE2 BIOGENERAL_RE2 
Rivastigmine|N|succinylcholine|neuromuscular blocking agent|use_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 :_LE1 synergistic_LE1 effect_LE1 may_LE1 be_LE1 expect_LE1 when_LE1 BIOGENERAL_LE1 be_LE1 give_LE1 concurrent_LE1 with_LE1 BIOENTITY similar_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 
Rocuronium|N|zemuron|rocuronium bromide|drug_LE1 interaction_LE1 :_LE1 the_LE1 use_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 injection_RE2 before_RE2 BIOGENERAL_RE2 for_RE2 the_RE2 purpose_RE2 of_RE2 attenuate_RE2 some_RE2 of_RE2 the_RE2 side_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 have_RE2 not_RE2 be_RE2 study_RE2 
Rocuronium|N|zemuron|succinylcholine|drug_LE1 interaction_LE1 :_LE1 the_LE1 use_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 injection_BE12 before_BE12 BIOENTITY for_RE2 the_RE2 purpose_RE2 of_RE2 attenuate_RE2 some_RE2 of_RE2 the_RE2 side_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 have_RE2 not_RE2 be_RE2 study_RE2 
Rocuronium|N|zemuron|succinylcholine|drug_LE1 interaction_LE1 :_LE1 the_LE1 use_LE1 of_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 injection_BE12 before_BE12 BIOGENERAL_BE12 for_BE12 the_BE12 purpose_BE12 of_BE12 attenuate_BE12 some_BE12 of_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 study_RE2 
Rocuronium|N|rocuronium bromide|succinylcholine|drug_LE1 interaction_LE1 :_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 injection_BE12 before_BE12 BIOENTITY for_RE2 the_RE2 purpose_RE2 of_RE2 attenuate_RE2 some_RE2 of_RE2 the_RE2 side_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 have_RE2 not_RE2 be_RE2 study_RE2 
Rocuronium|N|rocuronium bromide|succinylcholine|drug_LE1 interaction_LE1 :_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 injection_BE12 before_BE12 BIOGENERAL_BE12 for_BE12 the_BE12 purpose_BE12 of_BE12 attenuate_BE12 some_BE12 of_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 study_RE2 
Rocuronium|N|succinylcholine|succinylcholine|drug_LE1 interaction_LE1 :_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 injection_LE1 before_LE1 BIOENTITY for_BE12 the_BE12 purpose_BE12 of_BE12 attenuate_BE12 some_BE12 of_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 study_RE2 
Rocuronium|N|zemuron|succinylcholine|if_LE1 BIOENTITY be_BE12 administer_BE12 following_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 it_BE12 shall_BE12 not_BE12 be_BE12 give_BE12 until_BE12 recovery_BE12 from_BE12 BIOENTITY have_RE2 be_RE2 observe_RE2 
Rocuronium|N|succinylcholine|succinylcholine|if_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 following_LE1 administration_LE1 of_LE1 BIOENTITY it_BE12 shall_BE12 not_BE12 be_BE12 give_BE12 until_BE12 recovery_BE12 from_BE12 BIOENTITY have_RE2 be_RE2 observe_RE2 
Rocuronium|N|zemuron|succinylcholine|the_LE1 median_LE1 duration_LE1 of_LE1 action_LE1 of_LE1 BIOENTITY mg_BE12 administer_BE12 after_BE12 NUM_BE12 mg_BE12 dose_BE12 of_BE12 BIOENTITY when_RE2 NUM_RE2 return_RE2 to_RE2 NUM_RE2 of_RE2 control_RE2 be_RE2 NUM_RE2 minute_RE2 -LRB-_RE2 range_RE2 NUM_RE2 n=_RE2 -RRB-_RE2 vs_RE2 
Rocuronium|N|zemuron|nondepolarizing muscle relaxant|there_LE1 be_LE1 no_LE1 controlled_LE1 study_LE1 document_LE1 the_LE1 use_LE1 of_LE1 BIOENTITY before_BE12 or_BE12 after_BE12 other_BE12 BIOENTITY 
Ropivacaine|N|ropivacaine|amide-type local anesthetic|BIOENTITY shall_BE12 be_BE12 use_BE12 with_BE12 caution_BE12 in_BE12 patient_BE12 receive_BE12 other_BE12 local_BE12 BIOGENERAL_BE12 or_BE12 agent_BE12 structural_BE12 related_BE12 to_BE12 BIOENTITY since_RE2 the_RE2 toxic_RE2 effect_RE2 of_RE2 these_RE2 drug_RE2 be_RE2 additive_RE2 
Ropivacaine|N|anesthetic|amide-type local anesthetic|BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 with_LE1 caution_LE1 in_LE1 patient_LE1 receive_LE1 other_LE1 local_LE1 BIOENTITY or_BE12 agent_BE12 structural_BE12 related_BE12 to_BE12 BIOENTITY since_RE2 the_RE2 toxic_RE2 effect_RE2 of_RE2 these_RE2 drug_RE2 be_RE2 additive_RE2 
Ropivacaine|N|ropivacaine|ropivacaine|thus_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 pa_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 give_LE1 concomitant_LE1 during_LE1 administration_LE1 of_LE1 BIOENTITY can_BE12 interact_BE12 with_BE12 BIOGENERAL_BE12 lead_BE12 to_BE12 increase_BE12 BIOENTITY plasma_RE2 level_RE2 
Ropivacaine|N|ropivacaine|ropivacaine|thus_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 pa_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 give_LE1 concomitant_LE1 during_LE1 administration_LE1 of_LE1 BIOENTITY can_BE12 interact_BE12 with_BE12 BIOENTITY lead_RE2 to_RE2 increase_RE2 BIOGENERAL_RE2 plasma_RE2 level_RE2 
Ropivacaine|N|fluvoxamine|ropivacaine|thus_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 pa_LE1 such_LE1 as_LE1 BIOENTITY give_BE12 concomitant_BE12 during_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 can_BE12 interact_BE12 with_BE12 BIOGENERAL_BE12 lead_BE12 to_BE12 increase_BE12 BIOENTITY plasma_RE2 level_RE2 
Ropivacaine|N|fluvoxamine|ropivacaine|thus_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 pa_LE1 such_LE1 as_LE1 BIOENTITY give_BE12 concomitant_BE12 during_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 can_BE12 interact_BE12 with_BE12 BIOENTITY lead_RE2 to_RE2 increase_RE2 BIOGENERAL_RE2 plasma_RE2 level_RE2 
Ropivacaine|N|ropivacaine|ropivacaine|thus_LE1 strong_LE1 inhibitor_LE1 of_LE1 cytochrome_LE1 pa_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 give_LE1 concomitant_LE1 during_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 BIOENTITY lead_BE12 to_BE12 increase_BE12 BIOENTITY plasma_RE2 level_RE2 
Ropivacaine|N|theophylline|imipramine|possible_LE1 interaction_LE1 with_LE1 drug_LE1 know_LE1 to_LE1 be_LE1 metabolize_LE1 by_LE1 cypa_LE1 via_LE1 competitive_LE1 inhibition_LE1 such_LE1 as_LE1 BIOENTITY and_BE12 BIOENTITY may_RE2 also_RE2 occur_RE2 
Ropivacaine|N|ketoconazole|ropivacaine|coadministration_LE1 of_LE1 selective_LE1 and_LE1 potent_LE1 inhibitor_LE1 of_LE1 cypa_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 mg_BE12 bid_BE12 for_BE12 NUM_BE12 day_BE12 with_BE12 BIOENTITY infusion_RE2 administer_RE2 NUM_RE2 hour_RE2 after_RE2 BIOGENERAL_RE2 -RRB-_RE2 cause_RE2 NUM_RE2 reduction_RE2 in_RE2 invivo_RE2 plasma_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Ropivacaine|N|ketoconazole|ketoconazole|coadministration_LE1 of_LE1 selective_LE1 and_LE1 potent_LE1 inhibitor_LE1 of_LE1 cypa_LE1 BIOENTITY -LRB-_BE12 NUM_BE12 mg_BE12 bid_BE12 for_BE12 NUM_BE12 day_BE12 with_BE12 BIOGENERAL_BE12 infusion_BE12 administer_BE12 NUM_BE12 hour_BE12 after_BE12 BIOENTITY -RRB-_RE2 cause_RE2 NUM_RE2 reduction_RE2 in_RE2 invivo_RE2 plasma_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Ropivacaine|N|ropivacaine|ropivacaine|coadministration_LE1 of_LE1 selective_LE1 and_LE1 potent_LE1 inhibitor_LE1 of_LE1 cypa_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 bid_LE1 for_LE1 NUM_LE1 day_LE1 with_LE1 BIOENTITY infusion_BE12 administer_BE12 NUM_BE12 hour_BE12 after_BE12 BIOGENERAL_BE12 -RRB-_BE12 cause_BE12 NUM_BE12 reduction_BE12 in_BE12 invivo_BE12 plasma_BE12 clearance_BE12 of_BE12 BIOENTITY 
Ropivacaine|N|ketoconazole|ropivacaine|coadministration_LE1 of_LE1 selective_LE1 and_LE1 potent_LE1 inhibitor_LE1 of_LE1 cypa_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 bid_LE1 for_LE1 NUM_LE1 day_LE1 with_LE1 BIOGENERAL_LE1 infusion_LE1 administer_LE1 NUM_LE1 hour_LE1 after_LE1 BIOENTITY -RRB-_BE12 cause_BE12 NUM_BE12 reduction_BE12 in_BE12 invivo_BE12 plasma_BE12 clearance_BE12 of_BE12 BIOENTITY 
Ropivacaine|N|ropivacaine|ketoconazole|coadministration_LE1 of_LE1 selective_LE1 and_LE1 potent_LE1 inhibitor_LE1 of_LE1 cypa_LE1 BIOGENERAL_LE1 -LRB-_LE1 NUM_LE1 mg_LE1 bid_LE1 for_LE1 NUM_LE1 day_LE1 with_LE1 BIOENTITY infusion_BE12 administer_BE12 NUM_BE12 hour_BE12 after_BE12 BIOENTITY -RRB-_RE2 cause_RE2 NUM_RE2 reduction_RE2 in_RE2 invivo_RE2 plasma_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 
Rosiglitazone|N|gemfibrozil|rosiglitazone|inhibitor_LE1 of_LE1 cypc_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOENTITY -RRB-_BE12 may_BE12 increase_BE12 the_BE12 auc_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 inducer_BE12 of_BE12 cypc_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 decrease_BE12 the_BE12 auc_BE12 of_BE12 BIOENTITY 
Rosiglitazone|N|gemfibrozil|rifampin|inhibitor_LE1 of_LE1 cypc_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOENTITY -RRB-_BE12 may_BE12 increase_BE12 the_BE12 auc_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 inducer_BE12 of_BE12 cypc_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOENTITY -RRB-_RE2 may_RE2 decrease_RE2 the_RE2 auc_RE2 of_RE2 BIOGENERAL_RE2 
Rosiglitazone|N|rosiglitazone|rosiglitazone|inhibitor_LE1 of_LE1 cypc_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -RRB-_LE1 may_LE1 increase_LE1 the_LE1 auc_LE1 of_LE1 BIOENTITY and_BE12 inducer_BE12 of_BE12 cypc_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 decrease_BE12 the_BE12 auc_BE12 of_BE12 BIOENTITY 
Rosiglitazone|N|rosiglitazone|rifampin|inhibitor_LE1 of_LE1 cypc_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -RRB-_LE1 may_LE1 increase_LE1 the_LE1 auc_LE1 of_LE1 BIOENTITY and_BE12 inducer_BE12 of_BE12 cypc_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOENTITY -RRB-_RE2 may_RE2 decrease_RE2 the_RE2 auc_RE2 of_RE2 BIOGENERAL_RE2 
Roxithromycin|N|terfenadine|macrolide|concomitant_LE1 administration_LE1 not_LE1 recommend_LE1 :_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 :_BE12 certain_BE12 BIOENTITY interact_RE2 with_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 lead_RE2 to_RE2 increase_RE2 serum_RE2 concentration_RE2 of_RE2 the_RE2 latter_RE2 
Roxithromycin|N|terfenadine|astemizole|concomitant_LE1 administration_LE1 not_LE1 recommend_LE1 :_LE1 BIOENTITY and_BE12 BIOENTITY :_RE2 certain_RE2 BIOGENERAL_RE2 interact_RE2 with_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 lead_RE2 to_RE2 increase_RE2 serum_RE2 concentration_RE2 of_RE2 the_RE2 latter_RE2 
Roxithromycin|N|terfenadine|astemizole|concomitant_LE1 administration_LE1 not_LE1 recommend_LE1 :_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 :_BE12 certain_BE12 BIOGENERAL_BE12 interact_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY lead_RE2 to_RE2 increase_RE2 serum_RE2 concentration_RE2 of_RE2 the_RE2 latter_RE2 
Roxithromycin|N|terfenadine|terfenadine|concomitant_LE1 administration_LE1 not_LE1 recommend_LE1 :_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 :_BE12 certain_BE12 BIOGENERAL_BE12 interact_BE12 with_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 lead_RE2 to_RE2 increase_RE2 serum_RE2 concentration_RE2 of_RE2 the_RE2 latter_RE2 
Roxithromycin|N|astemizole|macrolide|concomitant_LE1 administration_LE1 not_LE1 recommend_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY :_BE12 certain_BE12 BIOENTITY interact_RE2 with_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 lead_RE2 to_RE2 increase_RE2 serum_RE2 concentration_RE2 of_RE2 the_RE2 latter_RE2 
Roxithromycin|N|astemizole|astemizole|concomitant_LE1 administration_LE1 not_LE1 recommend_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY :_BE12 certain_BE12 BIOGENERAL_BE12 interact_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY lead_RE2 to_RE2 increase_RE2 serum_RE2 concentration_RE2 of_RE2 the_RE2 latter_RE2 
Roxithromycin|N|astemizole|terfenadine|concomitant_LE1 administration_LE1 not_LE1 recommend_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY :_BE12 certain_BE12 BIOGENERAL_BE12 interact_BE12 with_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 lead_RE2 to_RE2 increase_RE2 serum_RE2 concentration_RE2 of_RE2 the_RE2 latter_RE2 
Roxithromycin|N|terfenadine|astemizole|concomitant_LE1 administration_LE1 not_LE1 recommend_LE1 :_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 :_LE1 certain_LE1 BIOGENERAL_LE1 interact_LE1 with_LE1 BIOENTITY and_BE12 BIOENTITY lead_RE2 to_RE2 increase_RE2 serum_RE2 concentration_RE2 of_RE2 the_RE2 latter_RE2 
Roxithromycin|N|roxithromycin|terfenadine|although_LE1 such_LE1 reaction_LE1 have_LE1 not_LE1 be_LE1 demonstrate_LE1 with_LE1 BIOENTITY concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 
Roxithromycin|N|roxithromycin|roxithromycin|although_LE1 such_LE1 reaction_LE1 have_LE1 not_LE1 be_LE1 demonstrate_LE1 with_LE1 BIOENTITY concomitant_BE12 administration_BE12 of_BE12 BIOENTITY with_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 
Roxithromycin|N|roxithromycin|astemizole|although_LE1 such_LE1 reaction_LE1 have_LE1 not_LE1 be_LE1 demonstrate_LE1 with_LE1 BIOENTITY concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY be_RE2 not_RE2 recommend_RE2 
Roxithromycin|N|terfenadine|astemizole|although_LE1 such_LE1 reaction_LE1 have_LE1 not_LE1 be_LE1 demonstrate_LE1 with_LE1 BIOGENERAL_LE1 concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY or_BE12 BIOENTITY be_RE2 not_RE2 recommend_RE2 
Roxithromycin|N|pimozide|macrolide antibacterial|BIOGENERAL_LE1 BIOGENERAL_LE1 :_LE1 other_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY which_BE12 be_BE12 metabolize_BE12 by_BE12 hepatic_BE12 cypa_BE12 isozyme_BE12 have_BE12 be_BE12 associate_BE12 with_BE12 qt_BE12 interval_BE12 prolongation_BE12 and_BE12 cardiac_BE12 arrythmia_BE12 -LRB-_BE12 typical_BE12 torsade_BE12 de_BE12 pointe_BE12 -RRB-_BE12 as_BE12 result_BE12 of_BE12 increase_BE12 in_BE12 their_BE12 serum_BE12 level_BE12 subsequent_BE12 to_BE12 interaction_BE12 with_BE12 significant_BE12 inhibitor_BE12 of_BE12 the_BE12 isozyme_BE12 including_BE12 some_BE12 BIOENTITY 
Roxithromycin|N|cisapride|macrolide antibacterial|BIOENTITY BIOGENERAL_BE12 :_BE12 other_BE12 drug_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 which_BE12 be_BE12 metabolize_BE12 by_BE12 hepatic_BE12 cypa_BE12 isozyme_BE12 have_BE12 be_BE12 associate_BE12 with_BE12 qt_BE12 interval_BE12 prolongation_BE12 and_BE12 cardiac_BE12 arrythmia_BE12 -LRB-_BE12 typical_BE12 torsade_BE12 de_BE12 pointe_BE12 -RRB-_BE12 as_BE12 result_BE12 of_BE12 increase_BE12 in_BE12 their_BE12 serum_BE12 level_BE12 subsequent_BE12 to_BE12 interaction_BE12 with_BE12 significant_BE12 inhibitor_BE12 of_BE12 the_BE12 isozyme_BE12 including_BE12 some_BE12 BIOENTITY 
Roxithromycin|N|cisapride|pimozide|BIOGENERAL_LE1 BIOGENERAL_LE1 :_LE1 other_LE1 drug_LE1 such_LE1 as_LE1 BIOENTITY or_BE12 BIOENTITY which_RE2 be_RE2 metabolize_RE2 by_RE2 hepatic_RE2 cypa_RE2 isozyme_RE2 have_RE2 be_RE2 associate_RE2 with_RE2 qt_RE2 interval_RE2 prolongation_RE2 and_RE2 cardiac_RE2 arrythmia_RE2 -LRB-_RE2 typical_RE2 torsade_RE2 de_RE2 pointe_RE2 -RRB-_RE2 as_RE2 result_RE2 of_RE2 increase_RE2 in_RE2 their_RE2 serum_RE2 level_RE2 subsequent_RE2 to_RE2 interaction_RE2 with_RE2 significant_RE2 inhibitor_RE2 of_RE2 the_RE2 isozyme_RE2 including_RE2 some_RE2 BIOGENERAL_RE2 
Roxithromycin|N|pimozide|pimozide|BIOGENERAL_LE1 BIOENTITY :_BE12 other_BE12 drug_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY which_RE2 be_RE2 metabolize_RE2 by_RE2 hepatic_RE2 cypa_RE2 isozyme_RE2 have_RE2 be_RE2 associate_RE2 with_RE2 qt_RE2 interval_RE2 prolongation_RE2 and_RE2 cardiac_RE2 arrythmia_RE2 -LRB-_RE2 typical_RE2 torsade_RE2 de_RE2 pointe_RE2 -RRB-_RE2 as_RE2 result_RE2 of_RE2 increase_RE2 in_RE2 their_RE2 serum_RE2 level_RE2 subsequent_RE2 to_RE2 interaction_RE2 with_RE2 significant_RE2 inhibitor_RE2 of_RE2 the_RE2 isozyme_RE2 including_RE2 some_RE2 BIOGENERAL_RE2 
Roxithromycin|N|cisapride|pimozide|BIOENTITY BIOGENERAL_BE12 :_BE12 other_BE12 drug_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY which_RE2 be_RE2 metabolize_RE2 by_RE2 hepatic_RE2 cypa_RE2 isozyme_RE2 have_RE2 be_RE2 associate_RE2 with_RE2 qt_RE2 interval_RE2 prolongation_RE2 and_RE2 cardiac_RE2 arrythmia_RE2 -LRB-_RE2 typical_RE2 torsade_RE2 de_RE2 pointe_RE2 -RRB-_RE2 as_RE2 result_RE2 of_RE2 increase_RE2 in_RE2 their_RE2 serum_RE2 level_RE2 subsequent_RE2 to_RE2 interaction_RE2 with_RE2 significant_RE2 inhibitor_RE2 of_RE2 the_RE2 isozyme_RE2 including_RE2 some_RE2 BIOGENERAL_RE2 
Roxithromycin|N|pimozide|cisapride|BIOGENERAL_LE1 BIOENTITY :_BE12 other_BE12 drug_BE12 such_BE12 as_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 which_RE2 be_RE2 metabolize_RE2 by_RE2 hepatic_RE2 cypa_RE2 isozyme_RE2 have_RE2 be_RE2 associate_RE2 with_RE2 qt_RE2 interval_RE2 prolongation_RE2 and_RE2 cardiac_RE2 arrythmia_RE2 -LRB-_RE2 typical_RE2 torsade_RE2 de_RE2 pointe_RE2 -RRB-_RE2 as_RE2 result_RE2 of_RE2 increase_RE2 in_RE2 their_RE2 serum_RE2 level_RE2 subsequent_RE2 to_RE2 interaction_RE2 with_RE2 significant_RE2 inhibitor_RE2 of_RE2 the_RE2 isozyme_RE2 including_RE2 some_RE2 BIOGENERAL_RE2 
Roxithromycin|N|cisapride|cisapride|BIOENTITY BIOGENERAL_BE12 :_BE12 other_BE12 drug_BE12 such_BE12 as_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 which_RE2 be_RE2 metabolize_RE2 by_RE2 hepatic_RE2 cypa_RE2 isozyme_RE2 have_RE2 be_RE2 associate_RE2 with_RE2 qt_RE2 interval_RE2 prolongation_RE2 and_RE2 cardiac_RE2 arrythmia_RE2 -LRB-_RE2 typical_RE2 torsade_RE2 de_RE2 pointe_RE2 -RRB-_RE2 as_RE2 result_RE2 of_RE2 increase_RE2 in_RE2 their_RE2 serum_RE2 level_RE2 subsequent_RE2 to_RE2 interaction_RE2 with_RE2 significant_RE2 inhibitor_RE2 of_RE2 the_RE2 isozyme_RE2 including_RE2 some_RE2 BIOGENERAL_RE2 
Roxithromycin|N|cisapride|pimozide|BIOENTITY BIOENTITY :_RE2 other_RE2 drug_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 which_RE2 be_RE2 metabolize_RE2 by_RE2 hepatic_RE2 cypa_RE2 isozyme_RE2 have_RE2 be_RE2 associate_RE2 with_RE2 qt_RE2 interval_RE2 prolongation_RE2 and_RE2 cardiac_RE2 arrythmia_RE2 -LRB-_RE2 typical_RE2 torsade_RE2 de_RE2 pointe_RE2 -RRB-_RE2 as_RE2 result_RE2 of_RE2 increase_RE2 in_RE2 their_RE2 serum_RE2 level_RE2 subsequent_RE2 to_RE2 interaction_RE2 with_RE2 significant_RE2 inhibitor_RE2 of_RE2 the_RE2 isozyme_RE2 including_RE2 some_RE2 BIOGENERAL_RE2 
Roxithromycin|N|roxithromycin|roxithromycin|although_LE1 such_LE1 risk_LE1 be_LE1 not_LE1 verify_LE1 for_LE1 BIOENTITY combination_BE12 of_BE12 BIOENTITY with_RE2 such_RE2 drug_RE2 be_RE2 not_RE2 recommend_RE2 
Salsalate|N|salicylate drug|salicylic acid|BIOGENERAL_LE1 AND_LE1 other_LE1 BIOENTITY will_BE12 be_BE12 additive_BE12 to_BE12 BIOGENERAL_BE12 AND_BE12 may_BE12 increase_BE12 plasma_BE12 concentration_BE12 OF_BE12 BIOENTITY to_RE2 toxic_RE2 level_RE2 
Salsalate|N|salicylate drug|salicylic acid|BIOGENERAL_LE1 AND_LE1 other_LE1 BIOENTITY will_BE12 be_BE12 additive_BE12 to_BE12 BIOGENERAL_BE12 AND_BE12 may_BE12 increase_BE12 plasma_BE12 concentration_BE12 OF_BE12 BIOENTITY to_RE2 toxic_RE2 level_RE2 
Salsalate|N|aspirin|salicylate drug|BIOENTITY AND_BE12 other_BE12 BIOENTITY will_RE2 be_RE2 additive_RE2 to_RE2 BIOGENERAL_RE2 AND_RE2 may_RE2 increase_RE2 plasma_RE2 concentration_RE2 OF_RE2 BIOGENERAL_RE2 to_RE2 toxic_RE2 level_RE2 
Salsalate|N|disalcid|salicylic acid|BIOGENERAL_LE1 AND_LE1 other_LE1 BIOGENERAL_LE1 will_LE1 be_LE1 additive_LE1 to_LE1 BIOENTITY AND_BE12 may_BE12 increase_BE12 plasma_BE12 concentration_BE12 OF_BE12 BIOENTITY to_RE2 toxic_RE2 level_RE2 
Salsalate|N|aspirin|salicylic acid|BIOENTITY AND_BE12 other_BE12 BIOGENERAL_BE12 will_BE12 be_BE12 additive_BE12 to_BE12 BIOGENERAL_BE12 AND_BE12 may_BE12 increase_BE12 plasma_BE12 concentration_BE12 OF_BE12 BIOENTITY to_RE2 toxic_RE2 level_RE2 
Salsalate|N|penicillin|thyroxine|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|penicillin|thiopental|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|penicillin|phenytoin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|penicillin|triiodothyronine|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|penicillin|naproxen|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|penicillin|sulfinpyrazone|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|penicillin|corticosteroid|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 possible_BE12 BIOENTITY 
Salsalate|N|penicillin|methotrexate|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|penicillin|warfarin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thiopental|thyroxine|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thiopental|thyroxine|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thyroxine|phenytoin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thyroxine|phenytoin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thyroxine|triiodothyronine|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thyroxine|triiodothyronine|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thyroxine|naproxen|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thyroxine|naproxen|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thyroxine|sulfinpyrazone|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thyroxine|sulfinpyrazone|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thyroxine|corticosteroid|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 possible_BE12 BIOENTITY 
Salsalate|N|thyroxine|methotrexate|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thyroxine|methotrexate|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thyroxine|warfarin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thyroxine|warfarin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thiopental|phenytoin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thiopental|phenytoin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thiopental|triiodothyronine|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thiopental|triiodothyronine|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thiopental|naproxen|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thiopental|naproxen|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thiopental|sulfinpyrazone|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thiopental|sulfinpyrazone|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thiopental|corticosteroid|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 possible_BE12 BIOENTITY 
Salsalate|N|thiopental|methotrexate|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thiopental|methotrexate|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thiopental|warfarin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|thiopental|warfarin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|triiodothyronine|phenytoin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|triiodothyronine|phenytoin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|phenytoin|naproxen|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|phenytoin|naproxen|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|phenytoin|sulfinpyrazone|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|phenytoin|sulfinpyrazone|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|phenytoin|corticosteroid|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 possible_BE12 BIOENTITY 
Salsalate|N|phenytoin|methotrexate|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|phenytoin|methotrexate|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|phenytoin|warfarin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|phenytoin|warfarin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|triiodothyronine|naproxen|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|triiodothyronine|naproxen|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|triiodothyronine|sulfinpyrazone|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|triiodothyronine|sulfinpyrazone|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|triiodothyronine|corticosteroid|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 possible_BE12 BIOENTITY 
Salsalate|N|triiodothyronine|methotrexate|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|triiodothyronine|methotrexate|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|triiodothyronine|warfarin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|triiodothyronine|warfarin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|sulfinpyrazone|naproxen|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|sulfinpyrazone|naproxen|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|naproxen|corticosteroid|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 possible_BE12 BIOENTITY 
Salsalate|N|naproxen|methotrexate|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|naproxen|methotrexate|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|naproxen|warfarin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|naproxen|warfarin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|sulfinpyrazone|corticosteroid|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 possible_BE12 BIOENTITY 
Salsalate|N|sulfinpyrazone|methotrexate|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|sulfinpyrazone|methotrexate|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|sulfinpyrazone|warfarin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|sulfinpyrazone|warfarin|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|methotrexate|corticosteroid|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 possible_BE12 BIOENTITY 
Salsalate|N|warfarin|corticosteroid|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 possible_BE12 BIOENTITY 
Salsalate|N|warfarin|methotrexate|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 possible_RE2 BIOGENERAL_RE2 
Salsalate|N|warfarin|methotrexate|BIOGENERAL_LE1 compete_LE1 with_LE1 number_LE1 of_LE1 drug_LE1 for_LE1 protein_LE1 binding_LE1 site_LE1 notable_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 possible_RE2 BIOGENERAL_RE2 
Sargramostim|N|lithium|corticosteroid|drug_LE1 which_LE1 may_LE1 potentiate_LE1 the_LE1 myeloproliferative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY and_BE12 BIOENTITY shall_RE2 be_RE2 use_RE2 with_RE2 caution_RE2 
Scopolamine|N|tranquilizer|alcohol|BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 with_LE1 care_LE1 in_LE1 patient_LE1 take_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 capable_LE1 of_LE1 cause_LE1 cns_LE1 effect_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Scopolamine|N|tranquilizer|alcohol|BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 with_LE1 care_LE1 in_LE1 patient_LE1 take_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 capable_LE1 of_LE1 cause_LE1 cns_LE1 effect_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Scopolamine|N|sedative|tranquilizer|BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 with_LE1 care_LE1 in_LE1 patient_LE1 take_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 capable_LE1 of_LE1 cause_LE1 cns_LE1 effect_LE1 such_LE1 as_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Scopolamine|N|sedative|alcohol|BIOGENERAL_LE1 shall_LE1 be_LE1 use_LE1 with_LE1 care_LE1 in_LE1 patient_LE1 take_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 capable_LE1 of_LE1 cause_LE1 cns_LE1 effect_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Scopolamine|N|belladonna alkaloid|antihistamine|e.g._LE1 other_LE1 BIOENTITY BIOENTITY -LRB-_RE2 include_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Scopolamine|N|antihistamine|muscle relaxant|e.g._LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Scopolamine|N|antihistamine|tricyclic antidepressant|e.g._LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Scopolamine|N|antihistamine|meclizine|e.g._LE1 other_LE1 BIOGENERAL_LE1 BIOENTITY -LRB-_BE12 include_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Scopolamine|N|belladonna alkaloid|muscle relaxant|e.g._LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Scopolamine|N|belladonna alkaloid|tricyclic antidepressant|e.g._LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Scopolamine|N|belladonna alkaloid|meclizine|e.g._LE1 other_LE1 BIOENTITY BIOGENERAL_BE12 -LRB-_BE12 include_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Scopolamine|N|tricyclic antidepressant|muscle relaxant|e.g._LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY and_BE12 BIOENTITY 
Scopolamine|N|meclizine|muscle relaxant|e.g._LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Scopolamine|N|meclizine|tricyclic antidepressant|e.g._LE1 other_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOENTITY -RRB-_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Secobarbital|N|corticosteroid|anticoagulant|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Secobarbital|N|corticosteroid|anticoagulant|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Secobarbital|N|anticoagulant|beta blocker|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Secobarbital|N|anticoagulant|beta blocker|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Secobarbital|N|antibiotic|anticoagulant|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Secobarbital|N|antibiotic|anticoagulant|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Secobarbital|N|contraceptive|anticoagulant|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Secobarbital|N|theophylline|anticoagulant|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Secobarbital|N|theophylline|anticoagulant|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Secobarbital|N|quinidine|anticoagulant|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Secobarbital|N|quinidine|anticoagulant|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Secobarbital|N|corticosteroid|beta blocker|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Secobarbital|N|corticosteroid|beta blocker|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Secobarbital|N|antibiotic|corticosteroid|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Secobarbital|N|antibiotic|corticosteroid|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Secobarbital|N|contraceptive|corticosteroid|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Secobarbital|N|theophylline|corticosteroid|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Secobarbital|N|theophylline|corticosteroid|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Secobarbital|N|quinidine|corticosteroid|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Secobarbital|N|quinidine|corticosteroid|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Secobarbital|N|antibiotic|beta blocker|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Secobarbital|N|antibiotic|beta blocker|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Secobarbital|N|contraceptive|beta blocker|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Secobarbital|N|theophylline|beta blocker|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Secobarbital|N|theophylline|beta blocker|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Secobarbital|N|quinidine|beta blocker|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Secobarbital|N|quinidine|beta blocker|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Secobarbital|N|contraceptive|antibiotic|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOENTITY certain_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Secobarbital|N|antibiotic|theophylline|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Secobarbital|N|antibiotic|theophylline|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Secobarbital|N|antibiotic|quinidine|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Secobarbital|N|antibiotic|quinidine|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Secobarbital|N|contraceptive|theophylline|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Secobarbital|N|contraceptive|quinidine|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOENTITY certain_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Secobarbital|N|quinidine|theophylline|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Secobarbital|N|quinidine|theophylline|BIOGENERAL_LE1 may_LE1 decrease_LE1 the_LE1 effectiveness_LE1 of_LE1 oral_LE1 BIOGENERAL_LE1 certain_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Selegiline|N|eldepryl|eldepryl|severe_LE1 toxicity_LE1 have_LE1 also_LE1 be_LE1 report_LE1 in_LE1 patient_LE1 receive_LE1 the_LE1 combination_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Selegiline|N|tricyclic antidepressant|eldepryl|severe_LE1 toxicity_LE1 have_LE1 also_LE1 be_LE1 report_LE1 in_LE1 patient_LE1 receive_LE1 the_LE1 combination_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Selegiline|N|eldepryl|selective serotonin reuptake inhibitor|severe_LE1 toxicity_LE1 have_LE1 also_LE1 be_LE1 report_LE1 in_LE1 patient_LE1 receive_LE1 the_LE1 combination_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY and_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Selegiline|N|tricyclic antidepressant|selective serotonin reuptake inhibitor|severe_LE1 toxicity_LE1 have_LE1 also_LE1 be_LE1 report_LE1 in_LE1 patient_LE1 receive_LE1 the_LE1 combination_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Selegiline|N|sympathomimetic medication|ephedrine|one_LE1 case_LE1 of_LE1 hypertensive_LE1 crisis_LE1 have_LE1 be_LE1 report_LE1 in_LE1 patient_LE1 take_LE1 the_LE1 recommend_LE1 dose_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -LRB-_BE12 BIOENTITY 
Sitagliptin|N|digoxin|sitagliptin|BIOENTITY :_BE12 there_BE12 be_BE12 slight_BE12 increase_BE12 in_BE12 the_BE12 area_BE12 under_BE12 the_BE12 curve_BE12 -LRB-_BE12 auc_BE12 NUM_BE12 -RRB-_BE12 and_BE12 mean_BE12 peak_BE12 drug_BE12 concentration_BE12 -LRB-_BE12 cmax_BE12 NUM_BE12 -RRB-_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 the_BE12 coadministration_BE12 of_BE12 NUM_BE12 mg_BE12 BIOENTITY for_RE2 NUM_RE2 day_RE2 
Sitagliptin|N|digoxin|digoxin|BIOENTITY :_BE12 there_BE12 be_BE12 slight_BE12 increase_BE12 in_BE12 the_BE12 area_BE12 under_BE12 the_BE12 curve_BE12 -LRB-_BE12 auc_BE12 NUM_BE12 -RRB-_BE12 and_BE12 mean_BE12 peak_BE12 drug_BE12 concentration_BE12 -LRB-_BE12 cmax_BE12 NUM_BE12 -RRB-_BE12 of_BE12 BIOENTITY with_RE2 the_RE2 coadministration_RE2 of_RE2 NUM_RE2 mg_RE2 BIOGENERAL_RE2 for_RE2 NUM_RE2 day_RE2 
Sitagliptin|N|digoxin|januvia|no_LE1 dosage_LE1 adjustment_LE1 of_LE1 BIOENTITY or_BE12 BIOENTITY be_RE2 recommend_RE2 
Sodium bicarbonate|N|norepinephrine|dobutamine|BIOENTITY and_BE12 BIOENTITY be_RE2 incompatible_RE2 with_RE2 BIOGENERAL_RE2 solution_RE2 
Sodium bicarbonate|N|sodium bicarbonate|calcium|the_LE1 addition_LE1 of_LE1 BIOENTITY to_BE12 parenteral_BE12 solution_BE12 contain_BE12 BIOENTITY shall_RE2 be_RE2 avoid_RE2 except_RE2 where_RE2 compatibility_RE2 have_RE2 be_RE2 previous_RE2 establish_RE2 
Solifenacin|N|solifenacin|solifenacin|patient_LE1 with_LE1 congenital_LE1 or_LE1 acquired_LE1 qt_LE1 prolongation_LE1 in_LE1 study_LE1 of_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 the_LE1 qt_LE1 interval_LE1 in_LE1 NUM_LE1 healthy_LE1 woman_LE1 the_LE1 qt_LE1 prolong_LE1 effect_LE1 appear_LE1 little_LE1 with_LE1 BIOENTITY NUM_BE12 mg_BE12 than_BE12 with_BE12 NUM_BE12 mg_BE12 -LRB-_BE12 three_BE12 time_BE12 the_BE12 maximum_BE12 recommend_BE12 dose_BE12 -RRB-_BE12 and_BE12 the_BE12 effect_BE12 of_BE12 BIOENTITY NUM_RE2 mg_RE2 do_RE2 not_RE2 appear_RE2 as_RE2 large_RE2 as_RE2 that_RE2 of_RE2 the_RE2 positive_RE2 control_RE2 BIOGENERAL_RE2 at_RE2 its_RE2 therapeutic_RE2 dose_RE2 
Solifenacin|N|solifenacin|solifenacin|patient_LE1 with_LE1 congenital_LE1 or_LE1 acquired_LE1 qt_LE1 prolongation_LE1 in_LE1 study_LE1 of_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 the_LE1 qt_LE1 interval_LE1 in_LE1 NUM_LE1 healthy_LE1 woman_LE1 the_LE1 qt_LE1 prolong_LE1 effect_LE1 appear_LE1 little_LE1 with_LE1 BIOENTITY NUM_BE12 mg_BE12 than_BE12 with_BE12 NUM_BE12 mg_BE12 -LRB-_BE12 three_BE12 time_BE12 the_BE12 maximum_BE12 recommend_BE12 dose_BE12 -RRB-_BE12 and_BE12 the_BE12 effect_BE12 of_BE12 BIOENTITY NUM_RE2 mg_RE2 do_RE2 not_RE2 appear_RE2 as_RE2 large_RE2 as_RE2 that_RE2 of_RE2 the_RE2 positive_RE2 control_RE2 BIOGENERAL_RE2 at_RE2 its_RE2 therapeutic_RE2 dose_RE2 
Solifenacin|N|solifenacin|moxifloxacin|patient_LE1 with_LE1 congenital_LE1 or_LE1 acquired_LE1 qt_LE1 prolongation_LE1 in_LE1 study_LE1 of_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 the_LE1 qt_LE1 interval_LE1 in_LE1 NUM_LE1 healthy_LE1 woman_LE1 the_LE1 qt_LE1 prolong_LE1 effect_LE1 appear_LE1 little_LE1 with_LE1 BIOENTITY NUM_BE12 mg_BE12 than_BE12 with_BE12 NUM_BE12 mg_BE12 -LRB-_BE12 three_BE12 time_BE12 the_BE12 maximum_BE12 recommend_BE12 dose_BE12 -RRB-_BE12 and_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 do_BE12 not_BE12 appear_BE12 as_BE12 large_BE12 as_BE12 that_BE12 of_BE12 the_BE12 positive_BE12 control_BE12 BIOENTITY at_RE2 its_RE2 therapeutic_RE2 dose_RE2 
Solifenacin|N|solifenacin|solifenacin|patient_LE1 with_LE1 congenital_LE1 or_LE1 acquired_LE1 qt_LE1 prolongation_LE1 in_LE1 study_LE1 of_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY on_BE12 the_BE12 qt_BE12 interval_BE12 in_BE12 NUM_BE12 healthy_BE12 woman_BE12 the_BE12 qt_BE12 prolong_BE12 effect_BE12 appear_BE12 little_BE12 with_BE12 BIOENTITY NUM_RE2 mg_RE2 than_RE2 with_RE2 NUM_RE2 mg_RE2 -LRB-_RE2 three_RE2 time_RE2 the_RE2 maximum_RE2 recommend_RE2 dose_RE2 -RRB-_RE2 and_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 NUM_RE2 mg_RE2 do_RE2 not_RE2 appear_RE2 as_RE2 large_RE2 as_RE2 that_RE2 of_RE2 the_RE2 positive_RE2 control_RE2 BIOGENERAL_RE2 at_RE2 its_RE2 therapeutic_RE2 dose_RE2 
Solifenacin|N|solifenacin|moxifloxacin|patient_LE1 with_LE1 congenital_LE1 or_LE1 acquired_LE1 qt_LE1 prolongation_LE1 in_LE1 study_LE1 of_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 on_LE1 the_LE1 qt_LE1 interval_LE1 in_LE1 NUM_LE1 healthy_LE1 woman_LE1 the_LE1 qt_LE1 prolong_LE1 effect_LE1 appear_LE1 little_LE1 with_LE1 BIOGENERAL_LE1 NUM_LE1 mg_LE1 than_LE1 with_LE1 NUM_LE1 mg_LE1 -LRB-_LE1 three_LE1 time_LE1 the_LE1 maximum_LE1 recommend_LE1 dose_LE1 -RRB-_LE1 and_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY NUM_BE12 mg_BE12 do_BE12 not_BE12 appear_BE12 as_BE12 large_BE12 as_BE12 that_BE12 of_BE12 the_BE12 positive_BE12 control_BE12 BIOENTITY at_RE2 its_RE2 therapeutic_RE2 dose_RE2 
Solifenacin|N|solifenacin|solifenacin|patient_LE1 with_LE1 congenital_LE1 or_LE1 acquired_LE1 qt_LE1 prolongation_LE1 in_LE1 study_LE1 of_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY on_BE12 the_BE12 qt_BE12 interval_BE12 in_BE12 NUM_BE12 healthy_BE12 woman_BE12 the_BE12 qt_BE12 prolong_BE12 effect_BE12 appear_BE12 little_BE12 with_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 than_BE12 with_BE12 NUM_BE12 mg_BE12 -LRB-_BE12 three_BE12 time_BE12 the_BE12 maximum_BE12 recommend_BE12 dose_BE12 -RRB-_BE12 and_BE12 the_BE12 effect_BE12 of_BE12 BIOENTITY NUM_RE2 mg_RE2 do_RE2 not_RE2 appear_RE2 as_RE2 large_RE2 as_RE2 that_RE2 of_RE2 the_RE2 positive_RE2 control_RE2 BIOGENERAL_RE2 at_RE2 its_RE2 therapeutic_RE2 dose_RE2 
Solifenacin|N|solifenacin|moxifloxacin|patient_LE1 with_LE1 congenital_LE1 or_LE1 acquired_LE1 qt_LE1 prolongation_LE1 in_LE1 study_LE1 of_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY on_BE12 the_BE12 qt_BE12 interval_BE12 in_BE12 NUM_BE12 healthy_BE12 woman_BE12 the_BE12 qt_BE12 prolong_BE12 effect_BE12 appear_BE12 little_BE12 with_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 than_BE12 with_BE12 NUM_BE12 mg_BE12 -LRB-_BE12 three_BE12 time_BE12 the_BE12 maximum_BE12 recommend_BE12 dose_BE12 -RRB-_BE12 and_BE12 the_BE12 effect_BE12 of_BE12 BIOGENERAL_BE12 NUM_BE12 mg_BE12 do_BE12 not_BE12 appear_BE12 as_BE12 large_BE12 as_BE12 that_BE12 of_BE12 the_BE12 positive_BE12 control_BE12 BIOENTITY at_RE2 its_RE2 therapeutic_RE2 dose_RE2 
Somatropin recombinant|N|glucocorticoid|glucocorticoid|if_LE1 BIOENTITY replacement_BE12 be_BE12 require_BE12 the_BE12 BIOENTITY dose_RE2 shall_RE2 be_RE2 careful_RE2 adjust_RE2 
Somatropin recombinant|N|corticosteroid|sex steroid|these_LE1 datum_LE1 suggest_LE1 that_LE1 BIOGENERAL_LE1 administration_LE1 may_LE1 alter_LE1 the_LE1 clearance_LE1 of_LE1 compound_LE1 know_LE1 to_LE1 be_LE1 metabolize_LE1 by_LE1 cp_LE1 liver_LE1 enzyme_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 rrb._RE2 
Somatropin recombinant|N|corticosteroid|anticonvulsant|these_LE1 datum_LE1 suggest_LE1 that_LE1 BIOGENERAL_LE1 administration_LE1 may_LE1 alter_LE1 the_LE1 clearance_LE1 of_LE1 compound_LE1 know_LE1 to_LE1 be_LE1 metabolize_LE1 by_LE1 cp_LE1 liver_LE1 enzyme_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Somatropin recombinant|N|corticosteroid|cyclosporin|these_LE1 datum_LE1 suggest_LE1 that_LE1 BIOGENERAL_LE1 administration_LE1 may_LE1 alter_LE1 the_LE1 clearance_LE1 of_LE1 compound_LE1 know_LE1 to_LE1 be_LE1 metabolize_LE1 by_LE1 cp_LE1 liver_LE1 enzyme_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Somatropin recombinant|N|sex steroid|anticonvulsant|these_LE1 datum_LE1 suggest_LE1 that_LE1 BIOGENERAL_LE1 administration_LE1 may_LE1 alter_LE1 the_LE1 clearance_LE1 of_LE1 compound_LE1 know_LE1 to_LE1 be_LE1 metabolize_LE1 by_LE1 cp_LE1 liver_LE1 enzyme_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 rrb._RE2 
Somatropin recombinant|N|sex steroid|cyclosporin|these_LE1 datum_LE1 suggest_LE1 that_LE1 BIOGENERAL_LE1 administration_LE1 may_LE1 alter_LE1 the_LE1 clearance_LE1 of_LE1 compound_LE1 know_LE1 to_LE1 be_LE1 metabolize_LE1 by_LE1 cp_LE1 liver_LE1 enzyme_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY rrb._RE2 
Somatropin recombinant|N|anticonvulsant|cyclosporin|these_LE1 datum_LE1 suggest_LE1 that_LE1 BIOGENERAL_LE1 administration_LE1 may_LE1 alter_LE1 the_LE1 clearance_LE1 of_LE1 compound_LE1 know_LE1 to_LE1 be_LE1 metabolize_LE1 by_LE1 cp_LE1 liver_LE1 enzyme_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY rrb._RE2 
Stavudine|N|doxorubicin|ribavirin|in_LE1 vitro_LE1 datum_LE1 indicate_LE1 that_LE1 the_LE1 phosphorylation_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 also_LE1 inhibit_LE1 at_LE1 relevant_LE1 concentration_LE1 by_LE1 BIOENTITY and_BE12 BIOENTITY 
Streptokinase|N|streptase|streptokinase|the_LE1 interaction_LE1 of_LE1 BIOENTITY BIOENTITY with_RE2 other_RE2 drug_RE2 have_RE2 not_RE2 be_RE2 well_RE2 study_RE2 
Streptokinase|N|streptase|streptokinase|use_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 --_LE1 BIOENTITY BIOENTITY alone_RE2 or_RE2 in_RE2 combination_RE2 with_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 cause_RE2 bleeding_RE2 complication_RE2 
Streptokinase|N|antiplatelet agent|streptase|use_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY --_BE12 BIOENTITY BIOGENERAL_RE2 alone_RE2 or_RE2 in_RE2 combination_RE2 with_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 cause_RE2 bleeding_RE2 complication_RE2 
Streptokinase|N|anticoagulant|streptase|use_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 --_BE12 BIOENTITY BIOGENERAL_RE2 alone_RE2 or_RE2 in_RE2 combination_RE2 with_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 cause_RE2 bleeding_RE2 complication_RE2 
Streptokinase|N|antiplatelet agent|streptokinase|use_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY --_BE12 BIOGENERAL_BE12 BIOENTITY alone_RE2 or_RE2 in_RE2 combination_RE2 with_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 cause_RE2 bleeding_RE2 complication_RE2 
Streptokinase|N|anticoagulant|streptokinase|use_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 --_BE12 BIOGENERAL_BE12 BIOENTITY alone_RE2 or_RE2 in_RE2 combination_RE2 with_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 cause_RE2 bleeding_RE2 complication_RE2 
Streptokinase|N|antiplatelet agent|anticoagulant|use_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 --_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 alone_LE1 or_LE1 in_LE1 combination_LE1 with_LE1 BIOENTITY and_BE12 BIOENTITY may_RE2 cause_RE2 bleeding_RE2 complication_RE2 
Streptokinase|N|antiplatelet agent|antiplatelet agent|use_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY --_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 alone_BE12 or_BE12 in_BE12 combination_BE12 with_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 cause_RE2 bleeding_RE2 complication_RE2 
Streptokinase|N|anticoagulant|antiplatelet agent|use_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 --_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 alone_BE12 or_BE12 in_BE12 combination_BE12 with_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 cause_RE2 bleeding_RE2 complication_RE2 
Streptokinase|N|antiplatelet agent|anticoagulant|use_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY --_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 alone_BE12 or_BE12 in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 cause_RE2 bleeding_RE2 complication_RE2 
Streptokinase|N|anticoagulant|anticoagulant|use_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 --_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 alone_BE12 or_BE12 in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 cause_RE2 bleeding_RE2 complication_RE2 
Streptokinase|N|anticoagulant|antiplatelet agent|use_LE1 of_LE1 BIOENTITY and_BE12 BIOENTITY --_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 alone_RE2 or_RE2 in_RE2 combination_RE2 with_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 may_RE2 cause_RE2 bleeding_RE2 complication_RE2 
Streptokinase|N|aspirin|streptokinase|In_LE1 the_LE1 treatment_LE1 of_LE1 acute_LE1 mi_LE1 BIOENTITY when_BE12 not_BE12 otherwise_BE12 contraindicate_BE12 shall_BE12 be_BE12 administer_BE12 with_BE12 BIOENTITY -LRB-_RE2 see_RE2 below_RE2 -RRB-_RE2 
Streptokinase|N|antiplatelet|aspirin|anticoagulation_LE1 and_LE1 BIOENTITY after_BE12 treatment_BE12 for_BE12 myocardial_BE12 infarction_BE12 --_BE12 In_BE12 the_BE12 treatment_BE12 of_BE12 acute_BE12 myocardial_BE12 infarction_BE12 the_BE12 use_BE12 of_BE12 BIOENTITY have_RE2 be_RE2 show_RE2 to_RE2 reduce_RE2 the_RE2 incidence_RE2 of_RE2 reinfarction_RE2 and_RE2 stroke_RE2 
Streptozocin|N|phenytoin|streptozocin|the_LE1 concurrent_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY have_BE12 be_BE12 report_BE12 in_BE12 one_BE12 case_BE12 to_BE12 result_BE12 in_BE12 reduce_BE12 BIOENTITY cytotoxicity_RE2 
Streptozocin|N|streptozocin|streptozocin|the_LE1 concurrent_LE1 use_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 report_BE12 in_BE12 one_BE12 case_BE12 to_BE12 result_BE12 in_BE12 reduce_BE12 BIOENTITY cytotoxicity_RE2 
Succimer|N|chemet|iron|BIOENTITY be_BE12 not_BE12 know_BE12 to_BE12 interact_BE12 with_BE12 other_BE12 drug_BE12 including_BE12 BIOENTITY supplement_RE2 
Sulfamethizole|N|barbiturate|tolbutamide|BIOGENERAL_LE1 may_LE1 increase_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Sulfamethizole|N|tolbutamide|uricosuric|BIOGENERAL_LE1 may_LE1 increase_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Sulfamethizole|N|tolbutamide|uricosuric|BIOGENERAL_LE1 may_LE1 increase_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Sulfamethizole|N|barbiturate|uricosuric|BIOGENERAL_LE1 may_LE1 increase_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Sulfamethizole|N|thiazide|cyclosporine|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 increase_BE12 thrombocytopenia_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 increase_RE2 nephrotoxicity_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 increase_RE2 hypoglycemic_RE2 response_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 increase_RE2 anticoagulant_RE2 effect_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|cyclosporine|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|cyclosporine|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|cyclosporine|warfarin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 increase_RE2 anticoagulant_RE2 effect_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|cyclosporine|sulfonylurea agent|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 increase_RE2 hypoglycemic_RE2 response_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 increase_RE2 anticoagulant_RE2 effect_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|cyclosporine|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 hepatic_BE12 clearance_BE12 of_BE12 BIOENTITY rrb._RE2 
Sulfamethizole|N|cyclosporine|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|thiazide|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 increase_BE12 thrombocytopenia_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|thiazide|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 increase_BE12 thrombocytopenia_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|thiazide|warfarin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 increase_BE12 thrombocytopenia_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 increase_RE2 anticoagulant_RE2 effect_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|thiazide|sulfonylurea agent|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 increase_BE12 thrombocytopenia_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 increase_RE2 hypoglycemic_RE2 response_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 increase_RE2 anticoagulant_RE2 effect_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|thiazide|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 increase_BE12 thrombocytopenia_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 hepatic_BE12 clearance_BE12 of_BE12 BIOENTITY rrb._RE2 
Sulfamethizole|N|thiazide|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 increase_BE12 thrombocytopenia_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|methotrexate|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 anticoagulant_LE1 effect_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|warfarin|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|sulfonylurea agent|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|methotrexate|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 anticoagulant_LE1 effect_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 decrease_LE1 renal_LE1 excretion_LE1 of_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 hepatic_BE12 clearance_BE12 of_BE12 BIOENTITY rrb._RE2 
Sulfamethizole|N|methotrexate|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 anticoagulant_LE1 effect_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 decrease_LE1 renal_LE1 excretion_LE1 of_LE1 BIOENTITY -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|warfarin|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|sulfonylurea agent|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|methotrexate|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 anticoagulant_LE1 effect_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 hepatic_BE12 clearance_BE12 of_BE12 BIOENTITY rrb._RE2 
Sulfamethizole|N|methotrexate|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 anticoagulant_LE1 effect_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|sulfonylurea agent|warfarin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 increase_RE2 anticoagulant_RE2 effect_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|warfarin|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 hepatic_BE12 clearance_BE12 of_BE12 BIOENTITY rrb._RE2 
Sulfamethizole|N|warfarin|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|sulfonylurea agent|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 hepatic_BE12 clearance_BE12 of_BE12 BIOENTITY rrb._RE2 
Sulfamethizole|N|sulfonylurea agent|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfamethizole|N|phenytoin|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 anticoagulant_LE1 effect_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 decrease_LE1 renal_LE1 excretion_LE1 of_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 decrease_BE12 hepatic_BE12 clearance_BE12 of_BE12 BIOENTITY rrb._RE2 
Sulfamethoxazole|N|diuretic|thiazide|In_LE1 elderly_LE1 patient_LE1 concurrent_LE1 receive_LE1 certain_LE1 BIOENTITY primary_BE12 BIOENTITY increase_RE2 incidence_RE2 of_RE2 thrombopenia_RE2 with_RE2 purpura_RE2 have_RE2 be_RE2 report_RE2 
Sulfamethoxazole|N|anticoagulant|warfarin|it_LE1 have_LE1 be_LE1 report_LE1 that_LE1 BIOGENERAL_LE1 may_LE1 prolong_LE1 the_LE1 prothrombin_LE1 time_LE1 in_LE1 patient_LE1 who_LE1 be_LE1 receive_LE1 the_LE1 BIOENTITY BIOENTITY 
Sulfamethoxazole|N|sulfamethoxazole|anticoagulant|it_LE1 have_LE1 be_LE1 report_LE1 that_LE1 BIOENTITY may_BE12 prolong_BE12 the_BE12 prothrombin_BE12 time_BE12 in_BE12 patient_BE12 who_BE12 be_BE12 receive_BE12 the_BE12 BIOENTITY BIOGENERAL_RE2 
Sulfamethoxazole|N|sulfamethoxazole|anticoagulant|it_LE1 have_LE1 be_LE1 report_LE1 that_LE1 BIOENTITY may_BE12 prolong_BE12 the_BE12 prothrombin_BE12 time_BE12 in_BE12 patient_BE12 who_BE12 be_BE12 receive_BE12 the_BE12 BIOENTITY BIOGENERAL_RE2 
Sulfamethoxazole|N|methotrexate|methotrexate|BIOGENERAL_LE1 can_LE1 also_LE1 displace_LE1 BIOENTITY from_BE12 plasma_BE12 proteinbinding_BE12 site_BE12 thus_BE12 increase_BE12 free_BE12 BIOENTITY concentration_RE2 
Sulfamethoxazole|N|sulfonamide|methotrexate|BIOENTITY can_BE12 also_BE12 displace_BE12 BIOGENERAL_BE12 from_BE12 plasma_BE12 proteinbinding_BE12 site_BE12 thus_BE12 increase_BE12 free_BE12 BIOENTITY concentration_RE2 
Sulfasalazine|N|folic acid|digoxin|reduce_LE1 absorption_LE1 of_LE1 BIOENTITY and_BE12 BIOENTITY have_RE2 be_RE2 report_RE2 when_RE2 those_RE2 agent_RE2 be_RE2 administer_RE2 concomitant_RE2 with_RE2 BIOGENERAL_RE2 
Sulfasalazine|N|sulfasalazine|methotrexate|when_LE1 daily_LE1 dose_LE1 of_LE1 BIOENTITY NUM_BE12 and_BE12 weekly_BE12 dose_BE12 of_BE12 BIOENTITY mg_RE2 be_RE2 coadminister_RE2 to_RE2 NUM_RE2 rheumatoid_RE2 arthritis_RE2 patient_RE2 in_RE2 drugdrug_RE2 interaction_RE2 study_RE2 the_RE2 pharmacokinetic_RE2 disposition_RE2 of_RE2 the_RE2 drug_RE2 be_RE2 not_RE2 alter_RE2 
Sulfasalazine|N|sulfasalazine|methotrexate|daily_LE1 dose_LE1 of_LE1 BIOENTITY NUM_BE12 -LRB-_BE12 maximum_BE12 NUM_BE12 -RRB-_BE12 and_BE12 weekly_BE12 dose_BE12 of_BE12 BIOENTITY mg_RE2 -LRB-_RE2 maximum_RE2 NUM_RE2 mg_RE2 -RRB-_RE2 be_RE2 administer_RE2 alone_RE2 or_RE2 in_RE2 combination_RE2 to_RE2 NUM_RE2 rheumatoid_RE2 arthritis_RE2 patient_RE2 in_RE2 two_RE2 controlled_RE2 week_RE2 clinical_RE2 study_RE2 
Sulfoxone|N|tolbutamide|uricosuric|BIOGENERAL_LE1 may_LE1 increase_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Sulfoxone|N|tolbutamide|uricosuric|BIOGENERAL_LE1 may_LE1 increase_LE1 the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Sulfoxone|N|barbiturate|tolbutamide|BIOGENERAL_LE1 may_LE1 increase_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Sulfoxone|N|barbiturate|uricosuric|BIOGENERAL_LE1 may_LE1 increase_LE1 the_LE1 effect_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Sulfoxone|N|thiazide|cyclosporine|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 increase_BE12 thrombocytopenia_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 increase_RE2 nephrotoxicity_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 increase_RE2 hypoglycemic_RE2 response_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 increase_RE2 anticoagulant_RE2 effect_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|thiazide|sulfonylurea agent|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 increase_BE12 thrombocytopenia_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 increase_RE2 hypoglycemic_RE2 response_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 increase_RE2 anticoagulant_RE2 effect_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|thiazide|warfarin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 increase_BE12 thrombocytopenia_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 increase_RE2 anticoagulant_RE2 effect_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|thiazide|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 increase_BE12 thrombocytopenia_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|thiazide|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 increase_BE12 thrombocytopenia_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|thiazide|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 increase_BE12 thrombocytopenia_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|thiazide|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOENTITY -LRB-_BE12 increase_BE12 thrombocytopenia_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 hepatic_BE12 clearance_BE12 of_BE12 BIOENTITY rrb._RE2 
Sulfoxone|N|cyclosporine|sulfonylurea agent|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 increase_RE2 hypoglycemic_RE2 response_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 increase_RE2 anticoagulant_RE2 effect_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|cyclosporine|warfarin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 increase_RE2 anticoagulant_RE2 effect_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|cyclosporine|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|cyclosporine|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|cyclosporine|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|cyclosporine|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 nephrotoxicity_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 hepatic_BE12 clearance_BE12 of_BE12 BIOENTITY rrb._RE2 
Sulfoxone|N|sulfonylurea agent|warfarin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 increase_RE2 anticoagulant_RE2 effect_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|sulfonylurea agent|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|sulfonylurea agent|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|sulfonylurea agent|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|sulfonylurea agent|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 hypoglycemic_BE12 response_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 hepatic_BE12 clearance_BE12 of_BE12 BIOENTITY rrb._RE2 
Sulfoxone|N|warfarin|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 renal_RE2 excretion_RE2 of_RE2 BIOGENERAL_RE2 -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|warfarin|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|warfarin|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|warfarin|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 increase_BE12 anticoagulant_BE12 effect_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 hepatic_BE12 clearance_BE12 of_BE12 BIOENTITY rrb._RE2 
Sulfoxone|N|methotrexate|methotrexate|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 anticoagulant_LE1 effect_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOENTITY -RRB-_RE2 BIOGENERAL_RE2 -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|methotrexate|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 anticoagulant_LE1 effect_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|methotrexate|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 anticoagulant_LE1 effect_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 decrease_BE12 renal_BE12 excretion_BE12 of_BE12 BIOGENERAL_BE12 -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 hepatic_BE12 clearance_BE12 of_BE12 BIOENTITY rrb._RE2 
Sulfoxone|N|methotrexate|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 anticoagulant_LE1 effect_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 decrease_LE1 renal_LE1 excretion_LE1 of_LE1 BIOENTITY -RRB-_BE12 BIOENTITY -LRB-_RE2 decrease_RE2 hepatic_RE2 clearance_RE2 of_RE2 BIOGENERAL_RE2 rrb._RE2 
Sulfoxone|N|methotrexate|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 anticoagulant_LE1 effect_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 decrease_LE1 renal_LE1 excretion_LE1 of_LE1 BIOENTITY -RRB-_BE12 BIOGENERAL_BE12 -LRB-_BE12 decrease_BE12 hepatic_BE12 clearance_BE12 of_BE12 BIOENTITY rrb._RE2 
Sulfoxone|N|phenytoin|phenytoin|it_LE1 may_LE1 also_LE1 interact_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 thrombocytopenia_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 nephrotoxicity_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 hypoglycemic_LE1 response_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 increase_LE1 anticoagulant_LE1 effect_LE1 -RRB-_LE1 BIOGENERAL_LE1 -LRB-_LE1 decrease_LE1 renal_LE1 excretion_LE1 of_LE1 BIOGENERAL_LE1 -RRB-_LE1 BIOENTITY -LRB-_BE12 decrease_BE12 hepatic_BE12 clearance_BE12 of_BE12 BIOENTITY rrb._RE2 
Sumatriptan|N|dihydroergotamine|methysergide|because_LE1 there_LE1 be_LE1 theoretical_LE1 basis_LE1 that_LE1 these_LE1 effect_LE1 may_LE1 be_LE1 additive_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 like_LE1 BIOENTITY or_BE12 BIOENTITY -RRB-_RE2 and_RE2 BIOGENERAL_RE2 within_RE2 NUM_RE2 hour_RE2 of_RE2 each_RE2 other_RE2 shall_RE2 be_RE2 avoid_RE2 
Sumatriptan|N|ergotamine|dihydroergotamine|because_LE1 there_LE1 be_LE1 theoretical_LE1 basis_LE1 that_LE1 these_LE1 effect_LE1 may_LE1 be_LE1 additive_LE1 use_LE1 of_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 -LRB-_BE12 like_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 within_RE2 NUM_RE2 hour_RE2 of_RE2 each_RE2 other_RE2 shall_RE2 be_RE2 avoid_RE2 
Sumatriptan|N|ergot-type medication|dihydroergotamine|because_LE1 there_LE1 be_LE1 theoretical_LE1 basis_LE1 that_LE1 these_LE1 effect_LE1 may_LE1 be_LE1 additive_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY -LRB-_BE12 like_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 within_RE2 NUM_RE2 hour_RE2 of_RE2 each_RE2 other_RE2 shall_RE2 be_RE2 avoid_RE2 
Sumatriptan|N|ergotamine|methysergide|because_LE1 there_LE1 be_LE1 theoretical_LE1 basis_LE1 that_LE1 these_LE1 effect_LE1 may_LE1 be_LE1 additive_LE1 use_LE1 of_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 -LRB-_BE12 like_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY -RRB-_RE2 and_RE2 BIOGENERAL_RE2 within_RE2 NUM_RE2 hour_RE2 of_RE2 each_RE2 other_RE2 shall_RE2 be_RE2 avoid_RE2 
Sumatriptan|N|ergot-type medication|methysergide|because_LE1 there_LE1 be_LE1 theoretical_LE1 basis_LE1 that_LE1 these_LE1 effect_LE1 may_LE1 be_LE1 additive_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY -LRB-_BE12 like_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY -RRB-_RE2 and_RE2 BIOGENERAL_RE2 within_RE2 NUM_RE2 hour_RE2 of_RE2 each_RE2 other_RE2 shall_RE2 be_RE2 avoid_RE2 
Sumatriptan|N|ergotamine|ergot-type medication|because_LE1 there_LE1 be_LE1 theoretical_LE1 basis_LE1 that_LE1 these_LE1 effect_LE1 may_LE1 be_LE1 additive_LE1 use_LE1 of_LE1 BIOENTITY or_BE12 BIOENTITY -LRB-_RE2 like_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -RRB-_RE2 and_RE2 BIOGENERAL_RE2 within_RE2 NUM_RE2 hour_RE2 of_RE2 each_RE2 other_RE2 shall_RE2 be_RE2 avoid_RE2 
Sumatriptan|N|mao-a inhibitor|sumatriptan|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOENTITY be_BE12 contraindicate_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 have_BE12 be_BE12 report_BE12 rare_BE12 to_BE12 cause_BE12 weakness_BE12 hyperreflexia_BE12 and_BE12 incoordination_BE12 when_BE12 coadminister_BE12 with_BE12 BIOENTITY 
Sumatriptan|N|sumatriptan succinate|sumatriptan|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOENTITY tablet_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 be_BE12 contraindicate_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 have_BE12 be_BE12 report_BE12 rare_BE12 to_BE12 cause_BE12 weakness_BE12 hyperreflexia_BE12 and_BE12 incoordination_BE12 when_BE12 coadminister_BE12 with_BE12 BIOENTITY 
Sumatriptan|N|paroxetine|sertraline|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 be_LE1 contraindicate_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|fluvoxamine|paroxetine|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 be_LE1 contraindicate_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|fluoxetine|paroxetine|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 be_LE1 contraindicate_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|ssri|paroxetine|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 be_LE1 contraindicate_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|selective serotonin reuptake inhibitor|paroxetine|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 be_LE1 contraindicate_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|mao-a inhibitor|paroxetine|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOENTITY be_BE12 contraindicate_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|sumatriptan succinate|paroxetine|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOENTITY tablet_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 be_BE12 contraindicate_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|fluvoxamine|sertraline|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 be_LE1 contraindicate_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|fluoxetine|sertraline|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 be_LE1 contraindicate_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|ssri|sertraline|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 be_LE1 contraindicate_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|selective serotonin reuptake inhibitor|sertraline|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 be_LE1 contraindicate_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|mao-a inhibitor|sertraline|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOENTITY be_BE12 contraindicate_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|sumatriptan succinate|sertraline|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOENTITY tablet_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 be_BE12 contraindicate_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|fluoxetine|fluvoxamine|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 be_LE1 contraindicate_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|ssri|fluvoxamine|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 be_LE1 contraindicate_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|selective serotonin reuptake inhibitor|fluvoxamine|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 be_LE1 contraindicate_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|mao-a inhibitor|fluvoxamine|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOENTITY be_BE12 contraindicate_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|sumatriptan succinate|fluvoxamine|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOENTITY tablet_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 be_BE12 contraindicate_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|ssri|fluoxetine|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 be_LE1 contraindicate_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|selective serotonin reuptake inhibitor|fluoxetine|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 be_LE1 contraindicate_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|mao-a inhibitor|fluoxetine|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOENTITY be_BE12 contraindicate_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|sumatriptan succinate|fluoxetine|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOENTITY tablet_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 be_BE12 contraindicate_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|selective serotonin reuptake inhibitor|ssri|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 be_LE1 contraindicate_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|mao-a inhibitor|ssri|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOENTITY be_BE12 contraindicate_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|sumatriptan succinate|ssri|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOENTITY tablet_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 be_BE12 contraindicate_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|mao-a inhibitor|selective serotonin reuptake inhibitor|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 tablet_LE1 in_LE1 patient_LE1 receive_LE1 BIOENTITY be_BE12 contraindicate_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sumatriptan|N|sumatriptan succinate|selective serotonin reuptake inhibitor|therefore_LE1 the_LE1 use_LE1 of_LE1 BIOENTITY tablet_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 be_BE12 contraindicate_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 have_RE2 be_RE2 report_RE2 rare_RE2 to_RE2 cause_RE2 weakness_RE2 hyperreflexia_RE2 and_RE2 incoordination_RE2 when_RE2 coadminister_RE2 with_RE2 BIOGENERAL_RE2 
Sunitinib|N|ketoconazole|clarithromycin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|ketoconazole|itraconazole|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|ketoconazole|saquinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|ketoconazole|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 increase_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|ketoconazole|ritonavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|ketoconazole|voriconizole|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|ketoconazole|indinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|ketoconazole|atazanavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|ketoconazole|nelfinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|ketoconazole|telithromycin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|ketoconazole|nefazodone|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|sutent|sunitinib|coadministration_LE1 of_LE1 BIOENTITY with_BE12 strong_BE12 inhibitor_BE12 of_BE12 the_BE12 cypa_BE12 family_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 increase_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|itraconazole|clarithromycin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|clarithromycin|saquinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|clarithromycin|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 increase_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|clarithromycin|ritonavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|clarithromycin|voriconizole|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|clarithromycin|indinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|clarithromycin|atazanavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|clarithromycin|nelfinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|clarithromycin|telithromycin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|clarithromycin|nefazodone|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|itraconazole|saquinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|itraconazole|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 increase_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|itraconazole|ritonavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|itraconazole|voriconizole|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|itraconazole|indinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|itraconazole|atazanavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|itraconazole|nelfinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|itraconazole|telithromycin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|itraconazole|nefazodone|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|saquinavir|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 increase_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|ritonavir|saquinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|saquinavir|voriconizole|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|indinavir|saquinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|atazanavir|saquinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|nelfinavir|saquinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|saquinavir|telithromycin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|nefazodone|saquinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|ritonavir|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 increase_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|voriconizole|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 may_BE12 increase_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|indinavir|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 increase_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|atazanavir|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 increase_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|nelfinavir|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 increase_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|telithromycin|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 may_BE12 increase_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|nefazodone|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 may_BE12 increase_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|ritonavir|voriconizole|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|indinavir|ritonavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|atazanavir|ritonavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|nelfinavir|ritonavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|ritonavir|telithromycin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|nefazodone|ritonavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|indinavir|voriconizole|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|atazanavir|voriconizole|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|nelfinavir|voriconizole|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|telithromycin|voriconizole|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|nefazodone|voriconizole|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|atazanavir|indinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|indinavir|nelfinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|indinavir|telithromycin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|indinavir|nefazodone|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|atazanavir|nelfinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|atazanavir|telithromycin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|atazanavir|nefazodone|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|nelfinavir|telithromycin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|nefazodone|nelfinavir|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|nefazodone|telithromycin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 strong_LE1 inhibitor_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 may_RE2 increase_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|rifapentin|phenobarbital|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|phenobarbital|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY st._BE12 john_BE12 wort_BE12 -RRB-_BE12 may_BE12 decrease_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|carbamazepine|phenobarbital|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|phenytoin|phenobarbital|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|rifabutin|phenobarbital|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|rifampin|phenobarbital|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|dexamethasone|phenobarbital|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|rifapentin|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 st._BE12 john_BE12 wort_BE12 -RRB-_BE12 may_BE12 decrease_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|carbamazepine|rifapentin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|phenytoin|rifapentin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|rifabutin|rifapentin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|rifampin|rifapentin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|dexamethasone|rifapentin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|carbamazepine|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 st._BE12 john_BE12 wort_BE12 -RRB-_BE12 may_BE12 decrease_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|phenytoin|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 st._BE12 john_BE12 wort_BE12 -RRB-_BE12 may_BE12 decrease_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|rifabutin|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 st._BE12 john_BE12 wort_BE12 -RRB-_BE12 may_BE12 decrease_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|rifampin|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 st._BE12 john_BE12 wort_BE12 -RRB-_BE12 may_BE12 decrease_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|dexamethasone|sunitinib|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 st._BE12 john_BE12 wort_BE12 -RRB-_BE12 may_BE12 decrease_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|sutent|sunitinib|coadministration_LE1 of_LE1 BIOENTITY with_BE12 inducer_BE12 of_BE12 the_BE12 cypa_BE12 family_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 st._BE12 john_BE12 wort_BE12 -RRB-_BE12 may_BE12 decrease_BE12 BIOENTITY concentration_RE2 
Sunitinib|N|phenytoin|carbamazepine|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|carbamazepine|rifabutin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|carbamazepine|rifampin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|dexamethasone|carbamazepine|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|phenytoin|rifabutin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|phenytoin|rifampin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|dexamethasone|phenytoin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|rifampin|rifabutin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|dexamethasone|rifabutin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Sunitinib|N|dexamethasone|rifampin|coadministration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 inducer_LE1 of_LE1 the_LE1 cypa_LE1 family_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 st._RE2 john_RE2 wort_RE2 -RRB-_RE2 may_RE2 decrease_RE2 BIOGENERAL_RE2 concentration_RE2 
Suprofen|N|acetylcholine chloride|miochol|other_LE1 eye_LE1 drop_LE1 or_LE1 medication_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 and_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 decrease_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 ophthalmic_RE2 
Suprofen|N|miochol|carboptic|other_LE1 eye_LE1 drop_LE1 or_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 may_RE2 decrease_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 ophthalmic_RE2 
Suprofen|N|miochol|carbachol|other_LE1 eye_LE1 drop_LE1 or_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 decrease_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 ophthalmic_RE2 
Suprofen|N|miochol|isopto carbachol|other_LE1 eye_LE1 drop_LE1 or_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 may_RE2 decrease_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 ophthalmic_RE2 
Suprofen|N|acetylcholine chloride|carboptic|other_LE1 eye_LE1 drop_LE1 or_LE1 medication_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 may_RE2 decrease_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 ophthalmic_RE2 
Suprofen|N|acetylcholine chloride|carbachol|other_LE1 eye_LE1 drop_LE1 or_LE1 medication_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 and_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 may_RE2 decrease_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 ophthalmic_RE2 
Suprofen|N|acetylcholine chloride|isopto carbachol|other_LE1 eye_LE1 drop_LE1 or_LE1 medication_LE1 such_LE1 as_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 and_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 may_RE2 decrease_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 ophthalmic_RE2 
Suprofen|N|carbachol|carboptic|other_LE1 eye_LE1 drop_LE1 or_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 and_LE1 BIOENTITY -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 may_RE2 decrease_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 ophthalmic_RE2 
Suprofen|N|carboptic|isopto carbachol|other_LE1 eye_LE1 drop_LE1 or_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 and_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOENTITY -RRB-_RE2 may_RE2 decrease_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 ophthalmic_RE2 
Suprofen|N|carbachol|isopto carbachol|other_LE1 eye_LE1 drop_LE1 or_LE1 medication_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 and_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 may_RE2 decrease_RE2 the_RE2 effect_RE2 of_RE2 BIOGENERAL_RE2 ophthalmic_RE2 
Tamsulosin|N|flomax|alpha-adrenergic blocking agent|drugdrug_LE1 interaction_LE1 :_LE1 the_LE1 pharmacokinetic_LE1 and_LE1 pharmacodynamic_LE1 interaction_LE1 between_LE1 BIOENTITY capsule_BE12 and_BE12 other_BE12 BIOENTITY have_RE2 not_RE2 be_RE2 determine_RE2 
Tamsulosin|N|cimetidine|flomax|the_LE1 pharmacokinetic_LE1 interaction_LE1 between_LE1 BIOENTITY and_BE12 BIOENTITY capsule_RE2 be_RE2 investigate_RE2 
Tamsulosin|N|tamsulosin hci|warfarin|result_LE1 from_LE1 limited_LE1 in_LE1 vitro_LE1 and_LE1 in_LE1 vivo_LE1 drugdrug_LE1 interaction_LE1 study_LE1 between_LE1 BIOENTITY and_BE12 BIOENTITY be_RE2 inconclusive_RE2 
Tenecteplase|N|tnkase|heparin|patient_LE1 study_LE1 in_LE1 clinical_LE1 trial_LE1 of_LE1 BIOENTITY be_BE12 routine_BE12 treat_BE12 with_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Tenecteplase|N|tnkase|aspirin|patient_LE1 study_LE1 in_LE1 clinical_LE1 trial_LE1 of_LE1 BIOENTITY be_BE12 routine_BE12 treat_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Tenecteplase|N|heparin|aspirin|patient_LE1 study_LE1 in_LE1 clinical_LE1 trial_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 routine_LE1 treat_LE1 with_LE1 BIOENTITY and_BE12 BIOENTITY 
Tenecteplase|N|acetylsalicylic acid|dipyridamole|BIOGENERAL_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 and_LE1 drug_LE1 that_LE1 alter_LE1 platelet_LE1 function_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOENTITY BIOENTITY and_RE2 gp_RE2 iib_RE2 inhibitor_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 during_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Tenecteplase|N|vitamin k antagonist|dipyridamole|BIOGENERAL_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 and_BE12 drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 gp_RE2 iib_RE2 inhibitor_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 during_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Tenecteplase|N|heparin|dipyridamole|BIOGENERAL_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 and_BE12 drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 gp_RE2 iib_RE2 inhibitor_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 during_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Tenecteplase|N|anticoagulant|dipyridamole|BIOENTITY -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 and_BE12 drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 gp_RE2 iib_RE2 inhibitor_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 during_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Tenecteplase|N|vitamin k antagonist|acetylsalicylic acid|BIOGENERAL_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 and_BE12 drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 gp_RE2 iib_RE2 inhibitor_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 during_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Tenecteplase|N|heparin|acetylsalicylic acid|BIOGENERAL_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 and_BE12 drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 gp_RE2 iib_RE2 inhibitor_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 during_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Tenecteplase|N|anticoagulant|acetylsalicylic acid|BIOENTITY -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 and_BE12 drug_BE12 that_BE12 alter_BE12 platelet_BE12 function_BE12 -LRB-_BE12 such_BE12 as_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 gp_RE2 iib_RE2 inhibitor_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 during_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Tenecteplase|N|heparin|vitamin k antagonist|BIOGENERAL_LE1 -LRB-_LE1 such_LE1 as_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 and_RE2 drug_RE2 that_RE2 alter_RE2 platelet_RE2 function_RE2 -LRB-_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 gp_RE2 iib_RE2 inhibitor_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 during_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Tenecteplase|N|anticoagulant|vitamin k antagonist|BIOENTITY -LRB-_BE12 such_BE12 as_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 and_RE2 drug_RE2 that_RE2 alter_RE2 platelet_RE2 function_RE2 -LRB-_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 gp_RE2 iib_RE2 inhibitor_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 during_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Tenecteplase|N|anticoagulant|heparin|BIOENTITY -LRB-_BE12 such_BE12 as_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 and_RE2 drug_RE2 that_RE2 alter_RE2 platelet_RE2 function_RE2 -LRB-_RE2 such_RE2 as_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 gp_RE2 iib_RE2 inhibitor_RE2 -RRB-_RE2 may_RE2 increase_RE2 the_RE2 risk_RE2 of_RE2 bleeding_RE2 if_RE2 administer_RE2 prior_RE2 to_RE2 during_RE2 or_RE2 after_RE2 BIOGENERAL_RE2 therapy_RE2 
Teniposide|N|sodium salicylate|sulfamethizole|In_LE1 study_LE1 in_LE1 which_LE1 NUM_LE1 different_LE1 drug_LE1 be_LE1 test_LE1 therapeutic_LE1 relevant_LE1 concentration_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY displace_RE2 proteinbound_RE2 BIOGENERAL_RE2 in_RE2 fresh_RE2 human_RE2 serum_RE2 to_RE2 small_RE2 but_RE2 significant_RE2 extent_RE2 
Teniposide|N|sodium salicylate|sulfamethizole|In_LE1 study_LE1 in_LE1 which_LE1 NUM_LE1 different_LE1 drug_LE1 be_LE1 test_LE1 therapeutic_LE1 relevant_LE1 concentration_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY displace_RE2 proteinbound_RE2 BIOGENERAL_RE2 in_RE2 fresh_RE2 human_RE2 serum_RE2 to_RE2 small_RE2 but_RE2 significant_RE2 extent_RE2 
Teniposide|N|tolbutamide|sodium salicylate|In_LE1 study_LE1 in_LE1 which_LE1 NUM_LE1 different_LE1 drug_LE1 be_LE1 test_LE1 therapeutic_LE1 relevant_LE1 concentration_LE1 of_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 displace_RE2 proteinbound_RE2 BIOGENERAL_RE2 in_RE2 fresh_RE2 human_RE2 serum_RE2 to_RE2 small_RE2 but_RE2 significant_RE2 extent_RE2 
Teniposide|N|tolbutamide|sulfamethizole|In_LE1 study_LE1 in_LE1 which_LE1 NUM_LE1 different_LE1 drug_LE1 be_LE1 test_LE1 therapeutic_LE1 relevant_LE1 concentration_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY displace_RE2 proteinbound_RE2 BIOGENERAL_RE2 in_RE2 fresh_RE2 human_RE2 serum_RE2 to_RE2 small_RE2 but_RE2 significant_RE2 extent_RE2 
Teniposide|N|vumon|teniposide|therefore_LE1 caution_LE1 shall_LE1 be_LE1 use_LE1 in_LE1 administer_LE1 BIOENTITY -LRB-_BE12 BIOENTITY injection_RE2 -RRB-_RE2 to_RE2 patient_RE2 receive_RE2 these_RE2 other_RE2 agent_RE2 
Teniposide|N|teniposide|methotrexate|there_LE1 be_LE1 no_LE1 change_LE1 in_LE1 the_LE1 plasma_LE1 kinetic_LE1 of_LE1 BIOENTITY when_BE12 coadminister_BE12 with_BE12 BIOENTITY 
Terbinafine|N|terbinafine|ethoxycoumarin|in_LE1 vitro_LE1 study_LE1 with_LE1 human_LE1 liver_LE1 microsome_LE1 show_LE1 that_LE1 BIOENTITY do_BE12 not_BE12 inhibit_BE12 the_BE12 metabolism_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Terbinafine|N|terbinafine|cyclosporine|in_LE1 vitro_LE1 study_LE1 with_LE1 human_LE1 liver_LE1 microsome_LE1 show_LE1 that_LE1 BIOENTITY do_BE12 not_BE12 inhibit_BE12 the_BE12 metabolism_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Terbinafine|N|terbinafine|tolbutamide|in_LE1 vitro_LE1 study_LE1 with_LE1 human_LE1 liver_LE1 microsome_LE1 show_LE1 that_LE1 BIOENTITY do_BE12 not_BE12 inhibit_BE12 the_BE12 metabolism_BE12 of_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|terbinafine|ethinylestradiol|in_LE1 vitro_LE1 study_LE1 with_LE1 human_LE1 liver_LE1 microsome_LE1 show_LE1 that_LE1 BIOENTITY do_BE12 not_BE12 inhibit_BE12 the_BE12 metabolism_BE12 of_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|ethoxycoumarin|cyclosporine|in_LE1 vitro_LE1 study_LE1 with_LE1 human_LE1 liver_LE1 microsome_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Terbinafine|N|ethoxycoumarin|cyclosporine|in_LE1 vitro_LE1 study_LE1 with_LE1 human_LE1 liver_LE1 microsome_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Terbinafine|N|tolbutamide|ethoxycoumarin|in_LE1 vitro_LE1 study_LE1 with_LE1 human_LE1 liver_LE1 microsome_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Terbinafine|N|ethinylestradiol|ethoxycoumarin|in_LE1 vitro_LE1 study_LE1 with_LE1 human_LE1 liver_LE1 microsome_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Terbinafine|N|ethinylestradiol|ethoxycoumarin|in_LE1 vitro_LE1 study_LE1 with_LE1 human_LE1 liver_LE1 microsome_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Terbinafine|N|tolbutamide|cyclosporine|in_LE1 vitro_LE1 study_LE1 with_LE1 human_LE1 liver_LE1 microsome_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Terbinafine|N|ethinylestradiol|cyclosporine|in_LE1 vitro_LE1 study_LE1 with_LE1 human_LE1 liver_LE1 microsome_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Terbinafine|N|ethinylestradiol|cyclosporine|in_LE1 vitro_LE1 study_LE1 with_LE1 human_LE1 liver_LE1 microsome_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Terbinafine|N|tolbutamide|ethinylestradiol|in_LE1 vitro_LE1 study_LE1 with_LE1 human_LE1 liver_LE1 microsome_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|tricyclic antidepressant|selective serotonin reuptake inhibitor|this_LE1 may_LE1 be_LE1 of_LE1 clinical_LE1 relevance_LE1 for_LE1 compound_LE1 predominant_LE1 metabolize_LE1 by_LE1 this_LE1 enzyme_LE1 such_LE1 as_LE1 BIOENTITY blocker_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 -RRB-_RE2 and_RE2 -LRB-_RE2 maois_RE2 -RRB-_RE2 BIOGENERAL_RE2 if_RE2 they_RE2 have_RE2 narrow_RE2 therapeutic_RE2 window_RE2 
Terbinafine|N|tricyclic antidepressant|ssri|this_LE1 may_LE1 be_LE1 of_LE1 clinical_LE1 relevance_LE1 for_LE1 compound_LE1 predominant_LE1 metabolize_LE1 by_LE1 this_LE1 enzyme_LE1 such_LE1 as_LE1 BIOENTITY blocker_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY -RRB-_RE2 and_RE2 -LRB-_RE2 maois_RE2 -RRB-_RE2 BIOGENERAL_RE2 if_RE2 they_RE2 have_RE2 narrow_RE2 therapeutic_RE2 window_RE2 
Terbinafine|N|tricyclic antidepressant|monoamine oxidase inhibitors (mao-is) type b|this_LE1 may_LE1 be_LE1 of_LE1 clinical_LE1 relevance_LE1 for_LE1 compound_LE1 predominant_LE1 metabolize_LE1 by_LE1 this_LE1 enzyme_LE1 such_LE1 as_LE1 BIOENTITY blocker_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 and_BE12 -LRB-_BE12 maois_BE12 -RRB-_BE12 BIOENTITY if_RE2 they_RE2 have_RE2 narrow_RE2 therapeutic_RE2 window_RE2 
Terbinafine|N|selective serotonin reuptake inhibitor|ssri|this_LE1 may_LE1 be_LE1 of_LE1 clinical_LE1 relevance_LE1 for_LE1 compound_LE1 predominant_LE1 metabolize_LE1 by_LE1 this_LE1 enzyme_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 blocker_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 and_RE2 -LRB-_RE2 maois_RE2 -RRB-_RE2 BIOGENERAL_RE2 if_RE2 they_RE2 have_RE2 narrow_RE2 therapeutic_RE2 window_RE2 
Terbinafine|N|selective serotonin reuptake inhibitor|monoamine oxidase inhibitors (mao-is) type b|this_LE1 may_LE1 be_LE1 of_LE1 clinical_LE1 relevance_LE1 for_LE1 compound_LE1 predominant_LE1 metabolize_LE1 by_LE1 this_LE1 enzyme_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 blocker_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 -RRB-_BE12 and_BE12 -LRB-_BE12 maois_BE12 -RRB-_BE12 BIOENTITY if_RE2 they_RE2 have_RE2 narrow_RE2 therapeutic_RE2 window_RE2 
Terbinafine|N|ssri|monoamine oxidase inhibitors (mao-is) type b|this_LE1 may_LE1 be_LE1 of_LE1 clinical_LE1 relevance_LE1 for_LE1 compound_LE1 predominant_LE1 metabolize_LE1 by_LE1 this_LE1 enzyme_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 blocker_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY -RRB-_BE12 and_BE12 -LRB-_BE12 maois_BE12 -RRB-_BE12 BIOENTITY if_RE2 they_RE2 have_RE2 narrow_RE2 therapeutic_RE2 window_RE2 
Terbinafine|N|terbinafine|digoxin|in_LE1 vivo_LE1 drugdrug_LE1 interaction_LE1 study_LE1 conduct_LE1 in_LE1 normal_LE1 volunteer_LE1 subject_LE1 show_LE1 that_LE1 BIOENTITY do_BE12 not_BE12 affect_BE12 the_BE12 clearance_BE12 of_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Terbinafine|N|antipyrine|digoxin|in_LE1 vivo_LE1 drugdrug_LE1 interaction_LE1 study_LE1 conduct_LE1 in_LE1 normal_LE1 volunteer_LE1 subject_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 do_LE1 not_LE1 affect_LE1 the_LE1 clearance_LE1 of_LE1 BIOENTITY or_BE12 BIOENTITY 
Terbinafine|N|terbinafine|antipyrine|in_LE1 vivo_LE1 drugdrug_LE1 interaction_LE1 study_LE1 conduct_LE1 in_LE1 normal_LE1 volunteer_LE1 subject_LE1 show_LE1 that_LE1 BIOENTITY do_BE12 not_BE12 affect_BE12 the_BE12 clearance_BE12 of_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Terbinafine|N|terbinafine|lamisil|there_LE1 have_LE1 be_LE1 spontaneous_LE1 report_LE1 of_LE1 increase_LE1 or_LE1 decrease_LE1 in_LE1 prothrombin_LE1 time_LE1 in_LE1 patient_LE1 concomitant_LE1 take_LE1 oral_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 however_BE12 causal_BE12 relationship_BE12 between_BE12 BIOENTITY tablet_RE2 and_RE2 these_RE2 change_RE2 have_RE2 not_RE2 be_RE2 establish_RE2 
Terbinafine|N|warfarin|lamisil|there_LE1 have_LE1 be_LE1 spontaneous_LE1 report_LE1 of_LE1 increase_LE1 or_LE1 decrease_LE1 in_LE1 prothrombin_LE1 time_LE1 in_LE1 patient_LE1 concomitant_LE1 take_LE1 oral_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY however_BE12 causal_BE12 relationship_BE12 between_BE12 BIOENTITY tablet_RE2 and_RE2 these_RE2 change_RE2 have_RE2 not_RE2 be_RE2 establish_RE2 
Terbinafine|N|rifampin|cimetidine|BIOGENERAL_LE1 clearance_LE1 be_LE1 increase_LE1 NUM_LE1 by_LE1 BIOENTITY cyp_BE12 enzyme_BE12 inducer_BE12 and_BE12 decrease_BE12 NUM_BE12 by_BE12 BIOENTITY cyp_RE2 enzyme_RE2 inhibitor_RE2 
Terbinafine|N|terbinafine|cyclosporine|BIOENTITY clearance_BE12 be_BE12 unaffect_BE12 by_BE12 BIOENTITY 
Terbinafine|N|contraceptive|hypoglycemic|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOENTITY hormone_BE12 replacement_BE12 therapy_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|contraceptive|hypoglycemic|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOENTITY hormone_BE12 replacement_BE12 therapy_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|hypoglycemic|phenytoin|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|hypoglycemic|phenytoin|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|hypoglycemic|theophylline|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|hypoglycemic|theophylline|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|hypoglycemic|beta blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Terbinafine|N|hypoglycemic|beta blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Terbinafine|N|hypoglycemic|thiazide diuretic|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|hypoglycemic|thiazide diuretic|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|hypoglycemic|calcium channel blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Terbinafine|N|hypoglycemic|calcium channel blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Terbinafine|N|contraceptive|phenytoin|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOENTITY hormone_BE12 replacement_BE12 therapy_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|contraceptive|phenytoin|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOENTITY hormone_BE12 replacement_BE12 therapy_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|contraceptive|theophylline|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOENTITY hormone_BE12 replacement_BE12 therapy_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|contraceptive|theophylline|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOENTITY hormone_BE12 replacement_BE12 therapy_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|contraceptive|beta blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOENTITY hormone_BE12 replacement_BE12 therapy_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Terbinafine|N|contraceptive|beta blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOENTITY hormone_BE12 replacement_BE12 therapy_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Terbinafine|N|contraceptive|thiazide diuretic|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOENTITY hormone_BE12 replacement_BE12 therapy_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|contraceptive|thiazide diuretic|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOENTITY hormone_BE12 replacement_BE12 therapy_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|contraceptive|calcium channel blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOENTITY hormone_BE12 replacement_BE12 therapy_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Terbinafine|N|contraceptive|calcium channel blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOENTITY hormone_BE12 replacement_BE12 therapy_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Terbinafine|N|theophylline|phenytoin|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|theophylline|phenytoin|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|phenytoin|beta blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Terbinafine|N|phenytoin|beta blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Terbinafine|N|phenytoin|thiazide diuretic|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|phenytoin|thiazide diuretic|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|phenytoin|calcium channel blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Terbinafine|N|phenytoin|calcium channel blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Terbinafine|N|theophylline|beta blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Terbinafine|N|theophylline|beta blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Terbinafine|N|theophylline|thiazide diuretic|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|theophylline|thiazide diuretic|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Terbinafine|N|theophylline|calcium channel blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Terbinafine|N|theophylline|calcium channel blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Terbinafine|N|thiazide diuretic|beta blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Terbinafine|N|thiazide diuretic|beta blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Terbinafine|N|beta blocker|calcium channel blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Terbinafine|N|beta blocker|calcium channel blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Terbinafine|N|thiazide diuretic|calcium channel blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Terbinafine|N|thiazide diuretic|calcium channel blocker|there_LE1 be_LE1 no_LE1 information_LE1 available_LE1 from_LE1 adequate_LE1 drugdrug_LE1 interaction_LE1 study_LE1 with_LE1 the_LE1 follow_LE1 class_LE1 of_LE1 drug_LE1 :_LE1 oral_LE1 BIOGENERAL_LE1 hormone_LE1 replacement_LE1 therapy_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Terfenadine|N|ketoconazole|ketoconazole|BIOENTITY :_BE12 spontaneous_BE12 adverse_BE12 reaction_BE12 report_BE12 of_BE12 patient_BE12 take_BE12 concomitant_BE12 BIOENTITY with_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 demonstrate_RE2 qt_RE2 interval_RE2 prolongation_RE2 and_RE2 rare_RE2 serious_RE2 cardiac_RE2 event_RE2 e.g._RE2 
Terfenadine|N|ketoconazole|terfenadine|BIOENTITY :_BE12 spontaneous_BE12 adverse_BE12 reaction_BE12 report_BE12 of_BE12 patient_BE12 take_BE12 concomitant_BE12 BIOGENERAL_BE12 with_BE12 recommend_BE12 dose_BE12 of_BE12 BIOENTITY demonstrate_RE2 qt_RE2 interval_RE2 prolongation_RE2 and_RE2 rare_RE2 serious_RE2 cardiac_RE2 event_RE2 e.g._RE2 
Terfenadine|N|ketoconazole|terfenadine|pharmacokinetic_LE1 datum_LE1 indicate_LE1 that_LE1 BIOENTITY marked_BE12 inhibit_BE12 the_BE12 metabolism_BE12 of_BE12 BIOGENERAL_BE12 result_BE12 in_BE12 elevated_BE12 plasma_BE12 BIOENTITY level_RE2 
Terfenadine|N|terfenadine|terfenadine|pharmacokinetic_LE1 datum_LE1 indicate_LE1 that_LE1 BIOGENERAL_LE1 marked_LE1 inhibit_LE1 the_LE1 metabolism_LE1 of_LE1 BIOENTITY result_BE12 in_BE12 elevated_BE12 plasma_BE12 BIOENTITY level_RE2 
Terfenadine|N|itraconazole|itraconazole|BIOGENERAL_LE1 :_LE1 torsade_LE1 de_LE1 pointes_LE1 and_LE1 elevated_LE1 parent_LE1 BIOGENERAL_LE1 level_LE1 have_LE1 be_LE1 report_LE1 during_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY in_BE12 clinical_BE12 trial_BE12 of_BE12 BIOENTITY and_RE2 from_RE2 foreign_RE2 postmarketing_RE2 source_RE2 
Terfenadine|N|itraconazole|itraconazole|BIOENTITY :_BE12 torsade_BE12 de_BE12 pointes_BE12 and_BE12 elevated_BE12 parent_BE12 BIOGENERAL_BE12 level_BE12 have_BE12 be_BE12 report_BE12 during_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY in_RE2 clinical_RE2 trial_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 from_RE2 foreign_RE2 postmarketing_RE2 source_RE2 
Terfenadine|N|terfenadine|itraconazole|BIOGENERAL_LE1 :_LE1 torsade_LE1 de_LE1 pointes_LE1 and_LE1 elevated_LE1 parent_LE1 BIOENTITY level_BE12 have_BE12 be_BE12 report_BE12 during_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY in_RE2 clinical_RE2 trial_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 from_RE2 foreign_RE2 postmarketing_RE2 source_RE2 
Terfenadine|N|itraconazole|itraconazole|BIOENTITY :_BE12 torsade_BE12 de_BE12 pointes_BE12 and_BE12 elevated_BE12 parent_BE12 BIOGENERAL_BE12 level_BE12 have_BE12 be_BE12 report_BE12 during_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 in_BE12 clinical_BE12 trial_BE12 of_BE12 BIOENTITY and_RE2 from_RE2 foreign_RE2 postmarketing_RE2 source_RE2 
Terfenadine|N|terfenadine|itraconazole|BIOGENERAL_LE1 :_LE1 torsade_LE1 de_LE1 pointes_LE1 and_LE1 elevated_LE1 parent_LE1 BIOENTITY level_BE12 have_BE12 be_BE12 report_BE12 during_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 in_BE12 clinical_BE12 trial_BE12 of_BE12 BIOENTITY and_RE2 from_RE2 foreign_RE2 postmarketing_RE2 source_RE2 
Terfenadine|N|terfenadine|itraconazole|BIOGENERAL_LE1 :_LE1 torsade_LE1 de_LE1 pointes_LE1 and_LE1 elevated_LE1 parent_LE1 BIOGENERAL_LE1 level_LE1 have_LE1 be_LE1 report_LE1 during_LE1 concomitant_LE1 use_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 in_BE12 clinical_BE12 trial_BE12 of_BE12 BIOENTITY and_RE2 from_RE2 foreign_RE2 postmarketing_RE2 source_RE2 
Terfenadine|N|itraconazole|terfenadine|BIOENTITY :_BE12 torsade_BE12 de_BE12 pointes_BE12 and_BE12 elevated_BE12 parent_BE12 BIOENTITY level_RE2 have_RE2 be_RE2 report_RE2 during_RE2 concomitant_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 in_RE2 clinical_RE2 trial_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 from_RE2 foreign_RE2 postmarketing_RE2 source_RE2 
Terfenadine|N|itraconazole|terfenadine|BIOENTITY :_BE12 torsade_BE12 de_BE12 pointes_BE12 and_BE12 elevated_BE12 parent_BE12 BIOGENERAL_BE12 level_BE12 have_BE12 be_BE12 report_BE12 during_BE12 concomitant_BE12 use_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 in_RE2 clinical_RE2 trial_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 from_RE2 foreign_RE2 postmarketing_RE2 source_RE2 
Terfenadine|N|terfenadine|terfenadine|BIOGENERAL_LE1 :_LE1 torsade_LE1 de_LE1 pointes_LE1 and_LE1 elevated_LE1 parent_LE1 BIOENTITY level_BE12 have_BE12 be_BE12 report_BE12 during_BE12 concomitant_BE12 use_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 in_RE2 clinical_RE2 trial_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 from_RE2 foreign_RE2 postmarketing_RE2 source_RE2 
Terfenadine|N|azole-type antifungal agent|fluconazole|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOENTITY -LRB-_BE12 include_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 -RRB-_RE2 to_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 concomitant_RE2 use_RE2 of_RE2 these_RE2 product_RE2 with_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|azole-type antifungal agent|ketoconazole|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOENTITY -LRB-_BE12 include_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 to_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 concomitant_RE2 use_RE2 of_RE2 these_RE2 product_RE2 with_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|azole-type antifungal agent|itraconazole|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOENTITY -LRB-_BE12 include_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 to_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY concomitant_RE2 use_RE2 of_RE2 these_RE2 product_RE2 with_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|azole-type antifungal agent|metronidazole|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOENTITY -LRB-_BE12 include_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 to_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 concomitant_RE2 use_RE2 of_RE2 these_RE2 product_RE2 with_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|azole-type antifungal agent|miconazole|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOENTITY -LRB-_BE12 include_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 to_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 concomitant_RE2 use_RE2 of_RE2 these_RE2 product_RE2 with_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|fluconazole|ketoconazole|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 to_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 concomitant_RE2 use_RE2 of_RE2 these_RE2 product_RE2 with_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|fluconazole|itraconazole|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 -RRB-_BE12 to_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY concomitant_RE2 use_RE2 of_RE2 these_RE2 product_RE2 with_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|fluconazole|metronidazole|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 -RRB-_RE2 to_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 concomitant_RE2 use_RE2 of_RE2 these_RE2 product_RE2 with_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|fluconazole|miconazole|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY -RRB-_RE2 to_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 concomitant_RE2 use_RE2 of_RE2 these_RE2 product_RE2 with_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|ketoconazole|terfenadine|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 to_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 concomitant_BE12 use_BE12 of_BE12 these_BE12 product_BE12 with_BE12 BIOENTITY be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|itraconazole|terfenadine|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 to_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY concomitant_BE12 use_BE12 of_BE12 these_BE12 product_BE12 with_BE12 BIOENTITY be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|ketoconazole|itraconazole|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 -RRB-_LE1 to_LE1 BIOENTITY and_BE12 BIOENTITY concomitant_RE2 use_RE2 of_RE2 these_RE2 product_RE2 with_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|metronidazole|ketoconazole|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 to_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 concomitant_RE2 use_RE2 of_RE2 these_RE2 product_RE2 with_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|miconazole|ketoconazole|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 to_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 concomitant_RE2 use_RE2 of_RE2 these_RE2 product_RE2 with_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|metronidazole|itraconazole|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 -RRB-_BE12 to_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY concomitant_RE2 use_RE2 of_RE2 these_RE2 product_RE2 with_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|miconazole|itraconazole|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY -RRB-_BE12 to_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY concomitant_RE2 use_RE2 of_RE2 these_RE2 product_RE2 with_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|metronidazole|miconazole|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 to_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 concomitant_RE2 use_RE2 of_RE2 these_RE2 product_RE2 with_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|metronidazole|miconazole|Due_LE1 to_LE1 the_LE1 chemical_LE1 similarity_LE1 of_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY -RRB-_RE2 to_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 concomitant_RE2 use_RE2 of_RE2 these_RE2 product_RE2 with_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 pend_RE2 full_RE2 examination_RE2 of_RE2 potential_RE2 interaction_RE2 
Terfenadine|N|macrolide|clarithromycin|BIOENTITY :_BE12 clinical_BE12 drug_BE12 interaction_BE12 study_BE12 indicate_BE12 that_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY can_RE2 exert_RE2 effect_RE2 on_RE2 BIOGENERAL_RE2 metabolism_RE2 by_RE2 mechanism_RE2 which_RE2 may_RE2 be_RE2 similar_RE2 to_RE2 that_RE2 of_RE2 BIOGENERAL_RE2 but_RE2 to_RE2 less_RE2 extent_RE2 
Terfenadine|N|macrolide|erythromycin|BIOENTITY :_BE12 clinical_BE12 drug_BE12 interaction_BE12 study_BE12 indicate_BE12 that_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 can_RE2 exert_RE2 effect_RE2 on_RE2 BIOGENERAL_RE2 metabolism_RE2 by_RE2 mechanism_RE2 which_RE2 may_RE2 be_RE2 similar_RE2 to_RE2 that_RE2 of_RE2 BIOGENERAL_RE2 but_RE2 to_RE2 less_RE2 extent_RE2 
Terfenadine|N|macrolide|ketoconazole|BIOENTITY :_BE12 clinical_BE12 drug_BE12 interaction_BE12 study_BE12 indicate_BE12 that_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 exert_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 metabolism_BE12 by_BE12 mechanism_BE12 which_BE12 may_BE12 be_BE12 similar_BE12 to_BE12 that_BE12 of_BE12 BIOENTITY but_RE2 to_RE2 less_RE2 extent_RE2 
Terfenadine|N|macrolide|ketoconazole|BIOENTITY :_BE12 clinical_BE12 drug_BE12 interaction_BE12 study_BE12 indicate_BE12 that_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 exert_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 metabolism_BE12 by_BE12 mechanism_BE12 which_BE12 may_BE12 be_BE12 similar_BE12 to_BE12 that_BE12 of_BE12 BIOENTITY but_RE2 to_RE2 less_RE2 extent_RE2 
Terfenadine|N|macrolide|terfenadine|BIOENTITY :_BE12 clinical_BE12 drug_BE12 interaction_BE12 study_BE12 indicate_BE12 that_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 can_BE12 exert_BE12 effect_BE12 on_BE12 BIOENTITY metabolism_RE2 by_RE2 mechanism_RE2 which_RE2 may_RE2 be_RE2 similar_RE2 to_RE2 that_RE2 of_RE2 BIOGENERAL_RE2 but_RE2 to_RE2 less_RE2 extent_RE2 
Terfenadine|N|erythromycin|clarithromycin|BIOGENERAL_LE1 :_LE1 clinical_LE1 drug_LE1 interaction_LE1 study_LE1 indicate_LE1 that_LE1 BIOENTITY and_BE12 BIOENTITY can_RE2 exert_RE2 effect_RE2 on_RE2 BIOGENERAL_RE2 metabolism_RE2 by_RE2 mechanism_RE2 which_RE2 may_RE2 be_RE2 similar_RE2 to_RE2 that_RE2 of_RE2 BIOGENERAL_RE2 but_RE2 to_RE2 less_RE2 extent_RE2 
Terfenadine|N|clarithromycin|ketoconazole|BIOGENERAL_LE1 :_LE1 clinical_LE1 drug_LE1 interaction_LE1 study_LE1 indicate_LE1 that_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY can_BE12 exert_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 metabolism_BE12 by_BE12 mechanism_BE12 which_BE12 may_BE12 be_BE12 similar_BE12 to_BE12 that_BE12 of_BE12 BIOENTITY but_RE2 to_RE2 less_RE2 extent_RE2 
Terfenadine|N|clarithromycin|ketoconazole|BIOGENERAL_LE1 :_LE1 clinical_LE1 drug_LE1 interaction_LE1 study_LE1 indicate_LE1 that_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY can_BE12 exert_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 metabolism_BE12 by_BE12 mechanism_BE12 which_BE12 may_BE12 be_BE12 similar_BE12 to_BE12 that_BE12 of_BE12 BIOENTITY but_RE2 to_RE2 less_RE2 extent_RE2 
Terfenadine|N|erythromycin|ketoconazole|BIOGENERAL_LE1 :_LE1 clinical_LE1 drug_LE1 interaction_LE1 study_LE1 indicate_LE1 that_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 can_BE12 exert_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 metabolism_BE12 by_BE12 mechanism_BE12 which_BE12 may_BE12 be_BE12 similar_BE12 to_BE12 that_BE12 of_BE12 BIOENTITY but_RE2 to_RE2 less_RE2 extent_RE2 
Terfenadine|N|erythromycin|ketoconazole|BIOGENERAL_LE1 :_LE1 clinical_LE1 drug_LE1 interaction_LE1 study_LE1 indicate_LE1 that_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 can_BE12 exert_BE12 effect_BE12 on_BE12 BIOGENERAL_BE12 metabolism_BE12 by_BE12 mechanism_BE12 which_BE12 may_BE12 be_BE12 similar_BE12 to_BE12 that_BE12 of_BE12 BIOENTITY but_RE2 to_RE2 less_RE2 extent_RE2 
Terfenadine|N|terfenadine|ketoconazole|BIOGENERAL_LE1 :_LE1 clinical_LE1 drug_LE1 interaction_LE1 study_LE1 indicate_LE1 that_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 exert_LE1 effect_LE1 on_LE1 BIOENTITY metabolism_BE12 by_BE12 mechanism_BE12 which_BE12 may_BE12 be_BE12 similar_BE12 to_BE12 that_BE12 of_BE12 BIOENTITY but_RE2 to_RE2 less_RE2 extent_RE2 
Terfenadine|N|terfenadine|ketoconazole|BIOGENERAL_LE1 :_LE1 clinical_LE1 drug_LE1 interaction_LE1 study_LE1 indicate_LE1 that_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 can_LE1 exert_LE1 effect_LE1 on_LE1 BIOENTITY metabolism_BE12 by_BE12 mechanism_BE12 which_BE12 may_BE12 be_BE12 similar_BE12 to_BE12 that_BE12 of_BE12 BIOENTITY but_RE2 to_RE2 less_RE2 extent_RE2 
Terfenadine|N|erythromycin|troleandomycin|few_LE1 spontaneous_LE1 account_LE1 of_LE1 qt_LE1 interval_LE1 prolongation_LE1 with_LE1 ventricular_LE1 arrhythmia_LE1 including_LE1 torsade_LE1 de_LE1 pointes_LE1 have_LE1 be_LE1 report_LE1 in_LE1 patient_LE1 receive_LE1 BIOENTITY or_BE12 BIOENTITY 
Terfenadine|N|macrolide antibiotic|azithromycin|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 be_LE1 contraindicate_LE1 :_LE1 pend_LE1 full_LE1 characterization_LE1 of_LE1 potential_LE1 interaction_LE1 concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 BIOENTITY including_BE12 BIOENTITY be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|erythromycin|azithromycin|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 be_BE12 contraindicate_BE12 :_BE12 pend_BE12 full_BE12 characterization_BE12 of_BE12 potential_BE12 interaction_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 other_BE12 BIOGENERAL_BE12 including_BE12 BIOENTITY be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|clarithromycin|azithromycin|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 be_BE12 contraindicate_BE12 :_BE12 pend_BE12 full_BE12 characterization_BE12 of_BE12 potential_BE12 interaction_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 other_BE12 BIOGENERAL_BE12 including_BE12 BIOENTITY be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|troleandomycin|azithromycin|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY be_BE12 contraindicate_BE12 :_BE12 pend_BE12 full_BE12 characterization_BE12 of_BE12 potential_BE12 interaction_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 other_BE12 BIOGENERAL_BE12 including_BE12 BIOENTITY be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|terfenadine|azithromycin|concomitant_LE1 administration_LE1 of_LE1 BIOENTITY with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 be_BE12 contraindicate_BE12 :_BE12 pend_BE12 full_BE12 characterization_BE12 of_BE12 potential_BE12 interaction_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 other_BE12 BIOGENERAL_BE12 including_BE12 BIOENTITY be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|erythromycin|macrolide antibiotic|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 be_BE12 contraindicate_BE12 :_BE12 pend_BE12 full_BE12 characterization_BE12 of_BE12 potential_BE12 interaction_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 other_BE12 BIOENTITY including_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|clarithromycin|macrolide antibiotic|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 be_BE12 contraindicate_BE12 :_BE12 pend_BE12 full_BE12 characterization_BE12 of_BE12 potential_BE12 interaction_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 other_BE12 BIOENTITY including_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|troleandomycin|macrolide antibiotic|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY be_BE12 contraindicate_BE12 :_BE12 pend_BE12 full_BE12 characterization_BE12 of_BE12 potential_BE12 interaction_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 other_BE12 BIOENTITY including_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|terfenadine|macrolide antibiotic|concomitant_LE1 administration_LE1 of_LE1 BIOENTITY with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 be_BE12 contraindicate_BE12 :_BE12 pend_BE12 full_BE12 characterization_BE12 of_BE12 potential_BE12 interaction_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOGENERAL_BE12 with_BE12 other_BE12 BIOENTITY including_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|clarithromycin|erythromycin|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 be_RE2 contraindicate_RE2 :_RE2 pend_RE2 full_RE2 characterization_RE2 of_RE2 potential_RE2 interaction_RE2 concomitant_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 other_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|erythromycin|terfenadine|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 be_BE12 contraindicate_BE12 :_BE12 pend_BE12 full_BE12 characterization_BE12 of_BE12 potential_BE12 interaction_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOENTITY with_RE2 other_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|erythromycin|troleandomycin|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY be_RE2 contraindicate_RE2 :_RE2 pend_RE2 full_RE2 characterization_RE2 of_RE2 potential_RE2 interaction_RE2 concomitant_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 other_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|erythromycin|troleandomycin|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY be_RE2 contraindicate_RE2 :_RE2 pend_RE2 full_RE2 characterization_RE2 of_RE2 potential_RE2 interaction_RE2 concomitant_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 other_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|clarithromycin|terfenadine|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 be_BE12 contraindicate_BE12 :_BE12 pend_BE12 full_BE12 characterization_BE12 of_BE12 potential_BE12 interaction_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOENTITY with_RE2 other_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|clarithromycin|troleandomycin|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY be_RE2 contraindicate_RE2 :_RE2 pend_RE2 full_RE2 characterization_RE2 of_RE2 potential_RE2 interaction_RE2 concomitant_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 with_RE2 other_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|troleandomycin|terfenadine|concomitant_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY be_BE12 contraindicate_BE12 :_BE12 pend_BE12 full_BE12 characterization_BE12 of_BE12 potential_BE12 interaction_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOENTITY with_RE2 other_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|terfenadine|terfenadine|concomitant_LE1 administration_LE1 of_LE1 BIOENTITY with_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 be_BE12 contraindicate_BE12 :_BE12 pend_BE12 full_BE12 characterization_BE12 of_BE12 potential_BE12 interaction_BE12 concomitant_BE12 administration_BE12 of_BE12 BIOENTITY with_RE2 other_RE2 BIOGENERAL_RE2 including_RE2 BIOGENERAL_RE2 be_RE2 not_RE2 recommend_RE2 
Terfenadine|N|terfenadine|azithromycin|study_LE1 to_LE1 evaluate_LE1 potential_LE1 interaction_LE1 of_LE1 BIOENTITY with_BE12 BIOENTITY be_RE2 in_RE2 progress_RE2 
Thalidomide|N|thalidomide|reserpine|BIOENTITY have_BE12 be_BE12 report_BE12 to_BE12 enhance_BE12 the_BE12 sedative_BE12 activity_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Thalidomide|N|thalidomide|alcohol|BIOENTITY have_BE12 be_BE12 report_BE12 to_BE12 enhance_BE12 the_BE12 sedative_BE12 activity_BE12 of_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Thalidomide|N|thalidomide|chlorpromazine|BIOENTITY have_BE12 be_BE12 report_BE12 to_BE12 enhance_BE12 the_BE12 sedative_BE12 activity_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Thalidomide|N|barbiturate|reserpine|BIOGENERAL_LE1 have_LE1 be_LE1 report_LE1 to_LE1 enhance_LE1 the_LE1 sedative_LE1 activity_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Thalidomide|N|barbiturate|alcohol|BIOGENERAL_LE1 have_LE1 be_LE1 report_LE1 to_LE1 enhance_LE1 the_LE1 sedative_LE1 activity_LE1 of_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Thalidomide|N|barbiturate|chlorpromazine|BIOGENERAL_LE1 have_LE1 be_LE1 report_LE1 to_LE1 enhance_LE1 the_LE1 sedative_LE1 activity_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Thalidomide|N|alcohol|reserpine|BIOGENERAL_LE1 have_LE1 be_LE1 report_LE1 to_LE1 enhance_LE1 the_LE1 sedative_LE1 activity_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Thalidomide|N|alcohol|reserpine|BIOGENERAL_LE1 have_LE1 be_LE1 report_LE1 to_LE1 enhance_LE1 the_LE1 sedative_LE1 activity_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Thalidomide|N|chlorpromazine|reserpine|BIOGENERAL_LE1 have_LE1 be_LE1 report_LE1 to_LE1 enhance_LE1 the_LE1 sedative_LE1 activity_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Thalidomide|N|chlorpromazine|reserpine|BIOGENERAL_LE1 have_LE1 be_LE1 report_LE1 to_LE1 enhance_LE1 the_LE1 sedative_LE1 activity_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Thalidomide|N|alcohol|chlorpromazine|BIOGENERAL_LE1 have_LE1 be_LE1 report_LE1 to_LE1 enhance_LE1 the_LE1 sedative_LE1 activity_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Thalidomide|N|alcohol|chlorpromazine|BIOGENERAL_LE1 have_LE1 be_LE1 report_LE1 to_LE1 enhance_LE1 the_LE1 sedative_LE1 activity_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Thalidomide|N|ethinyl estradiol|norethindrone acetate|oral_LE1 BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 healthy_LE1 woman_LE1 the_LE1 pharmacokinetic_LE1 profile_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY follow_BE12 administration_BE12 of_BE12 single_BE12 dose_BE12 contain_BE12 mg_BE12 of_BE12 BIOENTITY and_RE2 NUM_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 study_RE2 
Thalidomide|N|norethindrone|norethindrone acetate|oral_LE1 BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 healthy_LE1 woman_LE1 the_LE1 pharmacokinetic_LE1 profile_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 follow_BE12 administration_BE12 of_BE12 single_BE12 dose_BE12 contain_BE12 mg_BE12 of_BE12 BIOENTITY and_RE2 NUM_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 study_RE2 
Thalidomide|N|contraceptive|norethindrone acetate|oral_LE1 BIOENTITY :_BE12 In_BE12 NUM_BE12 healthy_BE12 woman_BE12 the_BE12 pharmacokinetic_BE12 profile_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 follow_BE12 administration_BE12 of_BE12 single_BE12 dose_BE12 contain_BE12 mg_BE12 of_BE12 BIOENTITY and_RE2 NUM_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 study_RE2 
Thalidomide|N|norethindrone acetate|ethinyl estradiol|oral_LE1 BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 healthy_LE1 woman_LE1 the_LE1 pharmacokinetic_LE1 profile_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 follow_LE1 administration_LE1 of_LE1 single_LE1 dose_LE1 contain_LE1 mg_LE1 of_LE1 BIOENTITY and_BE12 NUM_BE12 of_BE12 BIOENTITY be_RE2 study_RE2 
Thalidomide|N|norethindrone|ethinyl estradiol|oral_LE1 BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 healthy_LE1 woman_LE1 the_LE1 pharmacokinetic_LE1 profile_LE1 of_LE1 BIOENTITY and_BE12 BIOENTITY follow_RE2 administration_RE2 of_RE2 single_RE2 dose_RE2 contain_RE2 mg_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 NUM_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 study_RE2 
Thalidomide|N|contraceptive|ethinyl estradiol|oral_LE1 BIOENTITY :_BE12 In_BE12 NUM_BE12 healthy_BE12 woman_BE12 the_BE12 pharmacokinetic_BE12 profile_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY follow_RE2 administration_RE2 of_RE2 single_RE2 dose_RE2 contain_RE2 mg_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 NUM_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 study_RE2 
Thalidomide|N|ethinyl estradiol|ethinyl estradiol|oral_LE1 BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 healthy_LE1 woman_LE1 the_LE1 pharmacokinetic_LE1 profile_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY follow_BE12 administration_BE12 of_BE12 single_BE12 dose_BE12 contain_BE12 mg_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 NUM_BE12 of_BE12 BIOENTITY be_RE2 study_RE2 
Thalidomide|N|contraceptive|norethindrone|oral_LE1 BIOENTITY :_BE12 In_BE12 NUM_BE12 healthy_BE12 woman_BE12 the_BE12 pharmacokinetic_BE12 profile_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 follow_RE2 administration_RE2 of_RE2 single_RE2 dose_RE2 contain_RE2 mg_RE2 of_RE2 BIOGENERAL_RE2 and_RE2 NUM_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 study_RE2 
Thalidomide|N|norethindrone|ethinyl estradiol|oral_LE1 BIOGENERAL_LE1 :_LE1 In_LE1 NUM_LE1 healthy_LE1 woman_LE1 the_LE1 pharmacokinetic_LE1 profile_LE1 of_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 follow_BE12 administration_BE12 of_BE12 single_BE12 dose_BE12 contain_BE12 mg_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 NUM_BE12 of_BE12 BIOENTITY be_RE2 study_RE2 
Thalidomide|N|contraceptive|ethinyl estradiol|oral_LE1 BIOENTITY :_BE12 In_BE12 NUM_BE12 healthy_BE12 woman_BE12 the_BE12 pharmacokinetic_BE12 profile_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 follow_BE12 administration_BE12 of_BE12 single_BE12 dose_BE12 contain_BE12 mg_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 NUM_BE12 of_BE12 BIOENTITY be_RE2 study_RE2 
Thalidomide|N|hiv-protease inhibitor|griseofulvin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|hiv-protease inhibitor|modafinil|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|hiv-protease inhibitor|penicillin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|hiv-protease inhibitor|rifampin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|hiv-protease inhibitor|rifabutin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|hiv-protease inhibitor|phenytoin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|hiv-protease inhibitor|carbamazepine|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|hormonal contraceptive|hiv-protease inhibitor|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOENTITY :_BE12 concomitant_BE12 use_BE12 of_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|thalidomide|hiv-protease inhibitor|important_LE1 BIOENTITY drug_BE12 interaction_BE12 drug_BE12 that_BE12 interfere_BE12 with_BE12 BIOGENERAL_BE12 :_BE12 concomitant_BE12 use_BE12 of_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|griseofulvin|modafinil|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|griseofulvin|penicillin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|griseofulvin|rifampin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|griseofulvin|rifabutin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|griseofulvin|phenytoin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|griseofulvin|carbamazepine|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|hormonal contraceptive|griseofulvin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOENTITY :_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|thalidomide|griseofulvin|important_LE1 BIOENTITY drug_BE12 interaction_BE12 drug_BE12 that_BE12 interfere_BE12 with_BE12 BIOGENERAL_BE12 :_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|modafinil|penicillin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|modafinil|rifampin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|modafinil|rifabutin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|modafinil|phenytoin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|modafinil|carbamazepine|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|hormonal contraceptive|modafinil|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOENTITY :_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|thalidomide|modafinil|important_LE1 BIOENTITY drug_BE12 interaction_BE12 drug_BE12 that_BE12 interfere_BE12 with_BE12 BIOGENERAL_BE12 :_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|penicillin|rifampin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|penicillin|rifabutin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|penicillin|phenytoin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|penicillin|carbamazepine|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|hormonal contraceptive|penicillin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOENTITY :_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|thalidomide|penicillin|important_LE1 BIOENTITY drug_BE12 interaction_BE12 drug_BE12 that_BE12 interfere_BE12 with_BE12 BIOGENERAL_BE12 :_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|rifampin|rifabutin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|rifampin|phenytoin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|rifampin|carbamazepine|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|hormonal contraceptive|rifampin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOENTITY :_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|thalidomide|rifampin|important_LE1 BIOENTITY drug_BE12 interaction_BE12 drug_BE12 that_BE12 interfere_BE12 with_BE12 BIOGENERAL_BE12 :_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|rifabutin|phenytoin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|rifabutin|phenytoin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|rifabutin|carbamazepine|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|rifabutin|carbamazepine|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|hormonal contraceptive|rifabutin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOENTITY :_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|thalidomide|rifabutin|important_LE1 BIOENTITY drug_BE12 interaction_BE12 drug_BE12 that_BE12 interfere_BE12 with_BE12 BIOGENERAL_BE12 :_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|phenytoin|carbamazepine|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|phenytoin|carbamazepine|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOGENERAL_LE1 :_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|hormonal contraceptive|phenytoin|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOENTITY :_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|thalidomide|phenytoin|important_LE1 BIOENTITY drug_BE12 interaction_BE12 drug_BE12 that_BE12 interfere_BE12 with_BE12 BIOGENERAL_BE12 :_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|hormonal contraceptive|carbamazepine|important_LE1 BIOGENERAL_LE1 drug_LE1 interaction_LE1 drug_LE1 that_LE1 interfere_LE1 with_LE1 BIOENTITY :_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|thalidomide|carbamazepine|important_LE1 BIOENTITY drug_BE12 interaction_BE12 drug_BE12 that_BE12 interfere_BE12 with_BE12 BIOGENERAL_BE12 :_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thalidomide|N|thalidomide|hormonal contraceptive|important_LE1 BIOENTITY drug_BE12 interaction_BE12 drug_BE12 that_BE12 interfere_BE12 with_BE12 BIOENTITY :_RE2 concomitant_RE2 use_RE2 of_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 certain_RE2 herbal_RE2 supplement_RE2 such_RE2 as_RE2 st._RE2 
Thiamine|N|stavudine|tricyclic antidepressant|interaction_LE1 for_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 :_LE1 BIOGENERAL_LE1 oral_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY 
Thiamine|N|loop diuretic|tricyclic antidepressant|interaction_LE1 for_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 :_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY 
Thiamine|N|contraceptive|tricyclic antidepressant|interaction_LE1 for_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 :_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY 
Thiamine|N|loop diuretic|stavudine|interaction_LE1 for_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 :_LE1 BIOENTITY oral_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 
Thiamine|N|contraceptive|stavudine|interaction_LE1 for_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 :_LE1 BIOGENERAL_LE1 oral_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 
Thiamine|N|loop diuretic|contraceptive|interaction_LE1 for_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 :_LE1 BIOENTITY oral_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 
Thiamine|N|vitamin b1|thiamine|interaction_LE1 for_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 :_RE2 BIOGENERAL_RE2 oral_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 
Thiethylperazine|N|cns depressant|opiate|BIOGENERAL_LE1 be_LE1 capable_LE1 of_LE1 potentiating_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 etc_RE2 .rrb_RE2 
Thiethylperazine|N|cns depressant|alcohol|BIOGENERAL_LE1 be_LE1 capable_LE1 of_LE1 potentiating_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY etc_RE2 .rrb_RE2 
Thiethylperazine|N|cns depressant|barbiturate|BIOGENERAL_LE1 be_LE1 capable_LE1 of_LE1 potentiating_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 etc_RE2 .rrb_RE2 
Thiethylperazine|N|cns depressant|anesthetic|BIOGENERAL_LE1 be_LE1 capable_LE1 of_LE1 potentiating_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 etc_RE2 .rrb_RE2 
Thiethylperazine|N|opiate|alcohol|BIOGENERAL_LE1 be_LE1 capable_LE1 of_LE1 potentiating_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY etc_RE2 .rrb_RE2 
Thiethylperazine|N|barbiturate|opiate|BIOGENERAL_LE1 be_LE1 capable_LE1 of_LE1 potentiating_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 etc_RE2 .rrb_RE2 
Thiethylperazine|N|anesthetic|opiate|BIOGENERAL_LE1 be_LE1 capable_LE1 of_LE1 potentiating_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 etc_RE2 .rrb_RE2 
Thiethylperazine|N|barbiturate|alcohol|BIOGENERAL_LE1 be_LE1 capable_LE1 of_LE1 potentiating_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY etc_RE2 .rrb_RE2 
Thiethylperazine|N|anesthetic|alcohol|BIOGENERAL_LE1 be_LE1 capable_LE1 of_LE1 potentiating_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY etc_RE2 .rrb_RE2 
Thiethylperazine|N|barbiturate|anesthetic|BIOGENERAL_LE1 be_LE1 capable_LE1 of_LE1 potentiating_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 etc_RE2 .rrb_RE2 
Thiethylperazine|N|atropine|phosphorous insecticide|as_LE1 well_LE1 as_LE1 BIOENTITY and_BE12 BIOENTITY 
Thioguanine|N|purinethol|mercaptopurine|there_LE1 be_LE1 usual_LE1 complete_LE1 crossresistance_LE1 between_LE1 BIOENTITY -LRB-_BE12 BIOENTITY -RRB-_RE2 and_RE2 BIOGENERAL_RE2 brand_RE2 BIOGENERAL_RE2 
Thioguanine|N|tabloid|thioguanine|there_LE1 be_LE1 usual_LE1 complete_LE1 crossresistance_LE1 between_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 -RRB-_LE1 and_LE1 BIOENTITY brand_BE12 BIOENTITY 
Thioguanine|N|aminosalicylate derivative|olsalazine|as_LE1 there_LE1 be_LE1 in_LE1 vitro_LE1 evidence_LE1 that_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 -RRB-_RE2 inhibit_RE2 the_RE2 tpmt_RE2 enzyme_RE2 they_RE2 shall_RE2 be_RE2 administer_RE2 with_RE2 caution_RE2 to_RE2 patient_RE2 receive_RE2 concurrent_RE2 BIOGENERAL_RE2 therapy_RE2 
Thioguanine|N|olsalazine|mesalazine|as_LE1 there_LE1 be_LE1 in_LE1 vitro_LE1 evidence_LE1 that_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 -RRB-_RE2 inhibit_RE2 the_RE2 tpmt_RE2 enzyme_RE2 they_RE2 shall_RE2 be_RE2 administer_RE2 with_RE2 caution_RE2 to_RE2 patient_RE2 receive_RE2 concurrent_RE2 BIOGENERAL_RE2 therapy_RE2 
Thioguanine|N|olsalazine|sulphasalazine|as_LE1 there_LE1 be_LE1 in_LE1 vitro_LE1 evidence_LE1 that_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY -RRB-_RE2 inhibit_RE2 the_RE2 tpmt_RE2 enzyme_RE2 they_RE2 shall_RE2 be_RE2 administer_RE2 with_RE2 caution_RE2 to_RE2 patient_RE2 receive_RE2 concurrent_RE2 BIOGENERAL_RE2 therapy_RE2 
Thioguanine|N|aminosalicylate derivative|mesalazine|as_LE1 there_LE1 be_LE1 in_LE1 vitro_LE1 evidence_LE1 that_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 -RRB-_RE2 inhibit_RE2 the_RE2 tpmt_RE2 enzyme_RE2 they_RE2 shall_RE2 be_RE2 administer_RE2 with_RE2 caution_RE2 to_RE2 patient_RE2 receive_RE2 concurrent_RE2 BIOGENERAL_RE2 therapy_RE2 
Thioguanine|N|aminosalicylate derivative|sulphasalazine|as_LE1 there_LE1 be_LE1 in_LE1 vitro_LE1 evidence_LE1 that_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY -RRB-_RE2 inhibit_RE2 the_RE2 tpmt_RE2 enzyme_RE2 they_RE2 shall_RE2 be_RE2 administer_RE2 with_RE2 caution_RE2 to_RE2 patient_RE2 receive_RE2 concurrent_RE2 BIOGENERAL_RE2 therapy_RE2 
Thioguanine|N|mesalazine|sulphasalazine|as_LE1 there_LE1 be_LE1 in_LE1 vitro_LE1 evidence_LE1 that_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY -RRB-_RE2 inhibit_RE2 the_RE2 tpmt_RE2 enzyme_RE2 they_RE2 shall_RE2 be_RE2 administer_RE2 with_RE2 caution_RE2 to_RE2 patient_RE2 receive_RE2 concurrent_RE2 BIOGENERAL_RE2 therapy_RE2 
Thioguanine|N|mesalazine|sulphasalazine|as_LE1 there_LE1 be_LE1 in_LE1 vitro_LE1 evidence_LE1 that_LE1 BIOGENERAL_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY -RRB-_RE2 inhibit_RE2 the_RE2 tpmt_RE2 enzyme_RE2 they_RE2 shall_RE2 be_RE2 administer_RE2 with_RE2 caution_RE2 to_RE2 patient_RE2 receive_RE2 concurrent_RE2 BIOGENERAL_RE2 therapy_RE2 
Tigecycline|N|contraceptive|contraceptive|concurrent_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 oral_LE1 BIOENTITY may_BE12 render_BE12 oral_BE12 BIOENTITY little_RE2 effective_RE2 
Tigecycline|N|antibacterial drug|contraceptive|concurrent_LE1 use_LE1 of_LE1 BIOENTITY with_BE12 oral_BE12 BIOGENERAL_BE12 may_BE12 render_BE12 oral_BE12 BIOENTITY little_RE2 effective_RE2 
Tiludronate|N|skelid|magnesium|the_LE1 bioavailability_LE1 of_LE1 BIOENTITY be_BE12 decrease_BE12 NUM_BE12 by_BE12 BIOGENERAL_BE12 when_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|skelid|aluminum|the_LE1 bioavailability_LE1 of_LE1 BIOENTITY be_BE12 decrease_BE12 NUM_BE12 by_BE12 BIOGENERAL_BE12 when_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|skelid|skelid|the_LE1 bioavailability_LE1 of_LE1 BIOENTITY be_BE12 decrease_BE12 NUM_BE12 by_BE12 BIOGENERAL_BE12 when_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 administer_RE2 at_RE2 the_RE2 same_RE2 time_RE2 and_RE2 NUM_RE2 by_RE2 some_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|skelid|skelid|the_LE1 bioavailability_LE1 of_LE1 BIOENTITY be_BE12 decrease_BE12 NUM_BE12 by_BE12 BIOGENERAL_BE12 when_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 administer_RE2 at_RE2 the_RE2 same_RE2 time_RE2 and_RE2 NUM_RE2 by_RE2 some_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|skelid|calcium|the_LE1 bioavailability_LE1 of_LE1 BIOENTITY be_BE12 decrease_BE12 NUM_BE12 by_BE12 BIOGENERAL_BE12 when_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 at_RE2 the_RE2 same_RE2 time_RE2 and_RE2 NUM_RE2 by_RE2 some_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|skelid|calcium|the_LE1 bioavailability_LE1 of_LE1 BIOENTITY be_BE12 decrease_BE12 NUM_BE12 by_BE12 BIOGENERAL_BE12 when_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 at_RE2 the_RE2 same_RE2 time_RE2 and_RE2 NUM_RE2 by_RE2 some_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|skelid|skelid|the_LE1 bioavailability_LE1 of_LE1 BIOENTITY be_BE12 decrease_BE12 NUM_BE12 by_BE12 BIOGENERAL_BE12 when_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 when_BE12 administer_BE12 NUM_BE12 hour_BE12 before_BE12 BIOENTITY 
Tiludronate|N|skelid|antacid|the_LE1 bioavailability_LE1 of_LE1 BIOENTITY be_BE12 decrease_BE12 NUM_BE12 by_BE12 BIOGENERAL_BE12 when_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 BIOENTITY when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|calcium|magnesium|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOENTITY when_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|calcium|aluminum|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOENTITY when_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|calcium|skelid|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOENTITY when_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 administer_RE2 at_RE2 the_RE2 same_RE2 time_RE2 and_RE2 NUM_RE2 by_RE2 some_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|calcium|skelid|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOENTITY when_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY be_RE2 administer_RE2 at_RE2 the_RE2 same_RE2 time_RE2 and_RE2 NUM_RE2 by_RE2 some_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|calcium|calcium|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOENTITY when_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 at_RE2 the_RE2 same_RE2 time_RE2 and_RE2 NUM_RE2 by_RE2 some_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|calcium|calcium|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOENTITY when_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 be_RE2 administer_RE2 at_RE2 the_RE2 same_RE2 time_RE2 and_RE2 NUM_RE2 by_RE2 some_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|calcium|skelid|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOENTITY when_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 when_BE12 administer_BE12 NUM_BE12 hour_BE12 before_BE12 BIOENTITY 
Tiludronate|N|calcium|antacid|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOENTITY when_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 BIOENTITY when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|aluminum|magnesium|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 at_LE1 the_LE1 same_LE1 time_LE1 and_LE1 NUM_LE1 by_LE1 some_LE1 BIOENTITY or_BE12 BIOENTITY BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|skelid|magnesium|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|skelid|magnesium|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|calcium|magnesium|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|calcium|magnesium|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|magnesium|antacid|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 at_LE1 the_LE1 same_LE1 time_LE1 and_LE1 NUM_LE1 by_LE1 some_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY BIOENTITY when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|skelid|aluminum|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|skelid|aluminum|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|calcium|aluminum|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|calcium|aluminum|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|aluminum|antacid|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 at_LE1 the_LE1 same_LE1 time_LE1 and_LE1 NUM_LE1 by_LE1 some_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 BIOENTITY when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|calcium|skelid|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOENTITY and_BE12 BIOENTITY be_RE2 administer_RE2 at_RE2 the_RE2 same_RE2 time_RE2 and_RE2 NUM_RE2 by_RE2 some_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|skelid|skelid|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 when_BE12 administer_BE12 NUM_BE12 hour_BE12 before_BE12 BIOENTITY 
Tiludronate|N|skelid|skelid|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 when_BE12 administer_BE12 NUM_BE12 hour_BE12 before_BE12 BIOENTITY 
Tiludronate|N|skelid|antacid|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 BIOENTITY when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|skelid|antacid|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 BIOENTITY when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|calcium|skelid|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 when_BE12 administer_BE12 NUM_BE12 hour_BE12 before_BE12 BIOENTITY 
Tiludronate|N|calcium|skelid|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 when_BE12 administer_BE12 NUM_BE12 hour_BE12 before_BE12 BIOENTITY 
Tiludronate|N|calcium|antacid|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 BIOENTITY when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|calcium|antacid|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 be_BE12 administer_BE12 at_BE12 the_BE12 same_BE12 time_BE12 and_BE12 NUM_BE12 by_BE12 some_BE12 BIOGENERAL_BE12 or_BE12 BIOGENERAL_BE12 BIOENTITY when_RE2 administer_RE2 NUM_RE2 hour_RE2 before_RE2 BIOGENERAL_RE2 
Tiludronate|N|antacid|skelid|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 decrease_LE1 NUM_LE1 by_LE1 BIOGENERAL_LE1 when_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 be_LE1 administer_LE1 at_LE1 the_LE1 same_LE1 time_LE1 and_LE1 NUM_LE1 by_LE1 some_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 BIOENTITY when_BE12 administer_BE12 NUM_BE12 hour_BE12 before_BE12 BIOENTITY 
Tiludronate|N|skelid|skelid|BIOGENERAL_LE1 may_LE1 decrease_LE1 bioavailability_LE1 of_LE1 BIOENTITY by_BE12 up_BE12 to_BE12 NUM_BE12 when_BE12 take_BE12 NUM_BE12 hour_BE12 after_BE12 BIOENTITY 
Tiludronate|N|aspirin|skelid|BIOENTITY may_BE12 decrease_BE12 bioavailability_BE12 of_BE12 BIOGENERAL_BE12 by_BE12 up_BE12 to_BE12 NUM_BE12 when_BE12 take_BE12 NUM_BE12 hour_BE12 after_BE12 BIOENTITY 
Tiludronate|N|skelid|diclofenac|the_LE1 bioavailability_LE1 of_LE1 BIOENTITY be_BE12 increase_BE12 NUM_BE12 fold_BE12 by_BE12 BIOGENERAL_BE12 but_BE12 be_BE12 not_BE12 significant_BE12 alter_BE12 by_BE12 coadministration_BE12 of_BE12 BIOENTITY 
Tiludronate|N|indomethacin|diclofenac|the_LE1 bioavailability_LE1 of_LE1 BIOGENERAL_LE1 be_LE1 increase_LE1 NUM_LE1 fold_LE1 by_LE1 BIOENTITY but_BE12 be_BE12 not_BE12 significant_BE12 alter_BE12 by_BE12 coadministration_BE12 of_BE12 BIOENTITY 
Tiludronate|N|digoxin|skelid|the_LE1 pharmacokinetic_LE1 parameter_LE1 of_LE1 BIOENTITY be_BE12 not_BE12 significant_BE12 modify_BE12 by_BE12 BIOENTITY coadministration_RE2 
Tiludronate|N|tiludronate|warfarin|in_LE1 vitro_LE1 study_LE1 show_LE1 that_LE1 BIOENTITY do_BE12 not_BE12 displace_BE12 BIOENTITY from_RE2 its_RE2 bind_RE2 site_RE2 on_RE2 protein_RE2 
Tiotropium|N|methylxanthine|steroid|these_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 oral_BE12 and_BE12 inhaled_BE12 BIOENTITY 
Tiotropium|N|methylxanthine|steroid|these_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 oral_BE12 and_BE12 inhaled_BE12 BIOENTITY 
Tiotropium|N|sympathomimetic bronchodilator|steroid|these_LE1 include_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 oral_BE12 and_BE12 inhaled_BE12 BIOENTITY 
Tiotropium|N|sympathomimetic bronchodilator|methylxanthine|these_LE1 include_LE1 BIOENTITY BIOENTITY and_RE2 oral_RE2 and_RE2 inhaled_RE2 BIOGENERAL_RE2 
Tiotropium|N|anticholinergic|ipratropium|however_LE1 the_LE1 co_LE1 administration_LE1 of_LE1 BIOGENERAL_LE1 with_LE1 other_LE1 BIOENTITY containing_BE12 drug_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY -RRB-_RE2 have_RE2 not_RE2 be_RE2 study_RE2 and_RE2 be_RE2 therefore_RE2 not_RE2 recommend_RE2 
Tirofiban|N|aspirin|heparin|BIOGENERAL_LE1 have_LE1 be_LE1 study_LE1 on_LE1 background_LE1 of_LE1 BIOENTITY and_BE12 BIOENTITY 
Tirofiban|N|aggrastat|aspirin|BIOENTITY have_BE12 be_BE12 study_BE12 on_BE12 background_BE12 of_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Tirofiban|N|aggrastat|heparin|BIOENTITY have_BE12 be_BE12 study_BE12 on_BE12 background_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Tirofiban|N|heparin|heparin|the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 associate_BE12 with_BE12 increase_BE12 in_BE12 bleeding_BE12 compare_BE12 to_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 alone_RE2 -LRB-_RE2 see_RE2 
Tirofiban|N|heparin|aspirin|the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOENTITY and_BE12 BIOENTITY have_RE2 be_RE2 associate_RE2 with_RE2 increase_RE2 in_RE2 bleeding_RE2 compare_RE2 to_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 alone_RE2 -LRB-_RE2 see_RE2 
Tirofiban|N|heparin|aspirin|the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOENTITY and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 associate_BE12 with_BE12 increase_BE12 in_BE12 bleeding_BE12 compare_BE12 to_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY alone_RE2 -LRB-_RE2 see_RE2 
Tirofiban|N|aggrastat|heparin|the_LE1 use_LE1 of_LE1 BIOENTITY in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 associate_BE12 with_BE12 increase_BE12 in_BE12 bleeding_BE12 compare_BE12 to_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 alone_RE2 -LRB-_RE2 see_RE2 
Tirofiban|N|aggrastat|aspirin|the_LE1 use_LE1 of_LE1 BIOENTITY in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 and_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 associate_BE12 with_BE12 increase_BE12 in_BE12 bleeding_BE12 compare_BE12 to_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY alone_RE2 -LRB-_RE2 see_RE2 
Tirofiban|N|aspirin|heparin|the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY have_BE12 be_BE12 associate_BE12 with_BE12 increase_BE12 in_BE12 bleeding_BE12 compare_BE12 to_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 alone_RE2 -LRB-_RE2 see_RE2 
Tirofiban|N|heparin|aspirin|the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOGENERAL_LE1 have_LE1 be_LE1 associate_LE1 with_LE1 increase_LE1 in_LE1 bleeding_LE1 compare_LE1 to_LE1 BIOENTITY and_BE12 BIOENTITY alone_RE2 -LRB-_RE2 see_RE2 
Tirofiban|N|aspirin|aspirin|the_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOGENERAL_LE1 and_LE1 BIOENTITY have_BE12 be_BE12 associate_BE12 with_BE12 increase_BE12 in_BE12 bleeding_BE12 compare_BE12 to_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY alone_RE2 -LRB-_RE2 see_RE2 
Tobramycin|N|anti-pseudomonal antibiotic|aminoglycoside|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 genentech_LE1 -RRB-_LE1 -LRB-_LE1 beta_LE1 -RRB-_LE1 BIOGENERAL_LE1 inhaled_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY or_BE12 parenteral_BE12 BIOENTITY demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|anti-pseudomonal antibiotic|aminoglycoside|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 genentech_LE1 -RRB-_LE1 -LRB-_LE1 beta_LE1 -RRB-_LE1 BIOGENERAL_LE1 inhaled_LE1 BIOGENERAL_LE1 other_LE1 BIOENTITY or_BE12 parenteral_BE12 BIOENTITY demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|corticosteroid|aminoglycoside|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 genentech_LE1 -RRB-_LE1 -LRB-_LE1 beta_LE1 -RRB-_LE1 BIOGENERAL_LE1 inhaled_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 or_BE12 parenteral_BE12 BIOENTITY demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|corticosteroid|aminoglycoside|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 genentech_LE1 -RRB-_LE1 -LRB-_LE1 beta_LE1 -RRB-_LE1 BIOGENERAL_LE1 inhaled_LE1 BIOENTITY other_BE12 BIOGENERAL_BE12 or_BE12 parenteral_BE12 BIOENTITY demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|(beta)-agonist|aminoglycoside|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 genentech_LE1 -RRB-_LE1 -LRB-_LE1 beta_LE1 -RRB-_LE1 BIOENTITY inhaled_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 or_BE12 parenteral_BE12 BIOENTITY demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|(beta)-agonist|aminoglycoside|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 genentech_LE1 -RRB-_LE1 -LRB-_LE1 beta_LE1 -RRB-_LE1 BIOENTITY inhaled_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 or_BE12 parenteral_BE12 BIOENTITY demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|pulmozyme|aminoglycoside|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY genentech_BE12 -RRB-_BE12 -LRB-_BE12 beta_BE12 -RRB-_BE12 BIOGENERAL_BE12 inhaled_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 or_BE12 parenteral_BE12 BIOENTITY demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|dornase alfa|aminoglycoside|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 genentech_BE12 -RRB-_BE12 -LRB-_BE12 beta_BE12 -RRB-_BE12 BIOGENERAL_BE12 inhaled_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 or_BE12 parenteral_BE12 BIOENTITY demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|tobi|aminoglycoside|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOENTITY patient_BE12 take_BE12 BIOGENERAL_BE12 concomitant_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 genentech_BE12 -RRB-_BE12 -LRB-_BE12 beta_BE12 -RRB-_BE12 BIOGENERAL_BE12 inhaled_BE12 BIOGENERAL_BE12 other_BE12 BIOGENERAL_BE12 or_BE12 parenteral_BE12 BIOENTITY demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|corticosteroid|anti-pseudomonal antibiotic|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 genentech_LE1 -RRB-_LE1 -LRB-_LE1 beta_LE1 -RRB-_LE1 BIOGENERAL_LE1 inhaled_LE1 BIOENTITY other_BE12 BIOENTITY or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|corticosteroid|anti-pseudomonal antibiotic|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 genentech_LE1 -RRB-_LE1 -LRB-_LE1 beta_LE1 -RRB-_LE1 BIOGENERAL_LE1 inhaled_LE1 BIOENTITY other_BE12 BIOENTITY or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|(beta)-agonist|anti-pseudomonal antibiotic|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 genentech_LE1 -RRB-_LE1 -LRB-_LE1 beta_LE1 -RRB-_LE1 BIOENTITY inhaled_BE12 BIOGENERAL_BE12 other_BE12 BIOENTITY or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|(beta)-agonist|anti-pseudomonal antibiotic|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 genentech_LE1 -RRB-_LE1 -LRB-_LE1 beta_LE1 -RRB-_LE1 BIOENTITY inhaled_BE12 BIOGENERAL_BE12 other_BE12 BIOENTITY or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|pulmozyme|anti-pseudomonal antibiotic|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY genentech_BE12 -RRB-_BE12 -LRB-_BE12 beta_BE12 -RRB-_BE12 BIOGENERAL_BE12 inhaled_BE12 BIOGENERAL_BE12 other_BE12 BIOENTITY or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|dornase alfa|anti-pseudomonal antibiotic|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 genentech_BE12 -RRB-_BE12 -LRB-_BE12 beta_BE12 -RRB-_BE12 BIOGENERAL_BE12 inhaled_BE12 BIOGENERAL_BE12 other_BE12 BIOENTITY or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|tobi|anti-pseudomonal antibiotic|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOENTITY patient_BE12 take_BE12 BIOGENERAL_BE12 concomitant_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 genentech_BE12 -RRB-_BE12 -LRB-_BE12 beta_BE12 -RRB-_BE12 BIOGENERAL_BE12 inhaled_BE12 BIOGENERAL_BE12 other_BE12 BIOENTITY or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|(beta)-agonist|corticosteroid|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 genentech_LE1 -RRB-_LE1 -LRB-_LE1 beta_LE1 -RRB-_LE1 BIOENTITY inhaled_BE12 BIOENTITY other_RE2 BIOGENERAL_RE2 or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|(beta)-agonist|corticosteroid|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 genentech_LE1 -RRB-_LE1 -LRB-_LE1 beta_LE1 -RRB-_LE1 BIOENTITY inhaled_BE12 BIOENTITY other_RE2 BIOGENERAL_RE2 or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|pulmozyme|corticosteroid|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY genentech_BE12 -RRB-_BE12 -LRB-_BE12 beta_BE12 -RRB-_BE12 BIOGENERAL_BE12 inhaled_BE12 BIOENTITY other_RE2 BIOGENERAL_RE2 or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|dornase alfa|corticosteroid|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 genentech_BE12 -RRB-_BE12 -LRB-_BE12 beta_BE12 -RRB-_BE12 BIOGENERAL_BE12 inhaled_BE12 BIOENTITY other_RE2 BIOGENERAL_RE2 or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|tobi|corticosteroid|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOENTITY patient_BE12 take_BE12 BIOGENERAL_BE12 concomitant_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 genentech_BE12 -RRB-_BE12 -LRB-_BE12 beta_BE12 -RRB-_BE12 BIOGENERAL_BE12 inhaled_BE12 BIOENTITY other_RE2 BIOGENERAL_RE2 or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|pulmozyme|(beta)-agonist|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY genentech_BE12 -RRB-_BE12 -LRB-_BE12 beta_BE12 -RRB-_BE12 BIOENTITY inhaled_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|dornase alfa|(beta)-agonist|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 genentech_BE12 -RRB-_BE12 -LRB-_BE12 beta_BE12 -RRB-_BE12 BIOENTITY inhaled_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|tobi|(beta)-agonist|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOENTITY patient_BE12 take_BE12 BIOGENERAL_BE12 concomitant_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOGENERAL_BE12 genentech_BE12 -RRB-_BE12 -LRB-_BE12 beta_BE12 -RRB-_BE12 BIOENTITY inhaled_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|dornase alfa|pulmozyme|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOGENERAL_LE1 patient_LE1 take_LE1 BIOGENERAL_LE1 concomitant_LE1 with_LE1 BIOENTITY -LRB-_BE12 BIOENTITY genentech_RE2 -RRB-_RE2 -LRB-_RE2 beta_RE2 -RRB-_RE2 BIOGENERAL_RE2 inhaled_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|tobi|pulmozyme|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOENTITY patient_BE12 take_BE12 BIOGENERAL_BE12 concomitant_BE12 with_BE12 BIOGENERAL_BE12 -LRB-_BE12 BIOENTITY genentech_RE2 -RRB-_RE2 -LRB-_RE2 beta_RE2 -RRB-_RE2 BIOGENERAL_RE2 inhaled_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|tobi|dornase alfa|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOENTITY patient_BE12 take_BE12 BIOGENERAL_BE12 concomitant_BE12 with_BE12 BIOENTITY -LRB-_RE2 BIOGENERAL_RE2 genentech_RE2 -RRB-_RE2 -LRB-_RE2 beta_RE2 -RRB-_RE2 BIOGENERAL_RE2 inhaled_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|tobi|tobi|In_LE1 clinical_LE1 study_LE1 of_LE1 BIOENTITY patient_BE12 take_BE12 BIOENTITY concomitant_RE2 with_RE2 BIOGENERAL_RE2 -LRB-_RE2 BIOGENERAL_RE2 genentech_RE2 -RRB-_RE2 -LRB-_RE2 beta_RE2 -RRB-_RE2 BIOGENERAL_RE2 inhaled_RE2 BIOGENERAL_RE2 other_RE2 BIOGENERAL_RE2 or_RE2 parenteral_RE2 BIOGENERAL_RE2 demonstrate_RE2 adverse_RE2 experience_RE2 profile_RE2 similar_RE2 to_RE2 the_RE2 study_RE2 population_RE2 as_RE2 whole_RE2 
Tobramycin|N|aminoglycoside|antibiotic|some_LE1 BIOGENERAL_LE1 can_LE1 enhance_LE1 BIOENTITY toxicity_BE12 by_BE12 alter_BE12 BIOENTITY concentration_RE2 in_RE2 serum_RE2 and_RE2 tissue_RE2 
Tobramycin|N|diuretic|antibiotic|some_LE1 BIOENTITY can_BE12 enhance_BE12 BIOGENERAL_BE12 toxicity_BE12 by_BE12 alter_BE12 BIOENTITY concentration_RE2 in_RE2 serum_RE2 and_RE2 tissue_RE2 
Tobramycin|N|ethacrynic acid|furosemide|BIOGENERAL_LE1 shall_LE1 not_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 
Tobramycin|N|furosemide|urea|BIOGENERAL_LE1 shall_LE1 not_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Tobramycin|N|furosemide|urea|BIOGENERAL_LE1 shall_LE1 not_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 
Tobramycin|N|furosemide|mannitol|BIOGENERAL_LE1 shall_LE1 not_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Tobramycin|N|furosemide|mannitol|BIOGENERAL_LE1 shall_LE1 not_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY 
Tobramycin|N|ethacrynic acid|urea|BIOGENERAL_LE1 shall_LE1 not_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 
Tobramycin|N|ethacrynic acid|mannitol|BIOGENERAL_LE1 shall_LE1 not_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY 
Tobramycin|N|urea|mannitol|BIOGENERAL_LE1 shall_LE1 not_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Tobramycin|N|urea|mannitol|BIOGENERAL_LE1 shall_LE1 not_LE1 be_LE1 administer_LE1 concomitant_LE1 with_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY 
Tolmetin|N|warfarin|tolmetin|the_LE1 in_LE1 vitro_LE1 binding_LE1 of_LE1 BIOENTITY to_BE12 human_BE12 plasma_BE12 protein_BE12 be_BE12 unaffect_BE12 by_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 do_RE2 not_RE2 alter_RE2 the_RE2 prothrombin_RE2 time_RE2 of_RE2 normal_RE2 volunteer_RE2 
Tolmetin|N|warfarin|tolmetin|the_LE1 in_LE1 vitro_LE1 binding_LE1 of_LE1 BIOENTITY to_BE12 human_BE12 plasma_BE12 protein_BE12 be_BE12 unaffect_BE12 by_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY do_RE2 not_RE2 alter_RE2 the_RE2 prothrombin_RE2 time_RE2 of_RE2 normal_RE2 volunteer_RE2 
Tolmetin|N|tolmetin|tolmetin|the_LE1 in_LE1 vitro_LE1 binding_LE1 of_LE1 BIOGENERAL_LE1 to_LE1 human_LE1 plasma_LE1 protein_LE1 be_LE1 unaffect_LE1 by_LE1 BIOENTITY and_BE12 BIOENTITY do_RE2 not_RE2 alter_RE2 the_RE2 prothrombin_RE2 time_RE2 of_RE2 normal_RE2 volunteer_RE2 
Tolmetin|N|tolectin|hypoglycemic agent|In_LE1 adult_LE1 diabetic_LE1 patient_LE1 under_LE1 treatment_LE1 with_LE1 either_LE1 BIOGENERAL_LE1 or_LE1 BIOGENERAL_LE1 there_LE1 be_LE1 no_LE1 change_LE1 in_LE1 the_LE1 clinical_LE1 effect_LE1 of_LE1 either_LE1 BIOENTITY or_BE12 the_BE12 BIOENTITY 
Tolmetin|N|insulin|hypoglycemic agent|In_LE1 adult_LE1 diabetic_LE1 patient_LE1 under_LE1 treatment_LE1 with_LE1 either_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY there_BE12 be_BE12 no_BE12 change_BE12 in_BE12 the_BE12 clinical_BE12 effect_BE12 of_BE12 either_BE12 BIOGENERAL_BE12 or_BE12 the_BE12 BIOENTITY 
Tolmetin|N|sulfonylurea|hypoglycemic agent|In_LE1 adult_LE1 diabetic_LE1 patient_LE1 under_LE1 treatment_LE1 with_LE1 either_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 there_BE12 be_BE12 no_BE12 change_BE12 in_BE12 the_BE12 clinical_BE12 effect_BE12 of_BE12 either_BE12 BIOGENERAL_BE12 or_BE12 the_BE12 BIOENTITY 
Tolmetin|N|insulin|tolectin|In_LE1 adult_LE1 diabetic_LE1 patient_LE1 under_LE1 treatment_LE1 with_LE1 either_LE1 BIOGENERAL_LE1 or_LE1 BIOENTITY there_BE12 be_BE12 no_BE12 change_BE12 in_BE12 the_BE12 clinical_BE12 effect_BE12 of_BE12 either_BE12 BIOENTITY or_RE2 the_RE2 BIOGENERAL_RE2 
Tolmetin|N|sulfonylurea|tolectin|In_LE1 adult_LE1 diabetic_LE1 patient_LE1 under_LE1 treatment_LE1 with_LE1 either_LE1 BIOENTITY or_BE12 BIOGENERAL_BE12 there_BE12 be_BE12 no_BE12 change_BE12 in_BE12 the_BE12 clinical_BE12 effect_BE12 of_BE12 either_BE12 BIOENTITY or_RE2 the_RE2 BIOGENERAL_RE2 
Tolmetin|N|sulfonylurea|insulin|In_LE1 adult_LE1 diabetic_LE1 patient_LE1 under_LE1 treatment_LE1 with_LE1 either_LE1 BIOENTITY or_BE12 BIOENTITY there_RE2 be_RE2 no_RE2 change_RE2 in_RE2 the_RE2 clinical_RE2 effect_RE2 of_RE2 either_RE2 BIOGENERAL_RE2 or_RE2 the_RE2 BIOGENERAL_RE2 
Tolmetin|N|methotrexate|methotrexate|BIOGENERAL_LE1 and_LE1 other_LE1 BIOGENERAL_LE1 have_LE1 be_LE1 report_LE1 to_LE1 reduce_LE1 the_LE1 tubular_LE1 secretion_LE1 of_LE1 BIOENTITY in_BE12 animal_BE12 model_BE12 possible_BE12 enhance_BE12 the_BE12 toxicity_BE12 of_BE12 BIOENTITY 
Tolmetin|N|nonsteroidal anti-inflammatory drug|methotrexate|BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY have_BE12 be_BE12 report_BE12 to_BE12 reduce_BE12 the_BE12 tubular_BE12 secretion_BE12 of_BE12 BIOGENERAL_BE12 in_BE12 animal_BE12 model_BE12 possible_BE12 enhance_BE12 the_BE12 toxicity_BE12 of_BE12 BIOENTITY 
Tolmetin|N|tolectin|methotrexate|BIOENTITY and_BE12 other_BE12 BIOGENERAL_BE12 have_BE12 be_BE12 report_BE12 to_BE12 reduce_BE12 the_BE12 tubular_BE12 secretion_BE12 of_BE12 BIOGENERAL_BE12 in_BE12 animal_BE12 model_BE12 possible_BE12 enhance_BE12 the_BE12 toxicity_BE12 of_BE12 BIOENTITY 
Tolmetin|N|tolectin|nonsteroidal anti-inflammatory drug|BIOENTITY and_BE12 other_BE12 BIOENTITY have_RE2 be_RE2 report_RE2 to_RE2 reduce_RE2 the_RE2 tubular_RE2 secretion_RE2 of_RE2 BIOGENERAL_RE2 in_RE2 animal_RE2 model_RE2 possible_RE2 enhance_RE2 the_RE2 toxicity_RE2 of_RE2 BIOGENERAL_RE2 
Tolterodine|N|cyclosporine|vinblastine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOENTITY or_BE12 BIOENTITY the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|clarithromycin|vinblastine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|erythromycin|vinblastine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|macrolide antibiotic|vinblastine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|miconazole|vinblastine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|azole antifungal|vinblastine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|itraconazole|vinblastine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|ketoconazole|vinblastine|For_LE1 patient_LE1 receive_LE1 BIOENTITY or_BE12 other_BE12 potent_BE12 cypa_BE12 inhibitor_BE12 such_BE12 as_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|clarithromycin|cyclosporine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|clarithromycin|cyclosporine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|erythromycin|cyclosporine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|erythromycin|cyclosporine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|macrolide antibiotic|cyclosporine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|macrolide antibiotic|cyclosporine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|miconazole|cyclosporine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|miconazole|cyclosporine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|azole antifungal|cyclosporine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|azole antifungal|cyclosporine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|itraconazole|cyclosporine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|itraconazole|cyclosporine|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|ketoconazole|cyclosporine|For_LE1 patient_LE1 receive_LE1 BIOENTITY or_BE12 other_BE12 potent_BE12 cypa_BE12 inhibitor_BE12 such_BE12 as_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|erythromycin|clarithromycin|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|macrolide antibiotic|clarithromycin|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|miconazole|clarithromycin|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|azole antifungal|clarithromycin|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|itraconazole|clarithromycin|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|ketoconazole|clarithromycin|For_LE1 patient_LE1 receive_LE1 BIOENTITY or_BE12 other_BE12 potent_BE12 cypa_BE12 inhibitor_BE12 such_BE12 as_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|macrolide antibiotic|erythromycin|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 -RRB-_LE1 or_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|miconazole|erythromycin|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|azole antifungal|erythromycin|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|itraconazole|erythromycin|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|ketoconazole|erythromycin|For_LE1 patient_LE1 receive_LE1 BIOENTITY or_BE12 other_BE12 potent_BE12 cypa_BE12 inhibitor_BE12 such_BE12 as_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|miconazole|macrolide antibiotic|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOGENERAL_LE1 BIOENTITY -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 eg_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|azole antifungal|macrolide antibiotic|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 eg_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|itraconazole|macrolide antibiotic|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 eg_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|ketoconazole|macrolide antibiotic|For_LE1 patient_LE1 receive_LE1 BIOENTITY or_BE12 other_BE12 potent_BE12 cypa_BE12 inhibitor_BE12 such_BE12 as_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 -RRB-_BE12 or_BE12 BIOENTITY -LRB-_RE2 eg_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|azole antifungal|miconazole|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 eg_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|itraconazole|miconazole|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOGENERAL_LE1 -LRB-_LE1 eg_LE1 BIOENTITY BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 eg_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|ketoconazole|miconazole|For_LE1 patient_LE1 receive_LE1 BIOENTITY or_BE12 other_BE12 potent_BE12 cypa_BE12 inhibitor_BE12 such_BE12 as_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 eg_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|azole antifungal|itraconazole|For_LE1 patient_LE1 receive_LE1 BIOGENERAL_LE1 or_LE1 other_LE1 potent_LE1 cypa_LE1 inhibitor_LE1 such_LE1 as_LE1 other_LE1 BIOENTITY -LRB-_BE12 eg_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 eg_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|ketoconazole|azole antifungal|For_LE1 patient_LE1 receive_LE1 BIOENTITY or_BE12 other_BE12 potent_BE12 cypa_BE12 inhibitor_BE12 such_BE12 as_BE12 other_BE12 BIOENTITY -LRB-_RE2 eg_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 eg_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Tolterodine|N|ketoconazole|itraconazole|For_LE1 patient_LE1 receive_LE1 BIOENTITY or_BE12 other_BE12 potent_BE12 cypa_BE12 inhibitor_BE12 such_BE12 as_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 eg_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 -LRB-_RE2 eg_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 or_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 the_RE2 recommend_RE2 dose_RE2 of_RE2 BIOGENERAL_RE2 be_RE2 NUM_RE2 mg_RE2 daily_RE2 
Trastuzumab|N|herceptin|herceptin|administration_LE1 of_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOENTITY result_BE12 in_BE12 twofold_BE12 decrease_BE12 in_BE12 BIOENTITY clearance_RE2 in_RE2 nonhuman_RE2 primate_RE2 study_RE2 and_RE2 in_RE2 .fold_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 serum_RE2 level_RE2 in_RE2 clinical_RE2 study_RE2 
Trastuzumab|N|herceptin|herceptin|administration_LE1 of_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOGENERAL_LE1 result_LE1 in_LE1 twofold_LE1 decrease_LE1 in_LE1 BIOENTITY clearance_BE12 in_BE12 nonhuman_BE12 primate_BE12 study_BE12 and_BE12 in_BE12 .fold_BE12 increase_BE12 in_BE12 BIOENTITY serum_RE2 level_RE2 in_RE2 clinical_RE2 study_RE2 
Trastuzumab|N|paclitaxel|herceptin|administration_LE1 of_LE1 BIOENTITY in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 result_BE12 in_BE12 twofold_BE12 decrease_BE12 in_BE12 BIOENTITY clearance_RE2 in_RE2 nonhuman_RE2 primate_RE2 study_RE2 and_RE2 in_RE2 .fold_RE2 increase_RE2 in_RE2 BIOGENERAL_RE2 serum_RE2 level_RE2 in_RE2 clinical_RE2 study_RE2 
Trastuzumab|N|herceptin|herceptin|administration_LE1 of_LE1 BIOGENERAL_LE1 in_LE1 combination_LE1 with_LE1 BIOENTITY result_BE12 in_BE12 twofold_BE12 decrease_BE12 in_BE12 BIOGENERAL_BE12 clearance_BE12 in_BE12 nonhuman_BE12 primate_BE12 study_BE12 and_BE12 in_BE12 .fold_BE12 increase_BE12 in_BE12 BIOENTITY serum_RE2 level_RE2 in_RE2 clinical_RE2 study_RE2 
Trastuzumab|N|paclitaxel|herceptin|administration_LE1 of_LE1 BIOENTITY in_BE12 combination_BE12 with_BE12 BIOGENERAL_BE12 result_BE12 in_BE12 twofold_BE12 decrease_BE12 in_BE12 BIOGENERAL_BE12 clearance_BE12 in_BE12 nonhuman_BE12 primate_BE12 study_BE12 and_BE12 in_BE12 .fold_BE12 increase_BE12 in_BE12 BIOENTITY serum_RE2 level_RE2 in_RE2 clinical_RE2 study_RE2 
Trilostane|N|aminoglutethimide|mitotane|BIOGENERAL_LE1 may_LE1 interact_LE1 with_LE1 BIOENTITY or_BE12 BIOENTITY -LRB-_RE2 cause_RE2 too_RE2 great_RE2 decrease_RE2 in_RE2 adrenal_RE2 function_RE2 rrb._RE2 
Trimethoprim|N|phenytoin|phenytoin|BIOGENERAL_LE1 give_LE1 at_LE1 common_LE1 clinical_LE1 dosage_LE1 increase_LE1 the_LE1 BIOENTITY halflife_BE12 by_BE12 NUM_BE12 and_BE12 decrease_BE12 the_BE12 BIOENTITY metabolic_RE2 clearance_RE2 rate_RE2 by_RE2 NUM_RE2 %._RE2 
Trimetrexate|N|trimetrexate|trimetrexate|since_LE1 BIOENTITY be_BE12 metabolize_BE12 by_BE12 enzyme_BE12 system_BE12 drug_BE12 that_BE12 induce_BE12 or_BE12 inhibit_BE12 this_BE12 drug_BE12 metabolizing_BE12 enzyme_BE12 system_BE12 may_BE12 elicit_BE12 important_BE12 drugdrug_BE12 interaction_BE12 that_BE12 may_BE12 alter_BE12 BIOENTITY plasma_RE2 concentration_RE2 
Trimetrexate|N|trimetrexate|trimetrexate|since_LE1 BIOENTITY be_BE12 metabolize_BE12 by_BE12 enzyme_BE12 system_BE12 drug_BE12 that_BE12 induce_BE12 or_BE12 inhibit_BE12 this_BE12 drug_BE12 metabolizing_BE12 enzyme_BE12 system_BE12 may_BE12 elicit_BE12 important_BE12 drugdrug_BE12 interaction_BE12 that_BE12 may_BE12 alter_BE12 BIOENTITY plasma_RE2 concentration_RE2 
Trimetrexate|N|erythromycin|fluconazole|agent_LE1 that_LE1 may_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 in_LE1 aids_LE1 patient_LE1 for_LE1 other_LE1 indication_LE1 that_LE1 can_LE1 elicit_LE1 this_LE1 activity_LE1 include_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Trimetrexate|N|erythromycin|ketoconazole|agent_LE1 that_LE1 may_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 in_LE1 aids_LE1 patient_LE1 for_LE1 other_LE1 indication_LE1 that_LE1 can_LE1 elicit_LE1 this_LE1 activity_LE1 include_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Trimetrexate|N|erythromycin|rifabutin|agent_LE1 that_LE1 may_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 in_LE1 aids_LE1 patient_LE1 for_LE1 other_LE1 indication_LE1 that_LE1 can_LE1 elicit_LE1 this_LE1 activity_LE1 include_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Trimetrexate|N|erythromycin|rifampin|agent_LE1 that_LE1 may_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 in_LE1 aids_LE1 patient_LE1 for_LE1 other_LE1 indication_LE1 that_LE1 can_LE1 elicit_LE1 this_LE1 activity_LE1 include_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Trimetrexate|N|ketoconazole|fluconazole|agent_LE1 that_LE1 may_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 in_LE1 aids_LE1 patient_LE1 for_LE1 other_LE1 indication_LE1 that_LE1 can_LE1 elicit_LE1 this_LE1 activity_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Trimetrexate|N|ketoconazole|fluconazole|agent_LE1 that_LE1 may_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 in_LE1 aids_LE1 patient_LE1 for_LE1 other_LE1 indication_LE1 that_LE1 can_LE1 elicit_LE1 this_LE1 activity_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Trimetrexate|N|rifabutin|fluconazole|agent_LE1 that_LE1 may_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 in_LE1 aids_LE1 patient_LE1 for_LE1 other_LE1 indication_LE1 that_LE1 can_LE1 elicit_LE1 this_LE1 activity_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Trimetrexate|N|rifabutin|fluconazole|agent_LE1 that_LE1 may_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 in_LE1 aids_LE1 patient_LE1 for_LE1 other_LE1 indication_LE1 that_LE1 can_LE1 elicit_LE1 this_LE1 activity_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Trimetrexate|N|rifampin|fluconazole|agent_LE1 that_LE1 may_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 in_LE1 aids_LE1 patient_LE1 for_LE1 other_LE1 indication_LE1 that_LE1 can_LE1 elicit_LE1 this_LE1 activity_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Trimetrexate|N|rifampin|fluconazole|agent_LE1 that_LE1 may_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 in_LE1 aids_LE1 patient_LE1 for_LE1 other_LE1 indication_LE1 that_LE1 can_LE1 elicit_LE1 this_LE1 activity_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Trimetrexate|N|rifabutin|ketoconazole|agent_LE1 that_LE1 may_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 in_LE1 aids_LE1 patient_LE1 for_LE1 other_LE1 indication_LE1 that_LE1 can_LE1 elicit_LE1 this_LE1 activity_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Trimetrexate|N|rifabutin|ketoconazole|agent_LE1 that_LE1 may_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 in_LE1 aids_LE1 patient_LE1 for_LE1 other_LE1 indication_LE1 that_LE1 can_LE1 elicit_LE1 this_LE1 activity_LE1 include_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Trimetrexate|N|rifampin|ketoconazole|agent_LE1 that_LE1 may_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 in_LE1 aids_LE1 patient_LE1 for_LE1 other_LE1 indication_LE1 that_LE1 can_LE1 elicit_LE1 this_LE1 activity_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Trimetrexate|N|rifampin|ketoconazole|agent_LE1 that_LE1 may_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 in_LE1 aids_LE1 patient_LE1 for_LE1 other_LE1 indication_LE1 that_LE1 can_LE1 elicit_LE1 this_LE1 activity_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Trimetrexate|N|rifampin|rifabutin|agent_LE1 that_LE1 may_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 in_LE1 aids_LE1 patient_LE1 for_LE1 other_LE1 indication_LE1 that_LE1 can_LE1 elicit_LE1 this_LE1 activity_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Trimetrexate|N|rifampin|rifabutin|agent_LE1 that_LE1 may_LE1 be_LE1 coadminister_LE1 with_LE1 BIOGENERAL_LE1 in_LE1 aids_LE1 patient_LE1 for_LE1 other_LE1 indication_LE1 that_LE1 can_LE1 elicit_LE1 this_LE1 activity_LE1 include_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Trimetrexate|N|cimetidine|acetaminophen|in_LE1 vitro_LE1 perfusion_LE1 of_LE1 isolate_LE1 rat_LE1 liver_LE1 have_LE1 show_LE1 that_LE1 BIOENTITY cause_BE12 significant_BE12 reduction_BE12 in_BE12 BIOGENERAL_BE12 metabolism_BE12 and_BE12 that_BE12 BIOENTITY alter_RE2 the_RE2 relative_RE2 concentration_RE2 of_RE2 trimetrexate_RE2 metabolite_RE2 possible_RE2 by_RE2 compete_RE2 for_RE2 sulfate_RE2 metabolite_RE2 
Trimetrexate|N|trimetrexate|acetaminophen|in_LE1 vitro_LE1 perfusion_LE1 of_LE1 isolate_LE1 rat_LE1 liver_LE1 have_LE1 show_LE1 that_LE1 BIOGENERAL_LE1 cause_LE1 significant_LE1 reduction_LE1 in_LE1 BIOENTITY metabolism_BE12 and_BE12 that_BE12 BIOENTITY alter_RE2 the_RE2 relative_RE2 concentration_RE2 of_RE2 trimetrexate_RE2 metabolite_RE2 possible_RE2 by_RE2 compete_RE2 for_RE2 sulfate_RE2 metabolite_RE2 
Trimetrexate|N|ketoconazole|miconazole|Based_LE1 on_LE1 in_LE1 vitro_LE1 rat_LE1 liver_LE1 model_LE1 nitrogen_LE1 substitute_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY -RRB-_RE2 be_RE2 potent_RE2 noncompetitive_RE2 inhibitor_RE2 of_RE2 BIOGENERAL_RE2 metabolism_RE2 
Trimetrexate|N|imidazole drug|ketoconazole|Based_LE1 on_LE1 in_LE1 vitro_LE1 rat_LE1 liver_LE1 model_LE1 nitrogen_LE1 substitute_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 be_RE2 potent_RE2 noncompetitive_RE2 inhibitor_RE2 of_RE2 BIOGENERAL_RE2 metabolism_RE2 
Trimetrexate|N|clotrimazole|ketoconazole|Based_LE1 on_LE1 in_LE1 vitro_LE1 rat_LE1 liver_LE1 model_LE1 nitrogen_LE1 substitute_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 -RRB-_RE2 be_RE2 potent_RE2 noncompetitive_RE2 inhibitor_RE2 of_RE2 BIOGENERAL_RE2 metabolism_RE2 
Trimetrexate|N|imidazole drug|miconazole|Based_LE1 on_LE1 in_LE1 vitro_LE1 rat_LE1 liver_LE1 model_LE1 nitrogen_LE1 substitute_LE1 BIOENTITY -LRB-_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 be_RE2 potent_RE2 noncompetitive_RE2 inhibitor_RE2 of_RE2 BIOGENERAL_RE2 metabolism_RE2 
Trimetrexate|N|clotrimazole|miconazole|Based_LE1 on_LE1 in_LE1 vitro_LE1 rat_LE1 liver_LE1 model_LE1 nitrogen_LE1 substitute_LE1 BIOGENERAL_LE1 -LRB-_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY -RRB-_RE2 be_RE2 potent_RE2 noncompetitive_RE2 inhibitor_RE2 of_RE2 BIOGENERAL_RE2 metabolism_RE2 
Trimetrexate|N|imidazole drug|clotrimazole|Based_LE1 on_LE1 in_LE1 vitro_LE1 rat_LE1 liver_LE1 model_LE1 nitrogen_LE1 substitute_LE1 BIOENTITY -LRB-_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 -RRB-_RE2 be_RE2 potent_RE2 noncompetitive_RE2 inhibitor_RE2 of_RE2 BIOGENERAL_RE2 metabolism_RE2 
Triprolidine|N|sedative|tranquilliser|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Triprolidine|N|sedative|tranquilliser|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY 
Triprolidine|N|barbiturate|tranquilliser|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Triprolidine|N|barbiturate|tranquilliser|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Triprolidine|N|alcohol|tranquilliser|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Triprolidine|N|narcotic analgesic|tranquilliser|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Triprolidine|N|narcotic analgesic|tranquilliser|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY 
Triprolidine|N|hypnotic|tranquilliser|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Triprolidine|N|hypnotic|tranquilliser|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Triprolidine|N|central nervous system depressant|tranquilliser|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY 
Triprolidine|N|barbiturate|sedative|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Triprolidine|N|barbiturate|sedative|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Triprolidine|N|alcohol|sedative|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Triprolidine|N|narcotic analgesic|sedative|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Triprolidine|N|narcotic analgesic|sedative|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 
Triprolidine|N|hypnotic|sedative|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Triprolidine|N|hypnotic|sedative|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Triprolidine|N|central nervous system depressant|sedative|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 
Triprolidine|N|alcohol|barbiturate|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Triprolidine|N|barbiturate|narcotic analgesic|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Triprolidine|N|barbiturate|narcotic analgesic|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Triprolidine|N|barbiturate|hypnotic|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Triprolidine|N|barbiturate|hypnotic|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Triprolidine|N|central nervous system depressant|barbiturate|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Triprolidine|N|alcohol|narcotic analgesic|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Triprolidine|N|alcohol|hypnotic|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Triprolidine|N|central nervous system depressant|alcohol|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOENTITY including_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Triprolidine|N|hypnotic|narcotic analgesic|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Triprolidine|N|hypnotic|narcotic analgesic|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 including_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Triprolidine|N|central nervous system depressant|narcotic analgesic|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Triprolidine|N|central nervous system depressant|hypnotic|BIOGENERAL_LE1 may_LE1 enhance_LE1 the_LE1 sedative_LE1 effect_LE1 of_LE1 BIOENTITY including_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 
Triprolidine|N|anticholinergic drug|atropine|the_LE1 effect_LE1 of_LE1 BIOENTITY such_BE12 as_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 may_RE2 be_RE2 enhance_RE2 by_RE2 the_RE2 concomitant_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 
Triprolidine|N|anticholinergic drug|tricyclic antidepressant|the_LE1 effect_LE1 of_LE1 BIOENTITY such_BE12 as_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY may_RE2 be_RE2 enhance_RE2 by_RE2 the_RE2 concomitant_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 
Triprolidine|N|atropine|tricyclic antidepressant|the_LE1 effect_LE1 of_LE1 BIOGENERAL_LE1 such_LE1 as_LE1 BIOENTITY and_BE12 BIOENTITY may_RE2 be_RE2 enhance_RE2 by_RE2 the_RE2 concomitant_RE2 administration_RE2 of_RE2 BIOGENERAL_RE2 
Trospium|N|sanctura|vancomycin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOENTITY have_BE12 not_BE12 be_BE12 conduct_BE12 BIOGENERAL_BE12 have_BE12 the_BE12 potential_BE12 for_BE12 pharmacokinetic_BE12 interaction_BE12 with_BE12 other_BE12 drug_BE12 that_BE12 be_BE12 eliminate_BE12 by_BE12 active_BE12 tubular_BE12 secretion_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|sanctura|morphine|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOENTITY have_BE12 not_BE12 be_BE12 conduct_BE12 BIOGENERAL_BE12 have_BE12 the_BE12 potential_BE12 for_BE12 pharmacokinetic_BE12 interaction_BE12 with_BE12 other_BE12 drug_BE12 that_BE12 be_BE12 eliminate_BE12 by_BE12 active_BE12 tubular_BE12 secretion_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|sanctura|tenofovir|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOENTITY have_BE12 not_BE12 be_BE12 conduct_BE12 BIOGENERAL_BE12 have_BE12 the_BE12 potential_BE12 for_BE12 pharmacokinetic_BE12 interaction_BE12 with_BE12 other_BE12 drug_BE12 that_BE12 be_BE12 eliminate_BE12 by_BE12 active_BE12 tubular_BE12 secretion_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Trospium|N|sanctura|metformin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOENTITY have_BE12 not_BE12 be_BE12 conduct_BE12 BIOGENERAL_BE12 have_BE12 the_BE12 potential_BE12 for_BE12 pharmacokinetic_BE12 interaction_BE12 with_BE12 other_BE12 drug_BE12 that_BE12 be_BE12 eliminate_BE12 by_BE12 active_BE12 tubular_BE12 secretion_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|sanctura|digoxin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOENTITY have_BE12 not_BE12 be_BE12 conduct_BE12 BIOGENERAL_BE12 have_BE12 the_BE12 potential_BE12 for_BE12 pharmacokinetic_BE12 interaction_BE12 with_BE12 other_BE12 drug_BE12 that_BE12 be_BE12 eliminate_BE12 by_BE12 active_BE12 tubular_BE12 secretion_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|sanctura|sanctura|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOENTITY have_BE12 not_BE12 be_BE12 conduct_BE12 BIOENTITY have_RE2 the_RE2 potential_RE2 for_RE2 pharmacokinetic_RE2 interaction_RE2 with_RE2 other_RE2 drug_RE2 that_RE2 be_RE2 eliminate_RE2 by_RE2 active_RE2 tubular_RE2 secretion_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|sanctura|pancuronium|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOENTITY have_BE12 not_BE12 be_BE12 conduct_BE12 BIOGENERAL_BE12 have_BE12 the_BE12 potential_BE12 for_BE12 pharmacokinetic_BE12 interaction_BE12 with_BE12 other_BE12 drug_BE12 that_BE12 be_BE12 eliminate_BE12 by_BE12 active_BE12 tubular_BE12 secretion_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|sanctura|procainamide|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOENTITY have_BE12 not_BE12 be_BE12 conduct_BE12 BIOGENERAL_BE12 have_BE12 the_BE12 potential_BE12 for_BE12 pharmacokinetic_BE12 interaction_BE12 with_BE12 other_BE12 drug_BE12 that_BE12 be_BE12 eliminate_BE12 by_BE12 active_BE12 tubular_BE12 secretion_BE12 -LRB-_BE12 e.g._BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|morphine|vancomycin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|morphine|vancomycin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|vancomycin|tenofovir|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Trospium|N|vancomycin|tenofovir|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Trospium|N|vancomycin|metformin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|vancomycin|metformin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|digoxin|vancomycin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|pancuronium|vancomycin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|pancuronium|vancomycin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|procainamide|vancomycin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|procainamide|vancomycin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|morphine|tenofovir|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Trospium|N|morphine|tenofovir|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Trospium|N|morphine|metformin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|morphine|metformin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|digoxin|morphine|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|pancuronium|morphine|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|pancuronium|morphine|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|procainamide|morphine|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|procainamide|morphine|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|metformin|tenofovir|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY rrb._RE2 
Trospium|N|metformin|tenofovir|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY and_BE12 BIOENTITY rrb._RE2 
Trospium|N|digoxin|tenofovir|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Trospium|N|pancuronium|tenofovir|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Trospium|N|pancuronium|tenofovir|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Trospium|N|procainamide|tenofovir|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Trospium|N|procainamide|tenofovir|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 and_BE12 BIOENTITY rrb._RE2 
Trospium|N|digoxin|metformin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|pancuronium|metformin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|pancuronium|metformin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|procainamide|metformin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|procainamide|metformin|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|digoxin|pancuronium|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|digoxin|procainamide|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|procainamide|pancuronium|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|procainamide|pancuronium|drug_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 :_LE1 although_LE1 study_LE1 to_LE1 assess_LE1 drugdrug_LE1 interaction_LE1 with_LE1 BIOGENERAL_LE1 have_LE1 not_LE1 be_LE1 conduct_LE1 BIOGENERAL_LE1 have_LE1 the_LE1 potential_LE1 for_LE1 pharmacokinetic_LE1 interaction_LE1 with_LE1 other_LE1 drug_LE1 that_LE1 be_LE1 eliminate_LE1 by_LE1 active_LE1 tubular_LE1 secretion_LE1 -LRB-_LE1 e.g._LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 and_RE2 BIOGENERAL_RE2 rrb._RE2 
Trospium|N|sanctura|sanctura|coadministration_LE1 of_LE1 BIOENTITY with_BE12 drug_BE12 that_BE12 be_BE12 eliminate_BE12 by_BE12 active_BE12 renal_BE12 tubular_BE12 secretion_BE12 may_BE12 increase_BE12 the_BE12 serum_BE12 concentration_BE12 of_BE12 BIOENTITY and_RE2 the_RE2 coadministered_RE2 drug_RE2 due_RE2 to_RE2 competition_RE2 for_RE2 this_RE2 elimination_RE2 pathway_RE2 
Vancomycin|N|amphotericin b|aminoglycoside|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|amphotericin b|bacitracin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|amphotericin b|polymyxin b|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|amphotericin b|colistin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|amphotericin b|viomycin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|amphotericin b|cisplatin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|aminoglycoside|bacitracin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|aminoglycoside|polymyxin b|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|aminoglycoside|colistin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|aminoglycoside|viomycin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|aminoglycoside|cisplatin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|bacitracin|polymyxin b|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|bacitracin|polymyxin b|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|bacitracin|colistin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|bacitracin|colistin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|bacitracin|viomycin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|bacitracin|viomycin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|bacitracin|cisplatin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|bacitracin|cisplatin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|polymyxin b|colistin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|polymyxin b|colistin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY BIOGENERAL_RE2 or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|polymyxin b|viomycin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|polymyxin b|viomycin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOENTITY or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|polymyxin b|cisplatin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|polymyxin b|cisplatin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 BIOGENERAL_BE12 or_BE12 BIOENTITY when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|colistin|viomycin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|colistin|viomycin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOENTITY or_RE2 BIOGENERAL_RE2 when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|colistin|cisplatin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|colistin|cisplatin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY BIOGENERAL_BE12 or_BE12 BIOENTITY when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|viomycin|cisplatin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vancomycin|N|viomycin|cisplatin|concurrent_LE1 and_LE1 sequential_LE1 systemic_LE1 or_LE1 topical_LE1 use_LE1 of_LE1 other_LE1 potential_LE1 neurotoxic_LE1 and_LE1 nephrotoxic_LE1 drug_LE1 such_LE1 as_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOGENERAL_LE1 BIOENTITY or_BE12 BIOENTITY when_RE2 indicate_RE2 require_RE2 careful_RE2 monitoring_RE2 
Vigabatrin|N|phenytoin|phenytoin|In_LE1 NUM_LE1 drs_LE1 rimmer_LE1 and_LE1 richens_LE1 at_LE1 the_LE1 university_LE1 of_LE1 wales_LE1 report_LE1 that_LE1 administer_LE1 BIOGENERAL_LE1 with_LE1 BIOENTITY lower_BE12 the_BE12 serum_BE12 BIOENTITY concentration_RE2 in_RE2 patient_RE2 with_RE2 treatmentresistant_RE2 epilepsy_RE2 
Vigabatrin|N|vigabatrin|phenytoin|In_LE1 NUM_LE1 drs_LE1 rimmer_LE1 and_LE1 richens_LE1 at_LE1 the_LE1 university_LE1 of_LE1 wales_LE1 report_LE1 that_LE1 administer_LE1 BIOENTITY with_BE12 BIOGENERAL_BE12 lower_BE12 the_BE12 serum_BE12 BIOENTITY concentration_RE2 in_RE2 patient_RE2 with_RE2 treatmentresistant_RE2 epilepsy_RE2 
Vindesine|N|vindesine|vaccine|BIOENTITY can_BE12 interact_BE12 with_BE12 the_BE12 drug_BE12 of_BE12 the_BE12 following_BE12 category_BE12 :_BE12 blood_BE12 dyscrasia_BE12 :_BE12 can_BE12 cause_BE12 unpredictable_BE12 myelotoxicity_BE12 bone_BE12 marrow_BE12 depressant_BE12 :_BE12 can_BE12 cause_BE12 predictable_BE12 doserelated_BE12 myelotoxicity_BE12 radiation_BE12 therapy_BE12 :_BE12 may_BE12 cause_BE12 marrow_BE12 depression_BE12 neurotoxic_BE12 medication_BE12 :_BE12 can_BE12 cause_BE12 neurologic_BE12 toxicity_BE12 BIOGENERAL_BE12 :_BE12 can_BE12 increase_BE12 seizure_BE12 activity_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 potentiate_BE12 the_BE12 replication_BE12 of_BE12 the_BE12 BIOENTITY virus_RE2 may_RE2 increase_RE2 the_RE2 side_RE2 effect_RE2 of_RE2 the_RE2 vaccination_RE2 and_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 vaccine_RE2 BIOGENERAL_RE2 :_RE2 may_RE2 cause_RE2 shortness_RE2 of_RE2 breath_RE2 and_RE2 bronchospasm_RE2 BIOGENERAL_RE2 :_RE2 may_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 BIOGENERAL_RE2 
Vindesine|N|vindesine|vaccine|BIOENTITY can_BE12 interact_BE12 with_BE12 the_BE12 drug_BE12 of_BE12 the_BE12 following_BE12 category_BE12 :_BE12 blood_BE12 dyscrasia_BE12 :_BE12 can_BE12 cause_BE12 unpredictable_BE12 myelotoxicity_BE12 bone_BE12 marrow_BE12 depressant_BE12 :_BE12 can_BE12 cause_BE12 predictable_BE12 doserelated_BE12 myelotoxicity_BE12 radiation_BE12 therapy_BE12 :_BE12 may_BE12 cause_BE12 marrow_BE12 depression_BE12 neurotoxic_BE12 medication_BE12 :_BE12 can_BE12 cause_BE12 neurologic_BE12 toxicity_BE12 BIOGENERAL_BE12 :_BE12 can_BE12 increase_BE12 seizure_BE12 activity_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 potentiate_BE12 the_BE12 replication_BE12 of_BE12 the_BE12 BIOGENERAL_BE12 virus_BE12 may_BE12 increase_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 the_BE12 vaccination_BE12 and_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 vaccine_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 cause_BE12 shortness_BE12 of_BE12 breath_BE12 and_BE12 bronchospasm_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 BIOENTITY 
Vindesine|N|phenytoin|live virus vaccine|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOENTITY :_BE12 can_BE12 increase_BE12 seizure_BE12 activity_BE12 BIOENTITY :_RE2 may_RE2 potentiate_RE2 the_RE2 replication_RE2 of_RE2 the_RE2 BIOGENERAL_RE2 virus_RE2 may_RE2 increase_RE2 the_RE2 side_RE2 effect_RE2 of_RE2 the_RE2 vaccination_RE2 and_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 vaccine_RE2 BIOGENERAL_RE2 :_RE2 may_RE2 cause_RE2 shortness_RE2 of_RE2 breath_RE2 and_RE2 bronchospasm_RE2 BIOGENERAL_RE2 :_RE2 may_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 BIOGENERAL_RE2 
Vindesine|N|live virus vaccine|mitomycin-c|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOGENERAL_LE1 :_LE1 can_LE1 increase_LE1 seizure_LE1 activity_LE1 BIOENTITY :_BE12 may_BE12 potentiate_BE12 the_BE12 replication_BE12 of_BE12 the_BE12 BIOGENERAL_BE12 virus_BE12 may_BE12 increase_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 the_BE12 vaccination_BE12 and_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 vaccine_BE12 BIOENTITY :_RE2 may_RE2 cause_RE2 shortness_RE2 of_RE2 breath_RE2 and_RE2 bronchospasm_RE2 BIOGENERAL_RE2 :_RE2 may_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 BIOGENERAL_RE2 
Vindesine|N|live virus vaccine|vaccine|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOGENERAL_LE1 :_LE1 can_LE1 increase_LE1 seizure_LE1 activity_LE1 BIOENTITY :_BE12 may_BE12 potentiate_BE12 the_BE12 replication_BE12 of_BE12 the_BE12 BIOENTITY virus_RE2 may_RE2 increase_RE2 the_RE2 side_RE2 effect_RE2 of_RE2 the_RE2 vaccination_RE2 and_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 vaccine_RE2 BIOGENERAL_RE2 :_RE2 may_RE2 cause_RE2 shortness_RE2 of_RE2 breath_RE2 and_RE2 bronchospasm_RE2 BIOGENERAL_RE2 :_RE2 may_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 BIOGENERAL_RE2 
Vindesine|N|live virus vaccine|vaccine|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOGENERAL_LE1 :_LE1 can_LE1 increase_LE1 seizure_LE1 activity_LE1 BIOENTITY :_BE12 may_BE12 potentiate_BE12 the_BE12 replication_BE12 of_BE12 the_BE12 BIOGENERAL_BE12 virus_BE12 may_BE12 increase_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 the_BE12 vaccination_BE12 and_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 vaccine_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 cause_BE12 shortness_BE12 of_BE12 breath_BE12 and_BE12 bronchospasm_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 BIOENTITY 
Vindesine|N|live virus vaccine|killed virus vaccine|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOGENERAL_LE1 :_LE1 can_LE1 increase_LE1 seizure_LE1 activity_LE1 BIOENTITY :_BE12 may_BE12 potentiate_BE12 the_BE12 replication_BE12 of_BE12 the_BE12 BIOGENERAL_BE12 virus_BE12 may_BE12 increase_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 the_BE12 vaccination_BE12 and_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 vaccine_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 cause_BE12 shortness_BE12 of_BE12 breath_BE12 and_BE12 bronchospasm_BE12 BIOENTITY :_RE2 may_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 BIOGENERAL_RE2 
Vindesine|N|phenytoin|mitomycin-c|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOENTITY :_BE12 can_BE12 increase_BE12 seizure_BE12 activity_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 potentiate_BE12 the_BE12 replication_BE12 of_BE12 the_BE12 BIOGENERAL_BE12 virus_BE12 may_BE12 increase_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 the_BE12 vaccination_BE12 and_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 vaccine_BE12 BIOENTITY :_RE2 may_RE2 cause_RE2 shortness_RE2 of_RE2 breath_RE2 and_RE2 bronchospasm_RE2 BIOGENERAL_RE2 :_RE2 may_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 BIOGENERAL_RE2 
Vindesine|N|phenytoin|vaccine|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOENTITY :_BE12 can_BE12 increase_BE12 seizure_BE12 activity_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 potentiate_BE12 the_BE12 replication_BE12 of_BE12 the_BE12 BIOENTITY virus_RE2 may_RE2 increase_RE2 the_RE2 side_RE2 effect_RE2 of_RE2 the_RE2 vaccination_RE2 and_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 vaccine_RE2 BIOGENERAL_RE2 :_RE2 may_RE2 cause_RE2 shortness_RE2 of_RE2 breath_RE2 and_RE2 bronchospasm_RE2 BIOGENERAL_RE2 :_RE2 may_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 BIOGENERAL_RE2 
Vindesine|N|phenytoin|vaccine|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOENTITY :_BE12 can_BE12 increase_BE12 seizure_BE12 activity_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 potentiate_BE12 the_BE12 replication_BE12 of_BE12 the_BE12 BIOGENERAL_BE12 virus_BE12 may_BE12 increase_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 the_BE12 vaccination_BE12 and_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 vaccine_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 cause_BE12 shortness_BE12 of_BE12 breath_BE12 and_BE12 bronchospasm_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 BIOENTITY 
Vindesine|N|phenytoin|killed virus vaccine|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOENTITY :_BE12 can_BE12 increase_BE12 seizure_BE12 activity_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 potentiate_BE12 the_BE12 replication_BE12 of_BE12 the_BE12 BIOGENERAL_BE12 virus_BE12 may_BE12 increase_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 the_BE12 vaccination_BE12 and_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 vaccine_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 cause_BE12 shortness_BE12 of_BE12 breath_BE12 and_BE12 bronchospasm_BE12 BIOENTITY :_RE2 may_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 BIOGENERAL_RE2 
Vindesine|N|vaccine|mitomycin-c|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOGENERAL_LE1 :_LE1 can_LE1 increase_LE1 seizure_LE1 activity_LE1 BIOGENERAL_LE1 :_LE1 may_LE1 potentiate_LE1 the_LE1 replication_LE1 of_LE1 the_LE1 BIOENTITY virus_BE12 may_BE12 increase_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 the_BE12 vaccination_BE12 and_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 vaccine_BE12 BIOENTITY :_RE2 may_RE2 cause_RE2 shortness_RE2 of_RE2 breath_RE2 and_RE2 bronchospasm_RE2 BIOGENERAL_RE2 :_RE2 may_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 BIOGENERAL_RE2 
Vindesine|N|vaccine|mitomycin-c|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOGENERAL_LE1 :_LE1 can_LE1 increase_LE1 seizure_LE1 activity_LE1 BIOGENERAL_LE1 :_LE1 may_LE1 potentiate_LE1 the_LE1 replication_LE1 of_LE1 the_LE1 BIOENTITY virus_BE12 may_BE12 increase_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 the_BE12 vaccination_BE12 and_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 vaccine_BE12 BIOENTITY :_RE2 may_RE2 cause_RE2 shortness_RE2 of_RE2 breath_RE2 and_RE2 bronchospasm_RE2 BIOGENERAL_RE2 :_RE2 may_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 BIOGENERAL_RE2 
Vindesine|N|mitomycin-c|vaccine|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOGENERAL_LE1 :_LE1 can_LE1 increase_LE1 seizure_LE1 activity_LE1 BIOGENERAL_LE1 :_LE1 may_LE1 potentiate_LE1 the_LE1 replication_LE1 of_LE1 the_LE1 BIOGENERAL_LE1 virus_LE1 may_LE1 increase_LE1 the_LE1 side_LE1 effect_LE1 of_LE1 the_LE1 vaccination_LE1 and_LE1 decrease_LE1 patient_LE1 's_LE1 response_LE1 to_LE1 the_LE1 vaccine_LE1 BIOENTITY :_BE12 may_BE12 cause_BE12 shortness_BE12 of_BE12 breath_BE12 and_BE12 bronchospasm_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 BIOENTITY 
Vindesine|N|mitomycin-c|killed virus vaccine|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOGENERAL_LE1 :_LE1 can_LE1 increase_LE1 seizure_LE1 activity_LE1 BIOGENERAL_LE1 :_LE1 may_LE1 potentiate_LE1 the_LE1 replication_LE1 of_LE1 the_LE1 BIOGENERAL_LE1 virus_LE1 may_LE1 increase_LE1 the_LE1 side_LE1 effect_LE1 of_LE1 the_LE1 vaccination_LE1 and_LE1 decrease_LE1 patient_LE1 's_LE1 response_LE1 to_LE1 the_LE1 vaccine_LE1 BIOENTITY :_BE12 may_BE12 cause_BE12 shortness_BE12 of_BE12 breath_BE12 and_BE12 bronchospasm_BE12 BIOENTITY :_RE2 may_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 BIOGENERAL_RE2 
Vindesine|N|vaccine|vaccine|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOGENERAL_LE1 :_LE1 can_LE1 increase_LE1 seizure_LE1 activity_LE1 BIOGENERAL_LE1 :_LE1 may_LE1 potentiate_LE1 the_LE1 replication_LE1 of_LE1 the_LE1 BIOENTITY virus_BE12 may_BE12 increase_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 the_BE12 vaccination_BE12 and_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 vaccine_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 cause_BE12 shortness_BE12 of_BE12 breath_BE12 and_BE12 bronchospasm_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 BIOENTITY 
Vindesine|N|vaccine|killed virus vaccine|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOGENERAL_LE1 :_LE1 can_LE1 increase_LE1 seizure_LE1 activity_LE1 BIOGENERAL_LE1 :_LE1 may_LE1 potentiate_LE1 the_LE1 replication_LE1 of_LE1 the_LE1 BIOENTITY virus_BE12 may_BE12 increase_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 the_BE12 vaccination_BE12 and_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 vaccine_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 cause_BE12 shortness_BE12 of_BE12 breath_BE12 and_BE12 bronchospasm_BE12 BIOENTITY :_RE2 may_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 BIOGENERAL_RE2 
Vindesine|N|vaccine|killed virus vaccine|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOGENERAL_LE1 :_LE1 can_LE1 increase_LE1 seizure_LE1 activity_LE1 BIOGENERAL_LE1 :_LE1 may_LE1 potentiate_LE1 the_LE1 replication_LE1 of_LE1 the_LE1 BIOENTITY virus_BE12 may_BE12 increase_BE12 the_BE12 side_BE12 effect_BE12 of_BE12 the_BE12 vaccination_BE12 and_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 vaccine_BE12 BIOGENERAL_BE12 :_BE12 may_BE12 cause_BE12 shortness_BE12 of_BE12 breath_BE12 and_BE12 bronchospasm_BE12 BIOENTITY :_RE2 may_RE2 decrease_RE2 patient_RE2 's_RE2 response_RE2 to_RE2 the_RE2 BIOGENERAL_RE2 
Vindesine|N|killed virus vaccine|vaccine|BIOGENERAL_LE1 can_LE1 interact_LE1 with_LE1 the_LE1 drug_LE1 of_LE1 the_LE1 following_LE1 category_LE1 :_LE1 blood_LE1 dyscrasia_LE1 :_LE1 can_LE1 cause_LE1 unpredictable_LE1 myelotoxicity_LE1 bone_LE1 marrow_LE1 depressant_LE1 :_LE1 can_LE1 cause_LE1 predictable_LE1 doserelated_LE1 myelotoxicity_LE1 radiation_LE1 therapy_LE1 :_LE1 may_LE1 cause_LE1 marrow_LE1 depression_LE1 neurotoxic_LE1 medication_LE1 :_LE1 can_LE1 cause_LE1 neurologic_LE1 toxicity_LE1 BIOGENERAL_LE1 :_LE1 can_LE1 increase_LE1 seizure_LE1 activity_LE1 BIOGENERAL_LE1 :_LE1 may_LE1 potentiate_LE1 the_LE1 replication_LE1 of_LE1 the_LE1 BIOGENERAL_LE1 virus_LE1 may_LE1 increase_LE1 the_LE1 side_LE1 effect_LE1 of_LE1 the_LE1 vaccination_LE1 and_LE1 decrease_LE1 patient_LE1 's_LE1 response_LE1 to_LE1 the_LE1 vaccine_LE1 BIOGENERAL_LE1 :_LE1 may_LE1 cause_LE1 shortness_LE1 of_LE1 breath_LE1 and_LE1 bronchospasm_LE1 BIOENTITY :_BE12 may_BE12 decrease_BE12 patient_BE12 's_BE12 response_BE12 to_BE12 the_BE12 BIOENTITY 
Vorinostat|N|coumarin-derivative anticoagulant|zolinza|BIOENTITY :_BE12 prolongation_BE12 of_BE12 prothrombin_BE12 time_BE12 -LRB-_BE12 pt_BE12 -RRB-_BE12 and_BE12 international_BE12 normalize_BE12 ratio_BE12 -LRB-_BE12 inr_BE12 -RRB-_BE12 be_BE12 observe_BE12 in_BE12 patient_BE12 receive_BE12 BIOENTITY concomitant_RE2 with_RE2 BIOGENERAL_RE2 
Vorinostat|N|coumarin-derivative anticoagulant|coumarin-derivative anticoagulant|BIOENTITY :_BE12 prolongation_BE12 of_BE12 prothrombin_BE12 time_BE12 -LRB-_BE12 pt_BE12 -RRB-_BE12 and_BE12 international_BE12 normalize_BE12 ratio_BE12 -LRB-_BE12 inr_BE12 -RRB-_BE12 be_BE12 observe_BE12 in_BE12 patient_BE12 receive_BE12 BIOGENERAL_BE12 concomitant_BE12 with_BE12 BIOENTITY 
Vorinostat|N|hdac inhibitor|valproic acid|other_LE1 BIOGENERAL_LE1 severe_LE1 thrombocytopenia_LE1 and_LE1 gastrointestinal_LE1 bleeding_LE1 have_LE1 be_LE1 report_LE1 with_LE1 concomitant_LE1 use_LE1 of_LE1 BIOGENERAL_LE1 and_LE1 other_LE1 BIOENTITY -LRB-_BE12 e.g._BE12 BIOENTITY rrb._RE2 
Vorinostat|N|hdac inhibitor|hdac inhibitor|other_LE1 BIOENTITY severe_BE12 thrombocytopenia_BE12 and_BE12 gastrointestinal_BE12 bleeding_BE12 have_BE12 be_BE12 report_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOENTITY -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 rrb._RE2 
Vorinostat|N|hdac inhibitor|valproic acid|other_LE1 BIOENTITY severe_BE12 thrombocytopenia_BE12 and_BE12 gastrointestinal_BE12 bleeding_BE12 have_BE12 be_BE12 report_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 BIOGENERAL_BE12 and_BE12 other_BE12 BIOGENERAL_BE12 -LRB-_BE12 e.g._BE12 BIOENTITY rrb._RE2 
Vorinostat|N|hdac inhibitor|zolinza|other_LE1 BIOENTITY severe_BE12 thrombocytopenia_BE12 and_BE12 gastrointestinal_BE12 bleeding_BE12 have_BE12 be_BE12 report_BE12 with_BE12 concomitant_BE12 use_BE12 of_BE12 BIOENTITY and_RE2 other_RE2 BIOGENERAL_RE2 -LRB-_RE2 e.g._RE2 BIOGENERAL_RE2 rrb._RE2 
